<?xml version="1.0" encoding="utf-8"?>


<DOCUMENT xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dart3.xsd">

<DOCUMENT-NAME ACODE="11011">사업보고서</DOCUMENT-NAME>
<FORMULA-VERSION ADATE="20230220">5.0</FORMULA-VERSION>
<COMPANY-NAME AREGCIK="00210740">대화제약(주)</COMPANY-NAME>

<SUMMARY>
<EXTRACTION ACODE="LINK_FLAG" AFEATURE="BOTH">C</EXTRACTION>
<EXTRACTION ACODE="FIN_TYPE" AFEATURE="BOTH">A</EXTRACTION>
<EXTRACTION ACODE="CRP_RGS_NO_TEMP" AFEATURE="BOTH">211111-0001529</EXTRACTION>
</SUMMARY>


<BODY>

<COVER>
<P></P>
<COVER-TITLE ATOC="Y" AASSOCNOTE="COVER">사 업 보 고 서</COVER-TITLE>
<P></P>
<P USERMARK="F-16">                                    (제 39 기)</P>

<TABLE-GROUP ACLASS="COVER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="209"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="211"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD CLASS="NORMAL" ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="218" HEIGHT="60" AUPDATECONT="N">사업연도</TD>
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODFROM" AUNITVALUE="20220101">2022년 01월 01일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 부터</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TU CLASS="NORMAL" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30" AUNIT="PERIODTO" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD CLASS="NORMAL" VALIGN="MIDDLE" WIDTH="220" HEIGHT="30" AUPDATECONT="N"> 까지</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">금융위원회</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">한국거래소 귀중</TD>
<TD WIDTH="400" HEIGHT="30" ALIGN="RIGHT">2023년      3월     15일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="PB_VAL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">제출대상법인 유형 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_TYPE" AUNITVALUE="1">주권상장법인</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" HEIGHT="30" AUPDATECONT="N">면제사유발생 :</TD>
<TU WIDTH="400" HEIGHT="30" AUNIT="PB_CAMNT" AUNITVALUE="-">해당사항 없음</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE AFIXTABLE="N" BORDER="0" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">회      사      명 :</TD>
<TD WIDTH="400" HEIGHT="30">대화제약(주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">대   표    이   사 :</TD>
<TD WIDTH="400" HEIGHT="30">노병태, 김은석</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">본  점  소  재  지 :</TD>
<TD WIDTH="400" HEIGHT="30">강원도 횡성군 횡성읍 한우로 495</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화) 02-586-6451</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(홈페이지) http://www.dhpharm.co.kr</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">작  성  책  임  자 :</TD>
<TD WIDTH="400" HEIGHT="30">(직  책) 경영지원본부장    (성  명) 이상태</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30">(전  화) 02-586-6451</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"></TD>
<TD WIDTH="400" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</COVER>

<TITLE ATOC="N">목     차</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" WIDTH="625" BORDER="0">

<COLGROUP>
<COL WIDTH="368"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="37"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">【 대표이사 등의 확인 】</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">I. 회사의 개요</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">2</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   1. 회사의 개요</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">2</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   2. 회사의 연혁</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   3. 자본금 변동사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">6</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   4. 주식의 총수 등</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">7</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   5. 정관에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">9</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">II. 사업의 내용</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">11</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   1. 사업의 개요</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">11</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   2. 주요 제품 및 서비스</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">13</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   3. 원재료 및 생산설비</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">15</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   4. 매출 및 수주상황</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">23</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   5. 위험관리 및 파생거래</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">26</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   6. 주요계약 및 연구개발활동</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">32</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   7. 기타 참고사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">70</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">III. 재무에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">88</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   1. 요약재무정보</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">88</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   2. 연결재무제표</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">91</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   3. 연결재무제표 주석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   4. 재무제표</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">175</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   5. 재무제표 주석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">183</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   6. 배당에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">257</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   7. 증권의 발행을 통한 자금조달에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">259</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">      7-1. 증권의 발행을 통한 자금조달 실적</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">259</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">      7-2. 증권의 발행을 통해 조달된 자금의 사용실적</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">263</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   8. 기타 재무에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">264</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">IV. 이사의 경영진단 및 분석의견</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">278</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">V. 회계감사인의 감사의견 등</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">303</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   1. 외부감사에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">303</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   2. 내부통제에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">310</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">VI. 이사회 등 회사의 기관에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">311</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   1. 이사회에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">311</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   2. 감사제도에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">317</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   3. 주주총회 등에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">320</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">VII. 주주에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">323</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">VIII. 임원 및 직원 등에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">326</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   1. 임원 및 직원 등의 현황</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">326</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   2. 임원의 보수 등</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">332</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">IX. 계열회사 등에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">335</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">X. 대주주 등과의 거래내용</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">337</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">339</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   1. 공시내용 진행 및 변경사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">339</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   2. 우발부채 등에 관한 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">342</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   3. 제재 등과 관련된 사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">344</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   4. 작성기준일 이후 발생한 주요사항 등 기타사항</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">344</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">XII. 상세표</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">346</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   1. 연결대상 종속회사 현황(상세)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">346</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   2. 계열회사 현황(상세)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">347</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   3. 타법인출자 현황(상세)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">348</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   4. 매출실적 현황(상세)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">349</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   5. 특허권 현황(상세)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">351</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">【 전문가의 확인 】</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">354</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   1. 전문가의 확인</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">354</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="377" HEIGHT="30">   2. 전문가와의 이해관계</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="202" HEIGHT="30">-----------------------</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="46" HEIGHT="30">354</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>


<SECTION-1 AID="CEO-CERT" ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_CEO_CERT">【 대표이사 등의 확인 】</TITLE>

<IMAGE>
<IMG WIDTH="546" HEIGHT="772" ALIGN="CENTER" HSPACE="0">대표이사 등의 확인.jpg</IMG>
<IMG-CAPTION ATOC="N">대표이사 등의 확인</IMG-CAPTION>
</IMAGE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">I. 회사의 개요</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-1-0">1. 회사의 개요</TITLE>

<P>
<SPAN USERMARK="F-GL B">가. 회사의 법적, 상업적 명칭</SPAN>
<SPAN USERMARK="F-GL11">당사의 명칭은 '대화제약주식회사'라고 표기합니다. 또한 영문으로는 DAEHWA PHARM. CO.,LTD.라 표기합니다. 단, 약식으로 표기할 경우에는 대화제약(주), DHP라고 표기합니다.</SPAN>
<SPAN USERMARK="F-GL B">나. 설립일자 및 존속기간</SPAN>
<SPAN USERMARK="F-GL11">1984년 1월 19일에 의약품 및 의약부외품 외 제조 및 판매업을 주 영업 목적으로 설립되었으며, 2003년 2월 12일에 코스닥시장 상장을 승인받아 회사의 발행주식이 2003년 2월 14일 자로 한국증권선물거래소가 개설하는 코스닥증권시장에 상장되어 매매가 개시된 주권상장법인입니다.</SPAN>
<SPAN USERMARK="F-GL B">다. 본점의 주소, 전화번호 및 홈페이지</SPAN>
<SPAN USERMARK="F-GL11">주      소 : 강원도 횡성군 횡성읍 한우로 495전      화 : 033)342-5140홈페이지 : http://www.dhpharm.co.kr</SPAN>
<SPAN USERMARK="F-GL B">라. 연결대상 종속회사 현황(요약)</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_CMPN_SMR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="592"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="601" HEIGHT="30" AUPDATECONT="N">(단위 : 사)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="1">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="101" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">구분</TH>
<TH WIDTH="400" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="4" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">연결대상회사수</TH>
<TH WIDTH="100" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">주요종속회사수</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="100" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">기초</TH>
<TH WIDTH="100" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">증가</TH>
<TH WIDTH="100" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">감소</TH>
<TH WIDTH="100" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="101" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">상장</TD>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="LST_BASE">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="LST_INC">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="LST_DEC">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="LST_FIN">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="LST_MSUB">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="101" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비상장</TD>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ULST_BASE">5</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ULST_INC">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ULST_DEC">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ULST_FIN">5</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ULST_MSUB">1</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="101" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">합계</TD>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BASE_SUM">5</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="INC_SUM">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="DEC_SUM">-</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="FIN_SUM">5</TE>
<TE WIDTH="100" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="MSUB_SUM">1</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="593"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="602" HEIGHT="30" AUPDATECONT="N">
<A REFNO="XII. 상세표|NEF-001|ADX-001">※상세 현황은 '상세표-1. 연결대상 종속회사 현황(상세)' 참조</A>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK="F-GL B">마. 연결대상회사의 변동내용</P>

<TABLE-GROUP ACLASS="CONT_CHG" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="66"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="335"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="75" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">자회사</TH>
<TH WIDTH="344" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사 유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">신규연결</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_CPY">-</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_RES">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_CPY">-</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NEW_RES">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="75" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">연결제외</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_CPY">-</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_RES">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_CPY">-</TE>
<TE WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="EXP_RES">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL B">바. 중소기업 등 해당 여부</SPAN>
</P>

<TABLE-GROUP ACLASS="SM_VEN_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="31"></COL>
<COL WIDTH="251"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" COLSPAN="2">중소기업 해당 여부</TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" AUNIT="SML_YN" AUNITVALUE="N">미해당</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="40" HEIGHT="30" AUPDATECONT="N"></TD>
<TD WIDTH="260" HEIGHT="30" AUPDATECONT="N">벤처기업 해당 여부</TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" AUNIT="VEN_YN" AUNITVALUE="N">미해당</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" COLSPAN="2">중견기업 해당 여부</TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" AUNIT="MID_YN" AUNITVALUE="Y">해당</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>

<P>
<SPAN USERMARK="F-GL B">사. 주요사업의 내용</SPAN>
<SPAN USERMARK="F-GL11">대화제약은 의약품 제조 사업을 목적으로 1984년 설립되어 2003년 코스닥시장에 상장되었으며 보건복지부가 인증한 혁신형제약기업 입니다. GMP 인증을 획득한 제1,2,3공장을 보유하고 있습니다. </SPAN>
<SPAN USERMARK="F-GL11">사업부문은 의약품제조업부문, 의약품도매업부문, 의료정보시스템부문, 의약품원료 제조판매부문, 화장품의료기기 제조판매부문으로 국내 3개사, 해외(독일) 2개사, 총 5개의 종속회사를 보유하고 있습니다.  </SPAN>
<SPAN USERMARK="F-GL11">주요제품으로 감염질환치료제인 세파메칠정, 소화기 기관 치료제인 후로스판 정, 국내 OEM 시장의 65%를 추정 점유하고있는 카타플라스마, 플라스마 등 패치제제가 있으며, 미용의료기기인아말리안 필러 등이 있습니다. 주요거래 처는 병,의원, 제약회사입니다. 당기 카타플라스마 등 패치제제의 OEM 매출액은 의약품제조판매부분 매출액의 23.8%를차지하고 있습니다. </SPAN>
<SPAN USERMARK="F-GL11">중앙연구소, 판교연구소, 리독스바이오 연구소, 다수의 대학 및 연구소와의 체계적인 R&D네트워크 구성을 통해 다양한 연구 및 개발에 투자하고 다수의 국책과제를 수행해 왔습니다. </SPAN>
<SPAN USERMARK="F-GL11 U">☞ 사업 부분별 자세한 사항은 Ⅱ. 사업의 내용을 참조하시기 바랍니다</SPAN>
<SPAN USERMARK="F-GL B">사. 신용평가에 관한 사항</SPAN>
<SPAN USERMARK="F-GL11">당사의 신용평가에 관하여는 가장 최근인 2020년 11월 30일 기준으로 한국기업데이터 주식회사로부터 평가 받은 당사의 신용등급은 A- 입니다.</SPAN>
</P>
<P USERMARK="F-GL B">아. 회사의 주권상장(또는 등록ㆍ지정)여부 및 특례상장에 관한 사항</P>

<TABLE-GROUP ACLASS="SPC_CRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="165"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장(또는 등록ㆍ지정)여부</TH>
<TH WIDTH="174" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주권상장(또는 등록ㆍ지정)일자</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등여부</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">특례상장 등적용법규</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_CHK">코스닥시장사장</TE>
<TU WIDTH="174" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUNIT="SPC_DATE" AUNITVALUE="20030214">2003년 02월 14일</TU>
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_CHP">부</TE>
<TE WIDTH="141" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SPC_LAW">해당사항 없음</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-2-0">2. 회사의 연혁</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">가. 연혁</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">공시대상기간중 회사의 최대주주 변동은 없으며 주된 변동내용은 아래와 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1035">

<COLGROUP>
<COL WIDTH="184"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="701"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="193" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">일     자</TH>
<TH WIDTH="710" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내                          역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="810" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="27">대화제약(주)</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017년 04월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 서울사무소 이전(서초구 남부순환로 2145)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017년 09월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 리포락셀액(Liporaxel®), 중국 RMX Biopharma,Co.,Ltd와 기술이전 계약 체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017년 09월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 식품의약품안전처 리포락셀액(Liporaxel®) 유방암 2&3상 임상 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017년 09월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 독일, S & V Technologies GmbH, BSC Medical Devices GmbH 인수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017년 09월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 미국 FDA, 리포락셀액(Liporaxel®) 유방암 2상 임상시험계획(IND) 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017년 12월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 리포락셀액(Liporaxel®), 국내 유방암   2&3상 임상시험 개시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018년 02월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 리포락셀액(Liporaxel®), 대한민국 신약개발상 우수상</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018년 06월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 혁신형 제약기업 재인증(2018.06.20~2021.06.19)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018년 07월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 리포락셀액(Liporaxel®), 위암 임상3상을 중국 식품의약품감독관리총국(CFDA)으로부터 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019년 02월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 천연물 치매치료제(DHP1401) 국내 임상 2상 종료  </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019년 03월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 제1회 무기명식 이권부 무보증 사모 전환사채 200억원 발행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019년 06월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 제13회 국가지속가능경영 대상 시상식, 기업윤리 부문 공정거래위원회 위원장 상 수상</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019년 06월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 중국내 JHK Biopharma 조인트 벤처 설립 협약서 체결</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019년 08월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 부패방지경영시스템 'ISO37001' 인증 취득</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019년 08월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 자기주식 취득 결정(예상 취득 수량 360천주, 취득 예정금액 3,942,000,000원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019년 11월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> (주)씨트리 주식 매각 완료(보유지분 1,452,598주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019년 12월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 자기주식 취득 결정(취득 예정 수량 257천주, 취득 예정금액 3,019,750,000원)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020년 09월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 전환사채 전환권 행사로 발생주식 총수 변경(297,134주 증가, 발행주식 총수 18,522,108주) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020년 09월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 전환사채 전환권 행사로 발생주식 총수 변경(47,271주 증가, 발행주식 총수 18,569,379주) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020년 09월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 제4공장 신설 투자협약 체결(강원도, 횡성군) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020년 10월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 리포락셀액(Liporaxel®) 동유럽 3개국(세르비아, 불가리아, 헝가리) 유방암 3상 임상시험계획(IND) 승인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020년 11월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 리포락셀액(Liporaxel®) 체코, 유방암 2상 임상시험계획(IND) 승인 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021년 01월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 전환사채 전환권 행사로 발생주식 총수 변경(47,271주 증가, 발행주식 총수 18,616,650주) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021년 02월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 제2공장 B동 기공식 개최</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022년 07월</TD>

<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE">
<P> 준법경영시스템(ISO 37301)ㆍ부패방지경영시스템(ISO 37001) 통합인증</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022년 10월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 제2공장 B동 준공식 개최</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022년 12월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 안전보건경영시스템(ISO 45001) 인증</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="210" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="7">(주)리독스바이오</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017년 06월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 독일, S & V Technologies GmbH  BSC Medical Devices GmbH 인수 계약</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017년 09월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 독일, S & V Technologies GmbH, BSC Medical Devices GmbH 인수</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018년 08월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> GMP API(합성)공장 증축공사 계약 및 착공</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019년 05월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> GMP API(합성)공장 건축물 사용승인 및 준공</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2019년 06월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 금융투자협회 K-OCT시장 신규지정, 27일 거래시작</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020년 03월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 관리동 증축공사 계약 및 착공</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020년 08월</TD>
<TD WIDTH="710" HEIGHT="30" VALIGN="MIDDLE"> 관리동 준공</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">나. 본점소재지의 변동</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="729" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="126"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="448"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="135" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구    분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변동일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="457" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주    소</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="135" HEIGHT="30">대화제약(주)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30">2004년 02월 10일</TD>
<TD VALIGN="MIDDLE" WIDTH="457" HEIGHT="30">강원도 횡성군 횡성읍 한우로 495(마산리 308)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" VALIGN="MIDDLE" WIDTH="135" HEIGHT="90">디에이치호림(주)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30">2010년 06월 30일</TD>
<TD WIDTH="457" HEIGHT="30">서울시 서초구 방배동 944-2</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30">2011년 05월 14일</TD>
<TD WIDTH="457" HEIGHT="30">서울시 서초구 서초대로 56(방배동 944-1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30">2017년 06월 26일</TD>
<TD WIDTH="457" HEIGHT="30">서울시 서초구 남부순환로 2145</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="135" HEIGHT="60">(주)리독스바이오</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30">2011년 08월 29일</TD>
<TD WIDTH="457" HEIGHT="30">서울특별시 금천구 가산동 233-5 한국세라믹기술원 벤처관 303호</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30">2013년 09월 04일</TD>
<TD WIDTH="457" HEIGHT="30">경기도 화성시 향남읍 제약공단3길 83</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">다. 경영진의 중요한 변동</SPAN>
</P>

<LIBRARY>
<P></P>

<TABLE-GROUP ACLASS="MNG_IMP_CHG" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="687" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">변동일자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주총종류</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="272" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선임</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">임기만료또는 해임</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">신규</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재선임</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="53" AUNIT="CHG_DT" AUNITVALUE="20180323">2018년 03월 23일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" AUNIT="GM_TYPE" AUNITVALUE="1">정기주총</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="53" ACODE="NAPP_NM">사외이사 정혜선</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="53" ACODE="RAPP_NM">사내이사 양재권</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="53" ACODE="DISM_NM">사내이사 이상태(임기만료)시외이사 이준보(중도퇴임)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="119" AUNIT="CHG_DT" AUNITVALUE="20200324">2020년 03월 24일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="119" AUNIT="GM_TYPE" AUNITVALUE="1">정기주총</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="119" ACODE="NAPP_NM">
<P USERMARK="F-GL">사내이사 이상태</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="119" ACODE="RAPP_NM">
<P USERMARK="F-GL">사내이사 노병태</P>
<P USERMARK="F-GL">사내이사 김은석</P>
<P USERMARK="F-GL">사외이사 김종일</P>
<P USERMARK="F-GL">상근감사 강효원</P>
</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="119" ACODE="DISM_NM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="63" AUNIT="CHG_DT" AUNITVALUE="20200324">2020년 03월 24일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="63" AUNIT="GM_TYPE" AUNITVALUE="-">-</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="63" ACODE="NAPP_NM">
<P USERMARK="F-GL"> -</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="63" ACODE="RAPP_NM">
<P USERMARK="F-GL">대표이사 노병태</P>
<P USERMARK="F-GL">대표이사 김은석</P>
</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="63" ACODE="DISM_NM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="63" AUNIT="CHG_DT" AUNITVALUE="20210325">2021년 03월 25일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="63" AUNIT="GM_TYPE" AUNITVALUE="1">정기주총</TU>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="63" ACODE="NAPP_NM">
<P USERMARK="F-GL">-</P>
</TE>

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="63" ACODE="RAPP_NM">
<P USERMARK="F-GL">사내이사 양재권</P>
<P USERMARK="F-GL">사외이사 정혜선</P>
</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="63" ACODE="DISM_NM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>


<P>
<SPAN USERMARK="F-GL10">※대표이사는 2020년 03월 24일 개최한 이사회에서 선임하였습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">라. 상호의 변경</SPAN>
<SPAN USERMARK="F-GL11">[종속회사의 내용 - 디에이치호림(주)]</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구    분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변경일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변경전</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변경후</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="30">디에이치호림(주)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">2010년 06월 23일</TD>
<TD WIDTH="150" HEIGHT="30">데아체파르마(주)</TD>
<TD WIDTH="150" HEIGHT="30">디에이치호림(주)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="30">(주)리독스바이오</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">2011년 10월 25일</TD>
<TD WIDTH="150" HEIGHT="30">(주)와이언트</TD>
<TD WIDTH="150" HEIGHT="30">(주)리독스바이오</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-3-0">3. 자본금 변동사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11">당사는 2019년 3월 29일 제1회 무기명식 이권부 무보증 사모 전환사채 200억원을 발행하였습니다. 2020년도 중 51억원이 전환청구되어 보통주 344,405주를 발행하였으며 자본금 172,202,500원이 증가되었습니다. 2021년도 중 7억원이 전환청구되어 보통주 47,271주를 발행하였으며 자본금 23,635,500원이 증가하였습니다.</SPAN>
</P>
<P></P>

<P>
<SPAN USERMARK="F-DU B">가. 자본금 변동추이</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="840" BORDER="0">

<COLGROUP>
<COL WIDTH="301"></COL>
<COL WIDTH="521"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="310" HEIGHT="30"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="530" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="840" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">39기(2022년말)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">38기(2021년말)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">37기(2020년말)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">36기(2019년말)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">35기(2018년말)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="90">보통주</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">발행주식총수</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">18,616,650</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">18,616,650</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">18,569,379</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">18,224,974</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">18,224,974</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">액면금액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">500</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">500</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">500</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">500</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">자본금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">9,308,325,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">9,308,325,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">9,284,689,500</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">9,112,487,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">9,112,487,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="90">우선주</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">발행주식총수</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">액면금액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">자본금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="90">기타</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">발행주식총수</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">액면금액</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">자본금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">합계</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">자본금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">9,308,325,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">9,308,325,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">9,284,689,500</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">9,112,487,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="120" HEIGHT="30">9,112,487,000</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-4-0">4. 주식의 총수 등</TITLE>
<P></P>
<P USERMARK="F-GL B">가. 주식의 총수 현황</P>

<TABLE-GROUP ACLASS="TOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="663" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="316"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20231231">2023년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="325" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="665" BORDER="1">

<COLGROUP>
<COL WIDTH="25"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="95"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="247" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구  분</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="314" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="N" ACODE="STK_KND_TOT" ADELETECOL="N" AMOVECOL="N">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ACODE="STK_KND_TOT" ADELETECOL="Y" AMOVECOL="N">-</TE>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅰ. 발행할 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">60,000,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK1">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK1">60,000,000</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅱ. 현재까지 발행한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">18,616,650</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK2">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK2">18,616,650</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅲ. 현재까지 감소한 주식의 총수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TOT_RST">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RST">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="34" HEIGHT="120" AUPDATECONT="N"></TD>
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 1. 감자</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RDC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RDC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 2. 이익소각</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="DST_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_DST_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 3. 상환주식의 상환</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="RFD_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_RFD_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE5">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" AUPDATECONT="N"> 4. 기타</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ETC_CNT">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ETC_CNT">-</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE6">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅳ. 발행주식의 총수 (Ⅱ-Ⅲ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">18,616,650</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="ISU_STK3">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_ISU_STK3">18,616,650</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE7">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅴ. 자기주식수</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">1,100,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="TRS_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_TRS_STK">1,100,000</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE8">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="247" HEIGHT="30" AUPDATECONT="N"> Ⅵ. 유통주식수 (Ⅳ-Ⅴ)</TD>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">17,516,650</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="105" HEIGHT="30" ACODE="FLT_STK">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ACODE="SUM_FLT_STK">17,516,650</TE>
<TE VALIGN="MIDDLE" WIDTH="104" HEIGHT="30" ALIGN="CENTER" ACODE="NOTE9">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL10">2019년 3월 29일 발행한 전환사채 200억원 중 총 금액 58억원이 전환청구되어 297,134주 2020.09.16 상장,  47,271주 2020.10.13 상장, 47,271주 2021.01.26 상장 되었으며 제출일현재 전환사채 잔액은 없습니다. </SPAN>
<SPAN USERMARK="F-GL B">나.자기주식 취득 및 처분 현황</SPAN>
</P>

<LIBRARY>
<P></P>

<TABLE-GROUP ACLASS="OWN_SHR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="792" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="403"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20231231">2023년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="148" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="412" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="792" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="274" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2" COLSPAN="3">취득방법</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">기초수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="204" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">변동 수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">기말수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취득(+)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">처분(-)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소각(-)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="14" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="420" AUPDATECONT="N">배당가능이익범위이내취득</TD>
<TD ROWSPAN="8" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="240" AUPDATECONT="N">직접취득</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">장내 직접 취득</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="AJ_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AJ_STK_BGN">1,100,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AJ_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AJ_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AJ_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AJ_STK_END">1,100,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="AJ_STK_KND">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AJ_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AJ_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AJ_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AJ_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AJ_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">장외직접 취득</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="AO_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AO_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AO_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AO_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AO_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AO_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE9">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="AO_STK_KND">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AO_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AO_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AO_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AO_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AO_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE9">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">공개매수</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="AK_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AK_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AK_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AK_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AK_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AK_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE1">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="AK_STK_KND">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AK_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AK_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AK_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="AK_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="AK_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">소계(a)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="ASUM_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="ASUM_STK_BGN">1,100,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ASUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ASUM_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ASUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="ASUM_STK_END">1,100,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE3">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="ASUM_STK_KND">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="ASUM_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ASUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ASUM_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ASUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="ASUM_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="180" AUPDATECONT="N">신탁계약에 의한취득</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">수탁자 보유물량</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="BS_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BS_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BS_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BS_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BS_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BS_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE4">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="BS_STK_KND">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BS_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BS_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BS_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BS_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BS_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">현물보유물량</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="BH_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BH_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BH_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BH_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BH_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BH_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="BH_STK_KND">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BH_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BH_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BH_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BH_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BH_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE5">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="128" HEIGHT="60" AUPDATECONT="N" ROWSPAN="2">소계(b)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="BSUM_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BSUM_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BSUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BSUM_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BSUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BSUM_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE6">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="BSUM_STK_KND">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BSUM_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BSUM_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BSUM_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="BSUM_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="BSUM_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE6">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="274" HEIGHT="60" AUPDATECONT="N" COLSPAN="3">기타 취득(c)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="ETC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="ETC_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ETC_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ETC_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ETC_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="ETC_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE7">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="ETC_STK_KND">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="ETC_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ETC_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ETC_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="ETC_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="ETC_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE7">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="274" HEIGHT="60" AUPDATECONT="N" COLSPAN="3">총 계(a+b+c)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="TOT_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="TOT_STK_BGN">1,100,000</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="TOT_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="TOT_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="TOT_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="TOT_STK_END">1,100,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE8">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACODE="TOT_STK_KND">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="TOT_STK_BGN">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="TOT_STK_ACQ">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="TOT_STK_TRD">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACODE="TOT_STK_RTM">-</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACODE="TOT_STK_END">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="OWN_NOTE8">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL10">※ 자본시장과 금융투자업에 관한법률 제165조 3의 규정에 따라 총 1,100,000주의 자기주식을 직접 취득하여 당기말 현재 1,100,000주를 보유하고 있습니다.</SPAN>
</P>
</LIBRARY>


<P>
<SPAN USERMARK="F-GL B">다. 자기주식 직접 취득ㆍ처분 이행현황</SPAN>
</P>

<LIBRARY>
<P></P>

<TABLE-GROUP ACLASS="OWN_SHR_JCC" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="714" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="403"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20231231">2023년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="72" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="412" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE AFIXTABLE="N" ACLASS="EXTRACTION" WIDTH="713" BORDER="1">

<COLGROUP>
<COL WIDTH="74"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="83" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구 분</TH>
<TH WIDTH="274" HEIGHT="30" COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취득(처분)예상기간</TH>
<TH WIDTH="78" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">예정수량(A)</TH>
<TH WIDTH="78" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">이행수량(B)</TH>
<TH WIDTH="63" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">이행률(B/A)</TH>
<TH WIDTH="137" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">결과보고일</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시작일</TH>
<TH WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">종료일</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="N">
<TU WIDTH="83" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUNIT="JCC_GB" AUNITVALUE="1">직접 취득</TU>
<TU WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUNIT="JCC_CS_DT" AUNITVALUE="20190807">2019년 08월 07일</TU>
<TU WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUNIT="JCC_CE_DT" AUNITVALUE="20191106">2019년 11월 06일</TU>
<TE WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" ACODE="JCC_AMTA">360,000</TE>
<TE WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" ACODE="JCC_AMTB">302,373</TE>
<TE WIDTH="63" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" ACODE="JCC_BA_RT">84</TE>
<TU WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUNIT="JCC_RS_DT" AUNITVALUE="20191107">2019년 11월 07일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU WIDTH="83" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUNIT="JCC_GB" AUNITVALUE="1">직접 취득</TU>
<TU WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUNIT="JCC_CS_DT" AUNITVALUE="20191210">2019년 12월 10일</TU>
<TU WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUNIT="JCC_CE_DT" AUNITVALUE="20200309">2020년 03월 09일</TU>
<TE WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" ACODE="JCC_AMTA">257,000</TE>
<TE WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" ACODE="JCC_AMTB">257,000</TE>
<TE WIDTH="63" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT" ACODE="JCC_BA_RT">100</TE>
<TU WIDTH="137" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" AUNIT="JCC_RS_DT" AUNITVALUE="20200107">2020년 01월 07일</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>


<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-1-5-0">5. 정관에 관한 사항</TITLE>

<P>
<SPAN USERMARK="F-GL B">가. 정관의 최근 개정일</SPAN>
<SPAN USERMARK="F-GL11">정관의 최근 개정일은 당사의 제36기 정기주주총회일인 2020년 3월 24일 입니다.</SPAN>
<SPAN USERMARK="F-GL B">나. 정관 변경 이력</SPAN>
</P>

<LIBRARY>
<P>정관 변경 이력</P>

<TABLE-GROUP ACLASS="ART_BCK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1299" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="641"></COL>
<COL WIDTH="344"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">정관변경일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="159" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해당주총명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="650" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요변경사항</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="353" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">변경이유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="ART_DATE" AUNITVALUE="20200324" VALIGN="MIDDLE">2020년 03월 24일</TU>
<TE ALIGN="CENTER" WIDTH="159" HEIGHT="99" ACODE="ART_NAME" VALIGN="MIDDLE">제36기 정기주주총회</TE>
<TE ALIGN="CENTER" WIDTH="650" HEIGHT="99" ACODE="ART_CHN" VALIGN="MIDDLE">1. 제2조(목적)    ① 신설 2건(11항, 12항)   ② 목적 사항 수정 반영 9건(1항, 2항, 3항, 5항, 6항, 7항, 9항, 10항)   ③ 조항 번호 수정 1건(11항->13항)</TE>
<TE ALIGN="CENTER" WIDTH="353" HEIGHT="99" ACODE="ART_RSN" VALIGN="MIDDLE">목적 사항 추가 및 자구 수정 등 변경</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="122" AUNIT="ART_DATE" AUNITVALUE="20200324" VALIGN="MIDDLE">2020년 03월 24일</TU>
<TE ALIGN="CENTER" WIDTH="159" HEIGHT="122" ACODE="ART_NAME" VALIGN="MIDDLE">제36기 정기주주총회</TE>

<TE ALIGN="CENTER" WIDTH="650" HEIGHT="122" ACODE="ART_CHN" VALIGN="MIDDLE">1. 제8조(주권의 발행과 종류) : 주식 등이 전자등록 의무화에 따라 
<SPAN USERMARK=" U">제8조 삭제</SPAN>2. 제8조의2(주식 등의 전자등록) : 주식 등이 전자등록 의무화에 따라 근거 
<SPAN USERMARK=" U">신설</SPAN>3. 제14조(명의개서대리인) : 주식 등이 전자등록 의무화에 따라 
<SPAN USERMARK=" U">제3항 조문 변경</SPAN>4. 제15조(주주 등의 주소, 성명 및 인감신고) : 주식 등이 전자등록 의무화에 따라 
<SPAN USERMARK=" U">제15조 삭제</SPAN>5. 제19조(사채발행에 관한 준용 규정) :제15조 삭제와 관련 
<SPAN USERMARK=" U">문구 정비</SPAN>
</TE>

<TE ALIGN="CENTER" WIDTH="353" HEIGHT="122" ACODE="ART_RSN" VALIGN="MIDDLE">
<P USERMARK="F-GL11">주식 등이 전자등록 의무화에 따른 변경 내용 반영</P>
</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="ART_DATE" AUNITVALUE="20200324" VALIGN="MIDDLE">2020년 03월 24일</TU>
<TE ALIGN="CENTER" WIDTH="159" HEIGHT="76" ACODE="ART_NAME" VALIGN="MIDDLE">제36기 정기주주총회</TE>
<TE ALIGN="CENTER" WIDTH="650" HEIGHT="76" ACODE="ART_CHN" VALIGN="MIDDLE">1. 제17조(전환사채) : 발행 액면 총액 증액(200억원-> 5000억원)2. 제18조(신주인수권부사채의 발행) : 발행 액면 총액 증액(200억원-> 5000억원)3. 제18조의2(교환사채 발행) : 발행 액면 총액 증액(200억원->5000억원)</TE>
<TE ALIGN="CENTER" WIDTH="353" HEIGHT="76" ACODE="ART_RSN" VALIGN="MIDDLE">발행 액면 총액 증액</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="61" AUNIT="ART_DATE" AUNITVALUE="20200324" VALIGN="MIDDLE">2020년 03월 24일</TU>
<TE ALIGN="CENTER" WIDTH="159" HEIGHT="61" ACODE="ART_NAME" VALIGN="MIDDLE">제36기 정기주주총회</TE>

<TE ALIGN="CENTER" WIDTH="650" HEIGHT="61" ACODE="ART_CHN" VALIGN="MIDDLE">

<P>
<SPAN USERMARK="F-GL11">1. 제37조(이사의 보수와 퇴직금) : 제3항, 4항 </SPAN>
<SPAN USERMARK="F-GL11 U">신설</SPAN>
<SPAN USERMARK="F-GL11">    적대적 M&A로 인한 퇴직시 보상액 100억원 지급, 본 조항 변경시 효력 발생시기 규정</SPAN>
</P>
</TE>
<TE ALIGN="CENTER" WIDTH="353" HEIGHT="61" ACODE="ART_RSN" VALIGN="MIDDLE">적대적 M&A 방어를 위한 규정 신설</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="ART_DATE" AUNITVALUE="20200324" VALIGN="MIDDLE">2020년 03월 24일</TU>
<TE ALIGN="CENTER" WIDTH="159" HEIGHT="76" ACODE="ART_NAME" VALIGN="MIDDLE">제36기 정기주주총회</TE>
<TE ALIGN="CENTER" WIDTH="650" HEIGHT="76" ACODE="ART_CHN" VALIGN="MIDDLE">1. 제11조(주식매수선택권) : 상법 시행령 개정 사항 반영(제3항, 제8항 조문 변경)2. 제52조(외부감사인의 선임) : 법률 명칭변경에 따른 자구수정 및 개정내용 반영3. 제55조(분기배당) : 상법시행령 조문 변경 반영</TE>
<TE ALIGN="CENTER" WIDTH="353" HEIGHT="76" ACODE="ART_RSN" VALIGN="MIDDLE">법률 개정 사항 반영</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="34" AUNIT="ART_DATE" AUNITVALUE="20200324" VALIGN="MIDDLE">2020년 03월 24일</TU>
<TE ALIGN="CENTER" WIDTH="159" HEIGHT="34" ACODE="ART_NAME" VALIGN="MIDDLE">제36기 정기주주총회</TE>

<TE ALIGN="CENTER" WIDTH="650" HEIGHT="34" ACODE="ART_CHN" VALIGN="MIDDLE">
<P USERMARK="F-GL11">부칙신설 : 시행일 명시</P>
</TE>
<TE ALIGN="CENTER" WIDTH="353" HEIGHT="34" ACODE="ART_RSN" VALIGN="MIDDLE">정관변경 사항 시행일 명시</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>

<P>
<SPAN USERMARK="F-GL B">다. 정기주주총회 정관 변경 안건 포함 여부</SPAN>
<SPAN USERMARK="F-GL">보고서 제출 이후 2023년 3월 23일에 개최되는 제39기 정기주주총회의 안건에는 정관의 변경 안건이 포함되어 있습니다. 정관 변경에는 전자증권법, 상법에 따른 조문정비사항과 감사선임에 관한 조문 정비 사항이 포함되어 있습니다. </SPAN>
</P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-2-0-0">II. 사업의 내용</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11">지배회사인 대화제약주식회사와 그 종속회사의 사업부문은  의약품 및 의약품외품의 제조및 판매업, 도소매업, 원료의약품 제조 및 판매업 등을 주요 사업으로 영위하고 있으며, 보고서 제출일 현재 기타 신규 사업의 계획 및 추진 중인 사항은 없습니다.</SPAN>
</P>

<LIBRARY>
<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-1-L1">1. 사업의 개요</TITLE>
<P></P>
<P USERMARK="F-GL11">당사는 식품의약품안전처로부터 우수의약품 제조 및 품질관리기준인 GMP 인증 후 공장 가동을 시작하였습니다. 고형제를 생산하는 제1공장, 경피흡수제를 생산하는 제2공장, 항암제를 생산하는 제3공장 그리고스마트 물류동으로 구성되어 있으며 인구 고령화에 따른 경피용 진통제 시장의 급격한 수요 증가에 대비하기 위하여 총 금액 약 405억 원을 들여 TDDS 전문 공장을 신축을 진행하여 2022년 7월 건축물 사용승인을 득하였으며 금년 말 공장 가동을 목표로 준비 중에 있습니다. 주요 종속회사인 (주)리독스바이오에서는 2019년 05월 GMP API(합성) 증축공사가 완료되었으며 히알루론산(HA) 및 케미칼을 제조하고 있습니다.</P>
<P USERMARK="F-GL11">사업부문은 의약품제조업부문, 의약품도매업부문, 의료정보시스템부문, 의약품원료 제조판매부문, 화장품의료기기 제조판매부문으로 구성되어 있습니다. 국내 매출은 의약품 도매상을 통한 병의원 판매 및 제약회사 또는 병의원으로의 직접 판매가 이루어 지고 있으며, 국외 매출은 외국 현지 제약업체 또는 대형 도매업체 등을 통해 이루어지고 있습니다. 매출은 제품매출, 상품매출, 기타매출로 구성되며, 세부적으로 전문의약품, 일반의약품, 건강기능식품, 원료의약품, 기타제제 등으로 구분합니다. 댱기 '제품'이 전체 매출에서 차지하는 비중은 74.8%이며 '상품'이 전체 매출에서 차지하는 비중은 22.8%입니다. 당사의 주요 제품으로는 감염질환치료제인 세파메칠정, 소화기관 치료제인 후로스판정, 순환기질환 치료제인 탑스타틴정, 국내 OEM 시장의 65%를 추정 점유하고 있는 진통소염제인 카타플라스마, 플라스타 등의 파스제제, 안면부의 일시적 주름개선제인 미용의료기기 아말리안 필러가 있습니다. 당사의 주요 제품인 세파메칠정에 투입되는 주요 원재료는 메틸올세팔렉신리시네이트, 후로스판정에 투입되는 주요 원재료는 플로로글루시놀수화물입니다. 또한, 미용의료기기 아말리안 필러의 주요 원재료는Low molecular weight , High molecular weight입니다.</P>
<P USERMARK="F-GL11">당사는 해외 시장의 신규 사업 확장을 위해 2017년도 인수한 독일 내 자회사인 S&V Technologies GmbH, BSC Medical Devices GmbH 社와 미용의료기기 및 화장품 시장에 진출하였으며, 2018년 6월 중국 Sinopharm Zhijun Pharmaceutical 社와 10년간 1천억원에 달하는미용의료기기인 아말리안 필러의 중국 내 독점 공급계약을 체결한 바 있습니다. </P>

<P>
<SPAN USERMARK="F-GL11">당사는 38년간 축적된 독창적인 기술력을 바탕으로 국내외 시장을 넓혀 가고 있으며,  미래 성장을 위해 평균 매출액 대비 10% 이상의 R&D 투자를 진행하고 있습니다. 당기 매출액 대비 연구개발비용은 연결 연구개발비용은 약 10% 이며, 별도연구개발비용은 약 12.8%입니다. 중앙연구소, 판교연구소, ㈜리독스바이오 연구소와 유기적인R&D 네트워크를 구성하여 신약 개발, 패치제 제품 개발 및 바이오 합성 연구 등을 진행, 시너지 창출을 도모하고 있습니다. </SPAN>
<SPAN USERMARK="F-GL11">당사의 신약개발을 위한 연구활동으로는 흡수 증진제와 전처치가 필요 없는 단독 제형의 세계 최초 경구용 파클리탁셀인 리포락셀액(DHP107)이 있으며 2017년 9월 중국, 대만, 홍콩, 태국시장을 대상으로총 계약금액283억원의 라이선스아웃(License-out) 계약을 체결하였습니다. 미국 및 체코에서 Caucasian에 대한 임상적 Data 확보를 위한 약동학 및 유방암 2상 연구 진행 중이며, 신규 적응증 확장을 위하여 유방암에 대한 다국적 3상(한국/중국/헝가리/세르비아/불가리아) 진행 중에 있습니다.</SPAN>
</P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-2-L1">2. 주요 제품 및 서비스</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">가. 주요제품 매출</SPAN>
<SPAN USERMARK="F-GL 0X54AF00">                                     </SPAN>
<SPAN USERMARK="F-GL">                                                             (단위 : 천원,%)</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="1475" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="244"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="449"></COL>
<COL WIDTH="286"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="68"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="253" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부분</TH>
<TH ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출유형</TH>
<TH ALIGN="CENTER" WIDTH="208" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">분 류</TH>
<TH ALIGN="CENTER" WIDTH="458" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구체적용도</TH>
<TH ALIGN="CENTER" WIDTH="295" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요상표등</TH>
<TH ALIGN="CENTER" WIDTH="106" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH ALIGN="CENTER" WIDTH="77" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비 율(%)</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="13" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="253" HEIGHT="413">의약품제조판매부문</TD>
<TD ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="203">제품</TD>
<TD WIDTH="208" HEIGHT="53">항균 항생제</TD>
<TD WIDTH="458" HEIGHT="53">편도염, 인두염, 급성 신우신염, 방광염, 전립선염, 피부 및 연조직 감염증, 골 감염증</TD>
<TD WIDTH="295" HEIGHT="53">세파메칠 정</TD>
<TD WIDTH="106" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">6,421,114</TD>
<TD WIDTH="77" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">6.47</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">진경제</TD>
<TD WIDTH="458" HEIGHT="30">소화관 및 담도계의 기능장애에 의한 통증 외</TD>
<TD WIDTH="295" HEIGHT="30">후로스판 정</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,495,572</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4.53</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">무기질 제제</TD>
<TD WIDTH="458" HEIGHT="30">마그네슘결핍으로 인한 근육경련 외</TD>
<TD WIDTH="295" HEIGHT="30">마그네스 정</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,191,381</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3.22</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">OEM매출(주1)</TD>
<TD WIDTH="753" HEIGHT="30" COLSPAN="2">OEM 매출 참조(패치류)</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23,564,865</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">23.76</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" WIDTH="666" HEIGHT="30">기    타</TD>
<TD WIDTH="295" HEIGHT="30">탑스타틴 정 외</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">52,280,438</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">52.71</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" ALIGN="CENTER" WIDTH="961" HEIGHT="30">제 품 소 계</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">89,953,370</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">90.69</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="150">상품</TD>
<TD WIDTH="208" HEIGHT="30">의료기기</TD>
<TD WIDTH="458" HEIGHT="30">안면부 피부의 일시적인 주름 개선</TD>
<TD WIDTH="295" HEIGHT="30">아말리안</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,896,684</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4.94</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">의료기기</TD>
<TD WIDTH="458" HEIGHT="30">피부장벽강화, 피부장벽 지질 개선, 각질세포 강화</TD>
<TD WIDTH="295" HEIGHT="30">셀퓨전씨 엑스퍼트 베리덤 로션 엠디</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">380,083</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">0.38</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">근골격계 약물</TD>
<TD WIDTH="458" HEIGHT="30">슬관절의 골관절염, 견관절주위염 치료</TD>
<TD WIDTH="295" HEIGHT="30">아라간플러스 주</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">335,910</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">0.34</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" WIDTH="666" HEIGHT="30">기    타</TD>
<TD WIDTH="295" HEIGHT="30">엔슬림 정 외</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">666,140</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">0.67</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" ALIGN="CENTER" WIDTH="961" HEIGHT="30">상 품 소 계</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,278,816</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6.33</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" ALIGN="CENTER" WIDTH="1039" HEIGHT="30">기 타 매 출</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,960,193</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2.98</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" ALIGN="CENTER" WIDTH="1039" HEIGHT="30" USERMARK=" B">의 약 품 제 조 판 매 부 문 합 계</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK=" B">99,192,379</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" B">100.00</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="8" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="253" HEIGHT="240">의약품도매부문</TD>
<TD ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="180">상품</TD>
<TD WIDTH="208" HEIGHT="30">암 및 면역 관련 질환 치료제</TD>
<TD WIDTH="458" HEIGHT="30">신이식에서의 거부반응의 억제, 간이식에서의 거부반응의 억제 외</TD>
<TD WIDTH="295" HEIGHT="30">아스텔 프로그랍캅셀 1mg/100C</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">338,688</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1.43</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">당노병용제</TD>
<TD WIDTH="458" HEIGHT="30">성인 제2형 당뇨병 환자의 혈당 조절 개선</TD>
<TD WIDTH="295" HEIGHT="30">릴리 트루리시티 1.5mg/0.5ml/2Pen  </TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">142,538</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">0.60</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">화학요법제</TD>
<TD WIDTH="458" HEIGHT="30">만성C형간염 치료</TD>
<TD WIDTH="295" HEIGHT="30">애브비 마비렛정 84T</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">168,835</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">0.72</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30">항바이러스제</TD>
<TD WIDTH="458" HEIGHT="30">HIV-1치료, 만성 B형 감염 치료제</TD>
<TD WIDTH="295" HEIGHT="30">길리어 비리어드정 30T</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">126,424</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">0.54</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="666" HEIGHT="30" COLSPAN="2" ALIGN="CENTER">기    타</TD>
<TD WIDTH="295" HEIGHT="30">한미 로수젯정 10/5mg/30T 외</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">22,442,429</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">94.99</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="961" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">상 품 소 계 </TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23,218,914</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">98.28</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" ALIGN="CENTER" WIDTH="1039" HEIGHT="30">기 타 매 출</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">407,214</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1.72</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" ALIGN="CENTER" WIDTH="1039" HEIGHT="30" USERMARK=" B">의 약 품 도 매 부 문 합계</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" USERMARK=" B">23,626,128</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" B">100.00</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="253" HEIGHT="30">의료정보시스템</TD>
<TD ALIGN="CENTER" WIDTH="78" HEIGHT="30" VALIGN="MIDDLE">컨텐츠</TD>
<TD COLSPAN="3" ALIGN="CENTER" WIDTH="961" HEIGHT="30" USERMARK=" B">메디프레임 서비스, 컨텐츠 제작</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" USERMARK=" B">352,034</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" B">100.00</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="253" HEIGHT="240" ROWSPAN="8" VALIGN="MIDDLE">의약품원료제조 판매 부문</TD>
<TD ALIGN="CENTER" WIDTH="78" HEIGHT="150" VALIGN="MIDDLE" ROWSPAN="5">제품</TD>
<TD ALIGN="CENTER" WIDTH="208" HEIGHT="30">합성원료</TD>
<TD ALIGN="CENTER" WIDTH="458" HEIGHT="30">항생제</TD>
<TD ALIGN="CENTER" WIDTH="295" HEIGHT="30">Methylol Cephalex in Lysinate</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">4,315,127</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">31.26</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="208" HEIGHT="30">합성원료</TD>
<TD ALIGN="CENTER" WIDTH="458" HEIGHT="30">진통제</TD>
<TD ALIGN="CENTER" WIDTH="295" HEIGHT="30">록소프로펜나트륨</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">1,254,906</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">9.09</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="208" HEIGHT="30">합성원료</TD>
<TD ALIGN="CENTER" WIDTH="458" HEIGHT="30">진경제</TD>
<TD ALIGN="CENTER" WIDTH="295" HEIGHT="30">플로로글루시놀(플로로글루시놀무수물)</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">504,118</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3.65</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" WIDTH="666" HEIGHT="30">기    타</TD>
<TD ALIGN="CENTER" WIDTH="295" HEIGHT="30">Sodium Hyaluronate 외</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">3,915,955</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">28.37</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" ALIGN="CENTER" WIDTH="961" HEIGHT="30">제 품 소 계</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">9,990,106</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">72.37</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="78" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE">상품</TD>
<TD ALIGN="CENTER" WIDTH="208" HEIGHT="30">의료기기</TD>
<TD ALIGN="CENTER" WIDTH="458" HEIGHT="30">안면부 피부의 일시적인 주름개선</TD>
<TD ALIGN="CENTER" WIDTH="295" HEIGHT="30">아말리안</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">3,814,848</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER">27.63</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" ALIGN="CENTER" WIDTH="961" HEIGHT="30">상 품 소 계</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">3,814,848</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER">27.63</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" ALIGN="CENTER" WIDTH="1039" HEIGHT="30" VALIGN="MIDDLE" USERMARK=" B">의약품원료제조 및 판매 부문 합계</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" USERMARK=" B">13,804,954</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" USERMARK=" B">100.00</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="253" HEIGHT="30">화장품, 의료기기 제조 및 판매부문</TD>
<TD ALIGN="CENTER" WIDTH="78" HEIGHT="30" VALIGN="MIDDLE">제품</TD>
<TD COLSPAN="3" ALIGN="CENTER" WIDTH="961" HEIGHT="30" VALIGN="MIDDLE" USERMARK=" B">더말필러, 아말리안 화장품</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK=" B">8,991,709</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" B">100.00</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" ALIGN="CENTER" WIDTH="1292" HEIGHT="30">조      정(부문간 수익)</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT">(14,055,513)</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" ALIGN="CENTER" WIDTH="1292" HEIGHT="30" USERMARK=" B">합      계</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" USERMARK=" B">131,911,693</TD>
<TD WIDTH="77" HEIGHT="30" ALIGN="CENTER" USERMARK=" B">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(주1) OEM 매출 (파스,패치류) .</SPAN>
<SPAN USERMARK="F-GL11 U">아래사항은 OEM(파스,패치류) 매출에 대한 내역입니다. </SPAN>
<SPAN USERMARK="F-GL11">                                                                                                                                            (단위 : 천원,%)</SPAN>
</P>

<TABLE AFIXTABLE="N" BORDER="1" WIDTH="1031" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="321"></COL>
<COL WIDTH="185"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="85"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="48" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">사업부문</TH>
<TH WIDTH="63" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">매출유형</TH>
<TH WIDTH="169" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구체적용도</TH>
<TH WIDTH="330" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">주문사상표명</TH>
<TH WIDTH="194" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">주문사</TH>
<TH WIDTH="133" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">매출액</TH>
<TH WIDTH="94" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">비 율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="300" VALIGN="MIDDLE" ROWSPAN="10" ALIGN="CENTER">의약품제조업</TD>
<TD WIDTH="63" HEIGHT="300" VALIGN="MIDDLE" ROWSPAN="10" ALIGN="CENTER">제품(OEM)</TD>
<TD WIDTH="169" HEIGHT="240" ROWSPAN="8" VALIGN="MIDDLE" ALIGN="CENTER">진통 소염제 :타박상, 삠, 근육통, 골절통, 관절통, 요통, 견통, 어깨결림, 동창 등</TD>
<TD WIDTH="330" HEIGHT="30">안티푸라민더블파워카타플라스마 외</TD>
<TD WIDTH="194" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">㈜유한양행</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">10,960,858</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="CENTER">46.51</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="330" HEIGHT="30">캐롤쿨링더블파워카타플라스마 외</TD>
<TD WIDTH="194" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">일동제약㈜</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">2,556,670</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="CENTER">10.85</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="330" HEIGHT="30">종근당류파프카타플라스마 외</TD>
<TD WIDTH="194" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">㈜종근당</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">2,254,541</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="CENTER">9.57</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="330" HEIGHT="30">맨담록소펜카타플라스마 외</TD>
<TD WIDTH="194" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">보령제약㈜</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">1,669,134</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="CENTER">7.08</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="330" HEIGHT="30">한풍제통고카타플라스마</TD>
<TD WIDTH="194" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(유)한풍제약</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">1,012,365</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="CENTER">4.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="330" HEIGHT="30">제놀빅카타플라스마 외</TD>
<TD WIDTH="194" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">㈜녹십자</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">933,281</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="CENTER">3.96</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="330" HEIGHT="30">노펜24첩부제 외</TD>
<TD WIDTH="194" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">JW중외제약㈜</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">849,373</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="CENTER">3.60</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="330" HEIGHT="30">버물리플라스타 외</TD>
<TD WIDTH="194" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">현대약품(주) 외</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">2,632,213</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="CENTER">11.17</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="169" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">천식치료제</TD>
<TD WIDTH="330" HEIGHT="30">코부테롤패취1밀리그램 외</TD>
<TD WIDTH="194" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">코오롱제약(주) 외</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT">696,430</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="CENTER">2.96</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="499" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">합           계</TD>
<TD WIDTH="194" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">-</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" AUTOSUM="COLALL">23,564,865</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" AUTOSUM="COLALL">100</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL B">나. 주요 제품의 가격 변동</SPAN>
<SPAN USERMARK="F-GL11">제약업의 특성상 가격 변동 요인은 의료보험 수가의 변동, 수입자재의 가격 변동과 환율 변동에 주로 영향을 받습니다.당사의 제품은 생산체제가 다품종 소량 생산 체제이기 때문에 어느 제품의 가격 변동 추이를 측정하기 어려워 각 제품 유형별 매출액 기준으로 단순 평균한 제품의 가격 추이를 산출하였습니다.</SPAN>
</P>
<P USERMARK="F-GL11">                                                                                              (단위 : 원 )</P>

<TABLE BORDER="1" WIDTH="872" AFIXTABLE="N" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="299"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="107"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">부   문</TH>
<TH COLSPAN="2" WIDTH="356" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">품     목</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제39기 당기</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제38기</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제37기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="180" ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER">의약품 제조판매</TD>
<TD WIDTH="308" HEIGHT="30">세파메칠정 500T</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">265,563</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">287,411</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">291,322</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">후로스판 정 500T</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">53,424</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">52,911</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">52,799</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">마그네스디 정 100T</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">14,730</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">14,735</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">14,730</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">탑스타틴 정 10mg 28T</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">14,018</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">14,014</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">14,020</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">잘트론 정 500T</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">59,677</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">58,940</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">59,277</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">가스트릭캡슐 250C</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">54,286</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">53,725</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">54,397</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="210" ROWSPAN="7" VALIGN="MIDDLE" ALIGN="CENTER">의약품 도매</TD>
<TD WIDTH="308" HEIGHT="30">아스텔 프로그랍캅셀 1mg/100C</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">320,727</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">333,454</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">333,454</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">릴리 트루리시티 1.5mg/0.5ml/2Pen</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">56,692</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>58,416</P>
</TD>

<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">
<P>62,343</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="308" HEIGHT="30">
<P>애브비 마비렛정 84T</P>
</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">4,964,705</TD>

<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">
<P>4,964,705</P>
</TD>

<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">
<P>4,964,705</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">길리어 비리어드정 30T(유한)</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">68,263</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">68,318</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">68,318</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">한미 로수젯정 10/5mg/30T</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">22,172</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">23,018</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">24,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">대웅바이 글리아타민연질캡슐 90C</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">40,990</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">41,400</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">41,400</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="308" HEIGHT="30">노보 트레시바플렉스터치주100IU 3ml*5Pen</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">71,654</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">71,727</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">71,727</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">의약품원료제조 판매</TD>
<TD WIDTH="308" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">Methylol Cephalex in Lysinate (KG)</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">307,588</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">308,572</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">351,331</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-3-L1">3. 원재료 및 생산설비</TITLE>
<P></P>
<P USERMARK="F-GL11 B">가. 주요 원재료</P>

<P>
<SPAN USERMARK="F-GL11">국내 주요 의약품의 원료는 수입에 의존하고 있어 환율 변동에 민감합니다. 당사는 꾸준한거래선 관리와 신규 거래선 확보로 원료 원가관리하고 있습니다. 당사의 주요 제품에 투입되는 원재료의 내역 및 단가는 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-11">                                                                                             </SPAN>
<SPAN USERMARK="F-GL11">            (단위 : 원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1030">

<COLGROUP>
<COL WIDTH="154"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="107"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="163" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="213" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">품   목</TH>
<TH WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">단위</TH>
<TH WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수입국 및 매입처</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요투여제품명</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제39기 당기</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제38기</TH>
<TH WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제37기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" HEIGHT="150" ROWSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE">의약품 제조판매</TD>
<TD WIDTH="213" HEIGHT="30" ALIGN="CENTER">메틸올세팔렉신리시네이트</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">kg</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER">리독스바이오</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER">세파메칠정</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">300,000</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">300,000</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">300,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" ALIGN="CENTER">플로로글루시놀수화물</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">kg</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER">리독스바이오</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER">후로스판정</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">165,000</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">150,000</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">130,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" ALIGN="CENTER">락트산마그네슘수화물</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">kg</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER">㈜하이플</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER">마그네스정</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">30,000</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">25,000</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">24,488</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" ALIGN="CENTER">로수바스타틴칼슘</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">kg</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER">㈜하이플</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER">탑스타틴정</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">3,500,000</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">3,500,000</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">3,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" ALIGN="CENTER">잘토프로펜</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">kg</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER">㈜하이플</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER">잘트론정</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">530,000</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">410,000</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">410,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="163" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">의약품원료 제조 판매</TD>
<TD WIDTH="213" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> Low molecular weight </TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">kg</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)해피콜</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">아말리안</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  360,000 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">330,000</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">330,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> High molecular weight </TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">kg</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)해피콜</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">아말리안</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">  360,000 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">330,000</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">330,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">※ 상기 리독스바이오는 주요 종속회사이며 그외 매입처와는 특수관계에 해당하지 않습니다. </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">나. 생산 및 설비</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">1) 생산능력 및 산출 근거 (</SPAN>
<SPAN USERMARK="F-GL11">1) 제1공장제1공장의 1일 표준작업시간은 6시간이며 월평균 가동일수는 19.8일이며 총 가동일수는238일로 총 1,428시간을 가동하였습니다.제1공장의 상기 기간동안 정제, 캡슐제, 연고크림제의 각 표준생산 생산능력은 정제 592,800천정, 캡슐제 118,560천캡슐, 연고 크림제 2,964천개(충전 능력) 있습니다. 정제, 캡슐제는단위당 능력을 연고 크림제는 충전 능력을 충전 품목의 단위 수로 산출하였습니다.☞생산능력(최대 생산가능량)생산능력 = 일일 표준작업시간×근무 일수×설비의 시간당 생산량</SPAN> 
<SPAN USERMARK="F-GL11">(2) 제2공장제2공장의 1일 표준작업시간은 8시간이며 월 가동일수 와 가동시간은 다음과 같습니다.- 습포제 : 월 평균 가동일수 24.3일, 총가동시간 2,328시간- 첩부제 : 월 평균 가동일수 23.3일, 총가동시간 2,240시간- 첩부제(온큐제제) : 월 평균 가동일수 13.8일, 총가동시간 1,320시간- 첩부제(롤파스) : 월 평균 가동일수 1.3일, 총가동시간 128시간- 패취제(톨로부테롤 외) : 월 평균 가동일수 19.5일, 총가동시간 1,872시간- 모기패치 : 월 평균 가동일수 6.6일, 총가동시간 632시간</SPAN>
<SPAN USERMARK="F-GL11">제2공장의 상기 기간 동안 습포제의 표준시간 생산능력은 35,568천매, 첩부제는 51,870천매, 첩부제(온큐제제)는 86,075천매, 첩부제(롤파스)는 39,767천매, 패취제(톨로부테롤 외)는 11,856천개, 모기패치는 82,949천매입니다.☞생산능력(최대 생산가능량)생산능력 = 일일 표준작업시간×근무 일수×설비의 시간당 생산량</SPAN>
<SPAN USERMARK="F-GL11"> (3) 리독스바이오</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="604" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="595"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="604" HEIGHT="30">(단위 : kg, 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="632">

<COLGROUP>
<COL WIDTH="185"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH COLSPAN="2" WIDTH="152" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2022년 당기</TH>
<TH COLSPAN="2" WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2021년</TH>
<TH COLSPAN="2" WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="68" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수량</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수량</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수량</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">히알루론산(HA) 제조 부문</TD>
<TD WIDTH="68" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">176</TD>
<TD WIDTH="84" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">1,026,966</TD>
<TD WIDTH="63" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">180</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="84" HEIGHT="30">994,596</TD>
<TD WIDTH="55" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">205.2</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="84" HEIGHT="30">2,270,305</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">케미칼 제조 부문</TD>
<TD WIDTH="68" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">14,304 </TD>
<TD WIDTH="84" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">4,160,407</TD>
<TD WIDTH="63" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">13,969</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="84" HEIGHT="30">4,034,004</TD>
<TD WIDTH="55" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">6,985</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="84" HEIGHT="30">2,705,564</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(주1) 생산실적 금액을 바탕으로 가동률에 근거하여 산출하였습니다.(주2) 케미칼 부문은 2016년 사업을 이전받아 영위하기 시작하였습니다.(주3)생산능력 산출 히알루론산 =3.6kg * 1라인 * 1주 * 49주 = 176kg  케미칼 = 8시간 * 299일 *1라인 *5.98kg = 14,304kg</SPAN>
<SPAN USERMARK="F-GL11">☞생산능력(최대 생산가능량 및 금액)생산능력(수량) = 일일 표준작업시간×근무 일수×설비의 시간당 생산량생산능력(금액) = 생산실적 금액 / 생산실적 수량 ×생산능력(수량)</SPAN>
<SPAN USERMARK="F-GL">2) 생산실적 및 가동률</SPAN> 
<SPAN USERMARK="F-GL">(1) 1공장</SPAN>
<SPAN USERMARK="F-GL11">                                                                                   (단위 :천개,%)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="690" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">사업부문</TH>
<TH WIDTH="118" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">생산구분</TH>
<TH WIDTH="48" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">단위</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="2">2022년 당기</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="2">2021년</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="2">2020년</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">생산실적</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">가동률</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">생산실적</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">가동률</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">생산실적</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">가동률</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="93" VALIGN="MIDDLE" HEIGHT="90">의약품부문</TD>
<TD WIDTH="118" HEIGHT="30">정제</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">T</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">523,007</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">88.2</TD>
<TD WIDTH="86" ALIGN="RIGHT" HEIGHT="30">544,294</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">91.4</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">487,210 </TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">80.9</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" HEIGHT="30">캅셀제</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">C</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">39,440</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">33.3</TD>
<TD WIDTH="86" ALIGN="RIGHT" HEIGHT="30">39,745</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">33.4</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">34,230 </TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">28.4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" HEIGHT="30">연고 크림 겔제</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">2,812</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">94.9</TD>
<TD WIDTH="86" ALIGN="RIGHT" HEIGHT="30">2,519</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">84.6</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">2,273 </TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">75.5</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL 0X0000FF"> 
<SPAN USERMARK="F-11 0X000000">(2) 2공장                                                                                                    단위 : 천개,%)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="734" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">사업부문</TH>
<TH WIDTH="170" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">생산구분</TH>
<TH WIDTH="48" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2">단위</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="2">2022년 당기</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="2">2021년</TH>
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="2">2020년</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">생산실적</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">가동률</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">생산실적</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">가동률</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">생산실적</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">가동률</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="93" VALIGN="MIDDLE" HEIGHT="180">의약품부문</TD>
<TD WIDTH="170" HEIGHT="30">습포제</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">매</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">72,521</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">201.1</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">75,874</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">212.5</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">62,325</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">172.4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" HEIGHT="30">첩부제</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">매</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">64,443</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">124.2</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">79,271</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">152.2</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">63,641</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">120.7</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" HEIGHT="30">첩부제(온큐제제)</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">매</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">60,820</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">70.7</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">70,756</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">81.9</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">72,479</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">82.9</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" HEIGHT="30">모기패치</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">매</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">25,019</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">30.2</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">22,408</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">26.9</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">19,176</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">22.7</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" HEIGHT="30">패치제(톨로부테롤 외)</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">매</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">9,896</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">83.5</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">3,535</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">29.7</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">3,817</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">31.7</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="170" HEIGHT="30">첩부제(롤파스)</TD>
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">매</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">850</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.1</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">1,736</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4.3</TD>
<TD WIDTH="78" ALIGN="RIGHT" HEIGHT="30">2,621</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6.5</TD>
</TR>
</TBODY>
</TABLE>

<P> 
<SPAN USERMARK="F-GL11">(3) 리독스바이오</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">① 생산실적</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="680">

<COLGROUP>
<COL WIDTH="671"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="680" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : kg, 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="682">

<COLGROUP>
<COL WIDTH="185"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="75"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="194" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH COLSPAN="2" WIDTH="168" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2022년 당기</TH>
<TH COLSPAN="2" WIDTH="160" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2021년</TH>
<TH COLSPAN="2" WIDTH="160" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수량</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수량</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수량</TH>
<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">히알루론산(HA) 제조 부문</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">190.93</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,111,557</TD>
<TD WIDTH="76" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">128.41</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="84" HEIGHT="30">709,534</TD>
<TD WIDTH="76" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">42.37</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="84" HEIGHT="30">468,776</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">케미칼 제조부문</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,107.92</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,812,477</TD>
<TD WIDTH="76" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">13,427.78</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="84" HEIGHT="30">3,877,631</TD>
<TD WIDTH="76" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">10,603.99</TD>
<TD VALIGN="BOTTOM" ALIGN="RIGHT" WIDTH="84" HEIGHT="30">4,107,552</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 생산실적 금액은 제품제조원가명세서에 근거하여 작성하였습니다.</SPAN>
<SPAN USERMARK="F-GL11">② 평균가동률</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="566">

<COLGROUP>
<COL WIDTH="557"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="566" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위 : h)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="567">

<COLGROUP>
<COL WIDTH="185"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="194" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH WIDTH="130" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가동가능시간</TH>
<TH WIDTH="150" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">실제가동시간</TH>
<TH WIDTH="93" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평균가동률</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">히알루론산(HA) 제조 부문</TD>
<TD WIDTH="130" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">2,768</TD>
<TD WIDTH="150" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">2,232</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">80.6%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">케미칼 제조 부문</TD>
<TD WIDTH="130" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">2,392</TD>
<TD WIDTH="150" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">1,976</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30">82.6%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">다. 생산설비의 현황 등</SPAN>
<SPAN USERMARK="F-GL11">당사의 생산설비는 제1공장, 제2공장, 제3공장, 주요종속회사인 (주)리독스바이오의 공장을 보유하고 있으며 강화되어가는 정규 규제에 맞춘 새 GMP 공장으로 품질 강화와 생산량 향상에 기여하고 있습니다. 기타 사업장 소재지는 아래와 같습니다. </SPAN>
<SPAN USERMARK="F-GL11">【사업장 소재지】</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="665" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="174"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="321"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="183" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부 문 별</TH>
<TH WIDTH="152" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구       분</TH>
<TH WIDTH="330" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소    재    지</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="240" ROWSPAN="8">의약품제조판매부문</TD>
<TD WIDTH="152" HEIGHT="30">본사 및 제1,2,3공장</TD>
<TD WIDTH="330" HEIGHT="30">강원도 횡성군 횡성읍 한우로 495 외</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30">판교연구소</TD>
<TD WIDTH="330" HEIGHT="30">경기도 성남시 분당구 대왕판교로 700 C동 9층</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30">서울사무소</TD>
<TD WIDTH="330" HEIGHT="30">서울특별시 서초구 남부순환로 2145</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30">부산사무소</TD>
<TD WIDTH="330" HEIGHT="30">부산광역시 연제구 반송로 100 3층</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30">대구사무소</TD>
<TD WIDTH="330" HEIGHT="30">대구광역시 남구 봉덕로 66 우성빌딩 5층</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30">대전사무소</TD>
<TD WIDTH="330" HEIGHT="30">대전광역시 서구 둔지로 56 대화빌딩 7층</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30">광주사무소</TD>
<TD WIDTH="330" HEIGHT="30">광주광역시 서구 풍암순환로 1138-1 2층</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30">전주사무소</TD>
<TD WIDTH="330" HEIGHT="30">전주시 덕진구 전주천동로 475 3층</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30">의약품도매부문</TD>
<TD WIDTH="152" HEIGHT="30">본사</TD>
<TD WIDTH="330" HEIGHT="30">서울특별시 서초구 남부순환로 2145</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="183" HEIGHT="30">의약품원료제조판매부문</TD>
<TD WIDTH="152" HEIGHT="30">본사 및 공장</TD>
<TD WIDTH="330" HEIGHT="30">경기도 화성시 향남읍 제약공단3길 83</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11">1) 지배회사인 대화제약의 생산설비등의 현황</SPAN>
</P>
<P> </P>

<P>
<SPAN USERMARK="F-GL11">【자산항목 : 토지】2022.12.31일 현재                                                  (단위 : 천원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="740" AFIXTABLE="N" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="123"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">사 업 소</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">소유형태</TH>
<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">소재지</TH>
<TH ROWSPAN="2" WIDTH="75" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">구   분(면적㎡)</TH>
<TH ROWSPAN="2" WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">기초장부가액</TH>
<TH COLSPAN="2" WIDTH="116" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기증감</TH>
<TH ROWSPAN="2" WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">당기말장부가액</TH>
<TH ROWSPAN="2" WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">공시지가</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">증 가</TH>
<TH WIDTH="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">감 소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제1,2,3공장</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">강원도</TD>
<TD WIDTH="75" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">73,129.3</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">5,412,968</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">5,412,968</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">14,191,714 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서울사무소</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서울시</TD>
<TD WIDTH="75" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">1,773</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">21,375,895</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">21,375,895</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">24,325,560 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">판교연구소</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경기도</TD>
<TD WIDTH="75" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">366.64</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">996,735</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">996,735</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30"> 1,950,525</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대전사무소</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대전시</TD>
<TD WIDTH="75" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">637.50</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">931,040</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">931,040</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30"> 2,113,313</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="348" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" AUTOSUM="COLALL">28,716,638</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" AUTOSUM="COLALL">0</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" AUTOSUM="COLALL">0</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUTOSUM="COLALL">28,716,638</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUTOSUM="COLALL">42,581,112</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL10">주1) 당기말 회사의 차입금과 관련하여 28,694,478천원이 기업은행 외에 담보로 제공되었습니다. (기업은행외 대지 및 건물 채권최고액 103,280,000천원)주2) 투자부동산에 해당하는 장부가액이 포함되어 있습니다.</P>
<P></P>
<P></P>

<P>
<SPAN USERMARK="F-GL11">【자산항목 : 건물】2022.12.31일 현재                                                  (단위 : 천원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="864" AFIXTABLE="N" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="123"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="132" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">사 업 소</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">소유형태</TH>
<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">소재지</TH>
<TH ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">구   분(면적㎡)</TH>
<TH ROWSPAN="2" WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">기초장부가액</TH>
<TH COLSPAN="2" WIDTH="116" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기증감</TH>
<TH ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">당기상각</TH>
<TH ROWSPAN="2" WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">당기말장부가액</TH>
<TH ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">과세시가표준액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">증 가</TH>
<TH WIDTH="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">감 소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제1,2,3공장</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">강원도</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,026.61</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">20,661,217</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">745,514 </TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">19,915,703 </TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,585,776 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서울사무소</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서울시</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,455.98</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">6,323,409</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">179,301 </TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">6,144,108 </TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,783,365 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">판교연구소</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경기도</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,928.34</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">1,699,205</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">57,275 </TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">1,641,930 </TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,466,519 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="132" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대전사무소</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">대전시</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,983.07</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">1,186,311</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">53,908 </TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30">1,132,403 </TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,548,629 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="357" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUTOSUM="COLPART">29,870,142</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" AUTOSUM="COLPART">0</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT" AUTOSUM="COLPART">0</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30" AUTOSUM="COLPART">1,035,998</TD>
<TD WIDTH="92" ALIGN="RIGHT" HEIGHT="30" AUTOSUM="COLPART">28,834,144</TD>
<TD WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">주1) 당기말 회사의 차입금과 관련하여  28,729,761천원이 기업은행 외에 담보로 제공되었습니다. (기업은행외 대지 및 건물 채권최고액 103,280,000천원)주2) 투자부동산에 해당하는 장부가액이 포함되어 있습니다.</SPAN>
</P>
<P></P>

<P>
<SPAN USERMARK="F-GL11">【자산항목 : 기계장치】 2022.12.31일 현재                                           (단위 : 천원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="861" AFIXTABLE="N" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="50"></COL>
<COL WIDTH="64"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">사 업 소</TH>
<TH ROWSPAN="2" WIDTH="84" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">소유형태</TH>
<TH ROWSPAN="2" WIDTH="59" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">소재지</TH>
<TH ROWSPAN="2" WIDTH="73" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">구   분</TH>
<TH ROWSPAN="2" WIDTH="85" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">기초장부가액</TH>
<TH COLSPAN="2" WIDTH="170" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기증감</TH>
<TH ROWSPAN="2" WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">당기상각</TH>
<TH ROWSPAN="2" WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">당기말장부가액</TH>
<TH ROWSPAN="2" WIDTH="81" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">비   고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="85" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">증  가</TH>
<TH WIDTH="85" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">감  소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제1,2,3공장</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">강원도</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="85" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">5,775,602</TD>
<TD WIDTH="85" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">722,900</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">1,095,505</TD>
<TD WIDTH="89" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">5,402,997</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">판교연구소</TD>
<TD WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="59" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경기도</TD>
<TD WIDTH="73" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="85" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">31,563</TD>
<TD WIDTH="85" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">-</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">6,900</TD>
<TD WIDTH="89" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">24,663</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="344" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합    계</TD>
<TD WIDTH="85" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUTOSUM="COLALL">5,807,165</TD>
<TD WIDTH="85" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUTOSUM="COLALL">722,900</TD>
<TD WIDTH="85" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" AUTOSUM="COLALL">0</TD>
<TD WIDTH="92" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUTOSUM="COLALL">1,102,405</TD>
<TD WIDTH="89" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUTOSUM="COLALL">5,427,660</TD>
<TD WIDTH="81" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">주1) 당기말 회사의 차입금과 관련하여 5,263,350천원이 기업은행 외에 담보로 제공되었습니다</SPAN>
</P>
<P></P>
<P></P>

<P>
<SPAN USERMARK="F-GL11">【자산항목 : 공구기구비품】 2022.12.31일 현재                                    (단위 : 천원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="862" AFIXTABLE="N" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="68"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="130" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">사 업 소</TH>
<TH ROWSPAN="2" WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">소유형태</TH>
<TH ROWSPAN="2" WIDTH="77" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">소재지</TH>
<TH ROWSPAN="2" WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">구   분</TH>
<TH ROWSPAN="2" WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">기초장부가액</TH>
<TH COLSPAN="2" WIDTH="172" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기증감</TH>
<TH ROWSPAN="2" WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">당기상각</TH>
<TH ROWSPAN="2" WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">당기말장부가액</TH>
<TH ROWSPAN="2" WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">비   고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">증  가</TH>
<TH WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">감  소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">제1,2,3공장</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">강원도</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">442,655</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">133,060</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">170,403</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">405,312</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서울사무소외</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">서울시외</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">182,450</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">60,300</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">78,308</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">164,442</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">판교연구소</TD>
<TD WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">자가</TD>
<TD WIDTH="77" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">경기도</TD>
<TD WIDTH="63" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">21,638</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">-</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">6,317</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30">15,321</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" WIDTH="346" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합    계</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUTOSUM="COLALL">646,743</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUTOSUM="COLALL">193,360</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" AUTOSUM="COLALL">0</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUTOSUM="COLALL">255,028</TD>
<TD WIDTH="86" ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUTOSUM="COLALL">585,075</TD>
<TD WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">【자산항목 : 차량운반구】2022.12.31일 현재                                        (단위 : 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="862">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="51"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="131" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사 업 소</TH>
<TH WIDTH="75" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유형태</TH>
<TH WIDTH="80" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH WIDTH="60" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH WIDTH="86" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초장부가액</TH>
<TH WIDTH="172" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기증감</TH>
<TH WIDTH="86" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기상각</TH>
<TH WIDTH="86" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말장부가액</TH>
<TH WIDTH="86" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비   고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="85" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증  가</TH>
<TH WIDTH="87" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감  소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제1,2,3공장</TD>
<TD WIDTH="75" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자가</TD>
<TD WIDTH="80" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">강원도</TD>
<TD WIDTH="60" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,791</TD>
<TD WIDTH="87" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,039</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">19,756</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="346" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">합    계</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" AUTOSUM="COLPART">4</TD>
<TD WIDTH="85" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" AUTOSUM="COLPART">22,791</TD>
<TD WIDTH="87" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" AUTOSUM="COLPART">0</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" AUTOSUM="COLPART">3,039</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" AUTOSUM="COLPART">19,756</TD>
<TD WIDTH="86" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11">(2) 주요종속회사인 리독스바이오의 생산설비등 현황</SPAN>
<SPAN USERMARK=" B">                                                                                  </SPAN>
<SPAN USERMARK="F-GL11">    (단위 : 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="704">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="90"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사 업 소</TH>
<TH WIDTH="78" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유형태</TH>
<TH WIDTH="63" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH WIDTH="99" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초장부가액</TH>
<TH WIDTH="169" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기 증감</TH>
<TH WIDTH="103" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기상각</TH>
<TH WIDTH="99" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말장부가액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="81" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증  가</TH>
<TH WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감  소</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">토지</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자가</TD>
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">경기도</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,593,482</TD>
<TD WIDTH="81" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,593,482</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">건물</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자가</TD>
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">경기도</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,934,434</TD>
<TD WIDTH="81" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">244,379</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,690,055</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기계장치</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자가</TD>
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">경기도</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,361,860</TD>
<TD WIDTH="81" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">160,757</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,992</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">583,638</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,985,987</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">차량운반구</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자가</TD>
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">경기도</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1</TD>
<TD WIDTH="81" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">비품</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자가</TD>
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">경기도</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">82,872</TD>
<TD WIDTH="81" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,285</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">52,587</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,044,649</TD>
<TD WIDTH="81" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">160,757</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,992</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">858,302</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,322,112</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">주1) 투자부동산에 해당하는 장부가액이 포함되어 있습니다. </SPAN>
</P>
<P></P>

<P>
<SPAN USERMARK="F-GL11">한편, 리독스바이오가 보유중인 토지의 공시지가는 하기와 같으며, 당사 고정자산과 관련하여 설정된 담보 내역은 없습니다</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="597">

<COLGROUP>
<COL WIDTH="254"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="152"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="263" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주소</P>
</TH>

<TH WIDTH="173" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>개별공시지가(㎡당)</P>
</TH>

<TH WIDTH="161" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>면적(㎡)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="263" HEIGHT="30">
<P>경기 화성 향남읍 상신리 907</P>
</TD>
<TD WIDTH="173" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">484,800원</TD>

<TD WIDTH="161" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">
<P>4,937.2 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="263" HEIGHT="30">
<P>경기 파주 적성면 장현리 253-1</P>
</TD>
<TD WIDTH="173" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">129,900원</TD>

<TD WIDTH="161" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">
<P>1,643.0 </P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">라. 시설에 대한 투자</SPAN>
<SPAN USERMARK="F-GL11">1) 투자 목적 : TDDS(경피약품전달체계) 특화 기술을 바탕으로 TDDS 전문 제품 생산 시설 확대를 통한 경쟁력 강화2) 내용 : 횡성 공장내 제2공장 B동 신설3) 기간 : 2020년 9월 21일부터 2023년 1월 31일까지 4) 총 소요자금 및 기지출액 (1) 총 소요자금(예상) : 약 420억원 (2) 기 지출액 : 약 331억원(2022년 12월 31일 기준)</SPAN>
<SPAN USERMARK="F-GL11">5) 향후 기대 효과 : 최근 세계적으로 인구 고령화로 류마티스관절염, 퇴행성관절염 등의 만성질환 비율이 높아지고 있습니다. 경구용 진통제의 부작용 우려로 인해 통증 완화용 파스와크림 같은 국부 진통제에 대한 수요가 증가하고 있어 TDDS 관련 제품 시장은 국내ㆍ외 지속적으로 성장할 것으로 판단하고 있어 매출 신장에 기여할 것으로 기대하고 있습니다. 또한, TDDS 제품의 글로벌 시장 진출을 위해 2019년 6월 참여하게 된 JHK BioPharm(지분율 25% 보유) 조인트벤처를 통해 TDDS 제품과 ODF(구강용해필름) 제품에 대한 기술이전및 수출 사업의 일환으로 TDDS 의약품 수출 기준에 준한 신규 공장 설립 및 제조 능력 확보가 필요함에 따라 글로벌 TDDS 시장 진출을 위한 전초기지 역할을 할 것으로 기대하고 있습니다. </SPAN>
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-4-L1">4. 매출 및 수주상황</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">가. 매출실적</SPAN>
<SPAN USERMARK="F-GL11">제출일 현재 연결회사의 매출은 제품, 상품, 기타 매출로 구분할 수 있으며, 이중 제품 매출 비중이 약 74.8%를 차지하고 있습니다. </SPAN>
<SPAN USERMARK="F-GL11">제품에는 전문의약품과 일반의약품, 의약품원료로 구성되고 있습니다. 주요 제품에는 매출액 기준으로 세파메칠정, 후로스판정, 마그네스정 등 감염질환제, 외용소염진통제, 소화기질환, 순환기 제품의 주로 구성되어 있습니다. 상품 매출은 1만여 품목의 매출로 구성되어있으며 프로그랍캅셀, 트루리시티, 마비렛정, 비리어드정, 케이캡정 등이 있습니다. 연결회사의 매출내역은 다음과 같습니다.                                                                                            (단위 : 천원, US$)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="986">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="254"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="137"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="153" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH WIDTH="63" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출유형</TH>
<TH WIDTH="311" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">품       목</TH>
<TH WIDTH="167" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제39기 당기</TH>
<TH WIDTH="146" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제38기</TH>
<TH WIDTH="146" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제37기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="286" ROWSPAN="8" ALIGN="CENTER" VALIGN="MIDDLE">의약품제조판매부문</TD>
<TD WIDTH="63" HEIGHT="113" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">제   품</TD>
<TD WIDTH="263" HEIGHT="113" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">세파메칠 정 외</TD>
<TD WIDTH="48" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">수출</TD>
<TD WIDTH="167" HEIGHT="53" ALIGN="RIGHT">6,931,471(US$5,040,366.13)</TD>
<TD WIDTH="146" HEIGHT="53" ALIGN="RIGHT">6,165,573 (US$5,365,638.51)</TD>
<TD WIDTH="146" HEIGHT="53" ALIGN="RIGHT">5,007,358(US$4,261,153.08)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">내수</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">83,021,899</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">76,697,219</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">73,232,365</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">89,953,370</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">82,862,792</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">78,239,723</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">상   품</TD>
<TD WIDTH="263" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">아말리안 외</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">내수</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">6,278,816</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">5,841,580</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">4,054,059</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">6,278,816</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">5,841,580</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">4,054,059</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" HEIGHT="113" COLSPAN="2" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">기 타 매 출</TD>
<TD WIDTH="48" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">수출</TD>
<TD WIDTH="167" HEIGHT="53" ALIGN="RIGHT">             2,860,193 (US$1,999,995.00)</TD>
<TD WIDTH="146" HEIGHT="53" ALIGN="RIGHT">-</TD>
<TD WIDTH="146" HEIGHT="53" ALIGN="RIGHT">1,168(US$998.58)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">내수</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">                100,000 </TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">467</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">30,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">             2,960,193 </TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">467</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">31,168</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BU" WIDTH="479" HEIGHT="113" COLSPAN="3" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">의약품제조판매부문 합계</TD>
<TD WIDTH="48" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">수출</TD>
<TD WIDTH="167" HEIGHT="53" ALIGN="RIGHT">9,791,664(US$7,040,361.13 )</TD>
<TD WIDTH="146" HEIGHT="53" ALIGN="RIGHT">6,165,573 (US$5,365,638.51)</TD>
<TD WIDTH="146" HEIGHT="53" ALIGN="RIGHT">5,008,526(US$4,262,151.66)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">내수</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">89,400,715</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">82,539,266</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">77,316,424</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD USERMARK=" B" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">99,192,379</TD>
<TD USERMARK=" B" WIDTH="146" HEIGHT="30" ALIGN="RIGHT">88,704,839</TD>
<TD USERMARK=" B" WIDTH="146" HEIGHT="30" ALIGN="RIGHT">82,324,950</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">의약품도매부문</TD>
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">상   품</TD>
<TD WIDTH="263" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">아스텔 프로그랍캅셀 1mg/100C 외</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">내수</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">23,218,914</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">20,567,355</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">19,880,484</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">기 타 매 출</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">내수</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">407,214</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">351,265</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">342,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BU" WIDTH="479" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">의약품도매부문 합계</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">내수</TD>
<TD USERMARK=" B" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">23,626,128</TD>
<TD USERMARK=" B" WIDTH="146" HEIGHT="30" ALIGN="RIGHT">20,918,620</TD>
<TD USERMARK=" B" WIDTH="146" HEIGHT="30" ALIGN="RIGHT">20,223,284</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BU" WIDTH="479" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">의료정보시스템부문 합계</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">내수</TD>
<TD USERMARK=" B" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">352,034</TD>
<TD USERMARK=" B" WIDTH="146" HEIGHT="30" ALIGN="RIGHT">386,757</TD>
<TD USERMARK=" B" WIDTH="146" HEIGHT="30" ALIGN="RIGHT">370,150</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="143" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">의약품원료제조부문</TD>
<TD WIDTH="63" HEIGHT="113" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">제   품</TD>
<TD WIDTH="263" HEIGHT="113" ROWSPAN="3" VALIGN="MIDDLE">Methylol Cephalexin Lysinate  외</TD>
<TD WIDTH="48" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">수출</TD>
<TD WIDTH="167" HEIGHT="53" ALIGN="RIGHT">-</TD>
<TD WIDTH="146" HEIGHT="53" ALIGN="RIGHT">-</TD>
<TD WIDTH="146" HEIGHT="53" ALIGN="RIGHT">18,804(EUR14,500)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">내수</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">9,990,106</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">7,824,983</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">5,739,402</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">9,990,106</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">7,824,983</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">5,758,206</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">상   품</TD>
<TD WIDTH="263" HEIGHT="30" VALIGN="MIDDLE">아말리안</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">내수</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">3,814,848</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">2,248,208</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">1,709,070</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BU" WIDTH="479" HEIGHT="113" COLSPAN="3" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">의약품원료 부문 합계</TD>
<TD WIDTH="48" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">수출</TD>
<TD WIDTH="167" HEIGHT="53" ALIGN="RIGHT">-</TD>
<TD WIDTH="146" HEIGHT="53" ALIGN="RIGHT">-</TD>
<TD WIDTH="146" HEIGHT="53" ALIGN="RIGHT">18,804(EUR14,500)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">내수</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">           13,804,954 </TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">10,073,191</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">7,448,472</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD USERMARK=" B" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">       13,804,954 </TD>
<TD USERMARK=" B" WIDTH="146" HEIGHT="30" ALIGN="RIGHT">10,073,191</TD>
<TD USERMARK=" B" WIDTH="146" HEIGHT="30" ALIGN="RIGHT">7,467,276</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" 0X1814FF" WIDTH="479" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK=" 0X000000 BU">화장품, 의료기기 제조 및 판매 부문</SPAN>
</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD USERMARK=" B" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">8,991,709</TD>
<TD USERMARK=" B" WIDTH="146" HEIGHT="30" ALIGN="RIGHT">7,048,870</TD>
<TD USERMARK=" B" WIDTH="146" HEIGHT="30" ALIGN="RIGHT">5,766,097</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="479" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">조   정(부문간 수익)</TD>
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">(14,055,513)</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">(9,973,445)</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">(6,805,896)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BU" WIDTH="479" HEIGHT="136" COLSPAN="3" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">합             계</TD>
<TD WIDTH="48" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">수출</TD>
<TD WIDTH="167" HEIGHT="76" ALIGN="RIGHT">9,791,664(US$7,040,361.13 )</TD>
<TD WIDTH="146" HEIGHT="76" ALIGN="RIGHT">6,165,573 (US$5,365,638.51)</TD>
<TD WIDTH="146" HEIGHT="76" ALIGN="RIGHT">5,027,330(US$4,262,151.66)(EUR14,500)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">내수</TD>
<TD WIDTH="167" HEIGHT="30" ALIGN="RIGHT">122,120,029</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">110,993,259</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">104,318,532</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD USERMARK=" B" WIDTH="167" HEIGHT="30" ALIGN="RIGHT">131,911,693</TD>
<TD USERMARK=" B" WIDTH="146" HEIGHT="30" ALIGN="RIGHT">117,158,831</TD>
<TD USERMARK=" B" WIDTH="146" HEIGHT="30" ALIGN="RIGHT">109,345,862</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<A REFNO="XII. 상세표|NEF-1|ADX-1">※상세 현황은 '상세표-4. 매출실적 현황(상세)' 참조</A>
</TD>
</TR>
</TBODY>
</TABLE>

<P></P>

<P>
<SPAN USERMARK=" B">나. 판매 경로</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="427">

<COLGROUP>
<COL WIDTH="57"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="271"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="147" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="280" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">판매경로, 방법 및 조건</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="66" HEIGHT="106" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">내수</TD>
<TD WIDTH="81" HEIGHT="30" VALIGN="MIDDLE">도매</TD>
<TD WIDTH="280" HEIGHT="30" VALIGN="MIDDLE">회사 → 도매상 → 병원,약국 → 소비자</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="81" HEIGHT="76" VALIGN="MIDDLE">소매</TD>
<TD WIDTH="280" HEIGHT="76" VALIGN="MIDDLE">회사 → 병원,약국 → 소비자회사 → 온라인 채널 → 소비자회사 → 제약회사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="66" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">수출</TD>
<TD WIDTH="81" HEIGHT="53" VALIGN="MIDDLE">직접수출</TD>
<TD WIDTH="280" HEIGHT="53" VALIGN="MIDDLE">회사 → 현지의약품 수입상 → 거래처회사 → 현지 거래처</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="81" HEIGHT="30" VALIGN="MIDDLE">간접수출</TD>
<TD WIDTH="280" HEIGHT="30" VALIGN="MIDDLE">회사 →국내 수출상 → 거래처</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P USERMARK="F-GL">
<SPAN USERMARK=" B">다. 판매방법 및 조건</SPAN>
<SPAN USERMARK="F-11">당사 의약품은 국내 영업인 경우 주로 의약품 도매상을 통해 판매 되고 있으며, 그 밖에 전자상거래를 통해 판매하고 있습니다. 해외영업은 외국 현지의 제약업체 또는 대형 도매업체 등에 의약품을 직접 수출하는 직거래 및 국내 무역전문 업체를 통한 간접거래(LOCAL) 방식을 통하여 판매를 진행하고 있습니다. 국내영업은 판매되는 시점에서 매출로 인식하고 있으며, 수금 방법은 현금, 어음, 신용카드 등으로 결제 받고 있습니다. 대부분의 외상 매출은 1~ 6개월 사이 수금되고 있습니다. 해외영업은 직거래인 경우 선적을 기점으로 매출 인식을 하고, 간접거래인 경우에는 출고일을 매출일로 인식을 하고 있으며 간접거래 시에는 구매확인서를 통한 외환 결제조건 거래를 추진하고 있습니다. 결제조건의 경우 대부분 수주시 선결제 조건으로 진행하거나 출고일/선적 일로부터 15일 이내 지급하는 조건을기본으로 거래되고 있습니다.</SPAN>
<SPAN USERMARK=" B">라. 판매전략</SPAN>
<SPAN USERMARK="F-11">당사는 의약분업으로 인한 제약업체간 판촉경쟁이 더욱 치열해지고  쌍벌제 등 정부규제가 강화되고 있는 바, 약국과의 직거래를 없애고 도매업체와 직거래를 함으로써 , 다수의 약국 거래에 소요되는 비용과 투자 시간을 절약하고 영업사원의 MR(Medical Representative : 정보 전달자)화 전략을 펴고 있습니다. 병원 영업을 강화하여 자사제품 판매 활성화를 꾀하고 있으며, PDA(개인 휴대용 정보 단말기) 활용으로 주문 및 배송처리의 신속성으로 거래처 만족도 증대, 대중매체, 전문지 광고를 통한 회사 이미지 및 브랜드 마케팅 강화, 신제품 개발 강화 의 전략으로 대응하고 있습니다.</SPAN>
</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">해외 영업의 경우 CPhI 및 Bio 행사 등과 같은 주요 전시회에 꾸준히 Booth개설 참가(COVID-19로 Online 참관)를 진행하고 있으며, KOTRA 및 의약품수출입협회, 보건산업진흥원 및 제약바이오협회, 한국신약개발조합 등과 같은 전문 지자체단체를 활용한 제품 및 회사 홍보(Business Partnering 등)와 Online(영문 Homepage 운영 및 다양한 해외 및 국내 B2B site내 회사 및 제품정보 게재 등)을 활용한 홍보활동도 병행하여 그 인지도를 계속 넓혀 나가고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">또한, 시장개척 활동(출장 및 Business 상담회 등)을 통한 신규 거래처 확장 및 기존 거래 Partner들과의 긴밀한 관계 유지를 위해 노력하고 있으며 기 거래처의 경우 현지 제품 판매 및 재고 현황 파악을 통한 전략적 Support 그리고 각종 Promotion 및 CSR활동 지원 등을 통하여 꾸준한 성장세 유지에 집중하고 있습니다. 신규 거래처들에게는 다양한 시장 경험 및 제품정보를 서로 공유 제공하는 등 꾸준히 개척해 나가고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">특히 점점 거세지는 해외 비관세 장벽(인허가 및 관련 비용 문제)에 대비하여 효율적인 업무처리를 위한 데이터 축적 및 공통기술문서(인허가자료 등) 전문화 추진을 통하여 세계 어느 곳이든 제품을 등록하고 수출을 진행할 수 있도록 전담 RA를 육성하는 등 적극적으로 대처해 나가고 있으며, 수출의 방식도 다양화하여 기존 완제품 수출사업을 기반으로 원료의약품 및 건식 사업, 독일 관계사와 연계한 화장품 및 의료미용기기 등의 사업을 확장 중에 있습니다. 또한, 기술이전사업 및 해외 현지화 전략을 통한 합자회사 설립 등 다방면으로의 해외진출사업을 진행하고 있습니다.</P>

<P>
<SPAN USERMARK="F-GL B">마. 수주상황</SPAN>
<SPAN USERMARK="F-GL11">당사는 국내 매출의 경우 약국, 병ㆍ의원, 도매상 매출 등에 직접판매 및 국공립병원 입찰에 의하여 판매를 하기에 장기계약에 의한 수주 판매가 일어나지 않고 있습니다.</SPAN>
<SPAN USERMARK="F-GL11">해외수주사항(장기매출계약)은 계약에서 비공개사항으로 규정하고 있어 상근감사에게 보고를 하고 상세 수주사항에 대하여 공개를 생략합니다. 공시된 단일판매 공급계약 체결과 본문 </SPAN>
<SPAN USERMARK="F-GL11 U">XI. 그 밖에 투자자 보호를 위하여 필요한 사항을 </SPAN>
<SPAN USERMARK="F-GL11">참조하시기 바랍니다.</SPAN>
</P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-5-L1">5. 위험관리 및 파생거래</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">가. 시장위험과 위험관리</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">1) 환율 변동 리스크시장에 노출된 환율 변동 리스크가 중요하지 않아 기재를 생략합니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">2). 금리 변동 리스크당사는 고정이자율과 변동 이자율로 자금을 차입하고 있으며, 이로 인하여 이자율 위험에 노출되어 있습니다. 회사는 이자율위험을 관리하기 위하여 고정금리부 차입금과 변동 금리부 차입금의 적절한 균형을 유지하고 있습니다. 위험회피 활동은 이자율 현황과 정의된 위험성향을 적절히 조정하기 위해 정기적으로 평가되며 최적의 위험회피 전략이 적용되도록 하고 있습니다. </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">(1) 보고기간종료일 현재 연결회사가 보유하고 있는 이자부 금융상품의 장부금액은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="702" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="693"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="702" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="702" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="351" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="3">고정이자율</TH>
<TH WIDTH="351" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">변동이자율</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="117" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="117" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="117" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
<TH WIDTH="117" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="117" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="117" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="117" HEIGHT="30">  금융자산</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">10,082,000</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">16,172,241</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="CENTER">금융자산</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="117" HEIGHT="30">  금융부채</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="CENTER"> 금융부채</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(62,506,288)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(58,240,470)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>

<P>
<SPAN USERMARK="F-GL11">(2) 고정이자율 금융상품의 공정가치 민감도 분석연결회사는 고정이자율 금융상품을 당기손익인식금융상품으로 처리하고 있지 않으며, 파생상품을 공정가치위험회피회계의 위험회피수단으로 지정하지 않았습니다. 따라서, 이자율의 변동은 손익에 영향을 주지 않습니다.</SPAN>
</P>
<P USERMARK="F-GL11">(3) 변동이자율 금융상품의 현금흐름 민감도 분석</P>
<P USERMARK="F-GL11">당기말 현재 이자율이 100베이시스포인트 변동한다면, 자본과 손익은 증가 또는 감소하였을 것입니다. 이 분석은 환율과 같은 다른 변수는 변동하지 않는다고 가정하며, 전기에도 동일한 방법으로 분석하였습니다. 구체적인 자본 및 손익의 변동금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="641" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="632"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="641" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="641" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="179" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">구 분</TH>
<TH COLSPAN="2" WIDTH="232" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">손 익</TH>
<TH COLSPAN="2" WIDTH="230" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자 본</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="117" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">100bp 상승</TH>
<TH WIDTH="115" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">100bp 하락</TH>
<TH WIDTH="115" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">100bp 상승</TH>
<TH WIDTH="115" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">100bp 하락</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="641" HEIGHT="30"><당기말></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30">변동이자율 금융상품</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(625,063)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">625,063</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">(625,063)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">625,063</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="641" HEIGHT="30"><전기말></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30">변동이자율 금융상품</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(582,405)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">582,405</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">(582,405)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">582,405</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11">3) 신용위험</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">연결회사는 표준 지급기준을 결정하기 이전에 모든 신규 고객에 대해 개별적으로 신용도을 검토하도록 하는 신용정책을 수립하였습니다. 검토시에는 외부적인 등급과 은행의 평가 등을 고려합니다. 별도의 승인 요청 없이 가능한 최고 구매한도가 개별 고객별로 정해지며, 이 한도는 분기별로 검토 되고 있습니다. 연결회사의 신용기준을 충족하지 못한 고객은 선급금 지불 시에만 거래가 가능합니다.</SPAN>
<SPAN USERMARK="F-GL">(1) 신용위험에 대한 노출 </SPAN>
<SPAN USERMARK="F-GL11">금융자산의 장부금액은 신용위험에 대한 최대노출정도를 나타냅니다. 보고기간종료일 현재 연결회사의 신용위험에 대한 최대 노출정도는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="618" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="618" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="622" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="152"></COL>
<COL WIDTH="151"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="301" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="161" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당기말</TH>
<TH WIDTH="160" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30"> 기타포괄손익-공정가치측정금융자산</TD>
<TD WIDTH="161" ALIGN="RIGHT" HEIGHT="30">3,633,411</TD>
<TD WIDTH="160" ALIGN="RIGHT" HEIGHT="30">3,807,140</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30"> 상각후원가측정금융자산</TD>
<TD WIDTH="161" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">33,689,734</TD>
<TD WIDTH="160" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">38,798,268</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30"> 당기손익-공정가치측정금융자산</TD>
<TD WIDTH="161" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,593,067</TD>
<TD WIDTH="160" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3,066,361</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="161" ALIGN="RIGHT" HEIGHT="30">38,916,212</TD>
<TD WIDTH="160" ALIGN="RIGHT" HEIGHT="30">45,671,769</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 손상차손보고기간종료일 현재 매출채권의 연령 및 각 연령별로 손상된 채권금액은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" WIDTH="614" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="605"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="614" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="134"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="143" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">구 분</TH>
<TH COLSPAN="2" WIDTH="236" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH COLSPAN="2" WIDTH="236" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="118" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권잔액</TH>
<TH WIDTH="118" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">손상된 금액</TH>
<TH WIDTH="118" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권잔액</TH>
<TH WIDTH="118" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">손상된 금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30"> 0일-30일</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">10,819,288</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">61,492</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">10,126,729</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">96,821</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30"> 31일-120일</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">6,512,182</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">71,908</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">5,691,754</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">91,378</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30"> 120일-1년이내</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">1,036,831</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">97,615</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">1,175,355</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">86,893</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30"> 1년 이상 경과</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">1,807,746</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">1,807,746</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">1,853,235</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">1,853,235</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">20,176,047</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">2,038,761</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">18,847,073</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">2,128,327</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11">4) 유동성위험</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">보고기간종료일 현재 연결회사가 보유한 금융부채의 계약상 만기는 다음과 같습니다</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="836" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="827"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="836" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="840" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="184"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="193" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">구 분</TH>
<TH WIDTH="93" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">장부금액</TH>
<TH WIDTH="93" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">계약상현금흐름</TH>
<TH WIDTH="93" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">6개월이내</TH>
<TH WIDTH="92" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">6-12개월</TH>
<TH WIDTH="92" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">1-2년</TH>
<TH WIDTH="92" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">2-5년</TH>
<TH WIDTH="92" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">5년 이상</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="840" VALIGN="BOTTOM" HEIGHT="30" COLSPAN="8"> 당기말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">   단기차입금</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">59,054,800</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">59,054,800</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,694,790</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50,360,010</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">   장기차입금(유동성포함)</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,557,203</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,557,203</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,249,730</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27,307,473</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">   전환사채</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30">   매입채무와기타채무</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">22,089,559</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">22,089,570</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">18,688,785</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,935,785</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">465,000</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30">   리스부채</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">453,683</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">477,442</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">59,981</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">169,596</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">247,865</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">112,155,245</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">112,179,015</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">27,443,556</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">53,465,391</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">3,962,595</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">27,307,473</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="840" VALIGN="BOTTOM" HEIGHT="30" COLSPAN="8"> 전기말</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30">   단기차입금</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55,502,585</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55,502,585</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,109,880</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">47,392,705</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30">   장기차입금(유동성포함)</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">13,296,310</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">13,296,310</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">117,485</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,382,335</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,309,195</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">8,487,295</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30">   전환사채</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30">   매입채무와기타채무</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">16,158,919</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">16,158,919</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">12,791,432</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,899,636</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">467,851</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30">   리스부채</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">507,264</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">531,023</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">89,803</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">169,596</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">271,623</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">86,309,078</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">86,332,837</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">21,108,600</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">53,688,272</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">3,048,669</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">8,487,295</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">연결회사는 이 현금흐름이 유의적으로 더 이른 기간에 발생하거나, 유의적으로 다른 금액일 것으로 기대하지 않습니다. </P>

<P>
<SPAN USERMARK="F-GL B">나. 파생상품 및 풋백옵션 등 거래 현황 </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">당사는 현재 파생상품 및 풋백옵션 등의 거래는 없습니다. 다만, 당사의 전환사채에 부여된 전환권대가가 내재파생상품요건을 충족함에 따라 당기말 현재 공정가치로 평가하였으며, 보고일 현재 전환사채의 잔액은 없습니다. 1) 전환사채 발행내역</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="168"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="369"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">사채 종류</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">무기명식 이권부 무보증 사모 전환사채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">발행금액</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"> 20,000,000,000원 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">용도</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">운영자금, 시설자금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">표면이자율</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">만기이자율</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">원금상환 방법</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="122">만기까지 보유하고 있는 본 사채의 원금에 대하여는 2024년 03월 29일에 권면금액의 110.0000%에 해당하는 금액을 일시 상환한다. 단, 상환기일이 은행영업일이 아닌 경우에는 그 다음 영업일에 상환하고 원금 상환기일 이후의 이자는 계산하지 아니한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">발행시점 주식전환 행사가액</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">21,154원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">전환가액 (원/주)</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">14,808원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">당기말 현재 전환에  따라 발행할 주식</TD>
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">종류</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기명식 보통주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주식수</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">전환청구기간</TD>
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">시작일</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020년 03월 29일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">종료일</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2024년 02월 29일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">전환가액 조정에 관한 사항</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최초 전환가격의 70%까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">조기상환청구권(Put Option)</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="214"> 본 사채의 사채권자는 본 사채의 발행일로부터 21개월이 되는 2020년 12월 29일 및 이후 매 3개월에 해당되는 날(이하 “조기상환일”이라 한다)에 사채증서를 발행회사에게 반환하면서  본 사채의 전부 또는 일부에 대하여 그 권면금액 및 이에 대하여 조기상환수익률(연 단리 2.0%)이 적용된 조기상환 청구 금액을 만기 전 조기상환 할 것을 청구할 수 있다. 단, 조기상환지급일이 은행 영업일이 아닌 경우에는 그 다음 영업일에 상환하고 조기상환지급일 이후의 이자는 계산하지 아니한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="191">매도청구권(Call Option)</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="191"> 발행회사 또는 발행회사가 지정하는 자(이하 “매도청구권자”라 한다)는 발행일로부터 1년이 되는 날인 2020년 03월 29일부터 2021년 03월 29일까지 사채권자가 보유하고 있는 본 사채를 매수할 수 있는 권리(이하 “매도청구권”이라 한다)를 가진다. 단, 매도청구권자는 각 사채권자에 대하여 각 사채권자가 보유하고 있는 본 사채 발행가액의 30%를 초과하여 매도청구권을 행사할 수 없다. </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 본 사채권을 소유한 자가 전환청구를 하기 전에 시가를 하회하는 발행가액으로 유상증자, 주식배당 및 준비금의 자본전입 등에 따른 주식을 발행하거나 또는 시가를 하회하는 전환가액 또는 행사가액으로 특수사채를 발행하는 경우에 전환가액이 조정될 수 있습니다. 또한, 합병, 자본의 감소, 주식분할 및 병합 등에 의하여 전환가격의 조정이 필요한 경우 조정하며, 최저조정한도는 발행시 전환가액의 70% 이상으로 합니다. 1차 전환사채의 최초 발행시 행사가격은 21,154원/1주 였으며 주가의 하락으로 인해 1차 조정가액은 16,398원/1주, 2차 조정가액은 14,808원/1주로 최저 조정한도 발행시 전환가액의 70%의 조건에 따라 최종 행사가액은 14,808원/1주 입니다</SPAN>
<SPAN USERMARK="F-GL10 B">.</SPAN>
<SPAN USERMARK="F-GL10">(주2)전환권 청구  2020년 9월 51억원 청구 보통주 344,405주 발행, 2021년 1월 7억원 청구 보통주 47,271주 발행, 합계 58억원 보통주 391,676주 발행 하였습니다. (주3) 조기상환 청구 2020년 12월 9억원, 2021년 6월 90억원, 2021년 12월 35억원, 2022년 6월 5억원, 2022년 9월 3억원 총 142억원 상환하였습니다. (주4) 전환권, 조기상환 청구에 따라 보고서 제출일 현재 전환사채의 잔액은 없습니다. </SPAN>
</P>
<P></P>

<P>
<SPAN USERMARK="F-GL">2) 보고기간종료일 현재 전환사채의 내역</SPAN>
</P>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11"><당기></SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="739">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="430"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="439" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="743" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종 류</TH>
<TH WIDTH="97" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환청구</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">조기상환청구</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자비용</TH>
<TH WIDTH="126" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말잔액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30"> 전환사채</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">800,000</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30">(800,000)</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30"> 상환할증금(주1)</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">44,000</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30">(53,500)</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">9,500</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">844,000</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30">(-853,500)</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">9,500</TD>
<TD WIDTH="126" ALIGN="RIGHT" HEIGHT="30" USERMARK="F-BT">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11 0XFF0016">
<SPAN USERMARK="F-10 0X000000"> (주1) 회사는 당기말 상환시 지급하여야 할 이자비용을 사채상환할증금으로 인식하였습니다. </SPAN>
</P>
<P USERMARK="F-GL11">당기말 현재 주계약과 분리된 내재파생상품부채의 공정가치 변동 및 관련손익은 다음과같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="311"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="320" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종류</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="206" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">당기발행(전기이월)</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">44,800</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,231,018</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">파생상품평가손실</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,312,014)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">조기상환으로 인한 감소</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(44,800)</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(673,207)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">전환권행사</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(245,752)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="MIDDLE">당기말 현재공정가치</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-6-L1">6. 주요계약 및 연구개발활동</TITLE>
<P></P>
<P USERMARK="F-GL B">가. 경영상의 주요계약 등</P>

<P>
<SPAN USERMARK="F-GL11">1) 기술이전계약</SPAN>
<SPAN USERMARK="F-GL11">공시서류 작성기준일 현재 당사가 체결 중인 라이선스아웃(License-out) 계약의 현황은 다음과 같습니다. </SPAN> 
<SPAN USERMARK="F-GL">(</SPAN>
<SPAN USERMARK="F-GL11">1) 라이선스아웃 계약 총괄표   </SPAN>
<SPAN USERMARK="F-GL">                                                                                                                                                                            (단위 :억원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="1497" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="215"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="230"></COL>
<COL WIDTH="154"></COL>
<COL WIDTH="233"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">품목</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="224" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약상대방</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="198" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대상지역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약체결일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="209" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약종료일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="239" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">총 계약금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수취금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="242" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">진행단계</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="99">리포락셀액(경구용 항암제)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="224" HEIGHT="99">RMX Biopharma,Co.,Ltd (중국)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="198" HEIGHT="99">중국, 대만, 홍콩, 태국시장</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="99">2017.09.06.</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="209" HEIGHT="99"> 중국내 제품 시판 후 10년간</TD>

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="239" HEIGHT="99">283억원 + 
<SPAN USERMARK="F-10">Running Royalty($2,500만+ Running Royalty)</SPAN>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="99">121억원($1,000만)</TD>
<TD WIDTH="242" HEIGHT="99">유방암 : 3상 진행 중위암 : 신약허가신청(NDA) 완료'하단 상세내용 참조'</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">※ 상기 총계약금액은 계약일 당일 매매기준 환율로 환산한 금액이며, 수취금액은 수취일 매매기준 환율로 환산한 금액입니다.</SPAN>
<SPAN USERMARK="F-GL"> (</SPAN>
<SPAN USERMARK="F-GL11">2) 상세 내용</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="621" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="451"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TD COLSPAN="2" WIDTH="621" HEIGHT="30">
<P>리포락셀액(경구용 항암제)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="161" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">① 계약상대방</P>
</TD>

<TD WIDTH="460" HEIGHT="30">
<P>RMX Biopharma,Co.,Ltd (중국)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="161" HEIGHT="76" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">② 계약내용</P>
</TD>

<TD WIDTH="460" HEIGHT="76">
<P>계약상대방 RMX Biopharma은 중국, 대만, 홍콩, 태국시장내 개발 및 판매에 대한 독점적 권리를 가지고 임상시험, 허가, 생산,상업화 등을 진행</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="161" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">③ 대상지역</P>
</TD>

<TD WIDTH="460" HEIGHT="30">
<P>중국, 대만, 홍콩, 태국시장</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="161" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">④ 계약기간</P>
</TD>

<TD WIDTH="460" HEIGHT="30">
<P>2017.09.06.~ 중국내 제품 시판 후 10년간</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="161" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑤ 총 계약금액</P>
</TD>
<TD WIDTH="460" HEIGHT="30">Licensing fee $2,500만 + Royalty</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="161" HEIGHT="168" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑥ 수취금액</P>
</TD>

<TD WIDTH="460" HEIGHT="168">
<P><반환의무 없는 금액>계 약 금  : 약 40억원(USD 3,500,000) 2017년 9월,10월  수취마일스톤 : 약 11억원(USD 1,000,000) 2018년 3월 수취               약 41억원(USD 3,500,000) 2019년 5월 수취               약 29억원(USD 2,000,000) 2022년 9월 수취<빈환의무 발생가능 금액>: 해당없음.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="161" HEIGHT="191" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑦ 계약조건</P>
</TD>

<TD WIDTH="460" HEIGHT="191" VALIGN="MIDDLE">

<P>계 약 금  : 40억원(USD 3,500,000) 마일스톤 : 243억원(USD 21,500,000)수취조건 : 각 단계 진입성공(임상 및 시판허가 등)로 열 티  : 향후 매출 발생에 따른 경상기술료
<SPAN USERMARK="F-10">(Running Royalty)</SPAN>기      타 : 임상, 인허가 및 상업화 실패 시 계약은 종료될 수 있으며, 계약종료시 기수취분에 대한 회사의 위약금 반환의무는 없음
</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="161" HEIGHT="145" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑧ 회계처리방법</P>
</TD>

<TD WIDTH="460" HEIGHT="145" USERMARK=" 0X1814FF B">
<SPAN USERMARK=" 0X000000 !B">17년 계약금 수취액 40억원(USD 3,500,000)은 용역의 대가(Know-How 이전)로 전액 수익으로 인식마일스톤 수취액  81억원(USD 6,500,000)은 위암 및 유방암 임상 정보제공에  대한 대가로서 해당금액 전액 수익인식</SPAN>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="161" HEIGHT="168" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑨ 대상기술</P>
</TD>

<TD WIDTH="460" HEIGHT="168">
<P>리포락셀®액은 세계 최초로 개발/허가 받은 경구용 파클리탁셀 항암제로 안전한 지질부형제를 사용하여 주사제 투여 시 소요되는 전처치와 장시간의 주사시간 등이 불필요하며, 기타 주사제 치료 중단의 주요 사유인 말초신경병증 및 탈모 증상을 완화하여 환자의 삶의 질(QoL)을 대폭 향상시킨 개량신약임. 또한 주사제에서 필요한 스테로이드 전처치가 없어 향후 면역항암제와의 병용요법 개발도 가능할 것으로 기대하고 있음.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="161" HEIGHT="743" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑩ 개발 진행경과</P>
</TD>

<TD WIDTH="460" HEIGHT="743">
<P><거래상대방>① 2018년 3월 중국 IND 접수② 2018년 7월 위암에 대한 CTA 승인③ 2018년 10월 유방암에 대한 CTA 승인④ 2019년 4월 위암 Ⅲ 상 첫 대상자 등록⑤ 2019년 9월 유방암 첫 대상자 등록⑥ 2022년 9월 위암에 대한 신약허가신청(NDA) 완료</P>
<P>  <회사>① 2016년 9월 위암적응증 국내 시판허가 취득② 2017년 9월 국내 유방암 Ⅱ/Ⅲ IND 승인③ 2017년 12월 국내 유방암  Ⅱ/Ⅲ 첫 대상자 등록④ 2018년 11월 유방암  Ⅱ/Ⅲ상 중국 포함 확대 실시⑤ 2019년 9월 유방암 첫 대상자 등록, 2019 ESMO 국내 유방암 2상 결과 Poster 발표⑥ 2019년 12월 미국 유방암 2상, 2019 San Antonio 유방암학회(SABCS) Ongoing Trial Session 포스터 발표⑦ 2020년 3월 ~6월 국내 및 중국 유방암 Ⅲ상 2020 ASCO 'Trial in Progress' 포스터 채택 및 발표⑧ 2020년 6월 리포락셀 EU QP audit 실시 및 certification 획득⑨ 2020년 6월 ~10월 동유럽 3개국(세르비아, 헝가리, 불가리아)유방암 Ⅲ상 IND 제출 및 승인⑩ 2020년 11월 유방암 Ⅱ상 동유럽(체코) IND승인⑪ 2020년 12월 미국/체코 유방암  2020 Ⅱ상  San Antonio 유방암학회(SABCS)  PK 결과 포스터 발표⑫ 2021년 3월 유방암Ⅱ상 체코 첫 대상자 등록 및 진행⑬ 2021년 11월 유방암 Ⅱ/Ⅲ상 Ⅱ상 결과 "Therapeutic Advances in Medical Oncology" 논문 발표⑭ 2022년 9월 미국/체코 유방암  II상 2022 ESMO 유럽종양학회 결과 포스터 발표⑮ 2022년 12월 한국/중국/유럽 유방암 Ⅲ상 진행 중, 미국/체코 유방암 Ⅱ상 진행 중, 헝가리 고형암 Ⅰ상 진행 중</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">※ 상기 계약금액은 계약일자(2017.09.06) 매매기준율(미화1달러: 1,1122.70원)로 환산한 금액입니다. </SPAN>
<SPAN USERMARK="F-GL11">2) 공장 증축</SPAN>
<SPAN USERMARK="F-GL11">지배회사인 대화제약(주)는 2020년 09월 21일 이사회에서 420억원을 투자하여 공장내 제4공장 신설하는 결정을 하였으며 관련된 주요 계약은 아래와 같습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="873">

<COLGROUP>
<COL WIDTH="151"></COL>
<COL WIDTH="441"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="160" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약상대방</TH>
<TH WIDTH="450" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약의 목적 및 내역</TH>
<TH WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약일자</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약금액(천원)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">㈜녹십자이엠</TD>
<TD WIDTH="450" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대화제약(주) 제4공장 신설  건설공사 도급 계약</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.11.17 외</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21.590.000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">이케다산업기계(주)</TD>
<TD WIDTH="450" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">첩부제 절단 </TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.01.07</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,234,287</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)대창엔지니어링</TD>
<TD WIDTH="450" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">첩부제 도포기</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.02.02</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,288,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)뉴팩코리아</TD>
<TD WIDTH="450" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">습포제 절단 포장기</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.03.12</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,200,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">주식회사 에스엠코어</TD>
<TD WIDTH="450" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자동창고 제작 설치</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.02.19</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,866,416</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">조흥엔지니어링</TD>
<TD WIDTH="450" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">습포제 도포기</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.03.18</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">783,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="160" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(주)기은엔지니어링</TD>
<TD WIDTH="450" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">정제수 제조장치 및 분배시스템</TD>
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.12.17</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">615,000</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">나. 연구개발 활동</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">1) 연구개발 활동의 개요</SPAN>
<SPAN USERMARK="F-GL">당</SPAN>
<SPAN USERMARK="F-GL11">사는 미래 성장을 위한 꾸준한 R&D 투자를 통해 고부가 가치의 신제품을 개발하고 경구용 파클리탁셀인 리포락셀액의 성공적인 해외 임상시험과약물전달시스템(DDS) 기술을 활용한 전문의약품용 패치형 제품 개발, 천연물 신약개발에 역량을 집중하고 있습니다. 당사는 중앙연구소 등 3개의 연구소와 연계하여 신약개발, 패치제 개발(DDS 기술 활용), 생동용 제품은 물론 바이오 합성 연구까지 이루어 시너지 창출을 도모케하고, 인력의 확대와 투자를 계속해 나갈 것입니다.2) 연구개발 담당 조직당사는 중앙연구소, 판교 연구소, (주)리독스바이오 연구소를 두고 있습니다.중앙연구소에서는 Pilot Study 및 신규 인허가, 제제 개발 및 양산 지원, LASED Scale-up 연구, 개량신약 연구를 하고 있으며, 판교연구소에서는 TransDermal Drug Delivery System연구,  개량신약연구, 바이오합성연구 등을 하고 있습니다.리독스바이오는 지배회사의 현물출자로 지배회사의 연구인력이 흡수되면서 향후 제제화 기술, 원료의약품 합성, 약물전달시스템 개발, 천연물 의약품 후보물질 스크리닝 및 제품 개발활동이 적극적 전개될 예정입니다. 이로 인해 자체적 특성화된 기술을 보유하게 될 것이며, 수행과제의 내부적 관리·평가 시스템을 운영하여 효율적인 신약/개량신약 개발 프로세스를 진행할 수 있을 것이라 예상됩니다.</SPAN>
</P>
<P></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="320" ALIGN="CENTER" HSPACE="0">대화제약(주) 연구개발 조직도.jpg</IMG>
<IMG-CAPTION ATOC="N">대화제약(주) 연구개발 조직도</IMG-CAPTION>
</IMAGE>
<P></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="241" ALIGN="CENTER" HSPACE="0">(주)리독스바이오 연구개발 조직도.jpg</IMG>
<IMG-CAPTION ATOC="N">(주)리독스바이오 연구개발 조직도</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK="F-GL11">3) 연구개발 인력현황</SPAN> 
<SPAN USERMARK="F-GL11">(1)지배회사의 연구개발 인력현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="603">

<COLGROUP>
<COL WIDTH="279"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="288" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="315" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">인원(명)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">박사</TH>
<TH WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">석사</TH>
<TH WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타</TH>
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">연구개발본부장</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">판교연구소</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">16</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">19</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">중앙연구소</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">39</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">45</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="288" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">39</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">65</TD>
</TR>
</TBODY>
</TABLE>

<P> 
<SPAN USERMARK="F-GL">(</SPAN>
<SPAN USERMARK="F-GL11">2) 주요종속회사의 연구개발 인력현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="284" HEIGHT="60" COLSPAN="2" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연구소</TH>
<TH WIDTH="316" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">인 원(명)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH USERMARK=" BC0XBEBEBE" WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">박 사</TH>
<TH USERMARK=" BC0XBEBEBE" WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">석 사</TH>
<TH USERMARK=" BC0XBEBEBE" WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 타</TH>
<TH USERMARK=" BC0XBEBEBE" WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">중앙연구소</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">바이오 사업팀</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="164" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">의약품 합성팀</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="284" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">7</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">4) 핵심 연구인력 현황 (1) 지배회사의 핵심 연구인력 현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="883">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="354"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="48" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구분</P>
</TH>

<TH WIDTH="63" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>성명</P>
</TH>

<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>직급</P>
</TH>

<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>담당업무</P>
</TH>

<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>최종학위</P>
</TH>

<TH WIDTH="363" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요 학력 및 경력</P>
</TH>

<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>주요연구실적</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1</P>
</TD>

<TD WIDTH="63" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>추성남</P>
</TD>

<TD USERMARK=" 0X0000FF B" WIDTH="93" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>이사</P>
</TD>

<TD WIDTH="113" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>연구 총괄</P>
</TD>

<TD WIDTH="78" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>석사</P>
</TD>

<TD WIDTH="363" HEIGHT="168" VALIGN="MIDDLE">
<P>학력사항- 연세대학교 물리치료학과 학사</P>
<P>- 강원대학교 경영대학원 경영학과 석사</P>
<P>- 강원대학교 대학원 약학과 박사 수료경력사항</P>
<P>- 대화제약㈜ 연구소장 (현재)</P>
</TD>

<TD WIDTH="125" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">
<P>(주1)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" HEIGHT="260" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2</P>
</TD>
<TD WIDTH="63" HEIGHT="260" ALIGN="CENTER" VALIGN="MIDDLE">조우철</TD>
<TD WIDTH="93" HEIGHT="260" ALIGN="CENTER" VALIGN="MIDDLE">책임연구원</TD>

<TD WIDTH="113" HEIGHT="260" ALIGN="CENTER" VALIGN="MIDDLE">
<P>DDS 제형</P>
<P>개발</P>
</TD>

<TD WIDTH="78" HEIGHT="260" ALIGN="CENTER" VALIGN="MIDDLE">
<P>박사</P>
</TD>

<TD WIDTH="363" HEIGHT="260" VALIGN="MIDDLE">
<P>학력사항- 연변대학교(중국) 약학과 학사</P>
<P>- 원광대학교 대학원 약학과 석사</P>
<P>- 원광대학교 대학원 약학과 박사경력사항</P>
<P>- 원광대학교 약품연구소 박사후 연구원</P>
<P>- 원광대학교 약품연구소 교수</P>
<P>- 우신메딕스(주) 중앙연구소 수석연구원- 라보타치(주) QA/QC 책임</P>
<P>- 대화제약(주) TDS/1팀 팀장(현재)</P>
</TD>

<TD WIDTH="125" HEIGHT="260" ALIGN="CENTER" VALIGN="MIDDLE">
<P>(주2)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="214" ALIGN="CENTER" VALIGN="MIDDLE">3</TD>
<TD WIDTH="63" HEIGHT="214" ALIGN="CENTER" VALIGN="MIDDLE">김백경</TD>
<TD WIDTH="93" HEIGHT="214" ALIGN="CENTER" VALIGN="MIDDLE">책임연구원</TD>

<TD WIDTH="113" HEIGHT="214" ALIGN="CENTER" VALIGN="MIDDLE">
<P>DDS 신약</P>
<P>개발</P>
</TD>
<TD WIDTH="78" HEIGHT="214" ALIGN="CENTER" VALIGN="MIDDLE">박사</TD>

<TD WIDTH="363" HEIGHT="214" VALIGN="MIDDLE">
<P>학력사항- 건국대학교 생물학과 학사</P>
<P>- 고려대학교 대학원 생명공학과 석사</P>
<P>- 서울대학교 대학원 의학과 박사</P>
<P> </P>
<P>경력사항 </P>
<P>- 서울대병원 의생명연구원 연구원</P>
<P>- 보령제약(주) 중앙연구본부 연구원</P>
<P>- 대화제약(주) BIO신약팀 팀장(현재)</P>
</TD>
<TD WIDTH="125" HEIGHT="214" ALIGN="CENTER" VALIGN="MIDDLE">(주3)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="48" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">
<P>4</P>
</TD>

<TD WIDTH="63" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">
<P>송인범</P>
</TD>
<TD WIDTH="93" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">책임연구원</TD>

<TD WIDTH="113" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">
<P>DDS 제형</P>
<P>개발</P>
</TD>

<TD WIDTH="78" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">
<P>석사</P>
</TD>

<TD WIDTH="363" HEIGHT="145" VALIGN="MIDDLE">
<P>학력사항- 전북대학교 고분자공학과 학사</P>
<P>- 전북대학교 공과대학원 유기신물질공학과 석사경력사항</P>
<P>- 대화제약(주) TDS/2팀 팀장(현재)</P>
</TD>

<TD WIDTH="125" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">
<P>(주4)</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 B">(주1) 당 연구인력 추성남의 주요 연구실적은 다음과 같습니다.  </P>
<P USERMARK="F-GL11">●  생산성과 안정성이 개선된 시타글립틴 속방성 코팅방법 (2018)</P>
<P USERMARK="F-GL11">●  경도 및 청량감이 우수한 구강 붕해정 (2018)</P>
<P USERMARK="F-GL11">●  안정성이 개선된 플로로글루시놀 무수물 함유 속용성 정제의 제조방법 (2015)</P>
<P USERMARK="F-GL11">●  제제 중 카르복시메틸셀룰로오스 나트륨의 개선된 정량방법 (2015)</P>
<P USERMARK="F-GL11">●  펠라고니움시도이데스 추출물을 포함하는 약학적 조성물의 제조방법 (2015)</P>
<P USERMARK="F-GL11">●  광학 활성 라베프라졸 제제 (2014)</P>
<P USERMARK="F-GL11">●  엔테카비어를 포함하는 약학적 조성물의 제조방법 (2013)</P>
<P USERMARK="F-GL11">●  항-당뇨병제를 함유하는 위-체류형 서방성 정제 (2011)</P>
<P USERMARK="F-GL11">●  바클로펜을 함유하는 이중층 정제 (2011)</P>
<P USERMARK="F-GL11"><정부과제></P>
<P USERMARK="F-GL11">● "인공지능-컴퓨터 기반 신약개발(AI-CADD) 솔루션을 활용한 GLS 타켓 대사항암제 개발"과기부과제 총괄책임자 (2022)</P>
<P USERMARK="F-GL11">● "GLP-1 유래 펩타이드를 포함하는 경구용 당뇨비만 치료제 개발”복지부과제 총괄책임자 (2021)</P>
<P USERMARK="F-GL11">● "DH-ODF 플랫폼 기반의 글로벌 의약품 개발” 산자부과제 책임자 (2020)</P>

<P USERMARK="F-GL11">
<SPAN USERMARK=" B"> (주2) 당 연구인력 조우철의 주요 연구실적은 다음과 같습니다.</SPAN><논문>
</P>
<P USERMARK="F-GL11">● Apoptotic effect of propyl gallate in activated rat hepatic stellate cells. Arch Pharm Res. (2012)● Tetrandrine induces apoptosis in hepatic stellate cells. Phytother Res. 2004● 2',4',6'-Tris(methoxymethoxy) chalcone induces apoptosis by enhancing Fas-ligand inactivated hepatic stellate cells. Eur J Pharmacol. 2011 ● The chalcone butein from Rhus verniciflua shows antifibrogenic activity. Planta Med. 2003● Anti-fibrotic effect of PF2401-SF, a standardized fraction of Salvia miltiorrhiza, in thioacetamide-induced experimental rats liver fibrosis. Arch Pharm Res. 2015● Aloe emodin-induced apoptosis in t-HSC/Cl-6 cells involves a mitochondria-mediated pathway. Basic Clin Pharmacol Toxicol. 2005 ● 1,2,3,4,6-penta-O-galloyl-beta-D- glucose from Galla Rhois protects primary rat hepatocytes from necrosis and apoptosis. Planta Med. 2008● Tanshinone II A induces apoptosis and S phase cell cycle arrest in activated rat hepatic stellate cells. Basic Clin Pharmacol Toxicol. 2010 ● Skullcapflavone I from Scutellaria baicalensis induces apoptosis in activated rat hepatic stellate cells. Planta Med. 2005 ● Butein suppresses bile acid-induced hepatocyte apoptosis through a JNK-dependent but ERK-independent pathway. Planta Med. 2007 ● Honokiol induces apoptosis via cytochrome c release and caspase activation in activated rat hepatic stellate cells in vitro. Planta Med. 2005 ● A ginsenoside metabolite, 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol, triggers apoptosis in activated rat hepatic stellate cells via caspase-3 activation. Planta Med. 2006● Bakuchiol-induced caspase-3-dependent apoptosis occurs through c-Jun NH2-terminal kinase-mediated mitochondrial translocation of Bax in rat liver myofibroblasts. Eur J Pharmacol. 2007● Butein suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. J Pharm Pharmacol. 2003 ● Preventive effects of a purified extract isolated from Salvia miltiorrhiza enriched with tanshinone I, tanshinone IIA and cryptotanshinone on hepatocyte injury in vitro and in vivo. Food Chem Toxicol. 2009 ● Water-soluble polysaccharide from Eleutherococcus senticosus stems attenuates fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice. Basic Clin Pharmacol Toxicol. 2004 ● Induction of apoptosis by tanshinone I via cytochrome c release in activated hepatic stellate cells. Pharmacol Toxicol. 2003 ● Curcumin inhibits collagen synthesis and hepatic stellate cell activation in-vivo and in-vitro. J Pharm Pharmacol. 2002 ● Aloe emodin suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Pharmacol Toxicol. 2002 ● Protective effects of honokiol and magnolol on tertiary butyl hydroperoxide- or D-galactosamine-induced toxicity in rat primary hepatocytes. Planta Med. 2003 ● Honokiol reduces oxidative stress, c-jun-NH2-terminal kinase phosphorylation and protects against glycochenodeoxycholic acid-induced apoptosis in primary cultured rat hepatocytes. Planta Med. 2006 ● PF2401-SF, standardized fraction of Salvia miltiorrhiza and its constituents, tanshinone I, tanshinone IIA, and cryptotanshinone, protect primary cultured rat hepatocytes from bile acid-induced apoptosis by inhibiting JNK phosphorylation. Food Chem Toxicol. 2007 ● Acanthoic acid from Acanthopanax koreanum protects against liver injury induced by tert-butyl hydroperoxide or carbon tetrachloride in vitro and in vivo. Planta Med. 2004 ● Polyozellin inhibits nitric oxide production by down-regulating LPS-induced activity of NF-kappaB and SAPK/JNK in RAW 264.7 cells. Planta Med. 2006 <등록 특허>●  Transdermal Drug Delivery System, Patent No. : 101292768,(KOREA)●  Percutaneous absorption preparations for the treatment of dementia containg donepezil as an active ingredient, Patent No. : 101454362, (KOREA) </P>
<P USERMARK="F-GL B">(주3) 당 연구인력 김백경의 주요 연구실적은 다음과 같습니다.</P>
<P USERMARK="F-GL"> <논문></P>
<P USERMARK="F-GL11">● Activation of Protein Kinase G (PKG) Reduces Neointimal Hyperplasia, Inhibits Platelet</P>
<P USERMARK="F-GL11">Aggregation, and Facilitates Re endothelialization. Sci Rep. 2016 </P>
<P USERMARK="F-GL11">● Interaction between platelets and endothelial progenitor cells via LPA-Edg-2 axis is</P>
<P USERMARK="F-GL11">augmented by PPARdelta activation. J Mol Cell Cardiol. 2016 </P>
<P USERMARK="F-GL11">● PPARgamma Modulates Vascular Smooth Muscle Cell (VSMC) Phenotype via Protein Kinase G-dependent Pathway and Reduces Neointimal Hyperplasia after Vascular Injury. Exp Mol Med. 2013</P>
<P USERMARK="F-GL11">● Comparison of endothelialization and neointimal formation with stents coated with</P>
<P USERMARK="F-GL11">antibodies against cd34 and vascular endothelial cadherin. Biomaterials. 2012 </P>
<P USERMARK="F-GL11">● Peroxisome proliferator activated receptor gamma agonists suppress tissue factor</P>
<P USERMARK="F-GL11">overexpression in rat balloon injury model with paclitaxel infusion. PLoS One . 2011</P>
<P USERMARK="F-GL11">● Sulfasalazine induces haem oxygenase-1 via ROS-dependent Nrf2 signaling, leading to control of neoint imal hyperplasia. Cardiovasc Res. 2009<정부과제></P>
<P USERMARK="F-GL11">● "인공지능-컴퓨터 기반 신약개발(AI-CADD) 솔루션을 활용한 GLS 타켓 대사항암제 개발”과기부과제 실무책임자 (2022)</P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11 B">(주4) 당 연구인력 송인범의 주요 연구실적은 다음과 같습니다.</P>
<P USERMARK="F-GL11"><등록 특허></P>
<P USERMARK="F-GL11">●  A simple transdermal composition of rivastigmine, Patent No. : 101175925,(KOREA)</P>
<P USERMARK="F-GL11">●  The composition of transepidermal drug delivery system containing tulobuterol, Patent No. : 101081676,(KOREA)</P>
<P USERMARK="F-GL11">●  Transdermal delivery system having alleviated skin irritation, Patent No. : 1680801, (KOREA)</P>
<P USERMARK="F-GL11"> </P>
<P></P>

<P>
<SPAN USERMARK="F-GL"> (2) 주요종속회사의 핵심 연구인력 현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1273">

<COLGROUP>
<COL WIDTH="66"></COL>
<COL WIDTH="66"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="421"></COL>
<COL WIDTH="542"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" BC0XBEBEBE" WIDTH="75" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK=" BC0XBEBEBE">직위</P>
</TD>

<TD USERMARK=" BC0XBEBEBE" WIDTH="75" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK=" BC0XBEBEBE">성명</P>
</TD>

<TD USERMARK=" BC0XBEBEBE" WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK=" BC0XBEBEBE">담당업무</P>
</TD>

<TD USERMARK=" BC0XBEBEBE" WIDTH="430" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK=" BC0XBEBEBE">주요경력</P>
</TD>

<TD USERMARK=" BC0XBEBEBE" WIDTH="551" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK=" BC0XBEBEBE">주요 연구실적</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="75" HEIGHT="214" ALIGN="CENTER" VALIGN="MIDDLE">연구소장 (이사)</TD>
<TD WIDTH="75" HEIGHT="214" ALIGN="CENTER" VALIGN="MIDDLE">이한원</TD>
<TD WIDTH="142" HEIGHT="214" ALIGN="CENTER" VALIGN="MIDDLE">제네릭 원료의약품, 개량신약 개발</TD>
<TD WIDTH="430" HEIGHT="214" VALIGN="MIDDLE">한양대학교 화학과 유기화학 석사('93) CJ제일제당 바이오기술연구소 바이오화학센터 팀장('11~'13) 동국제약 중앙연구소 합성연구팀 팀장('07-'08) 대상그룹 중앙연구소 유기합성연구소, 선임연구원</TD>
<TD WIDTH="551" HEIGHT="214">1. 바이오 화학산업과 CJ, BT NEWS 18(2), 2011.09 2. 전립선암 치료용 장기서방출성 펩타이드 호르몬 제제 개발, ATC 과제, 2005 3.Sodium Iodide as a novel, neutral and facile deprotecting reagent of   N-tert-butyloxylcarbonyl groups in peptide chemistry, Protein and Peptide Letters 1998, 5(5):257-258 4. Sodium Iodide as a deprotection reagent in peptide synthesis, 80회 대한화학회 추계총회 논문초록, 1997, p352 5. 電氣化學的 方法에 의한 Epoxide Ring Opening Reaction과 Aldehyde와 Ketone의 合成, 대한화학회, 1992</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"> 주요종속회사의 핵심연구인력은 연구소장인 이한원 연구소장은 연구 및 사업화를 총괄하고 있으며, 생체 고분자 정제 및 생체 고분자를 이용한 담체 개발에 중점적인 연구 개발 및사업화를 하고 있습니다. 또한 제네릭 원료의약품 개발, 카이랄분리 기술을 이용한 개량신약개발 및 사업화를 진행하고 있습니다.</P>

<P>
<SPAN USERMARK="F-GL11 B">(주1) 당 연구인력 이한원의 주요 연구실적은 다음과 같습니다</SPAN>
<SPAN USERMARK="F-GL11"><등록특허>● 히알루론산 합성효소 변이 단백질 및 이를 이용한 히알루론산 생산 방법 (Mutant protein of hyaluronic acid synthase and method of producing hyaluronic acid using the system)● 비병원성 세균을 이용하여 히알루론산 생산을 위한 발현 시스템 및 상기 발현 시스템 을 이용한 히알루론산 생산방법 (Expression system for production of hyaluronic acid by using non-pathogenic bacteria and method of preparing hyaluronic acid using the same)<정부과제 참여>● 산업통상자원부 '경제협력권산업육성사업' [총괄과제명: 천연물 유래 기능성 물질 기반의 웰에이징 코스메슈티컬 제품 개발(2018.04.01~2020.12.31)]</SPAN>
<SPAN USERMARK="F-GL11">5) 연구개발 비용</SPAN>
<SPAN USERMARK="F-GL11">당사의 최근 3년간 연구개발 비용은 다음과 같습니다.</SPAN>
<SPAN USERMARK="F-GL11"> (1) 연결 연구개발 비용                                                                                                  (단위 : 천원, %)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="751">

<COLGROUP>
<COL WIDTH="118"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" WIDTH="270" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">과    목</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제39기 당기</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제38기</TH>
<TH WIDTH="127" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">제37기</TH>
<TH WIDTH="98" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="270" VALIGN="MIDDLE" HEIGHT="30">원 재 료 비 등</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,067,490</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">881,404</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,180,390</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="270" VALIGN="MIDDLE" HEIGHT="30">인      건     비</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,007,667</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,870,218</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,804,024</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="270" VALIGN="MIDDLE" HEIGHT="30">기              타</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,044,227</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,986,730</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">11,222,955</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="270" VALIGN="MIDDLE" HEIGHT="30">연구개발비용계</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,119,384</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,738,352</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,207,369</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" WIDTH="127" VALIGN="MIDDLE" HEIGHT="180">회계처리</TD>
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30">판매비와관리비</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,170,886</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,466,600</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,218,519</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30">제  조  경  비</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,589,564</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,044,772</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,971,439</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30">개발비(무형자산)</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,155,772</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,052,655</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,616,415</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30">회계처리금액 계</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,916,222</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,564,027</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,806,373</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30">정부보조금</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">203,162</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,174,325</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,400,996</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30">연구개발비용 합계</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,119,384</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,738,352</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,207,369</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="270" VALIGN="MIDDLE" HEIGHT="53">연구개발비 / 매출액 비율 [연구개발비용계÷당기 매출액×100]</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">9.95</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">11.7</TD>
<TD WIDTH="127" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">13.9</TD>
<TD WIDTH="98" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">(2) 별도 연구개발 비용                                                                                                 (단위 : 천원, %)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="751">

<COLGROUP>
<COL WIDTH="118"></COL>
<COL WIDTH="134"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="270" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과    목</TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제39기 당기 </TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제38기</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제37기</TH>
<TH WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30" COLSPAN="2" VALIGN="MIDDLE">원 재 료 비 등</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">819,956</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">845,301</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,145,348</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30" COLSPAN="2" VALIGN="MIDDLE">인      건     비</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,883,071</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,611,762</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,429,874</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30" COLSPAN="2" VALIGN="MIDDLE">기              타</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,030,728</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,224,395</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,304,779</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30" COLSPAN="2" VALIGN="MIDDLE">연구개발비용계</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,733,755</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,681,458</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,880,001</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="127" HEIGHT="180" ROWSPAN="6" VALIGN="MIDDLE">회계처리</TD>
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">판매비와관리비</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,850,560</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,006,026</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,801,493</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">제  조  경  비</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,537,759</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,004,412</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,926,587</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">개발비(무형자산)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,142,274</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,507,295</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,816,281</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">회계처리금액 계</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,530,593</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,517,733</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,544,361</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">정부보조금</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">203,162</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,163,725</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,335,640</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE">연구개발비용 합계</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,733,755</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,681,458</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,880,001</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="53" COLSPAN="2" VALIGN="MIDDLE">연구개발비 / 매출액 비율 [연구개발비용계÷당기 매출액×100]</TD>
<TD WIDTH="128" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">12.84</TD>
<TD WIDTH="128" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">15.42</TD>
<TD WIDTH="127" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">16.86</TD>
<TD WIDTH="98" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">6) 연구개발 실적</SPAN>
<SPAN USERMARK="F-GL11">당사는 신약개발을 위한 부단한 노력으로 세계최초로 흡수 증진제와 전처치가 필요 없는 단독 제형의 경구용 파클리탁셀인 리포락셀액(DHP107)을 개발 하였습니다.피부를 통해 약물을 전달하는 경피투과 약물전달시스템(피부에 붙이는 패치형 제품) 기술개발을 통해 2007년 정부의 바이오신약장기사업단의 우수 연구팀에 선정된 바 있습니다. 바이오신약장기사업단은 과학기술부, 보건복지부, 산업자원부 등 3개 부처가 10대 차세대성장동력 사업의 일환으로 추진, 선진국과 경쟁 가능한 생명공학기술(BT)을 육성하는 산업입니다. 이 특허기술을 응용하여 부작용을 최소화하면서 치료 효과를 증대시키는  패치형으로 제조 개발하여 출시할 계획에 있습니다.  이외 ODF제형 개발, 천연물 신약개발, 히아루론산을 이용한 주사제 개발 등을 진행하고 있습니다. 리독스바이오의 연구소에서는  원료의약품(API) 합성 연구(현물출자 이전 연구 내역 포함), 항체-약물 접합체(Antibody Drug Conjugate) LINKER 플랫폼 기술 연구 : 항암제를 암에 표적하여 효율적으로 전달하는 LINKER 개발을 진행하고 있으며 개량신약 연구, 제네릭 원료의약품(API) 합성 연구, 히알루론산 응용제품 개발 연구를 진행할 계획 입니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL"> (1) 연구개발 총괄표</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1501">

<COLGROUP>
<COL WIDTH="104"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="171"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="321"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="388"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH COLSPAN="2" ROWSPAN="2" WIDTH="241" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>구분</P>
</TH>

<TH ROWSPAN="2" WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>품목</P>
</TH>

<TH ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>적응증</P>
</TH>

<TH ROWSPAN="2" WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>연구시작일</P>
</TH>

<TH COLSPAN="2" WIDTH="467" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>현재국가진행단계</P>
</TH>

<TH ROWSPAN="2" WIDTH="397" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60">
<P>비고</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="330" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>단계(국가)</P>
</TH>

<TH WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>승인일</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="2" WIDTH="113" VALIGN="MIDDLE" HEIGHT="175" ALIGN="CENTER">
<P>바이오</P>
</TD>

<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="122" ALIGN="CENTER">
<P>천연물의약품</P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="122">
<P>(A)DHP1401</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="122">
<P>치매</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="122" ALIGN="CENTER">
<P>2013년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="122">
<P>임상 2b상(한국)</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="122" ALIGN="CENTER">
<P>2015년</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="122">
<P>임상시험완료: 1차 유효성 평가 변수에서 유의성 확인 불가. Subgroup 및 2차 유효성 평가 변수에서 통계적으로 유의한 개선 효능 확인</P>
<P>인지기능/기억력 개선 건강기능식품 원료 개발 검토 중과립차로 제품개발 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>건강기능식품</P>
</TD>

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="53">
<P>(B)DHP1501</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">
<P>혈압조절</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2015년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="53">
<P>건강기능식품 기능성원료 개별인정 승인(한국)</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2019년 07월 05일</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="53">
<P>식약처: 건강기능식품 기능성원료 개별인정 승인</P>
<P>승인번호: 제2019-11호</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="13" WIDTH="113" VALIGN="MIDDLE" HEIGHT="551" ALIGN="CENTER">화학합성</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ROWSPAN="3" HEIGHT="113" ALIGN="CENTER">신약</TD>

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">
<P>(C)DHP32005</P>
</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">관절염</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2020년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">
<P>비임상</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P> -</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">
<P>- </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="53">
<P>(D)DHP32007</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">
<P>항암</P>
<P>대사</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2020년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="53">
<P>비임상</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P> -</P>
</TD>
<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">
<P>(E)DHP32008</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">
<P>항암</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2021년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">
<P>비임상</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P> -</P>
</TD>
<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" ROWSPAN="10" HEIGHT="438" ALIGN="CENTER">개량신약</TD>

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="76">
<P>(F)리포락셀액</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="76">
<P>유방암</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">
<P>2017년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="76">
<P>임상 3상 (한국& 중국&유럽)</P>
<P>임상 2상 (미국&유럽)임상 1상 (헝가리)</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">
<P> -</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="76">
<P>리포락셀액 적응증 추가 임상시험</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="53">(F)리포락셀액</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">위암</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2018년</TD>
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="53">임상 3상 (중국)</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">-</TD>
<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="53">임상시험 진행중- 2016년 9월 9일 한국 허가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">
<P>(G)DHP23001</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">
<P>췌장암</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2016년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">
<P>비임상</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P> -</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">
<P>- </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">
<P>(H)DHP23002</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">
<P>췌장암</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2016년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">
<P>비임상</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P> -</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">
<P>- </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">
<P>(I)DHP23003</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">
<P>대장암</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2017년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">
<P>비임상</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P> -</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">
<P>- </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="53">
<P>(J)DHP23007</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">
<P>독감</P>
<P>치료</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2016년</P>
</TD>
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="53">임상1상 IND 승인</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P> -</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="53">
<P>정부과제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="53">
<P>(K)DHP26007</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">
<P>치매</P>
<P>치료</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2017년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="53">
<P>비임상</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P> -</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="53">
<P>- </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="53">
<P>(L)DHP26001</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">
<P>발기</P>
<P>부전</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P> -</P>
</TD>
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="53">허가취득 완료</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P> 2020년 5월2023년 1월</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="53">
<P>생물학적 동등성 적합, 10mg 자사 전환 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">
<P>(M)DHP26002</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">
<P>항구토</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P> -</P>
</TD>
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">허가취득 완료</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2021년 6월</P>
</TD>
<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">허가 취득 완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">(N)DHP33001</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">
<P>당뇨/비만</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2018년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">
<P>비임상</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P> </P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">
<P>정부과제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="113" VALIGN="MIDDLE" HEIGHT="572" ROWSPAN="16" ALIGN="CENTER">저분자 의약품</TD>
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">제형변형 제네릭</TD>

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">
<P>(O)가스트릭정</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">
<P>위십이지장궤양</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2019년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">
<P>임상1상(한국)</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2021년</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">
<P>임상1상(식전, 식후) 동등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="159" ROWSPAN="3" ALIGN="CENTER">염변경 개량신약</TD>

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="53">
<P>(P)시타비앙정</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">
<P>당뇨</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2017년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="53">
<P>임상1상 완료(한국)허가접수</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2020년</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="53">
<P>공동개발 (주관사)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="53">
<P>(Q)시타비앙듀오정</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">
<P>당뇨</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2017년</P>
</TD>
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="53">임상1상 완료(한국)허가접수</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2020년</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="53">
<P>공동개발 (주관사)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="53">
<P>(R)시타비앙듀오XR정</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">
<P>당뇨</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2017년</P>
</TD>
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="53">임상1상 완료(한국)허가접수</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>2020년</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="53">
<P>공동개발 (주관사)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="383" ALIGN="CENTER" ROWSPAN="12">제네릭</TD>

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">
<P>(S)타파진정</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">
<P>당뇨</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2020년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">
<P>임상1상 IND 신청</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2021년</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">
<P>임상1상 동등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">
<P>(T)아세렌캡슐</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">
<P>골관절염</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2021년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">
<P>임상1상(중국)</P>
</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>예정</P>
</TD>
<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">lab 안정성 평가</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">
<P>(U)콘트라브서방정 후발</P>
</TD>

<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">
<P>비만</P>
</TD>

<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2020년</P>
</TD>

<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">
<P>제제연구</P>
</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">(V)삼스카정 후발</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">저나트륨혈증</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022년</TD>
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">제제연구</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>예정</P>
</TD>
<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">(W)테고프라잔</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">위식도역류질환</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2021년</TD>
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">제제연구</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">예정</TD>
<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">(X)DHP2820</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">위식도역류질환</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022년</TD>
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">제제연구</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>예정</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="53">(Y)DHP2819</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="53">만성동맥폐색증 등</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2022년</TD>
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="53">제제연구</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>예정</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="53">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">(Z)DHP2821</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">파킨슨증후군</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022년</TD>
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">제제연구</TD>

<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>예정</P>
</TD>

<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">(AA)DHP1802</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">관절염</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022년</TD>
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">제제연구</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">예정</TD>
<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">(AB)시큐린정 30mg</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">혈관치매 등</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022년</TD>
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">제제연구</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">예정</TD>
<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">(AC)DHP2920</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">위궤양</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022년</TD>
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">제제연구</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">예정</TD>
<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" VALIGN="MIDDLE" HEIGHT="30">(AD)DHP2819</TD>
<TD WIDTH="123" VALIGN="MIDDLE" HEIGHT="30">항응고제 등</TD>
<TD WIDTH="93" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022년</TD>
<TD WIDTH="330" VALIGN="MIDDLE" HEIGHT="30">제제연구</TD>
<TD WIDTH="137" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">예정</TD>
<TD WIDTH="397" VALIGN="MIDDLE" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK="F-GL11">(A)품목: DHP1401</P>

<TABLE BORDER="1" WIDTH="764" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="613"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">① 구  분</P>
</TD>

<TD WIDTH="622" HEIGHT="30">
<P>천연물의약품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">② 적응증</P>
</TD>

<TD WIDTH="622" HEIGHT="30">
<P>알츠하이머성 치매치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">③ 작용기전</P>
</TD>

<TD WIDTH="622" HEIGHT="53">
<P>Plasmin 활성을 증가시켜 ERK-CREB-BDNF(뇌신경영양인자) 활성화에 의한 인지능 개선 기전 규명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="99" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">④ 제품의 특성</P>
</TD>

<TD WIDTH="622" HEIGHT="99">
<P>천연소재를 이용한 치매치료제로 기존의 합성의약품보다 높은 안전성을 확보하였으며, 비임상시험에서 BDNF 발현 증가 및 아밀로이드 β 단백질 응집 억제, 신경세포 염증 억제와 NMDA 수용체 조절, 시냅스 장기강화(LTP) 등의 복합 작용기전을 가지는 우수한 효능을 확인함.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="214" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑤ 진행경과</P>
</TD>

<TD WIDTH="622" HEIGHT="214">

<P USERMARK=" 0X1814FF B">
<SPAN USERMARK=" 0X000000 !B">임상시험제목: 도네페질(donepezil)로 치료 받고 있는 경증 내지 중등증의 알츠하이머성 치매 환자를 대상으로 DHP1401의 유효성 및 안전성을 평가하기 위한 다기관, 무작위배정, 이중눈가림, 위약대조, 제 2b상 임상시험</SPAN>
</P>
<P>임상시험대상자/연구기관: 180명(60명/3군), 건국대학교병원 포함 국내 16개 기관</P>
<P>임상시험 승인일: 2015.05.18</P>
<P>임상시험 시작일: 2016.12.28</P>
<P>임상시험 종료일: 2019.02.12 (식약처 임상시험 종료 보고일: 2019.02.27) 임상시험 결과: 1차 유효성 평가 변수에서 유의성 확인이 불가                     Subgroup 및 2차 유효성 평가 변수에서 통계적으로 유의한 개선 효능 확인</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑥ 향후계획</P>
</TD>
<TD WIDTH="622" HEIGHT="53">'인지기능 개선’ 또는‘기억력 개선’ 건강기능식품 원료 개발 논의 중중증보다 경증에 효과적인 점을 감안하여 현재 고체(과립) 음료개발 연구중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑦ 경쟁제품</P>
</TD>

<TD WIDTH="622" VALIGN="MIDDLE" HEIGHT="53">
<P>천연물 유래 치매치료제를 개발하는 대표적인 제약사로 일동제약 ID1201 3상 IND 승인, 메디포럼 PM012 임상 3상 승인, 메디헬프라인 WIN-1001X 임상2상 진행 중임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="444" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑧ 관련논문</P>
</TD>

<TD WIDTH="622" HEIGHT="444">
<P>1. Ethanolic extract of the seed of Zizyphus jujuba var. spinosa ameliorates cognitive impairment induced by cholinergic blockade in mice. Biomolecules & Therapeutics, 2013</P>
<P>2. Ameliorating effect of spinosin, a C-glycoside flavonoid, on scopolamine-induced memory impairment in mice. Pharmacology, Biochemistry and Behavior, 2014</P>
<P>3. Spinosin, a C-glucosylflavone, from Zizyphus jujuba var. spinosa ameliorates Aβ1-42 oligomer-induced memory impairment in mice. Biomolecules & Therapeutics, 2015</P>
<P>4. Spinosin, a C-glycoside flavonoid, enhances cognitive performance and adult hippocampal neurogenesis in mice. Pharmacology, Biochemistry and Behavior, 2016</P>
<P>5. Swertisin, a C-glucosylflavone, ameliorates scopolamine-induced memory impairment in mice with its adenosine A1 receptor antagonistic property. Behavioural Brain Research, 2016</P>
<P>6. Ethanol extract of the seed of Zizyphus jujuba var. spinosa potentiates hippocampal synaptic transmission through mitogen-activated protein kinase, adenylyl cyclase, and protein kinase A pathways. Journal of Ethnopharmacology, 2017</P>
<P>7. The seed of Zizyphus jujuba var. spinosa attenuates Alzheimer’s disease-associated hippocampal synaptic deficits through BDNF/TrkB signaling. Biological and Pharmaceutical Bulletin, 2017.8. Simultaneous determination of donepezil, 6-O-desmethyl donepezil and spinosin in beagle dog plasma using liquid chromatography?tandem mass spectrometry and its application to a drug-drug interaction study. Journal of Pharmaceutical and Biomedical Analysis, 2020</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="241" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑨ 시장규모</P>
</TD>

<TD WIDTH="622" ALIGN="RIGHT" HEIGHT="241">
<P>2018년도 치매치료제 국내 시장규모 (1,985 억원)</P>

<TABLE BORDER="0" WIDTH="535" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30">
<P>분류</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">
<P>상품명(성분명)</P>
</TD>

<TD WIDTH="118" VALIGN="MIDDLE" HEIGHT="30">
<P>매출액(‘18)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ROWSPAN="3" WIDTH="209" VALIGN="MIDDLE" HEIGHT="90">
<P>Acetylcholinesterase inhibitors</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">
<P>아리셉트 (donepezil)</P>
</TD>

<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,475억원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">
<P>엑셀론 (rivastigmine)</P>
</TD>

<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>142억원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">
<P>레미닐 (galantamine)</P>
</TD>

<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>151억원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30">
<P>NMDA receptor antagonists</P>
</TD>

<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30">
<P>에빅사 (memantine)</P>
</TD>

<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>217억원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="209" VALIGN="MIDDLE" HEIGHT="30">
<P>합계</P>
</TD>
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30"></TD>

<TD WIDTH="118" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<P>1,985억원</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P><참조: 디멘시아 뉴스, 2019.02.21 아이큐비아 통계 자료></P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑩ 기타사항</P>
</TD>

<TD WIDTH="622" HEIGHT="53">
<P>보건복지부 지원 첨단의료기술개발사업 선정 (2016.04.01~2019.12.31) </P>
<P>총 연구개발비 4,500백만원 (정부보조금: 2,700백만원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">【</SPAN>
<SPAN USERMARK="F-GL11 BU">추가 참조/ </SPAN>
<SPAN USERMARK="F-GL BU">DHP1401 : 천연물 치매치료제</SPAN>
<SPAN USERMARK="F-GL">】</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">1) 개요</SPAN>
</P>
<P USERMARK="F-GL11">치매(Dementia)는 다양한 원인에 의해 뇌기능이 손상되면서 기억력, 언어능력, 인지기능이 지속적이고 전반적으로 저하되어 일상생활에 상당한 지장을 초래하는 진행성, 퇴행성 질환으로 2012년 국내 65세 이상 노인 중 약 10%인 54만명이 치매환자이며 전세계 2015년 4,700만명, 2050년도 1억 3,200만명에 달할 것으로 추산되고 있습니다(메디파나 뉴스,2015.08.26). 치매는 알츠하이머성 치매, 혈관성 치매, 루이소체 치매, 알코올성 치매로 분류하고 있으며 이중 알츠하이머성 치매가 전체의 70%를 차지하고 있는 것으로 보고 되었습니다(중앙시사매거진, 201403호, 2014.02.17).알츠하이머성 치매의 정확한 발병 기전과 원인은 아직 명확하게 밝혀진 바가 없으나, 현재까지는 신경전달물질(neurotransmitter)의 불균형과 과발현된 베타아밀로이드 단백질(β- amyloid protein)이 뇌에 침착되면서 독성을 일으키는 것이 알츠하이머성 치매의 핵심적인 발병기전으로 알려져 있습니다. 현재까지 개발된 치매치료의 약물들은 도네페질(donepezil), 리바스티그민(rivastigmine), 갈란타민(galantamine), 메만틴(memantine) 등이 사용되고 있으나 대부분 일시적인 증상완화와 병의 진행속도를 다소 늦출 뿐 원인적인 치료는 어려운 현실이며 또한 치매는 진행성, 퇴행성 이라는 특성상 장기복용 하여야 함에도 불구하고 현재까지 개발된 약제들은 서맥, 저혈압, 기도수축, 간독성, 수지진전 설사, 구토와 같은 부작용을 동반하고 있습니다.</P>
<P USERMARK="F-GL11">2) 천연물 치매치료제 DHP1401 개발</P>
<P USERMARK="F-GL11">대화제약에서는 치료 효능이 우수하고 안전한 천연물을 이용한 치매치료제를 개발하기 위하여 전통적으로 안신(安神), 진정최면(鎭靜催眠)의 약제로 사용되던 산조인(酸棗仁)에 대해 꾸준한 연구를 진행해 왔습니다. 특히 산조인은 동의보감(東醫寶鑑)에 귀비탕(歸脾湯)의 주처방 약제로 현대의학에서는 치매 및 신경계통의 정신 장애에 개발되고 있는 약제 입니다.</P>
<P USERMARK="F-GL11">산조인을 이용한 추출공정과 다양한 치매동물모델에서 유효성을 확인했으며 특히 사람의 치매 발병기전과 유사한 유전자변형 치매모델(5XFAD transgenic mouse)에서도 치매유발물질인 베타아밀로이드 생성이 현저하게 억제되어 치매의 근본적인 원인을 치료하고 또한신경세포 보호 효과와 기억력 강화 등의 효능을 입증하였습니다. 이러한 연구결과는 국내외 학회 및 저널에 발표되어 우수성을 인정받았습니다</P>
<P USERMARK="F-GL11">또한 장기간 투여 독성시험에서 안전성이 확보되어 치료의 효과가 우수하고 안전한 치매치료제로서 개발 가능성이 높다고 판단됩니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">3) 연혁</P>
<P USERMARK="F-GL11">[2013. 05 ~ 2015. 05] 보건복지부 지원 첨단의료기술개발사업 선정 (경희대학교와 공동 연구)</P>
<P USERMARK="F-GL11">[2014. 10] 대한약학회 연구결과 발표: 우수구두발표상 수상</P>
<P USERMARK="F-GL11">[2015. 08] 유럽생약학회 연구결과 포스터 발표: 우수포스터 선정</P>
<P USERMARK="F-GL11">[2015. 05] 식품의약품안전처 “DHP1401” 임상2상 시험계획 신청</P>
<P USERMARK="F-GL11">[2015. 08] 식품의약품안전처 “DHP1401” 임상2상 시험계획 승인[2016. 04] 보건복지부 과제 선정</P>

<P USERMARK="F-GL11 0XBD814F">
<SPAN USERMARK=" 0X000000">[2016.12] DHP1401 임상 2상 첫 대상자 등록[2018.08] DHP1401 임상 2상 대상자 모집완료, 등록대상자 투약 진행 [2019.02] DHP1401 임상 2상시험 종료, 식약처 임상시험 종료보고 진행[2019.09] DHP1401 임상2상 결과발표 보고[2019.10] DHP1401 임상2상 결과관련 연구자 자문 미팅 개최[2019.12] 식약처 임상2상 결과 관련 미팅 진행[2020.05] 보건복지부 신약개발지원과제 최종발표[2021.~] 건강기능식품 또는 초기치매환자를 대상으로 제품개발 검토 중</SPAN>
</P>
<P USERMARK="F-GL11">4) 임상2상 시험</P>
<P USERMARK="F-GL11">2015년 08월에 식품의약품안전처로부터 임상2b상 시험계획을 승인 받아 2016년 하반기부터 건국대학병원 포함 국내 16개 기관에서 '도네페질(donepezil)로 치료를 받고 있는 경증 내지 중등증의 알츠하이머성 치매 환자를 대상으로 DHP1401의 유효성 및 안전성을 평가하기 위한 다기관, 무작위 배정, 이중눈가림, 위약대조를 통한 임상시험'을 진행 완료 하였음. 그 결과, 1차 유효성 평가 변수인 ADAS-cog에서는 대조군 대비 통계적으로 유의한 우월성을 확인할 수 없었으나, 추가 분석한 subgroup 경증 치매 환자에서 대조군 대비 우월함을 확인하였으며, 그 외 2차 유효성 평가 변수인 K-MMSE, K-TMT-e Test B에서 대조군 대비 통계적으로 유의한 개선을 확인하였음. 또한 DHP1401 고용량 복용 대상자군일수록 유효성이 개선되는 경향을 확인하였음.</P>
<P USERMARK="F-GL11">5) 시장규모</P>
<P USERMARK="F-GL11">2012년 국내 65세 이상 노인 중 약 10%인 54만 명이 치매환자이며 2050년도 약 15%인 2,700만 명에 달할 것으로 추산되고 있습니다. 전 세계 치매 인구는 2015년 약 4,700만 명에서 2050년 약 3배 증가해 1억 3,200만 명에 육박할 것으로 예상됩니다.</P>
<P USERMARK="F-GL11">국내 치매치료제 시장은 2010년 1,072억원에서 2014년 1,800억원대로 급속히 증가하고 있으며(2015년도 팜스코어 분석결과), 세계 치매치료제 시장 규모는 2013년 50억 달러(6조원)로 연평균 9.16% 성장해 2023년에는 121억 달러(15조원)를 넘어설 것으로 전망됩니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">6) 지식재산권 보유현황(DHP1401 주요 특허)</P>
<P USERMARK="F-GL11">① 발명의 명칭: 스피노신을 포함하는 인지기능장애 질환 예방 또는 치료용 약학조성물(Pharmaceutical composition comprising spinosin for prevention and treatment of cognitive disorder)</P>

<TABLE BORDER="1" WIDTH="507" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="127"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="78" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>국가</P>
</TH>

<TH WIDTH="156" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>출원번호</P>
</TH>

<TH WIDTH="137" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>취득일자</P>
</TH>

<TH WIDTH="136" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>등록번호</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>대한민국</P>
</TD>

<TD WIDTH="156" ALIGN="CENTER" HEIGHT="30">
<P>2011-0127108</P>
</TD>

<TD WIDTH="137" ALIGN="CENTER" HEIGHT="30">
<P>2014년 02월 03일</P>
</TD>

<TD WIDTH="136" ALIGN="CENTER" HEIGHT="30">
<P>10-1360109</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">일본</TD>
<TD WIDTH="156" ALIGN="CENTER" HEIGHT="30">제2014-544675호</TD>
<TD WIDTH="137" ALIGN="CENTER" HEIGHT="30">2016년 11월 11일</TD>
<TD WIDTH="136" ALIGN="CENTER" HEIGHT="30">6040256</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">일본</TD>
<TD WIDTH="156" ALIGN="CENTER" HEIGHT="30">제2016-149360호</TD>
<TD WIDTH="137" ALIGN="CENTER" HEIGHT="30">2017년 12월 22일</TD>
<TD WIDTH="136" ALIGN="CENTER" HEIGHT="30">6261677</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">중국</TD>
<TD WIDTH="156" ALIGN="CENTER" HEIGHT="30">제201280068416.6호</TD>
<TD WIDTH="137" ALIGN="CENTER" HEIGHT="30">2017년 01월 16일</TD>
<TD WIDTH="136" ALIGN="CENTER" HEIGHT="30">ZL201280068416.6</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">영국</TD>
<TD WIDTH="156" ALIGN="CENTER" HEIGHT="30">EP20120853870 </TD>
<TD WIDTH="137" ALIGN="CENTER" HEIGHT="30">2017년 11월 22일</TD>
<TD WIDTH="136" ALIGN="CENTER" HEIGHT="30">2786758</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">독일</TD>
<TD WIDTH="156" ALIGN="CENTER" HEIGHT="30">EP20120853870 </TD>
<TD WIDTH="137" ALIGN="CENTER" HEIGHT="30">2017년 11월 22일</TD>
<TD WIDTH="136" ALIGN="CENTER" HEIGHT="30">2786758</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">프랑스</TD>
<TD WIDTH="156" ALIGN="CENTER" HEIGHT="30">EP20120853870 </TD>
<TD WIDTH="137" ALIGN="CENTER" HEIGHT="30">2017년 11월 22일</TD>
<TD WIDTH="136" ALIGN="CENTER" HEIGHT="30">2786758</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">스위스</TD>
<TD WIDTH="156" ALIGN="CENTER" HEIGHT="30">EP20120853870 </TD>
<TD WIDTH="137" ALIGN="CENTER" HEIGHT="30">2017년 11월 22일</TD>
<TD WIDTH="136" ALIGN="CENTER" HEIGHT="30">2786758</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">미국</TD>
<TD WIDTH="156" ALIGN="CENTER" HEIGHT="30">15/343,075</TD>
<TD WIDTH="137" ALIGN="CENTER" HEIGHT="30">2018년 05월 01일</TD>
<TD WIDTH="136" ALIGN="CENTER" HEIGHT="30">9956242</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">② 발명의 명칭: 플라본-6-C-글루코스 유도체를 함유하는 신경정신질환의 치료 또는 예방용 약학적 조성물(Pharmaceutical compositionfor treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="170"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="78" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>국가</P>
</TH>

<TH WIDTH="156" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>출원번호</P>
</TH>

<TH WIDTH="179" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>취득일자</P>
</TH>

<TH WIDTH="210" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>등록번호</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="78" ALIGN="CENTER" HEIGHT="30">
<P>미국</P>
</TD>

<TD WIDTH="156" ALIGN="CENTER" HEIGHT="30">
<P>14/912,069</P>
</TD>

<TD WIDTH="179" ALIGN="CENTER" HEIGHT="30">
<P>2019년 04월 09일</P>
</TD>

<TD WIDTH="210" ALIGN="CENTER" HEIGHT="30">
<P>US 10,251,30282</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">7) 향후 계획- 기억력 개선 또는 인지기능 개선 건강기능 식품 개별인정형 개발 예정</P>

<P USERMARK="F-GL11 BI">
<SPAN USERMARK=" !B!I">- 2020년 인지능력/기억력개선 건강기능식품 기능성 원료 개발 </SPAN>
<SPAN USERMARK="F-BT12 !B!I">(B)품목: DHP1501</SPAN>
</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">① 구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>건강기능식품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>혈압조절</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">③ 작용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="53">
<P>AngiotensinⅡ의 생성에 관여하는 ACE의 활성억제 및 eNOS 활성화에 의한 NO 생성 증가로 혈관 확장을 통한 혈압강하 작용기전 규명</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="145" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="145">
<P>전통적으로 사용되어오던 천연소재를 이용한 고혈압 개선 건강기능식품으로, 기존 합성의약품의 혈관부종, 신장기능장애, 두통, 변비 등의 부작용이 없는 안전성을 확보하였으며, 선천적 고혈압 동물모델을 이용한 혈압강하 효능과 미니피그의 관상동맥의 혈관이완작용 및 eNOS 활성 증가, 혈압을 상승시키는 ACE 효소의 활성 저해의 효능연구를 기반으로 인체적용시험을 완료하였고, 위약대조 대비 DHP1501의 혈압강하에 대하여 통계적으로 유의한 결과를 도출하였음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="99" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑤ 진행경과</P>
</TD>

<TD WIDTH="567" HEIGHT="99">
<P>인체적용시험 제목: 혈압강하에 미치는 DHP1501의 유효성 및 안전성을 평가하기 위한 8주, 단일기관, 무작위배정, 이중눈가림, 위약대조 인체적용시험</P>
<P>기능성원료 개별인정신청: 2018.12.20기능성원료 개별인정 승인: 2019.07.05</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="42" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑥ 향후계획</P>
</TD>
<TD WIDTH="567" HEIGHT="42">제품 발매: 2021년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="99" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑦ 경쟁제품</P>
</TD>

<TD WIDTH="567" VALIGN="MIDDLE" HEIGHT="99">
<P>혈압조절과 관련한 개별인정형 기능성원료는 정어리펩타이드, 올리브잎주정추출물, 가쯔오부시올리고펩타이드 등 11종이며, 고시형 원료는 코엔자임 Q10 1종이 허가되어 식품의약품안전처에 등록되어 있음 </P>
<P><참조: 식품안전나라 https://www.foodsafetykorea.go.kr ></P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="122" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑧ 관련논문</P>
</TD>

<TD WIDTH="567" VALIGN="MIDDLE" HEIGHT="122">
<P>1. Antihypertensive effect of ethanolic extract from Acanthopanax sessiliflorus fruits and quality control of active compounds. Oxidative Medicine and Cellular Longevity, 2018</P>
<P>2. 오가피열매 주정추출물, DHP1501의 ACE 억제 및 eNOS 활성화를 통한 항고혈압 효능. 생약학회지, 2018</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="145" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑨ 시장규모</P>
</TD>

<TD WIDTH="567" VALIGN="MIDDLE" HEIGHT="145">
<P>건강기능식품은 주로 복합으로 기능성을 추가하므로 정확한 시장 규모는 추산하기 어려움</P>
<P>2017년도 혈압조절관련 건강기능식품 국내 시장규모 (총 24,148억원)</P>
<P>혈행개선: 11,246억원, 항산화: 11,104억원, 콜레스테롤개선: 945억원, 혈중중성지방개선: 740억원, 혈압조절: 113억원 </P>
<P><참조: BNK 투자증권 이슈리포트 2018.12.08 자료></P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="76" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑩ 기타사항</P>
</TD>

<TD WIDTH="567" VALIGN="MIDDLE" HEIGHT="76">
<P>농촌진흥청 지원 농축산물부가가치향상기술개발사업 선정 (2015.01.01~2017.12.31) </P>
<P>총 연구개발비 700.02백만원 (정부보조금: 420백만원)</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK="F-GL11">(C)품목 : DHP32005</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">① 구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>화학 합성 신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>관절염 치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">③ 적용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>관절염의 원인이 되는 신호 전달을 억제함.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>주사제 제형으로 개발될 예정.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑤ 진행경과</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>in vitro screening system 구축 후 현재 후보 물질 선별 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑥ 향후계획</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>후보물질 선별후에 비임상 시험에서 효력 확인 예정.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑦ 경쟁제품</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>연구개발 초기 단계로 경쟁제품을 특정하기 어려움.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑧ 관련논문</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>연구개발 초기 단계로 관련 논문을 명시하기 어려움. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑨ 시장규모</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>연구개발 초기 단계로 목표 시장을 특정하기 어려움.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑩ 기타사항</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P> -</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">(D)품목 : DHP32007</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">① 구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>화학 합성 신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>대사항암제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">③ 적용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>암세포의 에너지 대사를 차단하여 암세포 증식을 억제함.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>리포락셀액과 병용투여로 개발될 예정.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑤ 진행경과</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>in vitro screening system을 통해 후보물질 선별 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑥ 향후계획</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>후보물질 선별후에 비임상 시험에서 효력 확인 예정.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑦ 경쟁제품</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>연구개발 초기 단계로 경쟁제품을 특정하기 어려움.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑧ 관련논문</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>연구개발 초기 단계로 관련 논문을 명시하기 어려움. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑨ 시장규모</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>연구개발 초기 단계로 목표 시장을 특정하기 어려움.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑩ 기타사항</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"> </P>
<P>(E)품목 : DHP32008</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>화학 합성 신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>항암제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>③ 적용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>암세포의 이상신호전달 차단하여 암세포 증식을 억제함.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>리포락셀액과 병용투여로 개발될 예정.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="33" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>

<TD WIDTH="567" HEIGHT="33">
<P>in vitro screening system을 통해 후보물질 선별 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후계획</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>후보물질 선별후에 비임상 시험에서 효력 확인 예정.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>연구개발 초기 단계로 경쟁제품을 특정하기 어려움.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑧ 관련논문</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>연구개발 초기 단계로 관련 논문을 명시하기 어려움. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑨ 시장규모</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>연구개발 초기 단계로 목표 시장을 특정하기 어려움.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 U">(F)품목 : 리포락셀액</P>

<TABLE BORDER="1" WIDTH="722" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="571"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">① 구  분</P>
</TD>

<TD WIDTH="580" HEIGHT="30">
<P>화학 합성 개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">② 적응증</P>
</TD>

<TD WIDTH="580" HEIGHT="30">
<P>항암 치료제(위암, 유방암)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="76" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">③ 적용기전</P>
</TD>

<TD WIDTH="580" HEIGHT="76">
<P>파클리탁셀은 세포 주기 선택적으로 다양한 단계의 암세포를 공격하게 됨. 이 약물은 세포분열 과정 중 분열과 자가 복제의 기구인 미세소관(microtubule)이 분리되는 과정을 방해함으로써 암세포의 증식을 억제함.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">④ 제품의 특성</P>
</TD>

<TD WIDTH="580" HEIGHT="30">
<P>세계최초의 경구용 파클리탁셀 제형</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑤ 진행경과</P>
</TD>

<TD WIDTH="580" HEIGHT="53">
<P>미국,유럽 유방암 임상 2상, 국내 및 중국, 유럽 유방암 임상 2/3상 시험 진행 중중국 위암 3상 진행 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑥ 향후계획</P>
</TD>

<TD WIDTH="580" HEIGHT="30">
<P>임상시험 완료 후 적응증 추가 신청(유방암)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑦ 경쟁제품</P>
</TD>

<TD WIDTH="580" HEIGHT="30">
<P>Taxol, Abraxane, Genexol, Taxotere, Oraxol, Texetaxel</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="1042" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑧ 관련논문</P>
</TD>

<TD WIDTH="580" HEIGHT="1042">
<P>1. Subacute toxicity and toxicokinetics study of DHP107, an oral paclitaxel formulation with once-weekly dosing in mice.</P>
<P>Kim JY, Lee S, Kim Y, Jeong EJ, Lee IH, Son MH, Lee JY, Kim SK, Moon KS. Regul Toxicol Pharmacol. 2019 Apr;103:196-204. </P>
<P>2. Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy.</P>
<P>Kang YK, Ryu MH, Park SH, Kim JG, Kim JW, Cho SH, Park YI, Park SR, Rha SY, Kang MJ, Cho JY, Kang SY, Roh SY, Ryoo BY, Nam BH, Jo YW, Yoon KE, Oh SC.Ann Oncol. 2018 May 1;29(5):1220-1226. </P>
<P>3. A Phase I/IIa Study of DHP107, a Novel Oral Paclitaxel Formulation, in Patients with Advanced Solid Tumors or Gastric Cancer.</P>
<P>Ryu MH, Ryoo BY, Kim TW, Kim SB, Lim HS, Bae KS, Park SR, Jo YW, Cho HJ, Kang YK. Oncologist. 2017 Feb;22(2):129-e8. </P>
<P>4. Absorption mechanism of DHP107, an oral paclitaxel formulation that forms a hydrated lipidic sponge phase. Jang Y, Chung HJ, Hong JW, Yun CW, Chung H. Acta Pharmacol Sin. 2017 Jan;38(1):133-145.</P>
<P>5. Predicting the efficacy of an oral paclitaxel formulation (DHP107) through modeling and simulation. Lim HS, Bae KS, Jung JA, Noh YH, Hwang AK, Jo YW, Hong YS, Kim K, Lee JL, Park SJ, Kim JE, Kang YK, Kim TW. Clin Ther. 2015 Feb 1;37(2):402-17. </P>
<P>6. Metronomic oral paclitaxel shows anti-tumor effects in an orthotopic mouse model of ovarian cancer. Hahn HS, Lee KH, Lee IH, Lee JH, Whang CS, Jo YW, Kim TJ. J Gynecol Oncol. 2014 Apr;25(2):130-5. </P>
<P>7. A phase I study of DHP107, a mucoadhesive lipid form of oral paclitaxel, in patients with advanced solid tumors: crossover comparisons with intravenous paclitaxel. Hong YS, Kim KP, Lim HS, Bae KS, Ryu MH, Lee JL, Chang HM, Kang YK, Kim H, Kim TW. Invest New Drugs. 2013 Jun;31(3):616-22. </P>
<P>8. Efficacy and tissue distribution of DHP107, an oral paclitaxel formulation. Hong JW, Lee IH, Kwak YH, Park YT, Sung HC, Kwon IC, Chung H. Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3239-47.</P>
<P>9. In-Hyun Lee, Jung Wan Hong, Yura Jang, Yeong Taek Park and Hesson Chung, Development, Optimization and Absorption Mechanism of DHP107, Oral Paclitaxel Formulation for Single-Agent Anticancer Therapy. New Advances in the Basic and Clinical Gastroenterology, 2012; 357-374 (ISBN 978-953-51-0521-3).10. DHP107, a novel oral paclitaxel formulation induces less peripheral neuropathic pain and pain-related molecular alteration than intravenous paclitaxel preparation in rat, Md. Mahbubur Rahman, Minhee Son, Hyun Kim, In-Hyun Lee, Ha-young Jeon, Myung-jin Kim, Hansol Kwon, Sung-Jin Park, Junhee Jang, Sokho Kim, Journal of Advanced Biotechnology and Experimental Therapeutics, 2019;2(2):55-6411. Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study), Sung-Bae Kim, Jae Hong Seo, Jin-Hee Ahn, Tae-Yong Kim, Seok Yun Kang, Joohyuk Sohn, Yaewon Yang, Kyong Hwa Park, Yong Wha Moon, Seungtaek Lim,Myoung Joo Kang, Koung Eun Yoon, Hyun Ju Cho, Keun Seok Lee, Therapeutic Advances in Medical Oncology 2021, Vol. 13: 1-11.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑨ 시장규모</P>
</TD>

<TD WIDTH="580" HEIGHT="30">
<P>세계4조원 규모</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑩ 기타사항</P>
</TD>

<TD WIDTH="580" HEIGHT="30">
<P>DH-LASED PLATFORM으로 개발된 세계 최초 경구용 파클리탁셀 제형, 정부과제</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">【</SPAN>
<SPAN USERMARK="F-GL11 BU">추가 참조/ 리포락셀액(DHP107) : 경구용 파클리탁셀</SPAN>
<SPAN USERMARK="F-GL11 B">】</SPAN>
<SPAN USERMARK="F-GL11">1) 개요리포락셀액은 전세계적으로 30년 이상 사용되어온 블록버스터 항암제인 주사제 탁솔(Taxol®)을 경구투여로 개선한 신제형 항암제입니다. 리포락셀액은 탁솔의 주성분인 파클리탁셀이 난용성이며 생체 흡수율이 낮아 주사제로만 투여가 가능하고, 투여 시 입원을 해야할 뿐만 아니라, 부형제에 의한 독성이 심해 치료 과정이 고통스럽다는 점에 착안해 개발되었습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="861" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="413"></COL>
<COL WIDTH="430"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="422" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">탁솔(주사제)</TH>
<TH ALIGN="CENTER" WIDTH="439" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">리포락셀액(DHP107)</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="422" HEIGHT="214">- 최초의 블록버스터 항암제- 주성분 : 파클리탁셀- 효능 : 유방암, 폐암, 난소암, 위암 등- 부형제에 의한 심각한 과민반응으로 전처치후 3시간 이상      점적(infusion) 정맥투여- 시장현황: 4조/년(국내 400억원/년) (2016년 IMS Health 보     고자료 참조)</TD>

<TD WIDTH="439" HEIGHT="214">
<P>- 경구용 항암제, 세계최초로 흡수 증진제와 전처치가 필요      없는 단독 제형</P>
<P>- 주성분: 파클리탁셀- 효능 : 위암</P>
<P>- 기 허가된 부형제로 제형화</P>
<P>- 주사제 대비 안전성 향상, 재택 투여 가능</P>
<P>- GSK, IVAX, APOTEX 등 유수의 글로벌 기업들이 경구용 제    형에 도전했으나 실패하거나 보류되어 현재 가장 빠르게 개발 진행되고 있음</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">2) 연혁[1999.12 ~ 2004.10] 산업자원부 지원하에 KIST와 공동으로 DHP107 개발[2005.7] 산업자원부 산하 한국산업기술평가원으로부터 약효, 약동성 우수 평가[2007.2] 미국 코방스사(Covance) 및 한국화학연구원에서 독성시험 완료[2008.1] 식품의약품안전처 국내 임상 1상 시험 계획 승인[2008.3 ~ 2009. 12] 서울아산병원에서 임상1상 시험 진행 및 완료[2010.6] 식품의약품안전처 국내 전기임상2상(phase Ⅰ/Ⅱa)시험 계획 승인[2010.7~2012.11] 서울아산병원 고형암 중 소화기암(위암) 환자들 대상으로 전기 임상2상 시험 완료[2011.12] 보건신기술(NET) 인증[2013.2] 식품의약품안전처 국내 임상3상 시험 계획 승인[2015.2] 임상3상 시험 환자등록 완료[2013.2~2015.8] 서울아산병원 포함 국내 12개 기관 임상3상 시험 진행 완료(종료)[2015.10] 경구용 항암제 공장 준공[2016.2] 식품의약품안전처 품목허가 신청[2016.5] 미 FDA 유방암(Ⅰ&Ⅲ상) Pre-IND meeting 신청[2016.6] 미국 임상종양학회(ASCO) poster discussion session 임상3상 결과 발표[2016.9] 식품의약품안전처 시판허가 승인[2016.7] FDA 유방암 임상2상 Pre-IND 서면 답변 수신[2016.10] 미국임상시험조정자 및 실시기관 선정[2017.4] 국내 유방암Ⅱ/Ⅲ MFDS IND Submission[2017.6] 미국 PhaseⅡ 유방암 연구자 미팅 개최[2017.7] 국내 유방암 Ⅱ/Ⅲ 연구자 미팅 개최[2017.8] 미국 FDA 유방암Ⅱ  IND submission[2017.9] 중국 RMX Biopharma,Co.,Ltd에 기술수출[2017.9] 국내 유방암Ⅱ/Ⅲ IND 승인, 미국 FDA 유방암Ⅱ IND 승인[2017.12] 국내 유방암 Ⅱ/Ⅲ 첫대상자 등록[2018.3] 중국 위암3상 IND 신청[2018.7] 미국 유방암 Ⅱ 첫 대상자 등록[2018.7] 중국 위암3상 IND 승인[2018.7] 국내 유방암 Ⅱ/Ⅲ상 중국포함 확대 실시 및 중국 유방암 3상 IND 신청을 위한 중국 유방암 3상 IND 신청[2019.1] 국내 유방암 Ⅲ상 첫 대상자 등록. 진행중[2019.4] 국내 및 중국 유방암 Ⅲ상 연구자미팅 개최 / 중국 위암 3상 첫 대상자 등록[2019.6] 미국 유방암 Ⅱ상 연구자 미팅 개최[2019.9] 중국 유방암 Ⅲ상 첫 대상자 등록, 2019 ESMO 국내 유방암 2상 결과 Poster 발표[2019.12] 미국 유방암 2상, 2019 San Antonio 유방암학회(SABCS) Ongoing Trial Session 포스터 발표/ 동유럽 확대 진행[2020.3~6] 국내 및 중국 유방암 Ⅲ상 2020 ASCO 'Trial in Progress' 포스터 채택 및 발표[2020.6] 리포락셀 EU QP audit 실시 및 certification 획득[2020.06~2020.10] 유방암 Ⅲ상 동유럽 3개국(세르비아, 헝가리, 불가리아) IND 제출 및 승인[2020.11] 유방암 Ⅱ상 동유럽(체코) IND 승인[2020.12] 미국/체코 유방암 Ⅱ상  2020 San Antonio 유방암학회 (SABCS) PK 결과 포스터 발표[2021.3] 유방암 Ⅱ상 체코 첫 대상자 등록 및 진행[2021.11] 유방암 II/III 상 II상 결과 "Therapeutic Advances in Medical Oncology" 논문 발표[2022.09] 미국/체코 유방암  II상 2022 ESMO 유럽종양학회 결과 포스터 발표[2022.12] 한국/ 중국/ 유럽 유방암 Ⅲ상 진행 중 [2022.12] 미국/ 체코 유방암 Ⅱ상 진행 중[2022.12] 헝가리 고형암 1상 진행 중3) 시장규모전 세계 파클리탁셀 시장은 약 4조 규모, 국내 약 450억 규모로 (자료:2017년 IQVIA, 전체적응증 규모임)시장이 형성되어 있습니다.4) 지적 재산권 보유현황 [리포락셀액주요 특허]발명의 명칭 :- 파클리탁셀의 가용화용 조성물 및 그의 제조 방법 (Composition for solubilization of paclitaxel and preparation method thereof)</SPAN>
<SPAN USERMARK="F-GL">- 탁산을 포함하는 경구 투여용 약학 조성물 (Pharmaceutical composition for oral administration comprising Taxane)</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 U">14.그밖에 투자 의사결정에 필요한사항 중 가. 특허권을 참고 바랍니다</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">5) 향후 계획-.국내 시판, 중국외 지역 라이센싱 진행, 미국& 동유럽 유방암 환자대상 임상Ⅱ상 완료, 국내 및 중국 및 동유럽 유방암 Ⅲ 임상시험 진행 및 완료, 국내 및 중국 유럽, 미국 유방암 적응증 시판허가 신청</SPAN>
<SPAN USERMARK="F-GL11 BIU">※ 상기 진행 계획은 당사의 예상 일정이므로 향후 허가 진행과정에서 예상 일정과 차이가 있을 수 있습니다.  L/O 및 지역별 판매는 독자, 국내 기업 또는 지역 판매를 계획하고 제약사와의 공동 마케팅을 통해 직간접 수출을 할 계획을 가지고 진행 중에 있습니다.</SPAN>
</P>
<P USERMARK="F-GL">(G)품목 : DHP23001</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">① 구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>화학 합성 개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>항암치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="76" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">③ 적용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="76">
<P>도세탁셀은 세포 주기 선택적으로 다양한 세포 분열 주기 중 다양한 단계의 암세포를 공격하게 됩니다. 이 약물은 세포분열 과정 중 분열과 자가 복제의 기구인 미세소관(microtubule)이 분리되는 과정을 방해함으로써 암세포의 증식을 억제함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>경구용 도세탁셀 치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑤ 진행경과</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>제형 선별 후 비임상 PK 및 효력 시험 완료. GLP 설치류 단회투여독성시험 완료.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑥ 향후계획</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>독성 시험 완료 후 IND 제출 예정.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑦ 경쟁제품</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>Taxotere</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="122" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑧ 관련논문</P>
</TD>
<TD WIDTH="567" HEIGHT="122">1. Inhibition of Pancreatic Cancer Cell Viability and Tumor Growth Through Cell Cycle Arrest by an Oral Formulation of Docetaxel DHP23001, Jung Ae Kang, Jung Hyu Sin, Hye Lim Lee, Hye Rim Kim, Sung Hun Kim, Min-kyoung Kang, A-Ram Yu, Minhee Son, Hyejin Park, Jae Jun Lee, International Journal of Pharmacology, 2019, v15;8:994-1000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑨ 시장규모</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>세계 4조원 규모</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑩ 기타사항</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>DH-LASED PLATFORM으로 개발된 경구용 도세탁셀 제형, 정부과제</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">(H)품목 : DHP23002</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">① 구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>화학 합성 개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>항암치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="76" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">③ 적용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="76">
<P>파클리탁셀은 세포 주기 선택적으로 다양한 세포 분열 주기 중 다양한 단계의 암세포를 공격하게 됩니다. 이 약물은 세포분열 과정 중 분열과 자가 복제의 기구인 미세소관(microtubule)이 분리되는 과정을 방해함으로써 암세포의 증식을 억제함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>경구용 파클리탁셀 치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑤ 진행경과</P>
</TD>

<TD WIDTH="567" HEIGHT="53">
<P>제형 선별 후 비임상 PK 및 효력 시험 완료. </P>
<P>GLP 설치류 단회투여독성시험 완료.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑥ 향후계획</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>독성 시험 완료 후 IND 제출 예정.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑦ 경쟁제품</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>Taxol, Abraxane, Oraxol, Texetaxel</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="99" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑧ 관련논문</P>
</TD>
<TD WIDTH="567" HEIGHT="99">1. DHP23002 as a next generation oral paclitaxel formulation for pancreatic cancer therapy, Eunseo Jang, Minhee Son, Junhee Jang, In-hyun Lee, Sol Kim, Taejun Kwon, Yong-Hyun Jeon, Woo-Suk Koh, Kil-Soo Kim, Sang Kyoon Kim, PLoS One, 2019 Nov 19;14(11):e0225095</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑨ 시장규모</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>세계 4조원 규모</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑩ 기타사항</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>DH-LASED PLATFORM으로 개발된 경구용 도세탁셀 제형, 정부과제</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11">
<SPAN USERMARK="F-BT12">(I)품목 : DHP23003</SPAN>
</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">① 구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>화학 합성 개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>항암치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">③ 적용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="53">
<P>DHP23003의 주약물인Irinotecan (CPT-11, Camptoⓡ)은topoisomerase-1와 작용하여DNA 복제를 방해하는 기전으로 항암효과를 나타냄..</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>경구용 이리노테칸 치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑤ 진행경과</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>제형 선별 후 비임상 PK 및 대장암 효력 시험 완료. 독성 시험 계획 중. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑥ 향후계획</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>독성 시험 완료 후 IND 제출 예정.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑦ 경쟁제품</P>
</TD>
<TD WIDTH="567" HEIGHT="30">Calmtop</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑧ 관련논문</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>연구개발 초기 단계로 관련 논문을 명시하기 어려움. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑨ 시장규모</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>대장암 치료제 국내 2000억원 규모</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑩ 기타사항</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>DH-LASED PLATFORM으로 개발된 경구용 이리노테칸 제형</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">(J)품목 : DHP23007</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">①구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>화학 합성 개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>인플루엔자 치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="76" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">③ 적용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="76">
<P>DHP23007의 주약물인 자나미비르의 치료 기전은 신종플루를 포함하는 인플루엔자 A형 그리고 B형 바이러스의 neuraminidase 라는 효소를 저해하여 체내 확산을 저지하여 인플루엔자를 치료함.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>경구용 인플루엔자 치료제 (시럽제)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="122" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑤ 진행경과</P>
</TD>

<TD WIDTH="567" HEIGHT="122">
<P>제형 선별 후 비임상 PK 및 효력 시험 완료. </P>
<P>GLP 설치류 단회투여독성시험 완료</P>
<P>GLP 설치류 반복투여독성시험 완료</P>
<P>GLP 비설치류 반복투여독성시험 완료</P>
<P>국내 임상1상 시험을 위한 IND 신청 및 보완 진행 중 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑥ 향후계획</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>국내임상1상 진행 계획.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑦ 경쟁제품</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>타미플루, 리렌자</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑧ 관련논문</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>연구개발 초기 단계로 관련 논문을 명시하기 어려움. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑨ 시장규모</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>국내 800억</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑩ 기타사항</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>DH-LASED PLATFORM으로 개발된 경구용 인플루엔자 치료제 제형, 정부과제</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">(K) 품목 : DHP26007</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">① 구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>화학 합성 개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>치매치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="76" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">③ 적용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="76">
<P>DHP26007의 주 약물인 도네페질은 콜린 분해효소를 억제함으로써 시냅스에서 가용한 아세틸콜린의 양을 증가시키는 기전으로 작용하는데 환자의 인지증상 호전에 도움이 됨.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>도네페질 패취제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑤ 진행경과</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>제형 선별 후 비임상 PK에 의한 1차 선별  완료. 제형 최적화 중. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑥ 향후계획</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>제형 최적화 시험 완료 후 비임상 독성 시험 진행 예정.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑦ 경쟁제품</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>경구용 도네페질 정제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑧ 관련논문</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>연구개발 초기 단계로 관련 논문을 명시하기 어려움. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑨ 시장규모</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>국내 1500억원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑩ 기타사항</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>DH-TDDS PLATFORM 으로 개발된 도네패질 패취 제형</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">(L)품목 : DHP26001</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">① 구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>화학 합성 개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>발기부전치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">③ 적용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="53">
<P>PDE5를 억제해서 cGMP(cyclic guanosine monophosphate) 농도를 올림으로써 자연스런 발기효과를 나타냄</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>ODF 제형</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑤ 진행경과</P>
</TD>

<TD WIDTH="567" HEIGHT="53">
<P>제형 완성 후 임상 완료.10mg 자사 전환 완료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑥ 향후계획</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>글로벌 임상 준비</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑦ 경쟁제품</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>시알리스</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑧ 관련논문</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>관련 논문을 명시하기 어려움.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑨ 시장규모</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>국내 1400억원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑩ 기타사항</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>DH-ODF 기반기술로 개발된 경구용 타다라필 ODF 제형,정부과제</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(M)품목 : DHP26002</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="134"></COL>
<COL WIDTH="557"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="143" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">① 구  분</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>화학 합성 개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="143" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">② 적응증</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>수술 후 오심 및 구토의 예방을 위한 치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="143" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">③ 적용기전</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>5-hydroxytryptamine type 3 (5-HT3) 수용체의 선택적 길항제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="143" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">④ 제품의 특성</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>ODF 제형</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="143" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑤ 진행경과</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>허가등록 완료 </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="143" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑥ 향후계획</P>
</TD>
<TD WIDTH="566" HEIGHT="30">발매</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="143" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑦ 경쟁제품</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>나제아 오디정</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="143" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑧ 관련논문</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>관련 논문을 명시하기 어려움.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="143" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑨ 시장규모</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>세계 시장 4조 6천억원 규모</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="143" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑩ 기타사항</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>DH-ODF 기반기술로 개발된 경구용 라모세트론 ODF 제형, 정부과제</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>(
<SPAN USERMARK="F-GL">N) 품목 : DHP33001</SPAN>
</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>펩타이드 개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>당뇨병/비만치료제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="99" USERMARK=" BC0XF2F2F2">
<P>③ 적용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="99">
<P>DHP33001의 주약물인 리라글루타이드는 GLP-1 receptor agonist로 췌장암의 인슐린 분비를 촉진시키는 동시에 글루카곤의 분비를 저해하는 기전으로 혈당을 조절함. 또한, GLP-1 수용체에 작용하여 위 배출을 느리게 하고 음식물 섭취를 감소시켜 체중 감량에 도움이 됨. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>경구용 GLP-1 유사체 펩타이드 제제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="76" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>

<TD WIDTH="567" HEIGHT="76">
<P>설치류/비설치류 반복독성시험 완료</P>
<P>항비만 효력시험 완료.</P>
<P>임상 1상 IND 신청</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후계획</P>
</TD>
<TD WIDTH="567" HEIGHT="30">임상1상 IND 보완</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>빅토자주, 삭센다주</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑧ 관련논문</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>연구개발 초기 단계로 관련 논문을 명시하기 어려움. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑨ 시장규모</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>국내 1500억원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" VALIGN="MIDDLE" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>DH-LASED PLATFORM으로 개발된 경구용 GLP-1 유사체 제형, 정부과제</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">(O)품목 : 가스트릭정</SPAN>
</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">①구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>저분자의약품의 제형 추가</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>위십이지장궤양, 역류성식도염, 졸링거엘리슨 증후군</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">③ 적용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="53">
<P>H2 수용체 길항제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>기존 제형(캡슐)에 비해 제품의 안정성 및 생산성이 개선된 제품임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑤ 진행경과</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>임임상1상 식후, 식전 동등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑥ 향후계획</P>
</TD>
<TD WIDTH="567" HEIGHT="30">안정성, 유전독성, 금속불순물 완료 후 품목허가신청을 완료할 예정임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑦ 경쟁제품</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>록산정 / ㈜한독</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑧ 관련특허</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑨ 시장규모</P>
</TD>

<TD WIDTH="567" HEIGHT="53">
<P>제형 추가(캡슐제→정제)시 제조원가 절감 연간 약 2.95억원(연간 720만 캡슐 생산), 캡슐제의 경우 온도 변화에 따른 품질 변화가 심함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P USERMARK=" BC0XF2F2F2">⑩ 기타사항</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P> -</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK="F-GL">(P, Q, R)품목 : 시타비앙정, 시타비앙듀오정, 시타비앙듀오XR정</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>①  구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>저분자의약품의 염변경 개량신약</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>제2형 당뇨병환자의 혈당조절을 향상시키기 위한 약물</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>③ 적용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="53">
<P>시타글립틴의 DPP-4 억제제(Dipeptidyl Peptidase-4 inhibitor)와 메트포르민의 바이구아니드계(biguanides) 기전으로 하는 경구용 당뇨약물</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="53">
<P>수입의약품을 대체하기 위한 염변경 의약품으로 생산성과 안정성이 개선된 특허출원 경구용 약물 임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>임상1상 IND 신청단계로 건강한 사람을 대상으로 혈중약물동태를 비교 완료 함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후계획</P>
</TD>

<TD WIDTH="567" HEIGHT="53">
<P>12개사와 공동으로 진행중이며 임상1상 완료 후 수입의약품의 특허가 만료되는 2023년부터 국내에 판매할 예정임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>자누비아정, 자누메트정, 자누메트엑스알정 / 한국MSD</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑧ 관련특허</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>생산성과 안정성이 개선된 시타글립틴 속방성 코팅방법 (출원일 2018년)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>⑨ 시장규모</P>
</TD>

<TD WIDTH="567" HEIGHT="53">
<P>시타글립틴 관련 수입의약품의 2018년 국내시장 규모는 약 1530억원(출처: 유비스트 원외처방실적)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>2023년 이후 자사제품의 판매와 동시에 CMO 사업을 진행할 예정임</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK="F-GL">(S)품목 : 타파진정</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>저분자의약품의 제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>당뇨</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>③ 적용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="53">
<P>SGLT2 억제제로서 포도당의 재흡수를 감소시키고 포도당에 대한 RTG를 낮추어 혈장 포도당 농도를 감소시킴</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>수입약품을 대체하기 위한 제네릭 의약품으로 생산성과 안정성을 개선시킨 제품임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>
<TD WIDTH="567" HEIGHT="30">임상1상 동등으로 안정성, 유전독성, 금속불순물 자료 준비중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후계획</P>
</TD>
<TD WIDTH="567" HEIGHT="30">품목허가신청을 완료할 예정임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>포시가정 / 한국아스트라제네카㈜</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑧ 관련특허</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>물질특허(2024.01.08) 무효 확정시 2023.04.08</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑨ 시장규모</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>2019년 수입실적 $ 12,119,353</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P> -</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK="F-GL">(T)품목 : 아세렌캡슐</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>저분자의약품의 제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>골관절염</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="145" USERMARK=" BC0XF2F2F2">
<P>③ 적용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="145">
<P>- Anthraquinone 계열 물질로서 체내에서 rhein으로 바뀌어 염증매개물질인 interleukin 1의 농도를 감소</P>
<P>- 유해산소의 생성을 억제하고 호중구 및 대식세포의 화학주성 및 탐식능을 억제하여 염증을 감소시켜 관절연골파괴를 감소</P>
<P>- 관절파괴를 촉진시키는 collagenase의 관절세포로부터의 유리를 억제하여 관절연골파괴를 저해</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>중국 현지 대조약 대비 안정성 및 품질이 개선된 제네릭 의약품</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>임상1상(중국) 진행을 위하여 제제연구 진행중임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후계획</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>임상1상 진행 후 품목허가신청 진행 예정임</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>Artrodar 디아세레인캡슐 / Kunming Jida Pharmaceutical Co., Ltd.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>⑧ 관련특허</P>
</TD>
<TD WIDTH="567" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>⑨ 시장규모</P>
</TD>
<TD WIDTH="567" HEIGHT="53">중국의 65세 이상 인구 중 1.5억 명이 골관절염 환자로 추산되고 있으며, 연평균 환자 증가율이 약 20%에 달하는 것으로 예측</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 기타사항</P>
</TD>
<TD WIDTH="567" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK="F-GL">(U)품목 : 콘트라브서방정 후발의약품</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구  분</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>저분자의약품의 제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>비만</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="99" USERMARK=" BC0XF2F2F2">
<P>③ 적용기전</P>
</TD>

<TD WIDTH="567" HEIGHT="99">
<P>- 날트렉손염산염 : oxymorphone의 cyclopropyl 유도체로 오피오이드 수용체에 대한 길항제</P>
<P>- 부프로피온염산염 : 도파민과 노에피네프린의 재흡수를 차단하여 니코틴아세틸콜린 수용체를 차단</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="122" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="567" HEIGHT="122">
<P>- 항우울제 부프로피온(도파민 재흡수 억제제)과 알콜 의존성 치료에 사용하는 날트렉손(오피오이드 수용체 길항제)의 복합제임</P>
<P>- 오렉시젠과 독점판매 계약을 맺은 광동제약이 국내 출시</P>
<P>- 특히 향정신성 의약품으로 허가받은 '벨빅'과 달리 비향정신성 의약품으로 허가 받아 처방 및 관리에 유리함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>
<TD WIDTH="567" HEIGHT="30">특허회피 제제연구중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후계획</P>
</TD>
<TD WIDTH="567" HEIGHT="30">제제 안정성 및 처방 확정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>콘트라브서방정 / 광동제약㈜</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑧ 관련특허</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>용도조성 2024.04.21</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>⑨ 시장규모</P>
</TD>

<TD WIDTH="567" HEIGHT="53">
<P>2018년 생산실적 36,489,180원</P>
<P>2019년 생산실적 3,564,671원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P> -</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">(V)품목 : 삼스카정 후발의약품</SPAN>
</P>

<TABLE BORDER="1" WIDTH="709" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="558"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구  분</P>
</TD>
<TD WIDTH="567" HEIGHT="30">저분자의약품의 제네릭</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>
<TD WIDTH="567" HEIGHT="30">고혈량성 또는 정상혈량성 저나트륨혈증</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>③ 적용기전</P>
</TD>
<TD WIDTH="567" HEIGHT="53">바소프레신 수용체를 길항해ADPKD환자의 낭종 생성 및 신기능 저하를 억제해 말기신부전 도달 시기 지연</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="122" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>
<TD WIDTH="567" HEIGHT="122">Vasopressin V2 Receptor Antagonist로서 일반적으로는'Vaptan(밥탄)'이라고 불리우는 새로운 계열의First-in-Class 약제이며, 신장 집합관에서의 바소프레신 작용을 차단해 뇨 중 전해질 배설의 증가 없이 수분을 선택적으로 배설시키는 기전(Free Water Clearance)을 통해 심부전, 항이뇨호르몬 분비 이상 증후군(SIADH) 환자 등에서 발생하는 저나트륨혈증을 치료한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>
<TD WIDTH="567" HEIGHT="30">임상1상을 위하여 제제연구 진행중임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후계획</P>
</TD>
<TD WIDTH="567" HEIGHT="30">임상1상 진행 후 품목허가신청 진행 예정임</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>
<TD WIDTH="567" HEIGHT="30">삼스카정/ 한국오츠카제약㈜</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑧ 관련특허</P>
</TD>
<TD WIDTH="567" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑨ 시장규모</P>
</TD>
<TD WIDTH="567" HEIGHT="30">2021년 : 37.5억원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="567" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">(W)품목 : 무정형 테고프라잔</SPAN>
</P>

<TABLE BORDER="1" WIDTH="708" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="557"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구  분</P>
</TD>
<TD WIDTH="566" HEIGHT="30">저분자의약품의 제네릭</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>
<TD WIDTH="566" HEIGHT="30">위식도역류질환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="34" USERMARK=" BC0XF2F2F2">
<P>③ 적용기전</P>
</TD>
<TD WIDTH="566" HEIGHT="34">칼륨 경쟁적 위산분비차단제(Potassium competitive acid blocker: P-CAB)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>
<TD WIDTH="566" HEIGHT="53">기존 PPI 대비 빠른 효과를 가지며, 긴 약물 반감기와 작용 지속시간과 높은 야간 위산 분비억제 효과 및 음식물 섭취와 무관하게 투약이 가능함</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>
<TD WIDTH="566" HEIGHT="30">결정형 특허 회피를 위한 무정형 테고프라잔의 안정성 확인중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후계획</P>
</TD>
<TD WIDTH="566" HEIGHT="30">무정형 테고프라잔을 이용한 제제연구</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="37" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>
<TD WIDTH="566" HEIGHT="37">케이캡정50밀리그램/ 에이치케이이노엔㈜</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="31" USERMARK=" BC0XF2F2F2">
<P>⑧ 관련특허</P>
</TD>
<TD WIDTH="566" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="33" USERMARK=" BC0XF2F2F2">
<P>⑨ 시장규모</P>
</TD>
<TD WIDTH="566" HEIGHT="33">2021년1120억원(UBIST 처방조제액)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P>(X)품목 : DHP2820</P>

<TABLE BORDER="1" WIDTH="708" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="557"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구  분</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>저분자의약품의 제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>위식도역류질환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="34" USERMARK=" BC0XF2F2F2">
<P>③ 적용기전</P>
</TD>

<TD WIDTH="566" HEIGHT="34">
<P>칼륨 경쟁적 위산분비차단제(Potassium competitive acid blocker: P-CAB)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="566" HEIGHT="53">
<P>기존 PPI 대비 빠른 효과를 가지며, 긴 약물 반감기와 작용 지속시간과 높은 야간 위산 분비억제 효과 및 음식물 섭취와 무관하게 투약이 가능함</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>제조방법 특허 회피를 제제연구 진행중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후계획</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>단일제 및 복합제(NSAID) 제제연구</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="37" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="566" HEIGHT="37">
<P>보신티정 / 한국다케다제약㈜</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑧ 관련특허</P>
</TD>
<TD WIDTH="566" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="33" USERMARK=" BC0XF2F2F2">
<P>⑨ 시장규모</P>
</TD>

<TD WIDTH="566" HEIGHT="33">
<P>2021년 1096억원(P-CAB)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(Y)품목: DHP2819</P>

<TABLE BORDER="1" WIDTH="708" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="557"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구  분</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>저분자의약품의 제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>만성동맥폐색증</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="34" USERMARK=" BC0XF2F2F2">
<P>③ 적용기전</P>
</TD>

<TD WIDTH="566" HEIGHT="34">
<P>혈액응고 과정에서 factor Xa를 억제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="566" HEIGHT="53">
<P>ENGAGE-AF 대규모 임상연구에서 효과와 안정성 입증</P>
<P>네 번째 NOAC</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>Preformulation</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후계획</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>제제연구 진행</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="37" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="566" HEIGHT="37">
<P>릭시아나정 / 한국다이찌산쿄㈜</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="31" USERMARK=" BC0XF2F2F2">
<P>⑧ 관련특허</P>
</TD>
<TD WIDTH="566" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="33" USERMARK=" BC0XF2F2F2">
<P>⑨ 시장규모</P>
</TD>

<TD WIDTH="566" HEIGHT="33">
<P>2021년 849억원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(Z)품목 : DHP2821</P>

<TABLE BORDER="1" WIDTH="708" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="557"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구  분</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>제형변경 개량신약(캡슐→정제)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>파킨슨 증후군</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="34" USERMARK=" BC0XF2F2F2">
<P>③ 적용기전</P>
</TD>

<TD WIDTH="566" HEIGHT="34">
<P>COMT 저해제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="76" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="566" HEIGHT="76">
<P>1일 1회 요법으로 충분한 약효를 나타내어 환자의 복용 편의성을 높임. 부작용 측면에서도 2세대 COMT 저해제의 주요 부작용인 심각한 설사 및 소변변색과의 관련성이 나타나지 않음. 1년 이상 장기 투여 시에도 특별한 안전성 이슈가 나타나지 않음</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>Preformulation</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후계획</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>제제연구 진행</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="37" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="566" HEIGHT="37">
<P>온젠티스캡슐 / SK케미칼㈜</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="31" USERMARK=" BC0XF2F2F2">
<P>⑧ 관련특허</P>
</TD>
<TD WIDTH="566" HEIGHT="31">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="33" USERMARK=" BC0XF2F2F2">
<P>⑨ 시장규모</P>
</TD>

<TD WIDTH="566" HEIGHT="33">
<P>2021년 30.4억원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(AA)품목 : DHP1802</P>

<TABLE BORDER="1" WIDTH="708" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="557"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구  분</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>관절염</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="145" USERMARK=" BC0XF2F2F2">
<P>③ 적용기전</P>
</TD>

<TD WIDTH="566" HEIGHT="145">
<P>위령선은 거풍습 약재로서 동양의학에서는 현대의학적 개념의 소염, 진통작용 및 혈액순환 개선작용에 쓰여짐. 과루근은 거풍습 약재로, 소갈증이라 불렸던 당뇨병에 많이 사용돼 왔으며, 류마티즘과 고혈압에도 효과를 보이는 것으로 알려졌으며, 항병독 작용, 소염, 진통활성, 혈액순환 개선 및 관절연골 조직보호 활성의 주된 역할을 보임. 하고초는 이기·황혈 약재로, 동양의학에서는 현대의학 개념의 혈액순환 관련 병증에 사용됨.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="99" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="566" HEIGHT="99">
<P>관절염에 유의적으로 작용하는 성분인 위령선, 과루근, 하고초를 1:2:1의 건조생약 중량비로 혼합하고 30% 알코올 수용액으로 추출한 후 수포화부탄올 분획물을 모아 동결건조한 황갈색 분말을 유효성분으로 하는 생약 제제임. 개선된 품질과 안정성을 갖춘 제네릭 의약품. </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>제제연구 및 공정연구</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후계획</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>의약품동등성시험 수행</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="37" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="566" HEIGHT="37">
<P>조인스정200밀리그램 / 에스케이케미칼㈜</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="31" USERMARK=" BC0XF2F2F2">
<P>⑧ 관련특허</P>
</TD>

<TD WIDTH="566" HEIGHT="31">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="33" USERMARK=" BC0XF2F2F2">
<P>⑨ 시장규모</P>
</TD>

<TD WIDTH="566" HEIGHT="33">
<P>2022년 시장매출: 376</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">(AB)품목 : 시큐린정 30mg</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="708">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="557"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구  분</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>혈관치매 등</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>③ 적용기전</P>
</TD>

<TD WIDTH="566" HEIGHT="53">
<P>α-차단 효과, 혈관 확장, serotonin-유사작용, dopamine-유사작용, 뇌허혈시나 저산소증에서 에너지 대사 개선, 항혈소판 효과, 뇌전도(EEG) 상 개선효과 등이 있음.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="566" HEIGHT="53">
<P>콜린 성분 제제의 퇴출로 뇌기능개선제 시장에서 니세르골린 제제가 대안으로 떠오름. 오리지널 의약품 대비 개선된 품질과 안정성을 갖춘 제네릭 의약품.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>제제연구</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후계획</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>처방확정 및 생동시험 수행</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="566" HEIGHT="53">
<P>사미온정 / 일동제약㈜</P>
<P>니세골린정 / 한미약품㈜ </P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑧ 관련특허</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑨ 시장규모</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>2022년 시장매출: 12</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(AC)품목 : DHP2920</P>

<TABLE BORDER="1" WIDTH="708" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="557"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구  분</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>위궤양</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="99" USERMARK=" BC0XF2F2F2">
<P>③ 적용기전</P>
</TD>

<TD WIDTH="566" HEIGHT="99">
<P>위산분비억제 작용에 의해, 디곡신의 가수분해가 억제되어 혈중 디곡신의 농도가 상승할 수 있음. 이트라코나졸, 티로신키나아제 억제제의 효과가 감소될 수 있음. 이 약의 위산분비억제 작용에 의해, 혈중이트라코나졸, 티로신키나아제 억제제의 농도가 감소될 수 있음.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>P-CAB 제제 보신티정의 제네릭 의약품으로 개선된 품질 및 안정성을 확보</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>제제연구</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후계획</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>처방확정 및 생동시험 수행</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>보신티정 / 한국다케다제약㈜</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑧ 관련특허</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>-</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑨ 시장규모</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>2022년 시장매출: 980</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P>(AD)품목 : DHP2819</P>

<TABLE BORDER="1" WIDTH="708" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="557"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>① 구  분</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>제네릭</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>② 적응증</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>항응고제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="53" USERMARK=" BC0XF2F2F2">
<P>③ 적용기전</P>
</TD>

<TD WIDTH="566" HEIGHT="53">
<P>혈액응고 과정에서 factor Xa를 억제한다. 리바록사반 아픽사반과 작용기전은 동일하다. ENGAGE-AF란 대규모 임상 연구에서 효과와 안전성 연구를 발표함.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="99" USERMARK=" BC0XF2F2F2">
<P>④ 제품의 특성</P>
</TD>

<TD WIDTH="566" HEIGHT="99">
<P>에독사반을 복용한 환자는 와파린을 복용한 환자보다 허혈성 뇌졸중 위험이 30%, 두개내 출혈 위험이 60% 낮게 나타남. 에독사반은 와파린에 비해 위장관 출혈로 인한 입원 위험을 40%, 주요 출혈로 인한 입원 위험을 47% 줄였음. 오리지날 의약품 동등 이상으로 개선된 품질의 제네릭 의약품 개발.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑤ 진행경과</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>제제연구</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑥ 향후계획</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>처방 확정 및 생동시험 수행</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑦ 경쟁제품</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>릭시아나정 / 한국다이찌산쿄㈜</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑧ 관련특허</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>조성물 특허</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑨ 시장규모</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>2022년 시장매출: 738</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="142" HEIGHT="30" USERMARK=" BC0XF2F2F2">
<P>⑩ 기타사항</P>
</TD>

<TD WIDTH="566" HEIGHT="30">
<P>-</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">7) 연구개발활동 판매 중단 현황해당사항 없습니다. </SPAN>
<SPAN USERMARK="F-GL">8) 국책과제 진행 현황</SPAN>
<SPAN USERMARK="F-GL11">당사의 연구기술력을 인정받아 아래와 같이 국책과제를 진행하고 있습니다.(주관기관 선정 2건)                                                                                                      (단위 : 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1383">

<COLGROUP>
<COL WIDTH="30"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="582"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="39" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">NO</TH>
<TH WIDTH="153" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주관부처</TH>
<TH WIDTH="591" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과제명</TH>
<TH WIDTH="184" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기간</TH>
<TH WIDTH="338" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업비</TH>
<TH WIDTH="78" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">시작일</TH>
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종료일</TH>
<TH WIDTH="106" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정부지원금</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대화제약(주)</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="39" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="153" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">보건복지부</TD>
<TD WIDTH="591" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">GLP-1유래 펩타이드를 포함하는 경구용 당뇨병/비만 치료제 개발</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.04.23</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022.06.30</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">      525,000 </TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">         350,000 </TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">       875,000 </TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">주관기관</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="39" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2</TD>
<TD WIDTH="153" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">정보통신산업진흥원</TD>
<TD WIDTH="591" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">인공지능-컴퓨터 기반 신약개발(AI-CADD)솔루션을 활용한 GLS타켓 대사항암제 개발</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022.04.01</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022.10.31</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">      257,000 </TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">         111,000 </TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">       368,000 </TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">주관기관</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="967" HEIGHT="30" COLSPAN="5" ALIGN="CENTER">합    계</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" AUTOSUM="COLPART">782,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" AUTOSUM="COLPART">461,000</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="RIGHT" AUTOSUM="COLPART">1,243,000</TD>
<TD WIDTH="78" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">주1) 당사가 국책과제에 출자하는 금액은 현금 및 현물을 합산한 금액입니다. </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">9) 신제품개발실적</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1110">

<COLGROUP>
<COL WIDTH="94"></COL>
<COL WIDTH="175"></COL>
<COL WIDTH="325"></COL>
<COL WIDTH="480"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="103" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">발매년월</TH>
<TH WIDTH="184" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제품명</TH>
<TH WIDTH="334" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성분</TH>
<TH WIDTH="489" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">효능효과</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="103" HEIGHT="99" ALIGN="CENTER">
<P>2020.04</P>
</TD>

<TD WIDTH="184" HEIGHT="99" ALIGN="CENTER">
<P>글리아나 정</P>
</TD>

<TD WIDTH="334" HEIGHT="99">
<P>Choline alfoscerate</P>
<P>400mg</P>
</TD>

<TD WIDTH="489" HEIGHT="99">
<P>1.뇌혈관 결손에 의한 2차 증상 및</P>
<P> 변성 또는 퇴행성 뇌기질성 정신증후군</P>
<P>2. 감정 및 행동변화</P>
<P>3. 노인성 가성우울증</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="103" HEIGHT="99" ALIGN="CENTER">
<P>2020.05</P>
</TD>

<TD WIDTH="184" HEIGHT="99" ALIGN="CENTER">
<P>배리덤  MD 크림</P>
</TD>

<TD WIDTH="334" HEIGHT="99">
<P>Water, Methyl Gluceth-20, Algin, Trisodium</P>
<P>EDTA, panthenol, Myristica Fragrans (Nutmeg)</P>
<P>Extract, Squalane, Carbomer, Caprylic/Capric</P>
<P>Triglyceride, Macadamia Ternifolia Seed Oil</P>
</TD>

<TD WIDTH="489" HEIGHT="99">
<P>피부장벽 강화(피부 지질 개선, 각질 세포 강화)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="103" HEIGHT="99" ALIGN="CENTER">
<P>2020.05</P>
</TD>

<TD WIDTH="184" HEIGHT="99" ALIGN="CENTER">
<P>배리덤 로션</P>
</TD>

<TD WIDTH="334" HEIGHT="99">
<P>Water, Methyl Gluceth-20, Algin, Trisodium</P>
<P>EDTA, panthenol, Myristica Fragrans (Nutmeg)</P>
<P>Extract, Squalane, Carbomer, Caprylic/Capric</P>
<P>Triglyceride, Macadamia Ternifolia Seed Oil</P>
</TD>

<TD WIDTH="489" HEIGHT="99">
<P>피부장벽 강화(피부 지질 개선, 각질 세포 강화)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="103" HEIGHT="53" ALIGN="CENTER">
<P>2020.06</P>
</TD>

<TD WIDTH="184" HEIGHT="53" ALIGN="CENTER">
<P>마린티 캡슐</P>
</TD>

<TD WIDTH="334" HEIGHT="53">
<P>Green Tea Powder 250mg  Orthosiphon Powder 150mg</P>
</TD>

<TD WIDTH="489" HEIGHT="53">
<P>비만 또는 과체중시 체중감량 보조제</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="103" HEIGHT="99" ALIGN="CENTER">
<P>2020.07</P>
</TD>

<TD WIDTH="184" HEIGHT="99" ALIGN="CENTER">
<P>마그네스디 정</P>
</TD>

<TD WIDTH="334" HEIGHT="99">
<P>Magnesium lactate 940mg</P>
<P>Pyridoxine HCI 10mg</P>
</TD>

<TD WIDTH="489" HEIGHT="99">
<P>○다음 경우의 비타민 B6의 보급</P>
<P> -임신, 수유기</P>
<P> -병중, 병후의 체력저하 시</P>
<P>○마그네슘결핍으로 인한 근육경련</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="103" HEIGHT="53" ALIGN="CENTER">
<P>2020.08</P>
</TD>

<TD WIDTH="184" HEIGHT="53" ALIGN="CENTER">
<P>유디온 캡슐</P>
</TD>

<TD WIDTH="334" HEIGHT="53">
<P>Biphenyl dimethyl dicarboxylate 12.5mg</P>
<P>Ursodeoxycholic acid 50mg</P>
</TD>

<TD WIDTH="489" HEIGHT="53">
<P>지속적으로 SGPT가 상승되어 있는 만성지속성 간염</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="103" HEIGHT="30" ALIGN="CENTER">
<P>2020.08</P>
</TD>

<TD WIDTH="184" HEIGHT="30" ALIGN="CENTER">
<P>모사로 에스알 서방정</P>
</TD>

<TD WIDTH="334" HEIGHT="30">
<P>Mosapride citrate 15mg</P>
</TD>

<TD WIDTH="489" HEIGHT="30">
<P>기능성소화불량으로 인한 소화기증상(속쓰림, 구역, 구토)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="103" HEIGHT="53" ALIGN="CENTER">
<P>2020.08</P>
</TD>

<TD WIDTH="184" HEIGHT="53" ALIGN="CENTER">
<P>텔로스틴 정</P>
</TD>

<TD WIDTH="334" HEIGHT="53">
<P>Telmisartan 40mg Rosuvastatin calcium 10.4mg</P>
</TD>

<TD WIDTH="489" HEIGHT="53">
<P>이 약은 두 약물(텔미사르탄과 로수바스타틴)을 동시에 투여하여야 하는 환자에만 사용한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="103" HEIGHT="145" ALIGN="CENTER">
<P>2020.09</P>
</TD>

<TD WIDTH="184" HEIGHT="145" ALIGN="CENTER">
<P>텔로스틴 정</P>
</TD>

<TD WIDTH="334" HEIGHT="145">
<P>Telmisartan 40mg Rosuvastatin calcium 5.2mg Telmisartan 80mg Rosuvastatin calcium 5.2mg Telmisartan 80mg Rosuvastatin calcium 10.4mg</P>
</TD>

<TD WIDTH="489" HEIGHT="145">
<P>이 약은 두 약물(텔미사르탄과 로수바스타틴)을 동시에 투여하여야 하는 환자에만 사용한다.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="103" HEIGHT="53" ALIGN="CENTER">
<P>2020.09</P>
</TD>

<TD WIDTH="184" HEIGHT="53" ALIGN="CENTER">
<P>브롤라인 장용정</P>
</TD>

<TD WIDTH="334" HEIGHT="53">
<P>Bromelain 100mg</P>
</TD>

<TD WIDTH="489" HEIGHT="53">
<P>부종(부기)을 동반한 염증 증상의 완화, 외상(상처) 또는 수술 후의 부종(부기)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="103" HEIGHT="76" ALIGN="CENTER">
<P>2020.10</P>
</TD>

<TD WIDTH="184" HEIGHT="76" ALIGN="CENTER">
<P>티어엠맥스</P>
<P>점안액 0.15%</P>
</TD>

<TD WIDTH="334" HEIGHT="76">
<P>Sodium Hyaluronate 1.5mg</P>
</TD>

<TD WIDTH="489" HEIGHT="76">
<P>1. 쇼그렌증후군, 피부점막안증후군(스티븐스-존슨증후군), 건성안증후군과 같은 내인성 질환</P>
<P>2. 수술후, 약제성, 외상, 콘택트렌즈 착용 등에 의한 외인성 질환</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="103" HEIGHT="53" ALIGN="CENTER">2021.02</TD>

<TD WIDTH="184" HEIGHT="53" ALIGN="CENTER">
<P>디쿠솔점안액</P>
<P>0.4mL</P>
</TD>

<TD WIDTH="334" HEIGHT="53">
<P>Diquafosol sodium 30mg</P>
</TD>

<TD WIDTH="489" HEIGHT="53">
<P>안구건조증과 관련한 증상(각결막 상피 장애)의 개선</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="103" HEIGHT="53" ALIGN="CENTER">
<P>2021.05</P>
</TD>

<TD WIDTH="184" HEIGHT="53" ALIGN="CENTER">
<P>아토바에프 정</P>
</TD>

<TD WIDTH="334" HEIGHT="53">
<P>Ezetimibe/Atorvastatin 10/10mg</P>
<P>Ezetimibe/Atorvastatin 10/20mg</P>
</TD>

<TD WIDTH="489" HEIGHT="53">
<P>원발성 고콜레스테롤혈증(이형접합 가족형 및 비가족형) 또는 혼합형 이상지질혈증</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="103" HEIGHT="191" ALIGN="CENTER">2021.07</TD>
<TD WIDTH="184" HEIGHT="191" ALIGN="CENTER">대화졸레드론산주사액5mg/100mL</TD>
<TD WIDTH="334" HEIGHT="191">Zoledronic Acid Monohydrate 5.33mg/100mL (무수물(으)로서5mg)</TD>

<TD WIDTH="489" HEIGHT="191">
<P>1. 골다공증의 치료</P>
<P>(1) 폐경 후 여성의 대퇴골, 척추 및 비척추 골다공증성 골절의 발생율 감소</P>
<P>(2) 저충격 고관절 골절 후 새로운 골절 발생율 감소</P>
<P>(3) 남성의 골다공증 치료</P>
<P>2. 폐경 후 여성의 골다공증 예방</P>
<P>3. 글루코코르티코이드에 의한 골다공증의 치료 및 예방</P>
<P>4. 골파제트병의 치료</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="103" HEIGHT="122" ALIGN="CENTER" USERMARK=" 0X1814FF">
<P>2021.10</P>
</TD>

<TD WIDTH="184" HEIGHT="122" ALIGN="CENTER" USERMARK=" 0X1814FF">
<P>리바플로 정</P>
</TD>

<TD WIDTH="334" HEIGHT="122" USERMARK=" 0X1814FF">
<P>Micronized rivaroxaban 10mg, </P>
<P>Micronized rivaroxaban 15mg, </P>
<P>Micronized rivaroxaban 20mg</P>
</TD>

<TD WIDTH="489" HEIGHT="122" USERMARK=" 0X1814FF">
<P>1. 비판막성 심방세동 환자에서 뇌졸중 및 전신 색전증의 위험 감소</P>
<P>2. 심재성 정맥혈전증 및 폐색전증의 치료</P>
<P>3. 심재성 정맥혈전증 및 폐색전증으 재발 위험 감소</P>
<P>4. 하지의 주요 정형외과 수술(슬관절 또는 고관절 치환술)을 받은 성인 환자의 정맥혈전색전증예방</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="103" HEIGHT="76" ALIGN="CENTER" USERMARK=" 0X1814FF">
<P>2021.11</P>
</TD>

<TD WIDTH="184" HEIGHT="76" ALIGN="CENTER" USERMARK=" 0X1814FF">
<P>페노브 정</P>
</TD>

<TD WIDTH="334" HEIGHT="76" USERMARK=" 0X1814FF">
<P>Fenofibrate 160mg</P>
</TD>

<TD WIDTH="489" HEIGHT="76" USERMARK=" 0X1814FF">
<P>원발성 고지혈증 : 고콜레스테롤혈증(IIa형), 고콜레스테롤혈증과 고트리글리세라이드혈증의 복합형(IIb형, Ⅲ형), 고트리글리세라이드혈증 (IV형)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="103" HEIGHT="76" ALIGN="CENTER">2022.06</TD>
<TD WIDTH="184" HEIGHT="76" ALIGN="CENTER">바로포지 정</TD>

<TD WIDTH="334" HEIGHT="76">
<P>Amlodipine besylate/Valartan 6.94/80mg</P>
<P>Amlodipine besylate/Valartan 6.94/160mg</P>
<P>Amlodipine besylate/Valartan 13.87/160mg</P>
</TD>
<TD WIDTH="489" HEIGHT="76">암로디핀 또는 발사르탄 단독요법으로 혈압이 적절하게 조절되지 않는 본태성 고혈압</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="103" HEIGHT="76" ALIGN="CENTER">
<P>2022.07</P>
</TD>

<TD WIDTH="184" HEIGHT="76" ALIGN="CENTER">
<P>마르나에프정</P>
</TD>

<TD WIDTH="334" HEIGHT="76">
<P>방풍통성산건조엑스(4.6→1) 475mg</P>
</TD>

<TD WIDTH="489" HEIGHT="76">
<P>배에 피하(피부밑) 지방이 많고 변비기가 있는 환자의 다음 증상 : 고혈압의 동반증상(두근거림, 어깨결림, 홍조), 비만, 부기, 변비</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="L-0-2-7-L1">7. 기타 참고사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">가. 특허권</SPAN>
<SPAN USERMARK="F-GL11">다음은 당사 사업에 관련한 주요 특허권에 관련한 내용입니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="934" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="784"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="58"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="793" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">발명의 명칭</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">등록건수</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">국내</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">해외</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="793" HEIGHT="31">화학색전용 파클리탁셀 가용화용 유성조성물</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="31">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="31">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="793" HEIGHT="30">화학색전용 파클리탁셀 혼합조성물, 그의 유중수형 에멀전 및 제조방법\</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="793" HEIGHT="30">난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한 난용성 약물의 가용화용 제형 및 이들의 제조방법</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="793" HEIGHT="30">파클리탁셀의 가용화용 조성물 및 이의 제조방법</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">15</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="793" HEIGHT="30">고농도의 탁산을 포함하는 경구 투여용 약학 조성물</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">4</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="793" HEIGHT="30">옥틸로늄 브로마이드를 함유하는 항암제 흡수증진제</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="793" HEIGHT="30">방광내 투여를 통한 방광암 치료용 파클리탁셀 조성물 및 이의 제조방법</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="793" HEIGHT="30">파클리탁셀 조성물의 제조 방법</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="793" HEIGHT="30">탁산을 포함하는 경구 투여용 약학 조성물</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="793" HEIGHT="30">고농도탁산을 포함하는 경구 투여용 약학 조성물((PCT/KR2016/003552))</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">3</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="793" HEIGHT="30">고농도탁산을 포함하는 경구 투여용 약학 조성물((PCT/KR2016/003558)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="793" HEIGHT="30">스피노신을 포함하는 인지기능장애 질환 예방 또는 치료용 약학조성물</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">8</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="793" HEIGHT="30">
<P>인지기능장애 또는 퇴행성 뇌질환의 예방 또는 치료용 약학적 조성물</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="793" HEIGHT="30">
<P>플라본6-C-글루코스 유도체를 유효성분으로 함유하는 신경정신질환의 치료 또는 예방용 약학적 조성물</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="793" HEIGHT="30">
<P>산화안정성이 향상된 탁산을 포함하는 경구용 약학 조성물</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="793" HEIGHT="30">
<P>히알루론산 합성효소 변이 단백질 및 이를 이용한 히알루론산 생산 방법</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="793" HEIGHT="30">
<P>비병원성 세균을 이용하여 히알루론산 생산을 위한 발현 시스템 및 상기 발현 시스템을 이용한 히알루론산 생산방법</P>
</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="74" HEIGHT="30">1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="67" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<A REFNO="XII. 상세표|NEF-2|ADX-2">※상세 현황은 '상세표-5. 특허권 현황(상세)' 참조</A>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">나. 상표권</SPAN>
<SPAN USERMARK="F-GL11">당사는 다수의 상표권을 보유하고 있으며, 대표적인 상표권은 다음과 같습니다.</SPAN>
</P>

<TABLE AFIXTABLE="N" BORDER="1" WIDTH="624" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="255"></COL>
<COL WIDTH="351"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="264" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">명          칭</TH>
<TH WIDTH="360" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득일</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" HEIGHT="30" VALIGN="MIDDLE">대화제약주식회사</TD>
<TD WIDTH="360" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2005.11.17</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" HEIGHT="30" VALIGN="MIDDLE">DAE HWA PHARM. CO.LTD</TD>
<TD WIDTH="360" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2005.11.17</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" HEIGHT="30" VALIGN="MIDDLE">DHP</TD>
<TD WIDTH="360" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2009.08.19</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" HEIGHT="30" VALIGN="MIDDLE">리포락셀(LIPORAXEL)</TD>
<TD WIDTH="360" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2016.09.29</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" HEIGHT="30" VALIGN="MIDDLE">DH LASED</TD>
<TD WIDTH="360" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2016.09.29</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">다. 사업부문별 현황</SPAN>
<SPAN USERMARK="F-GL">1) 의약품 제조판매 부문</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11"> (1) 산업의 특성제약산업은 첨단 기술이 집약된 정밀화학산업으로 특허기술 보호 장벽이 높고 신약 의약품 개발이 어려워 기술 우위에 따른 독점력이 강한 부가가치가 매우 높은 기술 집약형 산업입니다. 국민건강 증진 및 국민생명과 직결된 산업으로 안전성 및  유효성 확보, 약가규제 등 다양한 정부 규제 및 정책이 강한 선진국형 산업입니다. 또한 기초연구에서 제조 및 판매까지의 가치사슬 단계가 타 산업에 비해 매우 광범위하며, 질병의 원인이 다양하여 다품종 소량 생산 하는 특성을 가지고 있는 산업입니다. </SPAN>
<SPAN USERMARK="F-GL11">☞국내 제약산업의 발전 단계▶1950년대 : 완제의약품 수입판매 단계▶1960년대 : 포장 및 제형의 국산화▶1970년대 : 원료합성기술 모방 KGMP 도입▶1980년대 : 신공정개발 기술 축적 및 수입 및 자본의 자유화▶1990년대 : 신약개발 착수 및 가시화, KGMP 전면실시, 물질특허 제도▶2000년대 : 신약개발 활성화 단계 진입, 천연물신약개발 착수, cGMP 도입 준비▶2010년대 : 천연물 신약개발 가시화, FTA로 인한 글로벌화 예상 (2) 산업의 성장성국내 제약시장은 인구 노령화, 만성질환 환자 증가, 삶의 질 향상과 건강에 대한 관심 증가로 향후 계속적으로 성장할 것으로 기대하고 있습니다. 실제로 건강보험심사평가원이 밝힌 '2021년 의료급여통계연보'에 따르면 2021년 지급결정된 급여비는 9조 5022억원으로전년대비 7.6% 증가 하였으며 1인당 의료급여비는 622만 4259원으로 전년 대비 6.3% 증가 하였다고 합니다. 특히 65세이상 급여비는 4조 8642억원으로 전년비 9.6% 증가, 1인당 의료급여비는 807만원으로 전년대비 4.3% 증가 하였하였습니다. 또한  전체 의료급여비의 51.2%의 비중을 차지하고 있습니다. </SPAN>
</P>
<P></P>

<IMAGE>
<IMG WIDTH="598" HEIGHT="429" ALIGN="CENTER" HSPACE="0">emb0000865836d7.jpg</IMG>
<IMG-CAPTION ATOC="N">의료급여 수급권자 진료 현황_2021년 의료급여 통계연보</IMG-CAPTION>
</IMAGE>

<IMAGE>
<IMG WIDTH="600" HEIGHT="378" ALIGN="CENTER" HSPACE="0">emb0000865836d6.jpg</IMG>
<IMG-CAPTION ATOC="N">65세 이상 의료급여 수급권자 비중 현황_2021년 의료급여 통계연보</IMG-CAPTION>
</IMAGE>
<P></P>

<P>
<SPAN USERMARK="F-GL11">해외 제약시장은 신흥국(Pharmering) 중심으로 높은 성장률을 보이고 있으며 인프라 개선,도시화, 가구의 구매력 향상, 건강관리에 대한 이해도 증진 및 개선을 위한 노력 증가와 의료시스템 확대 등에 힘입어 아프리카 제약시장은 꾸준히 성장을 할 것으로 기대되고 있습니다.더불어 전 세계적인 인구고령화 및 만성질환 환자의 증가, 삶의 질 향상을 추구하는 기조에 힘입어 제약산업은 국가의 주요 관리 산업으로서 지속 주목과 관심을 받게 될 것으로 기대하고 있습니다.</SPAN>
<SPAN USERMARK="F-GL11"> (3) 경기변동의 특성제약산업은 인간의 생명과 건강을 다루는 국민 건강사업의 특성으로 타산업에 비해 경기 방어적 성격이 강하다고 할 수 있습니다. 일반의약품의 경우 경기 변동과 계절적 요인에 다소 영향을 받는 편입니다.</SPAN>
<SPAN USERMARK="F-GL11"> (4) 국내시장 여건국내 제약시장은 과거 해외 오리지널 의약품을 국내 제약사가 라이선스인(licence-in) 하여 판매하였으나, 다국적사의 국내 진입으로 자체 판매로 전환되어 상대적으로 신약기술 기반이 취약한 국내 제약사들은 제네릭 위주로 성장을 하고 있습니다.그러나 신약개발에 어려움을 겪고 있는 다국적 제약기업이 제네릭 시장 진입을 확대 하고 있고 한미 FTA 체결로 지식재산 관련 법 및 데이터 독점권 등이 강화되어 국내 업체들이 제네릭 시장에 설자리가 점차 좁아질 것으로 전망되고 있습니다.평균수명 연장 등으로 건강보험 재정적자가 우려되면서 정부가 일괄약가 인하 정책, 실거래가 약가조정제도 등 영업정책에 영향을 주는 법적 규제를 시행하고 있어 향후 전망 또한불투명한 상태이며, FTA의 실시와 함께 cGMP(Current Good Manufacturing Practice) 품질기준의 생산설비를 갖추도록 하고 있어 중소제약업계에 부담으로 작용하고 있습니다.반면, 국내 제약산업은 근래 대규모 기술수출 계약을 체결하는 등 기존 내수 위주의 산업구조에서 연구개발을 강화하여 신약을 개발함으로써 기술수출, 해외진출 등 글로벌 전략으로 탈바꿈 되고 있습니다. 이에 따라 정부가 신사업 육성 신약개발 지원에 대한 세액 공제 및 육성 펀드를 조성하는 등 지원제도를 발표하고 제약산업을 세계 7대 강국으로 도약하기 위한 정책을 추진하고 있어 국내 제약 산업의 성장성은 꾸준히 이어갈 것으로 예측 되고 있습니다. 과거 제약사들의 핵심 경쟁요소가 마케팅력이었다면 향후 신약 R&D역량과 슈퍼제네릭(개량신약) 개발, 우수 의약품의 품질 경쟁력, 글로벌 시장경쟁력이 중요한 핵심 경쟁요소로 빠르게 부상하고 있습니다. (5) 해외시장 여건</SPAN>
</P>
<P USERMARK="F-GL11">해외 제약시장은 대부분 대량의 자본을 투입하여 신약개발을 달성해 낸 선진 다국적 제약회사들에 의하여 점유되고 있으며, 이의 독점적 지위 유지를 위한 허가특허연계제도 등 다양한 규제장벽들이 설정되고 있습니다. 더욱이 각 국가마다 자국민의 건강관리와 직결되는 집중관리육성산업으로 지정하여, 점진적으로 자국 산업보호를 강화하는 추세로 관세 및 비관세(규제강화 및Local 기업 지원책 등)의 장벽들이 늘어가고 있습니다. 특히 대형 시장을 보유하고 있는 북미 및 유럽 등지에 진출을 하려면 US cGMP나 EU GMP의 높은 기준을 만족시키기 위한 대대적 설비투자 및 System 운영 투자를 진행하여야 하며, 제품 인허가등록을 위한 방대한 자료를 준비해야 하는 등의 애로사항을 극복해야만 합니다. 특히, 미국의 경우 GDUFA(Generic Drugs User Fee Act)라는 제도를 통한 추가 인증비를 지불해야 하며, 중국의 경우도 허가비용 및 임상비의 급격한 인상 및 대대적 약가 인하 관리 등으로 그 진입이 점차 어려워지고 있는 실정입니다. 더불어 국내 식약처 허가요청자료 이상의 독자적 규정에 따른 자료 준비 등(KP 불인정에 따른 MV 진행 및 국내 미설정 기시 항목의 추가설정관리 외)의 어려움도 해외진출의 주요 장벽 중 하나가 되고 있습니다.그러나 세계적인 고령화 추세 및 수명연장의 기조, 각국 보험 비용절감정책 및 특허로 보호받고 있던 신약 품목들의 점진적 특허 만료 등으로 인하여 Generic시장은 더욱 확장될 것이며 제약시장은 지속적으로 성장될 것으로 예측하고 있으며 향후,정밀 맞춤형 의료의 발전 및 바이오시밀러에 대한 관심이 커지고 있어 새로운 영역인 유전자 재조합 또는 세포배양 기술을 통해 생산되는 단백질이나 호르몬 등의 바이오의약품과 환자의 복용 편의성 및 삶의 질 개선을 위한 제형 변경 및 투여경로 변경 등의 개량신약이 주도할 것이라 예상됩니다. </P>
<P USERMARK="F-GL11">  (6) 관계법령 또는 정부의 규제 및 지원① 관계 법령 : 약사법, 향정신성의약품 관리법, 우수의약품 제조기준(KGMP), 우수의약품유통관리기준(KGSP), 마약법 등② 정부 규제 : 신규 보험약가 상한가 제도, 의약품 선별등제 제도, 실거래가 상한제, 약가재평가제, 판매자 가격표시제, 고가의약품 사용억제정책, 포괄수가제, 보험약가 사후관리제, 약물경제성 평가제도, 의약품광고 관련규정, 소포장 및 안전용기 의무화, DMF제도, 리베이트 쌍벌제 일괄약가인하정책, 실거래가 약가조정제도 등③ 정부 지원 : 신약개발 연구지원, 선도기술 개발사업 등</P>

<P>
<SPAN USERMARK="F-GL">2) 의약품 도매업부문</SPAN>
</P>

<P> 
<SPAN USERMARK="F-GL11">(1) 산업의 특성도매업은 의약품을 병의원, 요양기관, 약국 등에 유통 판매하는 산업을 말합니다. 의약품 유통업은 약국 판매 도매업체와 병의원 납품 및 일부 약국 판매를 겸하는 도매업체로 대별되고 있으며 동일시장내에서 경쟁이 치열한 산업입니다. 동일 상품으로 시장에서 경쟁하므로 배송 관리와 거래처에 대한 서비스 강화 및 적정 수준의 재고 확보를 통한 적기 공급체계가 필요하며 많은 수의 품목을 취급하고 현대적 물류체계를 필요로 하는 산업입니다.  (2) 산업의 성장성</SPAN>
<SPAN USERMARK="F-GL11">2021년도 국내 완제의약품 유통업체의 수는 3,815개소로 그중 도매상이 3,332개소로 전체의 87.3%를 차지하고 있으며 전체 80조원에 달하는 완제의약품 공급금액 중 45조원을 도매상이 공급하여 약 56%를 점유하고 있습니다. 도매상의 완제의약품 유통 금액은 2020년 대비 5.7% 증가 하였으며 꾸준한 상승 추이를 보이고 있습니다. </SPAN>
</P>

<IMAGE>
<IMG WIDTH="578" HEIGHT="220" ALIGN="CENTER" HSPACE="0">완제의약품 공급업체 점유율_2021년 완제의약품 유통정보 통계집, 건강보험심사평가원.jpg</IMG>
<IMG-CAPTION ATOC="N">완제의약품 공급업체 점유율_2021년 완제의약품 유통정보 통계집, 건강보험심사평가원</IMG-CAPTION>
</IMAGE>
<P></P>

<IMAGE>
<IMG WIDTH="570" HEIGHT="448" ALIGN="CENTER" HSPACE="0">완제의약품 연도별 업태별 현황_2021년 완제의약품 유통정보 통계집, 건강보험심사평가원.jpg</IMG>
<IMG-CAPTION ATOC="N">완제의약품 연도별 업태별 현황_2021년 완제의약품 유통정보 통계집, 건강보험심사평가원</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK="F-GL11"> (3) 경기변동의 특성의약품 도매업은 제약산업에 기반을 두고 있어  경기변동에 영향을 비교적 덜 받습니다.  (4) 국내시장여건국내 의약품 도매업은 완제의약품 유통정보 통계집에 따르면 2019냔 2,888개사 에서 2021년도말 기준 3,278개사로 꾸준한 증가 추세에 있으며 이 중 상위 5%의 도매상이 전체 공급량의 63%를 점유하는 것으로 나타나고 있어 소규모 업체의 경쟁이 날로 심화될 것으로 예상됩니다.   (5) 관계법령① 관계 법령 : 약사법, 향정신성의약품 관리법, 우수의약품 유통관리기준(KGSP), 마                             약법 등② 정부 규제 : 친족도매거래제한법, 리베이트 쌍벌제등 </SPAN>
<SPAN USERMARK="F-GL11">3) 의약품원료 제조업 판매 부문</SPAN>
<SPAN USERMARK="F-GL11"> (1) 산업의 특성원료의약품 산업은 완제의약품의 제품경쟁력과 직결됨으로 제조한 모든 과정에 대해 관리가 이루워져야 지속적으로 우수한 균일된 품질의 API(원료의약품 : Active Pharmaceutical Ingredient)가 생산되는 산업으로 균일된 품질성과 안정성검증등 인허가 과정과 완제의약품생산업체와의 거래에서 특별한 절차가 요구되는 산업이며 판매관리비의 비중이 낮아 완제의약품 제약사 대비 영업이익률이 높은 산업입니다.</SPAN>
<SPAN USERMARK="F-GL11"> (2) 산업의 성장성원료의약품 시장은 완제의약품시장의 전세계적으로 노령인구의 증가에 따른 노화 관련질환과 식습관 등의 변화로 인한 심혈관계 질환의 증가와 암의 발병률이 증가하면서 성장이 매년 약 6%이상 지속될것으로 예상된다고 합니다. 특히 정부의 약가인하 정책등으로 제네릭 원료의약품 부문이 지속적인 성장률을 보일것으로 예상합니다. </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11"> (3) 경기변동의 특성원료의약품제조업은 인간의 생명과 건강을 다루는 제약산업에 기반을 두고 있어  경기변동에 영향을 비교적 덜 받습니다.</SPAN>
<SPAN USERMARK="F-GL11"> (4) 국내시장여건원료의약품 국내시장은 정부의 국내원료의약품에 대한 우대정책 철회와 약가인하정책으로 가격이 저렴한 중국 또는 인도산등의 수입원료로 대체 함으로써 국내시장 여건은 우호적이지만은 않은것이 현실이기도 합니다. 이러한 국내시장 여건을 극복하기 위해 원료의약품 품목 특화와 생산시설확대와 시설의 국제인증을 통해 경쟁력을 확보하고 글로벌 시장진출을 통한 성장을 도모하고 있습니다.</SPAN>
</P>
<P></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="110" ALIGN="CENTER" HSPACE="0">원료의약품 시장규모_식품의약품 안전처.jpg</IMG>
<IMG-CAPTION ATOC="N">원료의약품 시장규모_식품의약품 안전처</IMG-CAPTION>
</IMAGE>
<P></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="147" ALIGN="CENTER" HSPACE="0">국내 합성의약품과 바이오의약품 원료시장의 규모.jpg</IMG>
<IMG-CAPTION ATOC="N">국내 합성의약품과 바이오의약품 원료시장의 규모_한국보건산업 진흥원</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK="F-GL11"> (5) 관계법령의약품 및 의료기기는 국민의 건강과 직결되고 인체에 직접 사용되는 제품인만큼 제조에서 판매 이후 관리까지 법적 규제와 규제당국의 관리감독을 받는 산업입니다. 약사법과 의료기기법 등의 법령과 대통령령, 복지부장관령 및 다수의 식약처장 고시를 비롯한 많은 규정에 의하여 관리되고 있습니다. 또한 의약품 및 의료기기를 제조하기위해서는 식품의약품안전처로부터 제조업 허가및 우수한 제품의 생산 및 품질관리시스템을 사전 점검받아 GMP(Good Manufacturing Practice) 인정을 받아야 가능하며, 또한 개별 품목에 대해서 그안전성과 유효성을 입증할 수 있는 자료를 검토 받아 개별 허가를 취득해야 합니다. GMP는 한번 인정으로 끝나는 것이 아니라, 정기적인 실사를 통해 계속 유지여부를 감시를 받고 있으며, 허가 받은 대로 의약품을 제조하는지부터 시작해서 관리 및 유통까지 전체의 과정이 관리감독의 대상입니다. 국외에서는 유럽의 경우 CE 인증이나 미국 식품의약품안전국(FDA)의 허가 승인을 비롯한 각 국가별로 엄격하게 관리 감독되고 있으며, 미국과 유럽은 의약품의 효능을 의약품가치 평가 기준으로 도입하면서 신약 승인 절차가 더욱 까다로워지고 있습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">라. 회사의 현황</SPAN>
<SPAN USERMARK="F-GL">1) 의약품 제조판매 부문</SPAN> 
<SPAN USERMARK="F-GL">(</SPAN>
<SPAN USERMARK="F-GL11">1) 영업개황</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">당사는 1984년 1월 19일 설립이래 지금까지 국민건강의 증진을 위하여 의약품의 연구, 제조, 판매하는 중견제약기업으로 경구고형제(정제, 경연질캡슐제, 구강붕해필름-ODF제), 주사제, 경피흡수제(연고제, 첩부제, 습포제, 패치제) 등 제품을 생산, 판매하고 있습니다. 당사는 정부의 GMP 국제화 추진과 약업환경 변화에 부합되도록 국제규격 (cGMP:Current GoodManufacturing Practice : 최신 우수 의약품제조 및 품질관리기준) 수준을 만족시키는 자동화 설비를 갖춘 생산시설을 횡성 부지에 구축하여 운용하고 있습니다.</SPAN>
<SPAN USERMARK="F-GL11">당사는 창사이래 지속적인 R&D 투자 및 개발로 그 혁신성을 인정 받아 2012년 6월 "혁신형제약기업 인증제"의 도입부터 지금까지(2021년 6월 재인증) 해당 지위를 고수하고있습니다.  </SPAN>
<SPAN USERMARK="F-GL11">당사의 당기말 매출 실적은 전기말 대비 약 11.8% 증가한 약 992억원을, 영업이익은 약 56.5% 증가한 약 39억원 이며 당기순이익은 약 17.2% 감소한 약 19억원입니다.현재 당사는 신제품 개발 및 양질의 의약품을 공급하는데 중점을 두며, 매출의 다변화를 위하여 꾸준하게 해외시장 개척을 진행하고 있습니다. </SPAN>
<SPAN USERMARK="F-GL11">우선 Licensing 사업에 대하여, 당사가 개발하여 세계 최초 허가를 받은 경구용 파클리탁셀 개량신약인 리포락셀액(Liporaxel®)의 경우 16년 9월 허가 획득 후, 17년 9월 중국 RMX Biopharma,Co.,Ltd에 총액 미화 2,500만불(선급금 미화 350만불, 단계별 마일스톤 2,150만불)에 별도 로열티를 지급받는 조건으로 기술이전계약을 체결 후 18년 7월 및 10월 위암 및 유방암에 대한 임상비준을 받아 현재 임상 진행 중으로 해당 마일스톤 달성에 따른 기술료 수익 및 추가 임상자료 확보를 통한 가치 확대 추진 중이며. 지속적으로 기타 해외공급계약 및 Licensing을 추진, 진행하고 있어 추가 완제품수출 및 기술 수출에 따른 매출 신장을 기대하고 있습니다.</SPAN>
</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">아울러 국내에서 이미 정평이 나있는 TDDS(경피약물전달기술) 기술에 대한 Licensing 사업 및 핵심 기반기술인 DHLASED(지질기반자체유화약물전달기술)로부터 도출되는 다양한 Pipeline Project들의 개별 추가 Licensing 사업도 검토 논의 되고 있는 바, 지속적으로 당사의 기술력을 세계에 알리는 동시에 끊임없는 연구개발의 성과물을 창출해 냄으로써 DDS(약물전달기술) 방면에 있어 세계적 강자가 되기 위하여 지속 노력하고 있습니다. </P>
<P USERMARK="F-GL11">더불어 완제품 수출사업으로는 현재 당사의 주요 해외수출시장은 미얀마, 베트남 등지의 동남아시아권과 볼리비아,에콰도르 등의 남미권, 그리고 에티오피아, 가나 등의 아프리카권 시장으로, 지속적인 매출 증가를 통한 외형성장 및 권역 확대를 추진하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">특히 대형 시장인 중국의 경우 기체결된 Project들의 현지 인허가 추진 중(기관지 확장제인 레스날린의 경우 BE 승인을 득하여 중국 내 시험 진행을 통한 인허가 추진 중)에 있으며, 중국 파트너와 JHK Biopharm이라는 합자회사를 상하이에 건립하여 TDDS제품군 및 ODF 제품군 외 기타 전략적 협력 사업을 통한 사업 영역 확대를 추진 조율 중에 있으며, 러시아를 중심으로 한 유라시아 및 중동, 북아프리카 권역에 대한 신규계약 추가 체결로 현재 제품의 인허가 Project 진행 중에 있으며, 더욱더 관련 교역 품목 및 국가를 확장하여 글로벌사업을 확장/발전시키기 위하여 노력하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">또한, 17년도 인수한 독일의 관계사(S&V Technologies 및 BSC Medical Devices)와의 협력 사업을 통한 새로운 미용의료기기 및 화장품 영역의 해외사업도 추가 조율되고 있으며,대표적으로 18년 6월 중국 Sinopharm Zhijun Pharmaceutical社와 10년간 1천억원에 달하는중국 권역에 대한 독점공급계약을 체결하여 보고서 작성기준일 현재 현지 인허가를 위한 임상 최종보고서 도출 및 12월 인허가 접수를 목표로 진행 중에 있으며, 추가 신제품 개발 및 도입 유통과 해외 수출 연계사업도 준비되고 있는 바, 다각화된사업추진으로 그 결실을지속적으로 맺게 될 것이라 기대하고 있습니다. </P>
<P></P>

<P> 
<SPAN USERMARK="F-GL11">2) 시장점유율 </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">제약업체와 제품의 특성상 업체간 시장 점유율의 비교가 불가하여 한국표준산업분류(KISC-9) 의료용 물질 및 의약품 제조업(C21) 중 12월 결산법인 코스닥 상장를 대상으로 매출액의 시장점유율을 표기합니다.                                                                                                 (단위: 백만원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="596" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="219"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2021년</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="228" HEIGHT="30">코스닥상장기업 매출</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">10,068,322</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">7,735,996</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30">5,598,048</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="228" HEIGHT="30">코스닥상장기업 수</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">112개사</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">108개사</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30">93개사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="228" HEIGHT="30">코스닥상장기업평균매출</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">89,895</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">71,630</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30">60,194</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="228" HEIGHT="30">당사 매출</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">88,704</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">82,325</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30">87,314</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="228" HEIGHT="30">당사 코스닥상장기업 매출 순위</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">29위</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">25위</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30">21위</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="228" HEIGHT="30">당사 매출비 점유율(%)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">0.9</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="30">1.1</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30">1.6</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11">
<SPAN USERMARK="F-10">※상기 매출액은 금융감독원에 공시된 코스닥 공시자료중 별도기준 매출액를 표기   (업종분류대상은 금감감독원 업종분류에서 참조).※ 2021년 기말 기준 상위 10대 기업의 매출액은 약 494백억원으로 전체 매출의 49.1%를 점하고 있음.</SPAN> 3) 시장의 특성
</P>

<P>
<SPAN USERMARK="F-GL11">① 2000년 8월 1일부로 시행된 의약분업 이후 전문의약품 시장의 고도성장.② 정부의 규제 및 지원으로 중소제약사들 입지 축소.③ 일괄약가 인하로 제약시장 성장 폭이 둔화 예상.④ FTA 체결로 인한 외자 기업과의 경쟁이 더욱더 심화될 것임.⑤ 개량신약 보유업체, cGMP 시설 업체, 외자기업, 대기업 위주로 재편 가속화 예상.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">2) 의약품 도매업부문</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11"> (1) 영업 개황종속회사인 디에이치호림주식회사의 당기 매출은 전기 대비 약 12.9% 증가한 약 236억원을, 영업이익은 전기 대비 약 199% 증가한 약 2억원을,  당기순손실은 13백만원으로 적자지속 상태입니다. </SPAN> 
<SPAN USERMARK="F-GL11">(2) 시장점유율영세 도매업체들이 난립하고 있어 정확한 점유율의 산정은 어려움이 있는 바, 한국의약품유통협회의 유통업체 경영실적 데이터 자료에 등재된 업체의 총 매출액 대비 시장점유율을 산정하였습니다.                                                                                                   (단위 : 백만원)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="831" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="132"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="141" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">회 사 명</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">2021년도 </TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">시장점유율</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">2020년도 </TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">시장점유율</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">2019년도 </TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">시장점유율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">지오영</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">2,450,012</TD>
<TD WIDTH="115" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">   9.08 </TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">2,737,498</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">10.13</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">1,936,593</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">7.96</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">백제약품</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">1,692,071</TD>
<TD WIDTH="115" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">   6.27 </TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">1,744,574</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6.46</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">1,429,361</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">5.88</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">지오영네트웍스</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">1,027,431</TD>
<TD WIDTH="115" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">   3.81 </TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">1,104,375</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4.09</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">896,611</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3.69</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">쥴릭파마코리아</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">909,904</TD>
<TD WIDTH="115" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">   3.37 </TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">1,037,232</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3.84</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">1,018,474</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4.19</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">복산나이스</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">946,434</TD>
<TD WIDTH="115" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">   3.51 </TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">902,666</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3.34</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">785,094</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3.23</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">온라인팜</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">916,528</TD>
<TD WIDTH="115" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">   3.40 </TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">824,248</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3.05</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">783,220</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3.22</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">비아다빈치</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">784,898</TD>
<TD WIDTH="115" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">   2.91 </TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">704,332</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.61</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">661,894</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.72</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">인천약품</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">743,649</TD>
<TD WIDTH="115" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">   2.76 </TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">679,295</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.51</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">608,882</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.50</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">엠제이팜</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">718,928</TD>
<TD WIDTH="115" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">   2.67 </TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">642,353</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.38</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">629,868</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2.59</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30">디에이치호림</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">20,918</TD>
<TD WIDTH="115" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">   0.08 </TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">20,223</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0.07</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">19,239</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0.08</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">※ 도매업체 기준은 2021년 한국의약품유통협회 매출 자료에 등재된 162社의 매출액을 기준으로 산정※ 종속회사인 디에이치호림주식회사의 2021년도 매출 순위는 142위에 위치함</SPAN>
</P>

<P> (
<SPAN USERMARK="F-GL">3) 시장의 특성</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">① 1994년 도입된 종합병원 유통일원화제도로 도매업 유통비중 확대됨.② 2001년 1월 의약품 도매업소 면적 기준 폐지로 도매업체 수 급격히 증가.③ 2010년 종합병원 유통일원화제도 폐지로 제약업체와 유통 경쟁 심화.④ 일괄약가 인하로 제약시장 성장 폭이 둔화 예상.⑤ FTA 체결로 인한 외자 기업과의 경쟁이 더욱더 심화될 것임.⑥ 대기업 위주로 재편 가속화 예상.</SPAN>
<SPAN USERMARK="F-GL">3) 의약품원료 제조 판매 부문</SPAN>
<SPAN USERMARK="F-GL11"> (1) 영업 개황종속회사인 주식회사리독스바이오의 당기 매출은 전기 대비 약 37% 증가한 약 138억원을, 영업이익은 흑자전환하여 약 3억원을, 당기순이익은 흑자전환하여 6억원을 나타내고 있습니다.  ① 히알루론산(HA) 제조 및 필러 부문</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">주요 사업부문인 필러 제품의 원료는 히알루론산(Hyaluronic Acid Derivatives)으로 필러 제품의 원료로는 히알루론산(Hyaluronic Acid Derivatives),   자가이식 보형물(Autologous Dermal Implants), 동종이식 보형물(Allogenic Dermal Implants), 유전자 재조합 콜라겐(Recombinant Human Collangen), 합성물질 등이 사용되며 보톡스, 히알루론산 필러가 널리 사용되면서 콜라겐 제품의 감소하고 있는 추세입니다. 특히, 히알루론산 필러는 주입된 필러에 문제가 존재하더라도 외부로 히알루로니다아제를주입해 녹일 수 있다는 점에서 필러 성분으로써는 타 성분 들 대비 안전성이 높아 가장 대중화되어 있는 물질입니다.</SPAN>
<SPAN USERMARK="F-GL11">세계 시장은 히알루론산(HA) 필러에 대한 소비자들의 수요 증가와 더불어 시술가격의 하락의 영향으로 지속적인 성장세가 전망됩니다. [필러 세계 시장규모]</SPAN>
</P>

<IMAGE>
<IMG WIDTH="444" HEIGHT="337" ALIGN="CENTER" HSPACE="0">글로벌 필러 시장 규모 추이 및 전망_신한금융투자.jpg</IMG>
<IMG-CAPTION ATOC="N">글로벌 필러 시장 규모 추이 및 전망_신한금융투자</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK="F-GL11">2019년 시장규모가 30억 달러였던 글로벌 필러 시장은 코로나19의 영향으로 2020년 역성장 하였으나 백신 등의 영향으로 코로나19가 감소 추이를 보일 것으로 예상됨에 따라 2024냔 까지 연평균 14.4% 매출이 성장할 것으로 예상되고 있으며 필러의 효과가 일시적이기 때문에 환자들이 치료 효과를 유지하기 위해선 여러 차례 반복적인 치료가 필요하므로 지속적인 수익 창출로 이어질 것으로 사료되고 있습니다.</SPAN>
</P>

<P> 
<SPAN USERMARK="F-GL11"><의료기기 산업 현황>국내 안면 성형용 필러 제조업체 증가 및 제약사들이 개발한 제품 출시 확대로 인해 2012년부터 생산액 및 수출액은 지속적으로 증가하는 추세에 있으며, 2020년 의료기기 생산액은 10.14조원으로 전년대비 39.24%, 수출액은 7.83조원으로 전년대비 81.02%, 수입액은 5.23조원으로 전년대비 7.76%증가하였다.</SPAN>
</P>
<P USERMARK="F-GL11">(시장규모 7.53조원, 최근 5년 연평균 성장률: 6.42%)</P>

<IMAGE>
<IMG WIDTH="590" HEIGHT="524" ALIGN="CENTER" HSPACE="0">의료기기 산업 현황_식품의약품통계연보.jpg</IMG>
<IMG-CAPTION ATOC="N">의료기기 산업 현황_식품의약품통계연보</IMG-CAPTION>
</IMAGE>
<P></P>

<P>
<SPAN USERMARK="F-GL11">국내 필러 시장은 고성장하면서 신규 업체들의 시장 진입이 눈에 띄고 있습니다. 의료기기로 분류되는 특성상 진입장벽이 상대적으로 높지 않아 업체 수가 빠르게 증가한 것으로 분석되고 있습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">② 의약품  케미칼사업 부문.   의약품의 주성분인 원료의약품은 특성상 허가된 완제의약품 생산업체에 주로 공급되고 있어 품질, 기술 및 가격의 우위를 점한 경우 사업 경쟁력을 확보할 수 있습니다. 원료의약품증축시설로 선진국(유럽, 일본 등) 수준의 GMP시설 확보 및 국제 규격 품질관리로 품질, 기술 및 가격의 우위를 확보할 계획이며, 현재 생산중인 원료의약품 중에서 항궤양제, 진통제는 선진국에 수출을 구체적으로 계획중이며 향후 선진국수준의 GMP서설 확보 및 국제 규격 품질관리로 생산성 및 품질 안전성을 확보하여 국제 전시회를 통한 해외 바이어 상담으로 직접적인 수출 및 해외 distributor를 통한 수출을 진행할 계획에 있습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">한편, 종속회사인 리독스바이오가 생산하는 주요 합성원료는 다음과 같습니다.</SPAN>
</P>
<P USERMARK="F-GL11">록소프로펜나트륨 , 플로로글루시놀, 플로로글루시놀수화물, 클로피도그렐황산염, 툴로부테롤, 록사티딘아세테이트염산염, 보글리보스, 디클로페낙에폴아민,메칠올세팔렉신리지네이트, 리바스티그민, 노닐산바닐아미드, 에스암로디핀베실산염, 디아세레인 등의 주요 합성원료를 생산하고 있습니다.</P>

<P>
<SPAN USERMARK="F-GL11"> (2) 시장점유율식품의약품안전처 ‘2018 식품의약품통계연보’에 따르면 국내 원료의약품 생산 업체수는 2017년 231개 업체로 나타나고 있습니다. 영세한 원료의약품 업체들이 난립하고 있어 대표적인 원료의약품 생산업체의 별도 매출액으로 시장점유율을 기표합니다                                                                                                  (단위 : 백만원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="592">

<COLGROUP>
<COL WIDTH="132"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회 사 명</TH>
<TH WIDTH="151" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2021년도</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년도</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2019년도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대웅바이오</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">389,201</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">     338,942 </TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">     321,499 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">경보제약</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">170,659</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">     215,285 </TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">     191,706 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">코오롱생명과학</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">165,064</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">     129,432 </TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">     148,541 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">종근당바이오</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">142,042</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">     124,319 </TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">     137,184 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">에스티팜</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">139,139</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">     109,050 </TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">      92,995 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">유한화학공업</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">138,207</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">     123,777 </TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">     162,691 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">화일약품</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">106,989</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">     123,613 </TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">     108,744 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">한미정밀화학</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">87,157</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">      89,294 </TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"> 111,338 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">하이텍팜</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">73,287</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">      74,462 </TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">      63,067 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">에스텍파마</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">60,290</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">      61,102 </TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">      46,489 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="141" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">리독스바이오</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,073</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,467</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,679</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">※ 상기 매출액은 금융감독원에 공시된 공시자료중 별도기준 매출액을 표기.</SPAN>
<SPAN USERMARK="F-GL11"> (3) 시장의 특성- 제네릭 의약품 시장성장과 고부가가치 원료의약품 수요증가- 국내 주요 원료의약품 생산 전문제약사 국내 산재- 유럽의 제약사에서 인도, 중국의 제약사로 시장 확대가 용이</SPAN>
</P>

<P USERMARK="F-GL11 0XBD814F">
<SPAN USERMARK=" 0X000000">- 판매관리비 비중이 낮아 완제의약품 제약사 대비 영업이익률이 높음</SPAN>
</P>

<P USERMARK="F-GL11">
<SPAN USERMARK="F-12 B">마. 사업부문별 요약 재무현황</SPAN>
<SPAN USERMARK="F-16 B">                                                            </SPAN>
<SPAN USERMARK="F-12">     (단위 : 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="745">

<COLGROUP>
<COL WIDTH="153"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="162" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH WIDTH="136" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제39기 당기</TH>
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제38기</TH>
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제37기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
<TH WIDTH="149" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="162" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">의약품제조업부문</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매출액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">99,192,379</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">88,704,839</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">82,324,950</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">영업이익</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">3,897,189</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">2,491,089</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">4,610,559</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자산총액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">182,593,965</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">158,597,482</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">155,708,814</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">부채총액</TD>

<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">
<SPAN USERMARK=" BC0X31FFFF">99,014,536</SPAN>
</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">74,802,981</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">70,214,157</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="162" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">의약품도매업부문</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매출액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">23,626,128</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">20,918,620</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">20,223,284</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">영업이익</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">222,054</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">74,216</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">15,317</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자산총액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">5,456,037</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">4,668,525</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">4,787,160</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">부채총액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">9,683,281</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">8,881,702</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">8,809,686</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="162" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">의료정보시스템</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매출액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">352,034</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">386,757</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">370,150</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">영업이익</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">(89,535)</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">24,445</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">39,224</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자산총액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">145,961</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">265,097</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">260,099</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">부채총액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">749,845</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">768,961</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">786,010</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="162" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">의약품원료 제조 판매부문</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매출액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">13,804,954</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">10,073,191</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">7,467,276</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">영업이익</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">305,671</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">(209,106)</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">(832,426)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자산총액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">24,384,659</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">23,705,213</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">23,396,706</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">부채총액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">9,697,157</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">9,697,171</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">9,029,461</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="162" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">화장품, 의료기기 제조 및 판매부문</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매출액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">8,991,709</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">7,048,870</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">5,766,097</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">영업이익</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">1,327,519</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">591,594</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">(237,496)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자산총액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">9,708,066</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">8,918,018</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">8,684,449</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">부채총액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">1,674,830</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">1,845,668</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">2,231,806</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="162" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">조  정(부문간 거래)</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매출액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">(14,055,512)</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">(9,973,445)</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">(6,805,896)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">영업이익</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">185,196</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">311,745</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">347,137</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자산총액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">(23,232,215)</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">(18,778,496)</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">(17,790,441)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">부채총액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">(3,454,462)</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">(2,036,358)</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">(2,176,784)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="162" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매출액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">131,911,692</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">117,158,832</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">109,345,861</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">영업이익</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">5,848,094</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">3,283,983</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">3,942,315</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자산총액</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">199,056,473</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">177,375,839</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">175,046,787</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">부채총액</TD>

<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">
<SPAN USERMARK=" BC0X31FFFF">117,365,188</SPAN>
</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">93,960,125</TD>
<TD WIDTH="149" HEIGHT="30" ALIGN="RIGHT">88,894,336</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</SECTION-2>
</LIBRARY>

</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-0-0">III. 재무에 관한 사항</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="614">

<COLGROUP>
<COL WIDTH="605"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BU" WIDTH="614" HEIGHT="107">다음의 재무제표는 한국채택국제회계기준에 따라 작성되었으며 회계감사인으로 부터 감사 받은 재무제표입니다. 동 재무제표는 주주총회 승인 전 재무제표로 향후 정기주주총회에서 부결되거나 수정이 발생한 경우 정정보고를 통해 그 내용 및 사유 등을 반영할 예정입니다.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-1-0">1. 요약재무정보</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">가. 요약연결재무정보</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">                                                                                                  (단위 : 백만원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="855">

<COLGROUP>
<COL WIDTH="396"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="405" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구       분</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 39 기 당기 </TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 38 기</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 37 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" B" WIDTH="405" HEIGHT="30" VALIGN="MIDDLE">【연결재무상태정보】</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(2022년 12월 말)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(2021년 12월 말)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(2020년 12월 말)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">[유동자산]</TD>

<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">
<SPAN USERMARK=" BC0X57CF8A">51,213</SPAN>
</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">56,139</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">50,926</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">  ㆍ현금및현금성자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">3,125</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">4,002</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">3,410</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">  ㆍ매출채권 및 기타유동채권</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">19,837</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">19,035</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">18,854</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">  ㆍ기타유동금융자산</TD>

<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">
<SPAN USERMARK=" BC0X57CF8A">1</SPAN>
</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">14,420</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">8,949</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">  ㆍ재고자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">23,413</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">18,682</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">19,713</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">[비유동자산]</TD>

<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">
<SPAN USERMARK=" BC0X57CF8A">147,841</SPAN>
</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">121,237</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">124,120</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">  ㆍ유형자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">89,378</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">67,748</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">68,187</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">  ㆍ사용권자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">479</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">498</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">590</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">  ㆍ투자부동산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">15,469</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">15,626</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">15,783</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">  ㆍ영업권</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">693</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">693</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">2,124</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">  ㆍ영업권이외의무형자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">26,972</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">23,775</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">19,762</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">  ㆍ관계기업에 대한 투자</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">213</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">  ㆍ이연법인세자산</TD>

<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">
<SPAN USERMARK=" BC0X57CF8A">3,642</SPAN>
</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">4,172</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">3,734</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">  ㆍ기타비유동금융자산</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">11,208</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">8,725</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">13,727</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" B" WIDTH="405" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자산총계</TD>
<TD USERMARK=" B" WIDTH="150" HEIGHT="30" ALIGN="RIGHT">199,054</TD>
<TD USERMARK=" B" WIDTH="150" HEIGHT="30" ALIGN="RIGHT">177,376</TD>
<TD USERMARK=" B" WIDTH="150" HEIGHT="30" ALIGN="RIGHT">175,046</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">[유동부채]</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">83,260</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">75,335</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">77,608</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">[비유동부채]</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">34,105</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">18,625</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">11,286</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" B" WIDTH="405" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">부채총계</TD>
<TD USERMARK=" B" WIDTH="150" HEIGHT="30" ALIGN="RIGHT">117,365</TD>
<TD USERMARK=" B" WIDTH="150" HEIGHT="30" ALIGN="RIGHT">93,960</TD>
<TD USERMARK=" B" WIDTH="150" HEIGHT="30" ALIGN="RIGHT">88,894</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30" VALIGN="MIDDLE">[납입자본]</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">39,603</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">39,603</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">38,634</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30" VALIGN="MIDDLE">[이익잉여금]</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">45,862</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">46,529</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">46,807</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30" VALIGN="MIDDLE">[기타의자본구성요소]</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">(7,472)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">(6,458)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">(3,462)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30" VALIGN="MIDDLE">[지배기업의 소유주에게 귀속되는 자본]</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">77,993</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">79,674</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">81,979</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30" VALIGN="MIDDLE">[비지배지분]</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">3,696</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">3,742</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">4,173</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" B" WIDTH="405" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자본총계</TD>
<TD USERMARK=" B" WIDTH="150" HEIGHT="30" ALIGN="RIGHT">81,689</TD>
<TD USERMARK=" B" WIDTH="150" HEIGHT="30" ALIGN="RIGHT">83,416</TD>
<TD USERMARK=" B" WIDTH="150" HEIGHT="30" ALIGN="RIGHT">86,152</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" 0X0000FF B" WIDTH="405" HEIGHT="53" VALIGN="MIDDLE">
<SPAN USERMARK=" 0X000000 BC0XDAEAFF">종속ㆍ관계ㆍ공동기업 투자주식의 평가방법</SPAN>
</TD>
<TD USERMARK=" B" WIDTH="150" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">종속회사 : 원가법관계회사 : 지분법</TD>
<TD USERMARK=" B" WIDTH="150" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">종속회사 : 원가법관계회사 : 지분법</TD>
<TD USERMARK=" B" WIDTH="150" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">종속회사 : 원가법관계회사 : 지분법</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" B" WIDTH="405" HEIGHT="53" VALIGN="MIDDLE">【연결손익계산정보】</TD>
<TD WIDTH="150" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2022년 01월 01일~2022년 12월 31일</TD>
<TD WIDTH="150" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2021년 01월 01일~2021년 12월 31일</TD>
<TD WIDTH="150" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2020년 01월 01일~2020년 12월 31일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">매출액</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">131,912</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">117,159</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">109,346</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">영업이익</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">5,848</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">3,284</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">3,942</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">당기순이익(당기순손실)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">1,221</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">1,962</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">(2,483)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">지배기업의 소유주에게 귀속되는 당기순이익(당기순손실)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">1,116</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">2,217</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">     (2,008)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">비지배지분에 귀속되는 당기순이익(당기순손실)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">105</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">(255)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">       (475)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">주당순이익(단위 : 원)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">  ㆍ기본주당이익(손실)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">64</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">127</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">(116)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">  ㆍ희석주당이익(손실)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">64</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">127</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">(116)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30">연결에 포함된 회사수</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">5</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">5</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">5</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">주1) 당사는 2020년 1월 1일부터 기업회계기준서 제1103호 "사업의 정의", 기업회계기준서제1001호 및 제1008호 중요성의 정의(개정), 기업회계기준서에서 '개념체계'에 대한 참조(개정), 기업회계기준서 제1116호 리스(개정)을 적용하였고 동 개정사항들이 당사의 연결재무제표에 미치는 중요한 영향은 없습니다. 주2) 당사는 2021년 1월 1일부터 기업회계기준서 제1109호 "금융상품", 제1039호 "금융상품:인식과 측정", 제1107호"금융상품:공시", 제1104호 "보험계약" 및 제1116호 "리스" 개정-이자율지표 개혁을 적용하였고 동 개정사항들이 당사의 연결재무제표에 미치는 중요한 영향은 없습니다. </SPAN>
<SPAN USERMARK="F-GL10">주3) 당사는 2022년 1월 1일부터 기업회계기준서 제1103호 '사업결합'(개정), 제1016호 '유형자산'(개정), 제1037호 '충당부채, 우발부채 및 우발자산'(개정), 한국채택국제회계기준 2018-2020연차개선을 적용하였고 동 개정 사항들이 당사의 연결재무제표에 미치는 유의적인 영향은 없습니다.</SPAN>
</P>

<P USERMARK="F-GL10">
<SPAN USERMARK=" BU"> 상기 재 개정의  자세한 사항은 8. 기타 재무에 관한 사항을 참조 바랍니다</SPAN>.
<SPAN USERMARK="F-11 BU">※상기 재무제표는 주주총회 승인 전 재무제표이며 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정 보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다. </SPAN>
<SPAN USERMARK="F-12 B">나. 요약재무정보 </SPAN>
<SPAN USERMARK="F-12">                                                                                                                                                                                              (단위 : 백만원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="795">

<COLGROUP>
<COL WIDTH="315"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="149"></COL>
<COL WIDTH="148"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="324" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구       분</TH>
<TH WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 39 기 당기</TH>
<TH WIDTH="158" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 38 기</TH>
<TH WIDTH="157" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 37 기 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" B" WIDTH="324" HEIGHT="30">【재무상태정보】</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(2022년 12월 말)</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(2021년 12월 말)</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">(2020년 12월 말)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">[유동자산]</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">36,589</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">43,038</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">39,533</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">  ㆍ현금및현금성자산</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">320</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">1,415</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">2,060</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">  ㆍ매출채권및 기타유동채권         </TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">12,619</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">12,731</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">13,394</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">  ㆍ기타유동금융자산</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">4,736</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">14,339</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">8,895</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">  ㆍ재고자산</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">18,914</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">14,553</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">15,184</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">[비유동자산]</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">146,005</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">115,559</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">116,176</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">  ㆍ유형자산</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">77,834</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">52,558</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">51,110</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" 0XFF1200" WIDTH="324" HEIGHT="30">
<SPAN USERMARK=" 0X000000 BC0XDAEAFF">  ㆍ사용권자산</SPAN>
</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">464</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">427</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">432</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">  ㆍ투자부동산</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">15,300</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">15,448</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">15,595</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">  ㆍ영업권이외의 무형자산</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">25,879</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">22,390</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">17,970</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">  ㆍ종속기업과 관계기업에 대한 투자</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">12,713</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">12,875</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">14,017</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">  ㆍ이연법인세자산</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">2,958</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">3,256</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">3,058</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">  ㆍ기타비유동금융자산</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">10,857</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">8,605</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">13,994</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" B" WIDTH="324" HEIGHT="30">                     자산총계</TD>
<TD USERMARK=" B" WIDTH="156" HEIGHT="30" ALIGN="RIGHT">182,594</TD>
<TD USERMARK=" B" WIDTH="158" HEIGHT="30" ALIGN="RIGHT">158,597</TD>
<TD USERMARK=" B" WIDTH="157" HEIGHT="30" ALIGN="RIGHT">155,709</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">[유동부채]</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">68,806</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">61,288</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">65,103</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">[비유동부채]</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">30,208</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">13,514</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">5,111</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" B" WIDTH="324" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">부채총계</TD>
<TD USERMARK=" B" WIDTH="156" HEIGHT="30" ALIGN="RIGHT">99,014</TD>
<TD USERMARK=" B" WIDTH="158" HEIGHT="30" ALIGN="RIGHT">74,802</TD>
<TD USERMARK=" B" WIDTH="157" HEIGHT="30" ALIGN="RIGHT">70,214</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30" VALIGN="MIDDLE">[납입자본]</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">39,603</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">39,603</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">38,634</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30" VALIGN="MIDDLE">[이익잉여금]</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">53,702</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">53,608</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">53,791</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30" VALIGN="MIDDLE">[기타의자본구성요소]</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">(9,725)</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">(9,416)</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">(6,930)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" B" WIDTH="324" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자본총계</TD>
<TD USERMARK=" B" WIDTH="156" HEIGHT="30" ALIGN="RIGHT">83,580</TD>
<TD USERMARK=" B" WIDTH="158" HEIGHT="30" ALIGN="RIGHT">83,795</TD>
<TD USERMARK=" B" WIDTH="157" HEIGHT="30" ALIGN="RIGHT">85,495</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="53" VALIGN="MIDDLE">종속ㆍ관계ㆍ공동기업 투자주식의 평가방법</TD>

<TD USERMARK=" 0X1814FF B" WIDTH="156" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK=" 0X000000 BC0XDAEAFF">종속회사 : 원가법관계회사 : 원가법</SPAN>
</TD>
<TD USERMARK=" B" WIDTH="158" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">종속회사 : 원가법관계회사 : 원가법</TD>
<TD USERMARK=" B" WIDTH="157" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">종속회사 : 원가법관계회사 : 원가법</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" B" WIDTH="324" HEIGHT="53" VALIGN="MIDDLE">【손익계산정보】</TD>

<TD USERMARK=" 0X1814FF" WIDTH="156" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK=" 0X000000 BC0XDAEAFF">2022년 01월 01일~2022년 12월 31일</SPAN>
</TD>
<TD WIDTH="158" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2021년 01월 01일~2021년 12월 31일</TD>
<TD WIDTH="157" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">2020년 01월 01일~2020년 12월 31일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">매출액</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">99,192</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">88,705</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">82,325</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">영업이익</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">3,897</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">2,491</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">4,611</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">당기순이익(당기순손실)</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">1,923</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">2,322</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">(554)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">주당순이익(단위 : 원)</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">  ㆍ기본주당이익(손실)</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">110</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">133</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">(32)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="324" HEIGHT="30">  ㆍ희석주당이익(손실)</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">110</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="RIGHT">133</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">(32)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">주1) 당사는 2020년 1월 1일부터 기업회계기준서 제1103호 "사업의 정의", 기업회계기준서제1001호 및 제1008호 중요성의 정의(개정), 기업회계기준서에서 '개념체계'에 대한 참조(개정), 기업회계기준서 제1116호 리스(개정)을 적용하였고 동 개정사항들이 당사의 재무제표에 미치는 중요한 영향은 없습니다. 주2) 당사는 2021년 1월 1일부터 기업회계기준서 제1109호 "금융상품", 제1039호 "금융상품:인식과 측정", 제1107호"금융상품:공시", 제1104호 "보험계약" 및 제1116호 "리스" 개정-이자율지표 개혁을 적용하였고 동 개정사항들이 당사의 재무제표에 미치는 중요한 영향은 없습니다. </SPAN>
<SPAN USERMARK="F-GL10">주3) 당사는 2022년 1월 1일부터 기업회계기준서 제1103호 '사업결합'(개정), 제1016호 '유형자산'(개정), 제1037호 '충당부채, 우발부채 및 우발자산'(개정), 한국채택국제회계기준 2018-2020연차개선을 적용하였고 동 개정 사항들이 당사의 연결재무제표에 미치는 유의적인 영향은 없습니다</SPAN>.
</P>

<P>
<SPAN USERMARK="F-GL10 BU"> 상기 재 개정의  자세한 사항은 8. 기타 재무에 관한 사항을 참조 바랍니다</SPAN>
</P>
<P></P>

<P>
<SPAN USERMARK="F-GL11 BU">※상기 재무제표는 주주총회 승인 전 재무제표이며 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정 보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다. </SPAN>
</P>
<P></P>
</SECTION-2><LIBRARY>
<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-2-0">2. 연결재무제표</TITLE>

<P>
<SPAN USERMARK="F-GL B">가. 연결 재무상태표</SPAN>
</P>

<TABLE-GROUP ACLASS="{XBRL}BS" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="770" BORDER="0">

<COLGROUP>
<COL WIDTH="761"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="770" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">연결 재무상태표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="770" HEIGHT="30" AUPDATECONT="N">
<P>제 39 기          2022.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="770" HEIGHT="30" AUPDATECONT="N">
<P>제 38 기          2021.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="770" HEIGHT="30" AUPDATECONT="N">
<P>제 37 기          2020.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="770" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="773" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="377"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="386">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="129">
<P>제 39 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="129">
<P>제 38 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="129">
<P>제 37 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>51,212,556,542</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>56,138,734,803</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>50,926,394,102</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,125,134,744</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>4,001,730,165</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,410,487,258</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　매출채권 및 기타유동채권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>19,837,052,893</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>19,034,846,720</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>18,853,647,639</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　당기법인세자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>762,190</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>39,820</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>49,470</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　기타유동금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>4,836,711,893</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>14,420,337,674</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>8,949,138,841</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　재고자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>23,412,894,822</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>18,681,780,424</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>19,713,070,894</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　비유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>147,843,916,477</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>121,237,104,168</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>124,120,391,475</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　유형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>89,378,438,529</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>67,747,778,804</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>68,187,399,962</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　사용권자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>478,613,030</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>497,643,477</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>590,364,553</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　투자부동산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>15,469,465,059</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>15,626,301,777</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>15,783,138,495</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　영업권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>693,156,142</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>693,156,142</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,123,983,346</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　영업권 이외의 무형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>26,972,290,886</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>23,774,769,629</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>19,761,815,560</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　종속기업, 조인트벤처와 관계기업에 대한 투자자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>212,811,267</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　이연법인세자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,642,476,797</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>4,171,613,660</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,734,309,486</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　기타비유동금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>11,209,476,034</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>8,725,840,679</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>13,726,568,806</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　자산총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>199,056,473,019</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>177,375,838,971</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>175,046,785,577</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>83,259,700,454</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>75,335,033,973</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>77,607,517,154</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　매입채무 및 기타유동채무</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>19,291,048,534</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>13,530,584,215</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>14,544,797,277</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　유동성전환사채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>844,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>14,490,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　단기차입금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>62,304,530,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>58,002,405,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>43,217,715,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　단기이연수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>50,191,369</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>69,051,923</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>67,216,102</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　당기법인세부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>380,050,369</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,462,521,677</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>560,867,068</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　유동파생상품부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>44,800</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,231,018,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　기타유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,233,880,182</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,426,426,358</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,495,903,707</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　비유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>34,105,487,959</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>18,625,090,230</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>11,286,818,585</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　장기매입채무 및 기타비유동채무</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,517,760,687</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,421,093,864</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,376,976,867</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　장기차입금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>27,307,473,100</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>10,796,490,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>5,249,370,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　퇴직급여부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,274,835,834</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>4,402,388,556</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,655,252,693</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　비유동충당부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>5,418,338</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>5,117,810</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>5,219,025</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　부채총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>117,365,188,413</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>93,960,124,203</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>88,894,335,739</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>자본</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　지배기업의 소유주에게 귀속되는 자본</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>77,992,568,591</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>79,674,201,352</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>81,979,229,926</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　보통주자본금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>9,308,325,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>9,308,325,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>9,284,689,500</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　자본잉여금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>30,294,860,903</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>30,294,860,903</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>29,349,309,215</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　이익잉여금(결손금)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>45,862,209,424</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>46,528,838,384</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>46,807,476,413</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　기타자본구성요소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(7,472,826,736)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(6,457,822,935)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(3,462,245,202)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　　기타자본잉여금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>371,595,434</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>371,595,434</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>371,595,434</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　　기타포괄손익누계액</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(2,917,497,075)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(2,461,735,515)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(29,184,357)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　　자기주식</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(9,161,842,083)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(9,161,842,083)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(9,161,842,083)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　　기타자본조정</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>4,234,916,988</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>4,794,159,229</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>5,357,185,804</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　비지배지분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,698,716,015</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,741,513,416</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>4,173,219,912</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　자본총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>81,691,284,606</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>83,415,714,768</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>86,152,449,838</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>자본과부채총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>199,056,473,019</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>177,375,838,971</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>175,046,785,577</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL10">※상기 재무제표는 주주총회 승인 전 재무제표이며 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정 보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">나. 연결 포괄손익계산서</SPAN>
</P>

<TABLE-GROUP ACLASS="{XBRL}IS1" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="794" BORDER="0">

<COLGROUP>
<COL WIDTH="785"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="794" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">연결 포괄손익계산서</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="794" HEIGHT="30" AUPDATECONT="N">
<P>제 39 기 2022.01.01 부터 2022.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="794" HEIGHT="30" AUPDATECONT="N">
<P>제 38 기 2021.01.01 부터 2021.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="794" HEIGHT="30" AUPDATECONT="N">
<P>제 37 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="794" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="796" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="400"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="409">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="129">
<P>제 39 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="129">
<P>제 38 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="129">
<P>제 37 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>수익(매출액)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>131,911,692,836</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>117,158,831,459</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>109,345,861,658</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>매출원가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>85,812,582,040</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>73,486,227,423</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>66,575,455,921</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>매출총이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>46,099,110,796</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>43,672,604,036</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>42,770,405,737</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>판매비와관리비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>40,251,017,256</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>40,388,620,371</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>38,828,090,366</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>영업이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>5,848,093,540</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,283,983,665</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,942,315,371</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>기타이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,764,055,458</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,151,445,268</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,627,307,282</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>기타손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,402,397,730</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,953,983,020</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,437,225,722</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>금융수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>532,888,309</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>4,466,092,838</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,730,709,400</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>금융원가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,316,549,198</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,210,192,601</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>7,452,226,189</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>지분법이익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>지분법손실</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>212,811,267</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>206,863,733</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>법인세비용차감전순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,426,090,379</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>4,524,534,883</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(795,983,591)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>법인세비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,204,932,348</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,562,095,616</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,687,181,939</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,221,158,031</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,962,439,267</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(2,483,165,530)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>기타포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>418,987,512</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(2,296,677,545)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(1,298,296)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>　당기손익으로 재분류될 수 있는 항목(세후기타포괄손익)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(147,044,865)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>53,531,297</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>315,338,048</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>　당기손익으로 재분류되지 않는항목(세후기타포괄손익)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>566,032,377</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(2,350,208,842)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(316,636,344)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>총포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,640,145,543</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(334,238,278)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(2,484,463,826)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>당기순이익(손실)의 귀속</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>　지배기업의 소유주에게 귀속되는 당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,115,657,705</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,217,397,654</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(2,007,786,686)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>　비지배지분에 귀속되는 당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>105,500,326</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(254,958,387)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(475,378,844)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>총 포괄손익의 귀속</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>　총 포괄손익, 지배기업의 소유주에게 귀속되는 지분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,505,106,980</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(88,418,787)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(2,006,342,921)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>　총 포괄손익, 비지배지분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>135,038,563</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(245,819,491)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(478,120,905)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>주당이익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>　기본주당이익(손실) (단위 : 원)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>64</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>127</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(116)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="409">
<P>　희석주당이익(손실) (단위 : 원)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>64</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>127</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(116)</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL10">※상기 재무제표는 주주총회 승인 전 재무제표이며 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정 보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.</P>
<P></P>
<PGBRK></PGBRK>
<P USERMARK="F-GL B">다. 연결 자본변동표</P>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}EF" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="1614" BORDER="0">

<COLGROUP>
<COL WIDTH="1605"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1614" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">연결 자본변동표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1614" HEIGHT="30" AUPDATECONT="N">
<P>제 39 기 2022.01.01 부터 2022.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1614" HEIGHT="30" AUPDATECONT="N">
<P>제 38 기 2021.01.01 부터 2021.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1614" HEIGHT="30" AUPDATECONT="N">
<P>제 37 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1614" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="1619" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="143" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150" ROWSPAN="4">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="1469" COLSPAN="11">
<P>자본</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="1180" COLSPAN="9">
<P>지배기업의 소유주에게 귀속되는 자본</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="139" ROWSPAN="3">
<P>비지배지분</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="150" ROWSPAN="3">
<P>자본  합계</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="83" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="117" ROWSPAN="2">
<P>자본금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="83" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="130" ROWSPAN="2">
<P>자본잉여금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="83" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="136" ROWSPAN="2">
<P>이익잉여금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="625" COLSPAN="5">
<P>기타자본구성요소</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="83" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="172" ROWSPAN="2">
<P>지배기업의 소유주에게 귀속되는 자본  합계</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="131">
<P>기타자본잉여금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="109">
<P>기타포괄손익누계액</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="129">
<P>자기주식</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="123">
<P>기타자본</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>기타자본구성요소  합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2020.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="117">
<P>9,112,487,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="130">
<P>21,847,703,037</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="136">
<P>51,646,285,100</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="131">
<P>371,595,434</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="109">
<P>(288,934,223)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="129">
<P>(8,996,149,108)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="123">
<P>5,654,462,678</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="133">
<P>(3,259,025,219)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="172">
<P>79,347,449,918</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="139">
<P>4,703,259,780</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>84,050,709,698</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="130">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="136">
<P>(2,007,786,686)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="123">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="172">
<P>(2,007,786,686)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>(475,378,844)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,483,165,530)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="130">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="136">
<P>(258,306,101)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="131">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="109">
<P>259,749,866</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="123">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>259,749,866</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="172">
<P>1,443,765</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>(2,742,061)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(1,298,296)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>총포괄손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="130">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="136">
<P>(2,266,092,787)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="131">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="109">
<P>259,749,866</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="123">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>259,749,866</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="172">
<P>(2,006,342,921)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>(478,120,905)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,484,463,826)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>지분의 발행</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="117">
<P>172,202,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="130">
<P>7,501,606,178</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="136">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="123">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="172">
<P>7,673,808,678</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>7,673,808,678</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>배당금지급</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="130">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="136">
<P>(2,572,715,900)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="123">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="172">
<P>(2,572,715,900)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,572,715,900)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>자기주식 거래로 인한 증감</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="130">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="136">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="109">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="129">
<P>(165,692,975)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="123">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="133">
<P>(165,692,975)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="172">
<P>(165,692,975)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="139">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(165,692,975)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="150">
<P>지배력을 상실하지 않는 종속기업에 대한 소유지분의 변동에 따른 증가(감소)/비지배지분의 변동</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="130">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="136">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="129">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="123">
<P>(297,276,874)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="133">
<P>(297,276,874)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="172">
<P>(297,276,874)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="139">
<P>(51,918,963)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="150">
<P>(349,195,837)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익-공정가치 측정 금융자산 평가손익 적립금</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="130">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="136">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="123">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="172">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="139">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>자본 증가(감소) 합계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="117">
<P>172,202,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="130">
<P>7,501,606,178</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="136">
<P>(4,838,808,687)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="131">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="109">
<P>259,749,866</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="129">
<P>(165,692,975)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="123">
<P>(297,276,874)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="133">
<P>(203,219,983)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="172">
<P>2,631,780,008</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="139">
<P>(530,039,868)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2,101,740,140</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2020.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="117">
<P>9,284,689,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="130">
<P>29,349,309,215</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="136">
<P>46,807,476,413</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="131">
<P>371,595,434</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="109">
<P>(29,184,357)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="129">
<P>(9,161,842,083)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="123">
<P>5,357,185,804</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="133">
<P>(3,462,245,202)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="172">
<P>81,979,229,926</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="139">
<P>4,173,219,912</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>86,152,449,838</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2021.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="117">
<P>9,284,689,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="130">
<P>29,349,309,215</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="136">
<P>46,807,476,413</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="131">
<P>371,595,434</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="109">
<P>(29,184,357)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="129">
<P>(9,161,842,083)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="123">
<P>5,357,185,804</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="133">
<P>(3,462,245,202)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="172">
<P>81,979,229,926</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="139">
<P>4,173,219,912</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>86,152,449,838</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="130">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="136">
<P>2,217,397,654</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="123">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="172">
<P>2,217,397,654</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>(254,958,387)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,962,439,267</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="130">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="136">
<P>126,734,717</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="131">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="109">
<P>(2,432,551,158)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="123">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="133">
<P>(2,432,551,158)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="172">
<P>(2,305,816,441)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="139">
<P>9,138,896</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(2,296,677,545)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>총포괄손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="130">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="136">
<P>2,344,132,371</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="123">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="172">
<P>(88,418,787)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>(245,819,491)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(334,238,278)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>지분의 발행</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="117">
<P>23,635,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="130">
<P>945,551,688</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="136">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="123">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="172">
<P>969,187,188</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>969,187,188</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>배당금지급</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="130">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="136">
<P>(2,622,770,400)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="123">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="172">
<P>(2,622,770,400)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,622,770,400)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>자기주식 거래로 인한 증감</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="130">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="136">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="123">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="172">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="139">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="150">
<P>지배력을 상실하지 않는 종속기업에 대한 소유지분의 변동에 따른 증가(감소)/비지배지분의 변동</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="130">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="136">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="129">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="123">
<P>(563,026,575)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="133">
<P>(563,026,575)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="172">
<P>(563,026,575)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="139">
<P>(185,887,005)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="150">
<P>(748,913,580)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익-공정가치 측정 금융자산 평가손익 적립금</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="130">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="136">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="123">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="172">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="139">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>자본 증가(감소) 합계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="117">
<P>23,635,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="130">
<P>945,551,688</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="136">
<P>(278,638,029)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="131">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="109">
<P>(2,432,551,158)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="129">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="123">
<P>(563,026,575)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="133">
<P>(2,995,577,733)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="172">
<P>(2,305,028,574)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="139">
<P>(431,706,496)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(2,736,735,070)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2021.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="117">
<P>9,308,325,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="130">
<P>30,294,860,903</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="136">
<P>46,528,838,384</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="131">
<P>371,595,434</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="109">
<P>(2,461,735,515)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="129">
<P>(9,161,842,083)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="123">
<P>4,794,159,229</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="133">
<P>(6,457,822,935)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="172">
<P>79,674,201,352</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="139">
<P>3,741,513,416</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>83,415,714,768</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2022.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="117">
<P>9,308,325,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="130">
<P>30,294,860,903</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="136">
<P>46,528,838,384</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="131">
<P>371,595,434</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="109">
<P>(2,461,735,515)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="129">
<P>(9,161,842,083)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="123">
<P>4,794,159,229</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="133">
<P>(6,457,822,935)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="172">
<P>79,674,201,352</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="139">
<P>3,741,513,416</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>83,415,714,768</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="130">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="136">
<P>1,115,657,705</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="123">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="172">
<P>1,115,657,705</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>105,500,326</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,221,158,031</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="130">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="136">
<P>845,210,835</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="131">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="109">
<P>(455,761,560)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="123">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(455,761,560)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="172">
<P>389,449,275</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>29,538,237</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>418,987,512</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>총포괄손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="130">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="136">
<P>1,960,868,540</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="131">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="109">
<P>(455,761,560)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="123">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(455,761,560)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="172">
<P>1,505,106,980</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">
<P>135,038,563</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>1,640,145,543</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>지분의 발행</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="130">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="136">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="123">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="172">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>배당금지급</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="130">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="136">
<P>(2,627,497,500)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="123">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="172">
<P>(2,627,497,500)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="139">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="150">
<P>(2,627,497,500)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>자기주식 거래로 인한 증감</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="130">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="136">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="123">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="172">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="139">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="150">
<P>지배력을 상실하지 않는 종속기업에 대한 소유지분의 변동에 따른 증가(감소)/비지배지분의 변동</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="130">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="136">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="129">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="123">
<P>(559,242,241)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="133">
<P>(559,242,241)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="172">
<P>(559,242,241)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="139">
<P>(177,835,964)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="122" AUPDATECONT="N" WIDTH="150">
<P>(737,078,205)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">
<P>기타포괄손익-공정가치 측정 금융자산 평가손익 적립금</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="130">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="136">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="131">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="109">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="123">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="172">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="139">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="76" AUPDATECONT="N" WIDTH="150">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>자본 증가(감소) 합계</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="117">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="130">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="136">
<P>(666,628,960)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="131">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="109">
<P>(455,761,560)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="129">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="123">
<P>(559,242,241)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="133">
<P>(1,015,003,801)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="172">
<P>(1,681,632,761)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="139">
<P>(42,797,401)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>(1,724,430,162)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>2022.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="117">
<P>9,308,325,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="130">
<P>30,294,860,903</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="136">
<P>45,862,209,424</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="131">
<P>371,595,434</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="109">
<P>(2,917,497,075)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="129">
<P>(9,161,842,083)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="123">
<P>4,234,916,988</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="133">
<P>(7,472,826,736)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="172">
<P>77,992,568,591</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="139">
<P>3,698,716,015</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N" WIDTH="150">
<P>81,691,284,606</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL10">※상기 재무제표는 주주총회 승인 전 재무제표이며 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정 보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">라. 연결 현금흐름표</SPAN>
</P>

<TABLE-GROUP ACLASS="{XBRL}CF" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="786" BORDER="0">

<COLGROUP>
<COL WIDTH="777"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="786" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">연결 현금흐름표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="786" HEIGHT="30" AUPDATECONT="N">
<P>제 39 기 2022.01.01 부터 2022.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="786" HEIGHT="30" AUPDATECONT="N">
<P>제 38 기 2021.01.01 부터 2021.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="786" HEIGHT="30" AUPDATECONT="N">
<P>제 37 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="786" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="789" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="381"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="390">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 39 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 38 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 37 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>영업활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,192,963,094</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>10,385,544,854</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,653,286,587</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,221,158,031</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,962,439,267</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,483,165,530)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　당기순이익조정을 위한 가감</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>13,076,117,379</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>10,411,800,788</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>14,883,917,405</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　법인세비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,204,932,348</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,562,095,616</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,687,181,939</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　퇴직급여</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,486,655,892</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,728,422,290</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,674,353,994</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　대손상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(11,411,991)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>11,018,660</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,263,787,307)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　감가상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>3,238,469,701</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>3,491,089,355</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>3,707,199,233</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　사용권자산상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>253,259,661</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>310,518,980</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>309,573,150</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　리스자산해지손실(이익)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,348,381)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,628,378</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,061,108)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　무형자산상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,049,530,020</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,016,694,071</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,650,988,112</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　지급수수료</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>393,348</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>23,142,626</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>11,534,786</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　외화환산손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>38,758,046</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>906,313</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>38,194,076</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　유형자산처분손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,213,494</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,067,351</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>6,597,049</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　이자비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,365,000,358</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,519,030,284</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>5,406,246,053</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　영업권손상차손</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,430,827,204</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>966,811,438</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　외화환산이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(13,766,153)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(31,823,571)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(4,437,814)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　이자수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(314,228,740)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(405,179,698)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(329,816,622)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　배당금수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(33,964,475)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(22,058,192)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(22,476,460)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　재고자산처분손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>16,194,996</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>10,673,012</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　재고자산평가손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>113,336,006</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>100,334,431</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>161,716,323</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　유형자산손상차손</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,873,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,182,172,796</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　당기손익인식금융자산평가이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,961,650)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(562,746,498)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　금융자산처분이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(182,688,644)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,053,633,548)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(771,271,892)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　파생금융부채평가손실</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,707,206,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　당기손익인식금융자산평가손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>545,195,687</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>515,659,179</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>23,303,562</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　금융자산처분손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>406,353,153</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>175,503,138</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>315,470,574</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　지분법손실</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>212,811,267</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>206,863,733</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　잡손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>57,955,743</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　파생금융부채평가이익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,312,014,400)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　기타의금융수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(14,761,040)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(43,694,747)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(44,397,928)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　잡이익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(3,716,995)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　영업활동으로인한자산ㆍ부채의변동</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,664,237,939)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>480,955,975</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(3,745,803,079)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　장기선급금의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(335,704,573)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>20,932,259</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(32,212,845)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　단기매출채권의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,433,380,358)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(537,213,116)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,553,774,525</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　단기미수금의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(418,970,761)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>508,762,898</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,262,511,990</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　재고자산의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(4,860,645,400)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>923,273,826</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(3,030,764,329)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　그 밖의 기타단기충당부채의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(192,245,648)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(168,547,297)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(108,950,524)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　장기미지급금의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>103,223,372</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>47,480,992</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(376,523,712)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　단기매입채무의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>6,481,506,144</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>203,775,589</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,177,555,443)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　단기미지급금의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>244,350,182</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,142,903,567)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>912,384,259</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　단기미지급비용의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,930,477,055</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>123,412,514</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,679,482,964)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　단기선수금의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(19,928,170)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(66,297,636)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>155,060,829</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　사외적립자산의공정가치의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>124,381,118</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,117,813,984</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>939,300,652</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　퇴직급여채무의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,813,297,959)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,504,956,844)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,747,135,466)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　기타유동자산의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>288,444,377</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>40,020,292</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(32,436,164)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　기타유동부채의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(762,447,318)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(84,597,919)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>616,226,113</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　배당금수취(영업)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>33,964,475</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>22,058,192</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>22,476,460</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　이자지급(영업)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,815,153,102)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,341,557,872)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,015,232,851)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　이자수취(영업)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>381,319,735</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>30,912,547</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>264,447,943</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　법인세납부(환급)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,040,205,485)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,181,064,043)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(5,273,353,761)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>투자활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(25,246,768,256)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(17,653,636,217)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(11,554,858,342)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　임차보증금의 감소</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>28,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>52,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　임차보증금의 증가</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(10,000,000)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　유동당기손익인식금융자산의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>4,231,198,450</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>7,294,597,116</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,166,280,546</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　유동당기손익인식금융자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(3,499,036,921)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(6,995,089,677)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(8,226,043,958)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　상각후원가측정 금융자산의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>10,331,646</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>30,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　상각후원가측정 금융자산의 취득</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(6,826,420)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　단기금융상품의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,340,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(3,690,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,227,200,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　단기금융상품의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>13,680,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>7,560,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,640,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　기타유형자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(223,472,702)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(292,699,832)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(252,087,295)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　무형자산의 처분</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>340,609,569</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　장기금융상품의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(7,260,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(5,760,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(6,990,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　장기금융상품의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,010,240,675</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　종속기업에 대한 투자자산의 처분</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　기타포괄-공정가치금융자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(170,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,680,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(566,136,700)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　기타포괄-공정가치금융자산의 처분</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>27,944,855</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　건물의 취득</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(517,021,200)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　기계장치의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(380,090,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(778,018,492)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,712,236,561)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　기계장치의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>27,337,819</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,057,763</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　건설중인자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(27,086,742,719)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(8,613,015,271)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,285,878,082)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　개발 중인 무형자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(4,155,771,728)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(4,507,295,271)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(6,616,414,516)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　기타무형자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(90,762,776)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(204,346,133)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　관계기업에 대한 투자자산의 취득</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(419,675,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>재무활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>16,324,254,606</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>7,798,120,760</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>9,367,160,385</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　종속기업에 대한 소유지분의 변동으로 인한 지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(737,078,205)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(748,913,580)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(252,561,615)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　신주발행비 지급</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(598,564,612)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(4,368,062)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　임대보증금의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>28,408,800</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>19,000,000</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　임대보증금의 감소</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(10,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　단기차입금의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>49,303,407,607</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>47,507,219,834</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>47,204,272,028</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　단기차입금의 상환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(46,751,192,607)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(31,971,719,834)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(33,568,772,028)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　장기차입금의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>18,510,863,100</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>5,047,000,000</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　장기차입금의 상환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(249,970,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(250,690,000)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　전환사채의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(853,544,800)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(13,173,207,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(931,500,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　자기주식의 취득</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(165,692,975)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　금융리스부채의 지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(299,141,789)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(311,069,469)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(331,159,017)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　정부보조금의 수취</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>4,901,835,821</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　정부보조금의 상환</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(342,046)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　배당금지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,627,497,500)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,622,770,400)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,572,715,900)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>환율변동효과 반영전 현금및현금성자산의 순증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(729,550,556)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>530,029,397</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>465,588,630</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>해외사업환산차이</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(147,044,865)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>61,213,510</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>247,308,800</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>연결범위 변동에 따른 현금의 증가</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>현금및현금성자산의순증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(876,595,421)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>591,242,907</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>712,897,430</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>기초현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>4,001,730,165</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>3,410,487,258</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,697,589,828</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>기말현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>3,125,134,744</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>4,001,730,165</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>3,410,487,258</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL10">※상기 재무제표는 주주총회 승인 전 재무제표이며 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정 보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.</SPAN>
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-3-0">3. 연결재무제표 주석</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="CENTER">2022년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="CENTER">2021년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="53">회사명 : 대화제약 주식회사와 그 종속기업</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">1. 회사의 개요</SPAN>
</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">대화제약 주식회사(이하 '회사')와 그 종속회사 (이하 회사와 그 종속회사를 '연결회사')는의약품 개발 및 제조, 판매를 주 영업목적으로 하고 있습니다. 회사는 1984년 1월 19일에 설립되어 본사와 공장을 강원도 횡성군에 두고 의약품 및 의약부외품의 제조 및 판매 등을주된 영업으로 하고 있으며, 2003년 2월 14일 주식을 코스닥시장에 상장하였습니다.가. 회사의 종속기업 및 관계기업의 현황은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="987" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="88"></COL>
<COL WIDTH="205"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="167"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="76"></COL>
<COL WIDTH="76"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="97" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="214" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종속기업</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소재지</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="176" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">영업활동</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="153" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">최초취득일자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">출자목적</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="170" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)(주1)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="150" ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER">종속기업</TD>
<TD WIDTH="214" HEIGHT="30"> 디에이치호림㈜</TD>
<TD ALIGN="CENTER" WIDTH="68" HEIGHT="30">한국</TD>
<TD ALIGN="CENTER" WIDTH="176" HEIGHT="30">의약품 판매</TD>
<TD ALIGN="CENTER" WIDTH="153" HEIGHT="30">2007년 05월 17일</TD>
<TD ALIGN="CENTER" WIDTH="109" HEIGHT="30">자회사설립</TD>
<TD ALIGN="CENTER" WIDTH="85" HEIGHT="30">63.91</TD>
<TD ALIGN="CENTER" WIDTH="85" HEIGHT="30">63.91</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="214" HEIGHT="30"> ㈜스페셜라이즈드메드</TD>
<TD ALIGN="CENTER" WIDTH="68" HEIGHT="30">한국</TD>
<TD ALIGN="CENTER" WIDTH="176" HEIGHT="30">컨텐츠 서비스</TD>
<TD ALIGN="CENTER" WIDTH="153" HEIGHT="30">2007년 07월 06일</TD>
<TD ALIGN="CENTER" WIDTH="109" HEIGHT="30">타법인 출자</TD>
<TD ALIGN="CENTER" WIDTH="85" HEIGHT="30">61.24</TD>
<TD ALIGN="CENTER" WIDTH="85" HEIGHT="30">61.24</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="214" HEIGHT="30"> ㈜리독스바이오</TD>
<TD ALIGN="CENTER" WIDTH="68" HEIGHT="30">한국</TD>
<TD ALIGN="CENTER" WIDTH="176" HEIGHT="30">의약품 원료개발</TD>
<TD ALIGN="CENTER" WIDTH="153" HEIGHT="30">2014년 07월 01일</TD>
<TD ALIGN="CENTER" WIDTH="109" HEIGHT="30">타법인 출자</TD>
<TD ALIGN="CENTER" WIDTH="85" HEIGHT="30">62.72</TD>
<TD ALIGN="CENTER" WIDTH="85" HEIGHT="30">61.50</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="214" HEIGHT="30" VALIGN="MIDDLE"> S&V Technologies GmbH</TD>
<TD ALIGN="CENTER" WIDTH="68" HEIGHT="30">독일</TD>
<TD ALIGN="CENTER" WIDTH="176" HEIGHT="30">화장품 및 의료기기 제조</TD>
<TD ALIGN="CENTER" WIDTH="153" HEIGHT="30">2017년 09월 18일</TD>
<TD ALIGN="CENTER" WIDTH="109" HEIGHT="30">타법인 출자</TD>
<TD ALIGN="CENTER" WIDTH="85" HEIGHT="30">100</TD>
<TD ALIGN="CENTER" WIDTH="85" HEIGHT="30">100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="214" HEIGHT="30" VALIGN="MIDDLE"> BSC Medical Devices  GmbH</TD>
<TD ALIGN="CENTER" WIDTH="68" HEIGHT="30">독일</TD>
<TD ALIGN="CENTER" WIDTH="176" HEIGHT="30">의료기기제조 및 판매</TD>
<TD ALIGN="CENTER" WIDTH="153" HEIGHT="30">2017년 09월 18일</TD>
<TD ALIGN="CENTER" WIDTH="109" HEIGHT="30">타법인 출자</TD>
<TD ALIGN="CENTER" WIDTH="85" HEIGHT="30">100</TD>
<TD ALIGN="CENTER" WIDTH="85" HEIGHT="30">100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">관계기업</TD>
<TD WIDTH="214" HEIGHT="30" VALIGN="MIDDLE"> JHK Biopharm</TD>
<TD ALIGN="CENTER" WIDTH="68" HEIGHT="30">중국</TD>
<TD ALIGN="CENTER" WIDTH="176" HEIGHT="30">의약품 연구개발 및 판매</TD>
<TD ALIGN="CENTER" WIDTH="153" HEIGHT="30">2020년 5월 07일</TD>
<TD ALIGN="CENTER" WIDTH="109" HEIGHT="30">타법인 출자</TD>
<TD ALIGN="CENTER" WIDTH="85" HEIGHT="30">25</TD>
<TD ALIGN="CENTER" WIDTH="85" HEIGHT="30">25</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 연결지분율은 지배회사 및 종속회사 보유지분율을 합한 것입니다.</SPAN>
</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11">나. 회사의 종속기업의 재무적정보는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="970">

<COLGROUP>
<COL WIDTH="961"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="970" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="973">

<COLGROUP>
<COL WIDTH="215"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="224" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="376" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="373" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="94" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산</TH>
<TH WIDTH="94" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채</TH>
<TH WIDTH="94" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH WIDTH="94" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이익(손실)</TH>
<TH WIDTH="94" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이익(손실)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="973" HEIGHT="30" COLSPAN="9"><종속기업></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30"> 디에이치호림㈜</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">5,456,037</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">9,683,281</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">23,626,128</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">(13,143)</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">4,668,525</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT">8,881,702</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT">20,918,620</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT">(144,657)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30"> ㈜스페셜라이즈드메드</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">145,961</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">749,845</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">352,034</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">(100,020)</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">265,097</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT">768,961</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT">386,757</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT">17,627</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30"> ㈜리독스바이오</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">24,384,659</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">9,697,157</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">13,804,954</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">601,861</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">23,705,213</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT">9,697,171</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT">10,073,191</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT">(419,535)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30"> S&V Technologies GmbH</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">9,371,202</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">1,307,847</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">8,327,866</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">1,046,218</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">8,647,338</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT">1,491,865</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT">6,450,707</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT">549,893</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30"> BSC Medical Devices GmbH</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">336,864</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">366,984</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">663,844</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">61,713</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">270,680</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">353,803</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">598,163</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,601</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="973" HEIGHT="30" COLSPAN="9"><관계기업></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30"> JHK Biopharm</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">87,411</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">556,895</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(494,370)</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">195,297</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">196,586</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,182,946)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="224" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">39,782,134</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">22,362,009</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">46,774,826</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">1,102,259</TD>
<TD WIDTH="94" HEIGHT="30" ALIGN="RIGHT">37,752,150</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT">21,390,088</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT">38,427,438</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT">(1,171,017)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">다. 회사의 주요 주주현황은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="628">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="118"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="120" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주주명</TH>
<TH WIDTH="254" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식수(주)</TH>
<TH WIDTH="254" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="127" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE"> 김수지</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">1,849,600</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">1,840,050</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">9.94</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">9.88</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE"> 고준진</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">1,706,867</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">1,706,867</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">9.17</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">9.17</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE"> 김운장</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">813,000</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">815,000</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">4.37</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">4.38</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE"> 이한구</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">621,300</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">621,300</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">3.34</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">3.34</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="30" VALIGN="MIDDLE"> 기타</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">13,625,883</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">13,633,433</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">73.19</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">73.23</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">18,616,650</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">18,616,650</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">100</TD>
<TD WIDTH="127" HEIGHT="30" ALIGN="RIGHT">100</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11 B">2. 연결재무제표 작성기준</SPAN>
<SPAN USERMARK="F-GL11">가. 연결재무제표의 작성기준</SPAN>
</P>
<P USERMARK="F-GL11">연결회사는 주식회사의외부감사에관한법률 제13조 1항 1호에서 규정하고 있는 국제회계기준위원회의 국제회계기준을 채택하여 정한 회계처리기준인 한국채택국제회계기준에 따라 재무제표를 작성하였습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">나. 측정기준연결회사의 연결재무제표는 아래에서 열거하고 있는 연결재무상태표의 주요항목을 제외하고는 역사적원가를 기준으로 작성되었습니다.</P>
<P USERMARK="F-GL11">- 공정가치로 측정되는 금융상품</P>
<P USERMARK="F-GL11">- 확정급여채무의 현재가치에서 사외적립자산의 순공정가치와 미인식된 과거근무원가를 차감한 확정급여부채</P>
<P USERMARK="F-GL11"></P>
<PGBRK></PGBRK>
<P USERMARK="F-GL11">다. 기능통화와 표시통화</P>
<P USERMARK="F-GL11">연결회사는 연결재무제표에 포함되는 항목들을 연결회사의 영업활동이 이루어지는 주된 경제환경의 통화(기능통화)로 표시하고 있습니다. 연결재무제표 작성을 위해 연결회사의 경영성과와 재무상태는 연결회사의 기능통화이면서 연결재무제표 작성을 위한 표시통화인 '원'으로 표시하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">라. 추정과 판단</P>
<P USERMARK="F-GL11">한국채택국제회계기준에서는 한국채택국제회계기준에 따라 연결재무제표를 작성함에 있어서 경영진으로 하여금 회계정책의 적용이나, 보고기간말 현재 자산, 부채 및 수익, 비용의 보고금액에 영향을 미치는 판단, 추정치, 가정의 사용을 요구하고 있습니다. 보고기간말 현재 경영진의 최선의 판단을 기준으로 한 추정치와 가정이 실제 환경과 다를 경우 실제 결과는 이러한 추정치와 다를 수 있습니다. 추정치와 추정에 대한 기본 가정은 지속적으로 검토되고 있으며, 회계추정의 변경은 추정이 변경된 기간과 미래 영향을 받을 기간 동안 인식되고 있습니다.</P>
<P USERMARK="F-GL11 B">3. 중요한 회계정책</P>

<P>
<SPAN USERMARK="F-GL11">가. 제ㆍ개정 기준서의 적용당사(연결회사)는 2022년 1월 1일로 개시하는 회계기간부터 다음의 제 · 개정 기준서를 신규로 적용하였습니다.</SPAN>
</P>
<P></P>
<P USERMARK="F-GL11">(1) 기업회계기준서 제1103호 '사업결합' (개정) - '개념체계'에 대한 참조</P>
<P USERMARK="F-GL11">인식할 자산과 부채의 정의를 개정된 재무보고를 위한 개념체계를 참조하도록 개정되었으나, 기업회계기준서 제1037호 '충당부채, 우발부채 및 우발자산' 및 해석서 제2121호 '부담금'의 적용범위에 포함되는 부채 및 우발부채에 대해서는 해당 기준서를 적용하도록 예외를 추가하고, 우발자산이 취득일에 인식되지 않는다는 점을 명확히 하였습니다. </P>
<P USERMARK="F-GL11">동 개정사항이 재무제표에 미치는 유의적인 영향은 없습니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">(2) 기업회계기준서 제1016호 '유형자산'(개정) - 의도한 사용 전의 매각금액</P>
<P USERMARK="F-GL11">동 개정사항은 유형자산이 사용 가능하기 전에 생산된 재화의 매각금액, 즉 경영진이 의도하는 방식으로 가동하는 데 필요한 장소와 상태에 이르게 하기 전에 생산된 재화의 매각금액)을 유형자산의 원가에서 차감하는 것을 금지합니다. 따라서 그러한 매각금액과 관련 원가를 당기손익으로 인식하며, 해당 원가는 기업회계기준서 제1002호에 따라 측정합니다.</P>
<P USERMARK="F-GL11">또한 동 개정사항은 '유형자산이 정상적으로 작동되는지 여부를 시험하는 것'의 의미를 명확히 하여 자산의 기술적, 물리적 성능이 재화나 용역의 생산이나 제공, 타인에 대한 임대 또는 관리활동에 사용할 수 있는 정도인지를 평가하는 것으로 명시합니다. </P>
<P USERMARK="F-GL11">동 개정사항은 이 개정내용을 처음 적용하는 재무제표에 표시된 가장 이른 기간의 개시일 이후에 경영진이 의도한 방식으로 가동할 수 있는 장소와 상태에 이른 유형자산에 대해서만 소급 적용합니다. 동 개정사항의 최초 적용 누적효과는 표시되는 가장 이른 기간의 시작일에 이익잉여금(또는 적절하다면 자본의 다른 구성요소)의 기초 잔액을 조정하여 인식합니다. </P>
<P USERMARK="F-GL11">동 개정사항이 재무제표에 미치는 유의적인 영향은 없습니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">(3) 기업회계기준서 제1037호 '충당부채, 우발부채 및 우발자산' (개정) - 손실부담계약의 계약이행원가</P>
<P USERMARK="F-GL11">동 개정사항은 계약이 손실부담계약인지 또는 손실을 발생시키는 계약인지 평가할 때 기업이 포함해야할 원가를 명확하게 하였습니다.</P>
<P USERMARK="F-GL11">개정 기준서는 "직접 관련된 원가 접근법"을 적용합니다. 재화나 용역을 제공하는 계약에 직접적으로 관련되는 원가는 증분원가와 계약 활동에 직접적으로 관련되는 원가 배분액을 모두 포함합니다. 일반 관리 원가는 계약에 직접적으로 관련되지 않으며 계약에 따라 거래상대방에게 명시적으로 부과될 수 없다면 제외됩니다.</P>
<P USERMARK="F-GL11">동 개정사항은 이 개정사항을 최초로 적용하는 회계연도의 개시일에 모든 의무의 이행이 완료되지는 않은 계약에 적용합니다. 비교재무제표는 재작성 하지 않고, 그 대신 개정 내용을 최초로 적용함에 따른 누적효과를 최초적용일의 기초이익잉여금 또는 적절한 경우 다른 자본요소로 인식합니다.</P>
<P USERMARK="F-GL11">동 개정사항이 재무제표에 미치는 유의적인 영향은 없습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(4) 한국채택국제회계기준 2018-2020 연차개선</P>
<P USERMARK="F-GL11">1) 기업회계기준서 제 1101호 '한국채택국제회계기준의 최초채택' - 최초채택기업인 종속기업</P>
<P USERMARK="F-GL11">동 개정사항은 지배기업보다 늦게 최초채택기업이 되는 종속기업의 누적환산차이의 회계처리와 관련하여 추가적인 면제를 제공합니다. 기업회계기준서 제 1101호 문단 D16(1)의 면제규정을 적용하는 종속기업은 지배기업의 한국채택국제회계기준 전환일에 기초하여 지배기업의 연결재무제표에 포함될 장부금액으로 모든 해외사업장의 누적환산차이를 측정하는 것을 선택할 수 있습니다. 다만 지배기업이 종속기업을 취득하는 사업결합의 효과와 연결절차에 따른 조정사항은 제외합니다. 관계기업이나 공동기업이 기업회계기준 제 1101호 문단 D16(1)의 면제규정을 적용하는 경우에도 비슷한 선택을 할 수 있습니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">2) 기업회계기준서 제1109호 '금융상품' - 금융부채 제거 목적의 10% 테스트 관련 수수료</P>
<P USERMARK="F-GL11">동 개정사항은 금융부채의 제거 여부를 평가하기 위해 '10%' 테스트를 적용할 때, 기업(차입자)과 대여자 간에 수취하거나 지급하는 수수료만을 포함하며, 여기에는 기업이나 대여자가 다른 당사자를 대신하여 지급하거나 수취하는 수수료를 포함한다는 점을 명확히 하고 있습니다. 동 개정사항은 최초 적용일 이후 발생한 변경 및 교환에 대하여 전진적으로 적용됩니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">3) 기업회계기준서 제1116호 '리스' - 리스 인센티브</P>
<P USERMARK="F-GL11">동 개정사항은 기업회계기준서 제1116호 사례13에서 리스개량 변제액에 대한 내용을 삭제하였습니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">4) 기업회계기준서 제1041호 '농림어업' - 공정가치 측정</P>
<P USERMARK="F-GL11">동 개정사항은 생물자산의 공정가치를 측정할 때 세금 관련 현금흐름을 제외하는 요구사항을 삭제하였습니다. 이는 기업회계기준서 제1041호의 공정가치 측정과 내부적으로 일관된 현금흐름과 할인율을 사용하도록 하는 기업회계기준서 제1113호의 요구사항을 일치시키며, 기업은 가장 적절한 공정가치 측정을 위해 세전 또는 세후 현금흐름 및 할인율을 사용할지 선택할 수 있습니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">동 개정사항이 재무제표에 미치는 유의적인 영향은 없습니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">나. 제정ㆍ공표되었으나 아직 시행일이 도래하지 않아 적용하지 아니한 한국채택국제회계기준은 다음과 같습니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">(1) 기업회계기준서 제1001호 '재무제표 표시' (개정) - 부채의 유동/비유동 분류</P>
<P USERMARK="F-GL11">동 개정사항은 유동부채와 비유동부채의 분류는 보고기간말에 존재하는 기업의 권리에 근거한다는 점을 명확히 하고 기업이 부채의 결제를 연기할 수 있는 권리를 행사할 지 여부에 대한 기대와는 무관하다는 점을 강조합니다. 그리고 보고기간말에 차입약정을 준수하고 있다면 해당 권리가 존재한다고 설명하고 결제는 현금, 지분상품, 그 밖의 자산 또는 용역을 거래상대방에게 이전하는 것으로 그 정의를 명확히 합니다. </P>
<P USERMARK="F-GL11">동 개정사항은 2023 년 1 월 1 일 이후 최초로 시작하는 회계연도의 개시일 이후 소급적으로 적용되며 조기적용이 허용됩니다.</P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">(2) 기업회계기준서 제1117호 '보험계약' (제정)</P>
<P USERMARK="F-GL11">기업회계기준서 제1117호 '보험계약'은 현행 기업회계기준서 제1104호 '보험계약'을 대체할 예정입니다. </P>
<P USERMARK="F-GL11">보험회사는 보험계약에 따른 모든 현금흐름을 추정하고 보고시점의 가정과 위험을 반영한 할인율을 사용하여 보험부채를 즉정합니다. 보험수익은 발생주의에 따라 매 회계연도별로 보험회사가 계약자에게 제공한 서비스를 반영하여 수익을 인식합니다. 또한, 보험사건과 관계없이 보험계약자에게 지급하는 투자요소는 보험수익에서 제외하며, 보험손익과 투자손익을 구분표시합니다. </P>
<P USERMARK="F-GL11">동 개정사항은 2023년 1월 1일 이후 최초로 시작되는 회계연도부터 시행되며 조기적용이 허용됩니다.</P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">(3) 기업회계기준서 제1001호 '재무제표 표시' 및 국제회계기준 실무서2-'중요성에 대한 판단'(개정) - 회계정책 공시</P>
<P USERMARK="F-GL11">중요한 회계정책을 정의하고 공시하도록 하며, 중요성 개념을 적용하는 방법에 대한 지침을 제공하기 위하여 국제회계기준 실무서 2 '회계정책 공시'를 개정하였습니다. </P>
<P USERMARK="F-GL11">동 개정사항은 회계정책의 공시에 대한 기업회계기준서 제1001호의 요구사항을 변경하며, '유의적인 회계정책'이라는 모든 용어를 '중요한 회계정책 정보'로 대체합니다. </P>
<P USERMARK="F-GL11">기업회계기준서 제1001호 관련 문단도 중요하지 않는 거래, 그 밖의 사건 또는 상황과 관련되는 회계정책 정보는 중요하지 않으며 공시될 필요가 없다는 점을 명확히 하기 위해 개정합니다. 회계정책 정보는 금액이 중요하지 않을지라도 관련되는 거래, 그 밖의 사건 또는 상황의 성격 때문에 중요할 수 있습니다. 그러나 중요한 거래, 그 밖의 사건 또는 상황과 관련되는 모든 회계정책 정보가 그 자체로 중요한 것은 아닙니다. </P>
<P USERMARK="F-GL11">또한 국제회계기준 실무서2에서 기술한 '중요성 과정의 4단계'의 적용을 설명하고 적용하기 위한 지침과 사례가 개발되었습니다. </P>
<P USERMARK="F-GL11">동 개정사항은 2023년 1월 1일 이후 최초로 시작되는 회계연도부터 전진적으로 적용되며, 조기적용이 허용됩니다. 국제회계기준 실무서2에 대한 개정사항은 시행일이나 경과규정을 포함하지 않습니다.</P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">(4) 기업회계기준서 제1008호 '회계정책, 회계추정치의 변경과 오류'(개정) - 회계추정치의 정의</P>
<P USERMARK="F-GL11">동 개정사항은 회계추정의 변경에 대한 정의를 회계추정치의 정의로 대체합니다. 새로운 정의에 따르면 회계추정치는 "측정불확실성의 영향을 받는 재무제표상 화폐금액"입니다.</P>
<P USERMARK="F-GL11">동 개정사항은 2023년 1월 1일 이후 최초로 시작되는 회계연도부터 적용하되 조기적용이 허용됩니다 이 개정내용을 처음 적용하는 회계연도 시작일 이후에 발생하는 회계추정치 변경과 회계정책 변경에 적용합니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">(5) 기업회계기준서 제1012호 '법인세' - 단일 거래에서 생기는 자산과 부채에 관련되는 이연법인세</P>
<P USERMARK="F-GL11">동 개정사항은 최초인식 예외규정의 적용범위를 축소합니다. 동 개정사항에 따르면 동일한 금액으로 가산할 일시적차이와 차감할 일시적차이를 생기게 하는 거래에는 최초인식 예외규정을 적용하지 않습니다.</P>
<P USERMARK="F-GL11">기업회계기준서 제1012호의 개정에 따라 관련된 이연법인세자산과 이연법인세부채를 인식해야 하며, 이연법인세자산의 인식은 기업회계기준서 제1012호의 회수가능성 요건을 따르게 됩니다.</P>
<P USERMARK="F-GL11">동 개정사항은 2023년 1월 1일 이후 최초로 시작되는 회계연도부터 적용되며 조기적용이 허용됩니다.</P>

<P>
<SPAN USERMARK="F-GL11">동 개정사항이 재무제표에 미치는 유의적인 영향은 없습니다.</SPAN>
</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">나. 외화거래연결회사의 연결재무제표 작성에 있어서 연결회사의 기능통화 외의 통화(외화)로 이루어진 거래는거래일의 환율을 적용하여 기록하고 있습니다. 매 보고기간 말에 화폐성 외화항목은 보고기간 말의 마감환율로 환산하고 있으며, 공정가치로 측정하는 비화폐성 외화항목은 공정가치가 결정된 날의 환율로 환산하고, 역사적원가로 측정하는 비화폐성항목은 거래일의 환율로 환산하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">화폐성항목의 결제시점에 생기는 외환차이와 해외사업장순투자 환산차이 또는 현금흐름위험회피로 지정된 금융부채에서 발생한 환산차이를 제외한 화폐성항목의 환산으로 인해 발생한 외환차이는 모두 당기손익으로 인식하고 있습니다. 비화폐성항목에서 발생한 손익을 기타포괄손익으로 인식하는 경우에는 그 손익에 포함된 환율변동효과도 기타포괄손익으로 인식하고, 당기손익으로 인식하는 경우에는 환율변동효과도 당기손익으로 인식하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">다. 현금 및 현금성자산연결회사는 보유현금과 요구불예금, 유동성이 매우 높고 확정된 금액의 현금으로 전환이 용이하고 가치변동의 위험이 경미한 단기 투자자산을 현금 및 현금성자산으로 분류하고 있습니다. 지분상품은 현금성자산에서 제외하고 있으며 다만, 상환일이 정해져 있고 취득일로부터 상환일까지의 기간이 단기인 금융상품과 같이 실질적인 현금성자산인 경우에는 현금성자산에 포함하고 있습니다. 당좌차월은 현금 및 현금성자산에서 차감하고 있습니다</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">라. 금융자산(1) 최초 인식과 측정</P>
<P USERMARK="F-GL11">금융자산은 최초 인식 시점에 후속적으로 상각후원가로 측정되는 금융자산, 기타포괄손익-공정가치 측정 금융자산, 그리고 당기손익-공정가치 측정 금융자산으로 분류됩니다.</P>
<P USERMARK="F-GL11">최초 인식 시점에 금융자산의 분류는 금융자산의 계약상 현금흐름 특성과 금융자산을 관리하기 위한 연결기업의 사업모형에 따라 달라집니다. 유의적인 금융요소가 포함되지 않거나 실무적 간편법을 적용하는 매출채권을 제외하고는, 기업은 금융자산을 최초에 공정가치로 측정하며, 당기손익-공정가치로 측정하는 금융자산의 경우가 아니라면 거래원가를 가감합니다. 유의적인 금융요소가 포함되지 않거나 실무적 간편법을 적용하지 않은 매출채권은 기업회계기준서 제1115호에 따라 결정된 거래원가로 측정합니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">금융자산을 상각후원가 또는 기타포괄손익-공정가치로 측정하기 위해서는 현금흐름이 원리금만으로 구성(SPPI)되어야 합니다. 이 평가는 SPPI 테스트라고 하며, 개별 상품 수준에서 수행됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">금융자산의 관리를 위한 기업의 사업모형은 현금흐름을 발생시키기 위해 금융자산을관리하는 방법과 관련됩니다. 사업모형은 현금흐름의 원천이 금융자산의 계약상 현금흐름의 수취인지, 매도인지 또는 둘 다 인지를 결정합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">시장의 합의나 규제에 의해 설정된 기간 프레임 내에서 금융자산을 이전하는 것이 요구되는 금융자산의 매입 또는 매도(정형화된 거래)는 거래일에 인식됩니다. 즉, 연결기업이 금융자산을 매입하거나 매도하기로 약정한 날을 의미합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 후속 측정</P>
<P USERMARK="F-GL11">후속 측정을 위해 금융자산은 아래 네 가지의 범주로 분류됩니다.</P>

<TABLE WIDTH="600" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="21"></COL>
<COL WIDTH="561"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="570" HEIGHT="30">상각후원가 측정 금융자산 (채무상품)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="570" HEIGHT="53">누적 손익을 당기손익으로 재순환하는 기타포괄손익-공정가치 측정 금융자산 (채무상품)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="570" HEIGHT="53">제거시 누적 손익을 당기손익으로 재순환하지 않는 기타포괄손익-공정가치 측정 금융자산 (지분상품)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="570" HEIGHT="30">당기손익-공정가치 측정 금융자산</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11">(3) 상각후원가 측정 금융자산 (채무상품)</P>
<P USERMARK="F-GL11">이 범주는 기업과 가장 관련이 높습니다. 기업은 아래 조건을 모두 만족하는 경우에 금융자산을 상각후원가로 측정합니다.</P>

<TABLE WIDTH="600" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="21"></COL>
<COL WIDTH="561"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="570" HEIGHT="53">계약상 현금흐름을 수취하기 위해 보유하는 것이 목적인 사업모형 하에서 금융자산을 보유하고,</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="570" HEIGHT="53">금융자산의 계약 조건에 따라 특정일에 원금과 원금잔액에 대한 이자 지급만으로 구성되어 있는 현금흐름이 발생한다.</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">상각후원가 측정 금융자산은 후속적으로 유효이자율(EIR)법을 사용하여 측정되며, 손상을 인식합니다. 자산의 제거, 변경 또는 손상에서 발생하는 이익과 손실은 당기손익으로 인식됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(4) 기타포괄손익-공정가치 측정 금융자산 (채무상품)</P>
<P USERMARK="F-GL11">기업은 아래의 조건을 모두 충족하는 채무상품을 기타포괄손익-공정가치 금융자산으로 측정합니다.</P>

<TABLE WIDTH="600" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="21"></COL>
<COL WIDTH="561"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="570" HEIGHT="53">계약상 현금흐름의 수취와 금융자산의 매도 둘 다를 통해 목적을 이루는 사업모형 하에서 금융자산을 보유하고,</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="570" HEIGHT="53">금융자산의 계약 조건에 따라 특정일에 원리금 지급만으로 구성되어 있는 현금흐름이 발생한다.</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">기타포괄손익-공정가치 측정 채무상품에서, 이자수익, 외화환산손익, 그리고 손상 또는 환입은 상각후원가 측정 금융자산과 동일한 방법으로 계산되어 당기손익으로 인식됩니다. 나머지 공정가치 변동부분은 기타포괄손익으로 인식됩니다. 금융자산의제거 시, 기타포괄손익으로 인식한 공정가치 누적 변동분은 당기손익으로 재순환됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">기업의 기타포괄손익-공정가치 측정 채무상품은 비유동자산으로 분류되는 채무상품에 포함됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(5) 기타포괄손익-공정가치 측정 금융자산 (지분상품)</P>
<P USERMARK="F-GL11">최초 인식 시점에, 기업은 기업회계기준서 제1032호 ‘금융상품 표시’에서의 지분의 정의를 충족하고 투자 목적으로 보유하고 있지 않은 지분상품을 기타포괄손익-공정가치로 측정하도록 하는 취소 불가능한 선택을 할 수 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">이러한 금융자산에서 발생하는 손익은 당기손익으로 재순환되지 않습니다. 배당은 연결기업이 금융자산의 원가 중 일부를 회수하여 이익을 얻는 경우를 제외하고는, 받을 권리가 확정되었을 때 손익계산서에 기타수익으로 인식되며, 기타포괄손익으로 처리됩니다. 기타포괄손익-공정가치 측정 지분상품은 손상을 인식하지 않습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">기업은 비상장지분상품에 대해서도 취소불가능한 선택을 할 수 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(6) 당기손익-공정가치 측정 금융자산</P>
<P USERMARK="F-GL11">당기손익-공정가치 측정 금융자산은 단기매매항목, 최초 인식 시에 당기손익-공정가치로 측정하도록 지정된 금융자산 또는 공정가치로 측정하도록 요구되는 금융자산을 포함합니다. 단기간 내에 매도하거나 재구매할 목적으로 취득한 금융자산은 단기매매항목으로 분류됩니다. 분리된 내재파생상품을 포함한 파생상품은 효과적인 위험회피수단으로 지정되지 않았다면 단기매매항목으로 분류됩니다. 현금흐름이 원리금 지급만으로 구성되지 않은 금융자산은 사업모형에 관계없이 당기손익-공정가치 측정 금융자산으로 분류 및 측정됩니다. 상기 문단에서 서술된 것과 같이 채무상품이 상각후원가 또는 기타포괄손익-공정가치 측정 금융자산으로 분류됨에도 불구하고 회계 불일치를 제거하거나 유의적으로 감소시킬 수 있습니다면 채무상품을 당기손익-공정가치로 측정하도록 지정할 수 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">당기손익-공정가치 측정 금융자산은 재무상태표에 공정가치로 표시되며, 공정가치의 순변동은 손익계산서에서 당기손익으로 인식됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">이 범주는 파생상품과 공정가치의 변동을 기타포괄손익으로 처리하는 취소불가능한 선택을 하지않은 상장 지분 상품을 포함합니다. 상장 지분 상품에 대한 배당은 권리가 확정된 시점에 당기손익으로 인식합니다.</P>
<P USERMARK="F-GL11">복합계약에 내재된 파생상품은 경제적인 특성과 위험이 주계약에 밀접하게 관련되지않고, 내재파생상품과 동일한 조건인 별도의 상품이 파생상품의 정의를 충족하며, 복합계약이 당기손익-공정가치로 측정되지 않는다면 주계약으로부터 분리하여 별도의파생상품으로 회계처리합니다. 내재파생상품은 공정가치로 측정하고 공정가치의 변동을 당기손익으로 인식합니다. 현금흐름을 유의적으로 변경시키는 계약 조건의 변경이 있거나 당기손익-공정가치 측정 범주에 해당하지 않게 되는 경우에만 재평가가발생합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">주계약이 금융자산인 복합계약에서 내재파생상품은 분리하여 회계처리하지 않습니다. 주계약인 금융자산과 내재파생상품은 상품 전체를 당기손익-공정가치 측정 금융자산으로 분류합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(7) 제거</P>
<P USERMARK="F-GL11">금융자산 (또는, 금융자산의 일부 또는 비슷한 금융자산의 집합의 일부)는 다음과 같은 상황에서 우선적으로 제거됩니다.</P>

<TABLE WIDTH="600" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="21"></COL>
<COL WIDTH="561"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="570" HEIGHT="30">금융자산의 현금흐름을 수취할 권리가 소멸되거나</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="122">-</TD>
<TD WIDTH="570" HEIGHT="122">연결회사가 금융자산의 현금흐름을 수취할 권리를 양도하거나 양도(pass-through) 계약에 따라 수취한 현금흐름 전체를 중요한 지체 없이 제3자에게 지급할 의무가 있다. 이 경우에 연결기업은 금융자산의 보유에 따른 위험과 보상의 대부분을 이전하거나 금융자산의 보유에 따른 위험과 보상의 대부분을 이전하지도 보유하지도 않으나 자산에 대한 통제를 이전한다.</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">기업이 금융자산의 현금흐름을 수취할 권리를 이전하거나 양도(pass-through) 계약을 체결할 때, 자산을 소유함에 따른 위험과 보상을 유지하는지를 평가합니다. 기업이 금융자산의 위험과 보상의 대부분을 보유하지도 이전하지도 않았다면, 해당 금융자산에 지속적으로 관여하는 정도까지 그 금융자산을 계속 인식합니다. 이 경우에, 기업은 관련된 부채를 인식합니다. 양도된 자산과 관련된 부채는 기업이 보유한 권리와 의무를 반영하여 측정합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">보증을 제공하는 형태인 지속적 관여는, 양도된 자산의 장부금액과 수취한 대가 중 상환을요구받을 수 있는 최대 금액 중 낮은 금액으로 측정됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(8) 금융자산의 손상</P>
<P USERMARK="F-GL11">금융자산의 손상과 관련된 자세한 공시 사항은 아래 주석에 제공됩니다.</P>

<TABLE WIDTH="600" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="21"></COL>
<COL WIDTH="561"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="570" HEIGHT="30">유의적인 가정에 대한 공시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="570" HEIGHT="30">기타포괄손익-공정가치로 측정되는 채무상품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="30"></TD>
<TD WIDTH="570" HEIGHT="30">계약 자산을 포함한 매출채권</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">기업은 당기손익-공정가치 항목을 제외한 모든 채무상품에 대하여 기대신용손실(ECL)에 대한 충당금을 인식합니다. 기대신용손실은 계약상 수취하기로 한 현금흐름과 연결기업이 수취할 것으로 예상하는 모든 현금흐름의 차이를 최초의 유효이자율로 할인하여 추정합니다. 예상되는 현금흐름은 보유한 담보를 처분하거나 계약의 필수 조건인 그 밖의 신용 보강으로부터 발생하는 현금흐름을 포함합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">기대신용손실은 두 개의 stage로 인식합니다. 최초 인식 이후 신용위험의 유의적인 증가가 없는 신용 익스포저에 대하여, 기대신용손실은 향후 12개월 내에 발생할 가능성이 있는 채무불이행 사건으로부터 발생하는 신용손실(12개월 기대신용손실)을 반영합니다. 최초 인식 이후 신용위험의 유의적인 증가가 있는 신용 익스포저에 대하여, 손실충당금은 채무불이행 사건이 발생하는 시기와 무관하게 익스포저의 남은 존속기간에 대한 기대신용손실(전체기간 기대신용손실)을 측정하도록 요구됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">매출채권과 계약자산에 대하여, 기업은 기대신용손실 계산에 간편법을 적용할 수 있습니다. 따라서, 기업은 신용위험의 변동을 추적하지 않는 대신에, 각 결산일에 전체기간 기대신용손실에 해당하는 금액으로 손실충당금을 인식합니다. 기업은 특정 채무자에 대한 미래전망정보와 경제적 환경을 반영하여 조정된 과거 신용손실 경험에 근거하여 충당금 설정률표를 설정합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">기타포괄손익-공정가치 측정 채무상품에 대하여, 기업은 낮은 신용위험 간편법을 적용합니다. 매 결산일에, 기업은 과도한 원가나 노력 없이 이용할 수 있는 합리적이고 뒷받침될 수 있는 모든 정보를 사용하여 채무상품이 낮은 신용위험을 가지고 있는지 평가합니다. 이러한 평가를 위해서, 기업은 채무상품의 내부 신용등급을 재평가합니다. 또한, 기업은 계약상의 지급이 30일을 초과하였을 때 신용위험의 유의적인 증가가 있는지를 고려합니다.</P>
<P USERMARK="F-GL11">기업의 기타포괄손익-공정가치 측정 채무상품이 최상위 투자등급에 해당하는 상장 채권만으로 구성되어 있다면 낮은 신용 위험 투자자산으로 평가됩니다. 기업의 정책은 이러한 상품을 12개월 기대신용손실로 측정하는 것입니다. 그러나, 최초 인식 이후에 신용위험의 유의적인 증가가 있다면 손실충당금은 전체기간 기대신용손실에 근거하여 산출됩니다. 기업은 채무상품의 신용위험이 유의적으로 증가했는지를 결정하고 기대신용손실을 측정하기 위해 신용평가기관의 등급을 사용합니다.기업은 계약상 지급이 90일을 초과하여 연체되는 경우에 채무불이행이 발생한 것으로 봅니다. 그러나, 특정 상황에서, 기업은 내부 또는 외부 정보가 기업에 의한 모든 신용보강을 고려하기 전에는 기업이 계약상의 원금 전체를 수취하지 못할 것을 나타내는 경우에 금융자산에 채무불이행 사건이 발생했다고 볼 수 있습니다. 금융자산은 계약상 현금흐름을 회수하는 데에 합리적인 기대가 없을 때 제거됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">마. 금융부채(1) 최초 인식과 측정</P>
<P USERMARK="F-GL11">금융부채는 최초 인식 시점에 당기손익-공정가치 측정 금융부채, 대출과 차입, 미지급금 또는 효과적인 위험회피 수단으로 지정된 파생상품으로 적절하게 분류됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">모든 금융부채는 최초에 공정가치로 인식되고, 대여금, 차입금 및 미지급금의 경우에는 직접 관련된 거래원가를 차감합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">기업의 금융부채는 매입부채와 기타 미지급금, 당좌차월을 포함한 대여 및 차입과 파생상품부채를 포함합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 후속 측정</P>
<P USERMARK="F-GL11">금융부채의 측정은 아래에서 언급된 분류에 따릅니다.(a) 당기손익-공정가치 측정 금융부채</P>
<P USERMARK="F-GL11">당기손익-공정가치 측정 금융부채는 단기매매금융부채와 최초 인식 시점에 당기손익-공정가치로 측정하도록 지정된 금융부채를 포함합니다. </P>
<P USERMARK="F-GL11">금융부채가 단기간 내에 재매입되는 경우에는 단기매매항목으로 분류됩니다. 이 범주는 또한 기업회계기준서 제1109호에서 정의된 위험회피관계에 있는 위험회피수단으로 지정되지 않은 파생상품을 포함합니다. 또한 분리된 내재파생상품은 위험회피에 효과적인 수단으로 지정되지 않았다면 단기매매항목으로 분류됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">단기매매항목인 금융부채에서 발생하는 손익은 당기손익으로 인식됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">당기손익-공정가치 항목으로 지정된 금융부채는 기업회계기준서 제1109호의 기준을 충족하는 경우에 최초 인식 시점에만 지정됩니다. </P>
<P USERMARK="F-GL11">(b) 대여금 및 차입금</P>
<P USERMARK="F-GL11">이 범주는 기업과 관련이 높습니다. 최초 인식 이후에, 이자부 대여금과 차입금은 후속적으로 유효이자율법을 사용하여 상각후원가로 측정됩니다. 부채가 제거되거나 유효이자율 상각 절차에 따라 발생하는 손익은 당기손익으로 인식됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">상각후원가는 유효이자율의 필수적인 부분인 수수료나 원가에 대한 할인이나 할증액을 고려하여 계산됩니다. 이 범주는 일반적으로 이자부 대여나 차입에 적용합니다. (3) 제거금융부채는 지급 의무의 이행, 취소, 또는 만료된 경우에 제거됩니다. 기존 금융부채가 대여자는 동일하지만 조건이 실질적으로 다른 금융부채에 의해 교환되거나, 기존 부채의 조건이 실질적으로 변경된 경우에, 이러한 교환이나 변경은 최초의 부채를 제거하고 새로운 부채를 인식하게 합니다. 각 장부금액의 차이는 당기손익으로 인식합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(4) 금융상품의 상계금융자산과 금융부채는 인식한 자산과 부채에 대해 법적으로 집행 가능한 상계 권리를 현재 가지고 있거나, 차액으로 결제하거나 자산을 실현하는 동시에 부채를 결제할의도가 있는 경우에 재무상태표에서 상계하여 순액으로 표시됩니다.</P>
<P USERMARK="F-GL11">바. 납입자본보통주는 자본으로 분류하며 자본거래에 직접 관련되어 발생하는 증분원가는 세금효과를 반영한 순액으로 자본에서 차감하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">연결회사가 자기 지분상품을 재취득하는 경우에 이러한 지분상품은 자기주식의 과목으로자본에서 직접 차감하고 있습니다. 자기지분상품을 매입 또는 매도하거나 발행 또는 소각하는 경우의 손익은 당기손익으로 인식하지 아니합니다. 연결회사가 자기주식을 취득하여 보유하는 경우 지급하거나 수취한 대가는 자본에서 직접 인식하고 있습니다. </P>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">사. 유형자산유형자산은 최초에 원가로 측정하여 인식하고 있으며, 유형자산의 원가에는 경영진이 의도하는 방식으로 자산을 가동하는데 필요한 장소와 상태에 이르게 하는데 직접 관련되는 원가 및 자산을 해체, 제거하거나 부지를 복구하는데 소요될 것으로 추정되는 원가가 포함됩니다. </SPAN>
</P>
<P USERMARK="F-GL11">유형자산의 일부를 대체할 때 발생하는 원가는 해당 자산으로부터 발생하는 미래 경제적 효익이 연결회사에 유입될 가능성이 높으며 그 원가를 신뢰성 있게 측정할 수 있는 경우에 자산의 장부금액에 포함하거나 적절한 경우 별도의 자산으로 인식하고 있습니다. 이 때 대체된 부분의 장부금액은 제거하고 있습니다. 그 외의 일상적인 수선ㆍ유지와 관련하여 발생하는 원가는 발생시점에 당기손익으로 인식하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">유형자산 중 토지는 감가상각을 하지 않으며, 그 외 유형자산은 자산의 취득원가에서잔존가치를 차감한 금액에 대하여 아래에 제시된 경제적 내용연수에 걸쳐 해당 자산에 내재되어 있는 미래 경제적 효익의 예상 소비 형태를 가장 잘 반영한 방법으로 상각하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">유형자산을 구성하는 일부의 원가가 당해 유형자산의 전체원가와 비교하여 유의적이라면, 해당 유형자산을 감가상각할 때 그 부분은 별도로 구분하여 감가상각하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">유형자산의 제거로 인하여 발생하는 손익은 순매각금액과 장부금액의 차이로 결정되고 기타손익(유형자산 처분손익 등)으로 인식합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">당기 및 전기의 추정 내용연수 및 감가상각방법은 다음과 같습니다. </P>

<TABLE BORDER="1" WIDTH="668" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="112" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="112" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용연수</TH>
<TH WIDTH="111" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각방법</TH>
<TH WIDTH="111" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="111" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용연수</TH>
<TH WIDTH="111" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER">건물</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER">40년</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">정액법</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">차량운반구</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">5년</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">정액법</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER">기계장치</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER">5년~12년</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">정액법</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">비품</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">5년</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">정액법</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">연결회사는 매 회계연도 말에 자산의 잔존가치와 내용연수 및 감가상각방법을 재검토하고 재검토 결과 추정치가 종전 추정치와 다르다면 그 차이는 회계추정의 변경으로 처리하고 있습니다. </P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">아. 차입원가적격자산의 취득, 건설 또는 제조와 직접 관련된 차입원가는 당해 자산 원가의 일부로 자본화하고 있으며, 기타차입원가는 발생기간에 비용으로 인식하고 있습니다. 적격자산이란 의도된 용도로 사용하거나 판매가능한 상태가 될 때까지 상당한 기간을 필요로 하는 자산을 말하며, 금융자산과 단기간 내에 제조되거나 다른 방법으로 생산되는 재고자산은 적격자산에 해당되지 아니하며, 취득시점에 의도된 용도로 사용할 수 있거나 판매가능한 상태에 있는 자산인 경우에도 적격자산에 해당되지 아니합니다. </P>
<P USERMARK="F-GL11">적격자산을 취득하기 위한 목적으로 특정하여 차입한 자금에 한하여, 회계기간 동안 그 차입금으로부터 실제 발생한 차입원가에서 당해 차입금의 일시적 운용에서 생긴 투자수익을 차감한 금액을 자본화가능차입원가로 결정하며, 일반적인 목적으로 자금을 차입하고 이를 적격자산의 취득을 위해 사용하는 경우에 한하여 당해 자산 관련 지출액에 자본화이자율을 적용하는 방식으로 자본화가능차입원가를 결정하고 있습니다. 자본화이자율은 회계기간동안 차입한 자금(적격자산을 취득하기 위해 특정 목적으로 차입한 자금 제외)으로부터 발생된 차입원가를 가중평균하여 산정하고 있습니다. 회계기간 동안 자본화한 차입원가는 당해 기간동안 실제 발생한 차입원가를 초과할 수 없습니다.</P>
<P USERMARK="F-GL11">자. 무형자산무형자산은 최초 인식할 때 원가로 측정하며, 최초 인식 후에 원가에서 상각누계액과손상차손누계액을 차감한 금액을 장부금액으로 인식하고 있습니다. </P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">영업권을 제외한 무형자산은 사용 가능한 시점부터 잔존가치를 영("0")으로 하여 아래의 내용연수 동안 정액법으로 상각하고 있습니다. 다만, 일부 무형자산에 대해서는이를 이용할 수 있을 것으로 기대되는 기간에 대하여 예측가능한 제한이 없으므로 당해 무형자산의 내용년수가 비한정인 것으로 평가하고 상각하지 아니하고 있습니다. </P>

<TABLE BORDER="1" WIDTH="608" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="152" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="152" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용연수</TH>
<TH WIDTH="152" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="152" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용연수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">특허권과 상표권</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">10년</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">회원권</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">비한정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">전기공급시설이용권</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">비한정</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">개발비</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">5년 ~ 10년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">기타의무형자산</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">5년</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER"></TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER"></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">내용연수가 유한한 무형자산의 상각기간과 상각방법은 매 회계연도 말에 재검토하고내용연수가 비한정인 무형자산에 대해서는 그 자산의 내용연수가 비한정이라는 평가가 계속하여 정당한 지를 매 회계기간에 재검토하며, 이를 변경하는 것이 적절하다고판단되는 경우 회계추정의 변경으로 처리하고 있습니다. </P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">(1) 연구 및 개발연구 또는 내부프로젝트의 연구단계에 대한 지출은 발생시점에 비용으로 인식하고 있습니다. 개발단계의 지출은 자산을 완성할 수 있는 기술적 실현가능성, 자산을 완성하여 사용하거나 판매하려는 기업의 의도와 능력 및 필요한 자원의 입수가능성, 무형자산의 미래 경제적 효익을 모두 제시할 수 있고, 관련 지출을 신뢰성 있게 측정할 수 있는 경우에 무형자산으로 인식하고 있으며, 기타 개발관련 지출은 발생시점에 비용으로 인식하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 후속지출후속지출은 관련되는 특정자산에 속하는 미래의 경제적 효익이 증가하는 경우에만 자본화하며, 내부적으로 창출한 영업권 및 상표명 등을 포함한 다른 지출들은 발생 즉시 비용화하고 있습니다.</P>
<P USERMARK="F-GL11">차. 투자부동산</P>
<P USERMARK="F-GL11">임대수익이나 시세차익을 얻기 위하여 보유하는 부동산은 투자부동산으로 분류하고 있습니다. 투자부동산은 최초 인식시점에 거래원가를 포함하여 원가로 측정하고 있으며, 최초인식 후에는 공정가치로 측정하고 공정가치 변동으로 발생하는 손익은 발생한 기간의 당기손익에 반영하고 있습니다.</P>
<P USERMARK="F-GL11">자가사용의 개시나 정상적인 영업과정에서 판매를 위한 개발의 시작으로 공정가치로평가한 투자부동산을 유형자산이나 재고자산으로 대체하는 경우에는 사용목적 변경시점의 공정가치를 간주원가로 평가하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">자가사용의 종료로 자가사용부동산을 공정가치로 평가하는 투자부동산으로 대체하는 경우 사용목적 변경시점의 공정가치로 재측정하고 투자부동산으로 재분류합니다.</P>
<P USERMARK="F-GL11">카. 리스</P>
<P USERMARK="F-GL11">(1) 사용권자산 </P>
<P USERMARK="F-GL11">연결회사는 리스개시일(즉, 기초자산을 사용할 수 있는 날)에 사용권자산을 인식합니다. 사용권자산은 원가로 측정하고 감가상각누계액과 손상차손누계액을 차감한 금액으로 측정하며, 리스부채의 재측정이 발생하는 경우 조정합니다. 사용권자산의 원가에는 리스부채 인식금액, 리스개설직접원가 발생액이 포함되며, 리스개시일이나 그 전에 지급한 리스선급금이나 인센티브는 가감합니다. 연결회사가 리스기간 종료시점에 리스자산에 대한 소유권을 얻을 것이라고 합리적으로 예측되지 않는다면, 사용권자산은 추정내용연수와 리스기간 중 더 짧은 기간에 걸쳐 정액 기준으로 감가상각합니다. 연결회사는 사용권자산에 대한 손상 검토를 수행합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">당기말 현재 추정 내용연수 및 감가상각방법은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="604">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="302" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="302" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용연수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="30" ALIGN="CENTER">건물</TD>
<TD WIDTH="302" HEIGHT="30" ALIGN="CENTER">2 ~ 4년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="30" ALIGN="CENTER">차량운반구</TD>
<TD WIDTH="302" HEIGHT="30" ALIGN="CENTER">2 ~ 3년</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">(2) 리스부채 </P>
<P USERMARK="F-GL11">연결회사는 리스개시일에 그날 현재 지급하지 않은 리스료의 현재가치로 리스부채를측정합니다. 리스료에는 받을 리스 인센티브를 제외한 고정리스료(실질적인 고정리스료를 포함), 지수나 요율에 따라 달라지는 변동리스료와 잔존가치 보증에 따라 연결회사가 지급할 것으로 예상되는 금액이 포함됩니다. 또한 연결회사는 매수선택권을 행사할 것이 상당히 확실한 경우에 그 매수선택권의 행사가격과 리스기간이 연결회사의 종료선택권 행사를 반영하는 경우에 그 리스를 종료하기 위하여 부담하는 금액을 리스료에 포함합니다. 지수나 요율에 따라 달라지지 않는 변동리스료는 리스료를 지급하는 사건이 발생한 기간의 비용으로 인식합니다. </P>
<P USERMARK="F-GL11">연결회사는 리스료의 현재가치를 계산할 때, 리스의 내재이자율을 쉽게 산정할 수 없는 경우에는 리스개시일의 증분차입이자율을 사용합니다. 연결회사는 리스개시일후에 리스부채에 대한 이자를 반영하여 리스부채의 장부금액을 증액하고, 지급한 리스료를 반영하여 리스부채의 장부금액을 감액합니다. 또한 연결회사는 리스의 변경을 반영하거나 실질적인 고정리스료의 변경을 반영하거나 리스 기간의 변경 또는 기초자산 매수선택권 평가의 변경이 있는 경우 이 변경을 반영하여 리스부채를 재측정 합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(3) 단기리스 및 소액자산리스</P>
<P USERMARK="F-GL11">연결회사는 차량운반구 및 장비의 단기리스(예, 리스 기간이 리스개시일로부터 12개월 이하이고 매수선택권이 없는 리스)에 대해 인식면제를 적용합니다. 또한, 가치가 낮은 사무용 장비(예, USD 5,000이하인 리스)에 대해 소액자산리스로 인식면제를 적용합니다. 단기리스와 소액자산리스에 대한 리스료는 리스기간에 걸쳐 정액기준으로 비용을 인식합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(4) 연장선택권이 있는 계약에서 계약기간을 결정할 때 중요한 판단</P>
<P USERMARK="F-GL11">연결회사는 리스의 해지불능기간에 리스 연장선택권을 행사할 것이 상당히 확실한 경우에 그 선택권의 대상 기간과 리스 종료선택권을 행사하지 않을 것이 상당히 확실한 경우에 그 선택권의 대상 기간을 포함하여 리스기간을 산정합니다. 연결회사는 이선택권의 행사가능성이 상당히 확실한지를 평가할 때 판단을 적용합니다. 즉, 연장선택권을행사할 경제적 유인이 생기게 하는 모든 관련 요소를 고려합니다. 리스개시일 이후에중요한 영향을 미치는 사건이나 상황이 변하거나 통제할 수 있는 상황에 변화가 발생하여 선택권의 행사가능성 (또는 행사하지 않을 가능성)에 영향을 미친다면(예를 들어, 사업 전략의 변경), 연결회사는 리스 기간을 재평가 합니다. 연결회사는 계약기간 연장선택권의 사용유무가 연결재무제표에 미치는 중요성을 고려하여 리스 연장선택권 대상기간을 리스 기간에 포함하지 않습니다. </P>
<P USERMARK="F-GL11">타. 재고자산</P>
<P USERMARK="F-GL11">재고자산은 취득원가와 순실현가능가치 중 낮은 금액으로 측정하고 있습니다. 재고자산의 단위원가는 선입선출법(원재료와 부재료는 이동평균법)으로 결정하고 있으며취득원가는 매입원가, 전환원가 및 재고자산을 현재의 장소에 이르게 하는데 발생한 기타 모든 원가를 포함하고 있습니다. 제품이나 재공품의 원가에 포함되는 고정제조간접원가는 생산설비의 정상조업도에 기초하여 배부하고 있으며, 또한 원가에는 기타포괄손익으로 인식하였던 재고자산 구입을 위한 현금흐름위험회피로부터 발생한 손익이 포함될 수 있습니다. 재고자산의 판매 시, 관련된 수익을 인식하는 기간에 재고자산의 장부금액을 매출원가로 인식하며, 재고자산을 순실현가능가치로 감액한 평가손실과 모든 감모손실은 감액이나 감모가 발생한 기간에 비용으로 인식하고 있습니다. 또한 재고자산의 순실현가능가치의 상승으로 인한 재고자산평가손실의 환입은 환입이 발생한 기간의 비용으로 인식된 재고자산의 매출원가에서 차감하고 있습니다.파. 비금융자산의 손상상각대상 자산에 대하여 자산손상을 시사하는 징후가 있을 때 손상검사를 수행하고 있습니다. 손상차손은 회수가능액(사용가치 또는 처분부대원가를 차감한 공정가치 중 높은 금액)을 초과하는 장부금액만큼 인식되고 영업권 이외의 비금융자산에 대한 손상차손은 매 보고기간말에 환입가능성이 검토됩니다.회수가능액은 개별 자산별로, 또는 개별 자산의 회수가능액을 추정할 수 없다면 그 자산이 속하는 현금창출단위별로 회수가능액을 추정하고 있습니다. 회수가능액은 사용가치와 순공정가치 중 큰 금액으로 결정하고 있습니다. 사용가치는 자산이나 현금창출단위에서 창출될 것으로 기대되는 미래현금흐름을 화폐의 시간가치 및 미래현금흐름을 추정할 때 조정되지 아니한 자산의 특유위험에 대한 현행 시장의 평가를 반영한 세전할인율로 할인하여 추정합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">자산이나 현금창출단위의 회수가능액이 장부금액에 미달하는 경우 자산의 장부금액을 감소시키며 즉시 당기손익으로 인식하고 있습니다. </P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">사업결합으로 취득한 영업권은 사업결합으로 인한 시너지효과의 혜택을 받게 될 것으로 기대되는 각 현금창출단위에 배분합니다. 현금창출단위에 대한 손상차손은 우선, 현금창출단위에 배분된 영업권의 장부금액을 감소시키고, 그 다음 현금창출단위에 속하는 다른 자산 각각의 장부금액에 비례하여 자산의 장부금액을 감소시키고 있습니다. 영업권에 대해 인식한 손상차손은 후속기간에 환입할 수 없습니다.  매 보고기간말에 영업권을 제외한 자산에 대해 과거기간에 인식한 손상차손이 더 이상 존재하지 않거나 감소된 것을 시사하는 징후가 있는지를 검토하고 직전 손상차손의 인식시점 이후 회수가능액을 결정하는 데 사용된 추정치에 변화가 있는 경우에만 환입합니다. 손상차손환입으로 증가된 장부금액은 과거에 손상차손을 인식하기 전 장부금액의 감가상각 또는 상각 후 잔액을 초과할 수 없습니다.</P>
<P USERMARK="F-GL11">하. 매각예정비유동자산</P>
<P USERMARK="F-GL11">비유동자산 또는 처분자산집단의 장부금액이 계속 사용이 아닌 매각거래를 통하여 주로 회수될 것으로 예상된다면 이를 매각예정자산으로 분류하고 있습니다. 이러한 조건은 당해 자산(또는 처분자산집단)이 현재의 상태로 즉시 매각가능하여야 하며 매각될 가능성이 매우 높을 때에만 충족된 것으로 간주하고 있습니다. 자산(또는 처분자산집단)을 매각예정으로 최초 분류하기 직전에 해당 자산(또는 자산과 부채)의 장부금액과 순공정가치 중 작은 금액으로 측정하고 있습니다. 자산의 순공정가치가 하락하면 손상차손을 즉시 당기손익으로 인식하고, 순공정가치가 증가하면 과거에 인식하였던 손상차손누계액을 한도로 하여 이익으로 인식하고 있습니다. </P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">비유동자산이 매각예정으로 분류되거나 매각예정으로 분류된 처분자산집단의 일부인 경우에는 그 자산은 상각하지 아니하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">거. 종업원급여</P>
<P USERMARK="F-GL11">(1) 단기종업원급여종업원이 관련 근무용역을 제공한 회계기간의 말부터 12개월 이내에 결제될 단기종업원급여는 근무용역과 교환하여 지급이 예상되는 금액을, 근무용역이 제공된 때에 당기손익으로 인식하고 있습니다. 단기종업원급여는 할인하지 않은 금액으로 측정하고 있습니다. 종업원이 과거 근무용역의 결과 회사가 지급해야 할 법적의무 또는 의제의무가 있고, 그 채무금액을 신뢰성있게 추정할 있다면 이익분배금 및 상여금으로 지급이 예상되는 금액을 부채로 인식하고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">(2) 기타장기종업원급여종업원이 관련 근무용역을 제공한 회계기간의 말일부터 12개월 이내에 지급되지 않을 기타장기종업원급여는 당기와 과거기간에 제공한 근무용역의 대가로 획득한 미래의 급여액을 현재가치로 할인하고, 관련 채무를 직접 결제하는 데 사용할 수 있는 사외적립자산의 공정가치를 차감하여 부채로 인식하고 있습니다. 부채는 관련 급여의 만기와 유사한 만기를 가지는 우량회사채의 이자율을 사용하여 추정 미래 현금흐름을 할인한 후 결정되고 있습니다. 보험수리적 가정의 변동과 경험적 조정에서 발생하는 손익은 발생한 기간에 전액 당기손익으로 인식하고 있습니다. </P>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">(3) 퇴직급여확정급여형퇴직급여제도의 경우, 확정급여채무는 독립된 보험계리법인에 의해 예측단위적립방식을 이용하여 매 보고기간 말에 보험수리적 평가를 수행하여 계산하고 있습니다. 확정급여채무의 현재가치는 관련 퇴직급여채무의 지급시점과 만기가 유사한 우량회사채의 시장수익률로 기대미래현금유출액을 할인하여 산정하고 있습니다. </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">그러나 그러한 회사채에 대해 거래층이 두터운 시장이 없는 경우에는 보고기간말 현재 국공채의 시장수익률을 사용합니다. 보험수리적가정의 변경 및 보험수리적가정과실제로 발생한 결과의 차이에서 발생하는 보험수리적손익은 발생한 기간의 포괄손익계산서에 기타포괄손익으로 인식하고 있습니다. 기타포괄손익으로 인식한 보험수리적손익은 즉시 이익잉여금으로 인식하며, 그 후의 기간에 당기손익으로 재분류하지 않습니다. 과거근무원가는 이미 가득된 급여액을 한도로 즉시 인식되고, 그렇지 않을경우 관련 급여액이 가득될 때까지의 평균기간 동안 정액기준으로 상각하고 있습니다. 재무상태표상 퇴직급여채무는 미인식과거근무원가를 반영한 확정급여채무의 현재가치에서 사외적립자산의 공정가치를 차감하여 인식하고 있습니다. 이러한 계산으로산출된 순액이 자산일 경우, 이는 미인식과거근무원가에 환급가능금액과 미래 기여금감소액의 현재가치를 가산한 금액을 한도로 자산으로 인식하고 있습니다. </SPAN>
</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(4) 해고급여회사가 통상적인 퇴직시점 이전에 종업원을 해고할 것을 현실적인 철회가능성이 없이 명시적으로 확약하거나, 회사가 종업원에게 명예퇴직에 대한 해고급여를 제안하고 종업원이 자발적으로 제안을 수락하는 경우 해고급여를 당기 손익으로 인식하고 있습니다. 종업원에게 자발적 명예퇴직을 제안하는 경우에는 제안을 수락할 것으로 기대되는 종업원의 수에 기초하여 해고급여를 측정하여 당기 손익으로 인식하고 있습니다. 해고급여의 지급기일이 보고기간 후 12개월이 지난 후에 도래하는 경우에는현재가치로 할인하고 있습니다.  </P>
<P USERMARK="F-GL11">너. 충당부채</P>
<P USERMARK="F-GL11">과거사건의 결과, 현재의 법적의무 또는 의제의무가 존재하고, 당해 의무를 이행하기위하여 경제적효익을 갖는 자원이 유출될 가능성이 높으며, 당해 의무의 이행에 소요되는 금액을 신뢰성 있게 추정할 수 있는 경우에 충당부채를 인식하고 있습니다. 부채에 대한 최선의 추정치를 구할 때는 관련된 사건과 상황에 대한 불가피한 위험과 불확실성을 고려하고 있으며, 화폐의 시간가치가 중요한 경우에는 의무를 이행하기 위하여 예상되는 지출액의 현재가치로 평가하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">매 보고기간 말마다 충당부채의 잔액을 검토하고, 보고기간 말 현재 최선의 추정치를반영하여 조정하고 있습니다. 의무이행을 위하여 경제적 효익을 갖는 자원이 유출된 가능성이 더 이상 높지 않은 경우에는 관련 충당부채를 환입하고 있습니다. </P>
<P USERMARK="F-GL11">(1) 반품충당부채회사는 판매시점에 반품이 예상되는 부분의 매출액을 차감하고 매출에 해당하는 금액과 반품과 관련하여 발생할 것으로 예상되는 비용을 반품충당부채로 계상하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2)  마일리지충당부채회사는 고정고객 확보 및 우수고객 보상을 통하여 안정적인 수익의 원천을 관리하려는 영업정책의 일환으로 마일리지제도를 운영하고 있는 바, 기간손익의 적정화를 위하여 동 마일리지 부여에 따라 예상되는 추가적인 원가부담액을 마일리지충당부채로계상하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">충당부채는 최초 인식과 관련 있는 지출에만 사용하고 있습니다. 더. 수익</P>
<P USERMARK="F-GL11">수익은 재화의 판매, 용역의 제공이나 자산의 사용에 대하여 받았거나 받을 대가의 공정가액으로 측정하고 매출에누리와 할인 및 환입은 수익금액에서 차감하고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">(1) 재화의 판매재화의 소유에 따른 유의적인 위험과 보상이 구매자에게 이전되고, 판매된 재화의 소유권과 결부된 통상적 수준의 지속적인 관리상 관여와 효과적인 통제를 하지 않으며,거래와 관련한 경제적효익의 유입가능성이 높고, 수익금액과 거래와 관련하여 발생했거나 발생할 원가 및 반품가능성을 신뢰성 있게 측정할 수 있을 때 수익을 인식하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">위험과 보상의 이전 시점은 개별 계약조건에 따라 달라집니다. 일반적으로 상품 또는제품 판매의 경우에 보통 구매자의 창고에 제품이 도착할 때 이전되지만, 일부 국제적인 선적거래에서는 재화가 적절한 운반설비에 적재될 때 이전되고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 용역용역의 제공에 따른 수익은 매 보고기간말에 그 거래의 진행기준에 따라 인식하고 있습니다. 진행률은 작업수행 정도를 조사로 결정하고 있습니다.</P>
<P USERMARK="F-11"> </P>
<P USERMARK="F-GL11">(3) 수수료회사가 본인을 대신하여 대리인으로서 거래하는 경우 수수료 금액만을 수익으로 인식하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(4) 임대수익투자부동산으로부터의 임대수익은 리스기간에 걸쳐 정액기준으로 인식하고 있습니다. 한편, 리스 인센티브는 총원가를 리스기간에 걸쳐 정액기준에 따라 리스수익에서차감하여 인식하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">러. 정부보조금</P>
<P USERMARK="F-GL11">정부보조금은 회사가 정부보조금에 부수되는 조건을 준수하고 그 보조금을 수령하는것에 대해 합리적인 확신이 있을 경우에만 인식하고 있습니다. 비유동자산을 취득 또는 건설하는데 사용해야 한다는 기본조건이 부과된 정부보조금의 경우 재무상태표에이연수익으로 인식하며, 관련 자산의 내용년수에 걸쳐 체계적이고 합리적인 방식으로 손익으로 인식하고 있습니다.기타의 정부보조금은 보전하도록 의도된 비용에 대응시키기 위해 보전하려는 관련원가를 비용으로 인식하는 기간에 걸쳐 체계적인 기준에 따라 당기손익으로 인식하고 있습니다. 이미 발생한 비용이나 손실에 대한 보전 또는 향후 관련원가의 발생 없이 기업에 제공되는 즉각적인 금융지원으로 수취하는 정부보조금은 수취할 권리가 발생하는 기간에 당기손익으로 인식하고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">머. 금융수익과 비용 </P>
<P USERMARK="F-GL11">금융수익은 매도가능금융자산을 포함한 투자로부터의 이자수익, 배당수익, 매도가능금융자산처분손익, 당기손익인식금융상품의 공정가치의 변동, 당기손익으로 인식하는 위험회피수단의 평가차익을 포함하고 있습니다. 이자수익은 기간의 경과에 따라 유효이자율법을 적용하여 당기손익으로 인식하며, 배당수익은 주주로서 배당을 받을권리가 확정되는 시점에 수익을 인식하고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">금융비용은 차입금에 대한 이자비용, 충당부채의 상각액, 부채로 분류되는 우선주에 대한 배당금, 당기손익인식금융상품의 공정가치의 변동, 당기손익으로 인식하는 위험회피수단의 평가차손을 포함하고 있습니다. 차입금에 대한 이자비용은 유효이자율법을 적용하여 기간의 경과에 따라 당기손익으로 인식하고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">버. 법인세</P>
<P USERMARK="F-GL11">법인세비용은 당기법인세와 이연법인세로 구성되어 있으며, 기타포괄손익이나 자본에 직접 인식되는 거래나 사건 또는 사업결합에서 발생하는 세액을 제외하고는 당기손익으로 인식하고 있습니다. </P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">(1) 당기법인세당기법인세는 당기의 과세소득을 기초로 산정하고 있습니다. 과세소득은 포괄손익계산서상의 세전이익에서 다른 과세기간에 가산되거나 차감될 손익 및 비과세항목이나손금불인정항목을 제외하므로 포괄손익계산서상 손익과 차이가 있습니다. 회사의 당기법인세와 관련된 미지급법인세는 확정되었거나 실질적으로 확정된 세율을 사용하여 계산하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 이연법인세이연법인세는 연결재무제표상 자산과 부채의 장부금액과 과세소득 산출 시 사용되는세무기준액과의 차이를 바탕으로 인식되며, 자산부채법에 의하여 인식하고 있습니다. 이연법인세부채는 모든 가산할 일시적차이에 대하여 인식하며, 이연법인세자산은 차감할 일시적차이가 사용될 수 있는 과세소득의 발생가능성이 높은 경우에, 모든 차감할 일시적차이에 대하여 인식합니다. 그러나, 일시적차이가 영업권을 최초로 인식하는 경우나 자산ㆍ부채가 최초로 인식되는 거래가 사업결합 거래가 아니고, 거래 당시의 회계이익 또는 과세소득에 영향을 미치지 아니하는 거래의 경우 이연법인세를 인식하지 않고 있습니다. </P>
<P USERMARK="F-GL11">종속기업, 관계기업 및 조인트벤처 투자지분에 관한 가산할 일시적차이에 대해서는 회사가 일시적차이의 소멸시점을 통제할 수 있으며, 예측가능한 미래에 일시적차이가 소멸하지 않을 가능성이 높은 경우를 제외하고는 모두 이연법인세부채를 인식하고 있습니다. 또한, 차감할 일시적차이로 인하여 발생하는 이연법인세자산은 일시적차이가 예측가능한 미래에 소멸할 가능성이 높고, 일시적차이가 사용될 수 있는 과세소득이 발생할 가능성이 높은 경우에 인식하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">이연법인세자산의 장부금액은 매 보고기간 말에 검토하고, 이연법인세자산으로 인한혜택이 사용되기에 충분한 과세소득이 발생할 가능성이 더 이상 높지 않은 경우 이연법인세자산의 장부금액을 감소시키고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">이연법인세자산과 부채는 보고기간 말 제정되었거나 실질적으로 제정된 세법에 근거하여 당해 자산이 실현되거나 부채가 지급될 회계기간에 적용될 것으로 기대되는 세율을 사용하여 측정하고 있습니다. 이연법인세자산과 이연법인세부채를 측정할 때에는 보고기간 말 현재 회사가 관련 자산과 부채의 장부금액을 회수하거나 결제할 것으로 예상되는 방식에 따라 법인세효과를 반영하였습니다.</P>
<P USERMARK="F-GL11">이연법인세자산과 부채는 동일 과세당국이 부과하는 법인세이고, 회사가 인식된 금액을 상계할 수 있는 법적 권한을 가지고 있으며 당기 법인세부채와 자산을 순액으로결제할 의도가 있는 경우에만 상계하고 있습니다. 배당금 지급에 따라 추가적으로 발생하는 법인세비용이 있다면 배당금 지급과 관련한 부채가 인식되는 시점에 인식하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">서. 중단영업</P>
<P USERMARK="F-GL11">회사는 별도의 사업계열이나 영업지역을 처분하거나 매각예정분류기준을 충족하는 경우 또는 매각만을 목적으로 취득한 종속기업을 중단영업으로 분류하고 있습니다. 중단영업이 있는 경우, 포괄손익계산서에 비교 표시되는 기간의 기초부터 영업이 중단된 것처럼 재작성하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">어. 주당이익</P>

<P USERMARK="F-GL11">연결회사는 보통주 기본주당이익과 희석주당이익을 계속영업손익과 당기순손익에 대하여 계산하고 포괄손익계산서에 표시하고 있습니다. 기본주당이익은 보통주에 귀속되는 당기순손익을 회계기간 동안에 유통된 보통주식수를 가중평균한 주식수로 나누어계산하고 있습니다. 희석주당이익은 신주인수권부사채와 종업원에게 부여한 주식기준보상 등 모든 희석효과가 있는 잠재적 보통주의 영향을 고려하여 보통주에 귀속되는 당기순손익 및 가중평균유통보통주식수를 조정하여 계산하고 있습니다.
<SPAN USERMARK=" B">4. 금융위험 관리</SPAN>금융상품과 관련하여 연결회사는 신용위험, 유동성위험 및 시장위험에 노출되어 있습니다. 본 주석은 연결회사가 노출되어 있는 위의 위험에 대한 정보와 연결회사의 목표, 정책, 위험 평가 및 관리 절차, 그리고 자본관리에 대해 공시하고 있습니다. 추가적인 계량적 정보에 대해서는 본 연결재무제표 전반에 걸쳐서 공시되어 있습니다.
</P>

<P>
<SPAN USERMARK="F-GL11">가. 위험관리 정책</SPAN>
</P>
<P USERMARK="F-GL11">연결회사의 위험관리 정책은 연결회사가 직면한 위험을 식별 및 분석하고, 적절한 위험 한계치 및 통제를 설정하고, 위험이 한계치를 넘지 않도록 하기 위해 수립되었습니다. 위험관리정책과 시스템은 시장 상황과 연결회사의 활동의 변경을 반영하기 위해 정기적으로 검토되고 있습니다. 연결회사는 훈련 및 관리기준, 절차를 통해 모든 종업원들이 자신의 역할과 의무를 이해할 수 있는 엄격하고 구조적인 통제환경을 구축하는 것을 목표로 하고 있습니다.</P>
<P USERMARK="F-GL11">연결회사의 감사위원회는 경영진이 연결회사의 위험관리 정책 및 절차의 준수여부를어떻게 관리하는지 감독하고, 연결회사의 위험관리체계가 적절한지 검토합니다. 내부감사는 감사위원회의 감독기능을 보조하여, 위험관리 통제 및 절차에 대한 정기 및특별 검토를 수행하고 결과는 감사위원회에 보고하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">나. 신용위험</P>
<P USERMARK="F-GL11">신용위험이란 고객이나 거래상대방이 금융상품에 대한 계약상의 의무를 이행하지 않아 연결회사가 재무손실을 입을 위험을 의미합니다. 주로 거래처에 대한 매출채권과 투자자산에서 발생합니다. </P>
<P USERMARK="F-GL11">(1) 매출채권연결회사의 신용위험에 대한 노출은 주로 각 고객별 특성의 영향을 받습니다. 고객이영업하고 있는 산업 및 국가의 파산위험 등의 고객 분포는 신용위험에 큰 영향을 주지 않으며, 지리적으로 신용위험이 집중되어 있지는 않습니다.</P>
<P USERMARK="F-GL11">연결회사는 표준 지급기준을 결정하기 이전에 모든 신규 고객에 대해 개별적으로 신용도를 검토하도록 하는 신용정책을 수립하였습니다. 검토 시에는 외부적인 등급과 은행의 평가 등을 고려합니다. 별도의 승인 요청 없이 가능한 최고 구매한도가 개별 고객별로 정해지며, 이 한도는 분기별로 검토되고 있습니다. 연결회사의 신용기준을 충족하지 못한 고객은 선급금 지불 시에만 거래가 가능합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">법인 거래처의 경우 장기간 거래해 오고 있으며, 손실은 자주 발생하지 않습니다. 고객에 대한 신용위험 검토 시, 고객이 개인인지 법인인지, 도매업체인지 소매업체 혹은 소비자인지, 고객의 지리적인 위치, 산업, 신용, 연령, 성숙도, 이전의 재무적 어려움 등의 특성에 따라 분류하고 있습니다. 매출채권은 대부분 연결회사의 법인고객으로부터 발생합니다. "고위험"으로 분류된 고객들은 제한고객 목록에 포함하여 위험관리위원회가 관리하며, 향후 매출은 선급금 지불 시에만 가능합니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">소유권 유보 조항에 따라 제품이 판매되기 때문에 대금을 수령하지 못하더라도 연결연결회사는 담보청구 권리를 가질 수 있습니다.</P>
<P USERMARK="F-GL11">연결회사는 매출채권과 투자자산에 대해 발생할 것으로 예상되는 손실에 대해 충당금을 설정하고 있습니다. 이 충당금은 개별적으로 유의적인 항목에 대한 구체적인 손상차손과 유사한 특성을 가진 금융자산 집합의 발생하였으나 아직 식별되지 않은 손상으로 구성됩니다. 금융자산 집합의 충당금은 유사한 금융자산의 회수에 대한 과거 자료에 근거하여 결정되고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 보증</P>
<P USERMARK="F-GL11">연결회사는 지분을 일부 보유한 종속기업에도 보증을 제공하는 것이 회사의 정책입니다. 당기말 현재 회사가 종속기업에 제공한 보증 내역은 주석 23에서 설명하고  있습니다.</P>
<P USERMARK="F-GL11">다. 유동성위험</P>
<P USERMARK="F-GL11">유동성위험이란 연결회사가 금융부채에 관련된 의무를 충족하는 데 어려움을 겪게 될 위험을 의미합니다. 연결회사의 유동성 관리방법은 재무적으로 어려운 상황에서도 받아들일 수 없는 손실이 발생하거나, 연결회사의 평판에 손상을 입힐 위험 없이, 만기일에 부채를 상환할 수 있는 충분한 유동성을 유지하도록 하는 것입니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">라. 시장위험</P>
<P USERMARK="F-GL11">시장위험이란 시장가격의 변동으로 인하여 금융상품의 공정가치나 미래현금흐름이 변동할 위험을 의미합니다. 시장가격 관리의 목적은 수익은 최적화하는 반면 수용가능한 한계 이내로 시장위험 노출을 관리 및 통제하는 것입니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(1) 환위험연결회사의 기능통화인 원화 외의 통화로 표시되는 판매, 구매 및 차입에 대해 환위험에 노출되어 있습니다. 이러한 거래들이 표시되는 주된 통화는 USD, EUR, JPY 등입니다.</P>
<P USERMARK="F-GL11">(2) 이자율위험연결회사는 고정이자율과 변동이자율로 자금을 차입하고 있으며, 이로 인하여 이자율위험에 노출되어 있습니다. 연결회사는 이자율위험을 관리하기 위하여 고정금리부차입금과 변동금리부 차입금의 적절한 균형을 유지하고 있습니다. 위험회피활동은 이자율 현황과 정의된 위험성향을 적절히 조정하기 위해 정기적으로 평가되며 최적의 위험회피전략이 적용되도록 하고있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">마. 자본관리연결회사는 부채와 자본 잔액의 최적화를 통하여 주주이익을 극대화시키는 동시에 계속기업으로서 지속될 수 있도록 자본을 관리하고 있습니다. 연결회사의 전반적인 전략은 전기와 변동이 없습니다.</P>
<P USERMARK="F-GL11">연결회사는 자본관리지표로 부채비율을 이용하고 있으며 이 비율은 총부채를 총자본으로 나누어 산출하며, 총부채 및 총자본은 연결재무제표의 금액을 기준으로 계산하고 있는바, 보고기간종료일 현재 부채비율은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="200" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="200" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 당기말</TH>
<TH WIDTH="200" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" ALIGN="CENTER">부 채</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">117,473,188</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">93,960,124</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" ALIGN="CENTER">자 본</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">81,583,285</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="RIGHT">83,415,715</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" ALIGN="CENTER">부채비율</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">144%</TD>
<TD WIDTH="200" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">113%</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">연결회사는 외부적으로 강제된 자기자본규제의 대상은 아닙니다.</P>

<P>
<SPAN USERMARK="F-GL11 B">5. 유형자산</SPAN>
<SPAN USERMARK="F-GL11">가. 보고기간종료일 현재 연결회사의 유형자산 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="935" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="926"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="935" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="979">

<COLGROUP>
<COL WIDTH="88"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="97" HEIGHT="77" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE" USERMARK="F-10">과  목 </TH>
<TH WIDTH="433" HEIGHT="28" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" VALIGN="MIDDLE" USERMARK="F-10">당기말</TH>
<TH WIDTH="449" HEIGHT="28" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="5" VALIGN="MIDDLE" USERMARK="F-10">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="82" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">취득원가 </TH>
<TH WIDTH="83" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">상각누계액 </TH>
<TH WIDTH="101" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">손상차손누계액(주1)</TH>
<TH WIDTH="89" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">정부보조금</TH>
<TH WIDTH="78" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">장부금액 </TH>
<TH WIDTH="79" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">취득원가 </TH>
<TH WIDTH="89" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">상각누계액 </TH>
<TH WIDTH="120" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">손상차손누계액(주1)</TH>
<TH WIDTH="82" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">정부보조금</TH>
<TH WIDTH="79" HEIGHT="49" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" USERMARK="F-10">장부금액 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="28" USERMARK="F-10"> 토지</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">19,097,113</TD>
<TD WIDTH="83" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">-</TD>
<TD WIDTH="89" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="78" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">19,097,113</TD>
<TD WIDTH="79" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">19,097,113</TD>
<TD WIDTH="89" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">-</TD>
<TD WIDTH="120" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">-</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="79" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">19,097,113</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="28" USERMARK="F-10"> 건물</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">45,065,373</TD>
<TD WIDTH="83" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">(12,038,096)</TD>
<TD WIDTH="101" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">-</TD>
<TD WIDTH="89" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="78" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">33,027,277</TD>
<TD WIDTH="79" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">45,065,373</TD>
<TD WIDTH="89" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">(10,939,713)</TD>
<TD WIDTH="120" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">-</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="79" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">34,125,660</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="28" USERMARK="F-10"> 기계장치</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">39,856,900</TD>
<TD WIDTH="83" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">(28,704,369)</TD>
<TD WIDTH="101" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">(4,055,173)</TD>
<TD WIDTH="89" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(171,549)</TD>
<TD WIDTH="78" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">6,925,810</TD>
<TD WIDTH="79" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">38,957,436</TD>
<TD WIDTH="89" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">(26,961,593)</TD>
<TD WIDTH="120" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">(1,182,173)</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(207,655)</TD>
<TD WIDTH="79" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">10,606,015</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="28" USERMARK="F-10"> 차량운반구</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">171,785</TD>
<TD WIDTH="83" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">(151,878)</TD>
<TD WIDTH="101" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">-</TD>
<TD WIDTH="89" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="78" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">19,908</TD>
<TD WIDTH="79" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">148,995</TD>
<TD WIDTH="89" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">(148,839)</TD>
<TD WIDTH="120" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">-</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="79" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">156</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="28" USERMARK="F-10"> 비품</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">7,134,338</TD>
<TD WIDTH="83" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">(6,374,990)</TD>
<TD WIDTH="101" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">-</TD>
<TD WIDTH="89" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="78" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">759,348</TD>
<TD WIDTH="79" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">6,916,241</TD>
<TD WIDTH="89" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">(6,032,587)</TD>
<TD WIDTH="120" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">-</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="79" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">883,654</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="28" USERMARK="F-10"> 건설중인자산</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">34,448,984</TD>
<TD WIDTH="83" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">-</TD>
<TD WIDTH="89" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(4,900,000)</TD>
<TD WIDTH="78" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">29,548,984</TD>
<TD WIDTH="79" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">7,935,181</TD>
<TD WIDTH="89" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">-</TD>
<TD WIDTH="120" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">-</TD>
<TD WIDTH="82" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(4,900,000)</TD>
<TD WIDTH="79" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">3,035,181</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="49" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK="F-10">합 계</TD>
<TD WIDTH="82" HEIGHT="49" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">145,774,493</TD>
<TD WIDTH="83" HEIGHT="49" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">(47,269,333)</TD>
<TD WIDTH="101" HEIGHT="49" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">(4,055,173)</TD>
<TD WIDTH="89" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(5,071,549)</TD>
<TD WIDTH="78" HEIGHT="49" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">89,378,440</TD>
<TD WIDTH="79" HEIGHT="49" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">118,120,339</TD>
<TD WIDTH="89" HEIGHT="49" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">(44,082,732)</TD>
<TD WIDTH="120" HEIGHT="49" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">(1,182,173)</TD>
<TD WIDTH="82" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(5,107,655)</TD>
<TD WIDTH="79" HEIGHT="49" ALIGN="RIGHT" USERMARK="F-10" VALIGN="MIDDLE">67,747,779</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL10">(주1) 당기말 리독스바이오의 손상차손 인식액 2,873,000천원이 현금흐름 창출단위인 기계장치에 반영되었습니다.</P>
<P USERMARK="F-GL11">나. 당기 및 전기 중 유형자산 장부가액의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="816" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="394"></COL>
<COL WIDTH="404"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="403" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD ALIGN="RIGHT" WIDTH="413" HEIGHT="30" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="919" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="101"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="110" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">과 목 </TH>
<TH WIDTH="102" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기 초</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취 득</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">처 분</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">감가상각비</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">대 체(주1)</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">손 상</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기 타(주2)</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기 말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30"> 토지</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">19,097,113</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">19,097,113</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30"> 건물</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">34,125,660</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(1,098,383)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">33,027,277</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30"> 기계장치</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">10,606,015</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">380,090</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(478)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(1,651,808)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">547,190</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(2,873,000)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(82,199)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">6,925,810</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30"> 차량운반구</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">156</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">22,791</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(3,039)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">19,908</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30"> 비품</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">883,654</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">200,682</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(727)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(337,378)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">18,150</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(5,033)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">759,348</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30"> 건설중인자산</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">3,035,181</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">27,086,743</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(572,940)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">29,548,984</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">67,747,779</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">27,690,306</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(1,205)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(3,090,608)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(7,600)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(2,873,000)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(87,232)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">89,378,440</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL10 0X0000FF">
<SPAN USERMARK=" 0X000000">(주1) 당기 중 건설중인자산에서 무형자산으로 7,600천원 대체하였습니다.(주2) 환율변동효과 및 당기 중 수령한 국고보조금을 건설중인자산의 차감항목으로 대체한 내역입니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="820" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="346"></COL>
<COL WIDTH="456"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="355" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD ALIGN="RIGHT" WIDTH="465" HEIGHT="30" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="919" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="101"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="110" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">과 목 </TH>
<TH WIDTH="102" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기 초</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취 득</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">처 분</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">감가상각비</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">대 체(주1)</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">손 상</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기 타(주2)</TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기 말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30"> 토지</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">19,097,113</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">19,097,113</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30"> 건물</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">35,224,043</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(945,673)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(152,710)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">34,125,660</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30"> 기계장치</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">12,269,973</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">778,018</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">1,058</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(1,999,043)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">727,726</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(1,182,173)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">10,456</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">10,606,015</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30"> 차량운반구</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">6,344</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(6,519)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">331</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">156</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30"> 비품</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">995,329</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">292,701</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">1</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(391,993)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(12,384)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">883,654</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30"> 건설중인자산</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">594,598</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">8,613,015</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(1,272,433)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(4,900,000)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">3,035,180</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="102" ALIGN="RIGHT" HEIGHT="30">68,187,400</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">9,683,734</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">1,059</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(3,343,228)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(544,707)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(1,182,173)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">(5,054,307)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">67,747,778</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL10"></P>

<P>
<SPAN USERMARK="F-GL11">다. 연결회사는 매 보고기간 종료일마다 자산의 감가상각방법, 잔존가치 및 경제적 내용연수를 검토하고, 필요한 경우 회계추정의 변경으로 조정을 하고 있습니다.라. 당기말 현재 연결회사가 가입한 보험현황은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="685" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="676"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="685" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="684">

<COLGROUP>
<COL WIDTH="127"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="131"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="136" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">보험종류</TH>
<TH WIDTH="136" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">자  산</TH>
<TH WIDTH="136" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">장부금액</TH>
<TH WIDTH="136" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">부 보 액</TH>
<TH WIDTH="140" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">보험회사명</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="90" ROWSPAN="3" VALIGN="MIDDLE">화재보험</TD>
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="30">건 물(주1)</TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30">35,756,711</TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" VALIGN="MIDDLE">68,831,411</TD>
<TD WIDTH="140" HEIGHT="120" ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER">DB손해보험 한화손해보험</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="30">기계장치</TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30">9,402,856</TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" VALIGN="MIDDLE">21,103,250</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="136" HEIGHT="30">비품</TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30">637,665</TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" VALIGN="MIDDLE">2,499,896</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" WIDTH="272" HEIGHT="30">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30">45,797,232</TD>
<TD ALIGN="RIGHT" WIDTH="136" HEIGHT="30" VALIGN="MIDDLE">92,434,557</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 투자부동산에 해당하는 건물 장부가액 및 임차한 건물이 포함되어 있습니다.</SPAN>
<SPAN USERMARK="F-GL11">상기 유형자산에 대한 보험부보액 중42,353,681천원은 장ㆍ단기차입금의 차입처인 기업은행이 질권을 설정하고 있습니다. 한편, 연결회사는 상기 보험 이외에 차량운반구에대한 종합보험 및 책임보험, 가스사고배상보험 및 영업배상책임보험에 가입하고 있습니다.</SPAN>
</P>
<P USERMARK="F-GL11">마. 담보제공내역당기말 현재 연결회사의 장ㆍ단기차입금 등과 관련하여 담보로 제공된 일부 유형자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="696" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="687"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="696" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="702" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="167"></COL>
<COL WIDTH="167"></COL>
<COL WIDTH="166"></COL>
<COL WIDTH="166"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="176" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담보제공자산</TH>
<TH ALIGN="CENTER" WIDTH="176" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부가액</TH>
<TH ALIGN="CENTER" WIDTH="175" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권최고액</TH>
<TH ALIGN="CENTER" WIDTH="175" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담보권자</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" HEIGHT="30" VALIGN="MIDDLE"> 토지(주1)</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT">28,694,478</TD>
<TD ROWSPAN="4" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="175" HEIGHT="120">103,280,000</TD>
<TD ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="175" HEIGHT="120">기업은행 외</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" HEIGHT="30" VALIGN="MIDDLE"> 건물(주1)</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT">               28,729,761 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" HEIGHT="30" VALIGN="MIDDLE"> 기계장치</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT">                5,263,350 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="176" HEIGHT="30">합 계</TD>
<TD WIDTH="176" HEIGHT="30" ALIGN="RIGHT">               62,687,589 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL10">(주1) 투자부동산에 해당하는 토지와 건물 장부가액이 포함되어 있습니다.</P>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">바. 차입원가 자본화</SPAN>
<SPAN USERMARK="F-GL11">당기 및 전기 중 자본화된 차입원가와 자본화 이자율은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="508">

<COLGROUP>
<COL WIDTH="499"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="508" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="507">

<COLGROUP>
<COL WIDTH="160"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="160"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="169" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분 </TH>
<TH WIDTH="169" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="169" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="169" HEIGHT="30"> 자본화된 차입원가</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">638,747</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">60,239</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="169" HEIGHT="30"> 자본화 이자율</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">3.15%</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">2.11%</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11 B">6. 투자부동산</P>

<P>
<SPAN USERMARK="F-GL11">가. 보고기간종료일 현재 연결회사의 투자부동산 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="680" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="671"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="680" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="680" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="89"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="98" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE">과 목</TH>
<TH WIDTH="291" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" VALIGN="MIDDLE">당기말</TH>
<TH WIDTH="291" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" VALIGN="MIDDLE">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="97" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취득원가</TH>
<TH WIDTH="97" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">상각누계액</TH>
<TH WIDTH="97" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">장부금액</TH>
<TH WIDTH="97" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취득원가</TH>
<TH WIDTH="97" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">상각누계액</TH>
<TH WIDTH="97" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE"> 토 지</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">10,978,707</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">10,978,707</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">10,978,707</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">10,978,707</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE"> 건 물</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">6,093,969</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">(1,603,212)</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">4,490,758</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">6,093,969</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">(1,446,375)</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">4,647,594</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="98" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">17,072,676</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">(1,603,212)</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">15,469,465</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">17,072,676</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">(1,446,375)</TD>
<TD WIDTH="97" ALIGN="RIGHT" HEIGHT="30">15,626,301</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">나. 당기 및 전기 중 투자부동산 장부가액의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="599" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="367"></COL>
<COL WIDTH="214"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="376" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD ALIGN="RIGHT" WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="602" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="151" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">과 목</TH>
<TH WIDTH="151" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기 초</TH>
<TH WIDTH="150" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">감가상각비</TH>
<TH WIDTH="150" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기 말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" HEIGHT="30" VALIGN="MIDDLE"> 토 지</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">10,978,707</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">10,978,707</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" HEIGHT="30" VALIGN="MIDDLE"> 건 물</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">4,647,594</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">(156,837)</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">4,490,758</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">15,626,301</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">(156,837)</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">15,469,465</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" WIDTH="599" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="367"></COL>
<COL WIDTH="214"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="376" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD ALIGN="RIGHT" WIDTH="223" HEIGHT="30" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="602" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="151" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">과 목</TH>
<TH WIDTH="151" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기 초</TH>
<TH WIDTH="150" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">감가상각비</TH>
<TH WIDTH="150" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기 말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" HEIGHT="30" VALIGN="MIDDLE"> 토 지</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">10,978,707</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">10,978,707</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" HEIGHT="30" VALIGN="MIDDLE"> 건 물</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">4,804,431</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">(156,837)</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">4,647,594</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="151" ALIGN="RIGHT" HEIGHT="30">15,783,138</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">(156,837)</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">15,626,301</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL10"></P>
<P USERMARK="F-GL11">다. 투자부동산의 공정가치당기말 현재 투자부동산에 대한 공정가치 평가내역은 다음과 같습니다</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="724">

<COLGROUP>
<COL WIDTH="150"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="122"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 구 분 </TH>
<TH WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 최근기준일 </TH>
<TH WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 토지 (주1)</TH>
<TH WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 건물(주1) </TH>
<TH WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 합 계 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="724" VALIGN="MIDDLE" HEIGHT="30"><평가대상자산 장부가액> </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="308" VALIGN="MIDDLE" HEIGHT="30"> 장부가액 </TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,978,707</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,490,758</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,469,466</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="724" VALIGN="MIDDLE" HEIGHT="30"><자산별 세부평가결과> </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" HEIGHT="30"> 방배동사옥 </TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.01.01</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,745,814</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,135,394</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,881,208</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" HEIGHT="30"> 주차타워</TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.01.01</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,770,361</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">151,155</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,921,516</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" HEIGHT="30"> 대전사옥 </TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.01.01</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,810,485</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,126,742</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,937,226</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" HEIGHT="30"> 판교연구소 </TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.01.01</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">674,431</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">494,728</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,169,159</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" HEIGHT="30"> 리독스바이오</TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.01.01</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">213,426</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">31,862</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">245,288</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="308" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER"> 합 계</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,214,517</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,939,881</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,154,397</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL10">(주1) 토지 및 건물의 공정가치는 표준공시지가 및 기준시가에 근거하여 평가를 하였습니다.</P>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">라. 당기 및 전기 중 투자부동산에서 발생한 손익의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="625" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="616"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="625" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="322"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="331" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="147" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당 기</TH>
<TH WIDTH="147" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="331" HEIGHT="30"> 임대수익 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">485,827</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">421,057</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="331" HEIGHT="30"> 운영비용(임대수익이 발생한 투자부동산 관련) </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(156,837)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(156,837)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="331" HEIGHT="30" ALIGN="CENTER"> 합 계 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">328,990</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">264,220</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">7. 사용권자산</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">가. 사용권자산 및 리스부채회사의 당기 및 전기 중 사용권자산 및 리스부채의 장부금액과 보고기간 중 변동금액은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="788">

<COLGROUP>
<COL WIDTH="385"></COL>
<COL WIDTH="385"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="394" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD WIDTH="394" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="788">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="199" HEIGHT="60" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="442" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">사용권자산</TH>
<TH WIDTH="147" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">리스부채</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="148" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건물</TH>
<TH WIDTH="147" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차량운반구</TH>
<TH WIDTH="147" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">기 초</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">31,840</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">465,804</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">497,643</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">507,264</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">  신규취득</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">34,998</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">234,567</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">269,565</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">268,730</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">  중도해지</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(35,336)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(35,336)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(38,184)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">  감가상각</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(46,355)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(206,905)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(253,260)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">  이자비용</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">16,643</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE">  이자 및 원금지급</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(300,770)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE">기 말</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">20,483</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">458,130</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">478,612</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">453,683</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<TABLE ACLASS="NORMAL" WIDTH="788" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="385"></COL>
<COL WIDTH="385"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="394" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD ALIGN="RIGHT" WIDTH="394" HEIGHT="30" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="788">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="199" HEIGHT="60" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="442" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">사용권자산</TH>
<TH WIDTH="147" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">리스부채</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="148" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건물</TH>
<TH WIDTH="147" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차량운반구</TH>
<TH WIDTH="147" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">기 초</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">17,005</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">573,360</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">590,365</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">599,395</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">  신규취득</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">25,326</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">251,839</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">277,165</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">276,606</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">  중도해지</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(59,367)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(59,367)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(57,667)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">  감가상각</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(17,200)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(293,319)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(310,519)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">  이자비용</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">18,831</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE">  이자 및 원금지급</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(329,901)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE">기 말</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">25,131</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">472,513</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">497,644</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">507,264</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11 0X120FC8">
<SPAN USERMARK=" 0X000000">나. 회사의 당기 및 전기 중 손익계산서에 인식된 금액은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="611"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="620" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="206" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 사용권자산의 감가상각비</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">253,260</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">310,519</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 리스부채이자비용</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">16,643</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">18,831</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 임차보증금이자수익</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(909)</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(1,434)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 단기리스 관련 비용</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">14,639</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">3,630</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 소액기초자산리스 관련비용</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">315,408</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">349,787</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 중도해지로 인한 손실(이익)</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(1,348)</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">2,628</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">597,693</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">683,961</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">다. 리스부채에 대한 할인율(증분차입이자율)은 2.28% ~ 4.12%입니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">라. 당기말 현재 잔여기간별 리스부채의 계약상 만기는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="622">

<COLGROUP>
<COL WIDTH="613"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="622" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="623" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="147"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="146"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건물</TH>
<TH WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차량운반구</TH>
<TH WIDTH="155" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30"> 1개월이하</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,355</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,783</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,138</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30"> 1개월 ~ 3개월</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,345</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,138</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">19,483</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30"> 3개월 ~ 1년</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">8,925</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">175,123</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">184,048</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30"> 1년 ~ 5년</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">252,773</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">252,773</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계(주1)</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">14,625</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">462,817</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">477,442</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 계약상 명목금액으로써 현재가치로 평가되지 않은 금액입니다.</SPAN>
</P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">8. 영업권 및 무형자산</SPAN>
<SPAN USERMARK="F-GL11">가. 보고기간종료일 현재 영업권의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="619">

<COLGROUP>
<COL WIDTH="610"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="619" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="265"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="164"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="274" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="173" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="173" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30"> ㈜스페셜라이즈드메드</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30"> ㈜리독스바이오</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30"> S&V Technologies GmbH</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">693,156</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">693,156</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30"> BSC Medical Devices GmbH</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">693,156</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT">693,156</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11">나. 보고기간종료일 현재 무형자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="735" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="726"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="735" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="737">

<COLGROUP>
<COL WIDTH="157"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="166" HEIGHT="60" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="286" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" VALIGN="MIDDLE">당기말</TH>
<TH WIDTH="285" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" VALIGN="MIDDLE">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취득원가 </TH>
<TH WIDTH="95" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">상각누계액 </TH>
<TH WIDTH="95" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">장부금액</TH>
<TH WIDTH="95" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취득원가 </TH>
<TH WIDTH="95" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">상각누계액 </TH>
<TH WIDTH="95" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30"> 특허권</TD>
<TD ALIGN="RIGHT" WIDTH="96" HEIGHT="30">847,205</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(505,792)</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">341,413</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">821,349</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(443,122)</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">378,227</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30"> 상표권</TD>
<TD ALIGN="RIGHT" WIDTH="96" HEIGHT="30">422,485</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(186,449)</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">236,036</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">421,482</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(141,584)</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">279,898</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30"> 전기공급시설이용권</TD>
<TD ALIGN="RIGHT" WIDTH="96" HEIGHT="30">44,086</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">44,086</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">44,086</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">44,086</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30"> 소프트웨어</TD>
<TD ALIGN="RIGHT" WIDTH="96" HEIGHT="30">1,560,874</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(1,042,915)</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">517,959</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">1,495,113</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(852,533)</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">642,581</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30"> 회원권</TD>
<TD ALIGN="RIGHT" WIDTH="96" HEIGHT="30">923,313</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">923,313</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">919,800</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">919,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30"> 디자인권/기타재산권</TD>
<TD ALIGN="RIGHT" WIDTH="96" HEIGHT="30">894</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(888)</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">6</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">894</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(888)</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">6</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE"> 개발중인무형자산</TD>
<TD ALIGN="RIGHT" WIDTH="96" HEIGHT="30">28,936,290</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(4,026,813)</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">24,909,477</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">24,780,519</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(3,270,347)</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">21,510,171</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="96" HEIGHT="30">32,735,147</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(5,762,857)</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">26,972,290</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">28,483,243</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">(4,708,474)</TD>
<TD ALIGN="RIGHT" WIDTH="95" HEIGHT="30">23,774,769</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 0X120FC8"></P>

<P USERMARK=" B">
<SPAN USERMARK="F-GL11 !B">다. 당기 및 전기 중 무형자산 장부가액의 변동내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="734" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="353"></COL>
<COL WIDTH="363"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="362" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD ALIGN="RIGHT" WIDTH="372" HEIGHT="30" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="753">

<COLGROUP>
<COL WIDTH="152"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="161" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">과 목</TH>
<TH WIDTH="99" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기 초</TH>
<TH WIDTH="99" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취 득</TH>
<TH WIDTH="99" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">상각(주1)</TH>
<TH WIDTH="99" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">처분/손상</TH>
<TH WIDTH="98" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">대 체</TH>
<TH WIDTH="98" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기 말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30" VALIGN="MIDDLE"> 특허권</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">378,227</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">35,183</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">(61,289)</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">(10,708)</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">341,413</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30" VALIGN="MIDDLE"> 상표권</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">279,898</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">(44,865)</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">1,003</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">236,036</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30" VALIGN="MIDDLE"> 전기공급시설이용권</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">44,086</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">44,086</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30" VALIGN="MIDDLE"> 소프트웨어</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">642,581</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">55,580</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">(210,382)</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">30,181</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">517,959</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30" VALIGN="MIDDLE"> 회원권</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">919,800</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">3,513</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">923,313</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30" VALIGN="MIDDLE"> 디자인권/기타재산권</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">6</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">6</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30" VALIGN="MIDDLE"> 개발중인무형자산</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">21,510,171</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">4,155,772</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">(756,466)</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">24,909,477</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="161" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">23,774,769</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">4,246,535</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">(1,073,002)</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">23,989</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">26,972,290</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK="F-GL10 !B">(주1) 판매비와관리비 및 제조원가로 계상되었습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="735" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="353"></COL>
<COL WIDTH="364"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="362" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD ALIGN="RIGHT" WIDTH="373" HEIGHT="30" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="753">

<COLGROUP>
<COL WIDTH="157"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="166" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">과 목</TH>
<TH WIDTH="98" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기 초</TH>
<TH WIDTH="98" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취 득</TH>
<TH WIDTH="98" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">상 각</TH>
<TH WIDTH="98" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">처분/손상</TH>
<TH WIDTH="98" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">대 체</TH>
<TH WIDTH="97" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기 말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE"> 특허권</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">303,788</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">134,081</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">(59,843)</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">200</TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">378,227</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE"> 상표권</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">16,738</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">(66,015)</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">329,176</TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">279,898</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE"> 전기공급시설이용권</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">44,086</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">44,086</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE"> 소프트웨어</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">282,968</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">70,265</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">(153,923)</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">443,271</TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">642,581</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE"> 회원권</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">919,800</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">919,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE"> 디자인권/기타재산권</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">35</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">(29)</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">6</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE"> 개발중인무형자산</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">18,194,401</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">4,507,295</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">(736,885)</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">(454,640)</TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">21,510,171</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">19,761,816</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">4,711,641</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">(1,016,695)</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="98" HEIGHT="30">318,007</TD>
<TD ALIGN="RIGHT" WIDTH="97" HEIGHT="30">23,774,769</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">라. 개발중인무형자산(1) 일반사항  </SPAN>
</P>
<P USERMARK="F-GL11">신규개발 프로젝트는 신약후보물질발굴, 비임상, 임상1상, 임상2상, 임상3상, 정부승인 신청, 정부승인완료, 제품 판매시작 재심사연구 등의 단계로 진행됩니다. 회사는 일반적으로 해당 프로젝트가 임상3상 단계를 진입한 이후 발생한 지출을 무형자산으로 인식하고, 이전 단계에서 발생한 지출은 연구개발비로 보아 당기 비용처리하고 있습니다. 단, 기존 임상3상을 통과한 개발비와 제품허가 이후 제품의 허가사항 및 효능입증 업데이트를 위한 임상1상 및 임상2상 추가비용의 경우에도 무형자산으로 인식하고 있습니다.  </P>
<P USERMARK="F-GL11 0X120FC8"></P>
<P USERMARK="F-GL11">(2) 당기말 현재 무형자산으로 인식한 개발비는 다음과 같습니다</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="880">

<COLGROUP>
<COL WIDTH="871"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="880" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="883">

<COLGROUP>
<COL WIDTH="18"></COL>
<COL WIDTH="17"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="193"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="27" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">분류</TH>
<TH WIDTH="26" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">단계</TH>
<TH WIDTH="72" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER">구분</TH>
<TH WIDTH="202" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개발 자산명</TH>
<TH WIDTH="372" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개별자산명 자산화한 개발비 금액(누계액)</TH>
<TH WIDTH="92" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">장부금액</TH>
<TH WIDTH="92" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">잔여상각 기간(주4)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임상2상</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임상3상</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">판매승인</TH>
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="27" HEIGHT="330" ROWSPAN="11" VALIGN="MIDDLE">개발비</TD>
<TD WIDTH="26" HEIGHT="180" ROWSPAN="6" VALIGN="MIDDLE">개발완료</TD>
<TD WIDTH="72" HEIGHT="150" ROWSPAN="5" VALIGN="MIDDLE">개량신약</TD>
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE">가. 리포락셀</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE"> 리포락셀(위암) (주1)</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,406,908</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,406,908</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,989,193</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE"> 리포락셀(유방암) (주1)</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,508,080</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,508,080</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,508,080</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE"> 리포락셀(미국유방암) (주2)</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,583,034</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,583,034</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,583,034</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE">나. 고지혈증복합제(주3)</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">380,006</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">380,006</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">소 계</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,583,034</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,508,080</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,786,914</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">26,878,028</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,080,308</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="26" HEIGHT="150" ROWSPAN="5" VALIGN="MIDDLE">개발중</TD>
<TD WIDTH="72" HEIGHT="120" ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER">신약</TD>
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE">다. 소프트필러 (주5)</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,466,845</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,466,845</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">237,752</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2~6년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE">라. 리도카인필러 (주6)</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">322,030</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">322,030</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">322,030</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE">마. 유착방지제(주7)</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">269,388</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">269,388</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">269,388</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE">바. 기타</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">소 계</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,058,263</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,058,263</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">829,169</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="327" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="4" ALIGN="CENTER">합 계</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,583,034</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,566,343</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,786,914</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,936,290</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,909,477</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">(주1) 연결회사는 세계 최초로 경구형 파클리탁셀제품(리포락셀, DHP107)을 개발하여 한국에서 위암치료제로 의약품허가당국인 식약처의 검토 및 실사를 통해 제제기술, 제품의 효과 및 제조공장의 우수성을 확인받아 2016년 9월 9일 국내 시판허가를 득한 바 있으며, 현재 전세계 여러 회사를 대상으로 완제의약품 수출 또는 기술수출에 대한 협상을 진행하고 있습니다. 연결회사는  2017년 9월 중국 RMX 제약사에 238억 규모 상당액의 기술수출을 달성하였습니다. </SPAN>
</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">(주2) 또한 본 제품의 허가사항과 효능의 우수성을 기반으로 미국 및 유럽에서의 시판허가를 진행할 계획이며, 유방암 적응증에 대한 리포락셀 “DHP107 미국임상 2상 시험”이현재 미국에서 진행되고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">미국 2상 종료 시, 국내(&중국, 대만/ study nick name: OPTIMAL)에서 진행하여 도출한 2상 data와 현재 진행 중인 3상 중간 data를 가지고 FDA와 end of phase II 미팅을 진행할 수 있으며, 이를 통해 미국에서 추가 3상 시험 없이 미국 시판허가를 득할 가능성에 대해 기대할 수 있습니다. 미국2상 결과가 국내에서 기존에 진행한 PK 결과와 다르지 않고 인종차에 의한 흡수에 영향이 없다는 것이 증명된다면 충분히 가능할 수 있는 전략입니다. 이 경우 2022년 국내 시판허가와 동시에 미국 시판허가 신청이 가능하므로, 2022년 하반기 또는 2023년 상반기에 미국 시판허가를 득할 수 있을것으로 예상됩니다.</P>
<P USERMARK="F-GL11">대한민국은 허가대상 국가인 미국 또는 유럽과 허가절차의 유사성이 매우 높다고 볼 수 있습니다. 국내 개량신약의 경우 자료제출의약품 허가요건에 맞추어 임상시험 자료 등을 구비해야 하며, 미국에서도 이와 유사한 카테고리에 맞추어 개량신약의 허가가 진행되고 있습니다. 이외에도 국내의 혁신신약 허가 규정이나 미국의 breakthrough 등 비슷한 유형의 의약품에 대해서 비슷한 허가요건이 부여되고 있습니다. </P>

<P>
<SPAN USERMARK="F-GL11">의약품의 경우  globalization이 확립되어 미국 제약사에서 개발한 의약품이 유럽이나일본, 한국 등지에서 동일한 자료로 허가를 받게 되어 많은 다국적 제약사의 의약품이 국내에서 동일한 방식으로 허가를 받아 발매중이고, 국내에서 개발한 의약품이 미국에서도 허가를 받은 사례를 찾아볼 수 있습니다.</SPAN>
</P>
<P USERMARK="F-GL11">(주3) 연결회사는 고지혈증복합제(로수바스타틴/에제티미브) 관련 공동개발을 기반으로 현재 해당 제품을 판매하고 있습니다. </P>
<P USERMARK="F-GL11">(주4) 기존 EXPERT, LT의 기존필러에서 소프트필러(SF)제품개발을 하였으며, 이를 주력상품으로 현재 판매중에 있습니다. 현재 SF라인은 HA(히알루론산)의 함량에 따라 14,16,20,24의 4가지 제품이 개발되어 판매중에 있습니다. (주5) 리도카인을 함유한 필러 또한 개발이 완료되어  CE인증 등의 인허가를  2020년 2월중에 획득하였고 현재 연결회사가 유럽시장에 판매승인을 득한 상태이며 유럽시장에 판매주력 매출제품으로 포지셔닝을 위해 적극적인 홍보활동을 펼치고 있습니다.(주6) 창상 부위에 유착방지제를 도포하면 물리적인 장벽으로 작용하여 유착 형성을 막아 효과가 있는 유착방지제는 현재 독일에서 판매승인을 획득 상태입니다. 현재 상용화 여부를 검토중에 있습니다.</P>
<P></P>
<P USERMARK="F-GL11">(3) 당기 및 전기 중 비용으로 인식한 연구개발 관련 지출은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="623">

<COLGROUP>
<COL WIDTH="614"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="623" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="270"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="161"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="279" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>당 기</P>
</TH>

<TH WIDTH="170" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>전 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="279" VALIGN="MIDDLE" HEIGHT="30">
<P> 매출원가(제조원가)</P>
</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,589,564</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,044,772</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="279" VALIGN="MIDDLE" HEIGHT="30">
<P> 판매비와 관리비</P>
</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,374,048</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,640,925</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="279" VALIGN="MIDDLE" HEIGHT="30">
<P>    경상개발비</P>
</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,577,210</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,980,201</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="279" VALIGN="MIDDLE" HEIGHT="30">
<P>    정부보조금</P>
</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(203,162)</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,339,276)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="279" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합 계</P>
</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,963,612</TD>
<TD WIDTH="170" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,685,697</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">9. 관계기업투자 및 기타비유동금융자산</SPAN>
<SPAN USERMARK="F-GL11">가. 관계기업(1) 보고기간종료일 현재 관계기업투자의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="619" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="610"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="619" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="159"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="163"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="168" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">회사명</TH>
<TH WIDTH="106" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">지분율(%)</TH>
<TH WIDTH="173" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당기말</TH>
<TH WIDTH="172" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="168" HEIGHT="30"> JHK Biopharm</TD>
<TD ALIGN="CENTER" WIDTH="106" HEIGHT="30" VALIGN="MIDDLE">25</TD>
<TD ALIGN="RIGHT" WIDTH="173" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="172" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(2) 당기 및 전기 중 관계기업투자에 대한 변동내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="619" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="301"></COL>
<COL WIDTH="300"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD ALIGN="RIGHT" WIDTH="309" HEIGHT="30" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="125" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">회사명</TH>
<TH WIDTH="99" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기초</TH>
<TH WIDTH="99" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취득</TH>
<TH WIDTH="99" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">지분법손익</TH>
<TH WIDTH="99" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">처분</TH>
<TH WIDTH="99" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30"> JHK Biopharm</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="99" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<TABLE ACLASS="NORMAL" WIDTH="619" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="301"></COL>
<COL WIDTH="300"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD ALIGN="RIGHT" WIDTH="309" HEIGHT="30" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="117"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="126" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분법손익</TH>
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">처분</TH>
<TH WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="126" HEIGHT="30"> JHK Biopharm</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">212,811</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">(212,811)</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(3) 보고기간종료일 현재 관계기업의 요약재무정보는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="619" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="300"></COL>
<COL WIDTH="301"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" HEIGHT="30" VALIGN="MIDDLE"><당기말></TD>
<TD ALIGN="RIGHT" WIDTH="310" HEIGHT="30" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30"> JHK Biopharm</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">87,411</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">556,895</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(494,370)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<TABLE ACLASS="NORMAL" WIDTH="619" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="300"></COL>
<COL WIDTH="301"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" HEIGHT="30" VALIGN="MIDDLE"><전기말></TD>
<TD ALIGN="RIGHT" WIDTH="310" HEIGHT="30" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="124" HEIGHT="30"> JHK Biopharm</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">195,297</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">196,586</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT">(1,182,946)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(4) 보고기간종료일 현재 관계기업의 순자산에서 관계기업에 대한 지분의 장부금액으로 조정한 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="744">

<COLGROUP>
<COL WIDTH="363"></COL>
<COL WIDTH="363"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="372" HEIGHT="30" VALIGN="MIDDLE"><당기말></TD>
<TD WIDTH="372" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="743">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH USERMARK="F-BT" WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>회사명</P>
</TH>

<TH USERMARK="F-BT" WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>기말 순자산</P>
</TH>

<TH USERMARK="F-BT" WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>지분율(주1)</P>
</TH>

<TH USERMARK="F-BT" WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>순자산지분금액</P>
</TH>

<TH USERMARK="F-BT" WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>영업권</P>
</TH>

<TH USERMARK="F-BT" WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>기말 장부금액(주1)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK="F-BT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">
<P> JHK Biopharm</P>
</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 누적손실로 인하여 장부가액이 0 이하가 됨에 따라 지분법 적용을 중지하였습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="744">

<COLGROUP>
<COL WIDTH="363"></COL>
<COL WIDTH="363"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="372" HEIGHT="30" VALIGN="MIDDLE"><전기말></TD>
<TD WIDTH="372" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="743">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH USERMARK="F-BT" WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>회사명</P>
</TH>

<TH USERMARK="F-BT" WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>기말 순자산</P>
</TH>

<TH USERMARK="F-BT" WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>지분율(주1)</P>
</TH>

<TH USERMARK="F-BT" WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>순자산지분금액</P>
</TH>

<TH USERMARK="F-BT" WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>영업권</P>
</TH>

<TH USERMARK="F-BT" WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>기말 장부금액(주1)</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK="F-BT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">
<P> JHK Biopharm</P>
</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,289)</TD>

<TD USERMARK="F-BT" WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<P> 25.00%</P>
</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(322)</TD>
<TD WIDTH="119" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(5) 당기 중 지분법적용의 중지로 인하여 인식하지 못한 관계기업의 미반영 지분법손실은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="623">

<COLGROUP>
<COL WIDTH="363"></COL>
<COL WIDTH="242"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="372" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD WIDTH="251" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="624">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">

<TH USERMARK="F-BT" WIDTH="120" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>회사명</P>
</TH>
<TH WIDTH="126" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 초</TH>
<TH WIDTH="126" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">미인식지분법손익</TH>
<TH WIDTH="126" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">미인식지분법자본변동</TH>
<TH WIDTH="126" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK="F-BT" WIDTH="120" HEIGHT="30" VALIGN="MIDDLE">
<P> JHK Biopharm</P>
</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(123,593)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(123,593)</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL">
<SPAN USERMARK="F-11">나. 기타비유동금융자산(1) 보고기간종료일 현재 기타비유동금융자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="619" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="610"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="619" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="256"></COL>
<COL WIDTH="173"></COL>
<COL WIDTH="164"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="265" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">　구 분</TH>
<TH WIDTH="182" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당기말</TH>
<TH WIDTH="173" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" HEIGHT="30"> 기타포괄손익-공정가치측정금융자산</TD>
<TD ALIGN="RIGHT" WIDTH="182" HEIGHT="30">3,633,411</TD>
<TD ALIGN="RIGHT" WIDTH="173" HEIGHT="30">3,807,140</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" HEIGHT="30"> 장기금융상품</TD>
<TD ALIGN="RIGHT" WIDTH="182" HEIGHT="30">6,842,000</TD>
<TD ALIGN="RIGHT" WIDTH="173" HEIGHT="30">4,832,241</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" HEIGHT="30"> 임차(영업)보증금</TD>
<TD ALIGN="RIGHT" WIDTH="182" HEIGHT="30">400,969</TD>
<TD ALIGN="RIGHT" WIDTH="173" HEIGHT="30">83,600</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" HEIGHT="30"> 전신전화가입권</TD>
<TD ALIGN="RIGHT" WIDTH="182" HEIGHT="30">2,860</TD>
<TD ALIGN="RIGHT" WIDTH="173" HEIGHT="30">2,860</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="265" HEIGHT="30"> 장기미수수익</TD>
<TD ALIGN="RIGHT" WIDTH="182" HEIGHT="30">330,235</TD>
<TD ALIGN="RIGHT" WIDTH="173" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="265" HEIGHT="30">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="182" HEIGHT="30">11,209,475</TD>
<TD ALIGN="RIGHT" WIDTH="173" HEIGHT="30">8,725,841</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">상기 장기금융상품의 일부는 장단기차입금의 담보로 제공되어 있습니다(주석13,19 참조).</P>

<P USERMARK=" B">
<SPAN USERMARK="F-GL11 !B">(2) 보고기간종료일 현재기타포괄손익-공정가치측정금융자산의 내역은 다음과 같습니다</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="791" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="782"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="791" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="794">

<COLGROUP>
<COL WIDTH="88"></COL>
<COL WIDTH="271"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="98"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="97" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="280" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종 목</TH>
<TH WIDTH="310" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="107" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="107" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH WIDTH="107" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부가액</TH>
<TH WIDTH="96" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평가손익누계액(주1)</TH>
<TH WIDTH="107" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부가액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">지분상품</TD>
<TD WIDTH="280" HEIGHT="30"> ㈜킹고투자파트너스</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">1,100,000</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">1,110,335</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">10,335</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">1,051,440</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">지분상품</TD>
<TD WIDTH="280" HEIGHT="30"> 킹고바이오그로스 제1호 투자조합</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">500,000</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">482,848</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">(17,152)</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">491,445</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">지분상품</TD>
<TD WIDTH="280" HEIGHT="30"> Haihe Biopharma.Ltd(cayman)</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">3,375,048</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">164,635</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">(3,210,414)</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">564,043</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">지분상품</TD>
<TD WIDTH="280" HEIGHT="30"> 스마트마그나킹고그린펀드</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">850,000</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">821,577</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">(28,423)</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">664,727</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">지분상품</TD>
<TD WIDTH="280" HEIGHT="30"> ㈜피코이노베이션</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">1,000,000</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">932,696</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">(67,304)</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">968,956</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">지분상품</TD>
<TD WIDTH="280" HEIGHT="30" VALIGN="MIDDLE"> ㈜키메디</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">499,995</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">121,320</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(378,675)</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">66,528</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="377" HEIGHT="30" COLSPAN="2" ALIGN="CENTER">합 계</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">7,325,043</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">3,633,411</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">(3,691,633)</TD>
<TD WIDTH="107" HEIGHT="30" ALIGN="RIGHT">3,807,139</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 법인세효과 고려전 가액입니다. </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 B">10. 재고자산</SPAN>
<SPAN USERMARK="F-GL11">가. 보고기간종료일 현재 재고자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="644" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="635"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="644" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="643">

<COLGROUP>
<COL WIDTH="98"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="107" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE">구 분 </TH>
<TH WIDTH="269" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" VALIGN="MIDDLE">당기말</TH>
<TH WIDTH="267" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3" VALIGN="MIDDLE">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="90" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취득원가 </TH>
<TH WIDTH="90" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">평가충당금 </TH>
<TH WIDTH="89" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">장부금액 </TH>
<TH WIDTH="89" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">취득원가 </TH>
<TH WIDTH="89" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">평가충당금 </TH>
<TH WIDTH="89" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">장부금액 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="30" VALIGN="MIDDLE"> 원재료</TD>
<TD ALIGN="RIGHT" WIDTH="90" HEIGHT="30">9,240,764</TD>
<TD ALIGN="RIGHT" WIDTH="90" HEIGHT="30">(99,074)</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">9,141,689</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">3,816,805</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">(28,832)</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">3,787,973</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="30" VALIGN="MIDDLE"> 상품</TD>
<TD ALIGN="RIGHT" WIDTH="90" HEIGHT="30">1,876,163</TD>
<TD ALIGN="RIGHT" WIDTH="90" HEIGHT="30">(48,580)</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">1,827,583</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">1,288,644</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">(116,332)</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">1,172,313</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="30" VALIGN="MIDDLE"> 소모품</TD>
<TD ALIGN="RIGHT" WIDTH="90" HEIGHT="30">2,347,328</TD>
<TD ALIGN="RIGHT" WIDTH="90" HEIGHT="30">(142,667)</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">2,204,661</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">1,470,397</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">(140,789)</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">1,329,608</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="30" VALIGN="MIDDLE"> 재공품</TD>
<TD ALIGN="RIGHT" WIDTH="90" HEIGHT="30">1,915,807</TD>
<TD ALIGN="RIGHT" WIDTH="90" HEIGHT="30">(87,324)</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">1,828,483</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">4,288,690</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">(36,287)</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">4,252,403</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="30" VALIGN="MIDDLE"> 제품</TD>
<TD ALIGN="RIGHT" WIDTH="90" HEIGHT="30">8,726,394</TD>
<TD ALIGN="RIGHT" WIDTH="90" HEIGHT="30">(315,915)</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">8,410,479</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">8,301,683</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">(162,200)</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">8,139,483</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="107" HEIGHT="30">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="90" HEIGHT="30">24,106,456</TD>
<TD ALIGN="RIGHT" WIDTH="90" HEIGHT="30">(693,560)</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">23,412,895</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">19,166,219</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">(484,440)</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="30">18,681,780</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 B"></P>
<P USERMARK="F-GL11">나. 당기 및 전기 중 재고자산과 관련하여 인식한 평가손실 및 환입은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="621" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="612"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="621" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="623" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="303"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="146"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="312" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="156" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당 기</TH>
<TH WIDTH="155" VALIGN="BOTTOM" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="623" HEIGHT="30"> 매출원가:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="312" HEIGHT="30">  ―재고자산평가손실(환입)</TD>
<TD WIDTH="156" ALIGN="RIGHT" HEIGHT="30">209,119</TD>
<TD WIDTH="155" ALIGN="RIGHT" HEIGHT="30">130,247</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">11. 매출채권 및 기타유동채권</SPAN>
<SPAN USERMARK="F-GL11">가. 보고기간종료일 현재 매출채권 및 기타유동채권의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="718" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="709"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="718" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="717">

<COLGROUP>
<COL WIDTH="102"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="111" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="303" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">당기말</TH>
<TH WIDTH="303" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권총액 </TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대손충당금 </TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액 </TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권총액 </TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대손충당금 </TH>
<TH WIDTH="101" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="111" HEIGHT="30"> 매출채권</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">20,176,047</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">(2,038,760)</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">18,137,287</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">18,847,073</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">(2,128,327)</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">16,718,746</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="111" HEIGHT="30"> 미수금</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">1,273,322</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">1,273,322</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">854,339</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">854,339</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="111" HEIGHT="30"> 미수수익</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">39,690</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">39,690</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">662,862</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">662,862</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="111" HEIGHT="30"> 선급금</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">92,163</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">92,163</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">510,986</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">510,986</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="111" HEIGHT="30"> 선급비용</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">51,065</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">51,065</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">109,667</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">109,667</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="111" HEIGHT="30"> 부가세대급금</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">243,526</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">243,526</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">178,247</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">178,247</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="111" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">21,875,813</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(2,038,760)</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">19,837,053</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">21,163,174</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">(2,128,327)</TD>
<TD ALIGN="RIGHT" WIDTH="101" HEIGHT="30">19,034,847</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">나. 당기 및 전기 중 대손충당금의 변동 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="625" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="303"></COL>
<COL WIDTH="304"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="312" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD ALIGN="RIGHT" WIDTH="313" HEIGHT="30" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="628">

<COLGROUP>
<COL WIDTH="148"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="157" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 초</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각비(환입)</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 각</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="157" HEIGHT="30"> 매출채권</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">2,128,327</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(11,412)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(78,155)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">2,038,760</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" WIDTH="624" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="303"></COL>
<COL WIDTH="303"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="312" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD ALIGN="RIGHT" WIDTH="312" HEIGHT="30" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="628">

<COLGROUP>
<COL WIDTH="150"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="159" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 초</TH>
<TH WIDTH="132" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각비(환입)</TH>
<TH WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 각</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" HEIGHT="30"> 매출채권</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">2,406,128</TD>
<TD WIDTH="132" HEIGHT="30" ALIGN="RIGHT">11,019</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT">(288,820)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">2,128,327</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">12. 기타유동금융자산</SPAN>
<SPAN USERMARK="F-GL11">보고기간종료일 현재 기타유동금융자산의 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="605" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="237"></COL>
<COL WIDTH="171"></COL>
<COL WIDTH="170"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="246" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH ALIGN="CENTER" WIDTH="180" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH ALIGN="CENTER" WIDTH="179" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30"> 상각후원가측정금융자산</TD>
<TD ALIGN="RIGHT" WIDTH="180" HEIGHT="30">3,645</TD>
<TD ALIGN="RIGHT" WIDTH="179" HEIGHT="30">13,976</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30"> 단기금융상품</TD>
<TD ALIGN="RIGHT" WIDTH="180" HEIGHT="30">3,240,000</TD>
<TD ALIGN="RIGHT" WIDTH="179" HEIGHT="30">11,340,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30"> 당기손익-공정가치측정금융자산</TD>
<TD ALIGN="RIGHT" WIDTH="180" HEIGHT="30">1,593,067</TD>
<TD ALIGN="RIGHT" WIDTH="179" HEIGHT="30">3,066,361</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="180" HEIGHT="30">4,836,712</TD>
<TD ALIGN="RIGHT" WIDTH="179" HEIGHT="30">14,420,337</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">상기 단기금융상품의 일부는 장단기차입금의 담보로 제공되어 있습니다(주석13,19 참조).</P>
<P USERMARK="F-GL11">나. 보고기간종료일 현재 당기손익-공정가치측정금융자산의 내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="621">

<COLGROUP>
<COL WIDTH="612"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="621" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="150"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="137"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="159" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="170" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종 목</TH>
<TH WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="146" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" HEIGHT="30" VALIGN="MIDDLE"> 출자금</TD>
<TD WIDTH="170" HEIGHT="30"> 한국제약협동조합</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">19,992</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">19,992</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" HEIGHT="30" VALIGN="MIDDLE"> 출자금</TD>
<TD WIDTH="170" HEIGHT="30"> 향남제약사업 협동조합</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">13,690</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">13,690</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" HEIGHT="30" VALIGN="MIDDLE"> 시장성있는 지분상품</TD>
<TD WIDTH="170" HEIGHT="30" VALIGN="MIDDLE"> 한미약품 등</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,559,385</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,032,679</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="329" HEIGHT="30" COLSPAN="2" ALIGN="CENTER">합 계</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">1,593,067</TD>
<TD WIDTH="146" HEIGHT="30" ALIGN="RIGHT">3,066,361</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">13. 현금및현금성자산 및 사용제한 금융상품</SPAN>
<SPAN USERMARK="F-GL11">가. 보고기간종료일 현재 현금및현금성자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="616" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="607"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="616" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">　구 분</TH>
<TH WIDTH="210" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="209" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE"> 보유현금</TD>
<TD ALIGN="RIGHT" WIDTH="210" HEIGHT="30">37,332</TD>
<TD ALIGN="RIGHT" WIDTH="209" HEIGHT="30">40,233</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE"> 보통예금</TD>
<TD ALIGN="RIGHT" WIDTH="210" HEIGHT="30">3,087,803</TD>
<TD ALIGN="RIGHT" WIDTH="209" HEIGHT="30">3,961,498</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="201" HEIGHT="30">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="210" HEIGHT="30">3,125,135</TD>
<TD ALIGN="RIGHT" WIDTH="209" HEIGHT="30">4,001,731</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">나. 보고기간종료일 현재 사용이 제한된 금융상품의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="659" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="650"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="659" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="661">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="131" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">계정명</TH>
<TH WIDTH="131" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">금융기관</TH>
<TH WIDTH="155" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">내 역</TH>
<TH WIDTH="122" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
<TH WIDTH="122" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30" VALIGN="MIDDLE"> 단기금융상품</TD>
<TD ALIGN="CENTER" WIDTH="131" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" WIDTH="155" HEIGHT="30">차입금 담보</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="30">3,240,000</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="30">6,120,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30" VALIGN="MIDDLE"> 장기금융상품</TD>
<TD ALIGN="CENTER" WIDTH="131" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" WIDTH="155" HEIGHT="30">차입금 담보</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="30">5,700,000</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="30">2,710,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30" VALIGN="MIDDLE"> 장기금융상품</TD>
<TD ALIGN="CENTER" WIDTH="131" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" WIDTH="155" HEIGHT="30">당좌개설보증금</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="30">2,000</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="30">2,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="417" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="30">8,942,000</TD>
<TD ALIGN="RIGHT" WIDTH="122" HEIGHT="30">8,832,000</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">14. 납입자본</SPAN>
<SPAN USERMARK="F-GL11">회사의 정관에 의한 발행할 주식총수는 60,000,000주(1주의 금액: 500원)이며 당기말 현재 회사가 발행한 주식수는 보통주식 18,616,650주입니다. 당기 및 전기 중 회사의 자본금 및 주식발행초과금의 변동 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="548">

<COLGROUP>
<COL WIDTH="539"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="548" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="545">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="131"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="140" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">발행주식수</TH>
<TH WIDTH="140" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보통주자본금</TH>
<TH WIDTH="140" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식발행초과금</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30"> 전기초</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">18,569,379</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">9,284,690</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">29,349,309</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30">   전환권행사</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">47,271</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">23,636</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">945,552</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30"> 전기말</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">18,616,650</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">9,308,325</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">30,294,861</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30">   전환권행사</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30"> 당기말</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">18,616,650</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">9,308,325</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">30,294,861</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11">
<SPAN USERMARK=" B">15. 연결이익잉여금</SPAN>가. 보고기간종료일 현재 연결회사의 이익잉여금의 내역은 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" WIDTH="619" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="610"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="619" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="618" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="209" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당기말</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 법정적립금</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">3,456,693</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">3,193,943</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 임의적립금</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">11,262,509</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">11,262,509</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 미처분이익잉여금</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">31,143,007</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">32,072,386</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="209" ALIGN="RIGHT" HEIGHT="30">45,862,209</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">46,528,838</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(1) 법정적립금보고기간종료일 현재 연결회사의 법정적립금 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="621" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="612"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="621" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE AFIXTABLE="N" WIDTH="625" BORDER="1" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="203"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="213" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="212" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE"> 이익준비금(주1)</TD>
<TD ALIGN="RIGHT" WIDTH="213" HEIGHT="30">3,456,693</TD>
<TD ALIGN="RIGHT" WIDTH="212" HEIGHT="30">3,193,943</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL10">(주1) 연결회사는 상법에 따라 자본금의 50%에 달할 때까지 매 결산기마다 금전이익배당액의 10% 이상을 이익준비금으로 적립하며, 동 이익준비금은 현금으로 배당할 수 없으며 주주총회 결의에 의하여 이월결손금 보전과 자본전입에만 사용될 수 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 임의적립금 보고기간종료일 현재 연결회사의 임의적립금 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="616" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="607"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="616" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE AFIXTABLE="N" WIDTH="619" BORDER="1" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="193"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="202" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH ALIGN="CENTER" WIDTH="209" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH ALIGN="CENTER" WIDTH="208" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30"> 기업합리화적립금(주1)</TD>
<TD ALIGN="RIGHT" WIDTH="209" HEIGHT="30">462,509</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">462,509</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30"> 기업발전적립금(주2)</TD>
<TD ALIGN="RIGHT" WIDTH="209" HEIGHT="30">6,800,000</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">6,800,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30"> 기타적립금(주3)</TD>
<TD ALIGN="RIGHT" WIDTH="209" HEIGHT="30">4,000,000</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">4,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="202" HEIGHT="30">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="209" HEIGHT="30">11,262,509</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">11,262,509</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 연결회사는 종전의 조세특례제한법에 의거 세액공제, 세액감면 등을 받은 금액상당액을 기업합리화적립금으로 적립하였습니다. 동 적립금은 이월결손금의 보전 또는 자본전입에만 사용될 수 있었으나, 관계세법의 개정에 따라 기업합리화적립금의 적립의무가 소멸되었는 바, 당기말 현재의 기업합리화적립금은 임의적립금으로서 그사용에 제한이 없습니다.(주2) 연결회사는 종전의 적정유보초과소득에 대한 법인세에 대해 기업발전적립금을적립하였습니다. 동 적립금은 이월결손금의 보전 또는 자본전입에만 사용될 수 있으며, 이미 적립한 기업발전적립금의 처분과 용도 외의 처분에 대하여는 종전의 규정에따라 법인세를 납부하도록 하고 있습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL10">(주3) 연결회사는 임의적립금을 설정하고 있으며, 이는 주주총회의 결의에 의하여 배당이 가능한 잉여금입니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">(3) 당기 및 전기 중 연결회사의 미처분이익잉여금의 변동내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="618" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="618" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="621" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="379"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="107"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="388" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="117" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당 기</TH>
<TH WIDTH="116" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전  기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="388" HEIGHT="30">기초금액</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">32,072,386</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">32,611,343</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="388" HEIGHT="30">  법정적립금의 적립</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">(262,750)</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">(260,319)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="388" HEIGHT="30">  연차배당</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">(1,751,665)</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">(1,746,938)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="388" HEIGHT="30">  중간배당</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">(875,833)</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">(875,833)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="388" HEIGHT="30">  당기순이익(손실)</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">1,115,658</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">2,217,398</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="388" HEIGHT="30">  확정급여제도의 재측정요소</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">845,211</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">126,735</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="388" HEIGHT="30">기말금액</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">31,143,007</TD>
<TD WIDTH="116" ALIGN="RIGHT" HEIGHT="30">32,072,386</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11">나. 당기 및 전기 중 보통주배당금에 관한 사항은 다음과 같습니다(1) 배당금 산정내역</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="627">

<COLGROUP>
<COL WIDTH="618"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="627" HEIGHT="30" ALIGN="RIGHT">(단위: 주, 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="136"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="145" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="242" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="242" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">중간배당</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말배당</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">중간배당</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말배당</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30"> 배당을 받은주 식</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">17,516,650</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">17,516,650</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">17,516,650</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">17,516,650</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30"> 주당배당금</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">50</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">100</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">50</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30"> 액면배당율</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">10%</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">20%</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">10%</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">20%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30"> 배당할 금액</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">875,832,500</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">1,751,665,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">875,832,500</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">1,751,665,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(2) 배당성향</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="627">

<COLGROUP>
<COL WIDTH="618"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="627" HEIGHT="30" ALIGN="RIGHT">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="626">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="204"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="200" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="213" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="213" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 배당금(A)</TD>
<TD WIDTH="213" HEIGHT="30" ALIGN="RIGHT">2,627,497,500</TD>
<TD WIDTH="213" HEIGHT="30" ALIGN="RIGHT">2,627,497,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 지배주주 당기순이익(B)</TD>
<TD WIDTH="213" HEIGHT="30" ALIGN="RIGHT">1,115,657,705</TD>
<TD WIDTH="213" HEIGHT="30" ALIGN="RIGHT">2,217,397,654</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 배당성향(A/B)</TD>
<TD WIDTH="213" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">235.51%</TD>
<TD WIDTH="213" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">118.49%</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK="F-GL11 0X000000">(3) 배당수익률</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="627">

<COLGROUP>
<COL WIDTH="618"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="627" HEIGHT="30" ALIGN="RIGHT">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="203"></COL>
<COL WIDTH="203"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="212" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="212" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 주당배당금(A)</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">150</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">150</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 주가(B)</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">9,400</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="RIGHT">9,320</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 배당수익률(A/B)</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1.60%</TD>
<TD WIDTH="212" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1.61%</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11 B">16. 기타 자본구성요소</SPAN>
<SPAN USERMARK="F-GL11">가. 보고기간종료일 현재 기타 자본구성요소의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="604">

<COLGROUP>
<COL WIDTH="193"></COL>
<COL WIDTH="192"></COL>
<COL WIDTH="192"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="202" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="201" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="201" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30"> 기타의 자본잉여금</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">371,595</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">371,595</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30"> 기타포괄손익누계액</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">(2,917,497)</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30" VALIGN="MIDDLE">(2,461,736)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30"> 자기주식</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">(9,161,842)</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">(9,161,842)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30"> 자기주식처분이익</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">2,357,025</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">2,357,025</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30"> 기타자본조정</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">1,877,892</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">2,437,135</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="202" HEIGHT="30">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">(7,472,827)</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">(6,457,823)</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11">나. 당기 및 전기 중 기타 자본구성요소의 변동내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="911" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="902"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="911" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="914">

<COLGROUP>
<COL WIDTH="155"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="164" HEIGHT="56" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" USERMARK="F-10">구  분</TH>
<TH WIDTH="376" HEIGHT="28" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">당 기</TH>
<TH WIDTH="374" HEIGHT="28" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">전 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="94" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">기초</TH>
<TH WIDTH="94" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">증가</TH>
<TH WIDTH="94" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">감소</TH>
<TH WIDTH="94" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">기말</TH>
<TH WIDTH="94" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">기초</TH>
<TH WIDTH="94" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">증가</TH>
<TH WIDTH="93" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">감소</TH>
<TH WIDTH="93" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="164" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> 기타의 자본잉여금</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">371,595</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">371,595</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">371,595</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">371,595</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="164" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> 해외사업환산손익</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">149,629</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(147,045)</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">2,584</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">96,097</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">53,531</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">149,629</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="164" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> 기타포괄손익누계액</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(2,611,364)</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(308,717)</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(2,920,081)</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(125,282)</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(2,486,082)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(2,611,364)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="164" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> 자기주식</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(9,161,842)</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(9,161,842)</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(9,161,842)</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(9,161,842)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="164" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10"> 자기주식처분이익</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">2,357,025</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">2,357,025</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">2,357,025</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">2,357,025</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="164" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10"> 종속기업 소유지분변동에 의한 증감</TD>
<TD WIDTH="94" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">2,437,135</TD>
<TD WIDTH="94" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="94" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">559,242</TD>
<TD WIDTH="94" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">1,877,892</TD>
<TD WIDTH="94" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">3,000,161</TD>
<TD WIDTH="94" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="93" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">563,027</TD>
<TD WIDTH="93" HEIGHT="49" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">2,437,135</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="164" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">합 계</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(6,457,822)</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(455,762)</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">559,242</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(7,472,827)</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(3,462,246)</TD>
<TD WIDTH="94" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(2,432,551)</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">563,027</TD>
<TD WIDTH="93" HEIGHT="28" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">(6,457,822)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">다. 당기말 현재 보유하고 있는 자기주식  9,161,842천원(보통주 1,100,000주)이며 향후 주가상황에 따라 처분할 예정입니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 B">17. 충당부채</SPAN>
<SPAN USERMARK="F-GL11">당기 및 전기 중 비유동충당부채의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="714">

<COLGROUP>
<COL WIDTH="348"></COL>
<COL WIDTH="348"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="357" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD WIDTH="357" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="712">

<COLGROUP>
<COL WIDTH="185"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="194" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전입액(환입액)</TH>
<TH WIDTH="129" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사용액</TH>
<TH WIDTH="129" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="30" VALIGN="MIDDLE"> 유동: </TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="30" VALIGN="MIDDLE">   반품충당부채(주1)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">985,797</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(173,399)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">812,398</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="30" VALIGN="MIDDLE">   계약부채(매출할인)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">440,629</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(19,148)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">421,481</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">소 계</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,426,426</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(192,547)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,233,879</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="30" VALIGN="MIDDLE"> 비유동:</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="30" VALIGN="MIDDLE">   마일리지충당부채(주2)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,118</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,861</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,561)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,418</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,431,544</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(190,686)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,561)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,239,297</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 연결회사는 판매시점에 반품이 예상되는 부분의 매출액과 매출원가를 각각 차감하고 매출총이익에 해당하는 금액과 반품재고자산의 감액 등 반품과 관련하여 발생할 것으로 예상되는 비용을 반품충당부채로 계상하고 있습니다.(주2) 연결회사는 고정고객 확보 및 우수고객 보상을 통하여 안정적인 수익의 원천을관리하려는 영업정책의 일환으로 마일리지제도를 운영하고 있는 바, 기간손익의 적정화를 위하여 동 마일리지 부여에 따라 예상되는 추가적인 원가부담액을 마일리지충당부채로 계상하고 있습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="714">

<COLGROUP>
<COL WIDTH="348"></COL>
<COL WIDTH="348"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="357" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD WIDTH="357" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="712">

<COLGROUP>
<COL WIDTH="168"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="177" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="134" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="134" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전입액</TH>
<TH WIDTH="134" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사용액</TH>
<TH WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE"> 유동: </TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">   반품충당부채</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,092,727</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(106,930)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">985,797</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">   계약부채(매출할인)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">403,177</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">37,453</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">440,629</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">소 계</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,495,904</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(69,477)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,426,426</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE"> 비유동:</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE">   마일리지충당부채</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,219</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,586</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,688)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,117</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="177" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,501,124</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(67,891)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,688)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,431,543</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL B">18. 장기매입채무 및 기타비유동채무</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">보고기간종료일 현재 기타비유동채무의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="603">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="192"></COL>
<COL WIDTH="192"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="201" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">당기말</TH>
<TH WIDTH="201" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 미지급금</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">2,900,835</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">2,796,849</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 임대보증금</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">365,000</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">355,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 비유동리스부채</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">251,926</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">269,244</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">3,517,761</TD>
<TD ALIGN="RIGHT" WIDTH="201" HEIGHT="30">3,421,093</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11 B">19. 장ㆍ단기차입금 및 전환사채</SPAN>
<SPAN USERMARK="F-GL11">가. 보고기간종료일 현재 연결회사의 장ㆍ단기차입금의 구성내역은 다음과 같습니다.(1) 단기차입금</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="595">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종 류</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입처</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연이자율(%)</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">기업일반대출</TD>
<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">기업은행 외</TD>
<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">2.58% ~ 6.23%</TD>
<TD ALIGN="RIGHT" WIDTH="119" HEIGHT="30">52,390,000</TD>
<TD ALIGN="RIGHT" WIDTH="119" HEIGHT="30">49,310,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">구매자금대출</TD>
<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">기업은행 외</TD>
<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">4.216%~6.339%</TD>
<TD ALIGN="RIGHT" WIDTH="119" HEIGHT="30">6,465,000</TD>
<TD ALIGN="RIGHT" WIDTH="119" HEIGHT="30">6,010,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">당좌차월</TD>
<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">기업은행 외</TD>
<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">4.226%</TD>
<TD ALIGN="RIGHT" WIDTH="119" HEIGHT="30">199,800</TD>
<TD ALIGN="RIGHT" WIDTH="119" HEIGHT="30">175,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">기타</TD>
<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">특수관계자</TD>
<TD ALIGN="CENTER" WIDTH="119" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="119" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="119" HEIGHT="30">7,585</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" ALIGN="CENTER" WIDTH="357" HEIGHT="30">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="119" HEIGHT="30">59,054,800</TD>
<TD ALIGN="RIGHT" WIDTH="119" HEIGHT="30">55,502,585</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL B"></P>

<P USERMARK=" B">
<SPAN USERMARK="F-GL11 !B">(2) 장기차입금</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="596">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종 류</TH>
<TH WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입처</TH>
<TH WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연이자율(%)</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> 시설자금대출 </TD>
<TD WIDTH="131" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기업은행 외</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5.36% ~ 6.33%</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,557,203</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,296,310</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="361" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">소 계</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,557,203</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,296,310</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="361" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">차감 : 1년이내 만기도래분</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,249,730)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,499,820)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="361" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">합 계</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">27,307,473</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,796,490</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<P USERMARK=" B">
<SPAN USERMARK="F-GL11 !B">상기 장ㆍ단기차입금과 관련하여 연결회사 소유의 토지 및 건물, 금융상품이 담보로 제공되어 있습니다(주석 5와 12참조).</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">나. 전환사채</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">연결회사는 운영자금 조달을 목적으로 전환사채를 발행하였으며, 당기말 현재 주요 전환사채의 발행조건과 장부가액은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="311"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="320" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종 류</TH>
<TH WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">발행일</TH>
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상환기일</TH>
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">표면 이자율</TH>
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="76" ALIGN="CENTER">제1회 무기명식 이권부 무보증 사모 전환사채 </TD>
<TD WIDTH="100" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">2019.03.29</TD>
<TD WIDTH="99" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">2024.03.29</TD>
<TD WIDTH="99" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="99" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">20,000,000</TD>
<TD WIDTH="99" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">20,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="421" HEIGHT="30" ALIGN="CENTER" COLSPAN="4">전환사채의 보통주 전환</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">(5,800,000)</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">(5,800,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="421" HEIGHT="30" ALIGN="CENTER" COLSPAN="4">전환사채의 조기상환</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">(14,200,000)</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">(13,400,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="421" HEIGHT="30" ALIGN="CENTER" COLSPAN="4">전환사채 액면총액</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">800,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="421" HEIGHT="30" ALIGN="CENTER" COLSPAN="4">전환사채 상환할증금</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">44,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="421" HEIGHT="30" ALIGN="CENTER" COLSPAN="4">전환권조정</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="421" HEIGHT="30" ALIGN="CENTER" COLSPAN="4">전환사채 합계</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">844,000</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" B"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="237"></COL>
<COL WIDTH="365"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="246" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="374" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제1회 전환사채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30" ALIGN="CENTER">사채 종류</TD>
<TD WIDTH="374" HEIGHT="30" ALIGN="CENTER">무기명식 이권부 무보증 사모 전환사채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30" ALIGN="CENTER">사채 권면액</TD>
<TD WIDTH="374" HEIGHT="30" ALIGN="CENTER">20,000,000,000원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30" ALIGN="CENTER">발행시점 주식전환 행사가액</TD>
<TD WIDTH="374" HEIGHT="30" ALIGN="CENTER">21,154원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="53" ALIGN="CENTER">보고기간말 현재 조정된 주식전환 행사가액 (주1)</TD>
<TD WIDTH="374" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">14,808원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">이자지급과 상환방법</TD>
<TD WIDTH="374" HEIGHT="168" VALIGN="MIDDLE">본 사채의 표면이자는 0.0%이며, 별도의 이자지급기일은 없는 것으로 한다.만기까지 보유하고 있는 본 사채의 원금에 대하여는 2024년 03월 29일에 권면금액의 110.0000%에 해당하는 금액을 일시 상환한다. 단, 상환기일이 은행영업일이 아닌 경우에는 그 다음 영업일에 상환하고 원금 상환기일 이후의 이자는 계산하지 아니한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">보유자 조기상환청구권 (주2)</TD>
<TD WIDTH="374" HEIGHT="53" VALIGN="MIDDLE">발행일로부터 21개월이 되는 2020년 12월 29일 및 이후 매3개월에 해당되는 날</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">발행회사의 매도청구권 (주2) (주3)</TD>
<TD WIDTH="374" HEIGHT="53" VALIGN="MIDDLE">발행일로부터 1년이되는 날인 2020년 03월29일부터 2021년 03월29일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30" ALIGN="CENTER">미행사 잔여주식수</TD>
<TD WIDTH="374" HEIGHT="30" ALIGN="CENTER">0 주</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 본 사채권을 소유한 자가 전환청구를 하기 전에 시가를 하회하는 발행가액으로유상증자, 주식배당 및 준비금의 자본전입 등에 따른 주식을 발행하거나 또는 시가를하회하는 전환가액 또는 행사가액으로 특수사채를 발행하는 경우에 전환가액이 조정될 수 있습니다. 또한, 합병, 자본의 감소, 주식분할 및 병합 등에 의하여 전환가격의 조정이 필요한 경우 조정하며, 최저조정한도는 발행시 전환가액의 70% 이상으로 합니다. 전환가액 조정내역은 다음과 같습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-10">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="147"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="303"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">구 분</TH>
<TH WIDTH="155" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">전환가액</TH>
<TH WIDTH="312" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30" USERMARK="F-10"> 최초발행시</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-10">21,154</TD>
<TD WIDTH="312" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="28" USERMARK="F-10"> 1차 조정</TD>
<TD WIDTH="155" HEIGHT="28" ALIGN="RIGHT" USERMARK="F-10">16,398</TD>
<TD WIDTH="312" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30" USERMARK="F-10"> 2차 조정</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">14,808</TD>
<TD WIDTH="312" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">전환가액은 최초전환가액의  70%로 고정됨</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK="F-GL10 0X000000">(주2) 회사는 상기 전환사채에 부여된 조기상환권을 본 사채와 비분리하였습니다.(주3) 발행회사는 각 사채권자가 보유하고 있는 본 사채 발행가액의 30%범위 내에서만 매도청구권을 행사할 수 있으며, 본 사채의 인수인은 본 계약의 '발행회사의 매도청구권' 의 행사를 보장하기 위하여 매도청구권의 행사기간 종료일까지 발행 당시 각인수인별 인수금액의 30%에 해당하는 본 사채를 미전환 상태로 보유하여야 합니다.</SPAN>
</P>
<P USERMARK="F-GL11 0X1814FF"></P>
<P USERMARK="F-GL11">(2) 당기 중 전환사채의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="752">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="443"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="452" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="754" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="129"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종 류</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보통주 전환</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">조기상환</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자비용</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말잔액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30"> 전환사채</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">800,000</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">(800,000)</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" HEIGHT="30"> 상환할증금(주1)</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">44,000</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">(53,500)</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">9,500</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="138" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">(853,500)</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">9,500</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 연결회사는 당기말 상환시 지급하여야 할 이자비용을 사채상환할증금으로 인식하였습니다.</SPAN>
</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11">(3) 보고기간종료일 현재 주계약과 분리된 내재파생상품부채의 공정가치 변동 및 관련손익은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="311"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="320" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="620" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종 류</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30"> 기발행(전기이월)</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45 </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,231,018</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30"> 파생상품평가손실</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　-</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,312,014)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30"> 조기상환으로 인한 감소</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(45)</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(673,207)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30"> 전환권행사</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(245,752)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30"> 기말 현재공정가치</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P USERMARK="F-GL11">
<SPAN USERMARK=" B">20. 확정급여부채</SPAN>가. 연결회사는 종업원을 위하여 확정급여제도를 운영하고 있으며, 이 제도에 따르면종업원의 퇴직시 근속 1년당 최종 3개월 평균급여에 지급률 등을 가감한 금액을 지급하도록 되어 있습니다. 사외적립자산과 확정급여채무의 보험수리적 평가는 예측단위적립방식을 사용하여 적격성이 있는 독립적인 보험계리법인인 기업은행에 의하여 수행되었습니다. 연결회사의 확정급여채무와 관련된 부채의 내역은 다음과 같습니다
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="235"></COL>
<COL WIDTH="170"></COL>
<COL WIDTH="169"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="244" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="179" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당기말</TH>
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30"> 확정급여채무의 현재가치</TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">11,140,875</TD>
<TD WIDTH="178" ALIGN="RIGHT" HEIGHT="30">12,233,851</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30"> 사외적립자산의 공정가치</TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">(7,866,039)</TD>
<TD WIDTH="178" ALIGN="RIGHT" HEIGHT="30">(7,831,462)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30"> 확정급여제도의 부채 인식액</TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">3,274,836</TD>
<TD WIDTH="178" ALIGN="RIGHT" HEIGHT="30">4,402,389</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">나. 연결회사의 확정급여채무의 현재가치 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="601" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="249"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="162"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="258" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="172" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당 기</TH>
<TH WIDTH="171" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30"> 기초금액</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">12,233,851</TD>
<TD WIDTH="171" ALIGN="RIGHT" HEIGHT="30">12,025,454</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30">    퇴직급여 지급액</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">(1,813,298)</TD>
<TD WIDTH="171" ALIGN="RIGHT" HEIGHT="30">(1,504,957)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30">    당기근무원가와 이자</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">1,697,597</TD>
<TD WIDTH="171" ALIGN="RIGHT" HEIGHT="30">1,749,096</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30">    확정급여제도의 재측정요소(주1)</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">(1,189,113)</TD>
<TD WIDTH="171" ALIGN="RIGHT" HEIGHT="30">(256,099)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30">    기타(주2)</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">211,838</TD>
<TD WIDTH="171" ALIGN="RIGHT" HEIGHT="30">220,356</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="258" HEIGHT="30"> 기말금액</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">11,140,875</TD>
<TD WIDTH="171" ALIGN="RIGHT" HEIGHT="30">12,233,850</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL10">(주1) 상기 확정급여제도의 재측정요소는 법인세차감전금액입니다.(주2) 당기 중 경상연구개발비로 인식되었습니다. </P>
<P USERMARK="F-GL11">다. 사외적립자산은 다음 항목으로 구성됩니다. </P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="599" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="190"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당기말</TH>
<TH WIDTH="199" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 현금및현금성자산</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">7,864,340</TD>
<TD WIDTH="199" ALIGN="RIGHT" HEIGHT="30">7,829,763</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 국민연금전환금</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">1,700</TD>
<TD WIDTH="199" ALIGN="RIGHT" HEIGHT="30">1,700</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">7,866,040</TD>
<TD WIDTH="199" ALIGN="RIGHT" HEIGHT="30">7,831,463</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11">라. 사외적립자산 현재가치의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="248"></COL>
<COL WIDTH="163"></COL>
<COL WIDTH="162"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="257" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="172" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당 기</TH>
<TH WIDTH="171" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="257" HEIGHT="30"> 기초금액</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">7,831,462</TD>
<TD WIDTH="171" ALIGN="RIGHT" HEIGHT="30">9,370,202</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="257" HEIGHT="30">   사외적립자산 납입액</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">1,083,714</TD>
<TD WIDTH="171" ALIGN="RIGHT" HEIGHT="30">35,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="257" HEIGHT="30">   퇴직급여 지급액</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">(1,208,096)</TD>
<TD WIDTH="171" ALIGN="RIGHT" HEIGHT="30">(1,733,441)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="257" HEIGHT="30">   사외적립자산 기대수익</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">226,279</TD>
<TD WIDTH="171" ALIGN="RIGHT" HEIGHT="30">241,030</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="257" HEIGHT="30">   확정급여제도의 재측정요소(주1)</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">(67,320)</TD>
<TD WIDTH="171" ALIGN="RIGHT" HEIGHT="30">(81,328)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="257" HEIGHT="30"> 기말금액</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">7,866,039</TD>
<TD WIDTH="171" ALIGN="RIGHT" HEIGHT="30">7,831,463</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL10">(주1) 상기 확정급여제도의 재측정요소는 법인세차감전금액입니다.</P>
<P USERMARK="F-GL11">마. 당기손익으로 인식된 비용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="603" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="235"></COL>
<COL WIDTH="171"></COL>
<COL WIDTH="170"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="244" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="180" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당 기</TH>
<TH WIDTH="179" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30"> 당기근무원가와 이자 및 기타</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">1,486,656</TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">1,969,452</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30"> 사외적립자산 기대수익</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">(226,279)</TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">(241,030)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">1,260,377</TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">1,728,422</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11">바. 보고기간종료일 현재 주요 보험수리적가정은 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="598" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="265"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="153"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="274" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="162" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당기말</TH>
<TH WIDTH="162" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30"> 기대임금상승률</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">승급률</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">승급률</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30"> 할인률</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">5.603%</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3.140%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30"> 사외적립자산 기대수익률</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">5.603%</TD>
<TD WIDTH="162" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3.140%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">연결회사는 확정급여채무의 현재가치계산을 위하여 보고기간말 현재 확정급여채무의 통화 및 예상지급시기와 일관성이 있는 우량회사채(AA0 등급)의 시장수익률을 참조하여 할인률을 결정하였습니다.사. 당기말 현재 주요 가정의 변동에 따른 확정급여채무의 민감도 분석은 다음과 같습니다</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="598">

<COLGROUP>
<COL WIDTH="265"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="153"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="274" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="162" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1% 감소</TH>
<TH WIDTH="162" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1% 증가</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30"> 기대임금상승률</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,705,388</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,727,608</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30"> 할인률</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,720,991</TD>
<TD WIDTH="162" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,719,574</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11 B">21. 이연수익</P>

<P>
<SPAN USERMARK="F-GL11">보고기간종료일 현재 이연수익의 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="602">

<COLGROUP>
<COL WIDTH="239"></COL>
<COL WIDTH="168"></COL>
<COL WIDTH="168"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="248" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="177" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="177" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="248" HEIGHT="30"> 정부보조금관련 이연수익(주1)</TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT">50,191</TD>
<TD WIDTH="177" HEIGHT="30" ALIGN="RIGHT">69,052</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 복지부 1건, 정부산업통신진흥원과제 1건과 관련하여 정부보조금 수령하고 있으며, 관련 경상연구개발비에 대응하여 상계하고 있습니다.</SPAN>
</P>
<P USERMARK="F-GL11 B">22. 매입채무 및 기타유동채무</P>

<P>
<SPAN USERMARK="F-GL11">보고기간종료일 현재 매입채무 및 기타유동채무의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="623" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="614"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="623" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="209" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">　구 분</TH>
<TH WIDTH="208" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="208" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE"> 매입채무</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">12,924,654</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">8,026,010</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE"> 미지급금</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">2,337,335</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">2,111,416</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE"> 미지급비용</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">2,958,297</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">1,503,758</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE"> 예수금</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">373,483</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">367,153</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE"> 부가세예수금</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">229,955</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">998,732</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE"> 선수금</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">265,566</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">285,495</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE"> 유동리스부채</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">201,758</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">238,020</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="209" HEIGHT="30">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">19,291,048</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">13,530,584</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11 B">23. 우발부채와 약정사항</P>

<P>
<SPAN USERMARK="F-GL11">가. 연결회사의 주요 약정사항(1) 당기말 현재 연결회사가 금융기관과 체결한 주요 약정사항은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="614">

<COLGROUP>
<COL WIDTH="605"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="614" HEIGHT="30" ALIGN="RIGHT">(원화단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="614">

<COLGROUP>
<COL WIDTH="185"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="194" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">약정사항</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">한 도</TH>
<TH WIDTH="210" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">약정금융기관</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="194" HEIGHT="30"> 당좌차월 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="210" HEIGHT="30">1,200,000</TD>
<TD ROWSPAN="5" WIDTH="210" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">기업은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30"> L/C 개설약정 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="210" HEIGHT="30">USD 100,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30"> 시설자금대출</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="210" HEIGHT="30">55,400,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" VALIGN="MIDDLE" HEIGHT="30"> 회전자금대출한도약정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="210" HEIGHT="30">22,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="194" VALIGN="MIDDLE" HEIGHT="120"> 일반자금대출 </TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="210" HEIGHT="30">11,810,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="210" HEIGHT="30">5,000,000</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="210" HEIGHT="30">신한은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="210" HEIGHT="30">7,500,000</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="210" HEIGHT="30">우리은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="210" HEIGHT="30">4,000,000</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="210" HEIGHT="30">하나은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="194" HEIGHT="60" ROWSPAN="2">합 계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="210" HEIGHT="30">USD 100,000</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="210" HEIGHT="60" ROWSPAN="2"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="210" HEIGHT="30">107,410,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(2) 연결회사는 2018년 6월 10일 중국 Sinopharm Zhijun사와 Distribution Agreement를 체결하였습니다. 동 계약에 의해 Sinopharm Zhijun사는 연결회사의 독일지사인 에스앤브이 테크놀로지스(S&V Technologies)사에서 생산하는 Amalian SF 필러를 독점적으로 매입하여 홍콩, 마카오, 대만, 중국 본토지역에서 판매할 예정입니다. 계약기간은 수입허가 취득 후 10년간입니다(3) 연결회사는 2017년 9월 6일 중국 Haihe Biopharma(RMX)사와 연결회사의 리포락셀의 중국, 태국, 대만, 홍콩 지역에서의 양도 및 재이전이 가능한 독점적 기술이전 계약(LicenseAgreement)을 체결하였습니다. (4) 당기말 현재 연결회사는 서울보증보험으로부터 ㈜케이지이니시스의 INIPAY서비스 이용계약, ㈜참빛도시가스의 도시가스공급계약 및 정부과제 관련하여 1,235,689천원을 제공받고 있으며, 정부보조금 관련 기업은행으로부터 5,390,000천원의 지급보증을 제공받고 있습니다.나. 타인으로부터 제공받고 있는 담보는 없습니다.</SPAN>
</P>
<P USERMARK="F-GL11">다. 타인을 위하여 제공한 지급보증의 내역보고기간종료일 현재 지배기업이 종속회사를 위하여 제공하고 있는 지급보증 및 담보제공의 내용은 다음과 같습니다.(1) 지급보증</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="615"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="621" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="163"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="121"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융기관</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용</TH>
<TH WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" VALIGN="MIDDLE" HEIGHT="30"> 디에이치호림㈜</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기업은행</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">구매자금</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,600,000</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" VALIGN="MIDDLE" HEIGHT="30"> ㈜스페셜라이즈드메드</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기업은행</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차입금</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">240,000</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">240,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" VALIGN="MIDDLE" HEIGHT="30"> ㈜리독스바이오</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기업은행</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차입금</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,200,000</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="360" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,040,000</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,240,000</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11">(2) 담보제공 </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="615"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="163"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="121"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="172" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="93" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융기관/업체</TH>
<TH WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용</TH>
<TH WIDTH="131" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="130" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30" VALIGN="MIDDLE"> 디에이치호림㈜</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">담보제공</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,800,000</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,400,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="360" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,800,000</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,400,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">한편, 디에이치호림㈜와 판매계약을 맺고 있는 백제약품에 대화제약은 자사주 230,000주(종가 9,400원, 약 2,162,000천원)에 대하여 담보를 제공하고 있습니다.</SPAN>
</P>
<P USERMARK="F-11"></P>

<P>
<SPAN USERMARK="F-GL11">라. 당기말 현재 계류중인 소송사건은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="225"></COL>
<COL WIDTH="378"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="234" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>

<TH WIDTH="387" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>내 용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>소제기일자</P>
</TD>

<TD WIDTH="387" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2021. 11. 04.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>소송 당사자</P>
</TD>

<TD WIDTH="387" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>원고: 대화제약 주식회사 외 35개사</P>
<P>피고: 국민건강보험공단</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">사건명</TD>
<TD WIDTH="387" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">채무부존재확인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>소송 가액(주1)</P>
</TD>

<TD WIDTH="387" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">
<P>23,020,760원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>진행 상황</P>
</TD>
<TD WIDTH="387" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1심 원고 패소후 2심 변론기일 진행중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>향후 소송일정 및 대응방안</P>
</TD>

<TD WIDTH="387" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>회사 외 35개사와 공동으로 소송을 진행</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">상기 소송사건에 대해서는 소송의 결과를 합리적으로 예측할 수 없습니다</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 B">24. 매출액과 매출원가</SPAN>
<SPAN USERMARK="F-GL11">당기 및 전기 중 매출액과 매출원가의 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="747" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="738"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="747" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="747">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="375" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" COLSPAN="3">매출액</TH>
<TH WIDTH="372" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" COLSPAN="3">매출원가</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="125" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="125" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당 기</TH>
<TH WIDTH="125" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전 기</TH>
<TH WIDTH="124" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="124" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당 기</TH>
<TH WIDTH="124" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE"> 상품매출</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">30,162,354</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">27,014,545</TD>
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE"> 상품매출원가</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">22,454,232</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">20,867,649</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE"> 제품매출</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">98,683,319</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">89,998,786</TD>
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE"> 제품매출원가</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">63,358,350</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">52,618,578</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE"> 서비스매출</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">100,155</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">139,873</TD>
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE"> 서비스매출원가</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE"> 기타수익</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">2,960,193</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">467</TD>
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE"> 수수료수익</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">5,672</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">5,159</TD>
<TD WIDTH="124" HEIGHT="30" VALIGN="MIDDLE"></TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">131,911,693</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">117,158,831</TD>
<TD WIDTH="124" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">85,812,582</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">73,486,227</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">25. 판매비와관리비</SPAN>
<SPAN USERMARK="F-GL11">당기 및 전기 중 판매비와관리비의 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="200" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="200" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당 기</TH>
<TH WIDTH="200" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 급여</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">13,045,824</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">12,942,449</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 퇴직급여</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">942,215</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">1,007,412</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 복리후생비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">1,786,025</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">1,829,522</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 보험료</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">62,738</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">69,258</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 감가상각비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">249,678</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">335,528</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 무형자산상각비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">1,049,530</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">1,016,694</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 사용권자산상각비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">253,260</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">310,519</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 대손상각비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">(9,846)</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">11,019</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 지급수수료</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">1,678,137</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">1,160,299</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 광고선전비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">1,403,764</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">1,813,236</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 교육훈련비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">100,417</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">46,215</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 차량유지비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">29,705</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">23,436</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 도서인쇄비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">16,447</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">21,215</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 접대비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">2,000,503</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">1,895,085</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 임차료</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">511,896</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">410,048</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 통신비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">101,468</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">99,219</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 운반비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">560,308</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">515,366</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 세금과공과</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">352,586</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">308,246</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 소모품비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">252,359</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">141,784</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 수도광열비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">265,713</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">251,686</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 수선비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">455,683</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">397,198</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 경상개발비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">5,374,048</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">6,640,925</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 여비교통비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">2,802,673</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">2,852,586</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 견본비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">212,709</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">597,434</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 포장비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">109,854</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">90,792</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 판매수수료</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">4,082,037</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">3,067,836</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 판매촉진비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">1,631,602</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">1,643,253</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 해외시장개척비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">220,846</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">141,175</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 회의비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">705,061</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">746,346</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 잡비</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">3,777</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">2,840</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">40,251,017</TD>
<TD WIDTH="200" ALIGN="RIGHT" HEIGHT="30">40,388,621</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11 B">26. 비용의 성격별 분류 </SPAN>
<SPAN USERMARK="F-GL11">당기 및 전기 중 연결회사의 비용의 성격별 분류내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="602">

<COLGROUP>
<COL WIDTH="228"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="173"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="237" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="183" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당 기</TH>
<TH WIDTH="182" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30"> 재고자산의 변동</TD>
<TD WIDTH="183" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">30,560,933</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">29,578,723</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30"> 상품원가</TD>
<TD WIDTH="183" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">22,454,232</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">20,867,649</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30"> 급여</TD>
<TD WIDTH="183" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">20,379,120</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">19,046,399</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30"> 퇴직급여</TD>
<TD WIDTH="183" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,486,656</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,509,416</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30"> 복리후생비</TD>
<TD WIDTH="183" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3,034,926</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">2,908,751</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30"> 임차료</TD>
<TD WIDTH="183" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">637,093</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">521,622</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30"> 지급수수료</TD>
<TD WIDTH="183" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3,540,830</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3,343,719</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30"> 감가상각비와 무형자산상각비</TD>
<TD WIDTH="183" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">4,140,138</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">4,359,922</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30"> 사용권자산상각비</TD>
<TD WIDTH="183" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">253,260</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">310,519</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" HEIGHT="30"> 기타비용</TD>
<TD WIDTH="183" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">39,576,412</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">31,428,128</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="237" ALIGN="CENTER" HEIGHT="30">합 계(주1)</TD>
<TD WIDTH="183" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">126,063,600</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">113,874,848</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 연결포괄손익계산서의 매출원가와 판매비와관리비를 합한 금액입니다.</SPAN>
</P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">27. 기타수익과 기타비용</SPAN>
<SPAN USERMARK="F-GL11">가</SPAN>
<SPAN USERMARK="F-GL11 B">. </SPAN>
<SPAN USERMARK="F-GL11">당기 및 전기 중 기타수익의 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="231"></COL>
<COL WIDTH="171"></COL>
<COL WIDTH="171"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="240" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="180" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당 기</TH>
<TH WIDTH="180" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30"> 외화환산이익</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">13,766</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">31,824</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30"> 외환차익</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">229,433</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">98,259</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30"> 임대료수익</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">485,827</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">421,057</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30"> 수수료수익</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">55,264</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">35,580</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30"> 리스자산해지이익</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">1,348</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30"> 잡이익</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">1,505,985</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">427,646</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30"> 정부보조금으로인한이익</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">473,998</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">1,137,079</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30"> 대손충당금환입</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">(1,566)</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">2,764,055</TD>
<TD WIDTH="180" ALIGN="RIGHT" HEIGHT="30">2,151,445</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">나. 당기 및 전기 중 기타비용의 구성내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="597">

<COLGROUP>
<COL WIDTH="232"></COL>
<COL WIDTH="169"></COL>
<COL WIDTH="169"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="241" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="178" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="178" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30"> 유형자산처분손실</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">1,213</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">1,067</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30"> 기부금</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">47,622</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">69,311</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30"> 외화환산손실</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">38,758</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">906</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30"> 외환차손</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">219,792</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">24,843</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30"> 기타감가상각비</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">147,862</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">147,862</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30"> 재고자산폐기손실</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">16,195</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30"> 리스자산해지손실</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">2,628</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30"> 영업권손상차손</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">1,430,827</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30"> 유형자산손상차손</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">2,873,000</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">1,182,173</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30"> 기타</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">57,956</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">94,365</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">3,402,398</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">2,953,982</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P USERMARK="F-GL11">
<SPAN USERMARK=" B">28. 금융수익과 금융원가</SPAN>가. 당기 및 전기 중 금융수익의 상세내역은 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="598">

<COLGROUP>
<COL WIDTH="306"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="315" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="142" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당 기</TH>
<TH WIDTH="141" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30"> 이자수익</TD>
<TD WIDTH="142" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">314,229</TD>
<TD WIDTH="141" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">405,180</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30"> 배당금수익</TD>
<TD WIDTH="142" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">33,964</TD>
<TD WIDTH="141" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">22,058</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30"> 당기손익-공정가치측정금융자산평가이익</TD>
<TD WIDTH="142" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,962</TD>
<TD WIDTH="141" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30"> 당기손익-공정가치측정금융자산처분이익</TD>
<TD WIDTH="142" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">182,689</TD>
<TD WIDTH="141" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,053,634</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30"> 사채상환이익</TD>
<TD WIDTH="142" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">45</TD>
<TD WIDTH="141" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">673,207</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30"> 파생상품평가이익</TD>
<TD WIDTH="142" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD WIDTH="141" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">2,312,014</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="315" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="142" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">532,889</TD>
<TD WIDTH="141" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">4,466,093</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">나. 당기 및 전기 중 금융원가의 상세내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="596">

<COLGROUP>
<COL WIDTH="309"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="318" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="139" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="139" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="318" HEIGHT="30"> 이자비용</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,365,000</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,519,030</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="318" HEIGHT="30"> 당기손익-공정가치측정금융자산처분손실</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">406,353</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">175,503</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="318" HEIGHT="30"> 당기손익-공정가치측정금융자산평가손실</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">545,196</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">515,659</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="318" HEIGHT="30"> 파생상품평가손실</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="318" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,316,549</TD>
<TD WIDTH="139" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,210,192</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11 B">29. 법인세비용</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">가. 당기 및 전기 중 법인세비용의 구성요소는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="599" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="276"></COL>
<COL WIDTH="148"></COL>
<COL WIDTH="148"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="285" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="157" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당 기</TH>
<TH WIDTH="157" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30"> 당기 법인세 등 부담액</TD>
<TD WIDTH="157" ALIGN="RIGHT" HEIGHT="30">1,324,677</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">2,040,538</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30"> 일시적차이로 인한 이연법인세 변동액</TD>
<TD WIDTH="157" ALIGN="RIGHT" HEIGHT="30">529,137</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">(437,305)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30"> 자본에 직접 반영된 법인세비용</TD>
<TD WIDTH="157" ALIGN="RIGHT" HEIGHT="30">(212,031)</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">663,147</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30"> 법인세추납(환급)</TD>
<TD WIDTH="157" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">11,456</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30"> 미환류소득</TD>
<TD WIDTH="157" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">59,364</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30"> 기타</TD>
<TD WIDTH="157" ALIGN="RIGHT" HEIGHT="30">(436,851)</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">224,895</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="285" HEIGHT="30"> 법인세비용</TD>
<TD WIDTH="157" ALIGN="RIGHT" HEIGHT="30">1,204,932</TD>
<TD WIDTH="157" HEIGHT="30" ALIGN="RIGHT">2,562,095</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11 0X120FC8">
<SPAN USERMARK=" 0X000000">나. 법인세비용은 전체 회계연도에 대해서 예상되는 최선의 가중평균 연간법인세율의 추정에 기초하여 인식하였습니다.</SPAN>
</P>
<P USERMARK="F-GL11">다. 당기 및 전기 중 법인세비용과 회계이익의 관계는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="623" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="614"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="623" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="621" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="242"></COL>
<COL WIDTH="176"></COL>
<COL WIDTH="176"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="251" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분 </TH>
<TH WIDTH="185" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="185" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30"> 세전이익</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">2,426,090</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">4,524,535</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30"> 적용세율에 따른 법인세</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">511,740</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">973,398</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30"> 조정사항</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">693,192</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">1,588,698</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30">   비과세수익</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">(187,484)</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">(7,397)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30">   비공제비용</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">1,171,425</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">1,124,177</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30">   세율적용차이</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">178,177</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">75,734</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30">   세액공제</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">(507,876)</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">(512,037)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30">   미환류소득 </TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">59,364</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30">   미인식이연법인세 조정</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">188,100</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30">   기타</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">(149,150)</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">848,852</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30"> 법인세비용</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,204,932</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">2,562,096</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30"> 유효세율</TD>
<TD WIDTH="185" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD WIDTH="185" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">라. 당기 및 전기 중 이연법인세자산(부채)와 일시적차이 등의 발생과 소멸로 인한 이연법인세비용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="615"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="617">

<COLGROUP>
<COL WIDTH="241"></COL>
<COL WIDTH="175"></COL>
<COL WIDTH="174"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="250" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구 분 </TH>
<TH WIDTH="184" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당 기</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="30"> 기말 이연법인세자산(부채) </TD>
<TD WIDTH="184" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,642,477</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="183" HEIGHT="30">    4,171,614</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="30"> 기초 이연법인세자산(부채) </TD>
<TD WIDTH="184" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,171,614</TD>
<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,734,309</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="53"> 일시적차이 등의 발생과 소멸로 인한 이연법인세비용 </TD>
<TD WIDTH="184" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">529,137</TD>
<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">      (437,305)</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11 0X120FC8">
<SPAN USERMARK=" 0X000000">마. 당기 및 전기 중 이연법인세자산(부채)의 원천과 변동내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="810">

<COLGROUP>
<COL WIDTH="396"></COL>
<COL WIDTH="396"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD WIDTH="405" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="815">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="403" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차감할(가산할) 일시적차이</TH>
<TH WIDTH="101" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이연법인세 미인식</TH>
<TH WIDTH="101" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이연법인세자산(부채)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초 </TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가 </TH>
<TH WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소 </TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="815" HEIGHT="30" COLSPAN="7">Ⅰ. 일시적차이 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 미수수익 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(662,862)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(369,925)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(662,862)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(369,925)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(77,314)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 퇴직급여충당금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,833,807</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">748,733</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,679,481</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,903,059</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">102,939</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,175,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 단체퇴직보험</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(7,807,459)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,157,742)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,188,273)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(7,776,928)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,625,378)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 대손충당금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,611,520</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,424,086</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,005,910</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,029,695</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">481,236</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,196,971</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 대손상각비</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,400,652</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,400,652</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">728,433</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">818,303</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 재고자산평가손실</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">250,877</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">664,309</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">396,690</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">518,496</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">108,366</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 국고보조금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">277,022</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">213,015</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">269,012</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">221,026</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,194</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 반품충당금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">985,797</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">812,399</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">985,797</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">812,399</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">169,791</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 종속기업투자주식손상차손</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,095,310</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">900,000</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,995,310</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,253,020</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 관계회사대여금(손상차손)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">387,000</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">387,000</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">80,883</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 감가상각누계액</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(290,077)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">38,066</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(153,180)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(98,831)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(20,656)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 전기공급시설이용권</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(32,244)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(32,244)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(6,739)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 상표권</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,817</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">204</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,021</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,348</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 미지급비용(장기근속)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">328,937</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">315,445</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,492</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,820</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 정부보조금으로인한이익</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">69,052</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,191</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">69,052</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,191</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,490</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 미지급비용</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">705,147</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">748,124</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">705,147</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">748,124</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">156,358</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 마일리지충당금 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,118</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,418</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,118</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,418</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,132</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 유형자산처분이익</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,337,328)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,337,328)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(279,502)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="53"> 기타포괄손익-공정가치측정 금융자산평가손익</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">160,618</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">160,618</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">33,569</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 기타단기충당부채</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">440,629</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">410,197</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">440,629</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">410,197</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">85,731</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 사용권자산</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">497,643</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">478,613</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">497,643</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">478,613</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100,030</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 금융리스부채</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">507,264</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">453,684</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">507,264</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">453,684</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,819</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 상환할증금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">44,000</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">44,000</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 전환권대가</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="53"> 당기손익-공정가치측정금융  자산평가손익</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">515,659</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">547,158</TD>
<TD WIDTH="100" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">451,891</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">610,925</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">127,683</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 단기대여금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,346</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,346</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">209,072</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 기타</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,084,810</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">701,967</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,084,810</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,153,858</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">241,159</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"> 합 계 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">29,758,163</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,997,434</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,453,619</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">29,753,868</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,576,081</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,642,477</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-11 0X120FC8"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="810">

<COLGROUP>
<COL WIDTH="396"></COL>
<COL WIDTH="396"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="405" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD WIDTH="405" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="815">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="403" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차감할(가산할) 일시적차이</TH>
<TH WIDTH="101" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이연법인세 미인식</TH>
<TH WIDTH="101" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이연법인세자산(부채)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초 </TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가 </TH>
<TH WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소 </TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="815" HEIGHT="30" COLSPAN="7">Ⅰ. 일시적차이 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 미수수익 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(574,413)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(662,862)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(574,413)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(662,862)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(145,830)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 퇴직급여충당금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,557,295</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,659,962</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,383,450</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,833,807</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">102,939</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,500,498</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 단체퇴직보험</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(9,370,202)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(159,059)</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,721,802)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(7,807,459)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,717,641)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 대손충당금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,193,344</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,424,086</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,005,910</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,611,520</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">481,236</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">753,299</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 대손상각비</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,400,652</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,400,652</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">728,433</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">899,710</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 재고자산평가손실</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">266,443</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">250,877</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">266,443</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">250,877</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">55,193</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 국고보조금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">310,011</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">282,394</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">315,383</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">277,022</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">60,945</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 반품충당금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,092,727</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">985,797</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,092,727</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">985,797</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">216,875</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 종속기업투자주식손상차손</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,624,310</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,471,000</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,095,310</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,120,968</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 관계회사대여금(손상차손)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">387,000</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">387,000</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">85,140</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 감가상각누계액</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(801,920)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">27,561</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(484,283)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(290,077)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(63,817)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 전기공급시설이용권</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(32,244)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(32,244)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(7,094)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 상표권</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,270</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">453</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,817</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,480</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 미지급비용(장기근속)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">315,445</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">315,445</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">69,398</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 정부보조금으로인한이익</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">67,216</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">69,052</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">67,216</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">69,052</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,191</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 미지급비용</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">862,217</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">705,147</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">862,217</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">705,147</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">155,132</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 마일리지충당금 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,219</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,118</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,219</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,118</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,126</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="53"> 유형자산처분이익</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(1,337,328)</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(1,337,328)</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(294,212)</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="53"> 기타포괄손익-공정가치측정 금융자산평가손익</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">160,618</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">160,618</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">35,336</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 기타단기충당부채</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">402,775</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">440,629</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">402,775</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">440,629</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">96,938</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 사용권자산</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(552,642)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">497,643</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(552,642)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">497,643</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">109,482</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 금융리스부채</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">560,867</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">507,264</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">560,867</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">507,264</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">111,598</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 상환할증금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">490,000</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">44,000</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">490,000</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">44,000</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,680</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 전환권대가</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,231,018</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,231,018</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="53"> 당기손익-공정가치측정금융  자산평가손익</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(532,295)</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">515,659</TD>
<TD WIDTH="100" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(532,295)</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">515,659</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">113,445</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 단기대여금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,346</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,346</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">220,076</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30"> 기타</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,937,054</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,084,810</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,937,054</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,084,810</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">898,658</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> 합 계 </TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23,977,338</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,851,568</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,755,297</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,073,608</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,444,580</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,171,612</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">바. 당기 및 전기 중 당기손익 이외로 인식되는 항목과 관련된 법인세비용과 이연법인세는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="604">

<COLGROUP>
<COL WIDTH="595"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="604" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="604" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="320"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="329" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="138" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당 기</TH>
<TH WIDTH="137" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="329" HEIGHT="30" VALIGN="MIDDLE"> 보험수리적손익</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">(247,043)</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">(38,498)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="329" HEIGHT="30" VALIGN="MIDDLE"> 기타포괄손익-공정가치측정금융자산평가손익</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">35,012</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">701,645</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="329" HEIGHT="30" VALIGN="MIDDLE"> 자본에 직접 반영된 법인세비용(수익)</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">(212,031)</TD>
<TD WIDTH="137" ALIGN="RIGHT" HEIGHT="30">663,147</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<P USERMARK="F-GL11">
<SPAN USERMARK=" B">30. 주당손익</SPAN>가. 주당순이익은 연결회사의 지배기업 소유주지분 보통주 1주에 대한 순이익을 계산한 것으로, 회사의 1주당  순이익의 산출내역은 다음과 같습니다.
</P>
<P USERMARK="F-GL11">(1) 기본주당순이익</P>

<TABLE ACLASS="NORMAL" WIDTH="610" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="601"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="610" HEIGHT="30">(단위: 주, 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="611" BORDER="1">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="178"></COL>
<COL WIDTH="177"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="238" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH ALIGN="CENTER" WIDTH="187" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH ALIGN="CENTER" WIDTH="186" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30"> 지배주주지분 당기순이익(손실)</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">1,115,657,705</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">2,217,397,654</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30"> 가중평균유통보통주식수</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">17,516,650</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">17,515,096</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="238" HEIGHT="30"> 기본주당순이익(손실)</TD>
<TD WIDTH="187" HEIGHT="30" ALIGN="RIGHT">64</TD>
<TD WIDTH="186" HEIGHT="30" ALIGN="RIGHT">127</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 당기 중 가중평균유통보통주식수의 계산내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="695">

<COLGROUP>
<COL WIDTH="106"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="125"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="115" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">발행주식수</TH>
<TH WIDTH="112" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자기주식</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유통보통주식수</TH>
<TH WIDTH="83" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가중치</TH>
<TH WIDTH="134" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">적 수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> 기초주식수 </TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">18,616,650</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">(1,100,000)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">17,516,650</TD>
<TD WIDTH="83" HEIGHT="30" ALIGN="RIGHT">365</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT">6,393,577,250</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="478" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="83" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">365일</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT">6,393,577,250</TD>
</TR>
</TBODY>
</TABLE>
<P>유통보통주식수 : 6,393,577,250주 /  365일 = 17,516,650</P>
<P></P>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">31. 특수관계자</SPAN>
<SPAN USERMARK="F-GL11">연결회사 내 기업간 거래 및 관련 채권ㆍ채무는 연결시 제거되었으며, 당기 및 전기 중 연결실체와 기타 특수관계자와의 주요 거래내역 및 보고기간종료일 현재 주요 채권ㆍ채무 내역은 다음과 같습니다. </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">가. 당기말 현재 회사의 특수관계자 현황은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="585">

<COLGROUP>
<COL WIDTH="284"></COL>
<COL WIDTH="283"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="293" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="292" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자의 명칭</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">관계기업</TD>
<TD WIDTH="292" HEIGHT="30" VALIGN="MIDDLE"> JHK BioPharma Co., Ltd</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11">나. 당기 및 전기 중 특수관계자와의 중요한 영업상의 거래내용은 없습니다. </P>
<P USERMARK="F-GL11"> 다. 보고기간종료일 현재 동 특수관계자에 대한 채권ㆍ채무의 내역은 없습니다. </P>

<P>
<SPAN USERMARK="F-GL11">라. 당기 중 특수관계자와의 주요 자금거래 내역은 없습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">마. 주요 경영진과의 거래  당기 및 전기 중 연결회사의 주요 경영진에 대한 보상내역은 다음과 같습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="608" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="599"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="608" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="610" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="195"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="194"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="204" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="203" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당 기</TH>
<TH WIDTH="203" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 단기급여</TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">2,435,748</TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">2,697,833</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30"> 퇴직급여</TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">171,682</TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">246,315</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">2,607,430</TD>
<TD WIDTH="203" ALIGN="RIGHT" HEIGHT="30">2,944,148</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11 B">32. 영업부문</P>
<P USERMARK="F-GL11">가. 연결회사의 영업부문은 수익을 창출하고 비용을 발생시키는 사업활동을 영위하는 식별 가능한 구성단위로서 법적실체에 기반하여 영업부문을 구분하고 있습니다. 이에 따라 영업부문은 의약품 제조부문, 의약품 도매부문, 의료정보 시스템부문으로 구분하고 있습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="795">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="57"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="306"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="128" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">사업부문</TH>
<TH WIDTH="66" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유형</TH>
<TH WIDTH="137" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">품   목</TH>
<TH WIDTH="315" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">구체적 용도</TH>
<TH WIDTH="149" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주요상표 등</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="9" WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="270">의약품 제조부문</TD>
<TD ROWSPAN="5" WIDTH="66" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="150">제품</TD>
<TD WIDTH="137" HEIGHT="30">진경제</TD>
<TD WIDTH="315" HEIGHT="30">소화관 및 담도계의 기능장애에 의한 통증 외</TD>
<TD WIDTH="149" HEIGHT="30">후로스판 정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" HEIGHT="30">항균 항생제</TD>
<TD WIDTH="315" HEIGHT="30">중이염 폐렴인후두염 외</TD>
<TD WIDTH="149" HEIGHT="30">세파클러 캡슐</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" HEIGHT="30">항균 항생제</TD>
<TD WIDTH="315" HEIGHT="30">세균성폐렴, 중이염, 유양돌기염 외</TD>
<TD WIDTH="149" HEIGHT="30">세파메칠 정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" HEIGHT="30">OEM매출</TD>
<TD WIDTH="315" HEIGHT="30">파스류, 임신진단키트, 건강기능식품</TD>
<TD WIDTH="149" HEIGHT="30">케노펜플라스타 외</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="452" ALIGN="CENTER" HEIGHT="30">기              타</TD>
<TD WIDTH="149" HEIGHT="30">록사트론정 외</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="66" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="120">상품</TD>
<TD WIDTH="137" HEIGHT="30">순환기질환치료제</TD>
<TD WIDTH="315" HEIGHT="30">고혈압의 치료</TD>
<TD WIDTH="149" HEIGHT="30">로자틴 정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" HEIGHT="30">감염질환치료제</TD>
<TD WIDTH="315" HEIGHT="30">급성또는 재발성 질칸디다증 외</TD>
<TD WIDTH="149" HEIGHT="30">씨플루코 캡슐</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" HEIGHT="30">소화기질환치료제</TD>
<TD WIDTH="315" HEIGHT="30">위,십이지장 소화성불량 외</TD>
<TD WIDTH="149" HEIGHT="30">로자틴플러스 정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="452" ALIGN="CENTER" HEIGHT="30">기            타</TD>
<TD WIDTH="149" HEIGHT="30">브로메틴 외</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">의약품 도매부문</TD>
<TD WIDTH="66" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">상품</TD>
<TD COLSPAN="2" WIDTH="452" HEIGHT="30">의약품 도매업</TD>
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">의료정보시스템</TD>
<TD WIDTH="66" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">컨텐츠</TD>
<TD COLSPAN="2" WIDTH="452" HEIGHT="30">메디프레임 서비스, 컨텐츠 제작</TD>
<TD WIDTH="149" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" ALIGN="CENTER" HEIGHT="76" VALIGN="MIDDLE"> 의약품제조업 및 조직공학제품 </TD>
<TD WIDTH="66" ALIGN="CENTER" HEIGHT="76" VALIGN="MIDDLE">합성원료,상품 </TD>
<TD WIDTH="137" HEIGHT="76" VALIGN="MIDDLE">수술보조제 치료제</TD>
<TD WIDTH="315" HEIGHT="76" VALIGN="MIDDLE">성형재료  </TD>
<TD WIDTH="149" HEIGHT="76" VALIGN="MIDDLE">히알루론산, Filler </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">나. 연결회사는 자원의 배분을 위한 의사결정과 성과평가 목적으로 영업부문별 성과를 모니터하고 있으며, 영업손익에 기초하여 평가됩니다. 당기와 전기 중 영업부문별성과는 다음과 같습니다.(1) 수익 및 부문 당기손익</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="833" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="824"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="833" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="925">

<COLGROUP>
<COL WIDTH="204"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="213" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="77" USERMARK="F-10">구 분</TH>
<TH COLSPAN="4" WIDTH="356" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">당 기</TH>
<TH COLSPAN="4" WIDTH="356" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" USERMARK="F-10">전 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="89" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">총부문수익</TH>
<TH WIDTH="89" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">부문간수익(차감)</TH>
<TH WIDTH="89" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">외부고객으로부터의 수익</TH>
<TH WIDTH="89" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">영업이익</TH>
<TH WIDTH="89" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">총부문수익</TH>
<TH WIDTH="89" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">부문간수익(차감)</TH>
<TH WIDTH="89" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">외부고객으로부터의 수익</TH>
<TH WIDTH="89" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">영업이익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="28" USERMARK="F-10"> 의약품 제조업</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">99,192,379</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">(400,884)</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">99,593,263</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">3,897,189</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">88,704,839</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">(345,880)</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">89,050,719</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">2,491,089</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="28" USERMARK="F-10"> 의약품 도매업</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">23,626,128</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">401,542</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">23,224,586</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">222,054</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">20,918,620</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">346,106</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">20,572,514</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">74,216</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="28" USERMARK="F-10"> 의료정보시스템</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">352,034</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">250,330</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">101,705</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">(89,535)</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">386,757</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">243,374</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">143,383</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">24,445</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="28" USERMARK="F-10"> 의약품 원료 제조업</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">13,804,954</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">9,847,189</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">3,957,765</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">305,671</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">10,073,191</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">7,246,991</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">2,826,199</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">(209,106)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="28" USERMARK="F-10"> 화장품 및 의료기기 제조</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">8,991,709</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">3,957,335</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">5,034,374</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">1,327,519</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">7,048,870</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">2,482,853</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">4,566,017</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">591,594</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">조 정</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">185,196</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">311,744</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="213" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">145,967,204</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">14,055,512</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">131,911,693</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">5,848,094</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">127,132,277</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">9,973,444</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">117,158,832</TD>
<TD ALIGN="RIGHT" WIDTH="89" HEIGHT="28" USERMARK="F-10">3,283,982</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11">(2) 기타공시정보</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="1019" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1010"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="1019" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1025">

<COLGROUP>
<COL WIDTH="145"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="78"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="154" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="77" ROWSPAN="2" USERMARK="F-10">구 분</TH>
<TH WIDTH="433" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" COLSPAN="5" USERMARK="F-10">당 기</TH>
<TH WIDTH="438" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="28" COLSPAN="5" USERMARK="F-10">전 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="87" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">자산총액</TH>
<TH WIDTH="87" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">부채총액</TH>
<TH WIDTH="87" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">감가상각비</TH>
<TH WIDTH="86" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">법인세비용</TH>
<TH WIDTH="86" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">지분법이익(손실)</TH>
<TH WIDTH="88" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">자산총액</TH>
<TH WIDTH="88" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">부채총액</TH>
<TH WIDTH="88" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">감가상각비</TH>
<TH WIDTH="87" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">법인세비용</TH>
<TH WIDTH="87" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="49" USERMARK="F-10">지분법이익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="28" USERMARK="F-10"> 의약품 제조업</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">182,593,965</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">99,014,537</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">2,249,256</TD>
<TD ALIGN="RIGHT" WIDTH="86" HEIGHT="28" USERMARK="F-10">1,209,874</TD>
<TD ALIGN="RIGHT" WIDTH="86" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">161,590,644</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">74,802,981</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">2,520,823</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">2,581,215</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">(212,811)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="28" USERMARK="F-10"> 의약품 도매업</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">5,456,037</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">9,683,281</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="86" HEIGHT="28" USERMARK="F-10">(58)</TD>
<TD ALIGN="RIGHT" WIDTH="86" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">4,668,525</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">8,881,702</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">11,993</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="28" USERMARK="F-10"> 의료정보시스템</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">145,961</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">749,845</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">293</TD>
<TD ALIGN="RIGHT" WIDTH="86" HEIGHT="28" USERMARK="F-10">4</TD>
<TD ALIGN="RIGHT" WIDTH="86" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">265,097</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">768,961</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">1,181</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">414</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="28" USERMARK="F-10"> 의약품 원료 제조업</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">24,384,659</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">9,697,157</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">854,916</TD>
<TD ALIGN="RIGHT" WIDTH="86" HEIGHT="28" USERMARK="F-10">(227,066)</TD>
<TD ALIGN="RIGHT" WIDTH="86" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">23,705,213</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">9,697,171</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">839,722</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">(37,588)</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="28" USERMARK="F-10"> 화장품 및 의료기기제조</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">9,708,066</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">1,674,830</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">13,598</TD>
<TD ALIGN="RIGHT" WIDTH="86" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">222,179</TD>
<TD ALIGN="RIGHT" WIDTH="86" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">8,918,018</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">1,845,668</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">9,122</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10" VALIGN="MIDDLE">6,061</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">조 정</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">(23,232,215)</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">(3,454,462)</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">(27,455)</TD>
<TD ALIGN="RIGHT" WIDTH="86" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="86" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">(19,198,171)</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">(2,036,358)</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">(27,620)</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="28" USERMARK="F-10" ALIGN="CENTER">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">199,056,473</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">117,365,188</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">3,090,608</TD>
<TD ALIGN="RIGHT" WIDTH="86" HEIGHT="28" USERMARK="F-10">1,204,933</TD>
<TD ALIGN="RIGHT" WIDTH="86" HEIGHT="28" USERMARK="F-10">-</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">179,949,326</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">93,960,125</TD>
<TD ALIGN="RIGHT" WIDTH="88" HEIGHT="28" USERMARK="F-10">3,343,228</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">2,562,095</TD>
<TD ALIGN="RIGHT" WIDTH="87" HEIGHT="28" USERMARK="F-10">(212,811)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">다. 지역에 대한 정보연결회사는 국내 및 해외에서 영업하고 있으며, 지역별로 세분화된 연결회사의 외부고객으로부터의 계속영업수익에 대한 정보는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="598" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="190"></COL>
<COL WIDTH="190"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH ALIGN="CENTER" WIDTH="199" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH ALIGN="CENTER" WIDTH="199" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE"> 대한민국</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">117,085,654</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">108,237,821</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE"> 중국</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">3,617,003</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE"> 베트남</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">640,276</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">501,653</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE"> 미얀마/캄보디아</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">2,105,009</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">1,573,276</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE"> 에콰도르/볼리비아</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">1,161,623</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">855,767</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE"> 독 일</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">5,034,374</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">4,566,017</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE"> 기 타</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">2,267,753</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">1,424,298</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">131,911,692</TD>
<TD WIDTH="199" HEIGHT="30" ALIGN="RIGHT">117,158,832</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">라. 주요고객에 대한 정보의약품의 직접판매로 인한 수익 131,912백만원(전기: 117,159백만원)(주석 5.(2) 참고)에는 당기말 중 회사의 가장 큰 고객인 ㈜유한양행에 대한 매출액 약 10,961백만원(전기: 9,949백만원)이 포함되어 있습니다.당기 및 전기에 회사 수익의 10% 이상을 차지하는 단일 고객은 없습니다.</SPAN>
</P>
<P></P>
<P USERMARK="F-GL11 B">33. 범주별 금융자산 및 금융부채</P>
<P USERMARK="F-GL11">가. 보고기간종료일 현재 범주별 금융상품의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="1077" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="1068"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="1077" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1078" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="185"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="101"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="194" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="98" ALIGN="CENTER" ROWSPAN="2" USERMARK="F-10">재무상태표상 자산</TH>
<TH WIDTH="444" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="28" ALIGN="CENTER" COLSPAN="4" USERMARK="F-10">당기말</TH>
<TH WIDTH="440" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="28" ALIGN="CENTER" COLSPAN="4" USERMARK="F-10">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="70" ALIGN="CENTER" USERMARK="F-10">당기손익-공정가치측정금융자산</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="70" ALIGN="CENTER" USERMARK="F-10">상각후원가측정 금융자산</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="70" ALIGN="CENTER" USERMARK="F-10">기타포괄손익-공정가치측정금융자산</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="70" ALIGN="CENTER" USERMARK="F-10">합 계</TH>
<TH WIDTH="110" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="70" ALIGN="CENTER" USERMARK="F-10">당기손익-공정가치측정금융자산</TH>
<TH WIDTH="110" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="70" ALIGN="CENTER" USERMARK="F-10">상각후원가측정 금융자산</TH>
<TH WIDTH="110" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="70" ALIGN="CENTER" USERMARK="F-10">기타포괄손익-공정가치측정금융자산</TH>
<TH WIDTH="110" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="70" ALIGN="CENTER" USERMARK="F-10">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="9" WIDTH="1078" HEIGHT="28" USERMARK="F-10">유동자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="28" USERMARK="F-10">  현금및현금성자산</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,125,135</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,125,135</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">4,001,730</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">4,001,730</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">  매출채권 및 기타채권</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">19,744,890</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">19,744,890</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">18,523,861</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">18,523,861</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="28" USERMARK="F-10">  단기대여금및수취채권</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,645</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,645</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">13,976</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">13,976</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="49" USERMARK="F-10">  당기손익-공정가치  측정지분상품</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">1,593,067</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">1,593,067</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">3,066,361</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">3,066,361</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="28" USERMARK="F-10">  단기금융상품</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,240,000</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,240,000</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">11,340,000</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">11,340,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">합 계</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">1,593,067</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">26,113,670</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">27,706,737</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">3,066,361</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">33,879,567</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">36,945,928</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="9" WIDTH="1078" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">비유동자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="49" USERMARK="F-10">  기타포괄손익-공정가치  측정지분상품</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">3,633,411</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">3,633,411</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">3,807,140</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="49" VALIGN="MIDDLE" USERMARK="F-10">3,807,140</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="28" USERMARK="F-10">  장기매출채권 및 기타채권</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">734,065</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">734,065</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">86,460</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">86,460</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="28" USERMARK="F-10">  장기금융상품</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">6,842,000</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">6,842,000</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">4,832,241</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">4,832,241</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="194" HEIGHT="28" ALIGN="CENTER" USERMARK="F-10">합 계</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">-</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">7,576,065</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">3,633,411</TD>
<TD WIDTH="111" ALIGN="RIGHT" HEIGHT="28" USERMARK="F-10">11,209,476</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">4,918,701</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">3,807,140</TD>
<TD WIDTH="110" ALIGN="RIGHT" HEIGHT="28" VALIGN="MIDDLE" USERMARK="F-10">8,725,841</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" WIDTH="1003" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="994"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="1003" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="1007" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="207"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="129"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="216" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="106" ALIGN="CENTER" ROWSPAN="2">재무상태표상 부채</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" COLSPAN="3">당기말</TH>
<TH WIDTH="391" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER" COLSPAN="3">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="138" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76" ALIGN="CENTER">당기손익-공정가치측정 금융부채</TH>
<TH WIDTH="138" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76" ALIGN="CENTER">상각후원가로 측정하는 금융부채</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76" ALIGN="CENTER">합 계</TH>
<TH WIDTH="135" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76" ALIGN="CENTER">당기손익-공정가치측정 금융부채</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76" ALIGN="CENTER">상각후원가로 측정하는 금융부채</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76" ALIGN="CENTER">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="7" WIDTH="1007" HEIGHT="30">유동부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="53">   매입채무 및 기타유동채무  (선수금제외)</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">18,823,735</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">18,823,735</TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">-</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">13,007,070</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="53" VALIGN="MIDDLE">13,007,070</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">   단기차입금(유동성장기포함)</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">59,054,800</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">59,054,800</TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">55,502,585</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">55,502,585</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">   전환사채 </TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">   리스부채-유동</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">201,758</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">201,758</TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">238,020</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">238,020</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">   전환권대가</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="30">45</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">45</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">78,080,293</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">78,080,293</TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="30">45</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">69,591,675</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">69,591,720</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="7" WIDTH="1007" HEIGHT="30">비유동부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">   장기매입채무 및 기타채무</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">3,265,835</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">3,265,835</TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">3,151,849</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">3,151,849</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">   장기차입금</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">27,307,473</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">27,307,473</TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">10,796,490</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">10,796,490</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30">   리스부채-비유동</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">251,926</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">251,926</TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">269,244</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">269,244</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="216" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="138" ALIGN="RIGHT" HEIGHT="30">30,825,234</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">30,825,234</TD>
<TD WIDTH="135" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">14,217,583</TD>
<TD WIDTH="128" ALIGN="RIGHT" HEIGHT="30">14,217,583</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">나. 당기 및 전기 중 금융상품 범주별로 발생한 손익의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="1049">

<COLGROUP>
<COL WIDTH="480"></COL>
<COL WIDTH="551"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="489" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD WIDTH="560" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1049">

<COLGROUP>
<COL WIDTH="167"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="176" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="106">구 분</TH>
<TH COLSPAN="3" WIDTH="375" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">금융자산</TH>
<TH COLSPAN="4" WIDTH="498" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">금융부채</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">상각후원가측정 금융자산</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">당기손익-공정가치측정금융자산</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">기타포괄손익-공정가치측정금융자산</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">당기손익-공정가치측정금융부채</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">전환사채</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">리스부채</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">기타상각후원가로 측정하는 금융부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="176" HEIGHT="30"> 이자수익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">311,820</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="176" HEIGHT="30"> 배당금수익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">33,964</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="176" HEIGHT="30"> 평가이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">1,962</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="176" HEIGHT="30"> 처분이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">182,689</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="176" HEIGHT="30"> 파생상품평가이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="176" HEIGHT="30"> 이자비용</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">(9,500)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">(16,643)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">(2,338,858)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="176" HEIGHT="30"> 평가손실</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">(545,196)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">(173,729)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="176" HEIGHT="30"> 처분손실</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">(406,353)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="176" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">311,820</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">(732,934)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">(173,729)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">(9,500)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">(16,643)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">(2,338,858)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="1052">

<COLGROUP>
<COL WIDTH="480"></COL>
<COL WIDTH="554"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="489" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD WIDTH="563" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1049">

<COLGROUP>
<COL WIDTH="167"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="176" HEIGHT="106" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="375" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융자산</TH>
<TH WIDTH="498" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융부채</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="125" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가측정 금융자산</TH>
<TH WIDTH="125" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-공정가치측정금융자산</TH>
<TH WIDTH="125" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타포괄손익-공정가치측정금융자산</TH>
<TH WIDTH="125" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-공정가치측정금융부채</TH>
<TH WIDTH="125" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환사채</TH>
<TH WIDTH="124" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">리스부채</TH>
<TH WIDTH="124" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타상각후원가로 측정하는 금융부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" HEIGHT="30" VALIGN="MIDDLE"> 이자수익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">359,123</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" HEIGHT="30" VALIGN="MIDDLE"> 배당금수익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,058</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" HEIGHT="30" VALIGN="MIDDLE"> 평가이익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" HEIGHT="30" VALIGN="MIDDLE"> 처분이익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,053,634</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" HEIGHT="30" VALIGN="MIDDLE"> 파생상품평가이익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,312,014</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" HEIGHT="30" VALIGN="MIDDLE"> 이자비용</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(176,000)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(18,831)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,324,199)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" HEIGHT="30" VALIGN="MIDDLE"> 평가손실</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(515,659)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,486,082)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" HEIGHT="30" VALIGN="MIDDLE"> 처분손실</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(175,503)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="176" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">359,123</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">384,530</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,486,082)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,312,014</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(176,000)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(18,831)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,324,199)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL B">34. 금융상품 위험</SPAN>
</P>
<P USERMARK="F-GL11">가. 신용위험</P>
<P USERMARK="F-GL11">(1) 신용위험에 대한 노출 금융자산의 장부금액은 신용위험에 대한 최대노출정도를 나타냅니다. 보고기간종료일 현재 연결회사의 신용위험에 대한 최대 노출정도는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="618" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="618" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="622" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="152"></COL>
<COL WIDTH="151"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="301" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="161" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당기말</TH>
<TH WIDTH="160" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30"> 기타포괄손익-공정가치측정금융자산</TD>
<TD WIDTH="161" ALIGN="RIGHT" HEIGHT="30">3,633,411</TD>
<TD WIDTH="160" ALIGN="RIGHT" HEIGHT="30">3,807,140</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30"> 상각후원가측정금융자산</TD>
<TD WIDTH="161" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">33,689,734</TD>
<TD WIDTH="160" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">38,798,268</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30"> 당기손익-공정가치측정금융자산</TD>
<TD WIDTH="161" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">1,593,067</TD>
<TD WIDTH="160" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE">3,066,361</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="161" ALIGN="RIGHT" HEIGHT="30">38,916,212</TD>
<TD WIDTH="160" ALIGN="RIGHT" HEIGHT="30">45,671,769</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK="F-GL11">(2) 손상차손보고기간종료일 현재 매출채권의 연령 및 각 연령별로 손상된 채권금액은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" WIDTH="614" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="605"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="614" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="134"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="143" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">구 분</TH>
<TH COLSPAN="2" WIDTH="236" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH COLSPAN="2" WIDTH="236" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="118" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권잔액</TH>
<TH WIDTH="118" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">손상된 금액</TH>
<TH WIDTH="118" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권잔액</TH>
<TH WIDTH="118" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">손상된 금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30"> 0일-30일</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">10,819,288</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">61,492</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">10,126,729</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">96,821</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30"> 31일-120일</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">6,512,182</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">71,908</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">5,691,754</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">91,378</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30"> 120일-1년이내</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">1,036,831</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">97,615</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">1,175,355</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">86,893</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30"> 1년 이상 경과</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">1,807,746</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">1,807,746</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">1,853,235</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">1,853,235</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">20,176,047</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">2,038,761</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">18,847,073</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">2,128,327</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">나. 유동성위험</P>
<P USERMARK="F-GL11">보고기간종료일 현재 연결회사가 보유한 금융부채의 계약상 만기는 다음과 같습니다.</P>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" WIDTH="836" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="827"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="836" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="840" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="184"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="193" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">구 분</TH>
<TH WIDTH="93" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">장부금액</TH>
<TH WIDTH="93" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">계약상현금흐름</TH>
<TH WIDTH="93" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">6개월이내</TH>
<TH WIDTH="92" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">6-12개월</TH>
<TH WIDTH="92" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">1-2년</TH>
<TH WIDTH="92" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">2-5년</TH>
<TH WIDTH="92" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">5년 이상</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="840" VALIGN="BOTTOM" HEIGHT="30" COLSPAN="8"><당기말></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">  단기차입금</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">59,054,800</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">59,054,800</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,694,790</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50,360,010</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">  장기차입금(유동성 포함)</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,557,203</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">30,557,203</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,249,730</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">27,307,473</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" USERMARK=" 0XBD6F00">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30">  전환사채</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30">  매입채무와 기타채무</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">22,089,570</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">22,089,570</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">18,688,785</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,935,785</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">465,000</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30">  리스부채</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">453,683</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">477,442</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">59,981</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">169,596</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">247,865</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">112,155,256</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">112,179,015</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">27,443,556</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">53,465,391</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">3,962,595</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">27,307,473</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="840" VALIGN="BOTTOM" HEIGHT="30" COLSPAN="8"><전기말></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30">  단기차입금</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55,502,585</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">55,502,585</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,109,880</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">47,392,705</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30">  장기차입금(유동성 포함)</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">13,296,310</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">13,296,310</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">117,485</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,382,335</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,309,195</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">8,487,295</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30">  전환사채</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30">  매입채무와 기타채무</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">16,158,919</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">16,158,919</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">12,791,432</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">2,899,636</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">467,851</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="BOTTOM" HEIGHT="30">  리스부채</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">507,264</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">531,023</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">89,803</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">169,596</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">271,623</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">86,309,078</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">86,332,837</TD>
<TD WIDTH="93" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">21,108,600</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">53,688,272</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">3,048,669</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">8,487,295</TD>
<TD WIDTH="92" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">연결회사는 이 현금흐름이 유의적으로 더 이른 기간에 발생하거나, 유의적으로 다른 금액일 것으로 기대하지 않습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">다. 환위험에 대한 노출 연결회사는 해외자회사의 영업 활동을 수행함에 따라 각 개별회사의 기능통화와 다른 통화로 거래를 하고 있어 환율변동위험에 노출되어 있습니다. 환율변동위험에 노출되는 환포지션의 주요 통화로는 USD, EUR 등이 있습니다.연결회사는 환율변동과는 무관하게 통화별 금융자산과 금융부채의 규모를 일치하는 수준으로 유지하여 환율변동 영향을 최소화하는데 주력하고 있습니다.  연결회사는 효율적인 환율변동위험 관리를 위해 환위험을 주기적으로 모니터링 및 평가하고 있습니다.보고기간종료일 현재 기능통화와 다른 주요 외화로 표시된 금융자산 및 금융부채에 대하여 환율이 10% 변동할 경우 당기손익(법인세효과 반영 전)에 미치는 영향은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="616">

<COLGROUP>
<COL WIDTH="607"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="616" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="620" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="150" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60" VALIGN="MIDDLE">구 분</TH>
<TH COLSPAN="2" WIDTH="236" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당기말</TH>
<TH COLSPAN="2" WIDTH="234" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="118" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10% 상승시</TH>
<TH WIDTH="118" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10% 하락시</TH>
<TH WIDTH="117" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10% 상승시</TH>
<TH WIDTH="117" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10% 하락시</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="30" VALIGN="MIDDLE"> USD</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">119,216</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">(119,216)</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">152,822</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">(152,822)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="30" VALIGN="MIDDLE"> EUR</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">12,472</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">(12,472)</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">12,390</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">(12,390)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">131,688</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">(131,688)</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">165,212</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">(165,212)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11">라. 이자율위험</P>
<P USERMARK="F-GL11">(1) 보고기간종료일 현재 연결회사가 보유하고 있는 이자부 금융상품의 장부금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="702" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="693"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="702" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="702" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="351" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="3">고정이자율</TH>
<TH WIDTH="351" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">변동이자율</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="117" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="117" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="117" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
<TH WIDTH="117" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="117" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="117" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="117" HEIGHT="30">  금융자산</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">10,082,000</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">16,172,241</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="CENTER">금융자산</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="117" HEIGHT="30">  금융부채</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="CENTER">금융부채</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">62,506,288</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">58,240,470</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"> </P>

<P>
<SPAN USERMARK="F-GL11">(2) 고정이자율 금융상품의 공정가치 민감도 분석연결회사는 고정이자율 금융상품을 당기손익인식금융상품으로 처리하고 있지 않으며, 파생상품을 공정가치위험회피회계의 위험회피수단으로 지정하지 않았습니다. 따라서, 이자율의 변동은 손익에 영향을 주지 않습니다.</SPAN>
</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(3) 변동이자율 금융상품의 현금흐름 민감도 분석</P>
<P USERMARK="F-GL11">당기말 현재 이자율이 100베이시스포인트 변동한다면, 자본과 손익은 증가 또는 감소하였을 것입니다. 이 분석은 환율과 같은 다른 변수는 변동하지 않는다고 가정하며, 전기에도 동일한 방법으로 분석하였습니다. 구체적인 자본 및 손익의 변동금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="641" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="632"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="641" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="641" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="179" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">구 분</TH>
<TH COLSPAN="2" WIDTH="232" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">손 익</TH>
<TH COLSPAN="2" WIDTH="230" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자 본</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="117" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">100bp 상승</TH>
<TH WIDTH="115" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">100bp 하락</TH>
<TH WIDTH="115" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">100bp 상승</TH>
<TH WIDTH="115" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">100bp 하락</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="641" HEIGHT="30"><당기말></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30">변동이자율 금융상품</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(625,063)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">625,063</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">(625,063)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">625,063</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="641" HEIGHT="30"><전기말></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="179" HEIGHT="30">변동이자율 금융상품</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(582,405)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">582,405</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">(582,405)</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">582,405</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11">마. 공정가치</P>
<P USERMARK="F-GL11">(1) 공정가치와 장부금액연결회사의 금융자산과 부채의 장부금액과 공정가치는 다음과 같습니다</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="703">

<COLGROUP>
<COL WIDTH="694"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="703" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="817">

<COLGROUP>
<COL WIDTH="295"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="304" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH COLSPAN="2" WIDTH="257" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH COLSPAN="2" WIDTH="256" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="817" VALIGN="MIDDLE" HEIGHT="30">공정가치로 인식된 자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">  당기손익-공정가치측정금융자산</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,593,067</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,593,067</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,066,361</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,066,361</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">  기타포괄손익-공정가치측정금융자산</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,633,411</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,633,411</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,807,140</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,807,140</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="817" VALIGN="MIDDLE" HEIGHT="30">상각후원가로 인식된 자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">  대여금과 수취채권</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,645</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,645</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,976</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,976</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">  매출채권및기타채권</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,478,954</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,478,954</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,610,320</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,610,320</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">  장ㆍ단기금융상품</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,082,000</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,082,000</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,172,241</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,172,241</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">  현금 및 현금성자산</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,125,135</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,125,135</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,001,730</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,001,730</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,916,212</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,916,212</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45,671,768</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45,671,768</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="817" VALIGN="MIDDLE" HEIGHT="30" COLSPAN="5">공정가치로 인식된 부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">  당기손익-공정가치측정금융부채</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="817" VALIGN="MIDDLE" HEIGHT="30">상각후원가로 인식된 부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">  차입금</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">86,362,273</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">86,362,273</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,299,075</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,299,075</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">  매입채무와 기타채무</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,089,559</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,089,559</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,158,919</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,158,919</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">  전환사채</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" HEIGHT="30">  리스부채</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">453,683</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">453,683</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">507,264</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">507,264</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="304" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="129" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">108,905,515</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">108,905,515</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">83,809,303</TD>
<TD WIDTH="128" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">83,809,303</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 공정가치 서열체계아래 표에서는 공정가치로 인식되는 금융상품을 공정가치 측정방법별로 분석하였습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">공정가치에는 다음의 수준이 있습니다.</P>
<P USERMARK="F-GL11">1) 동일한 자산이나 부채에 대한 활성시장의 공시가격 (수준 1)</P>
<P USERMARK="F-GL11">2) 직접적으로 또는 간접적으로 관측가능한, 자산이나 부채에 대한 투입변수 (수준 2)</P>
<P USERMARK="F-GL11">3) 관측가능한 시장자료에 기초하지 않은, 자산이나 부채에 대한 투입변수 (수준 3)</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">당기말 현재 공정가치로 측정되는 금융상품의 각 종류별로 공정가치 수준별 측정치는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="729">

<COLGROUP>
<COL WIDTH="720"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="729" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="733">

<COLGROUP>
<COL WIDTH="273"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="103"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="282" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">수준1</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">수준2</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">수준3</TH>
<TH WIDTH="112" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="282" VALIGN="MIDDLE" HEIGHT="30"> 기타포괄손익-공정가치측정금융자산</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,633,411</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,633,411</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="282" VALIGN="MIDDLE" HEIGHT="30"> 당기손익-공정가치측정금융자산</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,593,067</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="112" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,593,067</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11">
<SPAN USERMARK=" B">35. 현금흐름표</SPAN>가. 연결회사의 현금흐름표는 간접법에 의해 작성되었으며, 당기 및 전기 중 현금의 유입과 유출이 없는 주요한 거래는 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" WIDTH="600" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="296"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="305" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH ALIGN="CENTER" WIDTH="148" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH ALIGN="CENTER" WIDTH="147" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30"> 장기금융상품의 유동성 대체</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">1,000,000</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">9,240,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30"> 장기차입금의 유동성 대체</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">3,249,730</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">1,749,190</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30"> 건설중인자산의 유형자산 대체</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">493,340</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">702,726</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30"> 건설중인자산의 무형자산 대체 </TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">7,600</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">544,707</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30"> 정부보조금 경상연구개발비와 상계</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30"> 전환사채의 전환권 행사에 따른 자본 대체</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">970,252</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30"> 리스부채인식 및 유동성대체</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT">205,282</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT">11,564</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">나. 당기 및 전기 중 재무활동에서 생기는 부채의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="649">

<COLGROUP>
<COL WIDTH="300"></COL>
<COL WIDTH="331"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD WIDTH="340" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="652">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">단기차입금</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장기차입금</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환사채</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">리스부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30">기 초</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">55,320,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">10,796,490</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="123" HEIGHT="30">844,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="123" HEIGHT="30">507,264</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30"> 재무활동순현금흐름</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">2,552,215</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">18,510,863</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="123" HEIGHT="30">(853,500)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="123" HEIGHT="30">(299,142)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30"> 이자비용</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="123" HEIGHT="30">9,500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="123" HEIGHT="30">16,643</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30"> 기타(환율효과 등)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">982,785</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">(1,999,880)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="123" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="123" HEIGHT="30">228,918</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30">기 말</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">58,855,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">27,307,473</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="123" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="123" HEIGHT="30">453,683</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="649">

<COLGROUP>
<COL WIDTH="300"></COL>
<COL WIDTH="331"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD WIDTH="340" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="652">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">단기차입금</TH>
<TH WIDTH="124" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장기차입금</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환사채</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">리스부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE">기 초</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">43,217,715</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,249,370</TD>

<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">
<SPAN USERMARK=" BC0X31FFFF">14,490,000</SPAN>
</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">599,395</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE"> 재무활동순현금흐름</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,535,500</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,046,940 </TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(13,771,772)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(329,901)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE"> 이자비용</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">176,000</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,831</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE"> 기타(환율효과 등)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3,433,215)</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,499,820)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(50,228)</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">218,939</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="158" HEIGHT="30" VALIGN="MIDDLE">기 말</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">55,320,000</TD>
<TD WIDTH="124" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,796,490</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">844,000</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">507,264</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11 B">36. 재무제표의 승인</SPAN>
<SPAN USERMARK="F-GL11">당기 재무제표는 2023년 2월 22일자로 이사회에서 확정되었으며, 2023년 3월 23일 정기주주총회에서 최종 승인될 예정입니다.</SPAN>
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-4-0">4. 재무제표</TITLE>

<P>
<SPAN USERMARK="F-GL B">가. 재무상태표</SPAN>
</P>

<TABLE-GROUP ACLASS="{XBRL}BS_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="770" BORDER="0">

<COLGROUP>
<COL WIDTH="761"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="770" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">재무상태표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="770" HEIGHT="30" AUPDATECONT="N">
<P>제 39 기          2022.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="770" HEIGHT="30" AUPDATECONT="N">
<P>제 38 기          2021.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="770" HEIGHT="30" AUPDATECONT="N">
<P>제 37 기          2020.12.31 현재</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="770" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="773" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="377"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="386">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="129">
<P>제 39 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="129">
<P>제 38 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="129">
<P>제 37 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>자산</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>36,589,747,095</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>43,038,187,064</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>39,533,005,713</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>320,380,514</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,415,085,173</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,060,416,429</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　매출채권 및 기타유동채권</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>12,618,564,133</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>12,730,741,696</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>13,393,845,596</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　기타유동금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>4,736,344,519</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>14,339,301,254</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>8,894,772,841</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　재고자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>18,914,457,929</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>14,553,058,941</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>15,183,970,847</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　비유동자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>146,004,217,856</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>115,559,294,767</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>116,175,808,099</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　유형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>77,833,554,042</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>52,557,956,561</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>51,110,103,459</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　사용권자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>464,438,292</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>426,641,273</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>432,265,552</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　투자부동산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>15,299,717,559</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>15,447,579,277</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>15,595,440,995</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　영업권 이외의 무형자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>25,879,034,439</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>22,390,308,454</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>17,969,675,396</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　종속기업, 조인트벤처와 관계기업에 대한 투자자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>12,712,627,601</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>12,875,549,396</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>14,017,310,816</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　이연법인세자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,958,173,139</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,256,127,927</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,058,151,875</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　기타비유동금융자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>10,856,672,784</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>8,605,131,879</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>13,992,860,006</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　자산총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>182,593,964,951</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>158,597,481,831</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>155,708,813,812</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>68,806,318,078</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>61,288,655,818</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>65,102,536,279</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　매입채무 및 기타유동채무</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>15,960,212,807</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>9,988,272,390</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>10,857,932,874</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　단기차입금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>51,200,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>47,500,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>34,400,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　유동성전환사채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>844,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>14,490,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　당기법인세부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>373,318,064</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,460,860,347</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>560,867,068</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　유동파생상품부채</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>44,800</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,231,018,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　단기이연수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>50,191,369</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>69,051,923</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>67,216,102</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　기타유동금융부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,222,595,838</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,426,426,358</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,495,502,235</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　비유동부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>30,208,218,520</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>13,514,325,351</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>5,111,620,407</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　장기매입채무 및 기타비유동채무</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,610,185,605</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,489,884,309</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,415,658,415</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　장기차입금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>24,057,863,100</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>6,547,000,000</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　기타비유동금융부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>28,224,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>62,400,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>62,400,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　퇴직급여부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,506,527,477</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,409,923,232</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>1,628,342,967</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　비유동충당부채</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>5,418,338</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>5,117,810</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>5,219,025</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　부채총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>99,014,536,598</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>74,802,981,169</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>70,214,156,686</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>자본</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　자본금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>9,308,325,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>9,308,325,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>9,284,689,500</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　자본잉여금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>30,294,860,903</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>30,294,860,903</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>29,349,309,215</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　기타자본구성요소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(9,724,898,229)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(9,416,181,534)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(6,930,099,079)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　자기주식</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(9,161,842,083)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(9,161,842,083)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(9,161,842,083)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　기타포괄손익누계액</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(2,920,080,866)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(2,611,364,171)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>(125,281,716)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　기타자본조정</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,357,024,720</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,357,024,720</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,357,024,720</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　이익잉여금(결손금)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>53,701,140,679</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>53,607,496,293</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>53,790,757,490</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　이익준비금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,456,692,577</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>3,193,942,827</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>2,933,624,167</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　임의적립금</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>11,262,509,432</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>11,262,509,432</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>11,262,509,432</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　　미처분이익잉여금(미처리결손금)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>38,981,938,670</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>39,151,044,034</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>39,594,623,891</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>　자본총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>83,579,428,353</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>83,794,500,662</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>85,494,657,126</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="386">
<P>자본과부채총계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>182,593,964,951</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>158,597,481,831</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="129">
<P>155,708,813,812</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL10">※상기 재무제표는 주주총회 승인 전 재무제표이며 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정 보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">나. 포괄손익계산서</SPAN>
</P>

<TABLE-GROUP ACLASS="{XBRL}IS_S1" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="761" BORDER="0">

<COLGROUP>
<COL WIDTH="752"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="761" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">포괄손익계산서</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="761" HEIGHT="30" AUPDATECONT="N">
<P>제 39 기 2022.01.01 부터 2022.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="761" HEIGHT="30" AUPDATECONT="N">
<P>제 38 기 2021.01.01 부터 2021.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="761" HEIGHT="30" AUPDATECONT="N">
<P>제 37 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="761" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="766" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="390"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="399">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="121">
<P>제 39 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="125">
<P>제 38 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="121">
<P>제 37 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>수익(매출액)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>99,192,379,166</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>88,704,838,883</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>82,324,950,011</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>매출원가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>61,918,245,441</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>52,010,011,778</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>44,882,257,773</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>매출총이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>37,274,133,725</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>36,694,827,105</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>37,442,692,238</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>판매비와관리비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>33,376,944,437</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>34,203,737,668</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>32,832,132,958</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>영업이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>3,897,189,288</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>2,491,089,437</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>4,610,559,280</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>기타이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>2,721,360,584</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>2,197,185,005</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>2,519,607,961</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>기타손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>1,288,488,528</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>2,537,809,933</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>643,019,814</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>금융수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>550,432,654</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>4,454,412,433</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>1,714,660,091</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>금융원가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>2,747,553,672</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>1,701,265,185</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>7,017,273,662</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>법인세비용차감전순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>3,132,940,326</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>4,903,611,757</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>1,184,533,856</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>법인세비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>1,209,873,796</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>2,581,215,485</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>1,738,139,692</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>1,923,066,530</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>2,322,396,272</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>(553,605,836)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>기타포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>489,358,661</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(2,368,969,524)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>(307,564,080)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>　당기손익으로 재분류되지 않는항목(세후기타포괄손익)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>489,358,661</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(2,368,969,524)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>(307,564,080)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>총포괄손익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>2,412,425,191</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(46,573,252)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>(861,169,916)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>주당이익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>　기본주당이익(손실) (단위 : 원)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>110</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>133</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>(32)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="399">
<P>　희석주당이익(손실) (단위 : 원)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>110</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>133</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>(32)</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL10">※상기 재무제표는 주주총회 승인 전 재무제표이며 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정 보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.</SPAN>
</P>
<PGBRK></PGBRK>
<P USERMARK="F-GL B">다. 자본변동표</P>
<P></P>

<TABLE-GROUP ACLASS="{XBRL}EF_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="1619" BORDER="0">

<COLGROUP>
<COL WIDTH="1610"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1619" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">자본변동표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1619" HEIGHT="30" AUPDATECONT="N">
<P>제 39 기 2022.01.01 부터 2022.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1619" HEIGHT="30" AUPDATECONT="N">
<P>제 38 기 2021.01.01 부터 2021.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="1619" HEIGHT="30" AUPDATECONT="N">
<P>제 37 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1619" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="1622" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="219"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="231"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="169"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="90" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="228" ROWSPAN="3">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="1394" COLSPAN="10">
<P>자본</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="113" ROWSPAN="2">
<P>자본금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="121" ROWSPAN="2">
<P>자본잉여금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="607" COLSPAN="4">
<P>이익잉여금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="428" COLSPAN="3">
<P>기타자본구성요소</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="125" ROWSPAN="2">
<P>자본  합계</P>
</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="113">
<P>이익준비금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="121">
<P>임의적립금</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="240">
<P>미처분이익잉여금(미처리결손금)</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>이익잉여금  합계</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="125">
<P>자기주식</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="125">
<P>기타자본</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="178">
<P>기타자본구성요소  합계</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>2020.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>9,112,487,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>21,847,703,037</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>2,673,555,712</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>11,262,509,432</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>43,233,453,296</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>57,169,518,440</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(8,996,149,108)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>2,286,867,870</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">
<P>(6,709,281,238)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>81,420,427,239</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>(553,605,836)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(553,605,836)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(553,605,836)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>기타포괄손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>(252,439,214)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(252,439,214)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(55,124,866)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">
<P>(55,124,866)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(307,564,080)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>배당금지급</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>(2,572,715,900)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,572,715,900)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(2,572,715,900)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>이익잉여금 처분으로 인한 증감</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>260,068,455</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>(260,068,455)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>자기주식 거래로 인한 증감</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(165,692,975)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">
<P>(165,692,975)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(165,692,975)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>복합금융상품 발행</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>지분의 발행</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>172,202,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>4,686,318,178</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>4,858,520,678</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>주식기준보상거래</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>2,815,288,000</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>2,815,288,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>자본 증가(감소) 합계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>172,202,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>7,501,606,178</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>260,068,455</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>(3,638,829,405)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(3,378,760,950)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(165,692,975)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(55,124,866)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">
<P>(220,817,841)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>4,074,229,887</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>2020.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>9,284,689,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>29,349,309,215</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>2,933,624,167</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>11,262,509,432</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>39,594,623,891</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>53,790,757,490</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(9,161,842,083)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>2,231,743,004</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">
<P>(6,930,099,079)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>85,494,657,126</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>2021.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>9,284,689,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>29,349,309,215</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>2,933,624,167</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>11,262,509,432</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>39,594,623,891</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>53,790,757,490</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(9,161,842,083)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>2,231,743,004</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">
<P>(6,930,099,079)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>85,494,657,126</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>2,322,396,272</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,322,396,272</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>2,322,396,272</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>기타포괄손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>117,112,931</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>117,112,931</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(2,486,082,455)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">
<P>(2,486,082,455)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(2,368,969,524)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>배당금지급</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>(2,622,770,400)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,622,770,400)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(2,622,770,400)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>이익잉여금 처분으로 인한 증감</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>260,318,660</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>(260,318,660)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>0</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>자기주식 거래로 인한 증감</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>복합금융상품 발행</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>지분의 발행</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>23,635,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>699,799,888</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>723,435,388</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>주식기준보상거래</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>245,751,800</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>245,751,800</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>자본 증가(감소) 합계</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>23,635,500</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>945,551,688</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>260,318,660</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>(443,579,857)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(183,261,197)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(2,486,082,455)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">
<P>(2,486,082,455)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(1,700,156,464)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>2021.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>9,308,325,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>30,294,860,903</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>3,193,942,827</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>11,262,509,432</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>39,151,044,034</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>53,607,496,293</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(9,161,842,083)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(254,339,451)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">
<P>(9,416,181,534)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>83,794,500,662</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>2022.01.01 (기초자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>9,308,325,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>30,294,860,903</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>3,193,942,827</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>11,262,509,432</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>39,151,044,034</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>53,607,496,293</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(9,161,842,083)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(254,339,451)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">
<P>(9,416,181,534)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>83,794,500,662</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>당기순이익(손실)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>1,923,066,530</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,923,066,530</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>1,923,066,530</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>기타포괄손익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>798,075,356</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>798,075,356</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(308,716,695)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">
<P>(308,716,695)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>489,358,661</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>배당금지급</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>(2,627,497,500)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,627,497,500)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(2,627,497,500)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>이익잉여금 처분으로 인한 증감</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>262,749,750</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>0</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>(262,749,750)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>자기주식 거래로 인한 증감</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>복합금융상품 발행</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>지분의 발행</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>주식기준보상거래</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>자본 증가(감소) 합계</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>262,749,750</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>(169,105,364)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>93,644,386</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(308,716,695)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">
<P>(308,716,695)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(215,072,309)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="228">
<P>2022.12.31 (기말자본)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>9,308,325,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>30,294,860,903</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="113">
<P>3,456,692,577</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="121">
<P>11,262,509,432</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="240">
<P>38,981,938,670</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>53,701,140,679</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>(563,056,146)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="178">
<P>(9,724,898,229)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="125">
<P>83,579,428,353</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL10">※상기 재무제표는 주주총회 승인 전 재무제표이며 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정 보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.</SPAN>
</P>
<PGBRK></PGBRK>

<P>
<SPAN USERMARK="F-GL B">라. 현금흐름표</SPAN>
</P>

<TABLE-GROUP ACLASS="{XBRL}CF_S" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="786" BORDER="0">

<COLGROUP>
<COL WIDTH="777"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="786" HEIGHT="31" AUPDATECONT="N">
<P USERMARK="F-12 B">현금흐름표</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="786" HEIGHT="30" AUPDATECONT="N">
<P>제 39 기 2022.01.01 부터 2022.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="786" HEIGHT="30" AUPDATECONT="N">
<P>제 38 기 2021.01.01 부터 2021.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="786" HEIGHT="30" AUPDATECONT="N">
<P>제 37 기 2020.01.01 부터 2020.12.31 까지</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="786" HEIGHT="30" AUPDATECONT="N">
<P>(단위 : 원)</P>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="789" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="381"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="390">　</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 39 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 38 기</P>
</TH>

<TH ALIGN="CENTER" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" WIDTH="133">
<P>제 37 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>영업활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>7,216,674,632</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>9,490,455,275</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,248,230,555</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　당기순이익(손실)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,923,066,530</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,322,396,272</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(553,605,836)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　당기순이익조정을 위한 가감</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>9,387,646,106</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,210,491,959</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>11,195,484,509</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　법인세비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,209,873,796</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,581,215,485</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,738,139,692</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　퇴직급여</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,691,938,609</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,739,612,352</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,454,938,644</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　대손상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(81,723,715)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(40,864,282)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,400,182,468)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　기타의 대손상각비</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>387,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>250,503,250</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　감가상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,397,117,556</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,668,685,046</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,681,080,148</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　무형자산상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>733,884,596</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>724,709,196</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>713,409,390</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　리스자산상각비</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>210,146,601</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>247,895,412</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>244,905,802</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　리스자산해지손실(이익)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,348,381)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,628,378</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,061,108)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　외화환산손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>38,758,046</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>906,313</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>38,194,069</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　이자비용</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,845,679,235</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,084,176,665</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>4,974,598,226</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　당기손익인식금융자산평가손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>508,969,199</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>451,891,482</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>23,303,562</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　금융자산처분손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>392,905,238</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>165,197,038</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>312,165,874</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　종속기업/관계기업/공동기업투자손상차손</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>900,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,890,675,000</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　지급수수료</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>22,797,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>11,459,141</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　재고자산평가손실</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>113,336,006</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>100,334,431</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>161,716,323</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　파생금융부채평가손실</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,707,206,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　외화환산이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(6,741,786)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(31,445,129)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(231,945)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　이자수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(345,373,255)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(359,554,066)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(327,863,793)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　배당금수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(33,779,255)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(21,558,172)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(17,975,980)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　당기손익인식금융자산평가이익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(555,598,998)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　금융자산처분이익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(171,235,344)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,044,384,048)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(768,823,392)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　파생금융부채평가이익</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,312,014,400)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　기타의금융수익</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(14,761,040)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(47,411,742)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(44,397,928)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　영업활동으로인한자산ㆍ부채의변동</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(19,896,614)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,025,427,625</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(3,902,930,542)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　장기선급금의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(335,704,573)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>20,932,259</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(32,212,845)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　단기매출채권의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(375,932,302)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>136,873,204</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,502,176,094</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　단기미수금의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(303,864,698)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>544,094,966</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>462,054,415</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　단기선급금의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>476,539,888</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>141,451,330</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(162,100,985)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　단기선급비용의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(7,526,955)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(706,956)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(353,644)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　재고자산의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(4,474,734,994)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>530,577,475</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,974,430,382)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　그 밖의 기타장기충당부채의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>300,528</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(101,215)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>333,720</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　그 밖의 기타단기충당부채의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(30,431,945)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>37,854,182</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(3,299,877)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　제품보증충당부채의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(173,398,575)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(106,930,059)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(85,722,441)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　장기미지급금의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>103,985,562</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>47,480,992</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(376,523,712)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　단기매입채무의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>4,852,938,106</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>305,337,920</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,131,099,161)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　단기미지급금의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>475,317,935</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(938,416,642)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>458,849,748</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　단기미지급비용의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,800,561,823</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>203,814,637</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,641,864,088)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　단기예수금의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>36,684,880</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(19,602,510)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>240,127,840</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　단기선수금의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>105,120,486</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(192,880,879)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>173,277,928</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　부가가치세 예수금의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(822,087,981)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(116,939,899)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>359,032,790</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　사외적립자산의공정가치의 감소(증가)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>188,273,001</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,721,801,530</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>938,692,148</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　　퇴직급여채무의 증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,535,936,800)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,289,212,710)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,629,868,090)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　배당금수취(영업)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>33,779,255</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>21,558,172</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>17,975,980</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　이자지급(영업)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,297,101,898)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(907,586,086)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(625,132,598)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　이자수취(영업)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>378,728,257</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>29,194,699</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>262,828,945</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　법인세납부(환급)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,189,547,004)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,211,027,366)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(5,146,389,903)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>투자활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(25,796,083,302)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(18,060,921,412)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(9,860,135,024)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　임차보증금의 감소</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>28,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>52,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　임차보증금의 증가</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(10,000,000)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　장기금융상품의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,010,240,675</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　유동당기손익인식금융자산의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>4,074,155,803</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>7,156,661,242</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,166,280,546</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　단기금융상품의 처분</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>13,680,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>7,560,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>8,640,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　기계장치의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(247,710,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(624,995,159)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(648,400,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　사무용비품의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(175,210,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(272,373,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(210,846,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　차량운반구의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(22,790,600)</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　건설중인자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(27,086,742,719)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(8,516,015,271)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,285,878,082)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　컴퓨터소프트웨어의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(50,600,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(60,204,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(23,800,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　저작권, 특허권, 기타 산업재산권, 용역운영권의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(26,235,733)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(131,892,246)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(117,734,799)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　개발 중인 무형자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(4,142,274,362)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(4,507,295,271)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(5,816,281,116)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　비유동매도가능금융자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(170,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,680,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(499,995,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　장기금융상품의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(7,260,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(5,760,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(6,990,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　유동당기손익인식금융자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(3,301,838,161)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(6,803,894,127)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(8,226,043,958)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　단기금융상품의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,340,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(3,690,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,227,200,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　종속기업에 대한 투자자산의 취득</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(737,078,205)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(748,913,580)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(252,561,615)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　관계기업에 대한 투자자산의 취득</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(419,675,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>재무활동현금흐름</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>17,484,704,011</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>7,925,134,881</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>9,046,719,093</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　단기차입금의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>24,150,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>25,400,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>25,500,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　단기차입금의 상환</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(21,450,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(10,800,000,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(12,500,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　장기차입금의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>18,510,863,100</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>5,047,000,000</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　전환사채의 감소</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(800,044,800)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(13,173,207,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(931,500,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　전환권/신주인수권 행사로 인한 현금유입</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(53,500,000)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(598,564,612)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(4,368,062)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　자기주식의 취득</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(165,692,975)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　금융리스부채의 지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(255,116,789)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(248,158,928)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(268,661,924)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　정부보조금의 수취</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>4,901,835,821</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　정부보조금의 상환</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(342,046)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　임대보증금의 증가</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>10,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>19,000,000</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(10,000,000)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>　배당금지급</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,627,497,500)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,622,770,400)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(2,572,715,900)</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>환율변동효과 반영전 현금및현금성자산의 순증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,094,704,659)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(645,331,256)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>434,814,624</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>현금및현금성자산에 대한 환율변동효과</P>
</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">　</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>현금및현금성자산의순증가(감소)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(1,094,704,659)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>(645,331,256)</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>434,814,624</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>기초현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,415,085,173</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,060,416,429</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,625,601,805</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="390">
<P>기말현금및현금성자산</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>320,380,514</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>1,415,085,173</P>
</TD>

<TD ALIGN="RIGHT" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N" WIDTH="133">
<P>2,060,416,429</P>
</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL10">※상기 재무제표는 주주총회 승인 전 재무제표이며 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생한 경우 정정 보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다.</SPAN>
</P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-5-0">5. 재무제표 주석</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="CENTER">2022년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="CENTER">2021년 12월 31일 현재</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30">회사명 : 대화제약 주식회사</TD>
</TR>
</TBODY>
</TABLE>
<P> </P>
<P USERMARK="F-GL">1. 회사의 개요</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">대화제약 주식회사(이하 "회사")는 1984년 1월 19일에 설립되어 본사와 공장을 강원도 횡성군에 두고 의약품 및 의약부외품의 제조 및 판매 등을 주된 영업으로 하고 있습니다. 회사는 2003년 2월 14일 주식을 코스닥시장에 상장하였으며, 당기말 및 전기말 현재 주요 주주는 다음과 같습니다.</P>

<TABLE BORDER="1" WIDTH="614" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주주명</TH>
<TH COLSPAN="2" WIDTH="248" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식수(주)</TH>
<TH COLSPAN="2" WIDTH="246" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">김수지</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">1,849,600</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">1,840,050</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">9.94</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">9.88</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">고준진</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">1,706,867</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">1,706,867</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">9.17</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">9.17</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">김운장</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">813,000</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">815,000</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">4.37</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">4.38</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">이한구</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">621,300</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">621,300</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">3.34</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">3.34</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">13,625,883</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">13,633,433</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">73.19</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">73.23</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">계</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">18,616,650</TD>
<TD WIDTH="124" ALIGN="RIGHT" HEIGHT="30">18,616,650</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">100</TD>
<TD WIDTH="123" ALIGN="RIGHT" HEIGHT="30">100</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL">당기말 현재 회사의 수권주식수는 60,000,000주(1주당금액: 500원)이며, 설립후  수차의 증자를 거쳐 당기말 현재 발행주식총수와 납입자본금은 각각 18,616,650주와 39,603,186천원 입니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 B">2. 재무제표 작성기준</SPAN>
<SPAN USERMARK="F-GL11">가. 별도재무제표의 작성기준회사는 한국채택국제회계기준을 적용하여 재무제표를 작성하고 있으며, 동 재무제표는 기업회계기준서 제1027호 '별도재무제표'에 따른 별도재무제표로, 별도재무제표는 지배기업 또는 피투자자에 대하여 공동지배력이나 유의적인 영향력이 있는 투자자가 투자자산을 원가법 또는 기업회계기준서 제1109호 '금융상품'에 따른 방법, 기업회계기준서 제1028호 '관계기업과 공동기업에 대한 투자'에서 규정하는 지분법 중 어느 하나를 적용하여 표시한 재무제표입니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">나. 측정기준회사의 재무제표는 아래에서 열거하고 있는 재무상태표의 주요항목을 제외하고는 역사적원가를 기준으로 작성되었습니다. </SPAN>
</P>
<P USERMARK="F-GL11">- 공정가치로 측정되는 금융상품</P>
<P USERMARK="F-GL11">- 확정급여채무의 현재가치에서 사외적립자산의 순공정가치와 미인식된 과거근무원   가를 차감한 확정급여부채</P>
<P USERMARK="F-GL11">다. 기능통화와 표시통화회사는 회사의 재무제표에 포함되는 항목들을 회사의 영업활동이 이루어지는 주된 경제환경의 통화(기능통화)로 표시하고 있습니다. 재무제표 작성을 위해 회사의 경영성과와 재무상태는 회사의 기능통화이면서 재무제표 작성을 위한 표시통화인 '원'으로 표시하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">라. 추정과 판단한국채택국제회계기준에서는 한국채택국제회계기준에 따라 재무제표를 작성함에 있어서 경영진으로 하여금 회계정책의 적용이나, 보고기간말 현재 자산, 부채 및 수익, 비용의 보고금액에 영향을 미치는 판단, 추정치, 가정의 사용을 요구하고 있습니다. 보고기간말 현재 경영진의 최선의 판단을 기준으로 한 추정치와 가정이 실제 환경과 다를 경우 실제 결과는 이러한 추정치와 다를 수 있습니다. 추정치와 추정에 대한 기본 가정은 지속적으로 검토되고 있으며, 회계추정의 변경은 추정이 변경된 기간과 미래 영향을 받을 기간 동안 인식되고 있습니다. </P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">3. 중요한 회계정책</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">가. 제ㆍ개정 기준서의 적용(1) 회사가 채택한 제ㆍ개정 기준서아래에서 설명하고 있는 2022년 1월 1일로 개시하는 회계기간부터 다음의 제 · 개정 기준서를 신규로 적용하였습니다.</SPAN>
</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 제ㆍ개정 기준서 및 해석서회사는 2021년 1월 1일로 개시하는 회계기간부터 다음의 제ㆍ개정 기준서를 신규로 적용하였습니다.</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">- 기업회계기준서 제1103호 ‘사업결합’ (개정) - ‘개념체계’에 대한 참조</SPAN>
</P>
<P USERMARK="F-GL11">인식할 자산과 부채의 정의를 개정된 재무보고를 위한 개념체계를 참조하도록 개정되었으나, 기업회계기준서 제1037호 ‘충당부채, 우발부채 및 우발자산’ 및 해석서 제2121호 ‘부담금’의 적용범위에 포함되는 부채 및 우발부채에 대해서는 해당 기준서를 적용하도록 예외를 추가하고, 우발자산이 취득일에 인식되지 않는다는 점을 명확히 하였습니다. </P>
<P USERMARK="F-GL11">동 개정사항이 재무제표에 미치는 유의적인 영향은 없습니다.</P>
<P USERMARK="F-GL11"></P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">- 기업회계기준서 제1016호 ‘유형자산’(개정) - 의도한 사용 전의 매각금액</SPAN>
</P>
<P USERMARK="F-GL11">동 개정사항은 유형자산이 사용 가능하기 전에 생산된 재화의 매각금액, 즉 경영진이 의도하는 방식으로 가동하는 데 필요한 장소와 상태에 이르게 하기 전에 생산된 재화의 매각금액)을 유형자산의 원가에서 차감하는 것을 금지합니다. 따라서 그러한 매각금액과 관련 원가를 당기손익으로 인식하며, 해당 원가는 기업회계기준서 제1002호에 따라 측정합니다.</P>
<P USERMARK="F-GL11">또한 동 개정사항은 ‘유형자산이 정상적으로 작동되는지 여부를 시험하는 것’의 의미를 명확히 하여 자산의 기술적, 물리적 성능이 재화나 용역의 생산이나 제공, 타인에 대한 임대 또는 관리활동에 사용할 수 있는 정도인지를 평가하는 것으로 명시합니다. </P>
<P USERMARK="F-GL11">동 개정사항은 이 개정내용을 처음 적용하는 재무제표에 표시된 가장 이른 기간의 개시일 이후에 경영진이 의도한 방식으로 가동할 수 있는 장소와 상태에 이른 유형자산에 대해서만 소급 적용합니다. 동 개정사항의 최초 적용 누적효과는 표시되는 가장 이른 기간의 시작일에 이익잉여금(또는 적절하다면 자본의 다른 구성요소)의 기초 잔액을 조정하여 인식합니다. </P>
<P USERMARK="F-GL11">동 개정사항이 재무제표에 미치는 유의적인 영향은 없습니다.</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">- 기업회계기준서 제1037호 ‘충당부채, 우발부채 및 우발자산’ (개정) - 손실부담계약의 계약이행원가</SPAN>
</P>
<P USERMARK="F-GL11">동 개정사항은 계약이 손실부담계약인지 또는 손실을 발생시키는 계약인지 평가할 때 기업이 포함해야할 원가를 명확하게 하였습니다.</P>
<P USERMARK="F-GL11">개정 기준서는 “직접 관련된 원가 접근법”을 적용합니다. 재화나 용역을 제공하는 계약에 직접적으로 관련되는 원가는 증분원가와 계약 활동에 직접적으로 관련되는 원가 배분액을 모두 포함합니다. 일반 관리 원가는 계약에 직접적으로 관련되지 않으며 계약에 따라 거래상대방에게 명시적으로 부과될 수 없다면 제외됩니다.</P>
<P USERMARK="F-GL11">동 개정사항은 이 개정사항을 최초로 적용하는 회계연도의 개시일에 모든 의무의 이행이 완료되지는 않은 계약에 적용합니다. 비교재무제표는 재작성 하지 않고, 그 대신 개정 내용을 최초로 적용함에 따른 누적효과를 최초적용일의 기초이익잉여금 또는 적절한 경우 다른 자본요소로 인식합니다.</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">동 개정사항이 재무제표에 미치는 유의적인 영향은 없습니다.- 한국채택국제회계기준 2018-2020 연차개선</SPAN>
</P>
<P USERMARK="F-GL11">1) 기업회계기준서 제 1101호 ‘한국채택국제회계기준의 최초채택’ - 최초채택기업인 종속기업</P>
<P USERMARK="F-GL11">동 개정사항은 지배기업보다 늦게 최초채택기업이 되는 종속기업의 누적환산차이의 회계처리와 관련하여 추가적인 면제를 제공합니다. 기업회계기준서 제 1101호 문단 D16(1)의 면제규정을 적용하는 종속기업은 지배기업의 한국채택국제회계기준 전환일에 기초하여 지배기업의 연결재무제표에 포함될 장부금액으로 모든 해외사업장의 누적환산차이를 측정하는 것을 선택할 수 있습니다. 다만 지배기업이 종속기업을 취득하는 사업결합의 효과와 연결절차에 따른 조정사항은 제외합니다. 관계기업이나 공동기업이 기업회계기준 제 1101호 문단 D16(1)의 면제규정을 적용하는 경우에도 비슷한 선택을 할 수 있습니다. </P>

<P USERMARK="F-11"> 
<SPAN USERMARK="F-GL">- 기업회계기준서 제1109호 ‘금융상품’ - 금융부채 제거 목적의 10% 테스트 관련 수수료</SPAN>
</P>
<P USERMARK="F-GL11">동 개정사항은 금융부채의 제거 여부를 평가하기 위해 ‘10%’ 테스트를 적용할 때, 기업(차입자)과 대여자 간에 수취하거나 지급하는 수수료만을 포함하며, 여기에는 기업이나 대여자가 다른 당사자를 대신하여 지급하거나 수취하는 수수료를 포함한다는 점을 명확히 하고 있습니다. 동 개정사항은 최초 적용일 이후 발생한 변경 및 교환에 대하여 전진적으로 적용됩니다. </P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">- 기업회계기준서 제1116호 ‘리스’ - 리스 인센티브</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">동 개정사항은 기업회계기준서 제1116호 사례13에서 리스개량 변제액에 대한 내용을 삭제하였습니다.</SPAN>
<SPAN USERMARK="F-GL">- </SPAN>
<SPAN USERMARK="F-GL11">기업회계기준서 제1041호 ‘농림어업’ - 공정가치 측정</SPAN>
</P>
<P USERMARK="F-GL11">동 개정사항은 생물자산의 공정가치를 측정할 때 세금 관련 현금흐름을 제외하는 요구사항을 삭제하였습니다. 이는 기업회계기준서 제1041호의 공정가치 측정과 내부적으로 일관된 현금흐름과 할인율을 사용하도록 하는 기업회계기준서 제1113호의 요구사항을 일치시키며, 기업은 가장 적절한 공정가치 측정을 위해 세전 또는 세후 현금흐름 및 할인율을 사용할지 선택할 수 있습니다. </P>
<P USERMARK="F-GL11">  동 개정사항이 재무제표에 미치는 유의적인 영향은 없습니다.</P>
<P></P>
<P USERMARK="F-GL11">(3) 회사가 적용하지 않은 제.개정 기준서제정ㆍ공표되었으나 아직 시행일이 도래하지 않아 적용하지 아니한 한국채택국제회계기준의 내역은 다음과 같습니다. </P>
<P USERMARK="F-GL11">- 기업회계기준서 제1001호 ‘재무제표 표시’ (개정) - 부채의 유동/비유동 분류</P>
<P USERMARK="F-GL11">동 개정사항은 유동부채와 비유동부채의 분류는 보고기간말에 존재하는 기업의 권리에 근거한다는 점을 명확히 하고 기업이 부채의 결제를 연기할 수 있는 권리를 행사할 지 여부에 대한 기대와는 무관하다는 점을 강조합니다. 그리고 보고기간말에 차입약정을 준수하고 있다면 해당 권리가 존재한다고 설명하고 결제는 현금, 지분상품, 그 밖의 자산 또는 용역을 거래상대방에게 이전하는 것으로 그 정의를 명확히 합니다. </P>
<P USERMARK="F-GL11">동 개정사항은 2023 년 1 월 1 일 이후 최초로 시작하는 회계연도의 개시일 이후 소급적으로 적용되며 조기적용이 허용됩니다.</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">- 기업회계기준서 제1001호 ‘재무제표 표시’ 및 국제회계기준 실무서2-‘중요성에 대한 판단’(개정) - 회계정책 공시</SPAN>
</P>
<P USERMARK="F-GL11">중요한 회계정책을 정의하고 공시하도록 하며, 중요성 개념을 적용하는 방법에 대한 지침을 제공하기 위하여 국제회계기준 실무서 2 ‘회계정책 공시’를 개정하였습니다. </P>
<P USERMARK="F-GL11">동 개정사항은 회계정책의 공시에 대한 기업회계기준서 제1001호의 요구사항을 변경하며, ‘유의적인 회계정책’이라는 모든 용어를 ‘중요한 회계정책 정보’로 대체합니다. </P>
<P USERMARK="F-GL11">기업회계기준서 제1001호 관련 문단도 중요하지 않는 거래, 그 밖의 사건 또는 상황과 관련되는 회계정책 정보는 중요하지 않으며 공시될 필요가 없다는 점을 명확히 하기 위해 개정합니다. 회계정책 정보는 금액이 중요하지 않을지라도 관련되는 거래, 그 밖의 사건 또는 상황의 성격 때문에 중요할 수 있습니다. 그러나 중요한 거래, 그 밖의 사건 또는 상황과 관련되는 모든 회계정책 정보가 그 자체로 중요한 것은 아닙니다. </P>
<P USERMARK="F-GL11">또한 국제회계기준 실무서2에서 기술한 ‘중요성 과정의 4단계’의 적용을 설명하고 적용하기 위한 지침과 사례가 개발되었습니다. </P>
<P USERMARK="F-GL11">동 개정사항은 2023년 1월 1일 이후 최초로 시작되는 회계연도부터 전진적으로 적용되며, 조기적용이 허용됩니다. 국제회계기준 실무서2에 대한 개정사항은 시행일이나 경과규정을 포함하지 않습니다.</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">- 기업회계기준서 제1008호 ‘회계정책, 회계추정치의 변경과 오류’(개정) ? 회계추정치의 정의</SPAN>
</P>
<P USERMARK="F-GL11">동 개정사항은 회계추정의 변경에 대한 정의를 회계추정치의 정의로 대체합니다. 새로운 정의에 따르면 회계추정치는 “측정불확실성의 영향을 받는 재무제표상 화폐금액”입니다.</P>
<P USERMARK="F-GL11">동 개정사항은 2023년 1월 1일 이후 최초로 시작되는 회계연도부터 적용하되 조기적용이 허용됩니다 이 개정내용을 처음 적용하는 회계연도 시작일 이후에 발생하는 회계추정치 변경과 회계정책 변경에 적용합니다. </P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">- 기업회계기준서 제1012호 ‘법인세’ - 단일 거래에서 생기는 자산과 부채에 관련되는 이연법인세</SPAN>
</P>
<P USERMARK="F-GL11">동 개정사항은 최초인식 예외규정의 적용범위를 축소합니다. 동 개정사항에 따르면 동일한 금액으로 가산할 일시적차이와 차감할 일시적차이를 생기게 하는 거래에는 최초인식 예외규정을 적용하지 않습니다.</P>
<P USERMARK="F-GL11">기업회계기준서 제1012호의 개정에 따라 관련된 이연법인세자산과 이연법인세부채를 인식해야 하며, 이연법인세자산의 인식은 기업회계기준서 제1012호의 회수가능성 요건을 따르게 됩니다.</P>
<P USERMARK="F-GL11">동 개정사항은 2023년 1월 1일 이후 최초로 시작되는 회계연도부터 적용되며 조기적용이 허용됩니다.</P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL">상기에 열거된 제ㆍ개정사항이 재무제표에 미치는 영향이 중요하지 않을 것으로 판단하고있습니다.</SPAN>
</P>
<P USERMARK="F-11"></P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">나. 외화거래회사의 재무제표 작성에 있어서 회사의 기능통화 외의 통화(외화)로 이루어진 거래는거래일의 환율을 적용하여 기록하고 있습니다. 매 보고기간 말에 화폐성 외화항목은 보고기간 말의 마감환율로 환산하고 있으며, 공정가치로 측정하는 비화폐성 외화항목은 공정가치가결정된 날의 환율로 환산하고, 역사적원가로 측정하는 비화폐성항목은 거래일의 환율로 환산하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">화폐성항목의 결제시점에 생기는 외환차이와 해외사업장순투자 환산차이 또는 현금흐름위험회피로 지정된 금융부채에서 발생한 환산차이를 제외한 화폐성항목의 환산으로 인해 발생한 외환차이는 모두 당기손익으로 인식하고 있습니다. 비화폐성항목에서 발생한 손익을 기타포괄손익으로 인식하는 경우에는 그 손익에 포함된 환율변동효과도 기타포괄손익으로 인식하고, 당기손익으로 인식하는 경우에는 환율변동효과도 당기손익으로 인식하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">다. 현금 및 현금성자산회사는 보유현금과 요구불예금, 유동성이 매우 높고 확정된 금액의 현금으로 전환이 용이하고 가치변동의 위험이 경미한 단기 투자자산을 현금 및 현금성자산으로 분류하고 있습니다. 지분상품은 현금성자산에서 제외하고 있으며 다만, 상환일이 정해져 있고 취득일로부터 상환일까지의 기간이 단기인 금융상품과 같이 실질적인 현금성자산인 경우에는 현금성자산에 포함하고 있습니다. 당좌차월은 현금 및 현금성자산에서 차감하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">라. 금융자산(1) 최초 인식과 측정</P>
<P USERMARK="F-GL11">금융자산은 최초 인식 시점에 후속적으로 상각후원가로 측정되는 금융자산, 기타포괄손익-공정가치 측정 금융자산, 그리고 당기손익-공정가치 측정 금융자산으로 분류됩니다.</P>
<P USERMARK="F-GL11">최초 인식 시점에 금융자산의 분류는 금융자산의 계약상 현금흐름 특성과 금융자산을 관리하기 위한 연결기업의 사업모형에 따라 달라집니다. 유의적인 금융요소가 포함되지 않거나 실무적 간편법을 적용하는 매출채권을 제외하고는, 기업은 금융자산을 최초에 공정가치로 측정하며, 당기손익-공정가치로 측정하는 금융자산의 경우가 아니라면 거래원가를 가감합니다. 유의적인 금융요소가 포함되지 않거나 실무적 간편법을 적용하지 않은 매출채권은 기업회계기준서 제1115호에 따라 결정된 거래원가로 측정합니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">금융자산을 상각후원가 또는 기타포괄손익-공정가치로 측정하기 위해서는 현금흐름이 원리금만으로 구성(SPPI)되어야 합니다. 이 평가는 SPPI 테스트라고 하며, 개별 상품 수준에서 수행됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">금융자산의 관리를 위한 기업의 사업모형은 현금흐름을 발생시키기 위해 금융자산을관리하는 방법과 관련됩니다. 사업모형은 현금흐름의 원천이 금융자산의 계약상 현금흐름의 수취인지, 매도인지 또는 둘 다 인지를 결정합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">시장의 합의나 규제에 의해 설정된 기간 프레임 내에서 금융자산을 이전하는 것이 요구되는 금융자산의 매입 또는 매도(정형화된 거래)는 거래일에 인식됩니다. 즉, 연결기업이 금융자산을 매입하거나 매도하기로 약정한 날을 의미합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 후속 측정</P>
<P USERMARK="F-GL11">후속 측정을 위해 금융자산은 아래 네 가지의 범주로 분류됩니다.</P>

<TABLE WIDTH="600" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="21"></COL>
<COL WIDTH="561"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="570" HEIGHT="30">상각후원가 측정 금융자산 (채무상품)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="570" HEIGHT="53">누적 손익을 당기손익으로 재순환하는 기타포괄손익-공정가치 측정 금융자산 (채무상품)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="570" HEIGHT="53">제거시 누적 손익을 당기손익으로 재순환하지 않는 기타포괄손익-공정가치 측정 금융자산 (지분상품)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="570" HEIGHT="30">당기손익-공정가치 측정 금융자산</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(3) 상각후원가 측정 금융자산 (채무상품)</P>
<P USERMARK="F-GL11">이 범주는 기업과 가장 관련이 높습니다. 기업은 아래 조건을 모두 만족하는 경우에 금융자산을 상각후원가로 측정합니다.</P>

<TABLE WIDTH="600" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="21"></COL>
<COL WIDTH="561"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="570" HEIGHT="53">계약상 현금흐름을 수취하기 위해 보유하는 것이 목적인 사업모형 하에서 금융자산을 보유하고,</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="570" HEIGHT="53">금융자산의 계약 조건에 따라 특정일에 원금과 원금잔액에 대한 이자 지급만으로 구성되어 있는 현금흐름이 발생한다.</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">상각후원가 측정 금융자산은 후속적으로 유효이자율(EIR)법을 사용하여 측정되며, 손상을 인식합니다. 자산의 제거, 변경 또는 손상에서 발생하는 이익과 손실은 당기손익으로 인식됩니다.</P>
<P USERMARK="F-GL11">(4) 기타포괄손익-공정가치측정금융자산 (채무상품)</P>
<P USERMARK="F-GL11">기업은 아래의 조건을 모두 충족하는 채무상품을 기타포괄손익-공정가치측정금융자산으로 측정합니다.</P>

<TABLE WIDTH="600" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="21"></COL>
<COL WIDTH="561"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="570" HEIGHT="53">계약상 현금흐름의 수취와 금융자산의 매도 둘 다를 통해 목적을 이루는 사업모형 하에서 금융자산을 보유하고,</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="53">-</TD>
<TD WIDTH="570" HEIGHT="53">금융자산의 계약 조건에 따라 특정일에 원리금 지급만으로 구성되어 있는 현금흐름이 발생한다.</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">기타포괄손익-공정가치측정채무상품에서, 이자수익, 외화환산손익, 그리고 손상 또는 환입은 상각후원가측정금융자산과 동일한 방법으로 계산되어 당기손익으로 인식됩니다. 나머지 공정가치 변동부분은 기타포괄손익으로 인식됩니다. 금융자산의제거시, 기타포괄손익으로 인식한 공정가치 누적 변동분은 당기손익으로 재순환됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">기업의 기타포괄손익-공정가치측정채무상품은 비유동자산으로 분류되는 채무상품에 포함됩니다.</P>
<P USERMARK="F-GL11">(5) 기타포괄손익-공정가치측정금융자산 (지분상품)</P>
<P USERMARK="F-GL11">최초 인식 시점에, 기업은 기업회계기준서 제1032호 ‘금융상품 표시’에서의 지분의 정의를 충족하고 투자 목적으로 보유하고 있지 않은 지분상품을 기타포괄손익-공정가치로 측정하도록 하는 취소 불가능한 선택을 할 수 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">이러한 금융자산에서 발생하는 손익은 당기손익으로 재순환되지 않습니다. 배당은 연결기업이 금융자산의 원가 중 일부를 회수하여 이익을 얻는 경우를 제외하고는, 받을 권리가 확정되었을 때 손익계산서에 기타수익으로 인식되며, 기타포괄손익으로 처리됩니다. 기타포괄손익-공정가치 측정 지분상품은 손상을 인식하지 않습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">기업은 비상장지분상품에 대해서도 취소불가능한 선택을 할 수 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(6) 당기손익-공정가치측정금융자산</P>
<P USERMARK="F-GL11">당기손익-공정가치 측정 금융자산은 단기매매항목, 최초 인식 시에 당기손익-공정가치로 측정하도록 지정된 금융자산 또는 공정가치로 측정하도록 요구되는 금융자산을 포함합니다. 단기간 내에 매도하거나 재구매할 목적으로 취득한 금융자산은 단기매매항목으로 분류됩니다. 분리된 내재파생상품을 포함한 파생상품은 효과적인 위험회피수단으로 지정되지 않았다면 단기매매항목으로 분류됩니다. 현금흐름이 원리금 지급만으로 구성되지 않은 금융자산은 사업모형에 관계없이 당기손익-공정가치 측정 금융자산으로 분류 및 측정됩니다. 상기 문단에서 서술된 것과 같이 채무상품이 상각후원가 또는 기타포괄손익-공정가치 측정 금융자산으로 분류됨에도 불구하고 회계 불일치를 제거하거나 유의적으로 감소시킬 수 있습니다면 채무상품을 당기손익-공정가치로 측정하도록 지정할 수 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">당기손익-공정가치 측정 금융자산은 재무상태표에 공정가치로 표시되며, 공정가치의 순변동은 손익계산서에서 당기손익으로 인식됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">이 범주는 파생상품과 공정가치의 변동을 기타포괄손익으로 처리하는 취소불가능한 선택을 하지않은 상장 지분 상품을 포함합니다. 상장 지분 상품에 대한 배당은 권리가 확정된 시점에 당기손익으로 인식합니다.</P>
<P USERMARK="F-GL11">복합계약에 내재된 파생상품은 경제적인 특성과 위험이 주계약에 밀접하게 관련되지않고, 내재파생상품과 동일한 조건인 별도의 상품이 파생상품의 정의를 충족하며, 복합계약이 당기손익-공정가치로 측정되지 않는다면 주계약으로부터 분리하여 별도의파생상품으로 회계처리합니다. 내재파생상품은 공정가치로 측정하고 공정가치의 변동을 당기손익으로 인식합니다. 현금흐름을 유의적으로 변경시키는 계약 조건의 변경이 있거나 당기손익-공정가치 측정 범주에 해당하지 않게 되는 경우에만 재평가가발생합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">주계약이 금융자산인 복합계약에서 내재파생상품은 분리하여 회계처리하지 않습니다. 주계약인 금융자산과 내재파생상품은 상품 전체를 당기손익-공정가치 측정 금융자산으로 분류합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(7) 제거</P>
<P USERMARK="F-GL11">금융자산 (또는, 금융자산의 일부 또는 비슷한 금융자산의 집합의 일부)는 다음과 같은 상황에서 우선적으로 제거됩니다.</P>

<TABLE WIDTH="600" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="21"></COL>
<COL WIDTH="561"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="570" HEIGHT="30">금융자산의 현금흐름을 수취할 권리가 소멸되거나</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="122">-</TD>
<TD WIDTH="570" HEIGHT="122">회사가 금융자산의 현금흐름을 수취할 권리를 양도하거나 양도(pass-through) 계약에 따라 수취한 현금흐름 전체를 중요한 지체 없이 제3자에게 지급할 의무가 있다. 이 경우에 연결기업은 금융자산의 보유에 따른 위험과 보상의 대부분을 이전하거나 금융자산의 보유에 따른 위험과 보상의 대부분을 이전하지도 보유하지도 않으나 자산에 대한 통제를 이전한다.</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">기업이 금융자산의 현금흐름을 수취할 권리를 이전하거나 양도(pass-through) 계약을 체결할 때, 자산을 소유함에 따른 위험과 보상을 유지하는지를 평가합니다. 기업이 금융자산의 위험과 보상의 대부분을 보유하지도 이전하지도 않았다면, 해당 금융자산에 지속적으로 관여하는 정도까지 그 금융자산을 계속 인식합니다. 이 경우에, 기업은 관련된 부채를 인식합니다. 양도된 자산과 관련된 부채는 기업이 보유한 권리와 의무를 반영하여 측정합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">보증을 제공하는 형태인 지속적 관여는, 양도된 자산의 장부금액과 수취한 대가 중 상환을 요구받을 수 있는 최대 금액 중 낮은 금액으로 측정됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(8) 금융자산의 손상</P>
<P USERMARK="F-GL11">금융자산의 손상과 관련된 자세한 공시 사항은 아래 주석에 제공됩니다.</P>

<TABLE WIDTH="600" BORDER="1" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="21"></COL>
<COL WIDTH="561"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="570" HEIGHT="30">유의적인 가정에 대한 공시</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="570" HEIGHT="30">기타포괄손익-공정가치로 측정되는 채무상품</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="30" ALIGN="CENTER" HEIGHT="30"></TD>
<TD WIDTH="570" HEIGHT="30">계약 자산을 포함한 매출채권</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">기업은 당기손익-공정가치 항목을 제외한 모든 채무상품에 대하여 기대신용손실(ECL)에 대한 충당금을 인식합니다. 기대신용손실은 계약상 수취하기로 한 현금흐름과 연결기업이 수취할 것으로 예상하는 모든 현금흐름의 차이를 최초의 유효이자율로 할인하여 추정합니다. 예상되는 현금흐름은 보유한 담보를 처분하거나 계약의 필수 조건인 그 밖의 신용 보강으로부터 발생하는 현금흐름을 포함합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">기대신용손실은 두 개의 stage로 인식합니다. 최초 인식 이후 신용위험의 유의적인 증가가 없는 신용 익스포저에 대하여, 기대신용손실은 향후 12개월 내에 발생할 가능성이 있는 채무불이행 사건으로부터 발생하는 신용손실(12개월 기대신용손실)을 반영합니다. 최초 인식 이후 신용위험의 유의적인 증가가 있는 신용 익스포저에 대하여, 손실충당금은 채무불이행 사건이 발생하는 시기와 무관하게 익스포저의 남은 존속기간에 대한 기대신용손실(전체기간 기대신용손실)을 측정하도록 요구됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">매출채권과 계약자산에 대하여, 기업은 기대신용손실 계산에 간편법을 적용할 수 있습니다. 따라서, 기업은 신용위험의 변동을 추적하지 않는 대신에, 각 결산일에 전체기간 기대신용손실에 해당하는 금액으로 손실충당금을 인식합니다. 기업은 특정 채무자에 대한 미래전망정보와 경제적 환경을 반영하여 조정된 과거 신용손실 경험에 근거하여 충당금 설정률표를 설정합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">기타포괄손익-공정가치 측정 채무상품에 대하여, 기업은 낮은 신용위험 간편법을 적용합니다. 매 결산일에, 기업은 과도한 원가나 노력 없이 이용할 수 있는 합리적이고 뒷받침될 수 있는 모든 정보를 사용하여 채무상품이 낮은 신용위험을 가지고 있는지 평가합니다. 이러한 평가를 위해서, 기업은 채무상품의 내부 신용등급을 재평가합니다. 또한, 기업은 계약상의 지급이 30일을 초과하였을 때 신용위험의 유의적인 증가가 있는지를 고려합니다.</P>
<P USERMARK="F-GL11">기업의 기타포괄손익-공정가치 측정 채무상품이 최상위 투자등급에 해당하는 상장 채권만으로 구성되어 있다면 낮은 신용 위험 투자자산으로 평가됩니다. 기업의 정책은 이러한 상품을 12개월 기대신용손실로 측정하는 것입니다. 그러나, 최초 인식 이후에 신용위험의 유의적인 증가가 있다면 손실충당금은 전체기간 기대신용손실에 근거하여 산출됩니다. 기업은 채무상품의 신용위험이 유의적으로 증가했는지를 결정하고 기대신용손실을 측정하기 위해 신용평가기관의 등급을 사용합니다.기업은 계약상 지급이 90일을 초과하여 연체되는 경우에 채무불이행이 발생한 것으로 봅니다. 그러나, 특정 상황에서, 기업은 내부 또는 외부 정보가 기업에 의한 모든 신용보강을 고려하기 전에는 기업이 계약상의 원금 전체를 수취하지 못할 것을 나타내는 경우에 금융자산에 채무불이행 사건이 발생했다고 볼 수 있습니다. 금융자산은 계약상 현금흐름을 회수하는 데에 합리적인 기대가 없을 때 제거됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">마. 금융부채(1) 최초 인식과 측정</P>
<P USERMARK="F-GL11">금융부채는 최초 인식 시점에 당기손익-공정가치 측정 금융부채, 대출과 차입, 미지급금 또는 효과적인 위험회피 수단으로 지정된 파생상품으로 적절하게 분류됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">모든 금융부채는 최초에 공정가치로 인식되고, 대여금, 차입금 및 미지급금의 경우에는 직접 관련된 거래원가를 차감합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">기업의 금융부채는 매입부채와 기타 미지급금, 당좌차월을 포함한 대여 및 차입과 파생상품부채를 포함합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 후속 측정</P>
<P USERMARK="F-GL11">금융부채의 측정은 아래에서 언급된 분류에 따릅니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(a) 당기손익-공정가치 측정 금융부채</P>
<P USERMARK="F-GL11">당기손익-공정가치 측정 금융부채는 단기매매금융부채와 최초 인식 시점에 당기손익-공정가치로 측정하도록 지정된 금융부채를 포함합니다. </P>
<P USERMARK="F-GL11">금융부채가 단기간 내에 재매입되는 경우에는 단기매매항목으로 분류됩니다. 이 범주는 또한 기업회계기준서 제1109호에서 정의된 위험회피관계에 있는 위험회피수단으로 지정되지 않은 파생상품을 포함합니다. 또한 분리된 내재파생상품은 위험회피에 효과적인 수단으로 지정되지 않았다면 단기매매항목으로 분류됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">단기매매항목인 금융부채에서 발생하는 손익은 당기손익으로 인식됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">당기손익-공정가치 항목으로 지정된 금융부채는 기업회계기준서 제1109호의 기준을 충족하는 경우에 최초 인식 시점에만 지정됩니다. </P>
<P USERMARK="F-GL11">(b) 대여금 및 차입금</P>
<P USERMARK="F-GL11">이 범주는 기업과 관련이 높습니다. 최초 인식 이후에, 이자부 대여금과 차입금은 후속적으로 유효이자율법을 사용하여 상각후원가로 측정됩니다. 부채가 제거되거나 유효이자율 상각 절차에 따라 발생하는 손익은 당기손익으로 인식됩니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">상각후원가는 유효이자율의 필수적인 부분인 수수료나 원가에 대한 할인이나 할증액을 고려하여 계산됩니다. 이 범주는 일반적으로 이자부 대여나 차입에 적용합니다. (3) 제거금융부채는 지급 의무의 이행, 취소, 또는 만료된 경우에 제거됩니다. 기존 금융부채가 대여자는 동일하지만 조건이 실질적으로 다른 금융부채에 의해 교환되거나, 기존 부채의 조건이 실질적으로 변경된 경우에, 이러한 교환이나 변경은 최초의 부채를 제거하고 새로운 부채를 인식하게 합니다. 각 장부금액의 차이는 당기손익으로 인식합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(4) 금융상품의 상계금융자산과 금융부채는 인식한 자산과 부채에 대해 법적으로 집행 가능한 상계 권리를 현재 가지고 있거나, 차액으로 결제하거나 자산을 실현하는 동시에 부채를 결제할의도가 있는 경우에 재무상태표에서 상계하여 순액으로 표시됩니다.</P>
<P USERMARK="F-GL11">바. 납입자본보통주는 자본으로 분류하며 자본거래에 직접 관련되어 발생하는 증분원가는 세금효과를 반영한 순액으로 자본에서 차감하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">회사가 자기 지분상품을 재취득하는 경우에 이러한 지분상품은 자기주식의 과목으로자본에서 직접 차감하고 있습니다. 자기지분상품을 매입 또는 매도하거나 발행 또는 소각하는 경우의 손익은 당기손익으로 인식하지 아니합니다. 회사가 자기주식을 취득하여 보유하는 경우 지급하거나 수취한 대가는 자본에서 직접 인식하고 있습니다. </P>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">사. 유형자산유형자산은 최초에 원가로 측정하여 인식하고 있으며, 유형자산의 원가에는 경영진이 의도하는 방식으로 자산을 가동하는데 필요한 장소와 상태에 이르게 하는데 직접 관련되는 원가 및 자산을 해체, 제거하거나 부지를 복구하는데 소요될 것으로 추정되는 원가가 포함됩니다. </SPAN>
</P>
<P USERMARK="F-GL11">유형자산의 일부를 대체할 때 발생하는 원가는 해당 자산으로부터 발생하는 미래 경제적 효익이 회사에 유입될 가능성이 높으며 그 원가를 신뢰성 있게 측정할 수 있는 경우에 자산의 장부금액에 포함하거나 적절한 경우 별도의 자산으로 인식하고 있습니다. 이 때 대체된 부분의 장부금액은 제거하고 있습니다. 그 외의 일상적인 수선ㆍ유지와 관련하여 발생하는 원가는 발생시점에 당기손익으로 인식하고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">유형자산 중 토지는 감가상각을 하지 않으며, 그 외 유형자산은 자산의 취득원가에서잔존가치를 차감한 금액에 대하여 아래에 제시된 경제적 내용연수에 걸쳐 해당 자산에 내재되어 있는 미래 경제적 효익의 예상 소비 형태를 가장 잘 반영한 방법으로 상각하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">유형자산을 구성하는 일부의 원가가 당해 유형자산의 전체원가와 비교하여 유의적이라면, 해당 유형자산을 감가상각할 때 그 부분은 별도로 구분하여 감가상각하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">유형자산의 제거로 인하여 발생하는 손익은 순매각금액과 장부금액의 차이로 결정되고 기타손익(유형자산 처분손익 등)으로 인식합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">당기 및 전기의 추정 내용연수 및 감가상각방법은 다음과 같습니다. </P>

<TABLE BORDER="1" WIDTH="668" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="112" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="112" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용연수</TH>
<TH WIDTH="111" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각방법</TH>
<TH WIDTH="111" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="111" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용연수</TH>
<TH WIDTH="111" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER">건물</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER">40년</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">정액법</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">차량운반구</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">5년</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">정액법</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER">기계장치</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER">5년~12년</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">정액법</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">비품</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">5년</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER">정액법</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">회사는 매 회계연도 말에 자산의 잔존가치와 내용연수 및 감가상각방법을 재검토하고 재검토 결과 추정치가 종전 추정치와 다르다면 그 차이는 회계추정의 변경으로 처리하고 있습니다. </P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">아. 차입원가적격자산의 취득, 건설 또는 제조와 직접 관련된 차입원가는 당해 자산 원가의 일부로 자본화하고 있으며, 기타차입원가는 발생기간에 비용으로 인식하고 있습니다. 적격자산이란 의도된 용도로 사용하거나 판매가능한 상태가 될 때까지 상당한 기간을 필요로 하는 자산을 말하며, 금융자산과 단기간 내에 제조되거나 다른 방법으로 생산되는 재고자산은 적격자산에 해당되지 아니하며, 취득시점에 의도된 용도로 사용할 수 있거나 판매가능한 상태에 있는 자산인 경우에도 적격자산에 해당되지 아니합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">적격자산을 취득하기 위한 목적으로 특정하여 차입한 자금에 한하여, 회계기간 동안 그 차입금으로부터 실제 발생한 차입원가에서 당해 차입금의 일시적 운용에서 생긴 투자수익을 차감한 금액을 자본화가능차입원가로 결정하며, 일반적인 목적으로 자금을 차입하고 이를 적격자산의 취득을 위해 사용하는 경우에 한하여 당해 자산 관련 지출액에 자본화이자율을 적용하는 방식으로 자본화가능차입원가를 결정하고 있습니다. 자본화이자율은 회계기간동안 차입한 자금(적격자산을 취득하기 위해 특정 목적으로 차입한 자금 제외)으로부터 발생된 차입원가를 가중평균하여 산정하고 있습니다. 회계기간 동안 자본화한 차입원가는 당해 기간동안 실제 발생한 차입원가를 초과할 수 없습니다.</P>
<P USERMARK="F-GL11">자. 무형자산무형자산은 최초 인식할 때 원가로 측정하며, 최초 인식 후에 원가에서 상각누계액과손상차손누계액을 차감한 금액을 장부금액으로 인식하고 있습니다. </P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">영업권을 제외한 무형자산은 사용 가능한 시점부터 잔존가치를 영("0")으로 하여 아래의 내용연수 동안 정액법으로 상각하고 있습니다. 다만, 일부 무형자산에 대해서는이를 이용할 수 있을 것으로 기대되는 기간에 대하여 예측가능한 제한이 없으므로 당해 무형자산의 내용년수가 비한정인 것으로 평가하고 상각하지 아니하고 있습니다. </P>

<TABLE BORDER="1" WIDTH="608" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="152" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="152" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용연수</TH>
<TH WIDTH="152" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="152" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용연수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">특허권과 상표권</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">10년</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">회원권</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">비한정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">전기공급시설이용권</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">비한정</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">개발비</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">5년 ~ 10년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">기타의무형자산</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">5년</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">내용연수가 유한한 무형자산의 상각기간과 상각방법은 매 회계연도 말에 재검토하고내용연수가 비한정인 무형자산에 대해서는 그 자산의 내용연수가 비한정이라는 평가가 계속하여 정당한 지를 매 회계기간에 재검토하며, 이를 변경하는 것이 적절하다고판단되는 경우 회계추정의 변경으로 처리하고 있습니다. </P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">(1) 연구 및 개발연구 또는 내부프로젝트의 연구단계에 대한 지출은 발생시점에 비용으로 인식하고 있습니다. 개발단계의 지출은 자산을 완성할 수 있는 기술적 실현가능성, 자산을 완성하여 사용하거나 판매하려는 기업의 의도와 능력 및 필요한 자원의 입수가능성, 무형자산의 미래 경제적 효익을 모두 제시할 수 있고, 관련 지출을 신뢰성 있게 측정할 수 있는 경우에 무형자산으로 인식하고 있으며, 기타 개발관련 지출은 발생시점에 비용으로 인식하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 후속지출후속지출은 관련되는 특정자산에 속하는 미래의 경제적 효익이 증가하는 경우에만 자본화하며, 내부적으로 창출한 영업권 및 상표명 등을 포함한 다른 지출들은 발생 즉시 비용화하고 있습니다.</P>
<P USERMARK="F-GL11">차. 투자부동산</P>
<P USERMARK="F-GL11">임대수익이나 시세차익을 얻기 위하여 보유하는 부동산은 투자부동산으로 분류하고 있습니다. 투자부동산은 최초 인식시점에 거래원가를 포함하여 원가로 측정하고 있으며, 최초인식 후에는 공정가치로 측정하고 공정가치 변동으로 발생하는 손익은 발생한 기간의 당기손익에 반영하고 있습니다.</P>
<P USERMARK="F-GL11">자가사용의 개시나 정상적인 영업과정에서 판매를 위한 개발의 시작으로 공정가치로평가한 투자부동산을 유형자산이나 재고자산으로 대체하는 경우에는 사용목적 변경시점의 공정가치를 간주원가로 평가하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">자가사용의 종료로 자가사용부동산을 공정가치로 평가하는 투자부동산으로 대체하는 경우 사용목적 변경시점의 공정가치로 재측정하고 투자부동산으로 재분류합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">카. 리스</P>
<P USERMARK="F-GL11">(1) 사용권자산 </P>
<P USERMARK="F-GL11">회사는 리스개시일(즉, 기초자산을 사용할 수 있는 날)에 사용권자산을 인식합니다. 사용권자산은 원가로 측정하고 감가상각누계액과 손상차손누계액을 차감한 금액으로 측정하며, 리스부채의 재측정이 발생하는 경우 조정합니다. 사용권자산의 원가에는 리스부채 인식금액, 리스개설직접원가 발생액이 포함되며, 리스개시일이나 그 전에 지급한 리스선급금이나 인센티브는 가감합니다. 회사가 리스기간 종료시점에 리스자산에 대한 소유권을 얻을 것이라고 합리적으로 예측되지 않는다면, 사용권자산은 추정내용연수와 리스기간 중 더 짧은 기간에 걸쳐 정액 기준으로 감가상각합니다.회사는 사용권자산에 대한 손상 검토를 수행합니다.당기말 현재 추정 내용연수 및 감가상각방법은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="604">

<COLGROUP>
<COL WIDTH="293"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="302" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="302" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용연수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="30" ALIGN="CENTER">건물</TD>
<TD WIDTH="302" HEIGHT="30" ALIGN="CENTER">2 ~ 4년</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="302" HEIGHT="30" ALIGN="CENTER">차량운반구</TD>
<TD WIDTH="302" HEIGHT="30" ALIGN="CENTER">2 ~ 3년</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11">(2) 리스부채 </P>
<P USERMARK="F-GL11">회사는 리스개시일에 그날 현재 지급하지 않은 리스료의 현재가치로 리스부채를 측정합니다. 리스료에는 받을 리스 인센티브를 제외한 고정리스료(실질적인 고정리스료를 포함), 지수나 요율에 따라 달라지는 변동리스료와 잔존가치 보증에 따라 회사가 지급할 것으로 예상되는 금액이 포함됩니다. 또한 회사는 매수선택권을 행사할 것이 상당히 확실한 경우에 그 매수선택권의 행사가격과 리스기간이 회사의 종료선택권 행사를 반영하는 경우에 그 리스를 종료하기 위하여 부담하는 금액을 리스료에 포함합니다. 지수나 요율에 따라 달라지지 않는 변동리스료는 리스료를 지급하는 사건이 발생한 기간의 비용으로 인식합니다</P>
<P USERMARK="F-GL11">회사는 리스료의 현재가치를 계산할 때, 리스의 내재이자율을 쉽게 산정할 수 없는 경우에는 리스개시일의 증분차입이자율을 사용합니다. 회사는 리스개시일후에 리스부채에 대한 이자를 반영하여 리스부채의 장부금액을 증액하고, 지급한 리스료를 반영하여 리스부채의장부금액을 감액합니다. 또한 회사는 리스의 변경을 반영하거나 실질적인 고정리스료의 변경을 반영하거나 리스 기간의 변경 또는 기초자산 매수선택권 평가의 변경이 있는 경우 이 변경을 반영하여 리스부채를 재측정 합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(3) 단기리스 및 소액자산리스</P>
<P USERMARK="F-GL11">회사는 차량운반구 및 장비의 단기리스(예, 리스 기간이 리스개시일로부터 12개월 이하이고 매수선택권이 없는 리스)에 대해 인식면제를 적용합니다. 또한, 가치가 낮은 사무용 장비(예, USD 5,000이하인 리스)에 대해 소액자산리스로 인식면제를 적용합니다. 단기리스와 소액자산리스에 대한 리스료는 리스기간에 걸쳐 정액기준으로 비용을 인식합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(4) 연장선택권이 있는 계약에서 계약기간을 결정할 때 중요한 판단</P>
<P USERMARK="F-GL11">회사는 리스의 해지불능기간에 리스 연장선택권을 행사할 것이 상당히 확실한 경우에 그 선택권의 대상 기간과 리스 종료선택권을 행사하지 않을 것이 상당히 확실한 경우에 그 선택권의 대상 기간을 포함하여 리스기간을 산정합니다. 회사는 이 선택권의 행사가능성이 상당히 확실한지를 평가할 때 판단을 적용합니다. 즉, 연장선택권을행사할 경제적 유인이 생기게 하는 모든 관련 요소를 고려합니다. 리스개시일 이후에중요한 영향을 미치는 사건이나 상황이 변하거나 통제할 수 있는 상황에 변화가 발생하여 선택권의 행사가능성 (또는 행사하지 않을 가능성)에 영향을 미친다면(예를 들어, 사업 전략의 변경), 회사는 리스 기간을 재평가 합니다. 회사는 계약기간 연장선택권의 사용유무가 재무제표에 미치는 중요성을 고려하여 리스 연장선택권 대상기간을 리스 기간에 포함하지 않습니다. </P>
<P USERMARK="F-GL11">타. 재고자산</P>
<P USERMARK="F-GL11">재고자산은 취득원가와 순실현가능가치 중 낮은 금액으로 측정하고 있습니다. 재고자산의 단위원가는 선입선출법(원재료와 부재료는 이동평균법)으로 결정하고 있으며취득원가는 매입원가, 전환원가 및 재고자산을 현재의 장소에 이르게 하는데 발생한 기타 모든 원가를 포함하고 있습니다. 제품이나 재공품의 원가에 포함되는 고정제조간접원가는 생산설비의 정상조업도에 기초하여 배부하고 있으며, 또한 원가에는 기타포괄손익으로 인식하였던 재고자산 구입을 위한 현금흐름위험회피로부터 발생한 손익이 포함될 수 있습니다. 재고자산의 판매 시, 관련된 수익을 인식하는 기간에 재고자산의 장부금액을 매출원가로 인식하며, 재고자산을 순실현가능가치로 감액한 평가손실과 모든 감모손실은 감액이나 감모가 발생한 기간에 비용으로 인식하고 있습니다. 또한 재고자산의 순실현가능가치의 상승으로 인한 재고자산평가손실의 환입은 환입이 발생한 기간의 비용으로 인식된 재고자산의 매출원가에서 차감하고 있습니다.파. 비금융자산의 손상상각대상 자산에 대하여 자산손상을 시사하는 징후가 있을 때 손상검사를 수행하고 있습니다. 손상차손은 회수가능액(사용가치 또는 처분부대원가를 차감한 공정가치 중 높은 금액)을 초과하는 장부금액만큼 인식되고 영업권 이외의 비금융자산에 대한 손상차손은 매 보고기간말에 환입가능성이 검토됩니다.회수가능액은 개별 자산별로, 또는 개별 자산의 회수가능액을 추정할 수 없다면 그 자산이 속하는 현금창출단위별로 회수가능액을 추정하고 있습니다. 회수가능액은 사용가치와 순공정가치 중 큰 금액으로 결정하고 있습니다. 사용가치는 자산이나 현금창출단위에서 창출될 것으로 기대되는 미래현금흐름을 화폐의 시간가치 및 미래현금흐름을 추정할 때 조정되지 아니한 자산의 특유위험에 대한 현행 시장의 평가를 반영한 세전할인율로 할인하여 추정합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">자산이나 현금창출단위의 회수가능액이 장부금액에 미달하는 경우 자산의 장부금액을 감소시키며 즉시 당기손익으로 인식하고 있습니다. </P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">사업결합으로 취득한 영업권은 사업결합으로 인한 시너지효과의 혜택을 받게 될 것으로 기대되는 각 현금창출단위에 배분합니다. 현금창출단위에 대한 손상차손은 우선, 현금창출단위에 배분된 영업권의 장부금액을 감소시키고, 그 다음 현금창출단위에 속하는 다른 자산 각각의 장부금액에 비례하여 자산의 장부금액을 감소시키고 있습니다. 영업권에 대해 인식한 손상차손은 후속기간에 환입할 수 없습니다.  매 보고기간말에 영업권을 제외한 자산에 대해 과거기간에 인식한 손상차손이 더 이상 존재하지 않거나 감소된 것을 시사하는 징후가 있는지를 검토하고 직전 손상차손의 인식시점 이후 회수가능액을 결정하는 데 사용된 추정치에 변화가 있는 경우에만 환입합니다. 손상차손환입으로 증가된 장부금액은 과거에 손상차손을 인식하기 전 장부금액의 감가상각 또는 상각 후 잔액을 초과할 수 없습니다.</P>
<P USERMARK="F-GL11">하. 매각예정비유동자산</P>
<P USERMARK="F-GL11">비유동자산 또는 처분자산집단의 장부금액이 계속 사용이 아닌 매각거래를 통하여 주로 회수될 것으로 예상된다면 이를 매각예정자산으로 분류하고 있습니다. 이러한 조건은 당해 자산(또는 처분자산집단)이 현재의 상태로 즉시 매각가능하여야 하며 매각될 가능성이 매우 높을 때에만 충족된 것으로 간주하고 있습니다. 자산(또는 처분자산집단)을 매각예정으로 최초 분류하기 직전에 해당 자산(또는 자산과 부채)의 장부금액과 순공정가치 중 작은 금액으로 측정하고 있습니다. 자산의 순공정가치가 하락하면 손상차손을 즉시 당기손익으로 인식하고, 순공정가치가 증가하면 과거에 인식하였던 손상차손누계액을 한도로 하여 이익으로 인식하고 있습니다. </P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">비유동자산이 매각예정으로 분류되거나 매각예정으로 분류된 처분자산집단의 일부인 경우에는 그 자산은 상각하지 아니하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">거. 종업원급여</P>
<P USERMARK="F-GL11">(1) 단기종업원급여종업원이 관련 근무용역을 제공한 회계기간의 말부터 12개월 이내에 결제될 단기종업원급여는 근무용역과 교환하여 지급이 예상되는 금액을, 근무용역이 제공된 때에 당기손익으로 인식하고 있습니다. 단기종업원급여는 할인하지 않은 금액으로 측정하고 있습니다. 종업원이 과거 근무용역의 결과 회사가 지급해야 할 법적의무 또는 의제의무가 있고, 그 채무금액을 신뢰성있게 추정할 있다면 이익분배금 및 상여금으로 지급이 예상되는 금액을 부채로 인식하고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">(2) 기타장기종업원급여종업원이 관련 근무용역을 제공한 회계기간의 말일부터 12개월 이내에 지급되지 않을 기타장기종업원급여는 당기와 과거기간에 제공한 근무용역의 대가로 획득한 미래의 급여액을 현재가치로 할인하고, 관련 채무를 직접 결제하는 데 사용할 수 있는 사외적립자산의 공정가치를 차감하여 부채로 인식하고 있습니다. 부채는 관련 급여의 만기와 유사한 만기를 가지는 우량회사채의 이자율을 사용하여 추정 미래 현금흐름을 할인한 후 결정되고 있습니다. 보험수리적 가정의 변동과 경험적 조정에서 발생하는 손익은 발생한 기간에 전액 당기손익으로 인식하고 있습니다. </P>

<P>
<SPAN USERMARK="F-GL11">(3) 퇴직급여확정급여형퇴직급여제도의 경우, 확정급여채무는 독립된 보험계리법인에 의해 예측단위적립방식을 이용하여 매 보고기간 말에 보험수리적 평가를 수행하여 계산하고 있습니다. 확정급여채무의 현재가치는 관련 퇴직급여채무의 지급시점과 만기가 유사한 우량회사채의 시장수익률로 기대미래현금유출액을 할인하여 산정하고 있습니다. </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">그러나 그러한 회사채에 대해 거래층이 두터운 시장이 없는 경우에는 보고기간말 현재 국공채의 시장수익률을 사용합니다. 보험수리적가정의 변경 및 보험수리적가정과실제로 발생한 결과의 차이에서 발생하는 보험수리적손익은 발생한 기간의 포괄손익계산서에 기타포괄손익으로 인식하고 있습니다. 기타포괄손익으로 인식한 보험수리적손익은 즉시 이익잉여금으로 인식하며, 그 후의 기간에 당기손익으로 재분류하지 않습니다. 과거근무원가는 이미 가득된 급여액을 한도로 즉시 인식되고, 그렇지 않을경우 관련 급여액이 가득될 때까지의 평균기간 동안 정액기준으로 상각하고 있습니다. 재무상태표상 퇴직급여채무는 미인식과거근무원가를 반영한 확정급여채무의 현재가치에서 사외적립자산의 공정가치를 차감하여 인식하고 있습니다. 이러한 계산으로산출된 순액이 자산일 경우, 이는 미인식과거근무원가에 환급가능금액과 미래 기여금감소액의 현재가치를 가산한 금액을 한도로 자산으로 인식하고 있습니다. </SPAN>
</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11">(4) 해고급여회사가 통상적인 퇴직시점 이전에 종업원을 해고할 것을 현실적인 철회가능성이 없이 명시적으로 확약하거나, 회사가 종업원에게 명예퇴직에 대한 해고급여를 제안하고 종업원이 자발적으로 제안을 수락하는 경우 해고급여를 당기 손익으로 인식하고 있습니다. 종업원에게 자발적 명예퇴직을 제안하는 경우에는 제안을 수락할 것으로 기대되는 종업원의 수에 기초하여 해고급여를 측정하여 당기 손익으로 인식하고 있습니다. 해고급여의 지급기일이 보고기간 후 12개월이 지난 후에 도래하는 경우에는현재가치로 할인하고 있습니다. </P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">너. 충당부채</P>
<P USERMARK="F-GL11">과거사건의 결과, 현재의 법적의무 또는 의제의무가 존재하고, 당해 의무를 이행하기위하여 경제적효익을 갖는 자원이 유출될 가능성이 높으며, 당해 의무의 이행에 소요되는 금액을 신뢰성 있게 추정할 수 있는 경우에 충당부채를 인식하고 있습니다. 부채에 대한 최선의 추정치를 구할 때는 관련된 사건과 상황에 대한 불가피한 위험과 불확실성을 고려하고 있으며, 화폐의 시간가치가 중요한 경우에는 의무를 이행하기 위하여 예상되는 지출액의 현재가치로 평가하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">매 보고기간 말마다 충당부채의 잔액을 검토하고, 보고기간 말 현재 최선의 추정치를반영하여 조정하고 있습니다. 의무이행을 위하여 경제적 효익을 갖는 자원이 유출된 가능성이 더 이상 높지 않은 경우에는 관련 충당부채를 환입하고 있습니다. </P>
<P USERMARK="F-GL11">(1) 반품충당부채회사는 판매시점에 반품이 예상되는 부분의 매출액을 차감하고 매출에 해당하는 금액과 반품과 관련하여 발생할 것으로 예상되는 비용을 반품충당부채로 계상하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2)  마일리지충당부채회사는 고정고객 확보 및 우수고객 보상을 통하여 안정적인 수익의 원천을 관리하려는 영업정책의 일환으로 마일리지제도를 운영하고 있는 바, 기간손익의 적정화를 위하여 동 마일리지 부여에 따라 예상되는 추가적인 원가부담액을 마일리지충당부채로계상하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">충당부채는 최초 인식과 관련 있는 지출에만 사용하고 있습니다. 더. 수익</P>
<P USERMARK="F-GL11">수익은 재화의 판매, 용역의 제공이나 자산의 사용에 대하여 받았거나 받을 대가의 공정가액으로 측정하고 매출에누리와 할인 및 환입은 수익금액에서 차감하고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">(1) 재화의 판매재화의 소유에 따른 유의적인 위험과 보상이 구매자에게 이전되고, 판매된 재화의 소유권과 결부된 통상적 수준의 지속적인 관리상 관여와 효과적인 통제를 하지 않으며,거래와 관련한 경제적효익의 유입가능성이 높고, 수익금액과 거래와 관련하여 발생했거나 발생할 원가 및 반품가능성을 신뢰성 있게 측정할 수 있을 때 수익을 인식하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">위험과 보상의 이전 시점은 개별 계약조건에 따라 달라집니다. 일반적으로 상품 또는제품 판매의 경우에 보통 구매자의 창고에 제품이 도착할 때 이전되지만, 일부 국제적인 선적거래에서는 재화가 적절한 운반설비에 적재될 때 이전되고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 용역용역의 제공에 따른 수익은 매 보고기간말에 그 거래의 진행기준에 따라 인식하고 있습니다. 진행률은 작업수행 정도를 조사로 결정하고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">(3) 수수료회사가 본인을 대신하여 대리인으로서 거래하는 경우 수수료 금액만을 수익으로 인식하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(4) 임대수익투자부동산으로부터의 임대수익은 리스기간에 걸쳐 정액기준으로 인식하고 있습니다. 한편, 리스 인센티브는 총원가를 리스기간에 걸쳐 정액기준에 따라 리스수익에서차감하여 인식하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">러. 정부보조금</P>
<P USERMARK="F-GL11">정부보조금은 회사가 정부보조금에 부수되는 조건을 준수하고 그 보조금을 수령하는것에 대해 합리적인 확신이 있을 경우에만 인식하고 있습니다. 비유동자산을 취득 또는 건설하는데 사용해야 한다는 기본조건이 부과된 정부보조금의 경우 재무상태표에이연수익으로 인식하며, 관련 자산의 내용년수에 걸쳐 체계적이고 합리적인 방식으로 손익으로 인식하고 있습니다.기타의 정부보조금은 보전하도록 의도된 비용에 대응시키기 위해 보전하려는 관련원가를 비용으로 인식하는 기간에 걸쳐 체계적인 기준에 따라 당기손익으로 인식하고 있습니다. 이미 발생한 비용이나 손실에 대한 보전 또는 향후 관련원가의 발생 없이 기업에 제공되는 즉각적인 금융지원으로 수취하는 정부보조금은 수취할 권리가 발생하는 기간에 당기손익으로 인식하고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">머. 금융수익과 비용 </P>
<P USERMARK="F-GL11">금융수익은 매도가능금융자산을 포함한 투자로부터의 이자수익, 배당수익, 매도가능금융자산처분손익, 당기손익인식금융상품의 공정가치의 변동, 당기손익으로 인식하는 위험회피수단의 평가차익을 포함하고 있습니다. 이자수익은 기간의 경과에 따라 유효이자율법을 적용하여 당기손익으로 인식하며, 배당수익은 주주로서 배당을 받을권리가 확정되는 시점에 수익을 인식하고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">금융비용은 차입금에 대한 이자비용, 충당부채의 상각액, 부채로 분류되는 우선주에 대한 배당금, 당기손익인식금융상품의 공정가치의 변동, 당기손익으로 인식하는 위험회피수단의 평가차손을 포함하고 있습니다. 차입금에 대한 이자비용은 유효이자율법을 적용하여 기간의 경과에 따라 당기손익으로 인식하고 있습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">버. 법인세</P>
<P USERMARK="F-GL11">법인세비용은 당기법인세와 이연법인세로 구성되어 있으며, 기타포괄손익이나 자본에 직접 인식되는 거래나 사건 또는 사업결합에서 발생하는 세액을 제외하고는 당기손익으로 인식하고 있습니다. </P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">(1) 당기법인세당기법인세는 당기의 과세소득을 기초로 산정하고 있습니다. 과세소득은 포괄손익계산서상의 세전이익에서 다른 과세기간에 가산되거나 차감될 손익 및 비과세항목이나손금불인정항목을 제외하므로 포괄손익계산서상 손익과 차이가 있습니다. 회사의 당기법인세와 관련된 미지급법인세는 확정되었거나 실질적으로 확정된 세율을 사용하여 계산하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 이연법인세이연법인세는 재무제표상 자산과 부채의 장부금액과 과세소득 산출 시 사용되는 세무기준액과의 차이를 바탕으로 인식되며, 자산부채법에 의하여 인식하고 있습니다. 이연법인세부채는 모든 가산할 일시적차이에 대하여 인식하며, 이연법인세자산은 차감할 일시적차이가 사용될 수 있는 과세소득의 발생가능성이 높은 경우에, 모든 차감할 일시적차이에 대하여 인식합니다. 그러나, 일시적차이가 영업권을 최초로 인식하는 경우나 자산ㆍ부채가 최초로 인식되는 거래가 사업결합 거래가 아니고, 거래 당시의 회계이익 또는 과세소득에 영향을 미치지 아니하는 거래의 경우 이연법인세를 인식하지 않고 있습니다. </P>
<P USERMARK="F-GL11">종속기업, 관계기업 및 조인트벤처 투자지분에 관한 가산할 일시적차이에 대해서는 회사가 일시적차이의 소멸시점을 통제할 수 있으며, 예측가능한 미래에 일시적차이가 소멸하지 않을 가능성이 높은 경우를 제외하고는 모두 이연법인세부채를 인식하고 있습니다. 또한, 차감할 일시적차이로 인하여 발생하는 이연법인세자산은 일시적차이가 예측가능한 미래에 소멸할 가능성이 높고, 일시적차이가 사용될 수 있는 과세소득이 발생할 가능성이 높은 경우에 인식하고 있습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">이연법인세자산의 장부금액은 매 보고기간 말에 검토하고, 이연법인세자산으로 인한혜택이 사용되기에 충분한 과세소득이 발생할 가능성이 더 이상 높지 않은 경우 이연법인세자산의 장부금액을 감소시키고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">이연법인세자산과 부채는 보고기간 말 제정되었거나 실질적으로 제정된 세법에 근거하여 당해 자산이 실현되거나 부채가 지급될 회계기간에 적용될 것으로 기대되는 세율을 사용하여 측정하고 있습니다. 이연법인세자산과 이연법인세부채를 측정할 때에는 보고기간 말 현재 회사가 관련 자산과 부채의 장부금액을 회수하거나 결제할 것으로 예상되는 방식에 따라 법인세효과를 반영하였습니다.</P>
<P USERMARK="F-GL11">이연법인세자산과 부채는 동일 과세당국이 부과하는 법인세이고, 회사가 인식된 금액을 상계할 수 있는 법적 권한을 가지고 있으며 당기 법인세부채와 자산을 순액으로결제할 의도가 있는 경우에만 상계하고 있습니다. 배당금 지급에 따라 추가적으로 발생하는 법인세비용이 있다면 배당금 지급과 관련한 부채가 인식되는 시점에 인식하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">서. 중단영업</P>
<P USERMARK="F-GL11">회사는 별도의 사업계열이나 영업지역을 처분하거나 매각예정분류기준을 충족하는 경우 또는 매각만을 목적으로 취득한 종속기업을 중단영업으로 분류하고 있습니다. 중단영업이 있는 경우, 포괄손익계산서에 비교 표시되는 기간의 기초부터 영업이 중단된 것처럼 재작성하고 있습니다.</P>
<P USERMARK="F-GL11">어. 주당이익</P>
<P USERMARK="F-GL11">회사는 보통주 기본주당이익과 희석주당이익을 계속영업손익과 당기순손익에 대하여 계산하고 포괄손익계산서에 표시하고 있습니다. 기본주당이익은 보통주에 귀속되는 당기순손익을 회계기간 동안에 유통된 보통주식수를 가중평균한 주식수로 나누어계산하고 있습니다. 희석주당이익은 신주인수권부사채와 종업원에게 부여한 주식기준보상 등 모든 희석효과가 있는 잠재적 보통주의 영향을 고려하여 보통주에 귀속되는 당기순손익 및 가중평균유통보통주식수를 조정하여 계산하고 있습니다.</P>
<P USERMARK="F-GL11"></P>

<P USERMARK="F-GL11">
<SPAN USERMARK=" B">4. 금융위험 관리</SPAN>금융상품과 관련하여 회사는 신용위험, 유동성위험 및 시장위험에 노출되어 있습니다. 본 주석은 회사가 노출되어 있는 위의 위험에 대한 정보와 회사의 목표, 정책, 위험 평가 및 관리 절차, 그리고 자본관리에 대해 공시하고 있습니다. 추가적인 계량적 정보에 대해서는본 재무제표 전반에 걸쳐서 공시되어 있습니다. 
</P>

<P>
<SPAN USERMARK="F-GL11">가. 위험관리 정책</SPAN>
</P>
<P USERMARK="F-GL11">회사의 위험관리 정책은 회사가 직면한 위험을 식별 및 분석하고, 적절한 위험 한계치 및 통제를 설정하고, 위험이 한계치를 넘지 않도록 하기 위해 수립되었습니다. 위험관리정책과 시스템은 시장 상황과 회사의 활동의 변경을 반영하기 위해 정기적으로 검토되고 있습니다. 회사는 훈련 및 관리기준, 절차를 통해 모든 종업원들이 자신의 역할과 의무를 이해할 수 있는 엄격하고 구조적인 통제환경을 구축하는 것을 목표로 하고 있습니다.</P>
<P USERMARK="F-GL11">회사의 감사인은 경영진이 회사의 위험관리 정책 및 절차의 준수여부를 어떻게 관리하는지 감독하고, 회사의 위험관리체계가 적절한지 검토합니다. 내부감사는 감독기능을 수행하며, 위험관리 통제 및 절차에 대한 정기 및 특별 검토를 수행하고 있습니다.</P>
<P USERMARK="F-GL11">나. 신용위험</P>
<P USERMARK="F-GL11">신용위험이란 고객이나 거래상대방이 금융상품에 대한 계약상의 의무를 이행하지 않아 회사가 재무손실을 입을 위험을 의미합니다. 주로 거래처에 대한 매출채권과 투자자산에서 발생합니다. </P>
<P USERMARK="F-GL11">(1) 매출채권회사의 신용위험에 대한 노출은 주로 각 고객별 특성의 영향을 받습니다. 고객이 영업하고있는 산업 및 국가의 파산위험 등의 고객 분포는 신용위험에 큰 영향을 주지 않으며, 지리적으로 신용위험이 집중되어 있지는 않습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">회사는 표준 지급기준을 결정하기 이전에 모든 신규 고객에 대해 개별적으로 신용도를 검토하도록 하는 신용정책을 수립하였습니다. 검토 시에는 외부적인 등급과 은행의 평가 등을 고려합니다. 별도의 승인 요청 없이 가능한 최고 구매한도가 개별 고객별로 정해지며, 이 한도는 분기별로 검토되고 있습니다. 회사의 신용기준을 충족하지못한 고객은 선급금 지불 시에만 거래가 가능합니다.</P>
<P USERMARK="F-GL11">법인 거래처의 경우 장기간 거래해 오고 있으며, 손실은 자주 발생하지 않습니다. 고객에 대한 신용위험 검토 시, 고객이 개인인지 법인인지, 도매업체인지 소매업체 혹은 소비자인지, 고객의 지리적인 위치, 산업, 신용, 연령, 성숙도, 이전의 재무적 어려움 등의 특성에 따라 분류하고 있습니다. 매출채권은 대부분 회사의 도매 고객으로부터 발생합니다. "고위험"으로 분류된 고객들은 제한고객 목록에 포함하여 위험관리위원회가 관리하며, 향후 매출은 선급금 지불시에만 가능합니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">소유권 유보 조항에 따라 제품이 판매되기 때문에 대금을 수령하지 못하더라도 회사는 담보청구 권리를 가질 수 있습니다. 회사는 매출채권과 관련하여 담보물을 요구하지는 않습니다.</P>
<P USERMARK="F-GL11">회사는 매출채권과 투자자산에 대해 발생할 것으로 예상되는 손실에 대해 충당금을 설정하고 있습니다. 이 충당금은 개별적으로 유의적인 항목에 대한 구체적인 손상차손과 유사한 특성을 가진 금융자산 집합의 발생하였으나 아직 식별되지 않은 손상으로 구성됩니다. 금융자산 집합의 충당금은 유사한 금융자산의 회수에 대한 과거 자료에 근거하여 결정되고 있습니다.</P>
<P USERMARK="F-GL11">(2) 보증</P>
<P USERMARK="F-GL11">회사는 지분을 일부 보유한 종속기업에도 보증을 제공하는 것이 회사의 정책입니다. 당기말 현재 회사가 제공한 보증 내역은 주석 25에서 설명하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">다. 유동성위험유동성위험이란 회사가 금융부채에 관련된 의무를 충족하는 데 어려움을 겪게 될 위험을 의미합니다. 회사의 유동성 관리방법은 재무적으로 어려운 상황에서도 받아들일 수 없는 손실이 발생하거나, 회사의 평판에 손상을 입힐 위험 없이, 만기일에 부채를 상환할 수 있는 충분한 유동성을 유지하도록 하는 것입니다. </P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">라. 시장위험시장위험이란 시장가격의 변동으로 인하여 금융상품의 공정가치나 미래현금흐름이 변동할 위험을 의미합니다. 시장가격 관리의 목적은 수익은 최적화하는 반면 수용가능 한 한계 이내로 시장위험 노출을 관리 및 통제하는 것입니다. </P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">(1) 환위험회사의 기능통화인 원화 외의 통화로 표시되는 판매, 구매 및 차입에 대해 환위험에 노출되어 있습니다. 이러한 거래들이 표시되는 주된 통화는 USD, EUR, JPY 등입니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 이자율위험회사는 고정이자율과 변동이자율로 자금을 차입하고 있으며, 이로 인하여 이자율위험에 노출되어 있습니다. 회사는 이자율위험을 관리하기 위하여 고정금리부차입금과변동금리부 차입금의 적절한 균형을 유지하고 있습니다. 위험회피활동은 이자율 현황과 정의된 위험성향을 적절히 조정하기 위해 정기적으로 평가되며 최적의 위험회피전략이 적용되도록 하고 있습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">마. 자본관리회사는 부채와 자본 잔액의 최적화를 통하여 주주이익을 극대화시키는 동시에 계속기업으로서 지속될 수 있도록 자본을 관리하고 있습니다. 회사의 전반적인 전략은   전기와 변동이 없습니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">회사는 자본관리지표로 부채비율을 이용하고 있으며 이 비율은 총부채를 총자본으로나누어 산출하고 있으며 총부채 및 총자본은 별도재무제표의 금액을 기준으로 계산하고 있으며, 보고기간종료일 현재 부채비율은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" WIDTH="623" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="614"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="623" HEIGHT="30">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 당기말</TH>
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER">부 채</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">99,014,537 </TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">74,802,981</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER">자 본</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">83,579,428 </TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">83,794,501</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER">부채비율</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">118.47%</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">89.27%</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">5. 유형자산</SPAN>
<SPAN USERMARK="F-GL">가. 당기말과 전기말 현재 회사의 유형자산 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="833">

<COLGROUP>
<COL WIDTH="824"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="833" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="833">

<COLGROUP>
<COL WIDTH="82"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH USERMARK="F-10" WIDTH="91" HEIGHT="56" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과  목 </TH>
<TH USERMARK="F-10" WIDTH="372" HEIGHT="28" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH USERMARK="F-10" WIDTH="370" HEIGHT="28" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH USERMARK="F-10" WIDTH="94" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가 </TH>
<TH USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각누계액 </TH>
<TH USERMARK="F-10" WIDTH="96" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정부보조금</TH>
<TH USERMARK="F-10" WIDTH="90" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액 </TH>
<TH USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가 </TH>
<TH USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각누계액 </TH>
<TH USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">정부보조금</TH>
<TH USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10" WIDTH="91" HEIGHT="28"> 토지</TD>
<TD USERMARK="F-10" WIDTH="94" HEIGHT="28" ALIGN="RIGHT">17,813,441</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">-</TD>
<TD USERMARK="F-10" WIDTH="96" HEIGHT="28" ALIGN="RIGHT">-</TD>
<TD USERMARK="F-10" WIDTH="90" HEIGHT="28" ALIGN="RIGHT">17,813,441</TD>
<TD USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="RIGHT">17,813,441</TD>
<TD USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="RIGHT">-</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">-</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">17,813,441</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10" WIDTH="91" HEIGHT="28"> 건물</TD>
<TD USERMARK="F-10" WIDTH="94" HEIGHT="28" ALIGN="RIGHT">35,525,420</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">(11,087,796)</TD>
<TD USERMARK="F-10" WIDTH="96" HEIGHT="28" ALIGN="RIGHT">-</TD>
<TD USERMARK="F-10" WIDTH="90" HEIGHT="28" ALIGN="RIGHT">24,437,624</TD>
<TD USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="RIGHT">35,525,420</TD>
<TD USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="RIGHT">(10,199,660)</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">-</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">25,325,759</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10" WIDTH="91" HEIGHT="28"> 기계장치</TD>
<TD USERMARK="F-10" WIDTH="94" HEIGHT="28" ALIGN="RIGHT">29,409,177</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">(23,833,949)</TD>
<TD USERMARK="F-10" WIDTH="96" HEIGHT="28" ALIGN="RIGHT">(146,555)</TD>
<TD USERMARK="F-10" WIDTH="90" HEIGHT="28" ALIGN="RIGHT">5,428,673</TD>
<TD USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="RIGHT">28,686,277</TD>
<TD USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="RIGHT">(22,698,173)</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">(179,276)</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">5,808,828</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10" WIDTH="91" HEIGHT="28"> 차량운반구</TD>
<TD USERMARK="F-10" WIDTH="94" HEIGHT="28" ALIGN="RIGHT">100,455</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">(80,700)</TD>
<TD USERMARK="F-10" WIDTH="96" HEIGHT="28" ALIGN="RIGHT">-</TD>
<TD USERMARK="F-10" WIDTH="90" HEIGHT="28" ALIGN="RIGHT">19,756</TD>
<TD USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="RIGHT">77,665</TD>
<TD USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="RIGHT">(77,661)</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">-</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10" WIDTH="91" HEIGHT="28"> 비품</TD>
<TD USERMARK="F-10" WIDTH="94" HEIGHT="28" ALIGN="RIGHT">2,977,585</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">(2,392,508)</TD>
<TD USERMARK="F-10" WIDTH="96" HEIGHT="28" ALIGN="RIGHT">-</TD>
<TD USERMARK="F-10" WIDTH="90" HEIGHT="28" ALIGN="RIGHT">585,077</TD>
<TD USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="RIGHT">2,784,225</TD>
<TD USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="RIGHT">(2,137,481)</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">-</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">646,744</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10" WIDTH="91" HEIGHT="28"> 건설중인자산</TD>
<TD USERMARK="F-10" WIDTH="94" HEIGHT="28" ALIGN="RIGHT">34,448,984</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">-</TD>
<TD USERMARK="F-10" WIDTH="96" HEIGHT="28" ALIGN="RIGHT">(4,900,000)</TD>
<TD USERMARK="F-10" WIDTH="90" HEIGHT="28" ALIGN="RIGHT">29,548,984</TD>
<TD USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="RIGHT">7,863,181</TD>
<TD USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="RIGHT">-</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">(4,900,000)</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">2,963,181</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK="F-10" WIDTH="91" HEIGHT="28" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD USERMARK="F-10" WIDTH="94" HEIGHT="28" ALIGN="RIGHT">120,275,062</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">(37,394,953)</TD>
<TD USERMARK="F-10" WIDTH="96" HEIGHT="28" ALIGN="RIGHT">(5,046,555)</TD>
<TD USERMARK="F-10" WIDTH="90" HEIGHT="28" ALIGN="RIGHT">77,833,555</TD>
<TD USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="RIGHT">92,750,209</TD>
<TD USERMARK="F-10" WIDTH="93" HEIGHT="28" ALIGN="RIGHT">(35,112,975)</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">(5,079,276)</TD>
<TD USERMARK="F-10" WIDTH="92" HEIGHT="28" ALIGN="RIGHT">52,557,957</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">나. 당기 및 전기 중 유형자산의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="828">

<COLGROUP>
<COL WIDTH="405"></COL>
<COL WIDTH="405"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="414" HEIGHT="30" VALIGN="MIDDLE"><당  기></TD>
<TD WIDTH="414" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="823" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="120" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과  목 </TH>
<TH WIDTH="118" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="117" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="117" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각비</TH>
<TH WIDTH="117" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대체(주1)</TH>
<TH WIDTH="117" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타증감</TH>
<TH WIDTH="117" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="30">토지 </TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">17,813,441 </TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">　-</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">-　</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">　-</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">17,813,441 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="30">건물</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">25,325,759 </TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">　-</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">(888,135)</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">　-</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">24,437,624 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="30">기계장치</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">5,808,828 </TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">247,710 </TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">(1,103,054)</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">475,190 </TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">5,428,673 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="30">차량운반구</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">4 </TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">22,791 </TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">(3,039)</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">　-</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">19,756 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="30">비품</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">646,744 </TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">175,210 </TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">(255,027)</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">18,150 </TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">585,077 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" HEIGHT="30">건설중인자산</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">2,963,181 </TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">27,086,743 </TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">　-</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">(500,940)</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">29,548,984 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="120" ALIGN="CENTER" HEIGHT="30">합   계</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">52,557,957 </TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">27,532,454 </TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">(2,249,255)</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">(7,600)</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="117" ALIGN="RIGHT" HEIGHT="30">77,833,555 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(주1)  당기 중 건설중인자산에서 무형자산으로 7,600천원 대체 하였습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="828">

<COLGROUP>
<COL WIDTH="819"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="828" HEIGHT="31" ALIGN="RIGHT" VALIGN="BOTTOM"><전  기>                                                                                                                                       (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="822">

<COLGROUP>
<COL WIDTH="110"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과  목 </TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각비</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대체</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타증감</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 토지 </TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">17,813,441</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">17,813,441</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 건물</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">26,213,895</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(888,135)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">25,325,759</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 기계장치</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">5,789,277</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">624,995</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(1,308,171)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">702,726</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">5,808,828</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 차량운반구</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">6,192</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(6,188)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 비품</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">692,700</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">272,373</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(318,329)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">646,744</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 건설중인자산</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">594,598</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">8,516,015</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(1,247,433)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(4,900,000)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">2,963,181</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">51,110,103</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">9,413,383</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(2,520,823)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(544,707)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(4,900,000)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">52,557,957</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">다. 회사는 매 보고기간 종료일마다 자산의 감가상각방법, 잔존가치 및 경제적 내용연수를 검토하고, 필요한 경우 회계추정의 변경으로 조정을 하고 있습니다.라. 당기말 현재 회사가 가입한 보험현황은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="612">

<COLGROUP>
<COL WIDTH="603"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="612" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="617">

<COLGROUP>
<COL WIDTH="80"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="89" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">보험종류</TH>
<TH WIDTH="148" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">자  산</TH>
<TH WIDTH="120" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">장부금액</TH>
<TH WIDTH="119" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">부 보 액</TH>
<TH WIDTH="141" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">보험회사명</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="89" HEIGHT="90" ROWSPAN="3" VALIGN="MIDDLE">화재보험</TD>
<TD ALIGN="CENTER" WIDTH="148" HEIGHT="30">건 물(주1)</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30">27,192,214</TD>
<TD ALIGN="RIGHT" WIDTH="119" HEIGHT="30">55,725,625</TD>
<TD WIDTH="141" HEIGHT="120" ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER">DB손해보험한화손해보험</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="148" HEIGHT="30">기계장치</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30">5,428,673</TD>
<TD ALIGN="RIGHT" WIDTH="119" HEIGHT="30" VALIGN="MIDDLE">16,413,265</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="148" HEIGHT="30">비품</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30">585,077</TD>
<TD ALIGN="RIGHT" WIDTH="119" HEIGHT="30" VALIGN="MIDDLE">2,340,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ALIGN="CENTER" WIDTH="237" HEIGHT="30">합   계</TD>
<TD ALIGN="RIGHT" WIDTH="120" HEIGHT="30">33,205,964</TD>
<TD ALIGN="RIGHT" WIDTH="119" HEIGHT="30">74,478,890</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">(주1) 투자부동산에 해당하는 건물 장부가액이 포함되어 있습니다.</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">마. 담보제공내역당기말 현재 회사의 차입금 등과 관련하여 담보로 제공된 일부 유형자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="612">

<COLGROUP>
<COL WIDTH="603"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="612" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="614" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="155"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담보제공자산</TH>
<TH ALIGN="CENTER" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부가액</TH>
<TH ALIGN="CENTER" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권최고액</TH>
<TH ALIGN="CENTER" WIDTH="164" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담보권자</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">토지(주1)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">28,694,478</TD>
<TD ROWSPAN="4" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="120">103,280,000 </TD>
<TD ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="164" HEIGHT="120">기업은행 외</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">건물(주1)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">28,729,761</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">기계장치</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">5,263,350</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30">합  계</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">62,687,589</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">(주1) 투자부동산에 해당하는 토지와 건물 장부가액이 포함되어 있습니다.</P>

<P>
<SPAN USERMARK="F-GL11">바. 차입원가 자본화당기 및 전기 중 자본화된 차입원가와 자본화 이자율은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="508">

<COLGROUP>
<COL WIDTH="499"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="508" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="507">

<COLGROUP>
<COL WIDTH="160"></COL>
<COL WIDTH="160"></COL>
<COL WIDTH="160"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="169" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분 </TH>
<TH WIDTH="169" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="169" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="169" HEIGHT="30"> 자본화된 차입원가</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">638,747</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">60,239</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="169" HEIGHT="30"> 자본화 이자율</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">3.15%</TD>
<TD WIDTH="169" HEIGHT="30" ALIGN="RIGHT">2.11%</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL B">6. 투자부동산</P>
<P USERMARK="F-GL">가. 당기말과 전기말 현재 회사의 투자부동산 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="677">

<COLGROUP>
<COL WIDTH="668"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="677" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="680">

<COLGROUP>
<COL WIDTH="90"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="99" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과  목</TH>
<TH WIDTH="290" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="291" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가 </TH>
<TH WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각누계액 </TH>
<TH WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액 </TH>
<TH WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가 </TH>
<TH WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각누계액 </TH>
<TH WIDTH="97" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30" VALIGN="MIDDLE">토  지</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">10,903,197</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">10,903,197</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">10,903,197</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">10,903,197</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30" VALIGN="MIDDLE">건  물</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">5,914,469</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">(1,517,949)</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">4,396,520</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">5,914,469</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">(1,370,087)</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">4,544,382</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" HEIGHT="30" ALIGN="CENTER">합    계</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">16,817,666</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">(1,517,949)</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">15,299,717</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">16,817,666</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">(1,370,087)</TD>
<TD WIDTH="97" HEIGHT="30" ALIGN="RIGHT">15,447,579</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK="F-GL">나. 당기 및 전기 중 투자부동산의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="599">

<COLGROUP>
<COL WIDTH="590"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="599" HEIGHT="53" ALIGN="RIGHT" VALIGN="BOTTOM"><당 기>                                                                                           (단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="602">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="151" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과  목</TH>
<TH WIDTH="151" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각비</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" HEIGHT="30" VALIGN="MIDDLE">토   지</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">10,903,197 </TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">10,903,197</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" HEIGHT="30" VALIGN="MIDDLE">건   물</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">4,544,382 </TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">(147,862)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">4,396,520</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="151" HEIGHT="30" ALIGN="CENTER">합   계</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">15,447,579 </TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">(147,862)</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT">15,299,717</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="604">

<COLGROUP>
<COL WIDTH="595"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="604" HEIGHT="53" ALIGN="RIGHT" VALIGN="BOTTOM"><전 기>   
<SPAN USERMARK=" 0X0000FF">                                                                                         </SPAN>(단위: 천원)
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="607" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="142"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="152" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과  목</TH>
<TH WIDTH="152" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="152" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감가상각비</TH>
<TH WIDTH="151" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30" VALIGN="MIDDLE"> 토 지</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">10,903,197</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">10,903,197</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30" VALIGN="MIDDLE"> 건 물</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">4,692,244</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">(147,862)</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">4,544,382</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="152" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">15,595,441</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">(147,862)</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="RIGHT">15,447,579</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">다. 투자부동산의 공정가치</P>
<P USERMARK="F-GL">당기말 현재 투자부동산에 대한 공정가치 평가내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="722">

<COLGROUP>
<COL WIDTH="713"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="722" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="724">

<COLGROUP>
<COL WIDTH="150"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="122"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="159" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 구 분 </TH>
<TH WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 최근기준일</TH>
<TH WIDTH="154" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 토지(주1)</TH>
<TH WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 건물(주1) </TH>
<TH WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 합 계 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="724" VALIGN="MIDDLE" HEIGHT="30"><평가대상자산 장부가액></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="308" VALIGN="MIDDLE" HEIGHT="30"> 장부가액 </TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,903,197</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,396,520</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,299,718</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="724" VALIGN="MIDDLE" HEIGHT="30"><자산별 세부평가결과></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" HEIGHT="30"> 방배동사옥 </TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.01.01</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,745,814</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,135,394</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,881,208</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" HEIGHT="30"> 주차타워</TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.01.01</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,268,045</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">151,155</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,419,200</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" HEIGHT="30"> 대전사옥 </TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.01.01</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,810,485</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,126,742</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,937,226</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="159" VALIGN="MIDDLE" HEIGHT="30"> 판교연구소 </TD>
<TD WIDTH="149" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.01.01</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">674,431</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">494,728</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,169,159</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="308" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER"> 합 계</TD>
<TD WIDTH="154" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,498,775</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,908,019</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">17,406,793</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">(주1) 토지 및 건물의 공정가치는 표준공시지가 및 기준시가에 근거하여 평가를 하였습니다</P>
<P USERMARK="F-GL">라. 당기 및 전기 중 투자부동산에서 발생한 손익의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="611"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="620" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구          분</TH>
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30">임대수익</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">574,927</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">515,574</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="53">운영비용(임대수익이 발생한 투자부동산 관련)</TD>
<TD WIDTH="208" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(147,862)</TD>
<TD WIDTH="208" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(147,862)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER">합  계</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">427,065</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">367,712</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL B">7. 사용권자산</P>

<P>
<SPAN USERMARK="F-GL">(1) 사용권자산 및 리스부채</SPAN>
<SPAN USERMARK="F-GL">회사의 당기 및 전기 중 사용권자산 및 리스부채의 장부금액과 보고기간 중 변동금액은 다음과 같습니다.</SPAN>
</P>
<P USERMARK="F-GL"></P>

<TABLE ACLASS="NORMAL" WIDTH="788" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="385"></COL>
<COL WIDTH="385"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="394" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD ALIGN="RIGHT" WIDTH="394" HEIGHT="30" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="788">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="199" HEIGHT="60" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="442" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">사용권자산</TH>
<TH WIDTH="147" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">리스부채</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="148" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건물</TH>
<TH WIDTH="147" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차량운반구</TH>
<TH WIDTH="147" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 기 초</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">25,131 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">401,510 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">426,641 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">433,319 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">   신규취득</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">34,998 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">234,567 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">269,565 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">268,730 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">   중도해지</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">　-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(21,621)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(21,621)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(22,970)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">   감가상각</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(46,355)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(163,792)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(210,147)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">　-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">   이자비용</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">　-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">　-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">　-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">15,015 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE">   이자 및 원금지급</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">　-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">　-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">　-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(255,117)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE"> 기 말</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">13,774 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">450,664 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">464,438 </TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">438,977 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<TABLE ACLASS="NORMAL" WIDTH="788" BORDER="0" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="385"></COL>
<COL WIDTH="385"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="394" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD ALIGN="RIGHT" WIDTH="394" HEIGHT="30" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="788">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="199" HEIGHT="60" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="442" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="3">사용권자산</TH>
<TH WIDTH="147" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">리스부채</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="148" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건물</TH>
<TH WIDTH="147" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차량운반구</TH>
<TH WIDTH="147" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 기 초</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">17,004</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">415,261</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">432,265</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">437,138</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">   신규취득</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">25,326</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">251,839</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">277,165</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">276,606</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">   중도해지</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(34,894)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(34,894)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(32,266)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">   감가상각</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(17,200)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(230,696)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(247,896)</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30">   이자비용</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">14,438</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE">   이자 및 원금지급</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(262,597)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE"> 기 말</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">25,131</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">401,510</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">426,641</TD>
<TD WIDTH="147" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">433,319</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">(2) 회사의 당기 및 전기 중 손익계산서에 인식된 금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="616">

<COLGROUP>
<COL WIDTH="607"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="616" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="616">

<COLGROUP>
<COL WIDTH="214"></COL>
<COL WIDTH="188"></COL>
<COL WIDTH="187"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="223" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="197" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="196" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30"> 사용권자산의 감가상각비</TD>
<TD WIDTH="197" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">210,147</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">247,895</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30"> 리스부채이자비용</TD>
<TD WIDTH="197" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">15,015</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">14,438</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30"> 임차보증금이자수익</TD>
<TD WIDTH="197" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(909)</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(1,434)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30"> 단기리스 관련 비용</TD>
<TD WIDTH="197" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">-</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">3,630</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30"> 소액기초자산리스 관련비용</TD>
<TD WIDTH="197" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">277,939</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">285,841</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30"> 중도해지로 인한 손실</TD>
<TD WIDTH="197" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">1,348</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(2,628)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="223" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="197" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">503,540</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">547,742</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">리스부채에 대한 할인율(증분차입이자율)은 2.28% ~ 4.12%입니다. (3) 당기말 잔여기간별 리스부채의 계약상 만기는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="622">

<COLGROUP>
<COL WIDTH="613"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="622" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="623" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="147"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="147"></COL>
<COL WIDTH="146"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">건물</TH>
<TH WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차량운반구</TH>
<TH WIDTH="155" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합   계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30"> 1개월이하</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,355</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,783</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,138</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30"> 1개월 ~ 3개월</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,345</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,138</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">19,483</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30"> 3개월 ~ 1년</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">8,925</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">158,110</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">167,035</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30"> 1년 ~ 5년</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">252,773</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">252,773</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계(주1)</TD>
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">14,625</TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">445,804</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">460,429</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">계약상 명목금액으로써 현재가치로 평가되지 않은 금액입니다.</P>
<P USERMARK="F-GL"></P>

<P USERMARK="F-GL">
<SPAN USERMARK=" B">8. 영업권 이외의 무형자산</SPAN>가.당기말과 전기말 현재 회사의 무형자산 내역은 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="725">

<COLGROUP>
<COL WIDTH="716"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="725" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="724">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="153" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="286" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="285" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="96" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각누계액</TH>
<TH WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각누계액</TH>
<TH WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30"> 특허권</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">831,023</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">(492,862)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">338,162</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">805,168</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">(431,138)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">374,030</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30"> 상표권</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">20,583</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">(17,262)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">3,321</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">20,203</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">(15,948)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">4,254</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30"> 전기공급시설이용권</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">44,086</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">44,086</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">44,086</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">44,086</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30"> 소프트웨어</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">1,395,242</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">(901,885)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">493,357</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">1,337,042</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">(725,137)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">611,905</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30"> 회원권</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">919,800</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">919,800</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">919,800</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">919,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30"> 디자인권</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">889</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">(888)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">1</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">889</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">(888)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30" VALIGN="MIDDLE"> 개발중인무형자산</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">26,878,028</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">(2,797,720)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">24,080,308</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">22,735,753</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">(2,299,521)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">20,436,232</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER">합    계</TD>
<TD WIDTH="96" HEIGHT="30" ALIGN="RIGHT">30,089,651</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">(4,210,617)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">25,879,035</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">25,862,941</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">(3,472,632)</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="RIGHT">22,390,308</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL 0X120FC8"></P>
<P USERMARK="F-GL">나. 당기 및 전기 중 무형자산의 변동내역은 다음과 같습니다.</P>
<P USERMARK="F-GL"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="857">

<COLGROUP>
<COL WIDTH="419"></COL>
<COL WIDTH="420"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="428" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD WIDTH="429" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="856">

<COLGROUP>
<COL WIDTH="145"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="107"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="154" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과 목</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 초</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득(주1)</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 상각(주2) </TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">처 분</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 대체(보조금)</TH>
<TH WIDTH="116" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30"> 특허권</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">374,030 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">25,856 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(57,624)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(4,100)</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">338,162 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30"> 상표권</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">4,254 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">380 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(1,314)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">3,321 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30"> 전기공급시설이용권</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">44,086 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">44,086 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30"> 소프트웨어</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">611,905 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">58,200 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(176,748)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">493,357 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30"> 회원권</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">919,800 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">919,800 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30"> 디자인권</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">1 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30"> 개발중인무형자산</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">20,436,232 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">4,142,274 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(498,199)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">24,080,308 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">22,390,308 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">4,226,710 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(733,885)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">　-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(4,100)</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">25,879,035 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 무형자산의 취득금액에는 건설중인자산에서 대체된 7,600천원이 포함되 있습니다.(주2) 무형자산상각비는 전액 판매비와관리비로 계상되었습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="857">

<COLGROUP>
<COL WIDTH="419"></COL>
<COL WIDTH="420"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="428" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD WIDTH="429" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="856">

<COLGROUP>
<COL WIDTH="145"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="107"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="154" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과 목</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 초</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 상각(주2) </TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">처 분</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N"> 대체(보조금)</TH>
<TH WIDTH="116" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30"> 특허권</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">298,645</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">131,892</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(57,751)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">1,244</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">374,030</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30"> 상표권</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">5,793</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(1,539)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">4,254</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30"> 전기공급시설이용권</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">44,086</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">44,086</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30"> 소프트웨어</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">248,853</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">604,911</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(141,859)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(100,000)</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">611,905</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30"> 회원권</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">919,800</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">919,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30"> 디자인권</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">30</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(29)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30"> 개발중인무형자산</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">16,452,468</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">4,507,295</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(523,532)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">20,436,232</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="154" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">17,969,675</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">5,244,098</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(724,710)</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">(98,756)</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">22,390,308</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL">다. 개발중인무형자산(1) 일반사항  </SPAN>
</P>
<P USERMARK="F-GL">신규개발 프로젝트는 신약후보물질발굴, 비임상, 임상1상, 임상2상, 임상3상, 정부승인 신청, 정부승인완료, 제품 판매시작 재심사연구 등의 단계로 진행됩니다. 회사는 일반적으로해당 프로젝트가 임상3상 단계를 진입한 이후 발생한 지출을 무형자산으로 인식하고, 이전 단계에서 발생한 지출은 연구개발비로 보아 당기 비용처리하고 있습니다. 단, 기존 임상3상을 통과한 개발비와 제품허가 이후 제품의 허가사항 및 효능입증 업데이트를 위한 임상1상 및 임상2상 추가비용의 경우에도 무형자산으로 인식하고 있습니다.</P>

<P USERMARK="F-GL 0X120FC8">
<SPAN USERMARK=" 0X000000">(2) 당기말 현재 무형자산으로 인식한 개발비는 다음과 같습니다</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="623">

<COLGROUP>
<COL WIDTH="614"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="623" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="942">

<COLGROUP>
<COL WIDTH="18"></COL>
<COL WIDTH="17"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="195"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="93"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="27" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">분류</TH>
<TH WIDTH="26" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">단계</TH>
<TH WIDTH="74" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="204" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개발 자산명</TH>
<TH WIDTH="407" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개별자산명 자산화한 개발비 누계액</TH>
<TH WIDTH="102" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">장부금액</TH>
<TH WIDTH="102" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">잔여상각 기간</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="103" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임상2상</TH>
<TH WIDTH="103" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임상3상</TH>
<TH WIDTH="103" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">판매승인</TH>
<TH WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="27" HEIGHT="180" ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER">개발비</TD>
<TD WIDTH="26" HEIGHT="180" ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER">개발완료</TD>
<TD WIDTH="74" HEIGHT="150" ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER">개량신약</TD>
<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE">가. 리포락셀 </TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE"> 리포락셀(위암) (주1)</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,406,908</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,406,908</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,989,193</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6(주4)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE"> 리포락셀(유방암) (주1)</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,508,080</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,508,080</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,508,080</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE"> 리포락셀(미국유방암) (주2)</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,583,034</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,583,034</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,583,034</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="204" HEIGHT="30" VALIGN="MIDDLE">나. 고지혈증복합제(주3)</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">380,006</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">380,006</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="278" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">소     계</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,583,034</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,508,080</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,786,914</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">26,878,028</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,080,308</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL 0X120FC8"></P>

<P>
<SPAN USERMARK="F-GL">(주1) 회사는 세계 최초로 경구형 파클리탁셀제품(리포락셀, DHP107)을 개발하여 한국에서 위암치료제로 의약품허가당국인 식약처의 검토 및 실사를 통해 제제기술, 제품의 효과 및 제조공장의 우수성을 확인받아 2016년 9월 9일 국내 시판허가를 득한 바 있으며, 현재 전세계 여러 회사를 대상으로 완제의약품 수출 또는 기술수출에 대한 협상을 진행하고 있습니다. 회사는 2017년 9월 중국 RMX 제약사에 USD 25,000,000 규모 상당액의 기술수출을 달성하였습니다.</SPAN>
</P>
<P USERMARK="F-GL"> </P>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK="F-GL 0X000000">(주2) 또한 본 제품 허가사항과 효능의 우수성을 기반으로 미국 및 유럽에서의 시판허가를진행 중이며, 유방암 적응증에 대한 리포락셀  "DHP107 미국임상 2상 시험" 이 현재 미국에서 진행되고 있습니다.</SPAN>
</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">미국 2상 종료 시, 국내(&중국, 대만/ study nick name: OPTIMAL)에서 진행하여 도출한 2상 data와 현재 진행 중인 3상 중간 data를 가지고 FDA와 end of phase II 미팅을 진행할 수 있으며, 이를 통해 미국에서 추가 3상 시험 없이 미국 시판허가를 득할 가능성에 대해 기대할 수 있습니다. 미국2상 결과가 국내에서 기존에 진행한 PK 결과와 다르지 않고 인종차에 의한 흡수에 영향이 없다는 것이 증명된다면 충분히 가능할 수 있는 전략입니다. 이 경우 2022년 국내 시판허가와 동시에 미국 시판허가 신청이 가능하므로, 2022년 하반기 또는 2023년 상반기에 미국 시판허가를 득할 수 있을 것으로 예상됩니다.</P>
<P USERMARK="F-GL">대한민국은 허가대상 국가인 미국 또는 유럽과 허가절차의 유사성이 매우 높다고 볼 수 있습니다. 국내 개량신약의 경우 자료제출의약품 허가요건에 맞추어 임상시험 자료 등을 구비해야 하며, 미국에서도 이와 유사한 카테고리에 맞추어 개량신약의 허가가 진행되고 있습니다. 이외에도 국내의 혁신신약 허가 규정이나 미국의 breakthrough 등 비슷한 유형의 의약품에 대해서 비슷한 허가요건이 부여되고 있습니다. </P>
<P USERMARK="F-GL">의약품의 경우  globalization이 확립되어 미국 제약사에서 개발한 의약품이 유렵이나일본, 한국 등지에서 동일한 자료로 허가를 받게 되어 많은 다국적 제약사의 의약품이 국내에서 동일한 방식으로 허가를 받아 발매중이고, 국내에서 개발한 의약품이 미국에서도 허가를 받은 사례를 찾아볼 수 있습니다.</P>
<P USERMARK="F-GL">(주3) 회사는 고지혈증복합제(로수바스타틴/에제티미브) 관련 공동개발을 기반으로 현재 해당 제품을 판매하고 있습니다. (주4) 회사는 판매승인이 완료된 개발중인 무형자산에 대하여 경제적효익이 유입됨에 따라 정액법을 적용하여 감가상각을 수행하고 있습니다. </P>
<P USERMARK="F-GL 0X120FC8"></P>

<P USERMARK="F-GL 0X120FC8">
<SPAN USERMARK=" 0X000000">(3) 당기 및 전기 중 비용으로 인식한 연구개발 관련 지출은 다음과 같습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="623">

<COLGROUP>
<COL WIDTH="614"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="623" HEIGHT="30" ALIGN="RIGHT" VALIGN="BOTTOM">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="197"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>구 분</P>
</TH>

<TH WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>당 기</P>
</TH>

<TH WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">
<P>전 기</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P> 매출원가(제조원가)</P>
</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,537,759 </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,004,412</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P> 판매비와 관리비</P>
</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,053,722 </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,169,751</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P>   경상개발비</P>
</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,256,884 </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,509,027</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30">
<P>   정부보조금</P>
</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(203,162)</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,339,276)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">
<P>합 계</P>
</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,591,481 </TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9,174,163</TD>
</TR>
</TBODY>
</TABLE>
<P>(4) 당기 및 전기 중 무형자산으로 인식한 개발비의 변동내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="822">

<COLGROUP>
<COL WIDTH="402"></COL>
<COL WIDTH="402"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="411" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD WIDTH="411" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="823">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">구 분</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">리포락셀(DHP107 DREAM, 위암)</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">리포락셀(DHP107 미국임상 OPERA)</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">리포락셀(DHP107 OPTIMAL, 유방암)</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">고지혈증복합제(로수바스타틴/에제티미브)</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="30"> 기 초</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,487,392 </TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,776,135 </TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,172,704 </TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1 </TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,436,232 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="30">   개별취득</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">806,899 </TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,335,376 </TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,142,274 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="30">   상각</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(498,199) </TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">　-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(498,199) </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="30"> 기 말</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,989,193 </TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,583,034 </TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,508,080 </TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1 </TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">24,080,308 </TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="822">

<COLGROUP>
<COL WIDTH="402"></COL>
<COL WIDTH="402"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="411" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD WIDTH="411" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="823">

<COLGROUP>
<COL WIDTH="119"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
<COL WIDTH="130"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">구 분</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">리포락셀(DHP107 DREAM, 위암)</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">리포락셀(DHP107 미국임상 OPERA)</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">리포락셀(DHP107 OPTIMAL, 유방암)</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">고지혈증복합제(로수바스타틴/에제티미브)</TH>
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="76">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="30"> 기 초</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,985,590</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,476,615</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">8,964,929</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,334</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,452,468</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="30">   개별취득</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,299,520</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,207,775</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,507,295</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="30">   상각</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(498,199)</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(25,333)</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(523,532)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="128" VALIGN="MIDDLE" HEIGHT="30"> 기 말</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,487,392</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,776,135</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12,172,704</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1</TD>
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,436,232</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL">9. 종속기업 및 관계기업투자 </P>
<P USERMARK="F-GL">가. 당기말 및 전기말 현재 종속기업 및 관계기업투자의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="914">

<COLGROUP>
<COL WIDTH="905"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="914" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="927">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="178"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="88"></COL>
<COL WIDTH="88"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="94" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="193" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">회사명</TH>
<TH WIDTH="63" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">소재지</TH>
<TH WIDTH="187" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">영업활동</TH>
<TH WIDTH="98" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">보유주식수</TH>
<TH WIDTH="98" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">지분율</TH>
<TH WIDTH="97" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당기말</TH>
<TH WIDTH="97" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" HEIGHT="173" ROWSPAN="5" VALIGN="MIDDLE" ALIGN="CENTER">종속기업</TD>

<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="193" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK="F-GL 0X000000">디에이치호림㈜</SPAN>
</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="63" HEIGHT="30">한국</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="187" HEIGHT="30">의약품 판매</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">5,435,820</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">63.91%</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="97" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="97" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="193" HEIGHT="30">㈜스페셜라이즈드메드</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="63" HEIGHT="30">한국</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="187" HEIGHT="30">컨텐츠 서비스</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="98" HEIGHT="30">136,471</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30">56.86%</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="97" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="97" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="193" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">㈜리독스바이오(주1)</TD>
<TD WIDTH="63" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">한국</TD>
<TD WIDTH="187" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">의약품 판매</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">15,435,370</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">62.72%</TD>
<TD WIDTH="97" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">7,384,833</TD>
<TD WIDTH="97" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">7,547,755</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="193" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK=" 0X120FC8">
<SPAN USERMARK=" 0X000000">S&V Technologies GmbH</SPAN>
</TD>
<TD WIDTH="63" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">독일</TD>
<TD WIDTH="187" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">화장품 및 의료기기 제조</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">60.00%</TD>
<TD WIDTH="97" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,965,811</TD>
<TD WIDTH="97" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,965,811</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="193" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER" USERMARK=" 0X120FC8">
<SPAN USERMARK=" 0X000000">BSC Medical Devices GmbH</SPAN>
</TD>
<TD WIDTH="63" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">독일</TD>
<TD WIDTH="187" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">의료기기제조 및 판매</TD>
<TD WIDTH="98" HEIGHT="53" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="98" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">60.00%</TD>
<TD WIDTH="97" HEIGHT="53" VALIGN="MIDDLE" ALIGN="RIGHT">361,983</TD>
<TD WIDTH="97" HEIGHT="53" VALIGN="MIDDLE" ALIGN="RIGHT">361,983</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="94" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">관계기업</TD>
<TD WIDTH="193" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER"> JHK Biopharm</TD>
<TD WIDTH="63" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">중국</TD>
<TD WIDTH="187" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">의약품 연구개발 및 판매</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">25.00%</TD>
<TD WIDTH="97" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="97" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="733" HEIGHT="30" COLSPAN="6">합    계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="97" HEIGHT="30">12,712,627</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="97" HEIGHT="30">12,875,549</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 당기 종속기업투자손상차손으로 인식된 금액은 900,000천원입니다.</SPAN>
</P>
<P USERMARK="F-GL">나. 당기말 및 전기말 현재 종속기업 및 관계기업의 요약재무정보는 다음과 같습니 다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="883">

<COLGROUP>
<COL WIDTH="874"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="883" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="885">

<COLGROUP>
<COL WIDTH="166"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="79"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="175" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구   분</TH>
<TH WIDTH="356" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="354" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산</TH>
<TH WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채</TH>
<TH WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이익</TH>
<TH WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자산</TH>
<TH WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부채</TH>
<TH WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매출액</TH>
<TH WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이익(손실)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="885" HEIGHT="30" COLSPAN="9"><종속기업></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30"> 디에이치호림㈜</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,456,037</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,683,281</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23,626,128</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(13,143)</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT">4,668,525</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT">8,881,702</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT">20,918,620</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT">(144,657)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30"> ㈜스페셜라이즈드메드</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">145,961</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">749,845</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">352,034</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(100,020)</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT">265,097</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT">768,961</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT">386,757</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT">17,627</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30"> ㈜리독스바이오</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,384,659</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,697,157</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,804,954</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">601,861</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT">23,705,213</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT">9,697,171</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT">10,073,191</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT">(419,535)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="53"> S&V Technologies GmbH</TD>
<TD WIDTH="89" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">9,371,202</TD>
<TD WIDTH="89" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">1,307,847</TD>
<TD WIDTH="89" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">8,327,866</TD>
<TD WIDTH="89" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">1,046,218</TD>
<TD WIDTH="89" HEIGHT="53" ALIGN="RIGHT">8,647,338</TD>
<TD WIDTH="89" HEIGHT="53" ALIGN="RIGHT">1,491,865</TD>
<TD WIDTH="88" HEIGHT="53" ALIGN="RIGHT">6,450,707</TD>
<TD WIDTH="88" HEIGHT="53" ALIGN="RIGHT">549,893</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="53"> BSC Medical Devices GmbH</TD>
<TD WIDTH="89" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">336,864</TD>
<TD WIDTH="89" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">366,984</TD>
<TD WIDTH="89" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">663,844</TD>
<TD WIDTH="89" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">61,713</TD>
<TD WIDTH="89" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">270,680</TD>
<TD WIDTH="89" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">353,803</TD>
<TD WIDTH="88" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">598,163</TD>
<TD WIDTH="88" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">8,601</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소    계</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">39,694,723</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,805,114</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,774,826</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,596,629</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">37,556,853</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,193,502</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">38,427,438</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,929</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="885" HEIGHT="30" COLSPAN="9"><관계기업></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">JHK Biopharm(주1)</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">87,411</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">556,895</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(494,370)</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">195,297</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">196,586</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,182,946)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" ALIGN="CENTER">합    계</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">39,782,134</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,362,009</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,774,826</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,102,259</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT">37,752,150</TD>
<TD WIDTH="89" HEIGHT="30" ALIGN="RIGHT">21,390,088</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT">38,427,438</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="RIGHT">(1,171,017)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(주1) JHK Biopharm는 2020년 1월 법인설립이후 투자를 진행하고 있는 과정으로 당기 매출액은 없습니다. </SPAN>
<SPAN USERMARK="F-GL">10. 기타비유동금융자산 </SPAN>
</P>
<P USERMARK="F-GL">가. 당기말 및 전기말 현재 기타비유동금융자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="597">

<COLGROUP>
<COL WIDTH="231"></COL>
<COL WIDTH="170"></COL>
<COL WIDTH="169"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="240" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">　구 분</TH>
<TH WIDTH="179" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당기말</TH>
<TH WIDTH="178" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="53"> 기타포괄손익-공정가치측정금융자산</TD>
<TD ALIGN="RIGHT" WIDTH="179" HEIGHT="53">3,533,411</TD>
<TD ALIGN="RIGHT" WIDTH="178" HEIGHT="53">3,707,140</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30"> 장기금융상품</TD>
<TD ALIGN="RIGHT" WIDTH="179" HEIGHT="30">6,840,000</TD>
<TD ALIGN="RIGHT" WIDTH="178" HEIGHT="30">4,830,241</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30"> 임차보증금</TD>
<TD ALIGN="RIGHT" WIDTH="179" HEIGHT="30">49,967</TD>
<TD ALIGN="RIGHT" WIDTH="178" HEIGHT="30">49,893</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30"> 장기선급금</TD>
<TD ALIGN="RIGHT" WIDTH="179" HEIGHT="30">350,702</TD>
<TD ALIGN="RIGHT" WIDTH="178" HEIGHT="30">14,998</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30"> 장기미수수익</TD>
<TD ALIGN="RIGHT" WIDTH="179" HEIGHT="30">79,732</TD>
<TD ALIGN="RIGHT" WIDTH="178" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" HEIGHT="30"> 전신전화가입권</TD>
<TD ALIGN="RIGHT" WIDTH="179" HEIGHT="30">2,860</TD>
<TD ALIGN="RIGHT" WIDTH="178" HEIGHT="30">2,860</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="240" HEIGHT="30">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="179" HEIGHT="30">10,856,672</TD>
<TD ALIGN="RIGHT" WIDTH="178" HEIGHT="30">8,605,132</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" B">
<SPAN USERMARK="F-GL11 !B">상기 장기금융상품의 일부는 장단기차입금의 담보로 제공되어 있습니다(주석14, 20 참조)</SPAN>
</P>
<P></P>

<P USERMARK=" B">
<SPAN USERMARK="F-GL !B">나. 당기말 및 전기말 현재 기타포괄-공정가치측정 금융자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="793">

<COLGROUP>
<COL WIDTH="784"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="793" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="794">

<COLGROUP>
<COL WIDTH="88"></COL>
<COL WIDTH="271"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="98"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="98"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="97" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="280" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종목</TH>
<TH WIDTH="310" ALIGN="CENTER" HEIGHT="30" COLSPAN="3" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="107" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="107" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH WIDTH="107" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부가액</TH>
<TH WIDTH="96" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평가손익누계액</TH>
<TH WIDTH="107" ALIGN="CENTER" HEIGHT="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부가액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">지분상품</TD>
<TD WIDTH="280" HEIGHT="30"> ㈜킹고투자파트너스</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30">1,000,000</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30">1,010,335</TD>
<TD ALIGN="RIGHT" WIDTH="96" HEIGHT="30">10,335</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30">951,440</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">지분상품</TD>
<TD WIDTH="280" HEIGHT="30"> 킹고바이오그로스 제1호 투자조합</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30">500,000</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30">482,848</TD>
<TD ALIGN="RIGHT" WIDTH="96" HEIGHT="30">(17,152)</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30">491,445</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">지분상품</TD>
<TD WIDTH="280" HEIGHT="30"> Haihe Biopharma.Ltd(cayman)</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30">3,375,048</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30">164,635</TD>
<TD ALIGN="RIGHT" WIDTH="96" HEIGHT="30">(3,210,414)</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30">564,043</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="30" VALIGN="BOTTOM" ALIGN="CENTER">지분상품</TD>
<TD WIDTH="280" HEIGHT="30" VALIGN="MIDDLE"> ㈜키메디</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30" VALIGN="MIDDLE">499,995</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30" VALIGN="MIDDLE">121,320</TD>
<TD ALIGN="RIGHT" WIDTH="96" HEIGHT="30" VALIGN="MIDDLE">(378,675)</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30" VALIGN="MIDDLE">66,529</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="30" VALIGN="BOTTOM" ALIGN="CENTER">지분상품</TD>
<TD WIDTH="280" HEIGHT="30" VALIGN="MIDDLE"> 스마트마그나킹고그린펀드</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30" VALIGN="MIDDLE">850,000</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30" VALIGN="MIDDLE">821,577</TD>
<TD ALIGN="RIGHT" WIDTH="96" HEIGHT="30" VALIGN="MIDDLE">(28,423)</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30" VALIGN="MIDDLE">664,727</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="97" HEIGHT="30" VALIGN="BOTTOM" ALIGN="CENTER">지분상품</TD>
<TD WIDTH="280" HEIGHT="30" VALIGN="MIDDLE"> ㈜피코이노베이션</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30" VALIGN="MIDDLE">1,000,000</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30" VALIGN="MIDDLE">932,696</TD>
<TD ALIGN="RIGHT" WIDTH="96" HEIGHT="30" VALIGN="MIDDLE">(67,304)</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30" VALIGN="MIDDLE">968,956</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="377" HEIGHT="30" ALIGN="CENTER" COLSPAN="2">합    계</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30">7,225,043</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30">3,533,411</TD>
<TD ALIGN="RIGHT" WIDTH="96" HEIGHT="30">(3,691,632)</TD>
<TD ALIGN="RIGHT" WIDTH="107" HEIGHT="30">3,707,140</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11 B">11. 재고자산</P>

<P>
<SPAN USERMARK="F-GL11">가. 보고기간종료일 현재 재고자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="656">

<COLGROUP>
<COL WIDTH="647"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="656" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="657">

<COLGROUP>
<COL WIDTH="98"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="82"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="107" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분 </TH>
<TH WIDTH="276" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="274" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평가충당금 </TH>
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액 </TH>
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가 </TH>
<TH WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">평가충당금 </TH>
<TH WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="30"> 원재료</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">7,174,541</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">(99,074)</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">7,075,467</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">2,967,815</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT">(28,832)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT">2,938,983</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="30"> 상품</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">1,692,623</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">(19,330)</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">1,673,293</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">1,095,423</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT">(28,582)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT">1,066,841</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="30"> 부재료</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">2,347,328</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">(142,667)</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">2,204,661</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">1,470,397</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT">(140,789)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT">1,329,608</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="30"> 재공품</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">1,510,858</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">(87,324)</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">1,423,534</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">3,715,589</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT">(36,287)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT">3,679,302</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="30"> 제품</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">6,669,222</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">(131,719)</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">6,537,503</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">5,670,612</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT">(132,288)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT">5,538,324</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">19,394,572 </TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">(480,114)</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">18,914,458 </TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">14,919,836</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT">(366,778)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT">14,553,058</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">나. 당기 및 전기 중 재고자산과 관련하여 인식한 평가손실 및 환입은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="623">

<COLGROUP>
<COL WIDTH="614"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="623" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="622" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="303"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="146"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="312" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="155" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당 기</TH>
<TH WIDTH="155" VALIGN="BOTTOM" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="622" HEIGHT="30"> 매출원가:</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="312" HEIGHT="30">   ―재고자산평가손실(환입)</TD>
<TD WIDTH="155" ALIGN="RIGHT" HEIGHT="30">113,336</TD>
<TD WIDTH="155" ALIGN="RIGHT" HEIGHT="30">100,334</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL 0X0000FF"></P>
<P USERMARK="F-GL 0X0000FF"></P>

<P>
<SPAN USERMARK="F-GL11 B">12. 매출채권 및 기타유동채권</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">가. 보고기간종료일 현재 매출채권 및 기타유동채권의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="708">

<COLGROUP>
<COL WIDTH="699"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="708" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="707">

<COLGROUP>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="101" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="303" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="303" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권총액 </TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대손충당금 </TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액 </TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권총액 </TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대손충당금 </TH>
<TH WIDTH="101" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" HEIGHT="30"> 매출채권</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">12,523,621</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(807,227)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">11,716,394</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">12,179,705</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(888,950)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">11,290,754</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" HEIGHT="30"> 미수금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">824,899</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">824,899</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">521,034</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">521,034</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" HEIGHT="30"> 미수수익</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">39,690</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">39,690</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">662,862</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(250,503)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">412,359</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" HEIGHT="30"> 선급금</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">15,308</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">15,308</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">491,848</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">491,848</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" HEIGHT="30"> 선급비용</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">22,274</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">22,274</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">14,747</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">14,747</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="101" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">13,425,792</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(807,227)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">12,618,565</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">13,870,196</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">(1,139,453)</TD>
<TD WIDTH="101" HEIGHT="30" ALIGN="RIGHT">12,730,742</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">나. 당기 및 전기 중 매출채권의 대손충당금의 변동 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="621">

<COLGROUP>
<COL WIDTH="301"></COL>
<COL WIDTH="302"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD WIDTH="311" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="95"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="121"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="104" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 초</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대손상각비(환입)</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권제각</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="104" HEIGHT="30" VALIGN="BOTTOM"> 매출채권</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT">888,950</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">(81,724)</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT">807,227</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="621">

<COLGROUP>
<COL WIDTH="301"></COL>
<COL WIDTH="302"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="310" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD WIDTH="311" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="101"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="119"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="110" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="129" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 초</TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대손상각비</TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권제각</TH>
<TH WIDTH="128" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30"> 매출채권</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">929,815</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">(40,864)</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="128" HEIGHT="30" ALIGN="RIGHT">888,950</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">13. 기타유동금융자산</SPAN>
<SPAN USERMARK="F-GL11">가. 보고기간종료일 현재 기타유동금융자산 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="621">

<COLGROUP>
<COL WIDTH="612"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="621" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="624" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="253"></COL>
<COL WIDTH="172"></COL>
<COL WIDTH="172"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="262" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH ALIGN="CENTER" WIDTH="181" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH ALIGN="CENTER" WIDTH="181" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30"> 단기금융상품</TD>
<TD ALIGN="RIGHT" WIDTH="181" HEIGHT="30">3,240,000</TD>
<TD ALIGN="RIGHT" WIDTH="181" HEIGHT="30">11,340,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30"> 당기손익-공정가치측정금융자산</TD>
<TD ALIGN="RIGHT" WIDTH="181" HEIGHT="30" VALIGN="MIDDLE">1,496,345</TD>
<TD ALIGN="RIGHT" WIDTH="181" HEIGHT="30" VALIGN="MIDDLE">2,999,301</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="262" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="181" HEIGHT="30">4,736,345</TD>
<TD ALIGN="RIGHT" WIDTH="181" HEIGHT="30">14,339,301</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">상기 단기금융상품의 일부는 차입금의 담보로 제공되어 있습니다.(주석14 참조)</P>
<P USERMARK="F-GL11">나. 보고기간종료일 현재 당기손익-공정가치측정금융자산의 내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="621">

<COLGROUP>
<COL WIDTH="612"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="621" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="147"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="91"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="156" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="164" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종 목</TH>
<TH WIDTH="200" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">취득원가</TH>
<TH WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부가액</TH>
<TH WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부가액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE"> 출자금</TD>
<TD WIDTH="164" HEIGHT="30">한국제약협동조합</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT">19,992</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT">19,992</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT">19,992</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE"> 출자금</TD>
<TD WIDTH="164" HEIGHT="30">향남제약사업 협동조합</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT">13,690</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT">13,690</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT">13,690</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30" VALIGN="MIDDLE"> 시장성있는 지분상품</TD>
<TD WIDTH="164" HEIGHT="30" VALIGN="MIDDLE">한미약품 등</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,971,632</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,462,663</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,965,619</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="320" HEIGHT="30" COLSPAN="2" ALIGN="CENTER">합 계</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT">2,005,314</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT">1,496,345</TD>
<TD WIDTH="100" HEIGHT="30" ALIGN="RIGHT">2,999,301</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 0X0000FF"></P>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL B">14. 현금및현금성자산 및 사용제한 금융상품</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">가. 보고기간종료일 현재 현금및현금성자산의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="627">

<COLGROUP>
<COL WIDTH="618"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="627" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="625">

<COLGROUP>
<COL WIDTH="200"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="209" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">　구 분</TH>
<TH WIDTH="208" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="208" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE"> 보유현금</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">17,258</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">11,004</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE"> 보통예금</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">303,122</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">1,404,081</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="209" HEIGHT="30">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">320,381</TD>
<TD ALIGN="RIGHT" WIDTH="208" HEIGHT="30">1,415,085</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">나. 보고기간종료일 현재 사용이 제한된 금융자산의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="627">

<COLGROUP>
<COL WIDTH="618"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="627" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="131" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">계정명</TH>
<TH WIDTH="131" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">금융기관</TH>
<TH WIDTH="144" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">내 역</TH>
<TH WIDTH="112" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당기말</TH>
<TH WIDTH="111" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30" VALIGN="MIDDLE"> 단기금융상품</TD>
<TD ALIGN="CENTER" WIDTH="131" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" WIDTH="144" HEIGHT="30">차입금 담보</TD>
<TD ALIGN="RIGHT" WIDTH="112" HEIGHT="30">3,240,000</TD>
<TD ALIGN="RIGHT" WIDTH="111" HEIGHT="30">11,340,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="30" VALIGN="MIDDLE"> 장기금융상품</TD>
<TD ALIGN="CENTER" WIDTH="131" HEIGHT="30">기업은행</TD>
<TD ALIGN="CENTER" WIDTH="144" HEIGHT="30">차입금 담보</TD>
<TD ALIGN="RIGHT" WIDTH="112" HEIGHT="30">5,700,000</TD>
<TD ALIGN="RIGHT" WIDTH="111" HEIGHT="30">3,050,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="406" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="112" HEIGHT="30">8,940,000</TD>
<TD ALIGN="RIGHT" WIDTH="111" HEIGHT="30">14,390,000</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 0X0000FF"></P>

<P>
<SPAN USERMARK="F-GL11 B">15. 납입자본</SPAN>
<SPAN USERMARK="F-GL11">회사의 정관에 의한 발행할 주식의 총수는 60,000,000주(1주의 금액: 500원)이며 당기말 현재 회사가 발행한 주식수는 보통주식 18,616,650주입니다. 당기 및 전기 중 회사의 자본금 및 주식발행초과금의 변동 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="548">

<COLGROUP>
<COL WIDTH="539"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="548" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="545">

<COLGROUP>
<COL WIDTH="116"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="131"></COL>
<COL WIDTH="131"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="140" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">발행주식수</TH>
<TH WIDTH="140" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보통주자본금</TH>
<TH WIDTH="140" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식발행초과금</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30"> 전기초</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">18,569,379</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">9,284,690</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">29,349,309</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30">   전환권행사</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">47,271</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">23,636</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">945,552</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30"> 전기말</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">18,616,650</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">9,308,325</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">30,294,861</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30">   전환권행사</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="125" HEIGHT="30"> 당기말</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">18,616,650</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">9,308,325</TD>
<TD WIDTH="140" HEIGHT="30" ALIGN="RIGHT">30,294,861</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">16. 이익잉여금</SPAN>
<SPAN USERMARK="F-GL11">가. 보고기간종료일 현재 회사의 이익잉여금의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="618">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="618" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="621" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="267"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="163"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="276" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="173" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당기말</TH>
<TH WIDTH="172" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="276" HEIGHT="30"> 법정적립금</TD>
<TD WIDTH="173" ALIGN="RIGHT" HEIGHT="30">3,456,693</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">3,193,943</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="276" HEIGHT="30"> 임의적립금</TD>
<TD WIDTH="173" ALIGN="RIGHT" HEIGHT="30">11,262,509</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">11,262,509</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="276" HEIGHT="30"> 미처분이익잉여금</TD>
<TD WIDTH="173" ALIGN="RIGHT" HEIGHT="30">38,981,939</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">39,151,044</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="276" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="173" ALIGN="RIGHT" HEIGHT="30">53,701,141</TD>
<TD WIDTH="172" ALIGN="RIGHT" HEIGHT="30">53,607,496</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL 0X0000FF"></P>

<P>
<SPAN USERMARK="F-GL11">(1) 법정적립금보고기간종료일 현재 회사의 법정적립금 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE AFIXTABLE="N" WIDTH="600" BORDER="1" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE"> 이익준비금(주1)</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">3,456,693</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">3,193,943</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL10">(주1) 회사는 상법의 규정에 따라 자본금의 50%에 달할 때까지 매 결산기마다 금전에의한 이익배당액의 10% 이상을 이익준비금으로 적립하고 있으며, 동 이익준비금은 현금으로 배당할 수 없으며 주주총회 결의에 의하여 이월결손금의 보전과 자본전입에만 사용될 수 있습니다.</P>

<P>
<SPAN USERMARK="F-GL11">(2) 임의적립금보고기간종료일 현재 회사의 임의적립금 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE AFIXTABLE="N" WIDTH="600" BORDER="1" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH ALIGN="CENTER" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH ALIGN="CENTER" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 기업합리화적립금(주1)</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">462,509</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">462,509</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 기업발전적립금(주2)</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">6,800,000</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">6,800,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 기타(주3)</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">4,000,000</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">4,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="200" HEIGHT="30">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">11,262,509</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">11,262,509</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL10 0X0000FF">
<SPAN USERMARK=" 0X000000">(주1) 회사는 종전의 조세특례제한법에 의거 세액공제, 세액감면 등을 받은 금액 상당액을 기업합리화적립금으로 적립하였습니다. 동 적립금은 이월결손금의 보전 또는자본전입에만 사용될 수 있었으나, 2002년 12월 11일 개정된 조세특례제한법에 따라 기업합리화적립금의 적립의무가 소멸되었는 바, 당기말 현재의 기업합리화적립금은 임의적립금으로서 그 사용에 제한이 없습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL10">(주2) 회사는 종전의 적정유보초과소득에 대한 법인세에 대해 기업발전적립금을 적립하였습니다. 동 적립금은 이월결손금의 보전 또는 자본전입에만 사용될 수 있으며,2001.12.31. 법인세법 개정에 의하여 적정유보초과소득에 대한 법인세과세제도를 폐지하였으나 법인세법 부칙에 의해 종전의 규정에 의하여 이미 적립한 기업발전적립금의 처분과 용도 외의 처분에 대하여는 종전의 규정에 따라 법인세를 납부하도록 하고 있습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL10">(주3) 회사는 기타의 임의적립금을 설정하고 있으며, 이는 주주총회의 결의에 의하여 배당이가능한 잉여금입니다.</SPAN>
<SPAN USERMARK="F-GL11">(3) 이익잉여금처분계산서</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="640" BORDER="0">

<COLGROUP>
<COL WIDTH="81"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="153"></COL>
<COL WIDTH="79"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="60">제39(당)기</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30">2022년   1월  1일</TD>
<TD VALIGN="MIDDLE" WIDTH="48" HEIGHT="30">부터</TD>
<TD ROWSPAN="2" ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="60">제38(전)기</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30">2021년   1월  1일</TD>
<TD VALIGN="MIDDLE" WIDTH="88" HEIGHT="30">부터</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30">2022년 12월 31일</TD>
<TD VALIGN="MIDDLE" WIDTH="48" HEIGHT="30">까지</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30">2021년 12월 31일</TD>
<TD VALIGN="MIDDLE" WIDTH="88" HEIGHT="30">까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30">처분예정일</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30">2023년   3월 23일</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30"></TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30">처분확정일</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="162" HEIGHT="30">2022년   3월 24일</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="88" HEIGHT="30"></TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="772" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="463"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">대화제약 주식회사</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="472" HEIGHT="30">(단위 : 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="774">

<COLGROUP>
<COL WIDTH="261"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="117"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="270" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">과 목</TH>
<TH WIDTH="252" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 38(당) 기</TH>
<TH WIDTH="252" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 37(당) 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30">미처분 이익잉여금</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">38,981,938,670</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">39,151,044,034</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30">  전기이월이익잉여금</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">37,136,629,284</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">37,587,367,331</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30">  중간배당액</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">(875,832,500)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">(875,832,500)</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30">  확정급여제도의 재측정요소</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">798,075,356</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">117,112,931</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30">  당기순이익</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">1,923,066,530</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">2,322,396,272</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30">임의적립금 등의 이입액</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">38,981,938,670</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">39,151,044,034</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30">이익잉여금 처분액</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">2,014,414,750</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">2,014,414,750</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="270" HEIGHT="30" USERMARK=" B">
<SPAN USERMARK=" !B">   이익준비금</SPAN>
</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">262,749,750</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">262,749,750</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="99">배당금  (현금배당주당배당금(률):  보통주: 당기 100원(20%)             전기 100원(20%)</TD>
<TD WIDTH="126" HEIGHT="99" ALIGN="RIGHT" VALIGN="MIDDLE">1,751,665,000</TD>
<TD WIDTH="126" HEIGHT="99" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="126" HEIGHT="99" ALIGN="RIGHT" VALIGN="MIDDLE">1,751,665,000</TD>
<TD WIDTH="126" HEIGHT="99" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="270" HEIGHT="30">차기이월미처분이익잉여금</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" USERMARK=" B"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">36,967,523,920</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" USERMARK=" B"></TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT">37,136,629,284</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">나. 당기 및 전기 중 보통주배당금에 관한 사항은 다음과 같습니다.(1) 배당금 산정내역</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="627">

<COLGROUP>
<COL WIDTH="618"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="627" HEIGHT="30" ALIGN="RIGHT">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="629">

<COLGROUP>
<COL WIDTH="137"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="146" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="242" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="241" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">중간배당</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말배당(주1)</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">중간배당</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말배당</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30"> 배당을 받은주식</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">17,516,650</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">17,516,650</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">17,516,650</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">17,516,650</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30"> 주당배당금</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">50</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">100</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">50</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30"> 주당배당율</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">10%</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">20%</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">10%</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">20%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="146" HEIGHT="30"> 배당할 금액</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">875,832,500</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">1,751,665,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT">875,832,500</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="RIGHT">1,751,665,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 기말배당금액은 2023년 3월 23일 정기주주총회에서 처분예정인 금액입니다.</SPAN>
<SPAN USERMARK="F-GL11">(2) 배당성향</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="611"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="620" HEIGHT="30" ALIGN="RIGHT">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="202"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="200" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="211" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="211" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 배당금(A)</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">2,627,497,500</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">2,627,497,500</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 당기순이익(B)</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">1,923,066,530</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">2,322,396,272</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30"> 배당성향(A/B)</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">136.6%</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">113.1%</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">(3) 배당수익률</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="611"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="620" HEIGHT="30" ALIGN="RIGHT">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="211" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="210" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 주당배당금(A)</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">150</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT">150</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 주가(B)</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="RIGHT">9,400</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="RIGHT">9,320</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 배당수익률(A/B)</TD>
<TD WIDTH="211" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1.60%</TD>
<TD WIDTH="210" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1.61%</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL 0X0000FF"></P>
<P USERMARK="F-GL 0X0000FF"></P>

<P>
<SPAN USERMARK="F-GL11 B">17. 기타 자본구성요소</SPAN>
<SPAN USERMARK="F-GL11">가. 보고기간종료일 현재 기타 자본구성요소의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="619">

<COLGROUP>
<COL WIDTH="610"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="619" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="152"></COL>
<COL WIDTH="152"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="301" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="161" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="161" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE"> 자기주식</TD>
<TD ALIGN="RIGHT" WIDTH="161" HEIGHT="30">(9,161,842)</TD>
<TD ALIGN="RIGHT" WIDTH="161" HEIGHT="30">(9,161,842)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE"> 자기주식처분이익</TD>
<TD ALIGN="RIGHT" WIDTH="161" HEIGHT="30">2,357,025</TD>
<TD ALIGN="RIGHT" WIDTH="161" HEIGHT="30">2,357,025</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="301" HEIGHT="30" VALIGN="MIDDLE"> 기타포괄손익누계액</TD>
<TD ALIGN="RIGHT" WIDTH="161" HEIGHT="30">(2,920,081)</TD>
<TD ALIGN="RIGHT" WIDTH="161" HEIGHT="30">(2,611,364)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="301" HEIGHT="30">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="161" HEIGHT="30">(9,724,898)</TD>
<TD ALIGN="RIGHT" WIDTH="161" HEIGHT="30">(9,416,181)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">나. 당기 및 전기 중 기타 자본구성요소의 변동내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="895">

<COLGROUP>
<COL WIDTH="886"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="895" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="897">

<COLGROUP>
<COL WIDTH="157"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="82"></COL>
<COL WIDTH="82"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="166" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="367" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="364" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
<TH WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
<TH WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가</TH>
<TH WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소</TH>
<TH WIDTH="91" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE"> 자기주식</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(9,161,842)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(9,161,842)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(9,161,842)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(9,161,842)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE"> 자기주식처분이익</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,357,025</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,357,025</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,357,025</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,357,025</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" VALIGN="MIDDLE"> 기타포괄손익누계액</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,611,364)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(308,717)</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,920,081)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(125,282)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,486,082)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,611,364)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="166" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(9,416,181)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(308,717)</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(9,724,898)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(6,930,099)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,486,082)</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="91" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(9,416,181)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">다. 당기말 현재 보유하고 있는 자기주식은  9,161,842천원(보통주 1,100,000주)이며 향후 주가상황에 따라 처분할 예정입니다.</SPAN>
</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL"></P>

<P USERMARK="F-GL11">
<SPAN USERMARK=" B">18. 충당부채</SPAN>
</P>
<P USERMARK="F-GL11">당기 및 전기 중 충당부채의 내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="734">

<COLGROUP>
<COL WIDTH="348"></COL>
<COL WIDTH="368"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="357" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD WIDTH="377" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="737">

<COLGROUP>
<COL WIDTH="193"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="202" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="134" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="134" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전입액(환입액)</TH>
<TH WIDTH="134" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사용액</TH>
<TH WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE"> 유동: </TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE">   반품충당부채(주1)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">985,797 </TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(173,399)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">812,398</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE">   계약부채(매출할인)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">440,629 </TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(30,432)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">410,197</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소 계</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,426,426 </TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(203,831)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,222,595</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE"> 비유동:</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" VALIGN="MIDDLE">   마일리지충당부채(주2)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,118 </TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,861 </TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,561)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,418</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="202" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,431,544 </TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(201,970)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,561)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,228,013</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-11">
<SPAN USERMARK="F-GL10">(주1) 회사는 판매시점에 반품이 예상되는 부분의 매출액을 차감하고 그 금액과 반품재고자산의 감액 등반품과 관련하여 발생할 것으로 예상되는 비용을 반품충당부채로 계상하고 있습니다.(주2) 회사는 고정고객 확보 및 우수고객 보상을 통하여 안정적인 수익의 원천을관리하려는 영업정책의 일환으로 마일리지제도를 운영하고 있는 바, 기간손익의 적정화를 위하여 동 마일리지 부여에 따라 예상되는 추가적인 원가부담액을 마일리지충당부채로 계상하고 있습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="737">

<COLGROUP>
<COL WIDTH="348"></COL>
<COL WIDTH="371"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="357" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD WIDTH="380" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="740">

<COLGROUP>
<COL WIDTH="196"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="205" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="134" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="134" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전입액</TH>
<TH WIDTH="134" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사용액</TH>
<TH WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE">유동: </TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE"> 반품충당부채</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,092,727</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(106,930)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">985,797</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE"> 계약부채(매출할인)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">402,775</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">37,854</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">440,629</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소   계</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,495,502</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(69,076)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,426,426</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE">비유동:</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE"> 마일리지충당부채</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,219</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,586</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,688)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,118</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,500,721</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(67,490)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,688)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,431,544</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 0X0000FF"></P>
<P USERMARK="F-GL11 0X0000FF"></P>
<P USERMARK="F-GL11 B">19. 장기매입채무 및 기타비유동채무</P>

<P>
<SPAN USERMARK="F-GL11">보고기간종료일 현재 장기매입채무 및 기타비유동채무의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="601">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="200" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">당기말</TH>
<TH WIDTH="200" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 미지급금</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">2,900,835</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">2,796,849</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 임대보증금</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">465,000</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">455,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 비유동리스부채</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">244,351</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">238,035</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">3,610,186</TD>
<TD ALIGN="RIGHT" WIDTH="200" HEIGHT="30">3,489,884</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 0X0000FF"></P>

<P>
<SPAN USERMARK="F-GL11 B">20. 장단기차입금 및 전환사채</SPAN>
<SPAN USERMARK="F-GL11">가. 보고기간종료일 현재 회사의 단기차입금 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="616">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="307"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="316" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="124"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종 류</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입처</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연이자율(%)</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER">기업일반대출</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER">2.58% ~ 5.38%</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">35,200,000</TD>

<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT 0X0000FF">
<P>38,100,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER">기업일반대출</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="CENTER">하나은행</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER">5.95% ~ 6.12%</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">4,000,000</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER">기업일반대출</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="CENTER">우리은행</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER">5.55% ~ 6.23%</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">6,000,000</TD>

<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT 0X0000FF">
<P>6,000,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER">기업일반대출</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="CENTER">신한은행</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER">5.1% ~ 5.6%</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">5,000,000</TD>

<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT 0X0000FF">
<P>2,400,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="376" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">합 계</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">50,200,000</TD>

<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-BT 0X0000FF">
<P>46,500,000</P>
</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL 0X0000FF B"></P>

<P USERMARK="F-GL B">
<SPAN USERMARK="F-11 !B">상기 장단기차입금과 관련하여 회사소유의 부동산 및 금융상품이 담보로 제공되어 있습니다(주석5,14 참조).</SPAN>
<SPAN USERMARK="F-11 !B">나. 보고기간종료일 현재 회사의 장기차입금 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="616">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="307"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="316" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="124"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종 류</TH>
<TH WIDTH="120" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입처</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연이자율(%)</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER">시설자금대출</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER">5.36% ~ 5.38%</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">23,557,863</TD>

<TD USERMARK="F-BT 0X0000FF" WIDTH="122" HEIGHT="30" ALIGN="RIGHT">
<P>5,047,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="133" HEIGHT="30" ALIGN="CENTER">운전자금대출</TD>
<TD WIDTH="120" HEIGHT="30" ALIGN="CENTER">우리은행</TD>
<TD WIDTH="123" HEIGHT="30" ALIGN="CENTER">6.330%</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">1,500,000</TD>

<TD USERMARK="F-BT 0X0000FF" WIDTH="122" HEIGHT="30" ALIGN="RIGHT">
<P>2,500,000</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="376" HEIGHT="30" ALIGN="CENTER" COLSPAN="3">소 계</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">25,057,863</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">7,547,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="376" HEIGHT="30" ALIGN="CENTER" COLSPAN="3">차감 : 1년이내 만기도래분</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(1,000,000)</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">(1,000,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="376" HEIGHT="30" COLSPAN="3" ALIGN="CENTER">합 계</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">24,057,863</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="RIGHT">6,547,000</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">상기 장기차입금과 관련하여 회사소유의 부동산 및 금융상품이 담보로 제공되어 있습니다(주석5,14참조).한편, 당기말 현재 장기차입금의 연도별 상환계획은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="412">

<COLGROUP>
<COL WIDTH="247"></COL>
<COL WIDTH="147"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="256" HEIGHT="30"></TD>
<TD WIDTH="156" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="411">

<COLGROUP>
<COL WIDTH="197"></COL>
<COL WIDTH="196"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="206" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">연 도</TH>
<TH WIDTH="205" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금 액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK="F-BT" WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">
<P> 2023년</P>
</TD>
<TD WIDTH="205" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK="F-BT" WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">
<P> 2024년</P>
</TD>
<TD WIDTH="205" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK="F-BT" WIDTH="206" HEIGHT="30" VALIGN="MIDDLE">
<P> 2025년</P>
</TD>
<TD WIDTH="205" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23,057,863</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK="F-BT" WIDTH="206" HEIGHT="30" ALIGN="CENTER">
<P>합 계</P>
</TD>
<TD WIDTH="205" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,057,863</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 0X0000FF"></P>

<P USERMARK=" B">
<SPAN USERMARK="F-GL11 !B">다. 전환사채회사는 운영자금 조달을 목적으로 전환사채를 발행하였으며, 보고기간종료일 현재 전환사채의 발행조건과 장부가액은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="311"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="320" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="114"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종 류</TH>
<TH WIDTH="100" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">발행일</TH>
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상환기일</TH>
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">표면 이자율</TH>
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="99" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="76" ALIGN="CENTER">제1회 무기명식 이권부 무보증 사모 전환사채 </TD>
<TD WIDTH="100" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">2019.03.29</TD>
<TD WIDTH="99" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">2024.03.29</TD>
<TD WIDTH="99" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="99" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">20,000,000</TD>
<TD WIDTH="99" HEIGHT="76" ALIGN="RIGHT" VALIGN="MIDDLE">20,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="421" HEIGHT="30" ALIGN="CENTER" COLSPAN="4">전환사채의 보통주 전환</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">(5,800,000)</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">(5,800,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="421" HEIGHT="30" ALIGN="CENTER" COLSPAN="4">전환사채의 조기상환</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">(14,200,000)</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">(13,400,000)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="421" HEIGHT="30" ALIGN="CENTER" COLSPAN="4">전환사채 액면총액</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">800,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="421" HEIGHT="30" ALIGN="CENTER" COLSPAN="4">전환사채 상환할증금</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">44,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="421" HEIGHT="30" ALIGN="CENTER" COLSPAN="4">전환권조정</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="421" HEIGHT="30" ALIGN="CENTER" COLSPAN="4">전환사채 합계</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="99" HEIGHT="30" ALIGN="RIGHT">844,000</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL B"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="237"></COL>
<COL WIDTH="365"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="246" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="374" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제1회 전환사채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30" ALIGN="CENTER">사채 종류</TD>
<TD WIDTH="374" HEIGHT="30" ALIGN="CENTER">무기명식 이권부 무보증 사모 전환사채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30" ALIGN="CENTER">사채 권면액</TD>
<TD WIDTH="374" HEIGHT="30" ALIGN="CENTER">20,000,000,000원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30" ALIGN="CENTER">발행시점 주식전환 행사가액</TD>
<TD WIDTH="374" HEIGHT="30" ALIGN="CENTER">21,154원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="53" ALIGN="CENTER">보고기간말 현재 조정된 주식전환 행사가액 (주1)</TD>
<TD WIDTH="374" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">14,808원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="168" ALIGN="CENTER" VALIGN="MIDDLE">이자지급과 상환방법</TD>
<TD WIDTH="374" HEIGHT="168" VALIGN="MIDDLE">본 사채의 표면이자는 0.0%이며, 별도의 이자지급기일은 없는 것으로 한다.만기까지 보유하고 있는 본 사채의 원금에 대하여는 2024년 03월 29일에 권면금액의 110.0000%에 해당하는 금액을 일시 상환한다. 단, 상환기일이 은행영업일이 아닌 경우에는 그 다음 영업일에 상환하고 원금 상환기일 이후의 이자는 계산하지 아니한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">보유자 조기상환청구권 (주2)</TD>
<TD WIDTH="374" HEIGHT="53" VALIGN="MIDDLE">발행일로부터 21개월이 되는 2020년 12월 29일 및 이후 매3개월에 해당되는 날</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">발행회사의 매도청구권 (주2) (주3)</TD>
<TD WIDTH="374" HEIGHT="53" VALIGN="MIDDLE">발행일로부터 1년이되는 날인 2020년 03월29일부터 2021년 03월29일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="246" HEIGHT="30" ALIGN="CENTER">미행사 잔여주식수</TD>
<TD WIDTH="374" HEIGHT="30" ALIGN="CENTER">0 주 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 본 사채권을 소유한 자가 전환청구를 하기 전에 시가를 하회하는 발행가액으로 유상증자, 주식배당 및 준비금의 자본전입 등에 따른 주식을 발행하거나 또는 시가를 하회하는전환가액 또는 행사가액으로 특수사채를 발행하는 경우에 전환가액이 조정될 수 있습니다. 또한, 합병, 자본의 감소, 주식분할 및 병합 등에 의하여 전환가격의 조정이 필요한 경우 조정하며, 최저조정한도는 발행시 전환가액의 70% 이상으로 합니다. 전환가액 조정내역은 다음과 같습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-10">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="600">

<COLGROUP>
<COL WIDTH="147"></COL>
<COL WIDTH="146"></COL>
<COL WIDTH="280"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="156" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">구 분</TH>
<TH WIDTH="155" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">전환가액</TH>
<TH WIDTH="289" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK="F-10">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30" USERMARK="F-10"> 최초발행시</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-10">21,154</TD>
<TD WIDTH="289" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30" USERMARK="F-10"> 1차 조정</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" USERMARK="F-10">16,398</TD>
<TD WIDTH="289" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="156" HEIGHT="30" USERMARK="F-10"> 2차 조정</TD>
<TD WIDTH="155" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-10">14,808</TD>
<TD WIDTH="289" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK="F-10">전환가액은 최초전환가액의  70%로 고정됨</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P USERMARK=" 0X0000FF">
<SPAN USERMARK="F-GL10 0X000000">(주2) 회사는 상기 전환사채에 부여된 조기상환권을 본 사채와 비분리하였습니다.(주3) 발행회사는 각 사채권자가 보유하고 있는 본 사채 발행가액의 30%범위 내에서만 매도청구권을 행사할 수 있으며, 본 사채의 인수인은 본 계약의 '발행회사의 매도청구권' 의 행사를 보장하기 위하여 매도청구권의 행사기간 종료일까지 발행 당시 각인수인별 인수금액의 30%에 해당하는 본 사채를 미전환 상태로 보유하여야 합니다.</SPAN>
</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 당기 중  전환사채의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="311"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="320" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="740" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="134"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="110"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종 류</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 초</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보통주 전환</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">조기상환</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자비용</TH>
<TH WIDTH="119" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30"> 전환사채</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">800,000</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">(800,000)</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" HEIGHT="30"> 상환할증금(주1)</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">44,000</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">(53,500)</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">9,500</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">(853,500)</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">9,500</TD>
<TD WIDTH="119" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL10">(주1) 회사는 당기말 상환시 지급하여야 할 이자비용을 사채상환할증금으로 인식하였습니다. </P>
<P USERMARK="F-GL10"></P>
<P USERMARK="F-GL11">(3) 당기 및 전기 중 주계약과 분리된 내재파생상품부채의 공정가치 변동 및 관련손익은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="311"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="300" HEIGHT="30"></TD>
<TD WIDTH="320" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="620" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="197"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종 류</TH>
<TH WIDTH="207" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="206" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30"> 기발행(전기이월)</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,231,018</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30"> 파생상품평가손실(이익)</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,312,014)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30"> 조기상환으로 인한 감소</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(45)</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(673,207)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30"> 전환권행사</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(245,752)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" VALIGN="MIDDLE" HEIGHT="30"> 기말 현재공정가치</TD>
<TD WIDTH="207" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="206" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 0X0000FF"></P>
<P USERMARK="F-GL11 0X0000FF"></P>

<P USERMARK="F-GL11">
<SPAN USERMARK=" B">21. 확정급여부채</SPAN>가. 회사는 종업원을 위하여 확정급여제도를 운영하고 있으며, 이 제도에 따르면 종업원의퇴직시 근속 1년당 최종 3개월 평균급여에 지급률 등을 가감한 금액을 지급하도록 되어 있습니다. 사외적립자산과 확정급여채무의 보험수리적 평가는 예측단위적립방식을 사용하여 적격성이 있는 독립적인 보험계리법인인 딜로그에 의하여 수행되었습니다. 보고기간종료일 현재 회사의확정급여채무와 관련된 부채의 내역은 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="619">

<COLGROUP>
<COL WIDTH="610"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="619" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="620" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="226"></COL>
<COL WIDTH="184"></COL>
<COL WIDTH="183"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="235" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="193" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당기말</TH>
<TH WIDTH="192" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30"> 확정급여채무의 현재가치</TD>
<TD WIDTH="193" ALIGN="RIGHT" HEIGHT="30">10,194,698</TD>
<TD WIDTH="192" ALIGN="RIGHT" HEIGHT="30">11,128,625</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30"> 사외적립자산의 공정가치</TD>
<TD WIDTH="193" ALIGN="RIGHT" HEIGHT="30">(7,688,171)</TD>
<TD WIDTH="192" ALIGN="RIGHT" HEIGHT="30">(7,718,702)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="235" HEIGHT="30"> 확정급여제도의 부채 인식액</TD>
<TD WIDTH="193" ALIGN="RIGHT" HEIGHT="30">2,506,527</TD>
<TD WIDTH="192" ALIGN="RIGHT" HEIGHT="30">3,409,923</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL 0X0000FF"></P>
<P USERMARK="F-GL11">나. 회사의 확정급여채무의 현재가치 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="614">

<COLGROUP>
<COL WIDTH="605"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="614" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="617" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="250"></COL>
<COL WIDTH="170"></COL>
<COL WIDTH="170"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="259" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="179" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당 기</TH>
<TH WIDTH="179" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" HEIGHT="30"> 기초금액</TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">11,128,625 </TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">10,909,787</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" HEIGHT="30">   퇴직급여 지급액</TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">(1,535,937)</TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">(1,289,213)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" HEIGHT="30">   당기근무원가와 이자</TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">1,480,101 </TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">1,519,256</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" HEIGHT="30">   확정급여제도의 재측정요소(주1)</TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">(1,089,929)</TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">(231,562)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" HEIGHT="30">   기타(주2)</TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">211,838 </TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">220,356</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" HEIGHT="30"> 기말금액</TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">10,194,698 </TD>
<TD WIDTH="179" ALIGN="RIGHT" HEIGHT="30">11,128,624</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 상기 확정급여제도의 재측정요소는 법인세를 차감하기 전 금액입니다.(주2) 당기 중 경상연구개발비로 인식되었습니다. </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">다. 사외적립자산은 다음 항목으로 구성됩니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="616">

<COLGROUP>
<COL WIDTH="607"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="616" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="619" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="232"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="180"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="241" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="189" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당기말</TH>
<TH WIDTH="189" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30"> 현금및현금성자산</TD>
<TD WIDTH="189" ALIGN="RIGHT" HEIGHT="30">7,686,471</TD>
<TD WIDTH="189" ALIGN="RIGHT" HEIGHT="30">7,717,002</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" HEIGHT="30"> 국민연금전환금</TD>
<TD WIDTH="189" ALIGN="RIGHT" HEIGHT="30">1,700</TD>
<TD WIDTH="189" ALIGN="RIGHT" HEIGHT="30">1,700</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="241" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="189" ALIGN="RIGHT" HEIGHT="30">7,688,171</TD>
<TD WIDTH="189" ALIGN="RIGHT" HEIGHT="30">7,718,702</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P USERMARK="F-GL11">라. 사외적립자산 현재가치의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="621">

<COLGROUP>
<COL WIDTH="612"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="621" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="622" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="250"></COL>
<COL WIDTH="173"></COL>
<COL WIDTH="172"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="259" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="182" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당 기</TH>
<TH WIDTH="181" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" HEIGHT="30"> 기초금액</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">7,718,703</TD>
<TD WIDTH="181" ALIGN="RIGHT" HEIGHT="30">9,281,445</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" HEIGHT="30">   사외적립자산 납입액</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">1,000,000</TD>
<TD WIDTH="181" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" HEIGHT="30">   퇴직급여 지급액</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">(1,188,273)</TD>
<TD WIDTH="181" ALIGN="RIGHT" HEIGHT="30">(1,721,802)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" HEIGHT="30">   사외적립자산 기대수익</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">224,497</TD>
<TD WIDTH="181" ALIGN="RIGHT" HEIGHT="30">240,476</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" HEIGHT="30">   확정급여제도의 재측정요소(주1)</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">(66,755)</TD>
<TD WIDTH="181" ALIGN="RIGHT" HEIGHT="30">(81,417)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="259" HEIGHT="30"> 기말금액</TD>
<TD WIDTH="182" ALIGN="RIGHT" HEIGHT="30">7,688,172</TD>
<TD WIDTH="181" ALIGN="RIGHT" HEIGHT="30">7,718,702</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL10">(주1) 상기 확정급여제도의 재측정요소는 법인세를 차감하기 전 금액입니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">마. 당기 및 전기 중 손익으로 인식된 비용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="614">

<COLGROUP>
<COL WIDTH="605"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="614" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="620" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="235"></COL>
<COL WIDTH="179"></COL>
<COL WIDTH="179"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="244" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="188" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당 기</TH>
<TH WIDTH="188" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30"> 당기근무원가와 이자 및 기타</TD>
<TD WIDTH="188" ALIGN="RIGHT" HEIGHT="30">1,691,939 </TD>
<TD WIDTH="188" ALIGN="RIGHT" HEIGHT="30">1,739,612</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30"> 사외적립자산 기대수익</TD>
<TD WIDTH="188" ALIGN="RIGHT" HEIGHT="30">(224,497)</TD>
<TD WIDTH="188" ALIGN="RIGHT" HEIGHT="30">(240,476)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="188" ALIGN="RIGHT" HEIGHT="30">1,467,442 </TD>
<TD WIDTH="188" ALIGN="RIGHT" HEIGHT="30">1,499,136</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">당기말손익으로 인식된 비용은 포괄손익계산서에서 전액 영업비용(퇴직급여 823,397천원, 경상연구비 35,594천원), 제조원가(퇴직급여 460,314천원, 경상시험비 148,135천원)으로 인식되었습니다.</SPAN>
</P>
<P USERMARK="F-GL11 0X0000FF"></P>

<P>
<SPAN USERMARK="F-GL11">바. 보고기간종료일 현재 주요 보험수리적가정은 다음과 같습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="619" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="265"></COL>
<COL WIDTH="164"></COL>
<COL WIDTH="163"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="274" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="173" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당기말</TH>
<TH WIDTH="172" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30"> 기대임금상승률</TD>
<TD WIDTH="173" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">승급률</TD>
<TD WIDTH="172" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">승급율</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30"> 할인률</TD>
<TD WIDTH="173" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">5.603%</TD>
<TD WIDTH="172" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3.140%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30"> 사외적립자산 기대수익률</TD>
<TD WIDTH="173" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">5.603%</TD>
<TD WIDTH="172" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">3.140%</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">회사는 확정급여채무의 현재가치계산을 위하여 보고기간말 현재 확정급여채무의 통화 및 예상지급시기와 일관성이 있는 우량회사채(AA0 등급)의 시장수익률을 참조하여 할인률을결정하였습니다.</P>
<P USERMARK="F-GL11">사. 당기말 현재 주요 가정의 변동에 따른 확정급여채무의 민감도분석은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="622">

<COLGROUP>
<COL WIDTH="613"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="622" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="265"></COL>
<COL WIDTH="166"></COL>
<COL WIDTH="165"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="274" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="175" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1% 감소</TH>
<TH WIDTH="174" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1% 증가</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30"> 기대임금상승률</TD>
<TD WIDTH="175" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,705,388</TD>
<TD WIDTH="174" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,727,608</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30"> 할인률</TD>
<TD WIDTH="175" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,720,991</TD>
<TD WIDTH="174" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,719,574</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL 0X0000FF"></P>

<P USERMARK="F-GL11">
<SPAN USERMARK=" B">22. 기타비유동금융부채</SPAN>보고기간종료일 현재 기타비유동부채의 내역은 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="618">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="618" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="265"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="164"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="274" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="174" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="173" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="274" HEIGHT="30">금융보증계약채무(주1)</TD>
<TD WIDTH="174" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,224</TD>
<TD WIDTH="173" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">62,400</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11">
<SPAN USERMARK="F-10">(주1) 회사는 종속기업인 디에이치호림</SPAN>㈜
<SPAN USERMARK="F-10">의 차입금 등에 대하여 무상으로 지급보증을 제공하고 있으며, 동 지급보증은 기업회계기준서 제1039호 '금융상품: 인식과 측정'의 금융보증계약의 정의를 충족합니다.이에 회사는 금융보증 제공시 금융보증부채를 인식하고 상대계정으로 종속기업에 대한 투자자산을 인식하고 있습니다.</SPAN>
</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11 B">23. 이연수익</P>

<P>
<SPAN USERMARK="F-GL11">보고기간종료일 현재 이연수익의 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="617">

<COLGROUP>
<COL WIDTH="608"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="617" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="322"></COL>
<COL WIDTH="135"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="331" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="331" HEIGHT="30"> 정부보조금관련 이연수익(주1)</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">50,191</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT">69,052</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">주1) 복지부 1건, 정부산업통신진흥원과제 1건과 관련하여 정부보조금 수령하고 있으며, 관련 경상연구개발비에 대응하여 상계하고 있습니다.</SPAN>
</P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11 B">24. 매입채무 및 기타유동채무</P>

<P>
<SPAN USERMARK="F-GL11">보고기간종료일 현재 매입채무 및 기타유동채무의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="611"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="620" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">　구 분</TH>
<TH WIDTH="207" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="207" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="BOTTOM"> 매입채무</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">10,780,253</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">5,927,315</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="BOTTOM"> 미지급금</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">1,688,332</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">1,213,014</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="BOTTOM"> 미지급비용</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">2,701,720</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">1,377,096</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="BOTTOM"> 예수금</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">357,534</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">320,850</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="BOTTOM"> 부가세예수금</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">822,088</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="BOTTOM"> 선수금</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">237,746</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">132,626</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" VALIGN="BOTTOM"> 유동리스부채</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">194,628</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">195,285</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="207" HEIGHT="30">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">15,960,213</TD>
<TD ALIGN="RIGHT" WIDTH="207" HEIGHT="30">9,988,274</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 0X0000FF"></P>
<P USERMARK="F-GL11 B">25. 우발부채와 약정사항</P>

<P>
<SPAN USERMARK="F-GL11">가. 회사의 주요 약정사항(1) 당기말 현재 회사가 금융기관과 체결한 주요 약정사항은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="617">

<COLGROUP>
<COL WIDTH="608"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="617" HEIGHT="30" ALIGN="RIGHT">(원화단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="614">

<COLGROUP>
<COL WIDTH="170"></COL>
<COL WIDTH="162"></COL>
<COL WIDTH="255"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="179" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">  약정금융기관  </TH>
<TH WIDTH="171" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정사항</TH>
<TH WIDTH="264" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">한 도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" VALIGN="MIDDLE" WIDTH="179" HEIGHT="120">  기업은행  </TD>
<TD VALIGN="MIDDLE" WIDTH="171" HEIGHT="30">L/C개설약정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="264" HEIGHT="30">USD 100,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="171" HEIGHT="30">일반자금대출</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="264" HEIGHT="30">3,100,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="171" HEIGHT="30">시설자금대출</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="264" HEIGHT="30">53.000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="171" HEIGHT="30">회전자금대출한도약정</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="264" HEIGHT="30">21,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="179" HEIGHT="30">  신한은행  </TD>
<TD VALIGN="MIDDLE" WIDTH="171" HEIGHT="30">일반자금대출</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="264" HEIGHT="30">5,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="179" HEIGHT="30">  우리은행  </TD>
<TD VALIGN="MIDDLE" WIDTH="171" HEIGHT="30">일반자금대출</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="264" HEIGHT="30">7,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="179" HEIGHT="30">  하나은행  </TD>
<TD VALIGN="MIDDLE" WIDTH="171" HEIGHT="30">운전자금대출</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="264" HEIGHT="30">4,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" ROWSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="350" HEIGHT="60">합 계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="264" HEIGHT="30">90,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="264" HEIGHT="30">USD 100,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(2) 회사는 2018년 6월 10일 중국 Sinopharm Zhijun사와 Distribution Agreement를 체결하였습니다. 동 계약에 의해 Sinopharm Zhijun사는 회사의 독일지사인 에스앤브이 테크놀로지스(S&V Technologies)사에서 생산하는 Amalian SF 필러를 독점적으로 매입하여 홍콩, 마카오, 대만, 중국 본토지역에서 판매할 예정입니다. 계약기간은 수입허가 취득 후 10년 간입니다(3) 회사는 2017년 9월 6일 중국 Haihe Biopharma(RMX)사와 회사의 리포락셀의 중국, 태국, 대만, 홍콩 지역에서의 양도 및 재이전이 가능한 독점적 기술이전 계약(LicenseAgreement)을 체결하였습니다. (4) 당기말 현재 회사는 서울보증보험으로부터 ㈜케이지이니시스의 INIPAY서비스 이용계약, ㈜참빛도시가스의 도시가스공급계약 및 정부과제 관련하여 1,235,689천원을 제공받고 있으며, 정부보조금 관련 기업은행으로부터 5,390,000천원의 지급보증을 제공받고 있습니다.</SPAN>
</P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11">나. 타인으로부터 제공받고 있는 담보는 없습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">다. 타인을 위하여 제공한 지급보증 등의 내역보고기간종료일 현재 회사가 종속회사를 위하여 제공하고 있는 지급보증 및 담보제공의 내용은 다음과 같습니다.(1) 지급보증</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="615"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="621" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="163"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="121"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="172" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융기관</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용</TH>
<TH WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="130" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" VALIGN="MIDDLE" HEIGHT="30"> 디에이치호림㈜</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기업은행</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">구매자금</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,600,000</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,000,000 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" VALIGN="MIDDLE" HEIGHT="30">(주)리독스바이오</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기업은행</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차입금</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,200,000</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" VALIGN="MIDDLE" HEIGHT="30"> ㈜스페셜라이즈드메드</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기업은행</TD>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차입금</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">240,000</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">240,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" WIDTH="360" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="131" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5,040,000</TD>
<TD WIDTH="130" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,240,000</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11">(2) 담보제공 </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="615"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="134"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="121"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="143" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금융기관/업체</TH>
<TH WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용</TH>
<TH WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="130" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" VALIGN="MIDDLE"> 디에이치호림㈜</TD>
<TD WIDTH="122" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="95" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">담보제공</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,800,000</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,400,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="360" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,800,000</TD>
<TD WIDTH="130" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,400,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">한편, 디에이치호림㈜와 판매계약을 맺고 있는 백제약품에 대화제약은 자사주 230,000주(2,143,600천원, 종가 9,320원 적용)에 대하여 담보를 제공하고 있습니다.</SPAN>
</P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11">라. 당기말 현재 계류중인 소송사건은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="225"></COL>
<COL WIDTH="378"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="234" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구 분</P>
</TH>

<TH WIDTH="387" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>내 용</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>소제기일자</P>
</TD>

<TD WIDTH="387" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>2021. 11. 04.</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>소송 당사자</P>
</TD>

<TD WIDTH="387" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">
<P>원고: 대화제약 주식회사 외 35개사</P>
<P>피고: 국민건강보험공단</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">사건명</TD>
<TD WIDTH="387" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">채무부존재확인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>소송 가액(주1)</P>
</TD>

<TD WIDTH="387" VALIGN="MIDDLE" HEIGHT="30" ALIGN="RIGHT">
<P>23,020,760원</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>진행 상황</P>
</TD>
<TD WIDTH="387" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1심 원고패소  2심 변론기일 진행중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="234" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>향후 소송일정 및 대응방안</P>
</TD>

<TD WIDTH="387" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">
<P>회사 외 35개사와 공동으로 소송을 진행</P>
</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">상기 소송사건에 대해서는 소송의 결과를 합리적으로 예측할 수없습니다</SPAN>
</P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">26. 매출액</SPAN>
<SPAN USERMARK="F-GL11">당기 및 전기 중 매출액의 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="621">

<COLGROUP>
<COL WIDTH="612"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="621" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE"> 제품매출</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">89,953,370</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">82,862,792</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE"> 상품매출</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">6,278,816</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">5,841,580</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" VALIGN="MIDDLE"> 기술료수익</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">2,960,193</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">467</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">99,192,379</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">88,704,839</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL 0X0000FF"></P>

<P>
<SPAN USERMARK="F-GL11 B">27. 매출원가</SPAN>
<SPAN USERMARK="F-GL11">당기 및 전기 중 매출원가의 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="615">

<COLGROUP>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="615" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="615">

<COLGROUP>
<COL WIDTH="196"></COL>
<COL WIDTH="196"></COL>
<COL WIDTH="196"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="205" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="205" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="205" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE"> 제품매출원가</TD>
<TD WIDTH="205" HEIGHT="30" ALIGN="RIGHT">58,060,341</TD>
<TD WIDTH="205" HEIGHT="30" ALIGN="RIGHT">48,523,484</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" VALIGN="MIDDLE"> 상품매출원가</TD>
<TD WIDTH="205" HEIGHT="30" ALIGN="RIGHT">3,857,904</TD>
<TD WIDTH="205" HEIGHT="30" ALIGN="RIGHT">3,486,528</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="205" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="205" HEIGHT="30" ALIGN="RIGHT">61,918,245</TD>
<TD WIDTH="205" HEIGHT="30" ALIGN="RIGHT">52,010,012</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">28. 판매비와관리비</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">당기 및 전기 중 판매비와관리비의 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="619">

<COLGROUP>
<COL WIDTH="610"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="619" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="202"></COL>
<COL WIDTH="201"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="199" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="211" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당 기</TH>
<TH WIDTH="210" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 급여</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">10,083,179</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">10,147,040</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 퇴직급여</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">823,397</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">874,433</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 복리후생비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">1,215,982</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">1,306,735</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 보험료</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">1,539</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">4,609</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 감가상각비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">234,147</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">323,968</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 사용권자산상각비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">210,147</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">247,895</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 무형자산상각비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">733,885</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">724,709</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 대손상각비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">(81,724)</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">(40,864)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 지급수수료</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">1,302,574</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">855,827</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 광고선전비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">1,537,412</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">1,957,396</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 교육훈련비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">99,696</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">45,756</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 도서인쇄비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">15,628</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">19,957</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 접대비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">1,945,834</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">1,847,309</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 임차료</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">167,382</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">178,599</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 통신비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">73,328</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">71,797</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 운반비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">494,950</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">463,554</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 세금과공과</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">303,915</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">270,982</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 소모품비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">118,254</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">76,767</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 수도광열비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">86,604</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">84,933</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 수선비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">249</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">16,057</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 경상개발비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">5,053,722</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">6,169,751</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 여비교통비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">2,589,228</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">2,712,299</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 견본비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">209,221</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">597,179</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 포장비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">73,640</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">67,033</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 판매수수료</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">3,595,117</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">2,650,547</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 판매촉진비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">1,629,338</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">1,641,899</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 잡비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">2,036</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">49</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE"> 해외시장개척비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">153,204</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">141,175</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30" VALIGN="MIDDLE"> 회의비</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">705,061</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">746,346</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="211" ALIGN="RIGHT" HEIGHT="30">33,376,945</TD>
<TD WIDTH="210" ALIGN="RIGHT" HEIGHT="30">34,203,737</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">29. 비용의 성격별 분류 </SPAN>
<SPAN USERMARK="F-GL11">당기 및 전기 중 회사의 비용의 성격별 분류내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="615"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 재고자산의 변동</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,489,949</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">26,695,990</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 상품매출원가</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,857,904</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,486,528</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 급여</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,453,623</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,333,653</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 퇴직급여</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,283,712</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,309,241</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 복리후생비</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,355,486</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,273,611</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 지급임차료</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">292,578</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">289,471</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 지급수수료</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,000,698</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,869,938</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 감가상각비</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,397,118</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,520,823</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 사용권자산상각비</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">210,147</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">724,709</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 무형자산상각비</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">733,885</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">247,895</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 기타비용</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,220,091</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,461,889</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" ALIGN="CENTER">영업비용의 합계(주1)</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">95,295,191</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">86,213,748</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">(주1) 포괄손익계산서의 매출원가와 판매비와관리비를 합한 금액입니다.</SPAN>
</P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11 B">30. 기타수익</SPAN>
<SPAN USERMARK="F-GL11">당기 및 전기 중 기타수익 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="611"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="620" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 외화환산이익</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">6,742</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">31,445</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 외환차익</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">172,466</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">95,636</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 임대료수익</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">574,927</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">515,574</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 수수료수익</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">55,264</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">35,580</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 잡이익</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">1,463,891</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">406,880</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 정부보조금으로인한이익</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">446,723</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">1,112,070</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30"> 리스자산해지이익</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">1,348</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">2,721,361</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">2,197,185</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11 B">31. 기타비용</SPAN>
<SPAN USERMARK="F-GL11">당기 및 전기 중 기타비용 구성내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="621">

<COLGROUP>
<COL WIDTH="612"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="621" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="623">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="198"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 기부금</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">24,541</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">32,100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 외화환산손실</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">38,758</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">906</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 외환차손</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">155,949</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">23,360</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 종속기업투자손상차손</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">900,000</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">1,471,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 관계기업투자손상차손</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">419,675</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 잡손실</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">21,379</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">53,279</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 기타의감가상각비</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">147,862</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">147,862</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 기타의대손상각비</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">387,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 리스자산해지손실</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">2,628</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="208" HEIGHT="30" ALIGN="RIGHT">1,288,489</TD>
<TD WIDTH="207" HEIGHT="30" ALIGN="RIGHT">2,537,810</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">32. 금융수익과 금융원가</SPAN>
<SPAN USERMARK="F-GL11">가. 당기 및 전기 중 금융수익의 상세내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="618">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="618" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="616">

<COLGROUP>
<COL WIDTH="312"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="321" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="148" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당 기</TH>
<TH WIDTH="147" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30"> 이자수익</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">345,373</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">359,554</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30"> 당기손익-공정가치측정금융자산평가이익</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30"> 배당금수익</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">33,779</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">21,558</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30"> 당기손익-공정가치측정금융자산처분이익</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">171,235</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">1,044,384</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30"> 파생상품평가이익</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">2,312,014</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30"> 기타</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">45</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">716,902</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="321" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">550,432</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">4,454,412</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">나. 당기 및 전기 중 금융원가의 상세내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="620">

<COLGROUP>
<COL WIDTH="611"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="620" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="620">

<COLGROUP>
<COL WIDTH="311"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="320" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="150" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당 기</TH>
<TH WIDTH="150" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="320" HEIGHT="30"> 이자비용(차입금)</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">1,821,164</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">893,738</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="320" HEIGHT="30"> 이자비용(전환사채)</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">9,500</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">176,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="320" HEIGHT="30"> 파생상품평가손실</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="320" HEIGHT="30"> 리스부채-이자비용</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">15,015</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">14,438</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="320" HEIGHT="30"> 당기손익-공정가치측정금융자산평가손실</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">508,969</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">451,891</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="320" HEIGHT="30"> 당기손익-공정가치측정금융자산처분손실</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">392,905</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">165,197</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="320" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">2,747,553</TD>
<TD WIDTH="150" ALIGN="RIGHT" HEIGHT="30">1,701,264</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 0X0000FF"></P>
<P USERMARK="F-GL11 0X0000FF"></P>

<P>
<SPAN USERMARK="F-GL11 B">33. 법인세비용 </SPAN>
</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">가. 당기 및 전기 중 법인세비용의 구성요소는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="600">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="600" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="599" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="285"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="143"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="294" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구 분</TH>
<TH WIDTH="153" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">당 기</TH>
<TH WIDTH="152" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="294" HEIGHT="30"> 당기 법인세 등 부담액</TD>
<TD WIDTH="153" ALIGN="RIGHT" HEIGHT="30">1,102,005</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">2,040,200</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="294" HEIGHT="30"> 일시적차이로 인한 이연법인세 변동액</TD>
<TD WIDTH="153" ALIGN="RIGHT" HEIGHT="30">297,955</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">(197,976)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="294" HEIGHT="30"> 자본에 직접 반영된 법인세비용</TD>
<TD WIDTH="153" ALIGN="RIGHT" HEIGHT="30">(190,086)</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">668,171</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="294" HEIGHT="30"> 법인세추납액(환급)</TD>
<TD WIDTH="153" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">11,456</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="294" HEIGHT="30"> 미환류소득</TD>
<TD WIDTH="153" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">59,364</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="294" HEIGHT="30"> 법인세비용</TD>
<TD WIDTH="153" ALIGN="RIGHT" HEIGHT="30">1,209,874</TD>
<TD WIDTH="152" HEIGHT="30" ALIGN="RIGHT">2,581,215</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL">
<SPAN USERMARK="F-11">나. 법인세비용은 전체 회계연도에 대해서 예상되는 최선의 가중평균 연간법인세율의 추정에 기초하여 인식하였습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">다. 당기 및 전기 중 법인세비용과 회계이익의 관계는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="619">

<COLGROUP>
<COL WIDTH="610"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="619" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="242"></COL>
<COL WIDTH="176"></COL>
<COL WIDTH="176"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="251" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구 분 </TH>
<TH WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당 기</TH>
<TH WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30"> 세전이익 </TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">3,132,940</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">4,903,612</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30"> 적용세율에 따른 법인세 </TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">667,247</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">1,056,795</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30"> 조정사항</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30"></TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30">   비과세수익 </TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">(265,664)</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">(733,325)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30">   비공제비용 </TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">1,092,267</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">1,013,680</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30">   세율적용차이</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">192,848</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">5,836</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30">   세액공제</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">(507,876)</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">(512,037)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30">   이연법인세자산평가효과</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">ㅣ188,100</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">1,004,224</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30">   기타</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">(157,048)</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">746,042</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30"> 법인세비용 </TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">1,209,874</TD>
<TD WIDTH="185" ALIGN="RIGHT" HEIGHT="30">2,581,215</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="251" VALIGN="BOTTOM" HEIGHT="30"> 유효세율</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">38.62%</TD>
<TD WIDTH="185" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">52.64%</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P USERMARK="F-GL11">라. 당기 및 전기 중 이연법인세자산(부채)와 일시적차이 등의 발생과 소멸로 인한 이연법인세비용은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="615"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="617">

<COLGROUP>
<COL WIDTH="241"></COL>
<COL WIDTH="175"></COL>
<COL WIDTH="174"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="250" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구 분 </TH>
<TH WIDTH="184" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당 기</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="30"> 기말 이연법인세자산(부채) </TD>
<TD WIDTH="184" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,958,173</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="183" HEIGHT="30">3,256,128</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="30"> 기초 이연법인세자산(부채) </TD>
<TD WIDTH="184" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,256,128</TD>
<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,058,152</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="250" VALIGN="MIDDLE" HEIGHT="53"> 일시적차이 등의 발생과 소멸로 인한 이연법인세비용 </TD>
<TD WIDTH="184" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">297,955</TD>
<TD WIDTH="183" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53">(197,976)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">마. 당기 및 전기 중 이연법인세자산(부채)의 원천과 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="777">

<COLGROUP>
<COL WIDTH="379"></COL>
<COL WIDTH="380"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="388" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD WIDTH="389" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="779">

<COLGROUP>
<COL WIDTH="203"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="212" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구 분</TH>
<TH WIDTH="454" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">누적일시적차이</TH>
<TH WIDTH="113" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">이연법인세자산(부채)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초 </TH>
<TH WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가 </TH>
<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소 </TH>
<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="779" HEIGHT="30" COLSPAN="6">Ⅰ. 일시적차이 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 미수수익 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(662,862)</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(369,925)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(662,862)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(369,925)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(77,314)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 퇴직급여충당금 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,126,925</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">602,010</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,535,937</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,192,998</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,130,337</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 단체퇴직보험 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(7,718,702)</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,157,742)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,188,273)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(7,688,171)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,606,828)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 대손충당금 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,358,550</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">883,349</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,358,550</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">883,349</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">184,620</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 대손상각비 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,089,594</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,089,594</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">854,725</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 재고자산평가손실 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">366,778</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">480,114</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">366,778</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">480,114</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100,344</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 국고보조금 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">265,626</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">212,905</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">265,626</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">212,905</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">44,497</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 반품충당금 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">985,797</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">812,399</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">985,797</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">812,399</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">169,791</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 종속기업투자손상차손</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,095,310</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">900,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,995,310</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 관계기업투자손상차손</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">419,675</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">419,675</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 관계회사대여금(손상차손)</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">387,000</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">387,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 감가상각누계액 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(320,797)</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(153,180)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(167,617)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(35,031)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 전기공급시설이용권 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(32,244)</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(32,244)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(6,739)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 국고보조금(특허등)</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,841</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,222</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,841</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,222</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,644</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 정부보조금으로인한이익 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">69,052</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,191</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">69,052</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,191</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,490</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 미지급비용 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">955,379</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,077,061</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">955,379</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,077,061</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">225,106</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 마일리지충당금 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,118</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,418</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,118</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,418</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,132</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 유형자산처분이익</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,337,328)</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,337,328)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="53"> 기타포괄-공정가치측정금융   자산평가손익</TD>
<TD WIDTH="114" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">3,347,903</TD>
<TD WIDTH="114" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">343,729</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">3,691,632</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">771,551</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 기타단기충당부채</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">440,629</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">410,197</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">440,629</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">410,197</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">85,731</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 사용권자산</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(426,641)</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(464,438)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(426,641)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(464,438)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(97,068)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 금융리스부채</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">433,700</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">439,285</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">433,700</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">439,285</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">91,810</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 상환할증금</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">44,000</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">44,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 전환권대가</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="53"> 당기손익-공정가치측정금융   자산평가손익</TD>
<TD WIDTH="114" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">451,891</TD>
<TD WIDTH="114" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">508,969</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">451,891</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">508,969</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">106,375</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">19,365,239</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,755,744</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,502,387</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">19,618,596</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,958,173</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="777">

<COLGROUP>
<COL WIDTH="379"></COL>
<COL WIDTH="380"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="388" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD WIDTH="389" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="779">

<COLGROUP>
<COL WIDTH="203"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="212" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="454" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">누적일시적차이</TH>
<TH WIDTH="113" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이연법인세자산(부채)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초 </TH>
<TH WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증가 </TH>
<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감소 </TH>
<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="779" HEIGHT="30" COLSPAN="6">Ⅰ. 일시적차이 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 미수수익 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(574,413)</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(662,862)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(574,413)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(662,862)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(145,830)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 퇴직급여충당금 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,908,088</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,506,351</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,287,513</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,126,925</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,447,924</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 단체퇴직보험 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(9,281,444)</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(159,059)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,721,802)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(7,718,702)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,698,114)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 대손충당금 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,005,910</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,358,550</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,005,910</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,358,550</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">298,881</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 대손상각비 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,089,594</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,089,594</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">899,711</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 재고자산평가손실 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">266,443</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">366,778</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">266,443</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">366,778</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">80,691</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 국고보조금 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">311,997</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">265,626</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">311,997</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">265,626</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">58,438</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 반품충당금 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,092,727</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">985,797</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,092,727</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">985,797</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">216,875</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 종속기업투자손상차손</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,624,310</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,471,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,095,310</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 관계기업투자손상차손</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">419,675</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">419,675</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 관계회사대여금(손상차손)</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">387,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">387,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 감가상각누계액 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(809,018)</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(488,221)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(320,797)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(70,575)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 전기공급시설이용권 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(32,244)</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(32,244)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(7,094)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 국고보조금(특허등)</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,841</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">20,841</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,585</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 정부보조금으로인한이익 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">67,216</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">69,052</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">67,216</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">69,052</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,191</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 미지급비용 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">806,645</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">955,379</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">806,645</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">955,379</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">210,184</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 마일리지충당금 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,219</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,118</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,219</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,118</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,126</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="53"> 유형자산처분이익</TD>
<TD WIDTH="114" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(1,337,328)</TD>
<TD WIDTH="114" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(1,337,328)</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="53"> 기타포괄-공정가치측정금융   자산평가손익</TD>
<TD WIDTH="114" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">160,618</TD>
<TD WIDTH="114" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">3,299,342</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">112,057</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">3,347,903</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">736,539</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 기타단기충당부채</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">402,775</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">440,629</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">402,775</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">440,629</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">96,938</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 사용권자산</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(432,266)</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(426,641)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(432,266)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(426,641)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(93,861)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 금융리스부채</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">437,138</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">433,700</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">437,138</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">433,700</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">95,415</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 상환할증금</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">490,000</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">44,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">490,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">44,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,680</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 전환권대가</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,231,018</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,231,018</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="53"> 당기손익-공정가치측정금융   자산평가손익</TD>
<TD WIDTH="114" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(532,295)</TD>
<TD WIDTH="114" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">451,891</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">(532,295)</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">451,891</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">99,414</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합 계 </TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,900,690</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,232,212</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,767,661</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">19,365,239</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,256,128</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL">
<SPAN USERMARK="F-11">바. 당기 및 전기 중 당기손익 이외로 인식되는 항목과 관련된 법인세비용과 이연법인세는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="623">

<COLGROUP>
<COL WIDTH="614"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="623" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="624" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="320"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="329" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="148" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">당 기</TH>
<TH WIDTH="147" VALIGN="BOTTOM" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="329" HEIGHT="30" VALIGN="BOTTOM"> 확정급여부채의 재측정요소</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">(225,098)</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">(33,032)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="329" HEIGHT="30" VALIGN="BOTTOM"> 기타포괄-공정가치금융자산평가손익</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">35,012</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">701,203</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="329" HEIGHT="30" VALIGN="BOTTOM"> 자본에 직접 반영된 법인세비용(수익)</TD>
<TD WIDTH="148" ALIGN="RIGHT" HEIGHT="30">(190,086)</TD>
<TD WIDTH="147" ALIGN="RIGHT" HEIGHT="30">667,171</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11">
<SPAN USERMARK=" B">34. 주당손익</SPAN>
</P>
<P USERMARK="F-GL11">가. 주당순이익은 보통주 1주에 대한 순이익을 계산한 것으로, 회사의 1주당  순이익의 산출내역은 다음과 같습니다.(1) 기본주당순이익</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="623">

<COLGROUP>
<COL WIDTH="614"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="623" HEIGHT="30" ALIGN="RIGHT">(단위: 원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="623" BORDER="1">

<COLGROUP>
<COL WIDTH="203"></COL>
<COL WIDTH="197"></COL>
<COL WIDTH="196"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="212" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">구 분</TH>
<TH ALIGN="CENTER" WIDTH="206" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH ALIGN="CENTER" WIDTH="205" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 당기순이익</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">1,923,066,530</TD>
<TD WIDTH="205" HEIGHT="30" ALIGN="RIGHT">2,322,396,272</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 가중평균유통보통주식수</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">17,516,650 </TD>
<TD WIDTH="205" HEIGHT="30" ALIGN="RIGHT">17,515,096</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="212" HEIGHT="30"> 기본주당순이익</TD>
<TD WIDTH="206" HEIGHT="30" ALIGN="RIGHT">110</TD>
<TD WIDTH="205" HEIGHT="30" ALIGN="RIGHT">133</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 0X0000FF"></P>
<P USERMARK="F-GL11">(2) 당기 중 가중평균유통보통주식수의 계산내역은 다음과 같습니다. </P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="695">

<COLGROUP>
<COL WIDTH="106"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="121"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="125"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="115" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="121" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">발행주식수</TH>
<TH WIDTH="112" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">자기주식</TH>
<TH WIDTH="130" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">유통보통주식수</TH>
<TH WIDTH="83" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">가중치</TH>
<TH WIDTH="134" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">적수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="115" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">기초주식수</TD>
<TD ALIGN="RIGHT" WIDTH="121" HEIGHT="30">18,616,650</TD>
<TD ALIGN="RIGHT" WIDTH="112" HEIGHT="30">(1,100,000)</TD>
<TD ALIGN="RIGHT" WIDTH="130" HEIGHT="30">17,516,650</TD>
<TD ALIGN="CENTER" WIDTH="83" HEIGHT="30" VALIGN="MIDDLE">365 </TD>
<TD ALIGN="RIGHT" WIDTH="134" HEIGHT="30">6,393,577,250 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="4" ALIGN="CENTER" WIDTH="478" HEIGHT="30" VALIGN="MIDDLE">합   계</TD>
<TD ALIGN="CENTER" WIDTH="83" HEIGHT="30" VALIGN="MIDDLE">365 </TD>
<TD ALIGN="RIGHT" WIDTH="134" HEIGHT="30">6,393,577,250 </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">유통보통주식수 : 6,393,577,250주 /  365일 = 17,516,650</SPAN>
</P>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">35. 특수관계자</SPAN>
<SPAN USERMARK="F-GL11">가. 당기말 현재 회사의 특수관계자 현황은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="649">

<COLGROUP>
<COL WIDTH="198"></COL>
<COL WIDTH="433"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="207" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="442" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특수관계자의 명칭</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">종속기업</TD>
<TD WIDTH="442" HEIGHT="53">디에이치호림㈜, ㈜스페셜라이즈드메드, ㈜리독스바이오S&V Technologies GmbH, BSC Medical Devices GmbH</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="207" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">관계기업</TD>
<TD WIDTH="442" HEIGHT="53" VALIGN="MIDDLE">JHK BioPharma Co., Ltd</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL 0X0000FF"></P>

<P>
<SPAN USERMARK="F-GL11">나. 당기 및 전기 중 특수관계자와의 중요한 거래내용은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="615">

<COLGROUP>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="615" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="162"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="155"></COL>
<COL WIDTH="152"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="171" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">거래내역</TH>
<TH WIDTH="164" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH WIDTH="161" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="90" ROWSPAN="3" VALIGN="MIDDLE"> 디에이치호림㈜</TD>
<TD WIDTH="123" HEIGHT="30">매출</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,869</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,724</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30">매입</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">401,542</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">346,106</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30">임대료수익</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,614</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,517</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE"> ㈜스페셜라이즈드메드</TD>

<TD USERMARK=" 0X0000FF" WIDTH="123" HEIGHT="30">
<SPAN USERMARK=" 0X000000">매출</SPAN>
</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,700</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30">매입</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">250,330</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">243,374</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="60" VALIGN="MIDDLE" ROWSPAN="2"> ㈜리독스바이오</TD>

<TD WIDTH="123" HEIGHT="30" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK="F-GL 0X000000">매출</SPAN>
</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,400</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30">매입</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,847,189</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,301,291</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="53" VALIGN="MIDDLE"> JHK BioPharma Co., Ltd</TD>
<TD WIDTH="123" HEIGHT="53">출자금의 납입</TD>
<TD WIDTH="164" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="161" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="120" ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="123" HEIGHT="30">매출</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,269</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,424</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30">매입</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,499,061</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,890,771</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30">임대료수익</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,614</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,517</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30">출자금의 납입</TD>
<TD WIDTH="164" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 0X0000FF"></P>

<P>
<SPAN USERMARK="F-GL11">다. 보고기간종료일 현재 동 특수관계자에 대한 채권ㆍ채무의 내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="871">

<COLGROUP>
<COL WIDTH="862"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="871" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="873">

<COLGROUP>
<COL WIDTH="163"></COL>
<COL WIDTH="113"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="172" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">회사명</TH>
<TH WIDTH="122" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">거래내역</TH>
<TH WIDTH="290" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">당기말</TH>
<TH WIDTH="289" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="2">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권 등</TH>
<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채무 등</TH>
<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권 등</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채무 등</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="90" ROWSPAN="3" VALIGN="MIDDLE"> 디에이치호림㈜</TD>
<TD WIDTH="122" HEIGHT="30">외상매출금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,638</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,958</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30">미지급금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,166</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,179</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30">임대보증금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100,000</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="30" VALIGN="MIDDLE"> ㈜스페셜라이즈드메드</TD>
<TD WIDTH="122" HEIGHT="30">미지급금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">38,381</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,562</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="60" VALIGN="MIDDLE" ROWSPAN="2"> ㈜리독스바이오</TD>
<TD WIDTH="122" HEIGHT="30">외상매출금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,640</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30">외상매입금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,670,514</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">548,716</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="172" HEIGHT="120" ROWSPAN="4" VALIGN="MIDDLE">          합 계</TD>
<TD WIDTH="122" HEIGHT="30">외상매출금</TD>

<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK="F-GL 0X000000">6,278</SPAN>
</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,958</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30">미지급금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">74,547</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">51,741</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30">임대보증금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>

<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK="F-GL 0X000000">100,000</SPAN>
</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="122" HEIGHT="30">외상매입금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>

<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK="F-BT 0X0000FF">
<SPAN USERMARK="F-GL 0X000000">1,670,514</SPAN>
</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">548,716</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11">마. 주요 경영진과의 거래당기 및 전기 중 회사의 주요 경영진에 대한 보상내역은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="615"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="624" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="199"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">구 분</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">당 기</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 단기급여</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">2,252,988 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">2,199,893</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" HEIGHT="30"> 퇴직급여</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">154,825 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">88,325</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="208" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">2,407,813 </TD>
<TD WIDTH="208" ALIGN="RIGHT" HEIGHT="30">2,288,218</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<P USERMARK="F-GL11">
<SPAN USERMARK=" B">36. 영업부문</SPAN>가. 회사는 한국채택국제회계기준 제1108호(영업부문)에 따른 보고부문이 단일부문으로 제품과 상품에 대한 정보는 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="786">

<COLGROUP>
<COL WIDTH="102"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="125"></COL>
<COL WIDTH="304"></COL>
<COL WIDTH="157"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="111" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">사업부문</TH>
<TH WIDTH="62" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유형</TH>
<TH WIDTH="134" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">품 목</TH>
<TH WIDTH="313" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">구체적 용도</TH>
<TH WIDTH="166" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주요상표 등</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="9" WIDTH="111" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="339">의약품 제조업</TD>
<TD ROWSPAN="5" WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="196">제품</TD>
<TD WIDTH="134" HEIGHT="30">진경제</TD>
<TD WIDTH="313" HEIGHT="30">소화관 및 담도계의 기능장애에 의한 통증 외</TD>
<TD WIDTH="166" HEIGHT="30">후로스판 정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="53">항균 항생제</TD>
<TD WIDTH="313" HEIGHT="53">편도염, 인두염, 급성 신우신염, 방광염, 전립선염, 피부 및 연조직 감염증, 골 감염증 외</TD>
<TD WIDTH="166" HEIGHT="53">세파메칠 정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="30">무기질 제제</TD>
<TD WIDTH="313" HEIGHT="30">마그네슘결핍으로 인한 근육경련 외</TD>
<TD WIDTH="166" HEIGHT="30">마그네스 정</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="53">OEM매출</TD>
<TD WIDTH="313" HEIGHT="53">패치류, 천식치료제, 건강기능식품</TD>
<TD WIDTH="166" HEIGHT="53">안티푸라민쿨카타플라스마 외</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="447" ALIGN="CENTER" HEIGHT="30">기     타</TD>
<TD WIDTH="166" HEIGHT="30">록사트론정 외</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="62" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="143">상품</TD>
<TD WIDTH="134" HEIGHT="30">의료기기</TD>
<TD WIDTH="313" HEIGHT="30">안면부 피부의 일시적인 주름 개선</TD>
<TD WIDTH="166" HEIGHT="30">아말리안</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="53">의료기기</TD>
<TD WIDTH="313" HEIGHT="53">피부장벽강화, 피부장벽 지질 개선, 각질세포 강화</TD>
<TD WIDTH="166" HEIGHT="53">셀퓨전씨 엑스퍼트 베리덤 로션 엠디</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="134" HEIGHT="30">골관절염치료제 </TD>
<TD WIDTH="313" HEIGHT="30">슬관절의 골관절염, 견관절주위염 치료 </TD>
<TD WIDTH="166" HEIGHT="30">아라간플러스주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="447" ALIGN="CENTER" HEIGHT="30">기     타</TD>
<TD WIDTH="166" HEIGHT="30">엔슬림 외</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">나. 지역에 대한 정보회사는 국내 및 해외에서 영업하고 있으며, 지역별로 세분화된 회사의 외부고객으로부터의 계속영업수익에 대한 정보는 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="625">

<COLGROUP>
<COL WIDTH="616"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="625" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" WIDTH="627" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="190"></COL>
<COL WIDTH="205"></COL>
<COL WIDTH="205"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="199" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH ALIGN="CENTER" WIDTH="214" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH ALIGN="CENTER" WIDTH="214" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 대한민국</TD>
<TD WIDTH="214" HEIGHT="30" ALIGN="RIGHT">89,400,715</TD>
<TD WIDTH="214" HEIGHT="30" ALIGN="RIGHT">82,614,399</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 베트남</TD>
<TD WIDTH="214" HEIGHT="30" ALIGN="RIGHT">640,276</TD>
<TD WIDTH="214" HEIGHT="30" ALIGN="RIGHT">926,585</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 미얀마/캄보디아</TD>
<TD WIDTH="214" HEIGHT="30" ALIGN="RIGHT">2,105,009</TD>
<TD WIDTH="214" HEIGHT="30" ALIGN="RIGHT">2,293,005</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 중국</TD>
<TD WIDTH="214" HEIGHT="30" ALIGN="RIGHT">3,617,003</TD>
<TD WIDTH="214" HEIGHT="30" ALIGN="RIGHT">102,173</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="199" HEIGHT="30"> 기타</TD>
<TD WIDTH="214" HEIGHT="30" ALIGN="RIGHT">3,429,376</TD>
<TD WIDTH="214" HEIGHT="30" ALIGN="RIGHT">2,768,677</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="199" HEIGHT="30">합 계</TD>
<TD WIDTH="214" HEIGHT="30" ALIGN="RIGHT">99,192,379</TD>
<TD WIDTH="214" HEIGHT="30" ALIGN="RIGHT">88,704,839</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11">다. 주요고객에 대한 정보의약품의 직접판매로 인한 수익 99,192백만원(전기: 88,705백만원)(주석 5.(2) 참고)에는 당기말 중 회사의 가장 큰 고객인 ㈜유한양행에 대한 매출액 약 10,961백만원(전기: 9,949백만원)이 포함되어 있습니다</SPAN>
</P>
<P></P>

<P USERMARK="F-GL11">
<SPAN USERMARK=" B">37. 범주별 금융자산 및 금융부채</SPAN>가. 보고기간종료일 현재 범주별 금융상품의 내역은 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="1099">

<COLGROUP>
<COL WIDTH="1090"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1099" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1102">

<COLGROUP>
<COL WIDTH="192"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="201" HEIGHT="106" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재무상태표 자산</TH>
<TH WIDTH="452" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="449" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-공정가치측정금융자산</TH>
<TH WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가측정금융자산</TH>
<TH WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타포괄손익-공정가치측정금융자산</TH>
<TH WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합 계</TH>
<TH WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-공정가치측정금융자산</TH>
<TH WIDTH="112" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가측정금융자산</TH>
<TH WIDTH="112" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타포괄손익-공정가치측정금융자산</TH>
<TH WIDTH="112" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1102" HEIGHT="30" COLSPAN="9">유동자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 현금및현금성자산</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">320,381</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">320,381</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,415,085</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,415,085</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="53"> 매출채권 및 기타채권 (선급금, 선급비용제외)</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">12,580,983</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">12,580,983</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">12,224,148</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">12,224,148</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="53" VALIGN="MIDDLE"> 당기손익-공정가치측정      지분상품</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">1,496,345</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">1,496,345</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">2,999,301</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">2,999,301</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" VALIGN="MIDDLE"> 단기금융상품</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,240,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,240,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,340,000</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,340,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">소 계</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,496,345</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,141,364</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">17,637,709</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,999,301</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,979,233</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">27,978,534</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1102" HEIGHT="30" COLSPAN="9" VALIGN="BOTTOM">비유동자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="53"> 기타포괄손익-공정가치 측정지분상품</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">3,533,411</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">3,533,411</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">3,707,140</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">3,707,140</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 대여금및수취채권</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30"> 장기금융상품</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,840,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,840,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,830,241</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,830,241</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">소 계</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">6,840,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">3,533,411</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">10,373,411</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">4,830,241</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">3,707,140</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">8,537,381</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">1,496,345</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">22,981,364</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">3,533,411</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">28,011,120</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">2,999,301</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">29,809,474</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">3,707,140</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">36,515,915</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 0X0000FF"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="1103">

<COLGROUP>
<COL WIDTH="1094"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1103" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1104">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="200" HEIGHT="106" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재무상태표상 부채</TH>
<TH WIDTH="452" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="452" HEIGHT="30" COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-공정가치측정 금융부채</TH>
<TH WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가측정금융부채</TH>
<TH WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타금융부채</TH>
<TH WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합 계</TH>
<TH WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기손익-공정가치측정 금융부채</TH>
<TH WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상각후원가측정금융부채</TH>
<TH WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기타금융부채</TH>
<TH WIDTH="113" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1104" HEIGHT="30" COLSPAN="9">유동부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="53">   매입채무 및 기타유동채무    (선수금 제외)</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">15,527,839</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">15,527,839</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">9,660,362</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="53" ALIGN="RIGHT" VALIGN="MIDDLE">9,660,362</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">   단기차입금</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">50,200,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">50,200,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">46,500,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">46,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">   유동성장기차입금</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">1,000,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">1,000,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">1,000,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">1,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">   전환사채</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">844,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">844,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">   리스부채-유동</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">194,628</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">194,628</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">195,285</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">195,285</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" VALIGN="MIDDLE">   전환권대가</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">45</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">45</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">소 계</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">66,922,467</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">66,922,467</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">45</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">58,199,647</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">58,199,692</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="1104" HEIGHT="30" COLSPAN="9">비유동부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">   장기매입채무 및 기타채무</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">3,365,835</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">3,365,835</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">3,251,849</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">3,251,849</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">   장기차입금</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">24,057,863</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">24,057,863</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">6,547,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">6,547,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">   금융보증채무</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT"></TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">28,224</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">28,224</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">62,400</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">62,400</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">   리스부채-비유동</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">244,351</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">244,351</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">238,035</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">238,035</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" ALIGN="CENTER" VALIGN="BOTTOM">소 계</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">27,668,049</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">28,224</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">27,696,273</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">10,036,884</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">62,400</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">10,099,284</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">94,590,516</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">28,224</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">94,618,740</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">45</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">68,236,531</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">62,400</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">68,298,976</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P USERMARK="F-GL11">나. 당기 및 전기 중 금융상품 범주별로 발생한 손익의 효과는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="771">

<COLGROUP>
<COL WIDTH="493"></COL>
<COL WIDTH="260"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="502" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD WIDTH="269" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="773">

<COLGROUP>
<COL WIDTH="98"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="107" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="106">구 분</TH>
<TH COLSPAN="3" WIDTH="333" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">금융자산</TH>
<TH COLSPAN="3" WIDTH="333" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">금융부채</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">당기손익-공정가치측정금융자산</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">상각후원가측정 금융자산</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">기타포괄손익-공정가치측정금융자산</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">상각후원가로 측정하는 금융부채</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">파생상품부채</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">기타금융부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30"> 이자수익</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">345,373</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30"> 배당수익</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">33,779</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30"> 처분이익</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">171,235</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30"> 평가이익</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30"> 이자비용</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,845,679)</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30"> 처분손실</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(392,905)</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30"> 평가손실</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(508,969)</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(308,717)</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="107" HEIGHT="30">합 계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30">(696,860)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30">345,373</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30">(308,717)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30">(1,845,679)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="771">

<COLGROUP>
<COL WIDTH="493"></COL>
<COL WIDTH="260"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="502" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD WIDTH="269" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="773">

<COLGROUP>
<COL WIDTH="98"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="102"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="107" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="106">구 분</TH>
<TH COLSPAN="3" WIDTH="333" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">금융자산</TH>
<TH COLSPAN="3" WIDTH="333" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">금융부채</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">당기손익-공정가치측정금융자산</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">관계기업투자주식</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">상각후원가측정 금융자산</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">상각후원가로 측정하는 금융부채</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">파생상품부채</TH>
<TH WIDTH="111" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="76">기타금융부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30"> 이자수익</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">403,249</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30"> 배당수익</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">21,558</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30"> 처분이익</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,044,384</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30"> 평가이익</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">2,312,014</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30"> 이자비용</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(1,084,177)</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30"> 처분손실</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(165,197)</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="107" VALIGN="MIDDLE" HEIGHT="30"> 평가손실</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(451,891)</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(2,486,082)</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="111" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="107" HEIGHT="30">합 계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30">448,854</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30">403,249</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30">(2,486,082)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30">(1,084,177)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30">2,312,014</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="111" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11 B">38. 금융상품 위험</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">가. 신용위험</P>
<P USERMARK="F-GL11">(1) 신용위험에 대한 노출</P>
<P USERMARK="F-GL11">금융자산의 장부금액은 신용위험에 대한 최대노출정도를 나타냅니다. 보고기간종료일 현재 회사의 신용위험에 대한 최대 노출정도는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="618">

<COLGROUP>
<COL WIDTH="609"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="618" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="255"></COL>
<COL WIDTH="170"></COL>
<COL WIDTH="169"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="264" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="179" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="178" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" HEIGHT="30"> 기타포괄손익-공정가치측정금융자산</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="RIGHT">3,533,411</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">3,707,140</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" HEIGHT="30"> 상각후원가측정금융자산</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,683,256</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,409,135</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" HEIGHT="30"> 당기손익-공정가치측정금융자산</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,496,345</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,999,301</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="264" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합 계</TD>
<TD WIDTH="179" HEIGHT="30" ALIGN="RIGHT">27,713,012</TD>
<TD WIDTH="178" HEIGHT="30" ALIGN="RIGHT">35,115,576</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11 0X0000FF"></P>
<P USERMARK="F-GL11">(2) 손상차손</P>
<P USERMARK="F-GL11">보고기간종료일 현재 매출채권의 연령 및 각 연령별로 손상된 채권금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="615">

<COLGROUP>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="615" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="134"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="143" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">구 분</TH>
<TH COLSPAN="2" WIDTH="236" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH COLSPAN="2" WIDTH="236" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="118" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권잔액</TH>
<TH WIDTH="118" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">손상된 금액</TH>
<TH WIDTH="118" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권잔액</TH>
<TH WIDTH="118" VALIGN="BOTTOM" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">손상된 금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30"> 0일-30일</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">8,384,017</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">61,151</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">7,509,862</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">91,197</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30"> 31일-120일</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">3,308,759</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">49,288</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">3,780,703</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">81,443</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30"> 120일-1년이내</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">183,408</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">49,350</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">245,517</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">72,687</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30"> 1년 이상 경과</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">647,437</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">647,437</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">643,623</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">643,623</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="143" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">12,523,621</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">807,226</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">12,179,705</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">888,950</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL 0X0000FF"></P>
<P USERMARK="F-GL11">나. 유동성위험</P>
<P USERMARK="F-GL11">(1) 보고기간종료일 현재 회사가 보유한 금융부채의 계약상 만기는 다음과 같습니다.</P>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="941">

<COLGROUP>
<COL WIDTH="932"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="941" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="940" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="175"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="184" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">구 분</TH>
<TH WIDTH="108" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">장부금액</TH>
<TH WIDTH="108" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">계약상현금흐름</TH>
<TH WIDTH="108" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">6개월이내</TH>
<TH WIDTH="108" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">6-12개월</TH>
<TH WIDTH="108" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">1-2년</TH>
<TH WIDTH="108" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">2-5년</TH>
<TH WIDTH="108" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE">5년 이상</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="940" VALIGN="BOTTOM" HEIGHT="30" COLSPAN="8"><당기말></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="184" VALIGN="BOTTOM" HEIGHT="30">  단기차입금</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50,200,000</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50,200,000</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50,200,000</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="184" VALIGN="BOTTOM" HEIGHT="30">  장기차입금</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,057,863</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,057,863</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">25,057,863</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="184" VALIGN="BOTTOM" HEIGHT="30">  전환사채</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="184" VALIGN="BOTTOM" HEIGHT="30">  매입채무 및 기타채무</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,332,652</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">19,354,103</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15,615,190</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,021,140</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">610,542</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">107,232</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="184" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">94,590,515</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">94,611,966</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">15,615,189</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">53,221,140</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">610,542</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">25,165,095</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="940" VALIGN="BOTTOM" HEIGHT="30" COLSPAN="8"><전기말></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="184" VALIGN="BOTTOM" HEIGHT="30">  단기차입금</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,500,000</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,500,000</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">46,500,000</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="184" VALIGN="BOTTOM" HEIGHT="30">  장기차입금</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,547,000</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">7,547,000</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,000,000</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">6,547,000</TD>
<TD WIDTH="108" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="184" VALIGN="BOTTOM" HEIGHT="30">  전환사채</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="184" VALIGN="MIDDLE" HEIGHT="30">  매입채무 및 기타채무</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">13,345,531</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">13,369,289</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">9,637,579</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">3,028,845</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">702,865</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="184" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">68,236,531</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">68,260,289</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">9,637,579</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">51,372,845</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">702,865</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">6,547,000</TD>
<TD WIDTH="108" VALIGN="BOTTOM" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">회사는 이 현금흐름이 유의적으로 더 이른 기간에 발생하거나, 유의적으로 다른 금액일 것으로 기대하지 않습니다. </SPAN>
<SPAN USERMARK="F-GL11">다. 환위험</SPAN>
</P>
<P USERMARK="F-GL11">(1) 환위험에 대한 노출보고기간종료일 현재 회사의 환위험에 대한 노출정도는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="743">

<COLGROUP>
<COL WIDTH="734"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="743" HEIGHT="30" ALIGN="RIGHT">(원화단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="747">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="42"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="41"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="54" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="159" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정과목</TH>
<TH WIDTH="262" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="272" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="157" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">외화금액</TH>
<TH WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">원화금액</TH>
<TH WIDTH="155" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">외화금액</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">원화금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="54" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">자산</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매출채권</TD>
<TD WIDTH="51" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">USD</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">940,710</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,192,162</TD>
<TD WIDTH="50" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">USD</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,289,092 </TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,528,218 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="54" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">부채</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매입채무</TD>
<TD WIDTH="51" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">USD</TD>
<TD WIDTH="106" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="50" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">USD</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL 0X0000FF"></P>
<P USERMARK="F-GL11">(2) 민감도분석보고기간종료일 현재 각 외화에 대한 원화환율 10% 변동시 환율변동이 손익에 미치는 영향은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="616">

<COLGROUP>
<COL WIDTH="607"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="616" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="617" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="150" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="60" VALIGN="MIDDLE">구 분</TH>
<TH COLSPAN="2" WIDTH="234" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">당기말</TH>
<TH COLSPAN="2" WIDTH="233" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="120" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10% 상승시</TH>
<TH WIDTH="114" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10% 하락시</TH>
<TH WIDTH="115" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10% 상승시</TH>
<TH WIDTH="118" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">10% 하락시</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" ALIGN="CENTER" HEIGHT="30">USD</TD>
<TD WIDTH="120" ALIGN="RIGHT" HEIGHT="30">119,216</TD>
<TD WIDTH="114" ALIGN="RIGHT" HEIGHT="30">(119,216)</TD>
<TD WIDTH="115" ALIGN="RIGHT" HEIGHT="30">152,822</TD>
<TD WIDTH="118" ALIGN="RIGHT" HEIGHT="30">(152,822)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">라. 이자율위험</P>
<P USERMARK="F-GL11">(1) 보고기간종료일 현재 회사가 보유하고 있는 이자부 금융상품의 장부금액은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="698">

<COLGROUP>
<COL WIDTH="689"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="698" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="702">

<COLGROUP>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="108"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="351" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">고정이자율</TH>
<TH WIDTH="351" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">변동이자율</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="117" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">금융자산</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">10,080,000</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">16,170,241</TD>
<TD WIDTH="117" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">금융자산</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="117" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">금융부채</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="117" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">금융부채</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">51,394,628</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT">47,695,329</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">(2) 고정이자율 금융상품의 공정가치 민감도 분석회사는 고정이자율 금융상품을 당기손익인식금융상품으로 처리하고 있지 않으며, 파생상품을 공정가치위험회피회계의 위험회피수단으로 지정하지 않았습니다. 따라서, 이자율의 변동은 손익에 영향을 주지 않습니다. </SPAN>
</P>
<P USERMARK="F-GL"></P>

<P>
<SPAN USERMARK="F-GL11">(3) 변동이자율 금융상품의 현금흐름 민감도 분석당기말 현재 이자율이 100베이시스포인트 변동한다면, 자본과 손익은 증가 또는 감소하였을 것입니다. 이 분석은 환율과 같은 다른 변수는 변동하지 않는다고 가정하며, 전기에도 동일한 방법으로 분석하였습니다. 구체적인 자본 및 손익의 변동금액은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="616">

<COLGROUP>
<COL WIDTH="607"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="616" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="153"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="162" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">구 분</TH>
<TH COLSPAN="2" WIDTH="227" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">손 익</TH>
<TH COLSPAN="2" WIDTH="226" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">자 본</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="114" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">100bp 상승</TH>
<TH WIDTH="113" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">100bp 하락</TH>
<TH WIDTH="113" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">100bp 상승</TH>
<TH WIDTH="113" VALIGN="BOTTOM" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">100bp 하락</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="615" HEIGHT="30"><당기말></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="162" HEIGHT="30"> 변동이자율 금융상품</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">513,946</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">(513,946)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">513,946</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">(513,946)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="615" HEIGHT="30"><전기말></TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="162" HEIGHT="30"> 변동이자율 금융상품</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">(476,953)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">476,953</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">(476,953)</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT">476,953</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK="F-GL11">마. 공정가치</P>
<P USERMARK="F-GL11">(1) 공정가치와 장부금액보고기간 종료일 현재 회사의 금융자산과 금융부채의 장부금액은 공정가치로 계상되어 있습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="789">

<COLGROUP>
<COL WIDTH="780"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="789" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="788">

<COLGROUP>
<COL WIDTH="278"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="287" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="251" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="250" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="126" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="788" HEIGHT="30" COLSPAN="5" VALIGN="MIDDLE">공정가치로 인식된 자산 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   당기손익-공정가치측정금융자산</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,496,345</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,496,345</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,999,301</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,999,301</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   기타포괄손익-공정가치측정금융자산</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,533,411</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,533,411</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,707,140</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,707,140</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소 계</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,029,756</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,029,756</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,706,442</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,706,442</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="788" HEIGHT="30" COLSPAN="5" VALIGN="MIDDLE">상각후원가로 인식된 자산 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   대여금과 수취채권</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   매출채권및기타채권</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,580,983</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,580,983</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,224,148</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,224,148</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   장ㆍ단기금융상품</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,080,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,080,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,170,241</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,170,241</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   현금 및 현금성자산</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">320,381</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">320,381</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,415,085</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,415,085</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">소 계</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,981,363</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,981,363</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">29,809,473</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">29,809,473</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,011,119</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,011,119</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,515,915</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,515,915</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="788" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5">공정가치로 인식된 부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   당기손익-공정가치측정금융부채</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="788" HEIGHT="30" COLSPAN="5" VALIGN="MIDDLE">상각후원가로 인식된 부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   단기차입금</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,200,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,200,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,500,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   유동성장기차입금</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   매입채무와 기타채무</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,893,674</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,893,674</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,912,212</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,912,212</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   장기차입금</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,057,863</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,057,863</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,547,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,547,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   전환사채</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">844,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">844,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   리스부채</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">438,978</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">438,978</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">433,319</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">433,319</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,590,515</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,590,515</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">68,236,576</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">68,236,576</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11">(2) 공정가치 서열체계아래 표에서는 공정가치로 인식되는 금융상품을 공정가치 측정방법별로 분석하였습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">공정가치에는 다음의 수준이 있습니다.</P>
<P USERMARK="F-GL11">1) 동일한 자산이나 부채에 대한 활성시장의 공시가격 (수준 1)</P>
<P USERMARK="F-GL11">2) 직접적으로 또는 간접적으로 관측가능한, 자산이나 부채에 대한 투입변수 (수준 2)</P>
<P USERMARK="F-GL11">3) 관측가능한 시장자료에 기초하지 않은, 자산이나 부채에 대한 투입변수 (수준 3)</P>
<P USERMARK="F-GL11">당기말 현재 공정가치로 측정되는 금융상품의 각 종류별로 공정가치 수준별 측정치는 다음과 같습니다</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="735">

<COLGROUP>
<COL WIDTH="726"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="735" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="741">

<COLGROUP>
<COL WIDTH="231"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="240" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30"> 구 분 </TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">수준1</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">수준2</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">수준3</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" VALIGN="MIDDLE" HEIGHT="30"> 당기손익-공정가치측정금융자산</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,496,345</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,496,345</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" VALIGN="MIDDLE" HEIGHT="30"> 기타포괄-공정가치측정금융자산</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,533,411</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,533,411</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>

<P USERMARK="F-GL11">
<SPAN USERMARK=" B">39. 현금흐름표</SPAN>가. 회사의 현금흐름표는 간접법에 의해 작성되었으며, 당기 및 전기 중 현금의 유입과 유출이 없는 주요한 거래는 다음과 같습니다.
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="624">

<COLGROUP>
<COL WIDTH="615"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="624" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="626" BORDER="1">

<COLGROUP>
<COL WIDTH="296"></COL>
<COL WIDTH="152"></COL>
<COL WIDTH="151"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="305" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH ALIGN="CENTER" WIDTH="161" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당 기</TH>
<TH ALIGN="CENTER" WIDTH="160" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전 기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30"> 장기금융상품의 유동성 대체</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">1,000,000</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT">9,240,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30"> 건설중인자산의 유형자산 대체</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">493,340</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT">702,726</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30"> 건설중인자산의 무형자산 대체</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">7,600</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT">544,707</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30"> 정부보조금 경상연구개발비와 상계</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT">4,100</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30"> 전환사채의 전환권 행사에 따른 자본 대체</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">970,252</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="305" HEIGHT="30"> 리스부채인식 및 유동성대체</TD>
<TD WIDTH="161" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">205,282</TD>
<TD WIDTH="160" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">11,564</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">나. 당기 및 전기 중 재무활동에서 발생한 부채의 변동내역은 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="908">

<COLGROUP>
<COL WIDTH="300"></COL>
<COL WIDTH="590"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" HEIGHT="30" VALIGN="MIDDLE"><당 기></TD>
<TD WIDTH="599" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="912">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">　구 분</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">단기차입금</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동성장기차입금</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장기차입금</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환사채</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">리스부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30"> 기초</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">46,500,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">1,000,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">6,547,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">844,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">433,319</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30"> 재무활동순현금흐름</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">3,700,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30"></TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">18,510,863</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">(853,500)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">(255,117)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30"> 이자비용</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">9,500</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">15,015</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30"> 전환권대가</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30"> 기타증감</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">(1,000,000)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">245,760</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30"> 기말</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">50,200,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">1,000,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">24,057,863</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">438,978</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="908">

<COLGROUP>
<COL WIDTH="300"></COL>
<COL WIDTH="590"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="309" HEIGHT="30" VALIGN="MIDDLE"><전 기></TD>
<TD WIDTH="599" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="912">

<COLGROUP>
<COL WIDTH="149"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="158" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">　구 분</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">단기차입금</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">유동성장기차입금</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장기차입금</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환사채</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">리스부채</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30"> 기초</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">34,400,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>

<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">
<SPAN USERMARK=" BC0X31FFFF">14,490,000</SPAN>
</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">437,138</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30"> 재무활동순현금흐름</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">12,100,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">7,547,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">(13,097,500)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">(262,597)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30"> 이자비용</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">176,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">14,438</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30"> 전환권대가</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">(724,500)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30"> 기타증감</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">1,000,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">(1,000,000)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">244,340</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="158" HEIGHT="30"> 기말</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">46,500,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">1,000,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">6,547,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="151" HEIGHT="30">844,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="150" HEIGHT="30">433,319</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL">
<SPAN USERMARK=" B">40. 재무제표의 승인</SPAN>당기말 재무제표는 2023년 2월 8일자로 이사회에서 확정되었으며, 2023년 3월 23일 정기주주총회에서 최종 승인될 예정입니다.
</P>
<PGBRK></PGBRK>
</SECTION-2>
</LIBRARY>


<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-6-0">6. 배당에 관한 사항</TITLE>
<P></P>
<P USERMARK="F-GL B">가. 배당에 관한 사항</P>

<P>
<SPAN USERMARK="F-GL11">당사는 정관에 의거 이사회 결의 및 주주총회의 결의를 통하여 주권 상장이래 매년 꾸준한배당을 실현하고 있으며, 주주중시 경영원칙을 지켜가고 있습니다. 당사는 미래 성장과 이익의 주주환원을 균형 있게 고려하여 배당을 실시할 계획입니다.</SPAN>
</P>
<P USERMARK="F-GL11">☞당사의 정관내용</P>

<TABLE ACLASS="NORMAL" WIDTH="603" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="594"></COL>
</COLGROUP>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="603" HEIGHT="651">제54조【이익배당】① 이익의 배당은 금전 또는 금전 외의 재산으로 할 수 있다.② 이익의 배당을 주식으로 하는 경우 회사가 수 종의 주식을 발행한 때에는 주주총회의     결의로 그와 다른 종류의 주식으로도 할 수 있다.③ 제1항의 배당은 매결산기말 현재의 주주명부에 기재된 주주 또는 등록된 질권자에게      지급한다.④ 이익배당은 주주총회의 결의로 정한다. 다만, 제51조제6항에 따라 재무제표를 이사회     가 승인하는 경우 이사회 결의로 이익배당을 정한다.제55조【분기배당】① 회사는 이사회의 결의로 사업년도 개시일 부터 3월,6월 및 9월의 말일(이하 "분기배당    기준일"이라 한다)의 주주에게 자본시장과 금융투자업에 관한 법률 제165조의 12에       따라 분기배당을 할 수 있다.② 제1항의 이사회결의는 분기배당 기준일 이후 45일내에 하여야 한다.③ 분기배당은 직전결산기의 대차대조표상의 순자산액에서 다음 각 호의 금액을 공제한     액을 한도로 한다.  1.직전결산기의 자본금의 액  2.직전결산기까지 적립된 자본준비금과 이익준비금의 합계액  3.직전결산기의 정기주주총회에서 이익배당하기로 정한 금액  4.직전결산기까지 정관의 규정 또는 주주총회의 결의에 의하여 특정목적을 위해 적립한     임의준비금  5.상법시행령 제18조에서 정한 미실현이익  6.분기배당에 따라 당해 결산기에 적립하여야 할 이익준비금의 합계액④ 사업년도 개시일 이후 분기배당 기준일 이전에 신주를 발행한 경우(준비금의 자본전      입, 주식배당, 전환사채의 전환청구, 신주인수권부사채의 신주인수권 행사에 의한 경     우를 포함한다)에는 분기 배당에 관해서는 당해 신주는 직전사업년도 말에 발행된 것     으로 본다. 다만 분기배당 기준일 후에 발행된 신주에 대하여는 최근 분기 배당 기준      일 직후에 발행된 것으로 본다.</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">나.최근 3사업연도 배당에 관한 사항</SPAN>
</P>
<P>주요배당지표</P>

<TABLE-GROUP ACLASS="DIVIDEND" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="820" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="146"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="180"></COL>
<COL WIDTH="180"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="155" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구   분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">당기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전기</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전전기</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제39기(2022.01.01~2022.12.31)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제38기(2021.01.01~2021.12.31)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="189" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">제37기(2020.01.01~2020.12.31)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주당액면가액(원)</TD>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X23" ADELIM="1" VALIGN="MIDDLE">500</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X23" ADELIM="2" VALIGN="MIDDLE">500</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X23" ADELIM="3" VALIGN="MIDDLE">500</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X01" ADELIM="1" VALIGN="MIDDLE">1,221</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X01" ADELIM="2" VALIGN="MIDDLE">1,962</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X01" ADELIM="3" VALIGN="MIDDLE">-2,483</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(별도)당기순이익(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X35" ADELIM="1" VALIGN="MIDDLE">1,923</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X35" ADELIM="2" VALIGN="MIDDLE">2,322</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X35" ADELIM="3" VALIGN="MIDDLE">-554</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)주당순이익(원)</TD>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X02" ADELIM="1" VALIGN="MIDDLE">58</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X02" ADELIM="2" VALIGN="MIDDLE">127</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X02" ADELIM="3" VALIGN="MIDDLE">-116</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">현금배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X24" ADELIM="1" VALIGN="MIDDLE">2,627</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X24" ADELIM="2" VALIGN="MIDDLE">2,627</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X24" ADELIM="3" VALIGN="MIDDLE">2,603</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">주식배당금총액(백만원)</TD>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X25" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X25" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X25" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="2" VALIGN="MIDDLE" WIDTH="253" HEIGHT="30" AUPDATECONT="N" ALIGN="CENTER">(연결)현금배당성향(%)</TD>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X05" ADELIM="1" VALIGN="MIDDLE">235.5</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X05" ADELIM="2" VALIGN="MIDDLE">118.5</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X05" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">현금배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">1.49</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">1.62</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">0.93</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X31" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X31" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X31" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주식배당수익률(%)</TD>
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X32" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X32" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X32" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 현금배당금(원)</TD>
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">150</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">150</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">150</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X33" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X33" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X33" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" VALIGN="MIDDLE" WIDTH="155" HEIGHT="60" AUPDATECONT="N" ALIGN="CENTER">주당 주식배당(주)</TD>
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="98" HEIGHT="30" ACODE="XQ4" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X34" ADELIM="1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X34" ADELIM="2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="189" HEIGHT="30" ACODE="X34" ADELIM="3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="603">

<COLGROUP>
<COL WIDTH="594"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="603" HEIGHT="283">주1)계산근거- 현금배당성향은 현금배당금 총액 ÷ 지배기업의 소유주지분 기준 당기순이익- 현금배당수익율은 1주당 현금배당금÷과거1주일간의 배당부 종가의 평균으로 산출- 매년 분기(반기) 배당과 기말 배당으로 구분하여 지급하고 있음.     2019년 분기(반기) 배당 50원, 기말배당 100원 합계 150원 배당     2020년 분기(반기) 배당 50원, 기말배당 100원 합계 150원 배당.     2021년 분기(반기) 배당 50원, 기말배당 100원 합계 150원 배당     2022년 분기(반기) 배당 50원 (2022년 8월 8일 현금배당 이사회 결의)
<SPAN USERMARK=" BU">주2)상기 표의 당기 기말 현금(주식)배당금은 정기주주총회 승인전 금액으로 향후 정기주주총회에서 부결되거나 수정이 발생한 경우 정정보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다</SPAN>
<SPAN USERMARK=" U">. </SPAN>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<LIBRARY>
<P>
<SPAN USERMARK="F-GL B">다. 과거 배당 이력</SPAN>
</P>

<TABLE-GROUP ACLASS="DIVIDEND_BCK" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위: 회, %)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="300" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">연속 배당횟수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="299" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">평균 배당수익률</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">분기(중간)배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">결산배당</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최근 3년간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="149" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최근 5년간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_QUA" VALIGN="MIDDLE">20</TE>
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_END" VALIGN="MIDDLE">20</TE>
<TE ALIGN="RIGHT" WIDTH="150" HEIGHT="30" ACODE="DIV_THR" VALIGN="MIDDLE">1.35</TE>
<TE ALIGN="RIGHT" WIDTH="149" HEIGHT="30" ACODE="DIV_FIV" VALIGN="MIDDLE">1.20</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL10">주1) 연속 배당횟수 및 평균 배당수익률은 제39기 기말 배당을 포함하여 산출하였습니다.</SPAN>
<SPAN USERMARK="F-GL10 BU">주2) 2023년 3월 23일에 개최될 정기주주총회 승인전 금액으로 향후 정기주주총회에서 부결되거나 수정이 발생할 경우 정정보고서를 통해 그 내용을 반영할 예정입니다.</SPAN>
</P>
</LIBRARY>

<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-7-0">7. 증권의 발행을 통한 자금조달에 관한 사항</TITLE>
<P></P>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-7-1">7-1. 증권의 발행을 통한 자금조달 실적</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">[지분증권의 발행 등과 관련된 사항]</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">가. 증자(감자)현황</SPAN>
</P>

<TABLE-GROUP ACLASS="INC_STAT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="666" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="360"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="369" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="668" BORDER="1">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="127"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식발행(감소)일자</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)형태</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="438" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">발행(감소)한 주식의 내용</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">수량</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당액면가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주당발행(감소)가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="136" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20200902">2020년 09월 02일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT">297,134</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">14,808</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30">제1회차 전환사채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20200923">2020년 09월 23일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT">47,271</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">14,808</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30">제1회차 전환사채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" AUNIT="INC_DT" AUNITVALUE="20210112">2021년 01월 12일</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" AUNIT="INC_DR_KND" AUNITVALUE="05">전환권행사</TU>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="INC_STK_KND">보통주</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="71" HEIGHT="30" ACODE="INC_CNT">47,271</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACODE="INC_PAR_AMT">500</TE>
<TE ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="90" HEIGHT="30" ACODE="INC_SL_AMT">14,808</TE>
<TD VALIGN="MIDDLE" WIDTH="136" HEIGHT="30">제1회차 전환사채</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>

<LIBRARY>
<TABLE-GROUP ACLASS="CB" ADELETETABLE="N">
<TITLE ATOC="N">미상환 전환사채 발행현황</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="685" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="379"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="388" HEIGHT="30" AUNIT="WONSTOCK" AUNITVALUE="1">(단위 : 원, 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1624" BORDER="1">

<COLGROUP>
<COL WIDTH="281"></COL>
<COL WIDTH="47"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="123"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="290" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">종류＼구분</TH>
<TH WIDTH="56" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">회차</TH>
<TH WIDTH="137" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">발행일</TH>
<TH WIDTH="137" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">만기일</TH>
<TH WIDTH="150" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">권면(전자등록)총액</TH>
<TH WIDTH="125" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환대상주식의 종류</TH>
<TH WIDTH="137" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환청구가능기간</TH>
<TH WIDTH="183" HEIGHT="30" COLSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환조건</TH>
<TH WIDTH="274" HEIGHT="30" COLSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">미상환사채</TH>
<TH WIDTH="135" HEIGHT="83" ROWSPAN="2" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="78" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환비율(%)</TH>
<TH WIDTH="105" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환가액</TH>
<TH WIDTH="142" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">권면(전자등록)총액</TH>
<TH WIDTH="132" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="CENTER">전환가능주식수</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="N">

<TE WIDTH="290" HEIGHT="63" ACODE="CB_KND" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-GL">무기명식 이권부 무보증사모 전환사채</P>
</TE>
<TE WIDTH="56" HEIGHT="63" ACODE="CB_SEQ" ALIGN="CENTER" VALIGN="MIDDLE">1회차</TE>
<TU WIDTH="137" HEIGHT="63" AUNIT="CB_DT" AUNITVALUE="20190329" ALIGN="CENTER" VALIGN="MIDDLE">2019년 03월 29일</TU>
<TU WIDTH="137" HEIGHT="63" AUNIT="CB_FDT" AUNITVALUE="20240329" ALIGN="CENTER" VALIGN="MIDDLE">2024년 03월 29일</TU>
<TE WIDTH="150" HEIGHT="63" ACODE="CB_EN" ALIGN="RIGHT" VALIGN="MIDDLE">20,000,000,000</TE>

<TE WIDTH="125" HEIGHT="63" ACODE="CB_KN" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-GL"> 기명식 보통주</P>
</TE>

<TE WIDTH="137" HEIGHT="63" ACODE="CB_PE" ALIGN="CENTER" VALIGN="MIDDLE">
<P USERMARK="F-GL">2020년 3월 29일~2024년 2월 29일</P>
</TE>

<TE WIDTH="78" HEIGHT="63" ACODE="CB_RAT" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-GL"> 100</P>
</TE>

<TE WIDTH="105" HEIGHT="63" ACODE="CB_PR" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-GL">14,808</P>
</TE>
<TE WIDTH="142" HEIGHT="63" ACODE="CB_AMN" ALIGN="RIGHT" VALIGN="MIDDLE">0</TE>
<TE WIDTH="132" HEIGHT="63" ACODE="CB_CN" ALIGN="RIGHT" VALIGN="MIDDLE">0</TE>
<TE WIDTH="135" HEIGHT="63" ACODE="NOTE" ALIGN="CENTER" VALIGN="MIDDLE">대한민국, 한국거래소</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="290" HEIGHT="35" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">합 계</TD>
<TD WIDTH="56" HEIGHT="35" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TD WIDTH="137" HEIGHT="35" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TD WIDTH="137" HEIGHT="35" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>
<TE WIDTH="150" HEIGHT="35" ACODE="CB_ENT" ALIGN="RIGHT" VALIGN="MIDDLE">20,000,000,000</TE>
<TE WIDTH="125" HEIGHT="35" ACODE="CB_KNT" ALIGN="CENTER" VALIGN="MIDDLE">-</TE>
<TD WIDTH="137" HEIGHT="35" VALIGN="MIDDLE" ALIGN="CENTER" AUPDATECONT="N">-</TD>

<TE WIDTH="78" HEIGHT="35" ACODE="CB_RATT" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-GL"> 100</P>
</TE>

<TE WIDTH="105" HEIGHT="35" ACODE="CB_PRT" ALIGN="RIGHT" VALIGN="MIDDLE">
<P USERMARK="F-GL">14,808</P>
</TE>
<TE WIDTH="142" HEIGHT="35" ACODE="CB_AMNT" ALIGN="RIGHT" VALIGN="MIDDLE">0</TE>
<TE WIDTH="132" HEIGHT="35" ACODE="CB_CNT" ALIGN="RIGHT" VALIGN="MIDDLE">0</TE>
<TE WIDTH="135" HEIGHT="35" ACODE="NOTET" ALIGN="CENTER" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P USERMARK="F-GL10">주1) 전환사채 200억원 중 58억원 전환청구로 391,676주 신주 발행, 142억원 조기상환으로 작성기준일 현재 
<SPAN USERMARK=" U">미상환 사채의 잔액은 없습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">[참고] 전환사채 전환가액 조정현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">일  자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환가능주식수</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="30">발 행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">2019.03.29</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">21,154</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">945,447</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="30">1차 전환가액 조정</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">2019.06.29</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">16,398</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">1,219,660</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="30">2차 전환가액 조정</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">2019.09.29</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">14,808</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">1,350,621</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">전환사채의 전환가액 조정은 발행일로부터 만기일 전월까지 매 3개월이 경과한 날을 전환가격 조정일로 하고 최저 조정한도 전환가액은 14,808원(발행 당시 전환가액의 70%) 입니다. 기타 사항은 2019년 3월 28일 금융감독원 전자공시시스템(http://dart.fss.or.kr)에 공시된 주요사항보고서(전환사채권발행결정) 내용을 참조 바랍니다</SPAN>
</P>
<P USERMARK="F-16 0X1814FF"></P>
</LIBRARY>

<P></P>

<P>
<SPAN USERMARK="F-GL11 B">다. 채무증권 발행실적 등</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">[채무증권의 발행 등과 관련된 사항]</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE-GROUP ACLASS="SUB_PIS" ADELETETABLE="N">
<TITLE ATOC="N">채무증권 발행실적</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1130" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="828"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="147" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="837" HEIGHT="30" AUNIT="WONPERCENT" AUNITVALUE="2">(단위 : 천원, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1133" BORDER="1">

<COLGROUP>
<COL WIDTH="96"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="118"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="105" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행회사</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">증권종류</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행방법</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">발행일자</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">권면(전자등록)총액</TH>
<TH WIDTH="127" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">이자율</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">평가등급(평가기관)</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">만기일</TH>
<TH WIDTH="153" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">상환여부</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주관회사</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_CMPY">대화제약(주)</TE>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_KNN" AUNITVALUE="3">회사채</TU>
<TU WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_STC" AUNITVALUE="2">사모</TU>
<TU WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_DAT" AUNITVALUE="20190329">2019년 03월 29일</TU>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="BSS_PIS_MON">20,000,000</TE>
<TE WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="BSS_PIS_RATE">표면이자율 : 0%만기이자율 : 2%</TE>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_LEV">-</TE>
<TU WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUNIT="BSS_PIS_LAS" AUNITVALUE="20240329">2024년 03월 29일</TU>
<TE WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_REC">일부 전환, 상환 완료</TE>
<TE WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="BSS_PIS_SUC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="105" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합  계</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_MONT">20,000,000</TE>
<TE WIDTH="127" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_PIS_RATET">-</TE>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_LEVT">-</TE>
<TD WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">-</TD>
<TE WIDTH="153" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_RECT">-</TE>
<TE WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="BSS_PIS_SUCT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL10">1) 발행일 당시 권면 총액은 200억원이었으나 58억원 전환권행사로 전환, 142억원 조기상환 청구로 상환되어 </SPAN>
<SPAN USERMARK="F-GL10 U">2022년 9월 29일 3억원 조기상환을 끝으로 현재 미상환 권면 총액은 없습니다.</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_BLC" ADELETETABLE="N">
<TITLE ATOC="N">기업어음증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="820" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="514"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="523" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="820" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="43"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="106" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과30일이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과90일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과180일이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과1년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과2년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과3년이하</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년 초과</TH>
<TH WIDTH="79" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BL_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="52" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA90">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA180">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA365">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA730">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1095">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DA1111">-</TE>
<TE WIDTH="79" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_BLC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_ELPN" ADELETETABLE="N">
<TITLE ATOC="N">단기사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="759" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="453"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="462" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="760" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10일초과30일이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30일초과90일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">90일초과180일이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">180일초과1년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">발행 한도</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">잔여 한도</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EL_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_EP_REM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA10">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA30">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA90">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA180">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DA365">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_DATT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_PUB">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_ELP_REM">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_CNC" ADELETETABLE="N">
<TITLE ATOC="N">회사채 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="762" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="456"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="465" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="761" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과2년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과3년이하</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과4년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CN_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CC_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA1">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA2">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA3">-</TE>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA4">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DA11">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CNC_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_NEF" ADELETETABLE="N">
<TITLE ATOC="N">신종자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="757" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="451"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="460" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="758" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="73"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="82" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과5년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과10년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과15년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">15년초과20년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과30년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA5">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA10">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA15">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA20">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA30">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DA31">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_NEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<TABLE-GROUP ACLASS="SUB_CEF" ADELETETABLE="N">
<TITLE ATOC="N">조건부자본증권 미상환 잔액</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="912" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="615" HEIGHT="30" AUNIT="WON" AUNITVALUE="1">(단위 : 원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="912" BORDER="1">

<COLGROUP>
<COL WIDTH="45"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="71"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="109" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" COLSPAN="2">잔여만기</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년 이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">1년초과2년이하</TH>
<TH WIDTH="81" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">2년초과3년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">3년초과4년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">4년초과5년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">5년초과10년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">10년초과20년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">20년초과30년이하</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">30년초과</TH>
<TH WIDTH="80" VALIGN="MIDDLE" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="54" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="90" AUPDATECONT="N" ROWSPAN="3">미상환 잔액</TD>
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">공모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CE_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">사모</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CF_DATT">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="55" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">합계</TD>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA1">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA2">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA3">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA4">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA5">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA10">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA20">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA30">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DA31">-</TE>
<TE WIDTH="80" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="BSS_CEF_DATT">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>

<P></P>
</SECTION-3>

<SECTION-3 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-7-2">7-2. 증권의 발행을 통해 조달된 자금의 사용실적</TITLE>
<P></P>
<P></P>

<P USERMARK="F-GL B">가. 사모자금의 사용내역</P>

<LIBRARY>
<P></P>

<TABLE-GROUP ACLASS="FUND_SA" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="641" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="59"></COL>
<COL WIDTH="332"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="68" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="341" HEIGHT="30" AUNIT="WON" AUNITVALUE="3">(단위 : 백만원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1405" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="274"></COL>
<COL WIDTH="47"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="535"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="283" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">구 분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="56" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">회차</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">납입일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="211" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">주요사항보고서의 자금사용 계획</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="174" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제 자금사용 내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="544" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">차이발생 사유 등</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사용용도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">조달금액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="111" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="283" HEIGHT="88" ACODE="PO_TYPE" VALIGN="MIDDLE">제1회 무기명식 이권부 무보증 사모 전환사채</TE>
<TE ALIGN="CENTER" WIDTH="56" HEIGHT="88" ACODE="MO_SEQ" VALIGN="MIDDLE">1회차</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="88" AUNIT="PYM_DT" VALIGN="MIDDLE" AUNITVALUE="20190329">2019년 03월 29일</TU>

<TE ALIGN="RIGHT" WIDTH="133" HEIGHT="88" ACODE="PLA_USE" VALIGN="MIDDLE">시설 및 운영자금(
<SPAN USERMARK=" U">하단 주1 참조)</SPAN>
</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="88" ACODE="PLA_AMT" VALIGN="MIDDLE">20,000</TE>
<TE ALIGN="CENTER" WIDTH="111" HEIGHT="88" ACODE="BRK_CON" VALIGN="MIDDLE" USERMARK=" U">하단 주2 참조</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="88" ACODE="BRK_AMT" VALIGN="MIDDLE">20,000</TE>

<TE ALIGN="CENTER" WIDTH="544" HEIGHT="88" ACODE="PS_AMT_PL" VALIGN="MIDDLE">

<P>
<SPAN USERMARK="F-GL11">보고서 제출일 현재 CB발행 자금은 효율적 운영을 위하여 CB발행 이율보다 높은금융기관 대출금 상환에 115억원을 사용 하였으며 기타 운영자금에 85억원을 사용하였습니다</SPAN>
</P>
</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK="F-GL11">주1) 주요사항보고서의 자금사용 계획</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="347"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">사용 목적</TH>
<TH WIDTH="356" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">상세 자금 사용 목적</TH>
<TH WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">운영자금</TD>
<TD WIDTH="356" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">임상시험비(리포락셀액, 천연물 치매치료제)</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">120억원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="356" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기타 운영자금(원재료 매입 등)</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">40억원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="498" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" B">운영자금 소계</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" B">160억원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">시설자금</TD>
<TD WIDTH="356" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">시설투자(제2공장 기계장치 등 시설 증설)</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">40억원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="498" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" B">시설자금 소계</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" B">40억원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="498" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BU">합 계</TD>
<TD WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" BU">200억원</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">주2) 실제 자금 사용 내역</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="347"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사용 목적</TH>
<TH WIDTH="356" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상세 자금 사용 목적</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">채무상환자금</TD>
<TD WIDTH="356" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대출금 상환</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">115억원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">운영자금</TD>
<TD WIDTH="356" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기타 운영자금(원재료 매입 등)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">85억원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" B" WIDTH="498" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK=" U">실제 자금 사용 합 계</SPAN>
</TD>
<TD USERMARK=" B" WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">200억원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" B" WIDTH="498" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">합계</TD>
<TD USERMARK=" B" WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">200억원</TD>
</TR>
</TBODY>
</TABLE>
</LIBRARY>

<P></P>

<P></P>
</SECTION-3>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-3-8-0">8. 기타 재무에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">가. 제</SPAN>
<SPAN USERMARK="F-GL11">ㆍ</SPAN>
<SPAN USERMARK="F-GL11 B">개정된 기준서 적용</SPAN>(
<SPAN USERMARK="F-GL11">1) 2020년 1월 1일부터  새로 도입된 기준서 및 해석서와 그로 인한 회계정책 변경의 내용은 다음과 같으며  </SPAN>
<SPAN USERMARK="F-GL11 U">해당 기준서의 개정이 연결재무제표에 미치는 유의적인 영향은 없습니다.</SPAN>
</P>

<P USERMARK="F-GL 0X1814FF">
<SPAN USERMARK="F-11 0X000000"> ①기업회계기준서 제1103호 '사업결합' 개정 : 최초 적용일 2020년 1월 1일 부터</SPAN>
</P>
<P USERMARK="F-GL11">사업이 일반적으로 산출물을 보유하지만 활동과 자산의 통합된 집합이 사업의 정의를 만족하기 위해서 산출물이 필수적이지 않다는 점을 명확히 합니다.취득한 활동과 자산의 집합이 사업으로 간주되기 위해서는 최소한 산출물의 창출에 함께 유의적으로 기여할 수 있는 능력을 가진 투입물과 실질적인과정을 포함해야 합니다. 동 개정사항은 시장참여자가 누락된 투입물이나 과정을 대체할 수 있고 계속 산출물을 창출할 수 있는 지에 대한 평가부분을 삭제하였습니다. 또한 실질적인 과정이 취득되었는지 여부를 결정하는데 도움이 되는 판단지침을 제시하고 있습니다.</P>
<P USERMARK="F-GL11">동 개정사항은 취득한 활동과 자산의 집합이 사업이 아닌지 여부를 간략하게 평가할 수 있는 선택적 집중테스트를 도입하였습니다. 해당 선택적 집중테스트에서 만약 취득한 총자산의 공정가치가 실질적으로 식별가능한 단일자산 또는 식별가능한 유사한자산집단에 집중되어 있다면 이는 사업이 아닙니다.</P>
<P USERMARK="F-GL11">동 개정사항은 취득일이 2020년 1월 1일 이후 최초로 시작되는 회계연도의 개시일 이후의 사업결합에 적용하며, 모든 사업결합과 자산취득거래에 전진적으로 적용됩니다.</P>
<P USERMARK="F-GL11"> ② 기업회계기준서 제1001호 및 제1008호 중요성의 정의(개정) : 최초 적용일 2020년 1월 1일 부터 </P>
<P USERMARK="F-GL11">기업회계기준서 제1001호에 정의된 중요성을 더 쉽게 이해할 수 있도록 하기 위한 것이며, 기업회계기준서에서의 중요성에 대한 기본 개념의 변경을 의도한 것은 아닙니다. 중요하지 않은 정보가 중요한 정보를 '불분명'하게 한다는 개념은 새로운 정의의 일부로 포함됩니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">기업회계기준서 제1008호에서 중요성의 정의는 기업회계기준서 제1001호의 중요성정의를 참조하도록 대체됩니다. 또한 국제회계기준위원회는 일관성을 보장하기 위해중요성의 정의를 포함하거나 '중요성'이라는 용어를 참조하는 다른 기준서와 '개념체계'를 수정하였습니다.</P>
<P USERMARK="F-GL11"> ③ 기업회계기준서에서 '개념체계'에 대한 참조(개정) :최초 적용일 2020년 1월 1일 부터기업회계기준서가 전면개정된 '개념체계'(2018)을 참조하도록합니다. 그러나 모든 개정사항이 그러한 참조나 인용과 관련된 문구가 전면개정된 '개념체계'(2018)을 참조하도록 하는 것은 아닙니다. 일부 문구는 참조하는 '개념체계'가 '재무제표의 작성과 표시를 위한 개념체계'(2007)인지, '개념체계'(2010)인지, 또는 신규로 개정된 '개념체계'(2018)인지를 명확히 하기 위해 개정되었으며, 다른 일부 문구는 기업회계기준서상의 정의가 전면개정된 '개념체계'(2018)에서 개발된 새로운 정의로 변경되지 않았다는 점을 명시하기 위해서 개정되었습니다. 개정된 기업회계기준서는 기업회계기준서 제1102호, 제1103호, 제1106호, 제1114호, 제1001호, 제1008호, 제1034호, 제1037호, 제1038호, 제2112호, 제2119호, 제2120호, 제2122호 및 제2032호입니다.</P>
<P USERMARK="F-GL11">  ④ 기업회계기준서 제1116호 리스(개정) :최초 적용일 2020년 1월 1일 부터</P>
<P USERMARK="F-GL11">코로나19의 직접적인 결과로 발생한 임차료 할인 등을 리스이용자가 회계처리하는데 실무적 경감을 제공하고 있습니다. 동 실무적 간편법은 리스이용자에게 코로나19관련 임차료 할인 등이 리스변경에 해당하는지 여부를 평가하지 않는선택을 할 수 있도록 허용합니다. 이러한 선택을 한 리스이용자는 코로나19 관련 임차료 할인 등으로 인한 리스료 변동을 그러한 변동이 리스변경이 아닐 경우에 리스이용자가 회계처리하는 방식과 일관되게 회계처리합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">동 실무적 간편법은 코로나19의 직접적인 결과로 발생한 임차료 할인 등에만 적용되며 아래의 조건을 모두 충족하는 경우에 적용합니다.</P>
<P USERMARK="F-GL11">   -  리스료의 변동으로 수정된 리스대가가 변경 전 리스대가와 실질적으로 동일하거나           그보다 작음</P>
<P USERMARK="F-GL11">   - 리스료 감면이 2021년 6월 30일 이전에 지급하여야 할 리스료에만 영향을 미침(예를        들어 임차료 할인 등이 2021년 5월 30일 이전에 지급하여야 할 리스료를 감소시키고        2021년 5월 30일 후에 리스료를 증가시키는 경우 이러한 조건을 충족함).</P>

<P USERMARK="F-GL11 0X1814FF">
<SPAN USERMARK=" 0X000000">   - 그 밖의 리스기간과 조건은 실질적으로 변경되지 않음(2) 2021년 1월 1일부터  새로 도입된 기준서 및 해석서와 그로 인한 회계정책 변경의 내용은 다음과 같으며 </SPAN>
<SPAN USERMARK=" 0X000000 U">해당 기준서의 개정이 연결재무제표에 미치는 중요한 영향은 없습니다. </SPAN>
</P>
<P USERMARK="F-GL11"> ① 기업회계기준서 제1116호 '리스' 개정 - 코로나19 관련 임차료 할인 등에 대한 실무적 간편법</P>
<P USERMARK="F-GL11">실무적 간편법으로, 리스이용자는 코로나19의 직접적인 결과로 발생한 임차료 할인 등이 리스변경에 해당하는지 평가하지 않을 수 있습니다. 이러한 선택을 한 리스이용자는 임차료 할인 등으로 인한 리스료 변동을 그러한 변동이 리스변경이 아닐 경우에 이 기준서가 규정하는 방식과 일관되게 회계처리하여야 합니다.</P>
<P USERMARK="F-GL11"> ② 기업회계기준서 제1109호 '금융상품', 제1039호 '금융상품: 인식과 측정', 제1107호 '금융상품: 공시', 제1104호 '보험계약' 및 제1116호 '리스' 개정 - 이자율지표 개혁(2단계 개정) </P>
<P USERMARK="F-GL11">이자율지표 개혁과 관련하여 상각후원가로 측정되는 금융상품의 이자율지표 대체시 장부금액이 아닌 유효이자율을 조정하고, 위험회피관계에서 이자율지표 대체가 발생한 경우에도 중단없이 위험회피회계를 계속할 수 있도록 하는 등의 예외규정을 포함하고 있습니다.</P>

<P USERMARK="F-GL11 0X1814FF">
<SPAN USERMARK=" 0X000000">(3) 2022년 1월 1일부터 새로 도입된 기준서 및 해석서와 그로 인한 회계정책 변경의 내용은 </SPAN>
<SPAN USERMARK=" 0X000000 U">다음과 같으며 해당 기준서의 개정이 연결재무제표에 미치는 중요한 영향은 없습니다.</SPAN>
</P>
<P USERMARK="F-GL11"> ① 기업회계기준서 제1103호 '사업결합' (개정) - '개념체계'에 대한 참조</P>
<P USERMARK="F-GL11">인식할 자산과 부채의 정의를 개정된 재무보고를 위한 개념체계를 참조하도록 개정되었으나, 기업회계기준서 제1037호 '충당부채, 우발부채 및 우발자산' 및 해석서 제2121호 '부담금'의 적용범위에 포함되는 부채 및 우발부채에 대해서는 해당 기준서를 적용하도록 예외를 추가하고, 우발자산이 취득일에 인식되지 않는다는 점을 명확히 하였습니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11"> ② 기업회계기준서 제1016호 '유형자산'(개정) - 의도한 사용 전의 매각금액</P>
<P USERMARK="F-GL11">동 개정사항은 유형자산이 사용 가능하기 전에 생산된 재화의 매각금액, 즉 경영진이 의도하는 방식으로 가동하는 데 필요한 장소와 상태에 이르게 하기 전에 생산된 재화의 매각금액)을 유형자산의 원가에서 차감하는 것을 금지합니다. 따라서 그러한 매각금액과 관련 원가를 당기손익으로 인식하며, 해당 원가는 기업회계기준서 제1002호에 따라 측정합니다.</P>
<P USERMARK="F-GL11">또한 동 개정사항은 '유형자산이 정상적으로 작동되는지 여부를 시험하는 것'의 의미를 명확히 하여 자산의 기술적, 물리적 성능이 재화나 용역의 생산이나 제공, 타인에 대한 임대 또는 관리활동에 사용할 수 있는 정도인지를 평가하는 것으로 명시합니다. </P>
<P USERMARK="F-GL11">동 개정사항은 이 개정내용을 처음 적용하는 재무제표에 표시된 가장 이른 기간의 개시일 이후에 경영진이 의도한 방식으로 가동할 수 있는 장소와 상태에 이른 유형자산에 대해서만 소급 적용합니다. 동 개정사항의 최초 적용 누적효과는 표시되는 가장 이른 기간의 시작일에 이익잉여금(또는 적절하다면 자본의 다른 구성요소)의 기초 잔액을 조정하여 인식합니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">  ③ 기업회계기준서 제1037호 '충당부채, 우발부채 및 우발자산' (개정) - 손실부담계약의 계약이행원가</P>
<P USERMARK="F-GL11">동 개정사항은 계약이 손실부담계약인지 또는 손실을 발생시키는 계약인지 평가할 때 기업이 포함해야할 원가를 명확하게 하였습니다.</P>
<P USERMARK="F-GL11">개정 기준서는 "직접 관련된 원가 접근법"을 적용합니다. 재화나 용역을 제공하는 계약에 직접적으로 관련되는 원가는 증분원가와 계약 활동에 직접적으로 관련되는 원가 배분액을 모두 포함합니다. 일반 관리 원가는 계약에 직접적으로 관련되지 않으며 계약에 따라 거래상대방에게 명시적으로 부과될 수 없다면 제외됩니다.</P>
<P USERMARK="F-GL11">동 개정사항은 이 개정사항을 최초로 적용하는 회계연도의 개시일에 모든 의무의 이행이 완료되지는 않은 계약에 적용합니다. 비교재무제표는 재작성 하지 않고, 그 대신 개정 내용을 최초로 적용함에 따른 누적효과를 최초적용일의 기초이익잉여금 또는 적절한 경우 다른 자본요소로 인식합니다.</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">  ④ 한국채택국제회계기준 2018-2020 연차개선</P>
<P USERMARK="F-GL11">  - 기업회계기준서 제 1101호 '한국채택국제회계기준의 최초채택' - 최초채택기업인 종속기업</P>
<P USERMARK="F-GL11">동 개정사항은 지배기업보다 늦게 최초채택기업이 되는 종속기업의 누적환산차이의 회계처리와 관련하여 추가적인 면제를 제공합니다. 기업회계기준서 제 1101호 문단 D16(1)의 면제규정을 적용하는 종속기업은 지배기업의 한국채택국제회계기준 전환일에 기초하여 지배기업의 연결재무제표에 포함될 장부금액으로 모든 해외사업장의 누적환산차이를 측정하는 것을 선택할 수 있습니다. 다만 지배기업이 종속기업을 취득하는 사업결합의 효과와 연결절차에 따른 조정사항은 제외합니다. 관계기업이나 공동기업이 기업회계기준 제 1101호 문단 D16(1)의 면제규정을 적용하는 경우에도 비슷한 선택을 할 수 있습니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">  - 기업회계기준서 제1109호 '금융상품' - 금융부채 제거 목적의 10% 테스트 관련 수수료</P>
<P USERMARK="F-GL11">동 개정사항은 금융부채의 제거 여부를 평가하기 위해 '10%' 테스트를 적용할 때, 기업(차입자)과 대여자 간에 수취하거나 지급하는 수수료만을 포함하며, 여기에는 기업이나 대여자가 다른 당사자를 대신하여 지급하거나 수취하는 수수료를 포함한다는 점을 명확히 하고 있습니다. 동 개정사항은 최초 적용일 이후 발생한 변경 및 교환에 대하여 전진적으로 적용됩니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">  - 기업회계기준서 제1116호 '리스' - 리스 인센티브</P>
<P USERMARK="F-GL11">동 개정사항은 기업회계기준서 제1116호 사례13에서 리스개량 변제액에 대한 내용을 삭제하였습니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">  - 기업회계기준서 제1041호 '농림어업' - 공정가치 측정</P>
<P USERMARK="F-GL11">동 개정사항은 생물자산의 공정가치를 측정할 때 세금 관련 현금흐름을 제외하는 요구사항을 삭제하였습니다. 이는 기업회계기준서 제1041호의 공정가치 측정과 내부적으로 일관된 현금흐름과 할인율을 사용하도록 하는 기업회계기준서 제1113호의 요구사항을 일치시키며, 기업은 가장 적절한 공정가치 측정을 위해 세전 또는 세후 현금흐름 및 할인율을 사용할지 선택할 수 있습니다. </P>
<P></P>

<P>
<SPAN USERMARK="F-GL B">나. 대손충당금 설정현황</SPAN>
<SPAN USERMARK="F-GL11">1) 연결 대손충당금 설정현황</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11"> (1) 최근 3사업연도의 계정과목별 대손충당금 설정내역</SPAN>
<SPAN USERMARK="F-GL11 0X1814FF">                                                                                               </SPAN>
<SPAN USERMARK="F-GL11">   (단위 : 천원, %)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="596">

<COLGROUP>
<COL WIDTH="62"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="71" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정과목</TH>
<TH WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권 총액</TH>
<TH WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대손충당금</TH>
<TH WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대손충당금설정률</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="210" ROWSPAN="7" ALIGN="CENTER" VALIGN="MIDDLE">제39기당기</TD>
<TD WIDTH="119" HEIGHT="30"> 매출채권 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">20,176,047</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">2,038,760</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">10.1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 미수금 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">1,273,322</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">　-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 미수수익 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">39,690</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">　-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 선급금 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">92,163</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">   -</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 선급비용 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">51,065</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">　-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 부가세대급금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">243,526</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">　-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">합계</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">21,875,813</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">2,038,760</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">　9.3</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="210" ROWSPAN="7" ALIGN="CENTER" VALIGN="MIDDLE">제38기</TD>
<TD WIDTH="119" HEIGHT="30"> 매출채권 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">18,847,073</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">2,128,327</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> 11.3</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 미수금 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">854,339</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 미수수익 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">662,862</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 선급금 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">510,986</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 선급비용 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">109,667</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 부가세대급금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">178,247</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">합계</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">21,163,174</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">2,128,327</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">10.1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="210" ROWSPAN="7" ALIGN="CENTER" VALIGN="MIDDLE">제37기</TD>
<TD WIDTH="119" HEIGHT="30"> 매출채권 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">18,723,448</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">2,406,128</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12.9</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 미수금 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">1,372,254</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 미수수익 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">323,910</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 선급금 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">661,866</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 선급비용 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">30,138</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 부가세대급금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">148,160</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">합계</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">21,259,776</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">2,406,128</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">11.3</TD>
</TR>
</TBODY>
</TABLE>

<P> 
<SPAN USERMARK="F-GL11">(2) 대손충당금 변동현황</SPAN>
<SPAN USERMARK="F-GL11 B">     </SPAN>
<SPAN USERMARK="F-GL11">                                                                                                       (단위 : 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="235"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="244" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제39기 당기</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제38기 </TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제37기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30">1. 기초 대손충당금 잔액합계</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,128,327</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,406,128</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">3,750,062</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30">2. 순대손처리액(①－②±③)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(78,155)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(277,801)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30">① 대손처리액(상각채권액)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">11,019</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30">② 상각채권회수액</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(78,155)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(288,820)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30">③ 기타증감액</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30">3. 대손상각비 계상(환입)액</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(11,412)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(1,343,934)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30">4. 기말 대손충당금 잔액합계</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,038,760</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,128,327</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,406,128</TD>
</TR>
</TBODY>
</TABLE>

<P> 
<SPAN USERMARK="F-GL11">(3) 매출채권관련 대손충당금 설정방침</SPAN>
<SPAN USERMARK="F-GL11">①대손충당금 설정방침연결실체는 개별적인 손상검사 및 집합적인 손상검사를 수행하고 있습니다.손상 징후가 있는 중요 수취채권 잔액에 대해 연결실체는 개별적으로 손상평가를 하며, 개별적으로 손상되지 않았다고 평가된 자산과 관련하여서는 확인되지는 않았지만 발생한 손상에 대한 집합적인 손상검사를 수행하고 있습니다.</SPAN>
<SPAN USERMARK="F-GL11">②대손경험률 및 대손예상액 산정근거연결실체가 받을 채권 중 거래처의 파산 또는 폐업 등 손상 징후로 회수가 불가능하다고 판단된 채권에 대해서는 전액 대손충당금을 설정하고 있으며, 집합적인 손상검사의 경우 과거 3년간의 장기연체 및 대손 사유 발생에 따른 경험률을 적용하여 채권에 대한 대손충당금을 설정하고 있습니다.</SPAN>
<SPAN USERMARK="F-GL11">(4) 보고서작성기준일 현재 경과기간별 매출채권잔액 현황</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">                                                                                                  (단위 : 천원,%)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="621">

<COLGROUP>
<COL WIDTH="101"></COL>
<COL WIDTH="89"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="93"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="110" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="98" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">30일이하</TH>
<TH WIDTH="104" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">30일 초과120일 이하</TH>
<TH WIDTH="103" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">120일 초과1년 이하</TH>
<TH WIDTH="104" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년 초과</TH>
<TH WIDTH="102" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30" ALIGN="CENTER">채권잔액</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT">10,819,288</TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT">6,512,182</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT">1,036,831</TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,807,746</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT">20,176,047</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30" ALIGN="CENTER">대손충당금</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">61,492</TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">71,908</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">97,615</TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,807,746</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,038,761</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30" ALIGN="CENTER">합    계</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,757,796</TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,440,274</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">939,216</TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,137,286</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="110" HEIGHT="30" ALIGN="CENTER">구성비율(%)</TD>
<TD WIDTH="98" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">59.31</TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">35.51</TD>
<TD WIDTH="103" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">5.18</TD>
<TD WIDTH="104" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">0.00</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">　100</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">2) 대손충당금 설정현황 (별도)</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11"> (1) 최근 3사업연도의 계정과목별 대손충당금 설정내역                                                                                                  (단위 : 천원, %)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="596">

<COLGROUP>
<COL WIDTH="62"></COL>
<COL WIDTH="110"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="71" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="119" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정과목</TH>
<TH WIDTH="136" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권 총액</TH>
<TH WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대손충당금</TH>
<TH WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대손충당금설정률</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">제39기당기</TD>
<TD WIDTH="119" HEIGHT="30">매출채권</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">12,523,621</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">807,227</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6.4</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">미수금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">824,899</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">미수수익</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">39,690</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">선급금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">15,308</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">선급비용</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">22,274</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">합   계</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">13,425,792</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">807,227</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6.0</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">제38기</TD>
<TD WIDTH="119" HEIGHT="30">매출채권</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">12,179,705</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">888,950</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">7.3</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">미수금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">521,034</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">미수수익</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">662,862</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">250,503</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">37.8</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">선급금</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">491,848</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">선급비용</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">14,747</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">합   계</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">13,870,196</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">1,139,453</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">8.2</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">제37기</TD>
<TD WIDTH="119" HEIGHT="30"> 매출채권 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">12,286,039</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">929,815</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">7.6</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 미수금 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">1,065,129</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 미수수익 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">323,910</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 선급금 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">634,543</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30"> 선급비용 </TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">14,040</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="119" HEIGHT="30">합   계</TD>
<TD WIDTH="136" HEIGHT="30" ALIGN="RIGHT">14,323,661</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT">929,815</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6.5</TD>
</TR>
</TBODY>
</TABLE>

<P> 
<SPAN USERMARK="F-GL11">(2) 대손충당금 변동현황                                                                                                    (단위 : 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="598">

<COLGROUP>
<COL WIDTH="235"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="109"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="244" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구     분</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제39기 당기 </TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제38기 </TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제37기 </TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30">1. 기초 대손충당금 잔액합계</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1,139,453</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">929,815</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">2,329,997</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30">2. 순대손처리액(①－②±③)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(250,503)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">250,503</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30">① 대손처리액(상각채권액)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">250,503</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30">② 상각채권회수액</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30">③ 기타증감액</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(250,503)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30">3. 대손상각비 계상(환입)액</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(81,724)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(40,865)</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">(1,400,182)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="244" HEIGHT="30">4. 기말 대손충당금 잔액합계</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">807,226</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">1,139,453</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="RIGHT">929,815</TD>
</TR>
</TBODY>
</TABLE>

<P> 
<SPAN USERMARK="F-GL11">(3) 매출채권관련 대손충당금 설정방침</SPAN>
<SPAN USERMARK="F-GL11">①대손충당금 설정방침당사는 재무상태표일 현재 수취채권 잔액의 회수 가능성에 대한 개별 및 집합적인 손상검사를 수행하고 있습니다. 손상 징후가 있는 중요 수취채권 잔액에 대해 연결실체는 개별적으로 손상평가를 하며, 개별적으로 손상되지 않았다고 평가된 자산과 관련하여서는 확인되지는 않았지만 발생한 손상에 대한 집합적인 손상검사를 수행하고 있습니다.②대손경험률 및 대손예상액 산정근거연결실체가 받을 채권 중 거래처의 파산 또는 폐업 등 손상 징후로 회수가 불가능하다고 판단된 채권에 대해서는 전액 대손충당금을 설정하고 있으며, 집합적인 손상검사의 경우 과거 3년간의 장기연체 및 대손 사유 발생에 따른 경험률을 적용하여 채권에 대한 대손충당금을 설정하고 있습니다.</SPAN>
<SPAN USERMARK="F-GL11"> (4) 보고서작성기준일 현재 경과기간별 매출채권잔액 현황                                                                                                 (단위 : 천원, %)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="713">

<COLGROUP>
<COL WIDTH="23"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="107"></COL>
<COL WIDTH="106"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="137" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="116" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">30일 이하</TH>
<TH WIDTH="115" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">30일 초과120일 이하</TH>
<TH WIDTH="114" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">120일 초과1년 이하</TH>
<TH WIDTH="116" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">1년 초과</TH>
<TH WIDTH="115" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="32" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">금액</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">채권잔액</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">8,384,017</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">3,308,759</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">183,408</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">647,437</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">12,523,621</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대손충당금</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">61,151</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">49,288</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">49,350</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">647,437</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">807,226</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">계</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT">8,322,866</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">3,259,471</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT">134,058</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="RIGHT">11,716,395</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">구성비율(%)</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">71.04</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">27.82</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1.14</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="115" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">　100.00</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">다. 재고자산 현황 등</SPAN>
<SPAN USERMARK="F-GL11"> (1) 재고자산의 보유현황연결회사의 재고자산은 상품, 제품, 원재료, 부재료, 기타로 이루워져 있으며, 2022년말 현재 재고자산총액은 23,413백만원으로 2021년말 대비 4,731백만원이 증가하였습니다. </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">                                                                                                  (단위 : 천원, %)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="788">

<COLGROUP>
<COL WIDTH="130"></COL>
<COL WIDTH="192"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
<COL WIDTH="103"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="139" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정과목</TH>
<TH WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제39기 당기 </TH>
<TH WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제38기 </TH>
<TH WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제37기 </TH>
<TH WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비  고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="139" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">의약품 제조 파매</TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">상   품</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,673,293</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,066,841</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,343,960</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제   품</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">6,537,503</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">5,538,324</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">5,431,603</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">원재료</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">7,075,467</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">2,938,983</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">3,441,964</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">부재료</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">2,204,661</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,329,608</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,314,725</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기   타</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,423,534</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">3,679,302</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">3,445,016</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">소   계</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">18,914,458</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">14,553,059</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">14,977,268</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="139" HEIGHT="120" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="4">의약품 원료 제조 판매</TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제품</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,342,733</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">2,022,075</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">2,109,493</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">원재료</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">865,383</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">281,110</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">453,140</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기   타</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">37,767</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">245,518</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">54,958</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">소   계</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">2,245,883</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">2,548,704</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">2,617,591</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="139" HEIGHT="150" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="5">의약품 도매 외</TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">상   품</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">154,290</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">105,472</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">139,889</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제   품</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">530,242</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">579,083</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">525,058</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">원재료</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,200,839</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">567,880</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">858,182</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기   타</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">367,182</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">327,583</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,523,129</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">소   계</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">2,252,553</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,580,018</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">3,046,258</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="139" HEIGHT="180" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="6">합계</TD>
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">상   품</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,827,583</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,172,313</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,483,849</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">제   품</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">8,410,479</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">8,139,483</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">8,066,154</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">원재료</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">9,141,689</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">3,787,973</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">4,753,287</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">부재료</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">2,204,661</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,329,608</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,314,725</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기  타</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">1,828,483</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">4,252,403</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">4,095,056</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="201" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합  계</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">23,412,895</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">18,681,780</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="RIGHT">19,713,071</TD>
<TD WIDTH="112" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="53" COLSPAN="2" ALIGN="CENTER">총자산대비 재고자산 구성비율(%)[재고자산합계÷기말자산총계×100]</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">11.76 </TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">10.38</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">11.26</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="340" HEIGHT="53" COLSPAN="2" ALIGN="CENTER">재고자산회전율(회수)[연환산 매출원가÷{(기초재고＋기말재고)÷2}]</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">4.08회</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">3.83회</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">3.61회</TD>
<TD WIDTH="112" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">① 실사일자 </SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
<COL WIDTH="191"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">법인명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">실사일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">실사입회자</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">대화제약(주)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">2023년 1월 3일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">대주회계법인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">(주)리독스바이오</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">2023년 1월 5일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">광교회계법인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="200" HEIGHT="30">디에이치호림(주)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">2023년 1월 2일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30">광교회계법인</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P USERMARK="F-GL11">② 재고실사시 독립적인 전문가 또는 전문기관, 감사인 등의 참여 및 입회여부 :지배회사 및 종속회사의 재고실사 시 공인회계사, 당사 내부회계관리담당,각 재고자산별 담당자가 입회하여 재고자산 실사를 시행 하였습니다.③ 실사 방법:  2022년 12월 31일 기준 장부상 재고수량과 실지재고수량을 확인하였으며, 그에 대한 중요한 차이가 발생되 지 않았습니다.</P>
<P></P>
<P USERMARK=" 0X1814FF"></P>

<P>
<SPAN USERMARK="F-GL B">라. 공정가치평가 내역</SPAN>
</P>
<P></P>

<P>
<SPAN USERMARK="F-GL11">1) 연결 공정가치평가 내역</SPAN>
</P>
<P USERMARK="F-GL11">당기말 및 전기말 현재 연결회사의 금융자산과 금융부채의 장부금액과 공정가치는 다음과같습니다.(1) 공정가치와 장부금액</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="668">

<COLGROUP>
<COL WIDTH="659"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="668" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="683">

<COLGROUP>
<COL WIDTH="302"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="85"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="311" VALIGN="MIDDLE" HEIGHT="60" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH COLSPAN="2" WIDTH="189" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH COLSPAN="2" WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="96" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="683" VALIGN="MIDDLE" HEIGHT="30">공정가치로 인식된 자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" VALIGN="MIDDLE" HEIGHT="30">   당기손익-측정금융자산매도가능금융자산</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,593,067</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,593,067</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,066,361</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,066,361</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" VALIGN="MIDDLE" HEIGHT="30">   기타포괄-공정가치측정금융자산</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,633,411</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,633,411</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,807,140</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,807,140</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="5" WIDTH="683" VALIGN="MIDDLE" HEIGHT="30">상각후원가로 인식된 자산</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" VALIGN="MIDDLE" HEIGHT="30">   대여금과 수취채권</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,645</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,645</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,976</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">13,976</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" VALIGN="MIDDLE" HEIGHT="30">   매출채권및기타채권</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,478,954</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">20,478,954</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,610,320</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">18,610,320</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" VALIGN="MIDDLE" HEIGHT="30">   장ㆍ단기금융상품</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,082,000</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">10,082,000</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,172,241</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,172,241</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" VALIGN="MIDDLE" HEIGHT="30">   현금 및 현금성자산</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,125,135</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,125,135</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,001,730</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">4,001,730</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">합 계</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,916,212</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">38,916,212</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45,671,768</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45,671,768</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="683" VALIGN="MIDDLE" COLSPAN="5" HEIGHT="30">공정가치로 인식된 부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" VALIGN="MIDDLE" HEIGHT="30">   당기손익-측정 금융부채</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="683" VALIGN="MIDDLE" COLSPAN="5" HEIGHT="30">상각후원가로 인식된 부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" VALIGN="MIDDLE" HEIGHT="30">   장.단기차입금</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">86,362,273</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">86,362,273</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,299,075</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">66,299,075</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" VALIGN="MIDDLE" HEIGHT="30">   매입채무와 기타채무</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,089,559</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">22,089,559</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,158,919</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16,158,919</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" VALIGN="MIDDLE" HEIGHT="30">   전환사채</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">844,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" VALIGN="MIDDLE" HEIGHT="30">   리스부채</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">453,683</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">453,683</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">507,264</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">507,264</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="311" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합 계</TD>
<TD WIDTH="96" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">108,905,515</TD>
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">108,905,515</TD>
<TD WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">83,809,303</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">83,809,303</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL11">(2) 공정가치 서열체계아래 표에서는 공정가치로 인식되는 금융상품을 공정가치 측정방법별로 분석하였습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">공정가치에는 다음의 수준이 있습니다.</P>
<P USERMARK="F-GL11">1) 동일한 자산이나 부채에 대한 활성시장의 공시가격 (수준 1)</P>
<P USERMARK="F-GL11">2) 직접적으로 또는 간접적으로 관측가능한, 자산이나 부채에 대한 투입변수 (수준 2)</P>
<P USERMARK="F-GL11">3) 관측가능한 시장자료에 기초하지 않은, 자산이나 부채에 대한 투입변수 (수준 3)</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">당기말 현재 공정가치로 측정되는 금융상품의 각 종류별로 공정가치 수준별 측정치는 다음과 같습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="615">

<COLGROUP>
<COL WIDTH="606"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="615" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="615" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="230"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
<COL WIDTH="85"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="239" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준1</TH>
<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준2</TH>
<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수준3</TH>
<TH WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">합 계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="239" VALIGN="MIDDLE" HEIGHT="30"> 기타포괄-공정가치측정금융자산</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,633,411</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,633,411</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="239" VALIGN="MIDDLE" HEIGHT="30"> 당기손익-공정가치측정금융자산</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,593,067</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="94" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,593,067</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL B"></P>

<P>
<SPAN USERMARK="F-GL11">2) 공정가치평가 내역(별도)</SPAN>
</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(1) 공정가치와 장부금액</P>
<P USERMARK="F-GL11">당기말 및 전기말 현재 회사의 금융자산과 금융부채의 장부금액은 공정가치로 계상되어있습니다.</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="787">

<COLGROUP>
<COL WIDTH="778"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="787" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="788">

<COLGROUP>
<COL WIDTH="278"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="287" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="251" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH WIDTH="250" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기말</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="126" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">장부금액</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">공정가치</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="788" HEIGHT="30" COLSPAN="5" VALIGN="MIDDLE">공정가치로 인식된 자산 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   당기손익-공정가치측정금융자산</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,496,345</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,496,345</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,999,301</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,999,301</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   기타포괄손익-공정가치측정금융자산</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,533,411</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,533,411</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,707,140</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,707,140</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">소 계</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,029,756</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,029,756</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,706,442</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,706,442</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="788" HEIGHT="30" COLSPAN="5" VALIGN="MIDDLE">상각후원가로 인식된 자산 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   대여금과 수취채권</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE"></TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   매출채권및기타채권</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,580,983</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,580,983</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,224,148</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,224,148</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   장ㆍ단기금융상품</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,080,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,080,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,170,241</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,170,241</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   현금 및 현금성자산</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">320,381</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">320,381</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,415,085</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,415,085</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">소 계</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,981,363</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,981,363</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">29,809,473</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">29,809,473</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,011,119</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28,011,119</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,515,915</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,515,915</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="788" HEIGHT="30" COLSPAN="5" VALIGN="MIDDLE">공정가치로 인식된 부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   당기손익-공정가치측정금융부채</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">45</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="788" HEIGHT="30" COLSPAN="5" VALIGN="MIDDLE">상각후원가로 인식된 부채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   단기차입금</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,200,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">50,200,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,500,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">46,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   유동성장기차입금</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   매입채무와 기타채무</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,893,674</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">18,893,674</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,912,212</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,912,212</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   장기차입금</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,057,863</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24,057,863</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,547,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,547,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   전환사채</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">844,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">844,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" VALIGN="MIDDLE">   리스부채</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">438,978</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">438,978</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">433,319</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">433,319</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="287" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="126" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,590,515</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,590,515</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">68,236,576</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">68,236,576</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(2) 공정가치 서열체계아래 표에서는 공정가치로 인식되는 금융상품을 공정가치 측정방법별로 분석하였습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">공정가치에는 다음의 수준이 있습니다.</P>
<P USERMARK="F-GL11">1) 동일한 자산이나 부채에 대한 활성시장의 공시가격 (수준 1)</P>
<P USERMARK="F-GL11">2) 직접적으로 또는 간접적으로 관측가능한, 자산이나 부채에 대한 투입변수 (수준 2)</P>
<P USERMARK="F-GL11">3) 관측가능한 시장자료에 기초하지 않은, 자산이나 부채에 대한 투입변수 (수준 3)</P>
<P USERMARK="F-GL11">당기말 현재 공정가치로 측정되는 금융상품의 각 종류별로 공정가치 수준별 측정치는 다음과 같습니다</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="735">

<COLGROUP>
<COL WIDTH="726"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="735" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="741">

<COLGROUP>
<COL WIDTH="231"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="240" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30"> 구 분 </TH>
<TH WIDTH="126" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">수준1</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">수준2</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">수준3</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">합계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" VALIGN="MIDDLE" HEIGHT="30"> 당기손익-공정가치측정금융자산</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,496,345</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">1,496,345</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="240" VALIGN="MIDDLE" HEIGHT="30"> 기타포괄-공정가치측정금융자산</TD>
<TD WIDTH="126" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,533,411</TD>
<TD WIDTH="125" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">3,533,411</TD>
</TR>
</TBODY>
</TABLE>

<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-4-0-0">IV. 이사의 경영진단 및 분석의견</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL16 0XFF1200 B">1. 예측정보에 대한 주의사항</SPAN>
<SPAN USERMARK="F-GL11">당사가 동 사업보고서에서 미래에 발생 할 것으로 예상ㆍ예측한 활동, 사건 또는 현상은 당해 공시서류 작성시점의 사건 및 재무성과를 기반으로 회사의 견해를 반영한 것입니다. 동 예측정보는 미래 사업환경과 관련된 다양한 가정에 기초하 고 있으며, 동 가정들은 결과적으로 부정확한 것으로 판명될 수도 있습니다. 또한, 이러한 가정들에는 예측정보에서 기재한 예상치와 실제 결과 간에 중요한 차이를 초래 할 수 있는 위험, 불확실성 및 기타 요인을 포함하고 있습니다. 이러한 중요한 차이를 초래 할 수 있는 요인에는 회사 내적요인과 외적요인이 포함되어 있으며, 이에 한하지 않습니다. 당사는 동 예측정보 작성시점 이후에 발생하는 위험 또는 불확실성을 반영하기 위하여 예측정보에 기재한 사항을 수정하는 정정보고서를 공시할 의무는 없습니다. 결론적으로, 동 사업보고서상에 회사가 예상한 결과 또는 사항이 실현되거나 회사가 당초에 예상한 영향이 발생한다는 확신을 제공 할 수없습니다. 당사는 동 보고서에 기재된 예측정보 작성시점 이후에 발생하는 위험 또는 불확실성을 반영하기 위하여 예측정보에 기재한 사항을 수정하는 정정보고서를 공시할 의무는없습니다. </SPAN>
<SPAN USERMARK="F-GL16 0XFF1200 B">2. 개요</SPAN>
<SPAN USERMARK="F-GL11">2022년 당사는 의약품제조 판매를 주업으로 하고 있으며 , 의약품제조 판매는 전문의약품이 주를 이루고 있습니다. 의약품제조 판매업은 국민건강에 연관되어 있는 국가 기본산업으로 경기에 민감하게 반응하는 편은 아니나, 정부의 정책 및 규제에 따라 민감하게 반응합니다. 그 외 종속회사에서 영위하는 의약품도매부문, 의료정보시스템부문(컨텐츠), 의약품원료부문(의약품제조 및 조직공학제품)이 있습니다.</SPAN>
<SPAN USERMARK="F-GL11">당사는 연결기준 자기자본 비율 41%, ROE 1.5%, 부채비율 144%를 별도기준 자기자본 비율 45.8%, ROE 2.3%, 부채비율 118.5%로 2공장 B동 건설 및 운영자금 차입 증가에 따른 이자비용 증가 등으로 전기 대비 연결 재무구조의 자기자본 비율과 ROE가 감소하고 부채비율은 증가하였습니다.당사는 인구 고령화에 따라 류마티스관절염 등의 만성질환 비율이 높아지고 경구용 진통제의 부작용 우려로 인해 통증 완화용 국부 진통제에 대한 수요가 증가하고 있다고 판단하여 당사의 TDDS특화 기술을 바탕으로 전문 생산시설 확충을 통해 경쟁력을 강화하고 매출 신장에 기여할 것으로 기대하고 있습니다. 당사는 현재 진행 중인 리포락셀액 미국/체코 유방암 임상 2상시험, 대한민국/중국/세르비아/헝가리/불가리아 유방암 3상 임상 시험에 총력을 기울여 진행해 나갈 것이며. 선택과집중을 통해 경쟁력 있는 신규 제품을 발매하여 실적 개선에 이바지할 수 있도록 만전을 기하겠습니다.   </SPAN>
<SPAN USERMARK="F-GL16 0XFF1200 B">3. 재무상태 및 영업성과</SPAN>
<SPAN USERMARK="F-GL11">단계적 경제 회복이 시작된 2022년에 연결회사는 의약품판매 제조부문의 11.8% 증가와 의약품도매업 부문매출 외 종속기업의 매출액이 약 17% 정도가 크게 증가하였습니다. 모기업의 매출액 증가 주요 원인으로는 내수경기 회복으로 인한 의약품 매출이 증가되었기 때문입니다. 전반적으로 국내외 위드코로나 대응전략이 매출 증대에 상당한 영향을 미쳤을 것이라 판단하고 있습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">당사는 과열된 국내 시장에 대응하기 위하여 동남아시아 등 신흥국가와 유럽으로 글로벌제약시장 진입을 위해 제품 등록 및 기술이전 등 매출 증진에 매진하고 있습니다. 또한 시장 다변화에 맞혀 특화된 제품개발에 역량을 쏟고 있으며 미용성형 분야 라인업을 강화하는 등 매출 부문의 다각화를 위하여 각고의 노력을 기울이고 있습니다. 연결회사는 국내 점진적 일상 회복과 해외 위드코로나 양상으로 인한 단계적 경제 회복으로 지배회사 및 종속회사의 판매 실적이 개선되고 있습니다. 코로나 이후 다변화된 시장을 심도 있게 분석하여 다각회된 판매루트를 통하여  기업으로서 브랜드 가치를 높이고자 노력하고 있습니다. 종속회사 S&V Technologies GmbH사는 유럽시장 판로 확장과 실적 증대에 적지않은 영향을 미칠 것으로 예상하고 있습니다.                                                                                              (단위 : 천원, %)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="583">

<COLGROUP>
<COL WIDTH="90"></COL>
<COL WIDTH="213"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">

<TH WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>구  분</P>
</TH>
<TH WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">산식</TH>

<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>2022년</P>
</TH>

<TH WIDTH="84" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" USERMARK=" 0X0000FF">
<P>2021년</P>
</TH>

<TH WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">
<P>증  감</P>
</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">영업이익</TD>
<TD WIDTH="222" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
<TD WIDTH="89" ALIGN="RIGHT" HEIGHT="30">5,848,094 </TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">3,283,984</TD>
<TD WIDTH="89" ALIGN="RIGHT" HEIGHT="30">2,564,110 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" USERMARK=" 0X1814FF">
<P>ROE(%) </P>
</TD>
<TD WIDTH="222" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">(당기순이익÷자기 자본) x 100</TD>

<TD WIDTH="89" ALIGN="RIGHT" HEIGHT="30">
<SPAN USERMARK=" BC0X31FFFF">1.49</SPAN>
</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">2.35</TD>
<TD WIDTH="89" ALIGN="RIGHT" HEIGHT="30">(0.86)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">BIS(%)</TD>
<TD WIDTH="222" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">(자본 총계 ÷자산 총계) x 100</TD>
<TD WIDTH="89" ALIGN="RIGHT" HEIGHT="30">41.04</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">47.03</TD>
<TD WIDTH="89" ALIGN="RIGHT" HEIGHT="30">(5.99)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">부채비율(%)</TD>
<TD WIDTH="222" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE">(부채 총계 ÷자기 자본) x 100</TD>
<TD WIDTH="89" ALIGN="RIGHT" HEIGHT="30">143.67</TD>
<TD WIDTH="84" ALIGN="RIGHT" HEIGHT="30">112.64</TD>
<TD WIDTH="89" ALIGN="RIGHT" HEIGHT="30">31.03</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11 B">가. 요약 재무상태표(연결)      </SPAN>
<SPAN USERMARK="F-GL11">                                                                                                                                                                               (단위 : 원,%)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="723">

<COLGROUP>
<COL WIDTH="264"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="58"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="273" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH WIDTH="129" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2022년</TH>
<TH WIDTH="129" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2021년</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감액</TH>
<TH WIDTH="67" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">유동자산</TD>

<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">
<SPAN USERMARK=" BC0X57CF8A">51,212,556,542</SPAN>
</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">56,138,734,803</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(4,926,178,261)</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(8.78)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 현금및현금성자산</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">3,125,134,744</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">4,001,730,165</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(876,595,421)</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(21.91)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 매출채권 및 기타유동채권</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">19,837,052,893</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">19,034,846,720</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">802,206,173</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4.21</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 기타유동금융자산</TD>

<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">
<SPAN USERMARK=" BC0X57CF8A">4,837,474,083</SPAN>
</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">14,420,377,494</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(9,582,903,411)</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(66.45)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 재고자산</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">23,412,894,822</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">18,681,780,424</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">4,731,114,398</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25.32</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">비유동자산</TD>

<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">
<SPAN USERMARK=" BC0X57CF8A">147,843,916,477</SPAN>
</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">121,237,104,168</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">26,606,812,309</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21.95</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 유형자산</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">89,378,438,529</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">67,747,778,804</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">21,630,659,725</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">31.93</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 사용권자산</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">478,613,030</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">497,643,477</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(19,030,447)</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(3.82)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 투자부동산</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">15,469,465,059</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">15,626,301,777</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(156,836,718)</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1.00)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 영업권</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">693,156,142</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">693,156,142</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.00</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 영업권이외의무형자산</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">26,972,290,886</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">23,774,769,629</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">3,197,521,257</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13.45</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 이연법인세자산</TD>

<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">
<SPAN USERMARK=" BC0X57CF8A">3,642,476,797</SPAN>
</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">4,171,613,660</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(529,136,863)</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(12.68)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 기타비유동금융자산</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">11,209,476,034</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">8,725,840,679</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">2,483,635,355</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">28.46</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">자   산   총   계</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">199,056,473,019</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">177,375,838,971</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">21,680,634,048</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12.22</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">유동부채</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">83,259,700,454</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">75,335,033,973</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">7,924,666,481</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10.52</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">비유동부채</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">34,105,487,959</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">18,625,090,230</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">15,480,397,729</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">83.12</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">부   채   총   계</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">117,365,188,413</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">93,960,124,203</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">23,405,064,210</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">24.91</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">납입자본</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">39,603,185,903</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">39,603,185,903</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">0.00</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">이익잉여금</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">45,862,209,424</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">46,528,838,384</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(666,628,960)</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1.43)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">기타자본구성요소</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(7,472,826,736)</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">(6,457,822,935)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(1,015,003,801)</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15.72</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">지배기업의 소유주에게 귀속되는 자본</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">77,992,568,591</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">79,674,201,352</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(1,681,632,761)</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2.11)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">비지배지분</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">3,698,716,015</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">3,741,513,416</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(42,797,401)</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1.14)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">자   본   총   계</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">81,691,284,606</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">83,415,714,768</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">(1,724,430,162)</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2.07)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30">자본과부채총계</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">199,056,473,019</TD>
<TD WIDTH="129" HEIGHT="30" ALIGN="RIGHT">177,375,838,971</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT">21,680,634,048</TD>
<TD WIDTH="67" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12.22</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11">
<SPAN USERMARK="F-10">※ 상기 2022년(당기) 재무제표는 주주총회 승인 전 연결재무제표입니다. 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생하는 경우 정정보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다. </SPAN>(1)자산2022년말 총자산은 1,991억원으로서 전기말 1,774억원 보다 217억원이 증가하였습니다. 그 중 유동자산은 49억원 감소, 비유동자산은 266억원 증가하였습니다. 유동자산의 감소는 단기금융상품(기타유동금융자산) 감소 때문이며 비유동자산의 증가는 생산량 증대를 목적으로 한 공장증축 및 신약에 대한 개발활동이 주된 요인입니다.(2)부채2022년말 총부채는 1,174억원으로서 전기말 940억원 보다 약 234억원이 증가하였습니다. 그 중 유동부채는 79억원, 비유동부채는 155억원이 증가하였습니다. 유동부채 증가는 재고자산 매입에 따른 매입채무 증가에, 비유동부채의 증가는 증축공장에 대한 특정차입금의 증가가 주된 요인입니다..
</P>

<P USERMARK="F-GL11">(3)자본2022년말 총자본은 817억원으로서 전기말 834억원 보다 17억원이 감소하였습니다. 이는 미처분이익잉여금 감소 10억, 기타포괄손익 및 종속기업 소유지분율 변동인 기타자본구성요서의 감소에 따른 것입니다.
<SPAN USERMARK=" B">나. 요약 손익계산서(연결)</SPAN>                                                                                                     (단위 : 원,%)
</P>

<TABLE BORDER="1" WIDTH="653" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="179"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="73"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="188" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">구   분</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">2022년(제39기)</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">2021년(제38기)</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">증감액</TH>
<TH WIDTH="82" VALIGN="MIDDLE" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30">증감율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">매출액</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">131,911,692,836</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">117,158,831,459</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">14,752,861,377</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">12.59</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">매출원가</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">85,812,582,040</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">73,486,227,423</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">12,326,354,617</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">16.77</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">매출총이익</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">46,099,110,796</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">43,672,604,036</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">2,426,506,760</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">5.56</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">판매비와 관리비</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">40,251,017,256</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">40,388,620,371</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">(137,603,115)</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(0.34)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">영업이익</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">5,848,093,540</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">3,283,983,665</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">2,564,109,875</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">78.08</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">기타수익</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">2,764,055,458</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">2,151,445,268</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">612,610,190</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">28.47</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">기타비용</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">3,402,397,730</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">2,953,983,020</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">448,414,710</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">15.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">금융수익</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">532,888,309</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">4,466,092,838</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">(3,933,204,529)</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(88.07)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">금융원가</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">3,316,549,198</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">2,210,192,601</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">1,106,356,597</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">50.06</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">지분법이익</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">(212,811,267)</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">212,811,267</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">법인세비용차감전 순이익</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">2,426,090,379</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">4,524,534,883</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">(2,098,444,504)</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(46.38)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">법인세비용</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">1,204,932,348</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">2,562,095,616</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">(1,249,163,268)</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(48.76)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">당기순이익</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">1,221,158,031</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">1,962,439,267</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">(741,281,236)</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(37.8%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">기타포괄손익</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">418,987,512</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">(2,296,677,545)</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">2,715,665,057</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">흑자전환</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="188" HEIGHT="30">총포괄손익</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">1,640,145,543</TD>
<TD WIDTH="129" ALIGN="RIGHT" HEIGHT="30">(334,238,278)</TD>
<TD WIDTH="125" ALIGN="RIGHT" HEIGHT="30">1,974,383,821</TD>
<TD WIDTH="82" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">흑자전환</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11 0X1814FF">
<SPAN USERMARK="F-10 0X000000">※ 상기 2022년(당기) 재무제표는 주주총회 승인 전 연결재무제표입니다. 향후 정기주주총회에서 재무제표 승인 관련 안건이 부결되거나 수정이 발생하는 경우 정정보고서를 통해 그 내용 및 사유 등을 반영할 예정입니다. </SPAN>
<SPAN USERMARK=" 0X000000">매출의 증가는 2022년부터 시작된 세계적인 경기회복으로 국내매출 및 자회사의 매출이 점진적으로 증가 되었기 때문입니다.영업이익의 증가는 경기회복에 수반되는 인플레이션 효과 즉, 주요 공급처의 매입가격 상승 등으로 매출원가는 상승하였으나 판매관리비 절감노력에 따른 것입니다.당기순이익 감소는 전년대비 비경상적인 파생상품에 대한 평가이익인 금융수익의 감소 및이자율 상승에 따른 금융원가의 상승에 따른 것으로 당기에 파생상품과 관련된 전환사채는 전액 조기상환 완료 하였습니다</SPAN>
</P>
<P USERMARK="F-GL11 0X1814FF"></P>

<P>
<SPAN USERMARK="F-GL B">다. 사업부문별 영업실적</SPAN>
<SPAN USERMARK="F-GL11">연결회사의 보고부문은 다음과 같이 구분됩니다.</SPAN>
<SPAN USERMARK="F-GL">(1) 연결회사의 구분</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="666" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="264"></COL>
<COL WIDTH="384"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="273" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="393" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요 영업 내역</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 의약품 제조업 </TD>
<TD WIDTH="393" HEIGHT="30">의약품 제조, 국내 및 해외 판매</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 의약품 도매업 </TD>
<TD WIDTH="393" HEIGHT="30">의약품 국내 유통판매</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 의료정보시스템 </TD>
<TD WIDTH="393" HEIGHT="30">컨텐츠 및 광고용역</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 의약품 원료 제조업 </TD>
<TD WIDTH="393" HEIGHT="30">합성원료 제조, 국매 및 해외판매, 의료기기 판매</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="273" HEIGHT="30"> 화장품 및 의료기기제조 및 판매부문 </TD>
<TD WIDTH="393" HEIGHT="30">코스메틱, 수술보조제 치료제, 성형재료 제조, 해외판매 </TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11 0X1814FF">
<SPAN USERMARK=" 0X000000">(2) 부문별 영업실적                                                                                                                                                                    (단위 : 원,%)</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="772" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="216"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="73"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="225" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업부문</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2022년</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2021년</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="125" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="82" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감율</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" HEIGHT="180" ROWSPAN="6">매출</TD>
<TD WIDTH="225" HEIGHT="30" USERMARK="F-10">의약품 제조업</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">99,192,379,166</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">88,704,838,883</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">10,487,540,283</TD>
<TD WIDTH="82" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">11.82</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" USERMARK="F-10">의약품 도매업</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">23,626,128,223</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">20,918,619,914</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,707,508,309</TD>
<TD WIDTH="82" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">12.94</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" USERMARK="F-10">의료정보시스템</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">352,034,431</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">386,756,736</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(34,722,305)</TD>
<TD WIDTH="82" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(8.98)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" USERMARK="F-10">의약품 원료 제조업</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">13,804,954,425</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">10,073,190,777</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,731,763,648</TD>
<TD WIDTH="82" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">37.05</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" USERMARK="F-10">화장품 및 의료기기제조 및 판매부문</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">8,991,709,428</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">7,048,870,169</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,942,839,259</TD>
<TD WIDTH="82" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">27.56</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">내부거래</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(14,055,512,837)</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(9,973,445,020)</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(4,082,067,817)</TD>
<TD WIDTH="82" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">40.93</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="303" HEIGHT="30" COLSPAN="2">연결 매출 계</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">131,911,692,836</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">117,158,831,459</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">14,752,861,377</TD>
<TD WIDTH="82" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">12.59</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="78" HEIGHT="180" ROWSPAN="6">영업이익</TD>
<TD WIDTH="225" HEIGHT="30" USERMARK="F-10">의약품 제조업</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,897,189,288</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,491,089,437</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,406,099,851</TD>
<TD WIDTH="82" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">56.45</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" USERMARK="F-10">의약품 도매업</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">222,053,775</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">74,216,235</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">147,837,540</TD>
<TD WIDTH="82" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">199.20</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" USERMARK="F-10">의료정보시스템</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(89,535,460)</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">24,444,994</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(113,980,454)</TD>
<TD WIDTH="82" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(466.27)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" USERMARK="F-10">의약품 원료 제조업</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">305,671,035</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(209,106,488)</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">514,777,523</TD>
<TD WIDTH="82" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(246.18)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30" USERMARK="F-10">화장품 및 의료기기제조 및 판매부문</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,327,518,985</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">591,594,292</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">735,924,693</TD>
<TD WIDTH="82" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">124.40</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="225" HEIGHT="30">내부거래</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">185,195,917</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">311,745,195</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(126,549,278)</TD>
<TD WIDTH="82" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(40.59)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="303" HEIGHT="30" COLSPAN="2">연결 영업이익 계</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">5,848,093,540</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,283,983,665</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">2,564,109,875</TD>
<TD WIDTH="82" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">78.08</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11">연결 영업실적 주요 내용은 다음과 같습니다.2022년도 매출은 전기 대비 12.6% 증가한 1,319억원이며 이중 지배회사인 대화제약(의약품제조업)의 매출은 전기대비 11.8%  증가한 약 992억원 입니다. 지배회사의 매출액의 주된 증가요인은 단계적 경기회복으로 인한 국내 매출 증가가 주요 원인이며, 특히 지배회사의 DDS사업부의 꾸준한 성장이 뒷받침 되었기 때문입니다. 그 밖에 종속회사인 디에이치호림(의약품도매업), 리독스바이오(의약품 원료 제조업) , S&V Technologies GmbH사와 BSC Medical Devices GmbH사(화장품 및 의료기기제조 및 판매부문) 또한 경기회복 등의 이유로 매출이 증가되었기 때문입니다.점진적인 경기회복으로 매출액이 상승하는 반면  주요 공급업체의 매입 가격 상승(인플레이션효과), 인건비 상승에도 불구 하고 판매관리비 절감 노력등으로 전년대비 영업이익은증가 하였습니다
<SPAN USERMARK=" U">사업부문별 영업실적 주요 내용은 다음과 같습니다. </SPAN>
<SPAN USERMARK=" B">[의약품제조부문]</SPAN>2022년 코로나19 위협으로 벗어난 단계적 경기회복으로 인하여 의약품제조부문 매출액은전기대비 11.8% 증가한 약 992억원 입니다.  매출액의 주된 증가요인은 위드코로나로 기인한 국내의 단계적 경기회복이 주된 요인입니다. 매출은 제품매출(91%), 상품매출(6%), 기타매출(3%)로 구성되어 있으며 주요 제품인 세파메칠정(4.5% 증가), 후로스판정(9.3% 증가), 마그네스정(8% 증가) 등의  제품 매출은 전년 대비 8.6%증가 하였으며 당기 매출의 24%를 구성하는 주문자 생산방식의 패치류(파스 등) 매출이 236억원을 기록하였으며 최근 3개년 동안 연평균 5.5%의 견조한 매출 증가를 나타내고 있으며 2공장 B동 증축으로 매출 증가가 지속될 것으로 기대하고 있습니다.  상품 매출은 상품 전체 매출의 78%를 구성하는 주력 상품인 아말리안 필러가 전기대비 23% 증가한 49억원의 매출을 기록하였습니다. 아말리안 최근 3개년 동안 연평균 25%의 폭발적인 성장세를 기록하고 있습니다.  매출원가는 전년 대비 상당폭 증가되었는데 이는 인플레이션 효과로 인한  주요 공급업체원재료 가격상승, 생산 도급인건비 상승 등이 증가요인으로 작용하였습니다. 영업이익의 증가는 앞서 설명한 판매관리비 절감 노력에 의해 전년대비 상승하였으나 이런 영업이익 상승에도 불구하고 전년대비 당기순이익감소는 비경상적인 파생상품에 대한 평가이익인 금융수익의 감소 및 이자율 상승에 따른 금융원가의 상승에 따른 것으로 당기에 파생상품과 관련된 전환사채는 전액 조기 상환 완료하였습니다.
<SPAN USERMARK=" B">[의약품원료제조업]</SPAN>2022년 매출액은 전년대비 37% 증가하여 전년 보다 37억원이 증가한 138억원 입니다. 증가 원인은 단계적 경기회복으로 인한 제약사의 원료공급 요구가 증가되었기 때문입니다.제품매출은 99억원으로 전기대비 28% 상승하였으며 상세 제품 내역은  의약품원료인 Methylol Cephalexin Lysinate가 전기 대비 39% 증가한 43억원을, 록스프로펜나트륨은 전기대비 13% 증가한 13억원을, 플로로글루시놀은 전기대비 40% 증가한 5억원입니다. 제품매출은 3사업연도 연평균 28.5%의 상승을 보여주고 있어 지속적인 성장을 기대하고 있습니다. 상품매출은 36억원을 기록한 아말리안 필러의 매출로 전기대비 70% 상승하였습니다. 아말리안 필러는 지배회사와의 판매량에 따라 증가 또는 감소하는 부문간 거래에 밀접한 영향을 받는 상품으로 대화제약의 매출 상승에 기인합니다. 지배회사의 아말리안 판매 호조로 지속적인 매출 상승을 기대하고 있습니다.  매출원가의 감소, 판매비와일반관리비 절감의 노력으로 전년대비 영업이익 및 당기순이익흑자 전환 하였습니다.
<SPAN USERMARK=" B">[의약품도매부문]</SPAN>2022년 매출액은 전년대비 12.9% 증가한 236억원으로 전년 보다 약 27억원이 증가하였습니다. 영업이익은 전년대비 1.5억원 증가 하였습니다.  매출액의 증가는 비대면 판매유통구조 변경효과와 단계적 경기회복이 주된 원인입니다. 도매업은 2021년말 기준 상위 5개사가 매출의 26%를 차지할만큼 쏠림 현상이 두드러지며영세업체의 난립으로 중소도매업체의 경영환경이 악화되는 실정황입니다. 이에 당사 의약품 도매부분 또한 매출이 하락하는 등 경영상황에 부침을 겪었으나 비대면 판매유통구조 변경하는 등 구조적 개선을 통해 3사업연도 연 평균 5.3% 증가를 나타내고 있습니다.도매업의 특성상 매출액의 98%가 상품매출로 구성되어 있으며 전기 대비 13% 증가하였습니다. 다품목을 다루는 업종 특성상 대표 매출 품목을 구분하는것은 의미가 없어 기재를 생략합니다. .
<SPAN USERMARK=" B">[화장품 및 의료기기제조 및 판매부문]</SPAN>2022년 매출액은 전년대비 28% 증가하여 전년 보다 19억원이 증가한  90억원입니다.  영업이익은 전년대비 7억원 증가하였습니다. 매출액, 영업이익의 주된 증가원인은 유럽전역의 위드코로나 여파로 인하여  경기가 회복되었기 때문입니다.
<SPAN USERMARK=" B">[의약품정보시스템, 콘텐츠서비스부문]</SPAN>2022년 매출액은 전년대비 9% 감소한 3.5억원으로 전년대비 0.3억이 감소 되었으며 이는 신속하게 변화하는 콘텐츠 시장에 대응하지 못한 원인입니다. 
<SPAN USERMARK=" U">다음은 각 사업부문별 거시환경, 경쟁 및 규제환경에 대해 설명드리겠습니다. </SPAN>
<SPAN USERMARK=" B">[의약품제조부문]</SPAN>① 산업의 특성 제약산업은 인간의 생명과 보건에 관련된 제품을 생산하는 국민의 건강과 직결된 산업으로서 제품의 개발에서 임상시험, 인허가 및 제조, 유통, 판매 등 전과정을 매우 엄격히 국가에서 규제하고 있습니다. 또한 정밀화학공의 일종인 제약산업은 신약개발을 위한 연구에서부터 원료 및 완제의약품의 생산과 판매 등 모든 과정을 포괄하는 첨단 부가가치 산업으로 기술 집약도가 높고 신제품 개발 여부에 따라 엄청난 부가가치를 창출할 수 있는 미래 신성장 동력산업입니다.
</P>
<P USERMARK="F-GL11">② 산업의 성장성제약산업은 첨단 기술이 집약된 정밀화학산업으로 특허기술 보호 장벽이 높고 신약 의약품 개발이 어려워 기술 우위에 따른 독점력이 강한 부가가치가 매우 높은 기술 집약형 산업입니다. 국민건강 증진 및 국민생명과 직결된 산업으로 안전성 및 유효성 확보, 약가규제 등 다양한 정부 규제 및 정책이강한 선진국형 산업입니다. 국내 제약시장은 인구 노령화, 만성질환 환자 증가, 삶의 질 향상과 건강에 대한 관심 증가로 향후 계속적으로 성장할 것으로 기대하고 있습니다. ③ 경기변동의 특성제약산업은 내수 처방의약품 시장 위주으로 여타 다른 업종에 비해 경기변동에 영향을 받지 않는 안정적인 모습을 보여주고 있는 한편 상대적으로 계절적 요인 및 경기 변동요인에 영향을 크게 받을 수 있는 일반의약품에 비해, 전문의약품은 계절적,  경기변동 등의 요인보다는 정책적 요인 등에 더 큰 영향을 받을 수 있습니다.④ 경쟁요소신약개발 보다는 원료합성을 통한 완제의약품 생산이 대부분으로 내수 중심의 제네릭 생산에 치중하고 있는 시장의 여건과 리베이트 규제 강화 등에 따른 영업력 위축으로 제약사간 과당경쟁이 예고됩니다. 국내외 제약산업의 환경변화에 따른 국내업체들의 성장 전략 변화 또한 경쟁요소로 작용하고 있습니다. </P>

<P>
<SPAN USERMARK="F-GL11 B">[의약품원료제조업]</SPAN>
<SPAN USERMARK="F-GL11">① 산업의 특성최근 원료의약품 공급망이 마비되면서 원료의약품 제조업체들의 가격협상력이 높아졌습니다. 중국과 인도는 가격경쟁력이 중요한 제네릭 원료의약품 부문에 과ㆍ독점적 지위를 유지하고 있으며 최근 공급망 이슈가 터짐에 따라 몇몇 품목의 가격을 대폭 인상하고 있습니다. 또한 품질 문제로 회수되고 환경문제로 공장을 닫게 되는 경우에도 공급망이 마비되어 주요국들은 원료의약품 공급망 강화 전략을 적극 추진 중입니다. 미국은 단기적으로 동맹국 위주의 수입선을 다변화하고, 필수의약품의 원료의약품 위주로 자국 생산을 유도하기 위한 경제적 인센티브 정책을 확대할 것으로 예상되고 중국은 기존 특화된 제네릭 원료의약품 부문을 넘어서 고부가가치 원료의약품 부문을 육성하고 원료의약품산업 및 연관 산업 육성을 통해 제약산업 경쟁력을 강화할 계획할 것으로 보입니다.</SPAN>
</P>
<P USERMARK="F-GL11 0X1814FF"> </P>
<P USERMARK="F-GL11">② 산업의 성장성미용/성형 시술 시장은 과거 절대적으로 여성 중심의 시장에서, 남성까지 시술 수요층이 확대 중에 있습니다. 영화배우, 가수 등 연예인을 중심으로 최근에는 변호사, 사업가 중 외모 경쟁력을 갖추고자 하는 계층까지 확대되어 시술건수가 가파른 속도로 증가가 지속될 것으로 전망됩니다.</P>
<P USERMARK="F-GL11"></P>

<P USERMARK="F-GL11 0X0000FF">
<SPAN USERMARK=" 0X000000">③ 경기변동의 특성주요 원자재 가격이 작년 5월 이후 지속적으로 상승하고 있습니다. 상승 초기에는 코로나19에 의한 가격 하락이 기저효과로 작용하였으나, 상승세가 이어지면서 최근에는 코로나19 이전보다 높은 수준을 기록하고 있습니다. 원자재 가격 상승은 수요가 공급보다 빠르게 증가하거나 공급에 중요한 장애 요인이 발생하였을 때 일어나며  최근의 원자재 가격 상승의 배경에는 코로나19라는 외생 충격에 대한 경제권별 비대칭적 반응에서 기인한 수급 불균형이 있습니다. 코로나19 발발 초기에는 수요와 공급이 모두 감소하였으나, 백신 보급 이후 선진권은 비교적 빠르게 경기 회복세로 돌아선 반면, 원자재 주요 공급 국가들은 여전히 공급을 늘리기 어려운 상황이기 때문입니다. 원자재 가격은 과거 수요 측 요인이 전체 가격 변동의 상당 부분을 설명한 것과 달리, 최근의 원자재 가격 상승은 감산 결정과 같은 공급측 요인이 더욱 크게 작용한 것으로 나타습니다. 또한 수급에 영향을 미친 일련의 사건들이 코로나19라고 하는 외부 충격에 대한 경제권의 비대칭적 반응에 기인하고 있습니다. 원자재 가격이 상승하는 경우 통상 기업들은 이를 제품 가격에 반영할 것으로 보이며 경쟁력이 낮은 기업들은 생산비용 증가를 제품 가격에 전가하지 못해 채산성이 악화되거나, 가격경쟁력을 상실하여 구조조정을 겪을 수 있습니다. 또한 원자재 가격 상승은 장기적으로 전반적인 물가상승을 통해 모든 경제 주체에게 영향을 미칠 수 있을 것으로 보여집니다.</SPAN>
</P>
<P USERMARK="F-GL11 0X1814FF"></P>

<P USERMARK="F-GL11 0X0000FF">
<SPAN USERMARK=" 0X000000">④ 경쟁요소제약원료산업은 과당경쟁과 초기 제조설비투자 과다로 다소 사업초기에는 원가경쟁력의 저하로 시장진입의 어려움이 있으며 진입후 원료시장 가격경쟁의 심화로 자금력이 뒷바침되어야 하는 특성이 수반됩니다. 또한 새로운 합성원료 및 천연물 성분을 개발 발굴하여 꾸준한 연구활동이 요구시 됩니다.  주원료의 수급이 해외의존도가 높은편으로 70년대 이후 국내 제약업체들의 연구 및 기술개발로 합성원료 및 국산화가 상당부분 진전되어 원료수급의 균형을 이뤘습니다. 국내 제약 및 바이오 산업의 꾸준한 성장으로 제약원료 생산은레드오션 시장경쟁이 예상됩니다.주요 경쟁요소는 다음과 같습니다. 다국적 기업의 국내진출 증가, 수입자유화, 물질특허제 확대, 시설투자비의 과다투입, 한미 FTA규제 등입니다.</SPAN>
</P>

<P USERMARK="F-GL11 0X1814FF">
<SPAN USERMARK=" 0X000000 B">[의약품도매부문]</SPAN>
<SPAN USERMARK=" 0X000000">① 산업의 특성도매업은 의약품을 병의원, 요양기관, 약국 등에 유통 판매하는 산업을 말합니다. 의약품 유통업은 약국 판매 도매업체와 병의원 납품 및 일부 약국 판매를 겸하는 도매업체로 대별되고 있으며 동일시장내에서 경쟁이 치열한 산업입니다. 동일 상품으로 시장에서 경쟁하므로 배송 관리와 거래처에 대한 서비스 강화 및 적정 수준의 재고 확보를 통한 적기 공급체계가 필요하며 많은 수의 품목을 취급하고 현대적 물류체계를 필요로 하는 산업입니다. 도매거래는 물류비용이 추가된다는 단점이 있지만, 직거래와 비교할 때 통합 및 전문화된 물류를 제공하여 거래효율성을 증가시킬 수 있는 장점이 있습니다. 병의원, 요양기관은 도매거래를 통해 다양한 의약품을 안정적으로 공급받을 수 있으며 제약사는 도매거래를 통해 재고부담, 물류비용, 판매촉진비, 인건비 등의 부담을 줄일 수  있기 때문에 도매영업을선호하기도 합니다.② 산업의 성장성의약품 유통금액은 매년 급증하는 추세로 지난해에는 약 71조 규모로 조사되었습니다. 이중 상위 5% 업체가 49조원을 차지하는 등 업체별 편차가 컸으며 최근 건강보험심사평가원은 이 같은 내용이 담긴 ‘2019년 완제의약품 유통정보 통계집’을 아래와 같이 공개했습니다. </SPAN>
</P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="194" ALIGN="LEFT" HSPACE="0">화면 캡처 2022-03-12 120035.jpg</IMG>
<IMG-CAPTION ATOC="N">.</IMG-CAPTION>
</IMAGE>

<P USERMARK="F-GL11 0X0000FF">
<SPAN USERMARK=" 0X000000">③ 경기변동의 특성우리나라에서 의약품이 유통되는 경로는 크게 제약회사와 요양기관 간 직거래와 도매 를 통한 거래로 나뉩니다. 의약품 유통일원화 폐지로 제약회사와 요양기관 간의 직거래가 가 능해졌음에도 제약사와 요양기관 간 직거래는 계속 감소하고 있습니다. 그 원인으로는 리베이 트 쌍벌제 등을 통해 요양기관 대상으로 하는 제약사의 판촉활동이 제한됨에 따라 요양기 관과의 관계에서 발생할 수 있는 비용 및 업무 부담으로 제약회사가 도매 거래를 선호하는 경향이 있기 때문입니다. 도매업체는 주로 약국을 대상으로 거래하는 일반(혹은 종합) 도매업 체와 병원을 대상으로 하는 간납(間納) 도매업체로 나눌 수 있고 중 간납 도매업체는 전 납(全納) 도매, 총판, 품목 도매, 입찰 도매 및 CSO(Contract Sales Organization) 입니다. 최근  CSO(Contract Sales Organization)  유통구조가 활성화 되고 있습니다.</SPAN>
<SPAN USERMARK=" 0X000000">④ 경쟁요소</SPAN>
</P>
<P USERMARK="F-GL11">도매업계에 대한 실질적인 관리 및 개선이 어려운 상황이다 보니 재무건전성이 낮은 영세 도매업체가 증가하고, 이는 도매 단계 추가로 이어지며 유통 투명화를 저해하게 됩니다. 이러한 상황은 도매업체의 경쟁력 약 화와 구매력 저하로 이어져 의약품 유통거래 관계에서 불리한 입장에 처할 수밖에 없을 것으로 보입니다.</P>

<P>
<SPAN USERMARK="F-GL11 B">[화장품 및 의료기기제조 및 판매부문]</SPAN>
<SPAN USERMARK="F-GL11">① 산업의 특성</SPAN>
<SPAN USERMARK="F-GL">독일 성형외과학회(Deutsche Gesellschaft der Plastischen, Rekonstruktiven und Asthetischen Chirurgen, DGRPAC)의 추정에 따르면 독일 사업자의 연간 매출액은 약 50억 유로에 달하며, 이 중 8억 유로는 개인적인 관심과 희망에 의해 이루어진 시술 또는 수술입니다.  또한 독일 내 남녀노소불문 지방흡입과 주사요법을 찾는 수요가 과거에 비해 빠른 속도로 증가하고 있으며 다른 국가와 비교해 독일의 미용업계 특히 미용시술 및 성형 분야는 상대적으로 관심이 적었으나 점차 미용에 대한 관심이 증가하면서 기능성 화장품, 보톡스, 필러 등 미용성형의 수요가 지속적으로 증가 추세에 있습니다.</SPAN>
</P>
<P USERMARK=" 0X1814FF"></P>

<IMAGE>
<IMG WIDTH="600" HEIGHT="281" ALIGN="CENTER" HSPACE="0">123333.jpg</IMG>
<IMG-CAPTION ATOC="N">.</IMG-CAPTION>
</IMAGE>

<P>
<SPAN USERMARK="F-GL11">② 산업의 성장성</SPAN>
</P>
<P USERMARK="F-GL11">국제 성형외과의협회(Internationale Verband plastischer Chirurgen, Isaps)에서 세계각국의 성형회과 의사 1400명을 대상으로 설문해 데이터를 수집한 결과에 따르면 2015년 약 2170만 건의 뷰티 시술 및 수술이 이루어졌으며, 이는 전년대비 약 150만 건이며  가장 인기있는 수술은 보톡스 및 히알루산 주사요법인 비외과적 수술입니다.  성형수술이 가장 흥행하는 국가로는 미국과 브라질이며 독일은 약 62만 건으로 6위를 차지하고 2016년 Isaps 통계에 따르면 보톨리움 독소 시술 역시 미국이 118만4000건으로 독보적으로 1위를 차지했으며, 그 뒤를 이어 브라질이 47만2600건, 독일은 18만7000건이 시술되었습니다. </P>

<P>
<SPAN USERMARK="F-GL11">전 세계 더말 필러 시장은 2016년 27억 2,565만 달러에서 연평균 성장률 7.01% 로 증가하여, 2021년에는 38억 2,515만 달러에 이를 것으로 전망됩니다. 전 세계 더말 필러 시장은 최종 사용자에 따라 피부과 클리닉, 병원 및 휴양원으로 분류되며, 피부과 클리닉은 2016년을 기준으로 53.52%의 점유율을 차지하였으며, 그 뒤를 병원 및 휴양원이 46.48%로 뒤따르고 있습니다. 피부과 클리닉은 2016년 14억 5,877만 달러에서 연평균 성장률 7.64%로증가하여, 2021년에는 21억 804만 달러에 이르고 병원 및 휴양원은 2016년 12억 6,688만 달러에서 연평균 성장률 6.27%로 증가하여, 2021년에는 17억 1,711만 달러에 이를 것으로 전망됩니다. </SPAN>
</P>

<IMAGE>
<IMG WIDTH="389" HEIGHT="194" ALIGN="CENTER" HSPACE="0">3333333333333.jpg</IMG>
<IMG-CAPTION ATOC="N">글로벌 페이셜 더말 필러 시장 규모 및 전망</IMG-CAPTION>
</IMAGE>

<P USERMARK="F-GL11 0X0000FF">
<SPAN USERMARK=" 0X000000">③ 경기변동의 특성계절적 요인은 영향을 덜 받은 편이며 경비변동에 따라 매출의 증감의 영향은 다소 있습니다. 아름다움에대한 인간의 욕구 증대로 젊음과 미에 투자하는 비용이 증가하는 추세하는 추세입니다.</SPAN>
<SPAN USERMARK=" 0X000000">④ 경쟁요소독일에서 사용하는 주름개선 등 안티에이징을 위한 제품, 필러, 보톡스 관련해 주로 스위스, 프랑스, 이탈리아 등 주변 유럽국에서 생산된 제품을 사용합니다. 가장 많은 비중을 차지하는 것은 단연 스위스제품이며  한국 기업 NeoDr의 스크류모델 주사침도 사용되고 있습니다. 안티에이징 등 기능성 화장품, 천연화장품 역시 인기가 지속적으로 상승 중에 있으며 독일 바이어 및 소비자 30~50대의 설문 결과, 화이트닝 및 브라이트닝 성분이 들어있는 제품은 꺼리는 추세입니다. 주근깨, 구릿빛 피부는 건강하고 매력적인 것으로 생각하므로 화이트닝에 대해 부정적인 인식을 가지고 있으므로 해당 제품군이 실적이 감소되는 추세입니다.</SPAN>
<SPAN USERMARK=" 0X000000 B">[의약품정보시스템, 콘텐츠서비스부문]</SPAN>
<SPAN USERMARK=" 0X000000">① 산업의 특성의약품콘텐츠서비스(메디프레임)은 미처 환자가 파악하지 못한 치료프로그램이나 특수 클리닉등을 충분히 홍보할 수 있는 도구로 사용되고 있습니다.  대형PDP벽걸이 TV등의 매체로 질병에 관한 정보는 물론, 병원에서 제공하는 여러 가지 의료서비스를 자세히 알려주는 시스템입니다. 생생한 정보를 제공하는 대기실이 병원의 신뢰도를 높여주고, 차별화된 대기실은 병원의 경쟁력을 높여줍니다. 또한 사회의 이슈가 되는 질환 및 건강정보, 환자들에게 관심이 높은 의료정보 등을 제공하는 서비스 산업입니다.</SPAN>
</P>

<P USERMARK="F-GL11 0X1814FF">
<SPAN USERMARK=" 0X000000">② 산업의 성장성최근 삶의 질의 향상, 노령인구의 증가, 사람들의 질환 및 건강정보에 대한 관심이 높아짐에 따라 건강정보를 제공해주는 네트워크 디스플레이컨텐츠 사업이 각광을 받는 추세입니다. 첨단 디지털미디어와 융합되어 맞춤형 서비스가 제공되어 공급자인 병의원, 제약사, 의사집단,수요자인 환자층과 일반인에게 다양한 의료컨텐츠가 서로 교류되는 매개역활로 포지셔닝되고 있습니다. </SPAN>
</P>

<IMAGE>
<IMG WIDTH="475" HEIGHT="231" ALIGN="CENTER" HSPACE="0">그림1.jpg</IMG>
<IMG-CAPTION ATOC="N">메디프레임 인기컨텐츠</IMG-CAPTION>
</IMAGE>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK="F-GL11 0X000000">③ 경기변동의 특성첨단 디지털미디어 버젼 업그레이드에 민감하고, 수요자의 정보 니즈의 요구에 신속한 적응이 필요시 되는 산업입니다. 신뢰성 있는 의료컨텐트가  다양한 디스플레이 H/W 로 제공되어져야 합니다. 또한 사회적으로 변화하는 건강정보에 민감하게 정보를 수록해야 하는 특성의 산업입니다. </SPAN>
<SPAN USERMARK="F-GL11 0X000000">④ 경쟁요소신속하게 업그레이드 되는 미디어와의 융합기술 적응도,  병의원 감소, 스마트폰 에서 제공되는 건강정보의 난립으로 의약품콘텐츠서비스(메디프레임)산업은 점차 하향세를 보이고 있습니다.</SPAN>
</P>
<P></P>

<P USERMARK="F-GL11">
<SPAN USERMARK="F-16 0XFF1200 B">4. 유동성 </SPAN>
<SPAN USERMARK="F-12 B">가. 유동성 현황</SPAN>
<SPAN USERMARK="F-16 B">                                                              </SPAN>    (단위 : 원,)
</P>

<TABLE ACLASS="NORMAL" WIDTH="679" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="271"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="280" HEIGHT="60" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="399" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">요약현금흐름표</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2022년</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2021년</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감액</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="280" HEIGHT="30">Ⅰ. 영업활동현금흐름</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">8,192,963,094</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">10,385,544,854</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(2,192,581,760)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="280" HEIGHT="30">Ⅱ. 투자활동현금흐름</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(25,246,768,256)</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(13,502,549,797)</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(11,744,218,459)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="280" HEIGHT="30">Ⅲ. 재무활동현금흐름</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">16,324,254,606</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,647,034,340</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">12,677,220,266</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="280" HEIGHT="30">Ⅳ. 해외사업환산차이</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(147,044,865)</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">61,213,510</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(208,258,375)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="280" HEIGHT="30">Ⅴ. 현금 및 현금성자산의 순증가(감소)</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(876,595,421)</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">591,242,907</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(1,467,838,328)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="280" HEIGHT="30">Ⅵ. 기초현금및현금성자산</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,001,730,165</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,410,487,258</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">591,242,907</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="280" HEIGHT="30">Ⅶ. 기말현금및현금성자산</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,125,134,744</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,001,730,165</TD>
<TD WIDTH="133" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">(876,595,421)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">나. 회사의 유동성 지표</SPAN>
<SPAN USERMARK="F-GL">                                                                                 </SPAN>
<SPAN USERMARK="F-GL11">           (단위 : %)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="680" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="130"></COL>
<COL WIDTH="214"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구 분</TH>
<TH WIDTH="223" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">산 식</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2022냔년</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2021년</TH>
<TH WIDTH="106" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">유 동 비 율</TD>
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">(유동 자산 ÷유동 부채) x 100</TD>

<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">
<SPAN USERMARK=" BC0X57CF8A">61.5</SPAN>
</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">74.5</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">(13.0)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">부 채 비 율</TD>
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">(부채 총계 ÷자기 자본) x 100</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">143.7</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">112.6</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">31.1</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="139" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">차입금 의존도</TD>
<TD WIDTH="223" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">(차입금 ÷총 자산) x 100</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">45.0</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">35.4</TD>
<TD WIDTH="106" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30">9.6</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11"></P>

<P>
<SPAN USERMARK="F-GL11">유동 비율은 유동자산 49억원 감소와 유동부채 79억원 증가에 의하여 전기 대비 13%p 감소한 61.5%입니다. 이는 현금및현금성자산, 단기금융상품의 감소와 매입채무 및 단기차입금의 증가에 기인합니다. 부채 비율은 부채총액 234억원 증가와 자기자본 17억원 감소에 의하여 전기 대비 31%p 증가한 143.7%입니다. 이는 차입금의 증가에 기인하였습니다. 차입금의 주요한 증가요인은 2공장 b동 신설 공사입니다. 차입금 의존도는 차입금 268억원 증가와 총자산 217억원 증가에 의하여 전기 대비 9.6%p 증가한 45%로 연결실체의 재무 안전성이 비교적 양호하다고 판단됩니다. </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">당사는 2022년 현재 약 31억원의 기말 현금및현금성자산을 유동자금으로 보유하고 있으며 전기대비 약 9억원이 감소하였습니다. 당사는 자금 수지 예측, 필요 현금 수준 산정, 수입, 지출 관리 등을 통하여 주기적으로 미래 현금 흐름을 예측하여 유동성을 관리하고 있습니다.  </SPAN>
<SPAN USERMARK="F-GL11">Ⅰ. 영업활동현금흐름                                                                                                         (단위 : 원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="659">

<COLGROUP>
<COL WIDTH="259"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="124"></COL>
<COL WIDTH="124"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="268" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="391" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">영업활동현금흐름</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2022년</TH>
<TH WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2021년</TH>
<TH WIDTH="133" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="268" HEIGHT="30">(1) 당기순이익</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,221,158,031</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,962,439,267</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(849,281,236)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="268" HEIGHT="30">(2) 당기순이익조정을 위한 가감</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,076,117,379</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,652,830,700</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,531,286,679</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="268" HEIGHT="30">(3) 영업자산ㆍ부채의 증감</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,664,237,939)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">239,926,063</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,904,164,002)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="268" HEIGHT="30">(4) 당기순이익조정을 위한 기타 가감</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(4,440,074,377)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,469,651,176)</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(1,970,423,201)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="268" HEIGHT="30">계</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,192,963,094</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,385,544,854</TD>
<TD WIDTH="133" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(2,192,581,760)</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">Ⅱ. 투자활동현금흐름2022년 연결회사의 현금흐름표상 투자활동의 현금유출은 전년대비 117억원이 증가하였습니다. 대표적인 투자활동으로는 2공장 B동 증축관련 건설중인자산외 취득으로 전년대비 약 184억원 현금유출이 증가되었으며, 단기금융상품처분외 등으로 약 61억원 정도 현금유입이 증가 되었습니다, Ⅲ. 재무활동현금흐름.2022년 연결회사의 현금흐름표상 재무활동의 현금유입은 전년대비 127억원이 증가하였습니다. 대표적인 재무활동으로는 증축관련 장기차입금의 차입으로 135억 정도의 현금유입이 발생 하였습니다.</SPAN>
<SPAN USERMARK="F-GL16 0XFF1200 B">5. 자금조달과 지출</SPAN>
<SPAN USERMARK="F-GL11 B">가. 최근 3개년도 차입금 잔액</SPAN>
<SPAN USERMARK="F-GL11">                                                                                                    (단위 : 원,%)</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="598" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="166"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="132"></COL>
<COL WIDTH="132"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="175" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2022년</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2021년</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2020년</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">금융기관 차입금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">83,147,003,100</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">62,788,895,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">34,400,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">  - 은행시설자금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">30,757,003,100</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">60,506,310,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">17,500,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">  - 은행운전자금</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">52,390,000,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">2,282,585,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">16,900,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">전환사채</TD>
<TD ALIGN="RIGHT" WIDTH="141" HEIGHT="30">-</TD>
<TD ALIGN="RIGHT" WIDTH="141" HEIGHT="30">844,000,000</TD>
<TD ALIGN="RIGHT" WIDTH="141" HEIGHT="30">14,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30"> 기타(구매자금)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">6,465,000,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">6,010,000,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">5,810,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="53">총계(전기대비 차입금 증감)</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="53">89,612,003,10026,823,108,100</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="53">62,788,895,00028,388,895,000</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="141" HEIGHT="53">34,400,000,0006,061,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">차입금 평균 금리(%)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">5.26/년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">2.89/년</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="141" HEIGHT="30">1.88/년</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK=" 0X1814FF">
<SPAN USERMARK="F-GL11 0X000000">당기말 현재 차입금은 896억원으로 전기말 628억원 대비 268억원 증가하였습니다. </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">①지배회사의 차입금 증감현황                                                                                                              (단위 : 원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="795">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="115"></COL>
<COL WIDTH="138"></COL>
<COL WIDTH="138"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="121" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH WIDTH="131" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기차입</TH>
<TH WIDTH="124" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기상환</TH>
<TH WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대체</TH>
<TH WIDTH="147" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말잔액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">단기차입금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">46,500,000,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="131" HEIGHT="30">24,150,000,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">20,450,000,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="147" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="147" HEIGHT="30">50,200,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">유동성장차입금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">1,000,000,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="131" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">1,000,000,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="147" HEIGHT="30">1,000,000,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="147" HEIGHT="30">1,000,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">장기차입금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">6,547,000,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="131" HEIGHT="30">18,510,863,100</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="147" HEIGHT="30">(1,000,000,000)</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="147" HEIGHT="30">24,057,863,100</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="121" HEIGHT="30">계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="125" HEIGHT="30">54,047,000,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="131" HEIGHT="30">42,660,863,100</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="124" HEIGHT="30">21,450,000,000</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="147" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="147" HEIGHT="30">75,257,863,100</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">당기말 현재 지배회사의 차입금은 약 753억원으로 전기말 540억원 대비 212억원 증가 하였습니다. </SPAN>
<SPAN USERMARK="F-GL11">② 지배회사의 차입금 세부현황                                                                                                  (단위 : 원, %)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="587">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="94"></COL>
<COL WIDTH="140"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정명</TH>
<TH WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입처</TH>
<TH WIDTH="103" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">용도</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입금액</TH>
<TH WIDTH="149" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" WIDTH="93" HEIGHT="180">   차입금</TD>
<TD ROWSPAN="3" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="93" HEIGHT="90">기업은행</TD>
<TD VALIGN="MIDDLE" WIDTH="103" HEIGHT="30" ALIGN="CENTER">회전자금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="149" HEIGHT="30">21,500,000,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">2.58 ~ 4.66</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="103" HEIGHT="30" ALIGN="CENTER">일반자금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="149" HEIGHT="30">13,700,000,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">2.58 ~ 5.38</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" WIDTH="103" HEIGHT="30" ALIGN="CENTER">시설자금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="149" HEIGHT="30">23,557,863,100 </TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">5.36 ~ 5.38</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="93" HEIGHT="30">하나은행</TD>
<TD VALIGN="MIDDLE" WIDTH="103" HEIGHT="30" ALIGN="CENTER">일반자금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="149" HEIGHT="30">4,000,000,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">5.95 ~ 6.12</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="93" HEIGHT="30">신한은행</TD>
<TD VALIGN="MIDDLE" WIDTH="103" HEIGHT="30" ALIGN="CENTER">일반자금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="149" HEIGHT="30">5,000,000,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">5.1~ 5.6</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="93" HEIGHT="30">우리은행</TD>
<TD VALIGN="MIDDLE" WIDTH="103" HEIGHT="30" ALIGN="CENTER">운전자금</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="149" HEIGHT="30">7,500,000,000 </TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">5.55 ~ 6.23</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" VALIGN="MIDDLE" WIDTH="289" HEIGHT="30">  계</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="149" HEIGHT="30">75,257,863,100 </TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">지배회사의 2022년 금융기관 차입금중 2공장 증축목적으로 기업은행으로 부터 약 236억원을 차입하였습니다. ③ 지배회사의 회사채 발행 현황(BW)</SPAN>
<SPAN USERMARK="F-GL11">당사는 공시대상기간 중 운영자금 및 시설자금의 용도로 무기명식 이권부 무보증 사모 전환사채 200억원을 발행하였으며 발행 상세 내역은 다음과 같습니다. 보고서 제출일 현재 전환사채의 가액은 없습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="627">

<COLGROUP>
<COL WIDTH="168"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="369"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">사채 종류</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">무기명식 이권부 무보증 사모 전환사채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">발행금액</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30"> 20,000,000,000원 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">용도</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">운영자금, 시설자금</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">표면이자율</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">만기이자율</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2%</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="122">원금상환 방법</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="122">만기까지 보유하고 있는 본 사채의 원금에 대하여는 2024년 03월 29일에 권면금액의 110.0000%에 해당하는 금액을 일시 상환한다. 단, 상환기일이 은행영업일이 아닌 경우에는 그 다음 영업일에 상환하고 원금 상환기일 이후의 이자는 계산하지 아니한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">발행시점 주식전환 행사가액</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">21,154원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">전환가액 (원/주)</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">14,808원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">당기말 현재 전환에  따라 발행할 주식</TD>
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">종류</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">기명식 보통주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">주식수</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">0주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="177" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">전환청구기간</TD>
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">시작일</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2020년 03월 29일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="72" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">종료일</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">2024년 02월 29일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">전환가액 조정에 관한 사항</TD>
<TD WIDTH="378" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">최초 전환가격의 70%까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="214">조기상환청구권(Put Option)</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="214"> 본 사채의 사채권자는 본 사채의 발행일로부터 21개월이 되는 2020년 12월 29일 및 이후 매 3개월에 해당되는 날(이하 “조기상환일”이라 한다)에 사채증서를 발행회사에게 반환하면서  본 사채의 전부 또는 일부에 대하여 그 권면금액 및 이에 대하여 조기상환수익률(연 단리 2.0%)이 적용된 조기상환 청구 금액을 만기 전 조기상환 할 것을 청구할 수 있다. 단, 조기상환지급일이 은행 영업일이 아닌 경우에는 그 다음 영업일에 상환하고 조기상환지급일 이후의 이자는 계산하지 아니한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="249" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="191">매도청구권(Call Option)</TD>
<TD WIDTH="378" VALIGN="MIDDLE" HEIGHT="191"> 발행회사 또는 발행회사가 지정하는 자(이하 “매도청구권자”라 한다)는 발행일로부터 1년이 되는 날인 2020년 03월 29일부터 2021년 03월 29일까지 사채권자가 보유하고 있는 본 사채를 매수할 수 있는 권리(이하 “매도청구권”이라 한다)를 가진다. 단, 매도청구권자는 각 사채권자에 대하여 각 사채권자가 보유하고 있는 본 사채 발행가액의 30%를 초과하여 매도청구권을 행사할 수 없다. </TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">전환사채의 전환 가액 조정 내역은 다음과 같습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="600" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구  분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">일  자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환가능주식수</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="30">발 행</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">2019.03.29</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">21,154</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">945,447</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="30">1차 전환가액 조정</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">2019.06.29</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">16,398</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">1,219,660</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="150" HEIGHT="30">2차 전환가액 조정</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">2019.09.29</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">14,808</TD>
<TD ALIGN="RIGHT" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30">1,350,621</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">전환사채의 전환가액 조정은 발행일로부터 만기일 전월까지 매 3개월이 경과한 날을 전환가격 조정일로 하고 최저 조정한도 전환가액은 14,808원(발행 당시 전환가액의 70%) 입니다. </SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">전환사채 자금 사용 내역은 다음과 같습니다. </SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="619">

<COLGROUP>
<COL WIDTH="133"></COL>
<COL WIDTH="347"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사용 목적</TH>
<TH WIDTH="356" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상세 자금 사용 목적</TH>
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">채무상환자금</TD>
<TD WIDTH="356" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대출금 상환</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">115억원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="142" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">운영자금</TD>
<TD WIDTH="356" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기타 운영자금(원재료 매입 등)</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">85억원</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD USERMARK=" B" WIDTH="498" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">
<SPAN USERMARK=" !BU">자금 사용 합 계</SPAN>
</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">200억원</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">전환사채의 전환청구 내역은 다음과 같습니다.                                                                                                     (단위 : 원, 주)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="802">

<COLGROUP>
<COL WIDTH="128"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="136"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="137" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식발행(감소)일자</TH>
<TH WIDTH="93" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">발행(감소)형태</TH>
<TH WIDTH="572" HEIGHT="30" COLSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">발행(감소)한 주식의 내용</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="63" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">종류</TH>
<TH WIDTH="71" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">수량</TH>
<TH WIDTH="78" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주당액면가액</TH>
<TH WIDTH="90" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주당발행(감소)가액</TH>
<TH WIDTH="125" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전환청구 금액</TH>
<TH WIDTH="145" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020년 09월 02일</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전환권행사</TD>
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">보통주</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">297,134</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">500</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,808</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">4,400,000,000</TD>
<TD WIDTH="145" HEIGHT="30" VALIGN="MIDDLE">제1회차 전환사채 </TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020년 09월 23일</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전환권행사</TD>
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">보통주</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">47,271</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">500</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,808</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">700,000,000</TD>
<TD WIDTH="145" HEIGHT="30" VALIGN="MIDDLE">제1회차 전환사채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="137" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021년 01월 12일</TD>
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">전환권행사</TD>
<TD WIDTH="63" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">보통주</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">47,271</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">500</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,808</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">700,000,000</TD>
<TD WIDTH="145" HEIGHT="30" VALIGN="MIDDLE">제1회차 전환사채</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="293" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="3">합계</TD>
<TD WIDTH="71" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">391,676</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">500</TD>
<TD WIDTH="90" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">14,808</TD>
<TD WIDTH="125" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">5,800,000,000</TD>
<TD WIDTH="145" HEIGHT="30" VALIGN="MIDDLE"></TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">전환사채의 조기상환 내역은 다음과 같습니다.                                                                                                   (단위 :원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="689">

<COLGROUP>
<COL WIDTH="135"></COL>
<COL WIDTH="179"></COL>
<COL WIDTH="159"></COL>
<COL WIDTH="180"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="144" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">일자</TH>
<TH WIDTH="188" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">조기상환 청구금액</TH>
<TH WIDTH="168" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">상환금액</TH>
<TH WIDTH="189" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" VALIGN="MIDDLE" ALIGN="CENTER">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2020년 12월 29일</TD>
<TD WIDTH="188" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">900,000,000</TD>
<TD WIDTH="168" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">931,500,000</TD>
<TD WIDTH="189" HEIGHT="180" ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER">만기이자율 2% 적용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2021년 06월 29일</TD>
<TD WIDTH="188" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">9,000,000,000</TD>
<TD WIDTH="168" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">9,405,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2021년 12월 29일</TD>
<TD WIDTH="188" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,500,000,000</TD>
<TD WIDTH="168" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">3,692,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022년 06월 29일</TD>
<TD WIDTH="188" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">500,000,000</TD>
<TD WIDTH="168" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">532,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022년 09월 29일</TD>
<TD WIDTH="188" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">300,000,000</TD>
<TD WIDTH="168" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">321,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="144" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합계</TD>
<TD WIDTH="188" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">14,200,000,000</TD>
<TD WIDTH="168" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">14,882,500,000</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11">④  종속기업의 차입금 - 디에이치호림(주)  차입금 증감현황                                                                                             (단위 : 원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="569">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">구분</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">기초잔액</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">당기차입</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">당기상환</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" BC0XD7D7D7">기말잔액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="30" VALIGN="MIDDLE">단기차입금</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,010,000,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">23,342,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,887,000,000</TD>
<TD WIDTH="121" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,465,000,000</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">- 디에이치호림(주)의 차입금 세부현황                                                                                    (단위 : 원, %)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="522">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="139"></COL>
<COL WIDTH="116"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정명</TH>
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입처</TH>
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">용도</TH>
<TH WIDTH="148" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입금액</TH>
<TH WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">단기차입금</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구매자금</TD>
<TD WIDTH="148" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,465,000,000</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4.216~6.339</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11 0X0000FF">
<SPAN USERMARK=" 0X000000">종속기업 디에이치호림(주)의 2022년 금융기관 차입금은 6개월 만기상환으로 운영되는 구매자금 대출실행 금액입니다.</SPAN>
<SPAN USERMARK=" 0X000000">- 종속기업 (주)리독스바이오의 차입금 증감현황                                                                                                         (단위 : 원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="795">

<COLGROUP>
<COL WIDTH="112"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="125"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="121" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">구분</TH>
<TH WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초잔액</TH>
<TH WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기차입</TH>
<TH WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기상환</TH>
<TH WIDTH="135" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">대체</TH>
<TH WIDTH="134" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기말잔액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE">단기차입금</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,810,000,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,570,000,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,190,000,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,190,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE">유동성장차입금</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,499,820,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">749,910,000</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,249,730,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE">장기차입금</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,249,490,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">249,970,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">(749,910,000)</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,249,610,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="121" HEIGHT="30" VALIGN="MIDDLE">          계</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,559,310,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,570,000,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,439,970,000</TD>
<TD WIDTH="135" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="134" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,689,340,000</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X1814FF"></P>
<P USERMARK="F-GL11">- 종속기업 (주)리독스바이오의 차입금 세부현황                                                                                            (단위 : 원, %)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="606">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="109"></COL>
<COL WIDTH="150"></COL>
<COL WIDTH="149"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정명</TH>
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입처</TH>
<TH WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">용도</TH>
<TH WIDTH="159" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입금액</TH>
<TH WIDTH="158" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="90" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="3">단기차입금</TD>
<TD WIDTH="78" HEIGHT="90" ALIGN="CENTER" VALIGN="MIDDLE" ROWSPAN="3">기업은행</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">회전자금</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">480,000,000</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4.396</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">시설자금</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">710,000,000</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4.139</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">일반자금</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,249,730,000</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2.83 ~ 5.96</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="93" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">장기차입금</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="118" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">시설자금</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,249,610,000</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2.83</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="289" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" COLSPAN="3">  계</TD>
<TD WIDTH="159" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,689,340,000</TD>
<TD WIDTH="158" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">　-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK=" 0X1814FF"></P>
<P USERMARK="F-GL11">- 그외 종속기업의 차입금 증감현황                                                                                                   (단위 :원)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="569">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD USERMARK=" BC0XD7D7D7" WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구분</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기초잔액</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당기차입</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당기상환</TD>
<TD USERMARK=" BC0XD7D7D7" WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기말잔액</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" HEIGHT="30" VALIGN="MIDDLE">단기차입금</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">182,585,000</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">199,800,000</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">182,585,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">199,800,000</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">- 그외 종속기업의 차입금 세부현황                                                                                           (단위 :원, %)</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="569">

<COLGROUP>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="105"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계정명</TH>
<TH WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입처</TH>
<TH WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">용도</TH>
<TH WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">차입금액</TH>
<TH WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">이자율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">단기차입금</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">당좌차월</TD>
<TD WIDTH="114" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">199,800,000</TD>
<TD WIDTH="113" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4.226</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL11">그외 종속기업의 차입금은 단기 운영목적으로  차입된 1년만기 당좌차월이며, 1년간 회사운영자금으로 용도로 차입한 단기차입금입니다.
<SPAN USERMARK=" B">나. 만기별 상환금액 도래현황                                                                                 </SPAN>      (단위 :원)
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="900">

<COLGROUP>
<COL WIDTH="166"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="175" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">구분</TH>
<TH WIDTH="125" HEIGHT="60" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ROWSPAN="2">2022년말 잔액</TH>
<TH WIDTH="600" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" COLSPAN="4">연도별 상환 금액</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2023년</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2024년</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2025년</TH>
<TH WIDTH="150" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">2026년</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">금융기관 차입금</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">83,147,003,100</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000,000</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,948,870,000</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">39,336,404,650</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">33,861,728,450</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">  - 은행시설자금</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">30,757,003,100</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,699,140,000</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,028,931,550</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">12,028,931,550</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">  - 은행운전자금</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">52,390,000,000</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,000,000,000</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,249,730,000</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">27,307,473,100</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">21,832,796,900</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30"> 기타(구매자금)</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,465,000,000</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,465,000,000</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30">계</TD>
<TD WIDTH="125" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">89,612,003,100</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,465,000,000</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">8,948,870,000</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">39,336,404,650</TD>
<TD WIDTH="150" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">33,861,728,450</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">연결회사의 차입금은  주로 지배회사인 대화제약(주)과 종속회사인 디에이치호림(주)와 (주)리독스바이오에서 차입하고 있습니다. 지배회사의 차입금은 2공장 증축(이사회 결정일 공사 예상 지출액 420억원)과 관련한 시설과 운영자금 목적으로 사용되었으며, 유동적으로 상환, 대환, 신규차입을 통해 자금을 효율적으로 운영하고 있습니다. 또한 종속회사인 디에이치호림(주)는 거래처 결제목적으로 단기(6개월) 구매자금대출을 활용하고 있으며, (주)리독스바이오는  시설자금과 운영자금을 금융기관으로 부터 차입하였습니다.</SPAN>
<SPAN USERMARK="F-GL16 0XFF1200 B">6. 그 밖에 투자의사결정에 필요한 사항</SPAN> 
<SPAN USERMARK="F-GL11 B">가. 중요한 회계정책 및 추정에 관한 사항</SPAN>
<SPAN USERMARK="F-GL11">당사는 2022년 1월 1일로 개시하는 회계기간부터 다음의 주요 제ㆍ개정 기준서를 신규 적용하였으며 해당 기준서의 개정이 연결재무제표에 미치는 유의적인 영향은 없습니다.</SPAN>
</P>
<P USERMARK="F-GL11">(1) 기업회계기준서 제1103호 '사업결합' (개정) - '개념체계'에 대한 참조</P>
<P USERMARK="F-GL11">인식할 자산과 부채의 정의를 개정된 재무보고를 위한 개념체계를 참조하도록 개정되었으나, 기업회계기준서 제1037호 '충당부채, 우발부채 및 우발자산' 및 해석서 제2121호 '부담금'의 적용범위에 포함되는 부채 및 우발부채에 대해서는 해당 기준서를 적용하도록 예외를 추가하고, 우발자산이 취득일에 인식되지 않는다는 점을 명확히 하였습니다. 동 개정사항이 재무제표에 미치는 유의적인 영향은 없습니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">(2) 기업회계기준서 제1016호 '유형자산'(개정) - 의도한 사용 전의 매각금액</P>
<P USERMARK="F-GL11">동 개정사항은 유형자산이 사용 가능하기 전에 생산된 재화의 매각금액, 즉 경영진이 의도하는 방식으로 가동하는 데 필요한 장소와 상태에 이르게 하기 전에 생산된 재화의 매각금액)을 유형자산의 원가에서 차감하는 것을 금지합니다. 따라서 그러한 매각금액과 관련 원가를 당기손익으로 인식하며, 해당 원가는 기업회계기준서 제1002호에 따라 측정합니다.</P>
<P USERMARK="F-GL11">또한 동 개정사항은 '유형자산이 정상적으로 작동되는지 여부를 시험하는 것'의 의미를 명확히 하여 자산의 기술적, 물리적 성능이 재화나 용역의 생산이나 제공, 타인에 대한 임대 또는 관리활동에 사용할 수 있는 정도인지를 평가하는 것으로 명시합니다. </P>
<P USERMARK="F-GL11">동 개정사항은 이 개정내용을 처음 적용하는 재무제표에 표시된 가장 이른 기간의 개시일 이후에 경영진이 의도한 방식으로 가동할 수 있는 장소와 상태에 이른 유형자산에 대해서만 소급 적용합니다. 동 개정사항의 최초 적용 누적효과는 표시되는 가장 이른 기간의 시작일에 이익잉여금(또는 적절하다면 자본의 다른 구성요소)의 기초 잔액을 조정하여 인식합니다. 동 개정사항이 재무제표에 미치는 유의적인 영향은 없습니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">(3) 기업회계기준서 제1037호 '충당부채, 우발부채 및 우발자산' (개정) - 손실부담계약의 계약이행원가</P>
<P USERMARK="F-GL11">동 개정사항은 계약이 손실부담계약인지 또는 손실을 발생시키는 계약인지 평가할 때 기업이 포함해야할 원가를 명확하게 하였습니다.</P>
<P USERMARK="F-GL11">개정 기준서는 "직접 관련된 원가 접근법"을 적용합니다. 재화나 용역을 제공하는 계약에 직접적으로 관련되는 원가는 증분원가와 계약 활동에 직접적으로 관련되는 원가 배분액을 모두 포함합니다. 일반 관리 원가는 계약에 직접적으로 관련되지 않으며 계약에 따라 거래상대방에게 명시적으로 부과될 수 없다면 제외됩니다.</P>
<P USERMARK="F-GL11">동 개정사항은 이 개정사항을 최초로 적용하는 회계연도의 개시일에 모든 의무의 이행이 완료되지는 않은 계약에 적용합니다. 비교재무제표는 재작성 하지 않고, 그 대신 개정 내용을 최초로 적용함에 따른 누적효과를 최초적용일의 기초이익잉여금 또는 적절한 경우 다른 자본요소로 인식합니다. 동 개정사항이 재무제표에 미치는 유의적인 영향은 없습니다. </P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">(4) 한국채택국제회계기준 2018-2020 연차개선</P>
<P USERMARK="F-GL11">1) 기업회계기준서 제 1101호 '한국채택국제회계기준의 최초채택' - 최초채택기업인 종속기업</P>
<P USERMARK="F-GL11">동 개정사항은 지배기업보다 늦게 최초채택기업이 되는 종속기업의 누적환산차이의 회계처리와 관련하여 추가적인 면제를 제공합니다. 기업회계기준서 제 1101호 문단 D16(1)의 면제규정을 적용하는 종속기업은 지배기업의 한국채택국제회계기준 전환일에 기초하여 지배기업의 연결재무제표에 포함될 장부금액으로 모든 해외사업장의 누적환산차이를 측정하는 것을 선택할 수 있습니다. 다만 지배기업이 종속기업을 취득하는 사업결합의 효과와 연결절차에 따른 조정사항은 제외합니다. 관계기업이나 공동기업이 기업회계기준 제 1101호 문단 D16(1)의 면제규정을 적용하는 경우에도 비슷한 선택을 할 수 있습니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">2) 기업회계기준서 제1109호 '금융상품' - 금융부채 제거 목적의 10% 테스트 관련 수수료</P>
<P USERMARK="F-GL11">동 개정사항은 금융부채의 제거 여부를 평가하기 위해 '10%' 테스트를 적용할 때, 기업(차입자)과 대여자 간에 수취하거나 지급하는 수수료만을 포함하며, 여기에는 기업이나 대여자가 다른 당사자를 대신하여 지급하거나 수취하는 수수료를 포함한다는 점을 명확히 하고 있습니다. 동 개정사항은 최초 적용일 이후 발생한 변경 및 교환에 대하여 전진적으로 적용됩니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">3) 기업회계기준서 제1116호 '리스' - 리스 인센티브</P>
<P USERMARK="F-GL11">동 개정사항은 기업회계기준서 제1116호 사례13에서 리스개량 변제액에 대한 내용을 삭제하였습니다. </P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">4) 기업회계기준서 제1041호 '농림어업' - 공정가치 측정</P>
<P USERMARK="F-GL11">동 개정사항은 생물자산의 공정가치를 측정할 때 세금 관련 현금흐름을 제외하는 요구사항을 삭제하였습니다. 이는 기업회계기준서 제1041호의 공정가치 측정과 내부적으로 일관된 현금흐름과 할인율을 사용하도록 하는 기업회계기준서 제1113호의 요구사항을 일치시키며, 기업은 가장 적절한 공정가치 측정을 위해 세전 또는 세후 현금흐름 및 할인율을 사용할지 선택할 수 있습니다. 동 개정사항이 재무제표에 미치는 유의적인 영향은 없습니다. </P>
<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-0-0">V. 회계감사인의 감사의견 등</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-1-0">1. 외부감사에 관한 사항</TITLE>
<P></P>
<LIBRARY>
<P>
<SPAN USERMARK="F-GL B">가. 회계감사인의 명칭 및 감사의견</SPAN>
</P>

<TABLE-GROUP ACLASS="AUD_OPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="641" BORDER="1">

<COLGROUP>
<COL WIDTH="117"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="207"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="126" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">감사의견</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">강조사항 등</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="216" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">핵심감사사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="126" HEIGHT="30" ACODE="OPN_YEAR1" VALIGN="MIDDLE">제 39기(당   기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_AUR1" VALIGN="MIDDLE">대주회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="OPN_CMT1" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_EMP1" VALIGN="MIDDLE">해당사항 없음</TE>

<TE ALIGN="CENTER" WIDTH="216" HEIGHT="30" ACODE="OPN_POT1" VALIGN="MIDDLE">연구개발비 손상평가 
<SPAN USERMARK=" BU">주1)</SPAN>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="126" HEIGHT="30" ACODE="OPN_YEAR2" VALIGN="MIDDLE">제 38기(전  기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_AUR2" VALIGN="MIDDLE">광교회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="OPN_CMT2" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_EMP2" VALIGN="MIDDLE">해당사항 없음</TE>

<TE ALIGN="CENTER" WIDTH="216" HEIGHT="30" ACODE="OPN_POT2" VALIGN="MIDDLE">내부창출 개발비 자산화 
<SPAN USERMARK=" BC0XDAEAFF BU">주2)</SPAN>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="126" HEIGHT="30" ACODE="OPN_YEAR3" VALIGN="MIDDLE">제 37기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="OPN_AUR3" VALIGN="MIDDLE">광교회계법인</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="OPN_CMT3" VALIGN="MIDDLE">적정</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACODE="OPN_EMP3" VALIGN="MIDDLE">해당사항 없음</TE>

<TE ALIGN="CENTER" WIDTH="216" HEIGHT="30" ACODE="OPN_POT3" VALIGN="MIDDLE">내부창출 개발비 자산화
<SPAN USERMARK=" BC0XDAEAFF BU"> 주3)</SPAN>
</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11">※ 제39기 핵심감사사항은 연구개발비 손상평가(1건)으로 회계감사인은 대주회계법인입니다.※ 제38기 핵심감사사항은 내부창출 개발비 자산화(1건), 제37기 핵심감사사항은 내부창출 개발비 자산화 1건이며 회계감사인은 광교회계법인입니다. ※ 종속회사인 (주)리독스바이오, 디에이치호림(주) 공시대상기간 중 모두 적정의견을 받았으며, 회계감사인은 광교회계법인입니다. </SPAN>
<SPAN USERMARK="F-GL11 BU">주1) 핵심감사사항</SPAN>
</P>
<P USERMARK=" U"><연결감사보고서></P>

<P>
<SPAN USERMARK="F-GL11 B">핵심감사사항</SPAN>
<SPAN USERMARK="F-GL11">핵심감사사항은 우리의 전문가적 판단에 따라 당기 재무제표감사에서 가장 유의적인감사사항들 입니다. 해당 사항들은 전체재무제표감사의 관점에서 우리의 의견형성시다루어졌으며, 우리는 이런 사항에 대하여 별도의 의견을 제공하지는 않습니다.</SPAN>
</P>
<P USERMARK="F-GL11"></P>
<P USERMARK="F-GL11">- 연구개발비 손상평가</P>
<P USERMARK="F-GL11">회사는 신약(위암 등 치료제)과 관련된 개발단계에서의 지출을 주석 8에서 설명하고 있는 바와 같이 개발비로 인식하고 있습니다. 해당 개발비는 매 회계기간 손상평가가 필요한 아직 사용할 수 없는 무형자산으로서, 무형자산의 회수가능액 추정 시 사용되는 주요한 가정과 투입변수에는 경영진의 추정이 개입되며, 투입변수의 변동으로 인한 손익의 민감도가 유의적이기에 이를 핵심감사사항으로 선정하였습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">당기 감사를 위해 해당 핵심감사사항과 관련하여 우리가 수행한 절차는 아래와 같습니다.</P>
<P USERMARK="F-GL11">- 회수가능액 추정 시 사용된 가정과 투입변수의 합리성 검토</P>
<P USERMARK="F-GL11">- 비교대상 장부금액 산정방식의 합리성 검토</P>
<P USERMARK="F-GL11">- 손상검사를 위해 경영진이 고용한 전문가의 적격성과 객관성 검토</P>
<P USERMARK="F-GL11">- 손상평가 관련 통제를 식별하고 통제의 유효성 검토</P>

<P>
<SPAN USERMARK="F-GL11 U"><별도감사보고서></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 B">핵심감사사항</SPAN>
<SPAN USERMARK="F-GL11">핵심감사사항은 우리의 전문가적 판단에 따라 당기 재무제표감사에서 가장 유의적인감사사항들 입니다. 해당 사항들은 전체재무제표감사의 관점에서 우리의 의견형성시다루어졌으며, 우리는 이런 사항에 대하여 별도의 의견을 제공하지는 않습니다.</SPAN>
</P>
<P USERMARK="F-GL11">  </P>
<P USERMARK="F-GL11">- 연구개발비 손상평가</P>
<P USERMARK="F-GL11">회사는 신약(위암 등 치료제)과 관련된 개발단계에서의 지출을 주석 8에서 설명하고 있는 바와 같이 개발비로 인식하고 있습니다. 해당 개발비는 매 회계기간 손상평가가 필요한 아직 사용할 수 없는 무형자산으로서, 무형자산의 회수가능액 추정 시 사용되는 주요한 가정과 투입변수에는 경영진의 추정이 개입되며, 투입변수의 변동으로 인한 손익의 민감도가 유의적이기에 이를 핵심감사사항으로 선정하였습니다.</P>
<P USERMARK="F-GL11"> </P>
<P USERMARK="F-GL11">당기 감사를 위해 해당 핵심감사사항과 관련하여 우리가 수행한 절차는 아래와 같습니다.</P>
<P USERMARK="F-GL11">- 회수가능액 추정 시 사용된 가정과 투입변수의 합리성 검토</P>
<P USERMARK="F-GL11">- 비교대상 장부금액 산정방식의 합리성 검토</P>
<P USERMARK="F-GL11">- 손상검사를 위해 경영진이 고용한 전문가의 적격성과 객관성 검토</P>
<P USERMARK="F-GL11">- 손상평가 관련 통제를 식별하고 통제의 유효성 검토</P>
<P></P>

<P>
<SPAN USERMARK="F-GL11 BU">주2) 핵심감사사항</SPAN>
<SPAN USERMARK="F-GL11 U"><연결감사보고서></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 B">핵심감사사항</SPAN>
</P>
<P USERMARK="F-GL11">핵심감사사항은 우리의 전문가적 판단에 따라 당기 연결재무제표감사에서 가장 유의적인사항들입니다. 해당 사항들은 연결재무제표 전체에 대한 감사의 관점에서 우리의 의견형성시 다루어졌으며, 우리는 이런 사항에 대하여 별도의 의견을 제공하지는 않습니다.</P>

<P>
<SPAN USERMARK="F-GL11">(1) 내부창출 개발비 자산화</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">1) 핵심감사사항으로 결정한 이유 주석8에서 공시한 바와 같이, 2021년 12월 31일 현재 회사의 내부창출 개발비는 215억원으로 재무제표에 중요한 금액입니다. 회사는 기업회계기준서 제1038호 '무형자산'에 따라 특정 조건을 충족하는 경우 관련 내부창출 개발비를 자산으로 인식하며, 손상 여부를 결정하기 위하여 기업회계기준서 제1036호 '자산손상'을 적용하고 있습니다. 내부창출 개발비는 회사 경영진의 가정에 기반하는 유의적인 판단과 추정이 연관되어 있으므로, 우리는 내부창출 개발비의 자산화 및 손상평가를 핵심감사사항에 포함하였습니다.2) 감사에서 다루어진 방법우리는 자산화된 개발 프로젝트 금액이 표시된 세부 명세를 수령하고 이를 총계정원장에 기록된 금액과 대사하였으며, 회사의 회계정책 및 내부통제가 기업회계기준서 제1038호 '무형자산'의 인식요건과 일관성이 있는지 여부에 대하여 평가하였습니다.우리는 표본 추출된 특정 프로젝트에 대하여, 다음과 같은 감사절차를 수행하였습니다.·경영진의 문서화된 판단 결과를 확인하고 프로젝트 담당자와 인터뷰를 수행하여 해당 프로젝트가 자산화 기준을 충족하였는지 이해하고 평가하였으며, 프로젝트 담당자의 설명이 문서화된 판단 결과와 일관되는지 확인·미래 경제적 효익의 창출의 근거가 되는 고객과의 계약, 주문서 또는 견적 내역 등을 확인·회사의 사업계획, 과거 실적, 경영진의 전략, 할인율 등에 대한 가정과 비교하여 손상평가에 적용된 주요 가정 및 기초 데이터들에 대한 평가 및 테스트 수행·자본화된 지출 중 일부 항목을 추출하고 적절한 증빙을 확인하여 그 발생사실과 집계 및배분의 정확성에 대한 테스트 수행</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 U"><별도감사보고서></SPAN>
</P>
<P USERMARK="F-GL11 B">핵심감사사항</P>
<P USERMARK="F-GL11">핵심감사사항은 우리의 전문가적 판단에 따라 당기 재무제표감사에서 가장 유의적인사항들입니다. 해당 사항들은 재무제표 전체에 대한 감사의 관점에서 우리의 의견형성시 다루어졌으며, 우리는 이런 사항에 대하여 별도의 의견을 제공하지는 않습니다.</P>
<P USERMARK="F-GL11">(1) 내부창출 개발비 자산화</P>

<P>
<SPAN USERMARK="F-GL11">1) 핵심감사사항으로 결정한 이유 주석8에서 공시한 바와 같이, 2021년 12월 31일 현재 회사의 내부창출 개발비는 204억원으로 재무제표에 중요한 금액입니다. 회사는 기업회계기준서 제1038호 '무형자산'에 따라특정 조건을 충족하는 경우 관련 내부창출 개발비를 자산으로 인식하며, 손상 여부를 결정하기 위하여 기업회계기준서 제1036호 '자산손상'을 적용하고 있습니다. 내부창출 개발비는 회사 경영진의 가정에 기반하는 유의적인 판단과 추정이 연관되어 있으므로, 우리는 내부창출 개발비의 자산화 및 손상평가를 핵심감사사항에 포함하였습니다.2) 감사에서 다루어진 방법우리는 자산화된 개발 프로젝트 금액이 표시된 세부 명세를 수령하고 이를 총계정원장에 기록된 금액과 대사하였으며, 회사의 회계정책 및 내부통제가 기업회계기준서 제1038호 '무형자산'의 인식요건과 일관성이 있는지 여부에 대하여 평가하였습니다.우리는 표본 추출된 특정 프로젝트에 대하여, 다음과 같은 감사절차를 수행하였습니다.·경영진의 문서화된 판단 결과를 확인하고 프로젝트 담당자와 인터뷰를 수행하여 해당 프로젝트가 자산화 기준을 충족하였는지 이해하고 평가하였으며, 프로젝트 담당자의 설명이 문서화된 판단 결과와 일관되는지 확인·미래 경제적 효익의 창출의 근거가 되는 고객과의 계약, 주문서 또는 견적 내역 등을 확인·회사의 사업계획, 과거 실적, 경영진의 전략, 할인율 등에 대한 가정과 비교하여 손상평가에 적용된 주요 가정 및 기초 데이터들에 대한 평가 및 테스트 수행·자본화된 지출 중 일부 항목을 추출하고 적절한 증빙을 확인하여 그 발생사실과 집계 및배분의 정확성에 대한 테스트 수행</SPAN>
<SPAN USERMARK="F-GL11 BU">주3) 핵심감사사항</SPAN>
<SPAN USERMARK="F-GL11 U"><연결감사보고서></SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 B">핵심감사사항</SPAN>
</P>
<P USERMARK="F-GL11">핵심감사사항은 우리의 전문가적 판단에 따라 당기 재무제표감사에서 가장 유의적인사항들입니다. 해당 사항들은 재무제표 전체에 대한 감사의 관점에서 우리의 의견형성시 다루어졌으며, 우리는 이런 사항에 대하여 별도의 의견을 제공하지는 않습니다. </P>

<P>
<SPAN USERMARK="F-GL11">내부창출 개발비 자산화</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">핵심감사사항으로 결정한 이유 주석8에서 공시한 바와 같이, 2020년 12월 31일 현재 회사의 내부창출 개발비는 182억원으로 재무제표에 중요한 금액입니다. 회사는 기업회계기준서 제1038호 '무형자산'에 따라 특정 조건을 충족하는 경우 관련 내부창출 개발비를 자산으로 인식하며, 손상 여부를 결정하기 위하여 기업회계기준서 제1036호 '자산손상'을 적용하고 있습니다.내부창출 개발비는 회사 경영진의 가정에 기반하는 유의적인 판단과 추정이 연관되어 있으므로, 우리는 내부창출 개발비의 자산화 및 손상평가를 핵심감사사항에 포함하였습니다.감사에서 다루어진 방법우리는 자산화된 개발 프로젝트 금액이 표시된 세부 명세를 수령하고 이를 총계정원장에 기록된 금액과 대사하였으며, 회사의 회계정책 및 내부통제가 기업회계기준서 제1038호 '무형자산'의 인식요건과 일관성이 있는지 여부에 대하여 평가하였습니다.우리는 표본 추출된 특정 프로젝트에 대하여, 다음과 같은 감사절차를 수행하였습니다.- 경영진의 문서화된 판단 결과를 확인하고 프로젝트 담당자와 인터뷰를 수행하여 해당 프로젝트가 자산화 기준을 충족하였는지 이해하고 평가하였으며, 프로젝트 담당자의 설명이 문서화된 판단 결과와 일관되는지 확인- 미래 경제적 효익의 창출의 근거가 되는 고객과의 계약, 주문서 또는 견적 내역 등을 확인- 회사의 사업계획, 과거 실적, 경영진의 전략, 할인율 등에 대한 가정과 비교하여 손상평가에 적용된 주요 가정 및 기초 데이터들에 대한 평가 및 테스트 수행- 자본화된 지출 중 일부 항목을 추출하고 적절한 증빙을 확인하여 그 발생사실과 집계 및 배분의 정확성에 대한 테스트 수행</SPAN>
<SPAN USERMARK="F-GL11 U"><별도감사보고서></SPAN>
</P>
<P USERMARK="F-GL11 B">핵심감사사항</P>
<P USERMARK="F-GL11">핵심감사사항은 우리의 전문가적 판단에 따라 당기 재무제표감사에서 가장 유의적인사항들입니다. 해당 사항들은 재무제표 전체에 대한 감사의 관점에서 우리의 의견형성시 다루어졌으며, 우리는 이런 사항에 대하여 별도의 의견을 제공하지는 않습니다.</P>
<P USERMARK="F-GL11">내부창출 개발비 자산화</P>

<P>
<SPAN USERMARK="F-GL11">핵심감사사항으로 결정한 이유 주석8에서 공시한 바와 같이, 2020년 12월 31일 현재 회사의 내부창출 개발비는 165억원으로 재무제표에 중요한 금액입니다.회사는 기업회계기준서 제1038호 '무형자산'에 따라 특정 조건을 충족하는 경우 관련 내부창출 개발비를 자산으로 인식하며, 손상 여부를 결정하기 위하여 기업회계기준서 제1036호 '자산손상'을 적용하고 있습니다.내부창출 개발비는 회사 경영진의 가정에 기반하는 유의적인 판단과 추정이 연관되어 있으므로, 우리는 내부창출 개발비의 자산화 및 손상평가를 핵심감사사항에 포함하였습니다.감사에서 다루어진 방법우리는 자산화된 개발 프로젝트 금액이 표시된 세부 명세를 수령하고 이를 총계정원장에 기록된 금액과 대사하였으며, 회사의 회계정책 및 내부통제가 기업회계기준서 제1038호 '무형자산'의 인식요건과 일관성이 있는지 여부에 대하여 평가하였습니다.우리는 표본 추출된 특정 프로젝트에 대하여, 다음과 같은 감사절차를 수행하였습니다.- 경영진의 문서화된 판단 결과를 확인하고 프로젝트 담당자와 인터뷰를 수행하여 해당 프로젝트가 자산화 기준을 충족하였는지 이해하고 평가하였으며, 프로젝트 담당자의 설명이 문서화된 판단 결과와 일관되는지 확인- 미래 경제적 효익의 창출의 근거가 되는 고객과의 계약, 주문서 또는 견적 내역 등을 확인- 회사의 사업계획, 과거 실적, 경영진의 전략, 할인율 등에 대한 가정과 비교하여 손상평가에 적용된 주요 가정 및 기초 데이터들에 대한 평가 및 테스트 수행- 자본화된 지출 중 일부 항목을 추출하고 적절한 증빙을 확인하여 그 발생사실과 집계 및 배분의 정확성에 대한 테스트 수행</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">나. 감사용역 체결현황</SPAN>..
</P>

<TABLE-GROUP ACLASS="AUD_SIGK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="950" BORDER="1">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="279"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="76"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="131" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">감사인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="288" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">내 용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="223" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">감사계약내역</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="200" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">실제수행내역</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="85" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">시간</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="131" HEIGHT="30" ACODE="SIGK_YEAR1" VALIGN="MIDDLE">제 39 기(당   기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR1" VALIGN="MIDDLE">대주회계법인</TE>
<TE ALIGN="CENTER" WIDTH="288" HEIGHT="30" ACODE="SIGK_CNT1" VALIGN="MIDDLE">반기검토, 중간감사, 기말감사, 연결감사</TE>
<TE ALIGN="RIGHT" WIDTH="115" HEIGHT="30" ACODE="SIGK_CPAY1" VALIGN="MIDDLE">210,000,000원</TE>
<TE ALIGN="RIGHT" WIDTH="108" HEIGHT="30" ACODE="SIGK_CTIM1" VALIGN="MIDDLE">1,726시간</TE>
<TE ALIGN="RIGHT" WIDTH="115" HEIGHT="30" ACODE="SIGK_FPAY1" VALIGN="MIDDLE">210,000,000원</TE>
<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="30" ACODE="SIGK_FTIM1" VALIGN="MIDDLE">1,726시간</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="131" HEIGHT="34" ACODE="SIGK_YEAR2" VALIGN="MIDDLE">제 38 기(전   기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="34" ACODE="SIGK_AUR2" VALIGN="MIDDLE">광교회계법인</TE>
<TE ALIGN="CENTER" WIDTH="288" HEIGHT="34" ACODE="SIGK_CNT2" VALIGN="MIDDLE">반기검토, 중간감사, 기말감사, 연결감사</TE>
<TE ALIGN="RIGHT" WIDTH="115" HEIGHT="34" ACODE="SIGK_CPAY2" VALIGN="MIDDLE">115,000,000원</TE>
<TE ALIGN="RIGHT" WIDTH="108" HEIGHT="34" ACODE="SIGK_CTIM2" VALIGN="MIDDLE">1,206시간</TE>
<TE ALIGN="RIGHT" WIDTH="115" HEIGHT="34" ACODE="SIGK_FPAY2" VALIGN="MIDDLE">115,000,000원</TE>

<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="34" ACODE="SIGK_FTIM2" VALIGN="MIDDLE">
<P USERMARK="F-GL11">1,110시간</P>
</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="131" HEIGHT="30" ACODE="SIGK_YEAR3" VALIGN="MIDDLE">제 37 기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="108" HEIGHT="30" ACODE="SIGK_AUR3" VALIGN="MIDDLE">광교회계법인</TE>
<TE ALIGN="CENTER" WIDTH="288" HEIGHT="30" ACODE="SIGK_CNT3" VALIGN="MIDDLE">반기검토, 중간감사, 기말감사, 연결감사</TE>
<TE ALIGN="RIGHT" WIDTH="115" HEIGHT="30" ACODE="SIGK_CPAY3" VALIGN="MIDDLE">104,000,000원</TE>
<TE ALIGN="RIGHT" WIDTH="108" HEIGHT="30" ACODE="SIGK_CTIM3" VALIGN="MIDDLE">해당사항없음</TE>
<TE ALIGN="RIGHT" WIDTH="115" HEIGHT="30" ACODE="SIGK_FPAY3" VALIGN="MIDDLE">104,000,000원</TE>
<TE ALIGN="RIGHT" WIDTH="85" HEIGHT="30" ACODE="SIGK_FTIM3" VALIGN="MIDDLE">1,097시간</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK="F-GL B">다. 회계감사인과의 비감사용역 계약체결 현황</SPAN>
</P>

<TABLE-GROUP ACLASS="AUD_SIGL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="138"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="70"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사업연도</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계약체결일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역내용</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="115" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역수행기간</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="80" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">용역보수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="79" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR1" VALIGN="MIDDLE" ROWSPAN="2">제 39 기(당   기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY1" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE1" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR2" VALIGN="MIDDLE" ROWSPAN="2">제 38 기(전   기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY2" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE2" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="147" HEIGHT="60" ACODE="SIGL_YEAR3" VALIGN="MIDDLE" ROWSPAN="2">제 37 기(전전기)</TE>
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="101" HEIGHT="30" ACODE="SIGL_CRT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACODE="SIGL_CNT3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="115" HEIGHT="30" ACODE="SIGL_TIM3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="80" HEIGHT="30" ACODE="SIGL_PAY3" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACODE="SIGL_NOTE3" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>


<LIBRARY>
<P USERMARK="F-GL 0X1814FF B">
<SPAN USERMARK=" 0X000000">라. 내부감사기구가 회계감사인과 논의한 결과</SPAN>
</P>

<TABLE-GROUP ACLASS="DIS_CUS" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="742" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="197"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">일자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="206" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">참석자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">방식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="303" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요 논의 내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">1</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20220620" VALIGN="MIDDLE">2022년 06월 20일</TU>
<TE ALIGN="CENTER" WIDTH="206" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">회사: 경영본부장, 재경이사감사인: 업무수행이사외 1인</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">대면</TE>
<TE ALIGN="CENTER" WIDTH="303" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">내부회계관리제도 운영 계획 등</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">2</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20220803" VALIGN="MIDDLE">2022년 08월 03일</TU>
<TE ALIGN="CENTER" WIDTH="206" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">회사: 경영본부장, 재경이사감사인: 업무수행이사외 1인</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">대면</TE>
<TE ALIGN="CENTER" WIDTH="303" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">반기 검토 사항 협의</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">3</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20221027" VALIGN="MIDDLE">2022년 10월 27일</TU>
<TE ALIGN="CENTER" WIDTH="206" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">회사: 경영본부장, 재경이사감사인: 업무수행이사외 1인</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">대면</TE>
<TE ALIGN="CENTER" WIDTH="303" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">기말 감사계획 협의 및 주요 통제활동 논의</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_DIV" VALIGN="MIDDLE">4</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="DIS_DATE" AUNITVALUE="20230217" VALIGN="MIDDLE">2023년 02월 17일</TU>
<TE ALIGN="CENTER" WIDTH="206" HEIGHT="53" ACODE="DIS_ATT" VALIGN="MIDDLE">회사: 경영본부장, 재경이사감사인: 업무수행이사외 1인</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="53" ACODE="DIS_WAY" VALIGN="MIDDLE">대면</TE>
<TE ALIGN="CENTER" WIDTH="303" HEIGHT="53" ACODE="DIS_CONT" VALIGN="MIDDLE">기말감사 수행결과 협의</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL B">마. 감사인의 변경</SPAN>
<SPAN USERMARK="F-GL11">주식회사 등의 외부감사에 관한 법률 제12조1에 의거하여 당사는 2022년부터 2024년까지연속하는 3개 사업연도의 외부감사인으로 '대주회계법인'을 2021년 12월 1일 선임하였으며 당사 홈페이지(www.dhpharm.co.kr) 공지&뉴스에 공고하였습니다.  </SPAN>
</P>
</LIBRARY>


<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-5-2-0">2. 내부통제에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11">당사의 상근감사는 일상감사, 반기감사, 결산감사 등의 정기감사와 특별감사, 시재감사 등의 수시감사 등을 실시하는 등 내부감시제도를 운영하고 있으며 효과적으로 운영되고 있음을 이사회 및 정기주주총회에 보고하였습니다. 또한 당사는 내부회계관리제도 시스템을 구축하여 운영하고 있습니다.[회계감사인의 내부회계관리제도에 대한 검토의견]</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="788">

<COLGROUP>
<COL WIDTH="122"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="365"></COL>
<COL WIDTH="151"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">사업연도</TH>
<TH WIDTH="123" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감사인</TH>
<TH WIDTH="374" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">감사의견 및 검토의견</TH>
<TH WIDTH="160" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지적사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">제 39기(당    기)</TD>
<TD WIDTH="123" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">대주회계법인</TD>
<TD WIDTH="374" HEIGHT="122" VALIGN="MIDDLE">[감사의견]회사의 내부회계관리제도는 2022년 12월 31일 현재 「내부회계관리제도 설계 및 운영 개념체계」에 따라 중요성의 관점에서 효과적으로 설계 및 운영되고 있습니다. </TD>
<TD WIDTH="160" HEIGHT="122" VALIGN="MIDDLE">해당사항 없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">제 38기(전    기)</TD>
<TD WIDTH="123" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">광교회계법인</TD>
<TD WIDTH="374" HEIGHT="122" VALIGN="MIDDLE">[검토의견] 경영자의 내부회계관리제도 운영실태보고서에 대한 우리의 검토결과, 상기 경영자의운영실태보고 내용이 중요성의 관점에서 내부회계관리제도 모범규준의 규정에 따라 작성되지 않았다고 판단하게 하는 점이 발견되지 아니하였습니다. </TD>
<TD WIDTH="160" HEIGHT="122" VALIGN="MIDDLE">해당사항 없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="131" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">제 37기(전전기)</TD>
<TD WIDTH="123" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">광교회계법인</TD>
<TD WIDTH="374" HEIGHT="122" VALIGN="MIDDLE">[검토의견] 경영자의 내부회계관리제도 운영실태보고서에 대한 우리의 검토결과, 상기 경영자의운영실태보고 내용이 중요성의 관점에서 내부회계관리제도 모범규준의 규정에 따라 작성되지 않았다고 판단하게 하는 점이 발견되지 아니하였습니다. </TD>
<TD WIDTH="160" HEIGHT="122" VALIGN="MIDDLE">해당사항 없음</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VI. 이사회 등 회사의 기관에 관한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-1-0">1. 이사회에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">가. 이사회 구성</SPAN>
<SPAN USERMARK="F-GL11">보고서 작성 기준일 현재 당사의 이사회는 4명의 상근이사와 2인의 사외이사 총 6인으로 구성되어있으며 이사회의 의장은 정관 제38조 [이사회의 구성과 소집]에 따라 노병태 대표이사가 맡고 있고.이사회의 의장은 대표이사를 겸직하고 있습니다</SPAN>
<SPAN USERMARK="F-11">.</SPAN>
<SPAN USERMARK="F-GL11"> (</SPAN>
<SPAN USERMARK="F-GL11 U">각 이사의 주요 이력 및 업무 분장은 제8장 임원의 현황을 참조하시기바랍니다.</SPAN>
<SPAN USERMARK="F-GL11">)</SPAN>
</P>
<P></P>

<P>
<SPAN USERMARK="F-GL B">나. 주요 의결사항</SPAN>
</P>

<TABLE AFIXTABLE="N" BORDER="1" WIDTH="1504" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="524"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="111"></COL>
<COL WIDTH="44"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="48" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="113" ROWSPAN="3">회차</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="113" ROWSPAN="3">개최일자</TH>
<TH WIDTH="533" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="113" ROWSPAN="3">의 안 내 용</TH>
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="113" ROWSPAN="3">가결여부</TH>
<TH WIDTH="700" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="6">이사의 성명</TH>
<TH WIDTH="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="113" ROWSPAN="3">비 고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">노병태(출석률 100%)</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">김은석(출석률 100%)</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">이상태(출석률 100%)</TH>
<TH WIDTH="115" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">양재권(출석률 100%)</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">김종일(출석률 92.9%)</TH>
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="53">정혜선(출석률 85.7%)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="700" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="6">찬반여부</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">1</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">2022.02.09</TD>
<TD WIDTH="533" HEIGHT="99">-제38기 재무제표 및 현금배당 승인에 관한 건제1호 의안 : 제38기(2021.01.01~2021.12.31) 재무제표 승인의 건제2호 의안 : 제38기 현금배당에 관한 건(주당 100원)-제38기 영업보고서 승인의 건</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">찬성</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">2</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">2022.02.23</TD>
<TD WIDTH="533" HEIGHT="76">제1호 의안 : 제38기(2021.01.01~2021.12.31) 연결재무제표 승인의 건제2호 의안 : 제38기 정기주주총회 소집에 과한 건제3호 의안 : 전자투표제도 도입에 관한 건</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">3</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.04.14</TD>
<TD WIDTH="533" HEIGHT="30">- 기업운전자금 대출의 건(기업은행 20억원)</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">4</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.04.22</TD>
<TD WIDTH="533" HEIGHT="30">- 기업운전자금 대출의 건(신한은행 30억원)</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">5</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2022.04.29</TD>
<TD WIDTH="533" HEIGHT="53">-디에이치호림(주)에 대한 채무보증 및 담보제공 금액 변경의 건  (채무보증 한도액 36억원, 담보제공 한도액 48억원)</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">불참</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">6</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.05.16</TD>
<TD WIDTH="533" HEIGHT="30">- 기업운전자금 대출의 건(신한은행 15억원)</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">7</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">2022.05.26</TD>
<TD WIDTH="533" HEIGHT="76">제1호 의안 : (주)리독스바이오에 대한 채무보증의 건(15억 6천만원)제2호 의안 : ISO 37301(컴플라이언스 경영시스템) 도입에 관한 건보고 : ISO 37301 & 37001 컴플라이언스 보고서</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">찬성</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">8</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.06.15</TD>
<TD WIDTH="533" HEIGHT="30">- 분기배당의 권리를 확정하기 위한 명의개서 정지</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">9</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="99" ALIGN="CENTER">2022.06.17</TD>
<TD WIDTH="533" HEIGHT="99">제1호 의안 : (주)스페셜라이즈드메드에 대한 채무보증 만기 연장의 건 (보증한도액 2억 4천만원)제2호 의안 : 디에이치호림(주)에 대한 채무보증 및 담보 제공 만기 연장의 건 (채무보증 한도액 36억원, 담보제공 한도액 48억원)</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">찬성</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">10</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">2022.06.23</TD>
<TD WIDTH="533" HEIGHT="53">- 윤리경영 운영규정 개정의 건보고: 2022년 3분기 타법인 주식 투자를 위한 투자 검토 보고</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">불참</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">찬성</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">11</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.06.30</TD>
<TD WIDTH="533" HEIGHT="30">- 하나은행 여신거래 약정의 건(30억원)</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">불참</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">12</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.08.08</TD>
<TD WIDTH="533" HEIGHT="30">- 2022년 분기(중간) 현금배당 결의</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">13</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.09.14</TD>
<TD WIDTH="533" HEIGHT="30">- 우리은행 운전자금 차입 연장의 건(60억원)</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">14</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.09.22</TD>
<TD WIDTH="533" HEIGHT="30">- 지배인 선임의 건</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">15</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.10.07</TD>
<TD WIDTH="533" HEIGHT="30">- 하나은행 여신거래 약정의 건(10억원)</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">16</TD>
<TD WIDTH="92" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">2022.12.23</TD>
<TD WIDTH="533" HEIGHT="30">- 단기 차입금 상환의 건(78억원)</TD>
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">가결</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="115" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">찬성</TD>
<TD WIDTH="53" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL B">다. 이사의 독립성
<SPAN USERMARK="F-11 !B">당사의 이사회는 대주주 및 경영진으로부터 독립성을 유지하고 있으며, 당사 이사의 선임은 이사회가 선정하여 주주총회 의안으로 제출하고, 주주총회에서 선임하고 있습니다. 이러한 절차를 통해 선임된 이사는 다음과 같습니다. </SPAN>
<SPAN USERMARK="F-11 !B">[2022년 12월 31일 현재]</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="1148" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="81"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="126"></COL>
<COL WIDTH="329"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="234"></COL>
<COL WIDTH="99"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직  명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성   명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="135" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임기(연임횟수)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="338" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">선임배경</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">추천인</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">활동분야</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="243" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">최대주주 또는 주요주주와의 관계</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사와의거래</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53">사내이사(대표이사)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53">노병태</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="135" HEIGHT="53">2020.03~2023.03(5회)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="338" HEIGHT="53">당사의 업무 총괄 및 대외적 업무를 안정적으로 수행하기 위함</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53">이사회</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53">경영전반총괄</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="243" HEIGHT="53">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53">해당없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53">사내이사(대표이사)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53">김은석</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="135" HEIGHT="53">2020.03~2023.03(4회)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="338" HEIGHT="53">당사의 업무 총괄 및 대외적 업무를 안정적으로 수행하기 위함</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53">이사회</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53">경영전반총괄</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="243" HEIGHT="53">최대주주의 자</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53">해당없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53">사내이사</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53">이상태</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="135" HEIGHT="53">2020.03~2023.03(신임)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="338" HEIGHT="53">당사의 경영지원본부를 총괄하고 대외적 업무를 안정적으로 수행하기 위함</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53">이사회</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53">경영지원본부</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="243" HEIGHT="53">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53">해당없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="99">사내이사</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="99">양재권</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="135" HEIGHT="99">2021.03~2024.03(3회)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="338" HEIGHT="99">약학 전공자로서 전문지식을 바탕으로 적합한 업무능력을 보유하고 있다고 평가되며 당사의 사업역량 및 경쟁력 강화에 효과적인 의사결정에 기여할수 있는 적임자로 판단</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="99">이사회</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="99">생산관리</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="243" HEIGHT="99">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="99">해당없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="53">사외이사</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53">김종일</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="135" HEIGHT="53">2020.03~2023.03(2회)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="338" HEIGHT="53">법률분야 전문가</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53">이사회</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53">경영감독</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="243" HEIGHT="53">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="53">해당없음</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="90" HEIGHT="76">사외이사</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76">정혜선</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="135" HEIGHT="76">2021.03~2024.03(2회)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="338" HEIGHT="76">R&D 분야 전문가,이사회의 결정과 경영활동에 다양한 시각과 가치를 부여해 줄 것으로 기대</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76">이사회</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="76">경영감독</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="243" HEIGHT="76">-</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="108" HEIGHT="76">해당없음</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL B">
<SPAN USERMARK="F-11 !B">1) 이사의 선임 (1) 사내이사 선임① 2021년 03월 10일(제37기 정기주주총회일: 2021년 3월 25일) 주주총회 소집 통지 공고사항을 통해서 공시(정보통신망 게재) 하였습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="1257" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="285"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">성   명</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">생년월</TH>
<TH ROWSPAN="2" WIDTH="294" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">주요직업 및 약력</TH>
<TH ROWSPAN="2" WIDTH="74" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">회사와의거래내역</TH>
<TH ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">최대주주와의 관계</TH>
<TH ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">신규선임여부</TH>
<TH ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">체납사실여부</TH>
<TH ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">부실기업 경영진 여부</TH>
<TH ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">법령상결격사유 유무</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">추천인</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">양재권(사내이사)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1963.01</TD>

<TD ROWSPAN="2" WIDTH="294" HEIGHT="60">
<P>(前)수도약품공업(주) 생산본부장</P>
<P>(現)대화제약(주) 전무이사/생산본부장</P>
</TD>
<TD ROWSPAN="2" WIDTH="74" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">없음</TD>
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">없음</TD>
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">재선임</TD>
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">부</TD>
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">부</TD>
<TD ROWSPAN="2" WIDTH="142" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="87" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">이사회</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL B">
<SPAN USERMARK="F-11 !B">② 2020년 02월 28일(제36기 정기주주총회일: 2020년 3월 24일) 주주총회 소집 통지 공고사항을 통해서 공시(정보통신망 게재) 하였습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="1072" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="81"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="309"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="119"></COL>
<COL WIDTH="114"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">성   명</TH>
<TH WIDTH="71" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">생년월</TH>
<TH ROWSPAN="2" WIDTH="318" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">주요직업 및 약력</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">회사와의거래내역</TH>
<TH ROWSPAN="2" WIDTH="108" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">최대주주와의 관계</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">신규선임여부</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">체납사실여부</TH>
<TH ROWSPAN="2" WIDTH="128" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">부실기업 경영진 여부</TH>
<TH ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">법령상결격사유 유무</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="71" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">추천인</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">노병태(사내이사)</TD>
<TD WIDTH="71" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1961.09</TD>

<TD ROWSPAN="2" WIDTH="318" HEIGHT="60">
<P>(現)(주)리독스바이오 이사(現)대화제약(주) 대표이사 회장</P>
</TD>
<TD ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">없음</TD>
<TD ROWSPAN="2" WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">없음</TD>
<TD ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">재선임</TD>
<TD ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">부</TD>
<TD ROWSPAN="2" WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">부</TD>
<TD ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">이사회</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">김은석(사내이사)</TD>
<TD WIDTH="71" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1975.11</TD>
<TD ROWSPAN="2" WIDTH="318" HEIGHT="60">(現)(주)리독스바이오 이사(現)대화제약(주) 대표이사 사장</TD>
<TD ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">없음</TD>
<TD ROWSPAN="2" WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">자</TD>
<TD ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">재선임</TD>
<TD ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">부</TD>
<TD ROWSPAN="2" WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">부</TD>
<TD ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60">무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">이사회</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">이상태(사내이사)</TD>
<TD WIDTH="71" VALIGN="MIDDLE" HEIGHT="46" ALIGN="CENTER">1964.08</TD>
<TD ROWSPAN="2" WIDTH="318" HEIGHT="76">(前)(주)리독스바이오 이사(前)(주)씨트리 부사장(現)대화제약(주) 전무이사 / 경영지원본부장</TD>
<TD ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">없음</TD>
<TD ROWSPAN="2" WIDTH="108" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">없음</TD>
<TD ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">신임</TD>
<TD ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">부</TD>
<TD ROWSPAN="2" WIDTH="128" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">부</TD>
<TD ROWSPAN="2" WIDTH="123" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76">무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="71" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">이사회</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL B"> 
<SPAN USERMARK="F-11 !B">(2) 사외이사 선임① 2021년 03월 10일(제37기 정기주주총회일: 2021년 3월 25일) 주주총회 소집 통지 공고사항을 통해서 공시(정보통신망 게재) 했습니다.</SPAN>
</P>

<TABLE BORDER="1" WIDTH="1257" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="423"></COL>
<COL WIDTH="77"></COL>
<COL WIDTH="127"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ROWSPAN="2" WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">성   명</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">생년월</TH>
<TH ROWSPAN="2" WIDTH="432" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">주요직업 및 약력</TH>
<TH ROWSPAN="2" WIDTH="86" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">회사와의거래내역</TH>
<TH ROWSPAN="2" WIDTH="136" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">최대주주와의 관계</TH>
<TH ROWSPAN="2" WIDTH="99" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">신규선임여부</TH>
<TH ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">체납사실여부</TH>
<TH ROWSPAN="2" WIDTH="125" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">부실기업 경영진 여부</TH>
<TH ROWSPAN="2" WIDTH="122" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="60">법령상결격사유 유무</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">추천인</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="2" WIDTH="92" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83">정혜선(사외이사)</TD>
<TD WIDTH="87" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">1961.11</TD>

<TD ROWSPAN="2" WIDTH="432" HEIGHT="83">
<P>(前)KIST 생체과학연구부 책임연구원</P>
<P>(現)KIST 한국과학기술연구원 혁신기업사업화센터 책임연구원(現)대화제약(주) 사외이사</P>
</TD>
<TD ROWSPAN="2" WIDTH="86" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83">없음</TD>
<TD ROWSPAN="2" WIDTH="136" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83">없음</TD>
<TD ROWSPAN="2" WIDTH="99" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83">재선임</TD>
<TD ROWSPAN="2" WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83">부</TD>
<TD ROWSPAN="2" WIDTH="125" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83">부</TD>
<TD ROWSPAN="2" WIDTH="122" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="83">무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="87" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">이사회</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL B">
<SPAN USERMARK="F-11 !B">② 2020년 02월 28일(제36기 정기주주총회일: 2020년 3월 24일) 주주총회 소집 통지 공고사항을 통해서 공시(정보통신망 게재) 하였습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1257">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="285"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성   명</TH>
<TH WIDTH="87" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">생년월일</TH>
<TH WIDTH="294" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요직업 및 약력</TH>
<TH WIDTH="74" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사와의거래내역</TH>
<TH WIDTH="142" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">최대주주와의 관계</TH>
<TH WIDTH="142" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신규선임여부</TH>
<TH WIDTH="142" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">체납사실여부</TH>
<TH WIDTH="142" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부실기업 경영진 여부</TH>
<TH WIDTH="142" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">법령상결격사유 유무</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="87" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">추천인</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="76" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">김종일(사외이사)</TD>
<TD WIDTH="87" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">1961.10</TD>
<TD WIDTH="294" HEIGHT="76" ROWSPAN="2">(現)법무법인 아시아 구성변호사(現)대한상사중재원 중재위원(現)대화제약(주) 사외이사</TD>
<TD WIDTH="74" HEIGHT="76" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">없음</TD>
<TD WIDTH="142" HEIGHT="76" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">없음</TD>
<TD WIDTH="142" HEIGHT="76" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">재선임</TD>
<TD WIDTH="142" HEIGHT="76" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">부</TD>
<TD WIDTH="142" HEIGHT="76" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">부</TD>
<TD WIDTH="142" HEIGHT="76" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="87" HEIGHT="44" ALIGN="CENTER" VALIGN="MIDDLE">이사회</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL11">2) 이사회의 구성과 소집당사의 정관 제5장 이사ㆍ이사회ㆍ대표이사  제38조 이사회의 구성과 소집에 관하여 다음과 같이 운영하게 되어 있습니다. (1) 이사회는 이사로 구성하며, 회사 업무 집행에 관한 중요사항을 결의하며, 의장은 대표이사가 된다. (2) 이사회는 대표이사 또는 이사회에서 따로 정한 이사가 있을 때에는 그 이사가 회의일 1주간 전에 각 이사 및 감사에게 통지하여 소집한다. (3) 제2항의 규정에 의하여 소집권자로 지정되지 않은 다른 이사는 소집권자인 이사에게 이사회 소집을 요구할 수 있다. 소집권자인 이사가 정당한 이유 없이 이사회 소집을 거절하는 경우에는 다른 이사가 이사회를 소집할 수 있다. (4) 이사 및 감사 전원의 동의가 있을 때에는 소집절차를 생략할 수 있다. (5) 이사회의 의장은 제2항 및 제3항의 규정에 의한 이사회의 소집권자로 한다. (6) 이사는 3개월에 1회 이상 업무의 집행상황을 이사회에 보고하여야 한다.3) 이사회의 결의방법당사의 정관 제5장 이사ㆍ이사회ㆍ대표이사 제39조 이사회의 결의방법에 관하여 다음과 같이 운영하게 되어 있습니다. (1) 이사회의 결의는 법령과 정관에 다른 정함이 있는 경우를 제외하고는 이사 과반수     의 출석과 출석이사의 과반수로 한다. (2) 이사회는 이사의 전부 또는 일부가 직접 회의에 출석하지 아니하고 모든 이사가 음성을동시에 송/수신하는 원격통신수단에 의하여 결의에 참가하는 것을 허용할 수 있다. 이 경우 당해 이사는 이사회에 직접 출석한 것으로 본다. (3) 이사회의 결의에 관하여 특별한 이해관계가 있는 자는 의결권을 행사하지 못한다.</SPAN>
</P>
<P></P>
<P USERMARK="F-GL B">라. 사외이사 및 그 변동현황</P>

<TABLE-GROUP ACLASS="OUT_DIR" ADELETETABLE="N">

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE"></TD>
<TD WIDTH="300" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE" ALIGN="RIGHT">(단위 : 명)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="121"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="100"></COL>
<COL WIDTH="113"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="130" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">이사의 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="129" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">사외이사 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="340" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">사외이사 변동현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="109" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">해임</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="122" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">중도퇴임</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="RIGHT" WIDTH="130" HEIGHT="30" ACODE="DIR_NUM" VALIGN="MIDDLE">6</TE>
<TE ALIGN="RIGHT" WIDTH="129" HEIGHT="30" ACODE="ODIR_NUM" VALIGN="MIDDLE">2</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_PRE" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="109" HEIGHT="30" ACODE="ODIR_DIS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="122" HEIGHT="30" ACODE="ODIR_RET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK="F-GL B">마. 사외이사 교육실시 여부 및 지원조직</SPAN>
<SPAN USERMARK="F-GL11">1)사외이사 지원 조직</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="675">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="260"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="108" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부서(팀)명</TH>
<TH WIDTH="90" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직원수(명)</TH>
<TH WIDTH="208" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직위(근속연수)</TH>
<TH WIDTH="269" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요 활동내역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">경영지원본부</TD>
<TD WIDTH="90" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="208" HEIGHT="31" ALIGN="CENTER" VALIGN="MIDDLE">부장(21.8년)</TD>
<TD WIDTH="269" HEIGHT="31" VALIGN="MIDDLE">사외이사 직무수행 보조, 이사회 개최</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<LIBRARY>
<P>
<SPAN USERMARK="F-GL11">2) 사외이사 교육 미실시 내역</SPAN>
</P>

<TABLE-GROUP ACLASS="ODRT_EDU_NOT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="191"></COL>
<COL WIDTH="391"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="200" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 실시여부</TH>
<TH WIDTH="400" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">사외이사 교육 미실시 사유</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="200" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" AUPDATECONT="N">미실시</TD>
<TE WIDTH="400" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" ACODE="ODRT_EDU_NOT_DTL">현재 당사는 담당 부서를 통하여 이사회의 원활한 활동을 지원하고 사외이사에 대한 경영정보 등의 제공, 직무수행에 필요한 요청사항에 대한 지원업무를 수행하고 있으며 향후 필요시 교육을 진행할 예정입니다.</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>

<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-2-0">2. 감사제도에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">가. 감사에 관한 사항</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">당사는 보고서 제출일 현재 감사위원회를 설치하고 있지 않으며, 주주총회 결의에 의하여 선임된 상근 감사 강효원, 1인이 감사업무를 수행하고 있습니다.감사는 이사회에 참석하여 독립적으로 이사의 업무를 감독할 수 있으며, 회계에 관한장부와 서류를 열람하고 재무제표 및 부속명세서에 대해서도 면밀히 검토하고 있으며, 필요하다고 인정되는 경우 대조, 입회, 기타 적절한 감사절차를 적용하여 조사할 수 있습니다.</SPAN>
<SPAN USERMARK="F-GL B">나. 감사의 주요활동내역</SPAN>
</P>

<TABLE AFIXTABLE="N" BORDER="1" WIDTH="882" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="524"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="44"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회차</TH>
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개최일자</TH>
<TH WIDTH="533" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">의 안 내 용</TH>
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">가결여부</TH>
<TH WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">참석현황</TH>
<TH WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">1</TD>
<TD WIDTH="92" HEIGHT="99" VALIGN="MIDDLE" ALIGN="CENTER">2022.02.09</TD>
<TD WIDTH="533" HEIGHT="99">-제38기 재무제표 및 현금배당 승인에 관한 건제1호 의안 : 제38기(2021.01.01~2021.12.31) 재무제표 승인의 건제2호 의안 : 제38기 현금배당에 관한 건(주당 100원)-제38기 영업보고서 승인의 건</TD>
<TD WIDTH="78" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">2</TD>
<TD WIDTH="92" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">2022.02.23</TD>
<TD WIDTH="533" HEIGHT="76">제1호 의안 : 제38기(2021.01.01~2021.12.31) 연결재무제표 승인의 건제2호 의안 : 제38기 정기주주총회 소집에 과한 건제3호 의안 : 전자투표제도 도입에 관한 건</TD>
<TD WIDTH="78" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3</TD>
<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022.04.14</TD>
<TD WIDTH="533" HEIGHT="30">- 기업운전자금 대출의 건(기업은행 20억원)</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4</TD>
<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022.04.22</TD>
<TD WIDTH="533" HEIGHT="30">- 기업운전자금 대출의 건(신한은행 30억원)</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">5</TD>
<TD WIDTH="92" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">2022.04.29</TD>
<TD WIDTH="533" HEIGHT="53">-디에이치호림(주)에 대한 채무보증 및 담보제공 금액 변경의 건  (채무보증 한도액 36억원, 담보제공 한도액 48억원)</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6</TD>
<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022.05.16</TD>
<TD WIDTH="533" HEIGHT="30">- 기업운전자금 대출의 건(신한은행 15억원)</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">7</TD>
<TD WIDTH="92" HEIGHT="76" VALIGN="MIDDLE" ALIGN="CENTER">2022.05.26</TD>
<TD WIDTH="533" HEIGHT="76">제1호 의안 : (주)리독스바이오에 대한 채무보증의 건(15억 6천만원)제2호 의안 : ISO 37301(컴플라이언스 경영시스템) 도입에 관한 건보고 : ISO 37301 & 37001 컴플라이언스 보고서</TD>
<TD WIDTH="78" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">8</TD>
<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022.06.15</TD>
<TD WIDTH="533" HEIGHT="30">- 분기배당의 권리를 확정하기 위한 명의개서 정지</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">9</TD>
<TD WIDTH="92" HEIGHT="99" VALIGN="MIDDLE" ALIGN="CENTER">2022.06.17</TD>
<TD WIDTH="533" HEIGHT="99">제1호 의안 : (주)스페셜라이즈드메드에 대한 채무보증 만기 연장의 건 (보증한도액 2억 4천만원)제2호 의안 : 디에이치호림(주)에 대한 채무보증 및 담보 제공 만기 연장의 건  (채무보증 한도액 36억원, 담보제공 한도액 48억원)</TD>
<TD WIDTH="78" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">10</TD>
<TD WIDTH="92" HEIGHT="53" VALIGN="MIDDLE" ALIGN="CENTER">2022.06.23</TD>
<TD WIDTH="533" HEIGHT="53">- 윤리경영 운영규정 개정의 건보고: 2022년 3분기 타법인 주식 투자를 위한 투자 검토 보고</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">11</TD>
<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022.06.30</TD>
<TD WIDTH="533" HEIGHT="30">- 하나은행 여신거래 약정의 건(30억원)</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12</TD>
<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022.08.08</TD>
<TD WIDTH="533" HEIGHT="30">- 2022년 분기(중간) 현금배당 결의</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">13</TD>
<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022.09.14</TD>
<TD WIDTH="533" HEIGHT="30">- 우리은행 운전자금 차입 연장의 건(60억원)</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">14</TD>
<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022.09.22</TD>
<TD WIDTH="533" HEIGHT="30">- 지배인 선임의 건</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">15</TD>
<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022.10.07</TD>
<TD WIDTH="533" HEIGHT="30">- 하나은행 여신거래 약정의 건(10억원)</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">16</TD>
<TD WIDTH="92" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022.12.23</TD>
<TD WIDTH="533" HEIGHT="30">- 단기 차입금 상환의 건(78억원)</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">가결</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">참석</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">다. 감사의 선임 현황</SPAN>
<SPAN USERMARK="F-GL11">2020년 02월 28일(제36기 정기주주총회일: 2020년 3월 24일) 주주총회 소집통지ㆍ공고사항을 통해서 공시(정보통신망 게재) 하였습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1257">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="283"></COL>
<COL WIDTH="65"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
<COL WIDTH="133"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" HEIGHT="76" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성   명</TH>
<TH WIDTH="89" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">생년월일</TH>
<TH WIDTH="292" HEIGHT="76" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요직업 및 약력</TH>
<TH WIDTH="74" HEIGHT="76" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사와의거래내역</TH>
<TH WIDTH="142" HEIGHT="76" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">최대주주와의 관계</TH>
<TH WIDTH="142" HEIGHT="76" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신규선임여부</TH>
<TH WIDTH="142" HEIGHT="76" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">체납사실여부</TH>
<TH WIDTH="142" HEIGHT="76" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">부실기업 경영진 여부</TH>
<TH WIDTH="142" HEIGHT="76" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">법령상결격사유 유무</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="89" HEIGHT="46" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">추천인</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="145" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">강효원(상근감사)</TD>
<TD WIDTH="89" HEIGHT="46" ALIGN="CENTER" VALIGN="MIDDLE">1959.08.10</TD>
<TD WIDTH="292" HEIGHT="145" ROWSPAN="2">(前)국세청 근무(前)근로복지공단 고문(前)(주)대우건설 고문(現)세무법인 드림새시대 대표세무사(現)학교법인 경희학원 고문(現)대화제약(주) 상근감사</TD>
<TD WIDTH="74" HEIGHT="145" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">없음</TD>
<TD WIDTH="142" HEIGHT="145" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">없음</TD>
<TD WIDTH="142" HEIGHT="145" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">재선임</TD>
<TD WIDTH="142" HEIGHT="145" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">부</TD>
<TD WIDTH="142" HEIGHT="145" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">부</TD>
<TD WIDTH="142" HEIGHT="145" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">무</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="89" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">이사회</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P></P>

<LIBRARY>
<P USERMARK="F-GL">1) 감사 교육실시 현황</P>

<TABLE-GROUP ACLASS="ADT_EDU" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="599" BORDER="1">

<COLGROUP>
<COL WIDTH="120"></COL>
<COL WIDTH="101"></COL>
<COL WIDTH="351"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">교육일자</TH>
<TH WIDTH="110" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">교육실시주체</TH>
<TH WIDTH="360" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주요 교육내용</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" AUNIT="ADT_EDU_DT" AUNITVALUE="20221128">2022년 11월 28일</TU>
<TE WIDTH="110" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="99" ACODE="ADT_EDU_MA">코스닥협회</TE>
<TE WIDTH="360" VALIGN="MIDDLE" HEIGHT="99" ACODE="ADT_EDU_DTL">2022년 코스닥 내부감사 포럼-외감법  내 내부감사의 역할-내부회계관리제도 적용 실무 이슈-중소기업 회계지원센터의 역할 및 주요 회계 이슈</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>

<P></P>

<LIBRARY>
<P USERMARK="F-GL">2) 감사 지원조직 현황</P>

<TABLE-GROUP ACLASS="ADTC_OGN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="652" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="193"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">부서(팀)명</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직원수(명)</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위(근속연수)</TH>
<TH WIDTH="202" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주요 활동내역</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="ADTC_OGN_NM">경영지원본부</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="ADTC_OGN_CNT">3</TE>
<TE WIDTH="150" VALIGN="MIDDLE" HEIGHT="76" ACODE="ADTC_OGN_PST" ALIGN="CENTER">본부장(33.8년)부장(10.7년)부장(21.8년)</TE>
<TE WIDTH="202" VALIGN="MIDDLE" HEIGHT="76" ACODE="ADTC_OGN_DTL">이사회 개최, 안건정리 송부,감사활동 지원,보고,</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADTC_OGN_NM">기획법무팀</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="ADTC_OGN_CNT">1</TE>
<TE WIDTH="150" VALIGN="MIDDLE" HEIGHT="30" ACODE="ADTC_OGN_PST" ALIGN="CENTER">팀장(13.2년)</TE>
<TE WIDTH="202" VALIGN="MIDDLE" HEIGHT="30" ACODE="ADTC_OGN_DTL">감사활동 지원</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>

<P></P>

<LIBRARY>
<P USERMARK=" B">
<SPAN USERMARK="F-GL">마. 준법지원인 등 지원조직 현황</SPAN>
<SPAN USERMARK="F-GL11">해당사항 없습니다.</SPAN>
</P>
</LIBRARY>

<P></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-6-3-0">3. 주주총회 등에 관한 사항</TITLE>
<P></P>
<P>투표제도 현황</P>

<TABLE-GROUP ACLASS="VOTE_CON" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="359"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="368" HEIGHT="30" AUPDATECONT="N">)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">투표제도 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">집중투표제</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">서면투표제</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전자투표제</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">도입여부</TD>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUNIT="JVOTE_DYN" AUNITVALUE="N">배제</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUNIT="SVOTE_DYN" AUNITVALUE="N">미도입</TU>
<TU ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUNIT="DVOTE_DYN" AUNITVALUE="Y">도입</TU>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" AUPDATECONT="N">실시여부</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="JVOTE_SYN">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="SVOTE_SYN">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="DVOTE_SYN">실시</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11">당사는 이사회에서 전자투표제도를 도입하기로 결정하여 2021년 3월 제37기 정기주주총회에서 실시하였으며 2022년 3월 24일 제38기 정기주주총회에도 도입하였습니다.  의결권 대리행사 권유제도는 실시하지 않았습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 B">나. 소주주권 및 경영권 경쟁</SPAN>
<SPAN USERMARK="F-GL11">당사는 공시대상기간 중에 소수주주권이 행사된 사실이 없고 경영지배권에 대한 경쟁은 없습니다. </SPAN>
<SPAN USERMARK="F-GL11 B">다. 의결권 현황</SPAN>
</P>
<P>의결권 현황</P>

<TABLE-GROUP ACLASS="VOT_STK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="294"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="303" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="229"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="115"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구     분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의 종류</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">발행주식총수(A)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">18,616,650</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISU_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISU_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권없는 주식수(B)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISN_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK">1,100,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE1">자기주식</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISN_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISN_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">정관에 의하여 의결권 행사가 배제된 주식수(C)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISQ_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISQ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">기타 법률에 의하여의결권 행사가 제한된 주식수(D)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISJ_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISJ_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권이 부활된 주식수(E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISB_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISB_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE4">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="238" HEIGHT="60" AUPDATECONT="N">의결권을 행사할 수 있는 주식수(F = A - B - C - D + E)</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">보통주</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK">17,516,650</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="93" HEIGHT="30" ACODE="ISH_STK_KND">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACODE="ISH_STK">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="124" HEIGHT="30" ACODE="VOT_NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK="F-GL11 B">라</SPAN>
<SPAN USERMARK="F-GL B">. 주식의 사무</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="646">

<COLGROUP>
<COL WIDTH="166"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="122"></COL>
<COL WIDTH="200"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="605" VALIGN="MIDDLE">정관상신주인수권의 내용</TD>
<TD WIDTH="471" HEIGHT="605" COLSPAN="3">제10조 (신주인수권) ① 주주는 그가 소유한 주식의 수에 비례하여 신주의 배정을 받을       권리를 가진다. ② 회사는 제1항의 규정에도 불구하고 다음 각 호의 어느 하나에        해 당하는 경우 이사회의 결의로 주주이외의 자에게 신주를 배       정할 수 있다.   1. 발행주식총수의 100분의 50을 초과하지 않는 범위 내에서 자         본시장과 금융투자업에 관한 법률 제165조의 6에 따라 일반공       모증자 방식으로 신주를 발행한 경우   2. 상법 제542조의3에 따른 주식매수선택권의 행사로 인하여 신         주를 발행하는 경우   3. 발행하는 주식총수의 100분의 20범위 내에서 우리사주조합원        에게 주식을 우선배정하는 경우   4. 근로복지기본법 제39조의 규정에 의한 우리사주매수선택권의        행사로 인하여 신주를 발행하는 경우   5. 발행주식총수의 100분의 50을 초과하지 않는 범위 내에서 긴         급한 자금조달을 위하여 국내외 금융기관 또는 기관투자자에         게 신주를 발행하는 경우   6. 발행주식총수의 100분의 50을 초과하지 않는 범위 내에서 사         업상 중요한 기술도입, 연구개발, 생산,판매, 자본제휴를 위하        여 그 상대방에게 신주를 발행하는 경우 ③ 제2항 각호중 어느 하나의 규정에 의해 신주를 발행할 경우 발       행할 주식의 종류와 수 및 발행 가격 등은 이사회의 결의로 정한     다.④ 주주가 신주인수권을 포기 또는 상실에 따른 주식과 신주배정에     서 발생한 단주에 대한 처리 방법은 이사회의 결의로 정한다.</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">결 산 일</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">12월 31일</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">정기주주총회</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">사업연도 종료 후 3개월 이내</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">주주명부폐쇄시기</TD>
<TD WIDTH="471" HEIGHT="30" COLSPAN="3" VALIGN="MIDDLE">1월 1일 ~ 1월 31일까지</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">주권의 종류</TD>
<TD WIDTH="471" HEIGHT="30" COLSPAN="3" VALIGN="MIDDLE">보통주</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">명의개서대리인</TD>
<TD WIDTH="471" HEIGHT="30" COLSPAN="3" VALIGN="MIDDLE">하나은행증권대행부(02-368-5850)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="175" HEIGHT="30" VALIGN="MIDDLE">주주의 특전</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="131" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">공고게재</TD>
<TD WIDTH="209" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">www.dhpharm.co.kr</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">마. 주주총회 의사록 요약</SPAN>
</P>
<P></P>

<TABLE AFIXTABLE="N" BORDER="1" WIDTH="916" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="99"></COL>
<COL WIDTH="515"></COL>
<COL WIDTH="222"></COL>
<COL WIDTH="44"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="108" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">주총일자</TH>
<TH WIDTH="524" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">안      건</TH>
<TH WIDTH="231" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">결 의 내 용</TH>
<TH WIDTH="53" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="30" ALIGN="CENTER">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="81" ALIGN="CENTER">제38기정기주주총회(2022.03.24)</TD>
<TD WIDTH="524" HEIGHT="81">1. 제38기 연결재무제표, 재무제표 및 이익잉여금 처분계산서(안) 승인의 건2. 이사 보수한도 승인의 건 3. 감사 보수한도 승인의 건 </TD>
<TD WIDTH="231" HEIGHT="81">1. 원안대로 승인 가결2. 원안대로 승인 가결(30억원)3. 원안대로 승인 가결(5천만원)</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="81" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="149" ALIGN="CENTER">제37기정기주주총회(2021.03.25)</TD>
<TD WIDTH="524" HEIGHT="149">1. 제37기 연결재무제표, 재무제표 및 이익잉여금 처분계산서(안) 승인의 건2. 이사 선임의 건(사내이사 1명, 사외이사 1명)     - 제2-1호 의안 : 사내이사 양재권 선임의 건(재선임)     - 제2-2호 의안 : 사외이사 정혜선 선임의 건(재선임) 3. 이사 보수한도 승인의 건 4. 감사 보수한도 승인의 건 </TD>
<TD WIDTH="231" HEIGHT="149">1. 원안대로 승인 가결2.   - 제2-1호 원안대로 승인 가결  - 제2-2호 원안대로 승인 가결3. 원안대로 승인 가결(30억원)4. 원안대로 승인 가결(5천만원)</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="149" ALIGN="CENTER">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="108" VALIGN="MIDDLE" HEIGHT="237" ALIGN="CENTER">제36기정기주주총회(2020.03.24)</TD>
<TD WIDTH="524" HEIGHT="237">1. 제36기 연결재무제표, 재무제표 및 이익잉여금 처분계산서(안) 승인의 건2. 이사 선임의 건(사내이사 3명, 사외이사 1명) - 제2-1호 의안 : 사내이사 노병태 선임의 건(재선임) - 제2-2호 의안 : 사내이사 김은석 선임의 건(재선임) - 제2-3호 의안 : 사내이사 이상태 선임의 건(신임) - 제2-4호 의안 : 사외이사 김종일 선임의 건(재선임)3. 감사 선임(1명)의 건(상근감사 강효원, 재선임)4. 이사 보수한도 승인의 건5. 감사 보수한도 승인의 건6. 정관 일부 변경의 건</TD>
<TD WIDTH="231" HEIGHT="237">1. 원안대로 승인 가결2.   - 제2-1호 원안대로 승인 가결  - 제2-2호 원안대로 승인 가결  - 제2-3호 원안대로 승인 가결  - 제2-4호 원안대로 승인 가결3. 원안대로 승인 가결4. 원안대로 승인 가결5. 원안대로 승인 가결(15억원)6. 원안대로 승인 가결(5천만원)</TD>
<TD WIDTH="53" VALIGN="MIDDLE" HEIGHT="237" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-7-0-0">VII. 주주에 관한 사항</TITLE>
<P></P>

<P USERMARK="F-16">
<SPAN USERMARK="F-GL 0XFF1200 B">1. 최대주주 및 그 특수관계인의 주식소유 현황</SPAN>
<SPAN USERMARK="F-GL11">보고서 작성 기준일 현재 당사의 최대주주 김수지는 발행주식 18,616,650주 중 9.94%의 지분을 보유하고 있으며, 특수관계인을 포함하여 총 29.28%를 보유하고 있습니다. 공시대상 기간중 최대주주의 변경은 없습니다. </SPAN>
<SPAN USERMARK="F-GL11 U">최대주주의 주요경력은 VIII. 임원 및 직원 등에 관한 사항을 참조하시기 바랍니다.</SPAN>
<SPAN USERMARK="F-GL12 B">가. 최대주주 및 특수관계인의 주식소유 현황</SPAN>
</P>

<TABLE-GROUP ACLASS="BSH_SPCL" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="619" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="299"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="SH5_CUR_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="308" HEIGHT="30" AUNIT="STOCKPERCENT" AUNITVALUE="1">(단위 : 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="681" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="116"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="111"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성 명</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="125" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">관 계</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식의종류</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="310" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수 및 지분율</TH>
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="120" HEIGHT="90" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="163" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 초</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="147" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기 말</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="84" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주식수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">지분율</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김수지</TE>
<TE ALIGN="CENTER" WIDTH="125" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">본         인</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">1,840,050</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">9.88</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">1,849,600</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">9.94</TE>
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">장내매수</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">고준진</TE>
<TE ALIGN="CENTER" WIDTH="125" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">미등기임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">1,706,867</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">9.17</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">1,706,867</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">9.17</TE>
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">김운장</TE>
<TE ALIGN="CENTER" WIDTH="125" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">미등기임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">815,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">4.38</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">813,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">4.37</TE>
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">장내매도</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">이한구</TE>
<TE ALIGN="CENTER" WIDTH="125" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">미등기임원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">621,300</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">3.34</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">621,300</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">3.34</TE>
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="53" ACODE="SH5_NM_T" VALIGN="MIDDLE">노병태</TE>
<TE ALIGN="CENTER" WIDTH="125" HEIGHT="53" ACODE="SH5_RET" VALIGN="MIDDLE">등 기 임 원(대표이사 회장)</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="53" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">27,583</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="53" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.15</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="53" ACODE="SH5_END_CNT" VALIGN="MIDDLE">27,583</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="53" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.15</TE>
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="53" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="53" ACODE="SH5_NM_T" VALIGN="MIDDLE">김은석</TE>
<TE ALIGN="CENTER" WIDTH="125" HEIGHT="53" ACODE="SH5_RET" VALIGN="MIDDLE">자/등기임원(대표이사 사장)</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="53" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="53" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">146,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="53" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.78</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="53" ACODE="SH5_END_CNT" VALIGN="MIDDLE">166,330</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="53" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.89</TE>
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="53" ACODE="NOTE5" VALIGN="MIDDLE">장내매수</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">이주희</TE>
<TE ALIGN="CENTER" WIDTH="125" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">친   인   척</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">50,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.27</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">45,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.24</TE>
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">장내매도</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">양재권</TE>
<TE ALIGN="CENTER" WIDTH="125" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">등 기 임 원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">190</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.00</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">190</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.00</TE>
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">이명희</TE>
<TE ALIGN="CENTER" WIDTH="125" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">처</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">153,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.82</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">206,230</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">1.11</TE>
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">장내매수</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_NM_T" VALIGN="MIDDLE">이상태</TE>
<TE ALIGN="CENTER" WIDTH="125" HEIGHT="30" ACODE="SH5_RET" VALIGN="MIDDLE">등 기 임 원</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACODE="STK_KND">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="SH5_BGN_CNT" VALIGN="MIDDLE">14,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_BGN_RT" VALIGN="MIDDLE">0.08</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="SH5_END_CNT" VALIGN="MIDDLE">14,000</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="SH5_END_RT" VALIGN="MIDDLE">0.08</TE>
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="NOTE5" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="188" HEIGHT="60" AUPDATECONT="N">계</TD>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">보통주</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">5,373,990</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">28.87</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">5,450,100</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">29.28</TE>
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACODE="SH5_STK_KNDT" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="100" HEIGHT="30" ACODE="STK_CNT_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_BIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="84" HEIGHT="30" ACODE="STK_CNT_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="63" HEIGHT="30" ACODE="STK_RATE_GIML" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="120" HEIGHT="30" ACODE="NOTE4" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
<P USERMARK="F-16"></P>

<P>
<SPAN USERMARK="F-GL B">나. 최대주주의 주요경력 및 개요</SPAN>
</P>
<P></P>

<P>
<SPAN USERMARK="F-GL">1) 최대주주 : 김수지2) 경력사항 (최근5년간)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="617">

<COLGROUP>
<COL WIDTH="186"></COL>
<COL WIDTH="168"></COL>
<COL WIDTH="236"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="195" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직    위</TH>
<TH WIDTH="177" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기    간</TH>
<TH WIDTH="245" HEIGHT="30" ALIGN="CENTER" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">겸임현황</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대화제약(주) 명예회장</TD>
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2008.03.21~2014.03.20</TD>
<TD WIDTH="245" HEIGHT="90" VALIGN="MIDDLE" ROWSPAN="3">디에이치호림(주) 사내이사(주)스페셜라이즈드메드 대표이사(주)리독스바이오 대표이사</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대화제약(주) 대표이사회장</TD>
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2014.03.21~2015.03.20</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="195" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대화제약(주) 명예회장</TD>
<TD WIDTH="177" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2015.03.21~현재</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">3) 최대주주 변동을 초래할수 있는 주식담보 계약</P>

<TABLE ACLASS="NORMAL" WIDTH="1092" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="207"></COL>
<COL WIDTH="120"></COL>
<COL WIDTH="69"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">순번</TH>
<TH ALIGN="CENTER" WIDTH="63" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성 명</TH>
<TH ALIGN="CENTER" WIDTH="113" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주식등의 종류</TH>
<TH ALIGN="CENTER" WIDTH="105" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약상대방</TH>
<TH ALIGN="CENTER" WIDTH="93" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약의종류</TH>
<TH ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기초</TH>
<TH ALIGN="CENTER" WIDTH="79" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감</TH>
<TH ALIGN="CENTER" WIDTH="84" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
<TH ALIGN="CENTER" WIDTH="216" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">계약체결(변경)일</TH>
<TH ALIGN="CENTER" WIDTH="129" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">만기일</TH>
<TH ALIGN="CENTER" WIDTH="78" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비  고</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">1)</TD>
<TD ALIGN="CENTER" WIDTH="63" HEIGHT="30" VALIGN="MIDDLE">김수지</TD>
<TD ALIGN="CENTER" WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="CENTER" WIDTH="105" HEIGHT="30" VALIGN="MIDDLE">기업은행</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30" VALIGN="MIDDLE">담보계약</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30" VALIGN="MIDDLE">736,000</TD>
<TD WIDTH="79" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">736,000</TD>
<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022년 7월 13일(연장일)</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2023년 7월 13일</TD>
<TD WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">개인용도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="48" HEIGHT="30" VALIGN="MIDDLE">2)</TD>
<TD ALIGN="CENTER" WIDTH="63" HEIGHT="30" VALIGN="MIDDLE">김수지</TD>
<TD ALIGN="CENTER" WIDTH="113" HEIGHT="30" VALIGN="MIDDLE">보통주</TD>
<TD ALIGN="CENTER" WIDTH="105" HEIGHT="30" VALIGN="MIDDLE">기업은행</TD>
<TD ALIGN="CENTER" WIDTH="93" HEIGHT="30" VALIGN="MIDDLE">담보계약</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30" VALIGN="MIDDLE">379,268</TD>
<TD WIDTH="79" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">379,268</TD>
<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022년 8월 11일(연장일)</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2023년 8월 11일</TD>
<TD WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">개인용도</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="422" HEIGHT="30" VALIGN="MIDDLE" COLSPAN="5">합 계</TD>
<TD ALIGN="RIGHT" WIDTH="84" HEIGHT="30" VALIGN="MIDDLE">1,115,268</TD>
<TD WIDTH="79" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">-</TD>
<TD WIDTH="84" HEIGHT="30" VALIGN="MIDDLE" ALIGN="RIGHT">1,115,268</TD>
<TD WIDTH="216" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">-</TD>
<TD WIDTH="129" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">-</TD>
<TD WIDTH="78" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">주1) 기업은행 방배동지점과 2022년 7월 13일 주식 736,000주를 담보로 대출 27.6억원, 담보설정금액은 60억원의 1년 연장 계약을 체결하였습니다.(담보유지비율 없음)주2) 기업은행 방배동지점과 2022년 8월 10일 주식 379,268주를 담보로 대출 12억원, 담보설정금액은 18억원의 1년 연장 계약을 체결하였습니다. (담보유지비율 없음)</SPAN>
</P>
<P></P>

<P></P>

<P>
<SPAN USERMARK="F-GL16 0XFF1200 B">2. 주식의 분포</SPAN>
<SPAN USERMARK="F-GL B">가. 주식 소유현황</SPAN>
</P>

<TABLE-GROUP ACLASS="SH5_PRE_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="290"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="72" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="299" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="72"></COL>
<COL WIDTH="86"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="120" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구분</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주명</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">소유주식수</TH>
<TH WIDTH="81" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">지분율(%)</TH>
<TH WIDTH="95" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="120" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="60" ROWSPAN="2" AUPDATECONT="N">5% 이상 주주</TD>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">김수지</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">1,849,600</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">9.94</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="SH5_NM">고준진</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_CNT">1,706,867</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_TOT_RT">9.17</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="303" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" COLSPAN="2" AUPDATECONT="N">우리사주조합</TD>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_CNT">-</TE>
<TE WIDTH="81" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="SH5_WOO_RT">-</TE>
<TD WIDTH="95" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL B">나. 소액주주현황</SPAN>
</P>

<LIBRARY>
<TABLE-GROUP ACLASS="SH4_PRE_STT" ADELETETABLE="N">
<TITLE ATOC="N">소액주주현황</TITLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="58"></COL>
<COL WIDTH="295"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="79" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="151" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="67" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="304" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="706" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="46"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="206"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="78" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">구 분</TH>
<TH WIDTH="181" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">주주</TH>
<TH WIDTH="232" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30" COLSPAN="3">소유주식</TH>
<TH WIDTH="215" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="83" ROWSPAN="2">비 고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액주주수</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">전체주주수</TH>
<TH WIDTH="55" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율(%)</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">소액주식수</TH>
<TH WIDTH="92" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">총발행주식수</TH>
<TH WIDTH="48" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="78" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">소액주주</TD>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_CNT">16,669</TE>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_CNTT">16,676</TE>
<TE WIDTH="55" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_JJ_RT">99.96</TE>
<TE WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_CNT">11,760,125</TE>
<TE WIDTH="92" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_CNTT">18,616,650</TE>
<TE WIDTH="48" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="SH4_BB_RT">63.2</TE>
<TE WIDTH="215" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE">발행주식 총수의 100분의 1에미달하는 주식을 보유한 주주</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
</LIBRARY>

<P></P>

<P>
<SPAN USERMARK="F-GL16 0XFF1200 B">3. 주가 및 주식거래 실적</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL">                                                                                                    (단위 :원, 주)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="812" ACLASS="NORMAL" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="71"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="92"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH COLSPAN="3" WIDTH="206" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">종 류</TH>
<TH WIDTH="101" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">2022년 07월</TH>
<TH WIDTH="101" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">2022년 08월</TH>
<TH WIDTH="101" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">2022년 09월</TH>
<TH WIDTH="101" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">2022년 10월</TH>
<TH WIDTH="101" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">2022년 11월</TH>
<TH WIDTH="101" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" HEIGHT="30">2022년 12월</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="7" WIDTH="63" VALIGN="MIDDLE" HEIGHT="210" ALIGN="CENTER">보통주</TD>
<TD ROWSPAN="3" WIDTH="63" VALIGN="MIDDLE" HEIGHT="90" ALIGN="CENTER">주   가</TD>
<TD WIDTH="80" VALIGN="MIDDLE" HEIGHT="30">최 고</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">7,430</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">8,130</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">11,900</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">12,200</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">10,750</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">11,050</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="80" VALIGN="MIDDLE" HEIGHT="30">최 저</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">6,420</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">7,160</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">6,670</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">9,900</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">9,600</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">9,400</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="80" VALIGN="MIDDLE" HEIGHT="30">평 균</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">7,141</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">7,731</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">10,565</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">11,689</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">10,316</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">10,488</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" WIDTH="63" VALIGN="MIDDLE" HEIGHT="120" ALIGN="CENTER">거래량</TD>
<TD WIDTH="80" VALIGN="MIDDLE" HEIGHT="30">최고(일)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">53,522</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">317,040</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">8,701,664</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">8,434,279</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">639,315</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">774,932</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="80" VALIGN="MIDDLE" HEIGHT="30">최저(일)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">8,138</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">2,800</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">4,500</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">224,465</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">83,963</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">83,413</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="80" VALIGN="MIDDLE" HEIGHT="30">평균</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">21,325</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">38,499</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">2,082,316</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">2,064,763</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">235,196</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">208,321</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="80" VALIGN="MIDDLE" HEIGHT="30">월 간(총)</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">447,835</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">846,973</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">41,646,319</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">39,230,498</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">5,174,315</TD>
<TD WIDTH="101" ALIGN="RIGHT" HEIGHT="30">4,374,735</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">주1) 상기 내역은 한국거래소 종목별 주가 자료를 참조 하였습니다.주2) 최고 최저 가격은 종가 기준입니다.주3) 주가의 평균가는 월별 총거래대금/총거래량 입니다.</SPAN>
</P>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">VIII. 임원 및 직원 등에 관한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-1-0">1. 임원 및 직원 등의 현황</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">가. 임원의 현황</SPAN>
<SPAN USERMARK="F-GL11">당사의 임원은 임원의현황표 작성 기준일 현재 총 24명으로 등기임원은 7명, 미등기임원 17명(자문위원 4명 포함) 입니다. 이중 노병태, 김은석이 각자 대표를 맡고 있습니다.</SPAN>
</P>

<TABLE-GROUP ACLASS="SH5_DRCT_STT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="931" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="582"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="108" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="591" HEIGHT="30" AUNIT="STOCK" AUNITVALUE="1">(단위 : 주)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1447" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="390"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="128"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직위</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">등기임원여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상근여부</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="123" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">담당업무</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="399" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="166" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">소유주식수</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의관계</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">재직기간</TH>
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">임기만료일</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권있는 주식</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="83" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">의결권없는 주식</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_NM_T" VALIGN="MIDDLE">노병태</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="99" AUNIT="SH5_BIH" AUNITVALUE="196109" VALIGN="MIDDLE">1961년 09월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_LEV" VALIGN="MIDDLE">회장</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="SH5_REG_DRCT" AUNITVALUE="3" VALIGN="MIDDLE">사내이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="99" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="99" ACODE="SH5_OBJ" VALIGN="MIDDLE">대표이사</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="99" ACODE="SH5_SKL" VALIGN="MIDDLE">한사대학교 공업디자인과 졸(현,대구대학교)대화제약(주) 대표이사 사장(주)리독스바이오 이사</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">27,583</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="99" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_PER" VALIGN="MIDDLE">1985.12.~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="SH5_FIH" AUNITVALUE="20230324" VALIGN="MIDDLE">2023년 03월 24일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="122" ACODE="SH5_NM_T" VALIGN="MIDDLE">김은석</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="122" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="122" AUNIT="SH5_BIH" AUNITVALUE="197511" VALIGN="MIDDLE">1975년 11월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="122" ACODE="SH5_LEV" VALIGN="MIDDLE">사장</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="122" AUNIT="SH5_REG_DRCT" AUNITVALUE="3" VALIGN="MIDDLE">사내이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="122" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="122" ACODE="SH5_OBJ" VALIGN="MIDDLE">대표이사</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="122" ACODE="SH5_SKL" VALIGN="MIDDLE">성균관대학교 산업심리학과 졸성균관대학교대학원 경영학과 석사 졸부광약품(주)근무대화제약(주) 상무이사(주)리독스바이오 이사</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="122" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">166,330</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="122" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="122" ACODE="SH5_RLTN" VALIGN="MIDDLE">최대주주의 자</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="122" ACODE="SH5_PER" VALIGN="MIDDLE">2008.02~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="122" AUNIT="SH5_FIH" AUNITVALUE="20230324" VALIGN="MIDDLE">2023년 03월 24일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_NM_T" VALIGN="MIDDLE">이상태</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="99" AUNIT="SH5_BIH" AUNITVALUE="196408" VALIGN="MIDDLE">1964년 08월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_LEV" VALIGN="MIDDLE">전무</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="SH5_REG_DRCT" AUNITVALUE="3" VALIGN="MIDDLE">사내이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="99" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="99" ACODE="SH5_OBJ" VALIGN="MIDDLE">경영지원본부장</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="99" ACODE="SH5_SKL" VALIGN="MIDDLE">봉화종합고등학교 졸대화제약(주) 입사대화제약(주) 총무,관리 이사(주)씨트리 부사장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">14,000</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="99" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_PER" VALIGN="MIDDLE">1989.03~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="SH5_FIH" AUNITVALUE="20230324" VALIGN="MIDDLE">2023년 03월 24일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_NM_T" VALIGN="MIDDLE">양재권</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="99" AUNIT="SH5_BIH" AUNITVALUE="196301" VALIGN="MIDDLE">1963년 01월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_LEV" VALIGN="MIDDLE">전무</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="SH5_REG_DRCT" AUNITVALUE="3" VALIGN="MIDDLE">사내이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="99" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="99" ACODE="SH5_OBJ" VALIGN="MIDDLE">생산본부장중앙연구소장</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="99" ACODE="SH5_SKL" VALIGN="MIDDLE">성균관대학교 약학과 졸성균관대학교 대학원 제약학과 박사학위 취득대원제약 생산부 이사수도약품공업(주) 생산본부장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">190</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="99" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_PER" VALIGN="MIDDLE">2008.10~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="SH5_FIH" AUNITVALUE="20240325" VALIGN="MIDDLE">2024년 03월 25일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_NM_T" VALIGN="MIDDLE">정혜선</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="99" AUNIT="SH5_BIH" AUNITVALUE="196111" VALIGN="MIDDLE">1961년 11월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_LEV" VALIGN="MIDDLE">사외이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="SH5_REG_DRCT" AUNITVALUE="4" VALIGN="MIDDLE">사외이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="99" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="99" ACODE="SH5_OBJ" VALIGN="MIDDLE">사외이사</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="99" ACODE="SH5_SKL" VALIGN="MIDDLE">이화여자대학교 화학과, 이학사이화여자대학교 화학과 대학원, 이학석사미 Ohio State University, Dept Chemistry, Ph.D현) 한국과학기술연구원 혁신기업사업화센터 책임연구원</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="99" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_PER" VALIGN="MIDDLE">2018.03~현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="SH5_FIH" AUNITVALUE="20240325" VALIGN="MIDDLE">2024년 03월 25일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="122" ACODE="SH5_NM_T" VALIGN="MIDDLE">김종일</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="122" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="122" AUNIT="SH5_BIH" AUNITVALUE="196110" VALIGN="MIDDLE">1961년 10월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="122" ACODE="SH5_LEV" VALIGN="MIDDLE">사외이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="122" AUNIT="SH5_REG_DRCT" AUNITVALUE="4" VALIGN="MIDDLE">사외이사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="122" AUNIT="SH5_FUL" AUNITVALUE="2" VALIGN="MIDDLE">비상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="122" ACODE="SH5_OBJ" VALIGN="MIDDLE">사외이사</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="122" ACODE="SH5_SKL" VALIGN="MIDDLE">서울시립대학교 법정대학 외래교수서울중앙지방법원 조정위원대한상사중재원 중재위원서울지방변호사회 위원회위원현)법무법인 아시아 구성변호사</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="122" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="122" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="122" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="122" ACODE="SH5_PER" VALIGN="MIDDLE">2017.03~현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="122" AUNIT="SH5_FIH" AUNITVALUE="20230324" VALIGN="MIDDLE">2023년 03월 24일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="145" ACODE="SH5_NM_T" VALIGN="MIDDLE">강효원</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="145" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="145" AUNIT="SH5_BIH" AUNITVALUE="195908" VALIGN="MIDDLE">1959년 08월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="145" ACODE="SH5_LEV" VALIGN="MIDDLE">상근감사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="145" AUNIT="SH5_REG_DRCT" AUNITVALUE="6" VALIGN="MIDDLE">감사</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="145" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="145" ACODE="SH5_OBJ" VALIGN="MIDDLE">감사</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="145" ACODE="SH5_SKL" VALIGN="MIDDLE">순창고 졸국세청 근무근로복지공단 고문(주)대우건설 고문세무법인 드림새시대 대표세무사학교법인 경희학원 고문</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="145" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE" USERMARK=" B">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="145" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="145" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="145" ACODE="SH5_PER" VALIGN="MIDDLE">2011.03~현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="145" AUNIT="SH5_FIH" AUNITVALUE="20230324" VALIGN="MIDDLE">2023년 03월 24일</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="76" ACODE="SH5_NM_T" VALIGN="MIDDLE">지신배</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="76" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="76" AUNIT="SH5_BIH" AUNITVALUE="196311" VALIGN="MIDDLE">1963년 11월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_LEV" VALIGN="MIDDLE">상무</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="76" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="76" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="76" ACODE="SH5_OBJ" VALIGN="MIDDLE">제1공장장</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="76" ACODE="SH5_SKL" VALIGN="MIDDLE">해룡고등학교 졸대화제약(주) 입사대화제약(주) 이사</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="76" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_PER" VALIGN="MIDDLE">1984.01~현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="53" ACODE="SH5_NM_T" VALIGN="MIDDLE">방신원</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="53" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="53" AUNIT="SH5_BIH" AUNITVALUE="197005" VALIGN="MIDDLE">1970년 05월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="SH5_LEV" VALIGN="MIDDLE">상무</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="53" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="53" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="53" ACODE="SH5_OBJ" VALIGN="MIDDLE">영업본부장</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="53" ACODE="SH5_SKL" VALIGN="MIDDLE">중앙대학교 대학원 경영학 석사대웅제약 근무</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="53" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">3,183</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="53" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="53" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="SH5_PER" VALIGN="MIDDLE">2020.09~현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_NM_T" VALIGN="MIDDLE">이명철</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="99" AUNIT="SH5_BIH" AUNITVALUE="197304" VALIGN="MIDDLE">1973년 04월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_LEV" VALIGN="MIDDLE">상무</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="99" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="99" ACODE="SH5_OBJ" VALIGN="MIDDLE">연구개발본부장</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="99" ACODE="SH5_SKL" VALIGN="MIDDLE">삼육대학교 약학과 졸서울대학교대학원 약학과 석사학위 취득성균관대학교대학원 약학과 박사학위 수료에스케이케미칼(주) 근무</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="99" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_PER" VALIGN="MIDDLE">2022.07~현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="53" ACODE="SH5_NM_T" VALIGN="MIDDLE">한남수</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="53" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="53" AUNIT="SH5_BIH" AUNITVALUE="195611" VALIGN="MIDDLE">1956년 11월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="53" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="53" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="53" ACODE="SH5_OBJ" VALIGN="MIDDLE">제2공장장</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="53" ACODE="SH5_SKL" VALIGN="MIDDLE">경원전문대학 기업경영학과 졸돌핀산업주식회사 근무</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="53" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="53" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="53" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="SH5_PER" VALIGN="MIDDLE">2002.08~현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="53" ACODE="SH5_NM_T" VALIGN="MIDDLE">안분연</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="53" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="53" AUNIT="SH5_BIH" AUNITVALUE="196509" VALIGN="MIDDLE">1965년 09월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="53" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="53" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="53" ACODE="SH5_OBJ" VALIGN="MIDDLE">정보시스템팀장</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="53" ACODE="SH5_SKL" VALIGN="MIDDLE">해성여자전산상업고등학교 졸(주)종근당 근무</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="53" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="53" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="53" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="53" ACODE="SH5_PER" VALIGN="MIDDLE">1992.05~현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="53" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="76" ACODE="SH5_NM_T" VALIGN="MIDDLE">윤종태</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="76" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="76" AUNIT="SH5_BIH" AUNITVALUE="197605" VALIGN="MIDDLE">1976년 05월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="76" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="76" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="76" ACODE="SH5_OBJ" VALIGN="MIDDLE">해외사업팀</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="76" ACODE="SH5_SKL" VALIGN="MIDDLE">서울시립대학교 도시행정학과 졸한울회계법인 이사회계법인새시대 총괄본부장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="76" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_PER" VALIGN="MIDDLE">2017.07~현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="76" ACODE="SH5_NM_T" VALIGN="MIDDLE">김태훈</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="76" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="76" AUNIT="SH5_BIH" AUNITVALUE="197508" VALIGN="MIDDLE">1975년 08월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="76" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="76" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="76" ACODE="SH5_OBJ" VALIGN="MIDDLE">인사총무팀장</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="76" ACODE="SH5_SKL" VALIGN="MIDDLE">성균관대학교 산업심리학과 졸CJ대한통운 근무한세실업 근무</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="76" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_PER" VALIGN="MIDDLE">2018.05~현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="76" ACODE="SH5_NM_T" VALIGN="MIDDLE">나재성</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="76" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="76" AUNIT="SH5_BIH" AUNITVALUE="196906" VALIGN="MIDDLE">1969년 06월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="76" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="76" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="76" ACODE="SH5_OBJ" VALIGN="MIDDLE">회계팀장</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="76" ACODE="SH5_SKL" VALIGN="MIDDLE">벌교상업고등학교 졸대화제약(주) 입사대화제약(주) 회계팀 팀장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="76" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_PER" VALIGN="MIDDLE">1993.02~현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="76" ACODE="SH5_NM_T" VALIGN="MIDDLE">전병윤</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="76" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="76" AUNIT="SH5_BIH" AUNITVALUE="196909" VALIGN="MIDDLE">1969년 09월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="76" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="76" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="76" ACODE="SH5_OBJ" VALIGN="MIDDLE">지방사업부장</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="76" ACODE="SH5_SKL" VALIGN="MIDDLE">동의대학교 사학과 졸대화제약(주) 입사대화제약(주) 부산1팀 팀장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">373</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="76" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_PER" VALIGN="MIDDLE">1997.05~현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="142" ACODE="SH5_NM_T" VALIGN="MIDDLE">추성남</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="142" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="142" AUNIT="SH5_BIH" AUNITVALUE="197701" VALIGN="MIDDLE">1977년 01월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="142" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="142" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="142" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="142" ACODE="SH5_OBJ" VALIGN="MIDDLE">연구소장</TE>

<TE ALIGN="CENTER" WIDTH="399" HEIGHT="142" ACODE="SH5_SKL" VALIGN="MIDDLE">
<P USERMARK="F-GL11">연세대학교 물리치료학과 학사강원대학교 경영대학원 경영학과 석사강원대학교 대학원 약학과 박사 수료</P>
<P USERMARK="F-GL11">대화제약(주) 입사대화제약(주) 제제연구팀 팀장</P>
</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="142" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">255</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="142" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="142" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="142" ACODE="SH5_PER" VALIGN="MIDDLE">2004.02~현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="142" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_NM_T" VALIGN="MIDDLE">오미경</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="SH5_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="99" AUNIT="SH5_BIH" AUNITVALUE="196307" VALIGN="MIDDLE">1963년 07월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="99" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="99" ACODE="SH5_OBJ" VALIGN="MIDDLE">제조약사</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="99" ACODE="SH5_SKL" VALIGN="MIDDLE">성균관대학교 약학과 졸알보젠코리아(주) 근무(주)네이처셀 근무(주)알바이오 근무</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">7</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="99" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_PER" VALIGN="MIDDLE">2021.07~현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="99" ACODE="SH5_NM_T" VALIGN="MIDDLE">윤국렬</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="99" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="99" AUNIT="SH5_BIH" AUNITVALUE="195708" VALIGN="MIDDLE">1957년 08월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="99" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="99" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="99" ACODE="SH5_OBJ" VALIGN="MIDDLE">해외사업팀</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="99" ACODE="SH5_SKL" VALIGN="MIDDLE">성균관대학교 약학과 졸성균관대학교대학원 제약학과 박사 졸(주)케미랜드 근무(주)마성상사 근무</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="99" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="99" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="99" ACODE="SH5_PER" VALIGN="MIDDLE">2021.11~현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="99" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="76" ACODE="SH5_NM_T" VALIGN="MIDDLE">김형민</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="76" AUNIT="SH5_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="76" AUNIT="SH5_BIH" AUNITVALUE="197608" VALIGN="MIDDLE">1976년 08월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_LEV" VALIGN="MIDDLE">이사</TE>
<TU ALIGN="CENTER" WIDTH="78" HEIGHT="76" AUNIT="SH5_REG_DRCT" AUNITVALUE="2" VALIGN="MIDDLE">미등기</TU>
<TU ALIGN="CENTER" WIDTH="63" HEIGHT="76" AUNIT="SH5_FUL" AUNITVALUE="1" VALIGN="MIDDLE">상근</TU>
<TE ALIGN="CENTER" WIDTH="123" HEIGHT="76" ACODE="SH5_OBJ" VALIGN="MIDDLE">생산지원팀</TE>
<TE ALIGN="CENTER" WIDTH="399" HEIGHT="76" ACODE="SH5_SKL" VALIGN="MIDDLE">명지대학교 정보통신공학과 졸대화제약(주) 입사대화제약(주) 생산지원팀 팀장</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTY" VALIGN="MIDDLE">30,562</TE>
<TE ALIGN="RIGHT" WIDTH="83" HEIGHT="76" ACODE="SH5_STK_VOTN" VALIGN="MIDDLE">-</TE>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="76" ACODE="SH5_RLTN" VALIGN="MIDDLE">없음</TE>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="SH5_PER" VALIGN="MIDDLE">2012.09~ 현재</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="SH5_FIH" AUNITVALUE="-" VALIGN="MIDDLE">-</TU>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK="F-GL"><작성 기준일 이후 변동 사항 </SPAN>
<SPAN USERMARK="F-GL11">>당사의 임원은 임원의현황표 제출일 현재 총 25명으로 등기임원은 7명, 미등기임원 18명(자문위원 4명 포함) 입니다. 이중 노병태, 김은석이 각자 대표를 맡고 있습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1521">

<COLGROUP>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="375"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="63" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성명</TH>
<TH WIDTH="48" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성별</TH>
<TH WIDTH="101" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">출생년월</TH>
<TH WIDTH="108" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직위</TH>
<TH WIDTH="93" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">등기임원여부</TH>
<TH WIDTH="63" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상근여부</TH>
<TH WIDTH="154" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담당업무</TH>
<TH WIDTH="384" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요경력</TH>
<TH WIDTH="166" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식수</TH>
<TH WIDTH="113" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">최대주주와의관계</TH>
<TH WIDTH="78" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재직기간</TH>
<TH WIDTH="150" HEIGHT="83" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">임기만료일</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="83" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">의결권있는 주식</TH>
<TH WIDTH="83" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">의결권없는 주식</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">김은석</TD>
<TD WIDTH="48" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">남</TD>
<TD WIDTH="101" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">1975년 11월</TD>
<TD WIDTH="108" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">사장</TD>
<TD WIDTH="93" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">사내이사</TD>
<TD WIDTH="63" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">상근</TD>
<TD WIDTH="154" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">대표이사</TD>
<TD WIDTH="384" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">성균관대학교 산업심리학과 졸성균관대학교대학원 경영학과 석사 졸부광약품(주)근무대화제약(주) 상무이사(주)리독스바이오 이사</TD>
<TD WIDTH="83" HEIGHT="122" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK=" U">169,926</TD>
<TD WIDTH="83" HEIGHT="122" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">최대주주의 자</TD>
<TD WIDTH="78" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">2008.02~ 현재</TD>
<TD WIDTH="150" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">2023년 03월 24일</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">윤종태</TD>
<TD WIDTH="48" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">남</TD>
<TD WIDTH="101" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">1976년 05월</TD>
<TD WIDTH="108" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" U">상무</TD>
<TD WIDTH="93" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">미등기</TD>
<TD WIDTH="63" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">상근</TD>
<TD WIDTH="154" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">해외사업팀</TD>
<TD WIDTH="384" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">서울시립대학교 도시행정학과 졸한울회계법인 이사회계법인새시대 총괄본부장</TD>
<TD WIDTH="83" HEIGHT="99" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="83" HEIGHT="99" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="113" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">없음</TD>
<TD WIDTH="78" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2017.07~현재</TD>
<TD WIDTH="150" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" U">오성종</TD>
<TD WIDTH="48" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" U">남</TD>
<TD WIDTH="101" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" U">1967년 09월</TD>
<TD WIDTH="108" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" U">이사</TD>
<TD WIDTH="93" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" U">미등기</TD>
<TD WIDTH="63" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" U">상근</TD>
<TD WIDTH="154" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" U">서울사업부장</TD>
<TD WIDTH="384" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" U">남원상업고등학교 졸(주)세일산업 근무(주)신보건영 근무대화제약(주) 인천1팀 팀장</TD>
<TD WIDTH="83" HEIGHT="99" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK=" U">1,000</TD>
<TD WIDTH="83" HEIGHT="99" ALIGN="RIGHT" VALIGN="MIDDLE" USERMARK=" U">-</TD>
<TD WIDTH="113" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" U">없음</TD>
<TD WIDTH="78" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" U">1997.09~ 현재</TD>
<TD WIDTH="150" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE" USERMARK=" U">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">※ 김은석 대표이사 주식수 변동, 윤종태 직위 변경, 오성종 미등기 이사 추가</P>

<P>
<SPAN USERMARK="F-GL B">나. 자문위원 </SPAN>
<SPAN USERMARK="F-GL11">(2022년 12월 31일 기준)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="894">

<COLGROUP>
<COL WIDTH="70"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="250"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="95"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="97"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직위</TH>
<TH WIDTH="62" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성명</TH>
<TH WIDTH="76" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">생년월일</TH>
<TH WIDTH="259" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">주요경력</TH>
<TH WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당담업무</TH>
<TH WIDTH="104" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식수</TH>
<TH WIDTH="106" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">재직기간</TH>
<TH WIDTH="106" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">명예회장(상근)</TD>
<TD WIDTH="62" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">김수지</TD>
<TD WIDTH="76" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">44.04.01</TD>
<TD WIDTH="259" HEIGHT="99" VALIGN="MIDDLE">성균관대학교 약학과 졸성균관대학교 대학원 무역학과 졸필립무역상사 근무대화제약(주) 대표이사 회장</TD>
<TD WIDTH="102" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">경영자문</TD>
<TD WIDTH="104" HEIGHT="99" ALIGN="RIGHT" VALIGN="MIDDLE">1,849,600</TD>
<TD WIDTH="106" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="106" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">최대주주 본인</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" HEIGHT="131" ALIGN="CENTER" VALIGN="MIDDLE">명예회장(상근)</TD>
<TD WIDTH="62" HEIGHT="131" ALIGN="CENTER" VALIGN="MIDDLE">이한구</TD>
<TD WIDTH="76" HEIGHT="131" ALIGN="CENTER" VALIGN="MIDDLE">47.02.18</TD>
<TD WIDTH="259" HEIGHT="131" VALIGN="MIDDLE">성균관대학교 약학과 졸성균관대학교 대학원 약학과 박사 졸중외제약(주)중앙연구소 부소장디에스앤지(주) 대표이사 사장대화제약(주) 대표이사 회장</TD>
<TD WIDTH="102" HEIGHT="131" ALIGN="CENTER" VALIGN="MIDDLE">경영자문</TD>
<TD WIDTH="104" HEIGHT="131" ALIGN="RIGHT" VALIGN="MIDDLE">621,300</TD>
<TD WIDTH="106" HEIGHT="131" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="106" HEIGHT="131" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">명예회장(상근)</TD>
<TD WIDTH="62" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">김운장</TD>
<TD WIDTH="76" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">45.09.21</TD>
<TD WIDTH="259" HEIGHT="99" VALIGN="MIDDLE">성균관대학교 약학과 졸성균관대학원 약학과 졸국립보건연구원 근무대화제약(주) 대표이사 회장</TD>
<TD WIDTH="102" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">경영자문</TD>
<TD WIDTH="104" HEIGHT="99" ALIGN="RIGHT" VALIGN="MIDDLE">813,000</TD>
<TD WIDTH="106" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="106" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="79" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">명예회장(상근)</TD>
<TD WIDTH="62" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">고준진</TD>
<TD WIDTH="76" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">46.12.31</TD>
<TD WIDTH="259" HEIGHT="99" VALIGN="MIDDLE">성균관대학교 약학과 졸한일약품 근무한국화이자(주) 근무대화제약(주) 부회장</TD>
<TD WIDTH="102" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">경영자문</TD>
<TD WIDTH="104" HEIGHT="99" ALIGN="RIGHT" VALIGN="MIDDLE">1,706,867</TD>
<TD WIDTH="106" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="106" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL10"></P>

<P>
<SPAN USERMARK="F-GL11 B">다. 임직원 겸직현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="526" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="59"></COL>
<COL WIDTH="171"></COL>
<COL WIDTH="201"></COL>
<COL WIDTH="59"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성    명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="180" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">겸직회사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="210" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직    위</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비    고</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="120">김수지</TD>
<TD WIDTH="180" HEIGHT="30">대화제약(주)</TD>
<TD WIDTH="210" HEIGHT="30">자문위원(미등기임원)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" HEIGHT="30">디에이치호림(주)</TD>
<TD WIDTH="210" HEIGHT="30">사내이사(등기임원)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" HEIGHT="30">(주)스페셜라이즈드메드</TD>
<TD WIDTH="210" HEIGHT="30">대표이사(등기임원)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" HEIGHT="30">(주)리독스바이오</TD>
<TD WIDTH="210" HEIGHT="30">대표이사(등기임원)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="60" ROWSPAN="2">고준진</TD>
<TD WIDTH="180" HEIGHT="30">대화제약(주)</TD>
<TD WIDTH="210" HEIGHT="30">자문위원(미등기임원)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" HEIGHT="30">디에이치호림(주)</TD>
<TD WIDTH="210" HEIGHT="30">사내이사(등기임원)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="60" ROWSPAN="2">이한구</TD>
<TD WIDTH="180" HEIGHT="30">대화제약(주)</TD>
<TD WIDTH="210" HEIGHT="30">자문위원(미등기임원)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" HEIGHT="30">(주)리독스바이오</TD>
<TD WIDTH="210" HEIGHT="30">대표이사(등기임원)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="60" ROWSPAN="2">김은석</TD>
<TD WIDTH="180" HEIGHT="30">대화제약(주)</TD>
<TD WIDTH="210" HEIGHT="30">대표이사(등기임원)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" HEIGHT="30">(주)리독스바이오</TD>
<TD WIDTH="210" HEIGHT="30">사내이사(등기임원)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30">비상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="120">강효원</TD>
<TD WIDTH="180" HEIGHT="30">대화제약(주)</TD>
<TD WIDTH="210" HEIGHT="30">상근감사(등기임원)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" HEIGHT="30">(주)리독스바이오</TD>
<TD WIDTH="210" HEIGHT="30">감사(등기임원)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30">비상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" HEIGHT="30">(주)스페셜라이즈드메드</TD>
<TD WIDTH="210" HEIGHT="30">감사(등기임원)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30">비상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="180" HEIGHT="30">디에이치호림(주)</TD>
<TD WIDTH="210" HEIGHT="30">감사(등기임원)</TD>
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="68" HEIGHT="30">비상근</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">라. 등기임원 선임 후보자 및 해임 대상자 현황</SPAN>
</P>

<LIBRARY>
<TABLE-GROUP ACLASS="PSN_MBER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="756" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="161"></COL>
<COL WIDTH="497"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="170" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="506" HEIGHT="30" AUPDATECONT="N">)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="853" BORDER="1">

<COLGROUP>
<COL WIDTH="39"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="92"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="256"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="104"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">구분</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">성별</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="101" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출생년월</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">사외이사후보자해당여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="265" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">주요경력</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="137" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">선ㆍ해임예정일</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="113" HEIGHT="76" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">최대주주와의관계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="76" AUNIT="PSN_APP" AUNITVALUE="Y" VALIGN="MIDDLE">선임</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="76" ACODE="PSN_NAM" VALIGN="MIDDLE">노병태</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="76" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="76" AUNIT="PSN_BIH" AUNITVALUE="196109" VALIGN="MIDDLE">1961년 09월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="76" ACODE="PSN_DIR" VALIGN="MIDDLE">사내이사</TE>
<TE ALIGN="CENTER" WIDTH="265" HEIGHT="76" ACODE="PSN_CAR" VALIGN="MIDDLE">(주)리독스바이오 이사대화제약(주) 대표이사 사장(現)대화제약(주) 대표이사 회장</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="76" AUNIT="PSN_DAT" AUNITVALUE="20230323" VALIGN="MIDDLE">2023년 03월 23일</TU>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="76" ACODE="PSN_RSP" VALIGN="MIDDLE">해당사항 없음</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="122" AUNIT="PSN_APP" AUNITVALUE="Y" VALIGN="MIDDLE">선임</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="122" ACODE="PSN_NAM" VALIGN="MIDDLE">김은석</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="122" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="122" AUNIT="PSN_BIH" AUNITVALUE="197511" VALIGN="MIDDLE">1975년 11월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="122" ACODE="PSN_DIR" VALIGN="MIDDLE">사내이사</TE>
<TE ALIGN="CENTER" WIDTH="265" HEIGHT="122" ACODE="PSN_CAR" VALIGN="MIDDLE">대화제약(주) 이사대화제약(주) 상무이사(現)(주)리독스바이오 이사(現)한국의약품수출입협회 부회장(現)대화제약(주) 대표이사 사장</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="122" AUNIT="PSN_DAT" AUNITVALUE="20230323" VALIGN="MIDDLE">2023년 03월 23일</TU>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="122" ACODE="PSN_RSP" VALIGN="MIDDLE">자</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="122" AUNIT="PSN_APP" AUNITVALUE="Y" VALIGN="MIDDLE">선임</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="122" ACODE="PSN_NAM" VALIGN="MIDDLE">이상태</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="122" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="122" AUNIT="PSN_BIH" AUNITVALUE="196408" VALIGN="MIDDLE">1964년 08월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="122" ACODE="PSN_DIR" VALIGN="MIDDLE">사내이사</TE>
<TE ALIGN="CENTER" WIDTH="265" HEIGHT="122" ACODE="PSN_CAR" VALIGN="MIDDLE">(주)리독스바이오 이사(주)씨트리 부사장대화제약(주) 이사대화제약(주) 상무이사(現)대화제약(주) 전무이사</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="122" AUNIT="PSN_DAT" AUNITVALUE="20230323" VALIGN="MIDDLE">2023년 03월 23일</TU>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="122" ACODE="PSN_RSP" VALIGN="MIDDLE">해당사항 없음</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="122" AUNIT="PSN_APP" AUNITVALUE="Y" VALIGN="MIDDLE">선임</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="122" ACODE="PSN_NAM" VALIGN="MIDDLE">박정일</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="122" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="122" AUNIT="PSN_BIH" AUNITVALUE="197004" VALIGN="MIDDLE">1970년 04월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="122" ACODE="PSN_DIR" VALIGN="MIDDLE">사외이사</TE>
<TE ALIGN="CENTER" WIDTH="265" HEIGHT="122" ACODE="PSN_CAR" VALIGN="MIDDLE">Law & Pharm 법률사무소 개설법무법인 로고스 구성원 변호사(現)한국의약연구소 사외이사(現)정연 법률사무소 구성원 변호사(現)한국의약연구소 감사위원</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="122" AUNIT="PSN_DAT" AUNITVALUE="20230323" VALIGN="MIDDLE">2023년 03월 23일</TU>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="122" ACODE="PSN_RSP" VALIGN="MIDDLE">해당사항 없음</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="145" AUNIT="PSN_APP" AUNITVALUE="Y" VALIGN="MIDDLE">선임</TU>
<TE ALIGN="CENTER" WIDTH="63" HEIGHT="145" ACODE="PSN_NAM" VALIGN="MIDDLE">강효원</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="145" AUNIT="PSN_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TU ALIGN="CENTER" WIDTH="101" HEIGHT="145" AUNIT="PSN_BIH" AUNITVALUE="195908" VALIGN="MIDDLE">1959년 08월</TU>
<TE ALIGN="CENTER" WIDTH="78" HEIGHT="145" ACODE="PSN_DIR" VALIGN="MIDDLE">감사</TE>
<TE ALIGN="CENTER" WIDTH="265" HEIGHT="145" ACODE="PSN_CAR" VALIGN="MIDDLE">국세청 근무근로복지공단 고문(주)대우건설 고문(現)세무법인 드림새시대 대표세무사(現)학교법인 경희학원 고문(現)대화제약(주) 상근감사</TE>
<TU ALIGN="CENTER" WIDTH="137" HEIGHT="145" AUNIT="PSN_DAT" AUNITVALUE="20230323" VALIGN="MIDDLE">2023년 03월 23일</TU>
<TE ALIGN="CENTER" WIDTH="113" HEIGHT="145" ACODE="PSN_RSP" VALIGN="MIDDLE">해당사항 없음</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
</LIBRARY>


<P>
<SPAN USERMARK="F-GL11 BU">※ 상기 표의 등기 선임 후보자 현황은 2023년 3월 23일 개최하는 정기주주 총회에서 선임 안건이 부결될 경우 정정보고서를 통해  그 내용을 수정하여반영할 예정입니다. </SPAN>
<SPAN USERMARK="F-GL B">마. 직원 등 현황</SPAN>
</P>
<P></P>

<TABLE-GROUP ACLASS="EMPLOYEE" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="854" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="487"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="496" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="856" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="124"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="60"></COL>
<COL WIDTH="44"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="24"></COL>
<COL WIDTH="24"></COL>
<COL WIDTH="24"></COL>
<COL WIDTH="39"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="709" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="10">직원</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="3">소속 외근로자</TH>
<TH ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="189" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비고</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="133" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">사업부문</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">성별</TH>
<TH COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="287" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">직 원 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">평 균근속연수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">연간급여총 액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="71" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">1인평균급여액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="33" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">남</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="33" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">여</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="33" HEIGHT="136" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="3">계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간의 정함이없는 근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="117" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">기간제근로자</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="53" HEIGHT="106" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">합 계</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간근로자)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">전체</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="69" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">(단시간근로자)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">의약품 제조 판매</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="1" VALIGN="MIDDLE">남</TU>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">223</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">28</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">251</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">6.8</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">13,110,839</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">52,234</TE>
<TE ALIGN="RIGHT" WIDTH="33" HEIGHT="90" ACODE="EMP_MAN" VALIGN="MIDDLE" ROWSPAN="3">-</TE>
<TE ALIGN="RIGHT" WIDTH="33" HEIGHT="90" ACODE="EMP_WOM" VALIGN="MIDDLE" ROWSPAN="3">9</TE>
<TE ALIGN="RIGHT" WIDTH="33" HEIGHT="90" ACODE="EMP_MW_TOTAL" VALIGN="MIDDLE" ROWSPAN="3">9</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" WIDTH="133" HEIGHT="30" ACODE="EMP_OPR" VALIGN="MIDDLE">의약품 제조 판매</TE>
<TU ALIGN="CENTER" WIDTH="48" HEIGHT="30" AUNIT="EMP_SEX" AUNITVALUE="2" VALIGN="MIDDLE">여</TU>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_REO" VALIGN="MIDDLE">150</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REOS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_COC" VALIGN="MIDDLE">11</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_COCS" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="30" ACODE="EMP_CN" VALIGN="MIDDLE">161</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="EMP_AVY" VALIGN="MIDDLE">4.5</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="EMP_AIC" VALIGN="MIDDLE">5,417,382</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_VIC" VALIGN="MIDDLE">33,648</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTE" VALIGN="MIDDLE">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" WIDTH="181" HEIGHT="30" AUPDATECONT="N" COLSPAN="2" VALIGN="MIDDLE">합 계</TD>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_REOT" VALIGN="MIDDLE">373</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_REOST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="48" HEIGHT="30" ACODE="EMP_COCT" VALIGN="MIDDLE">39</TE>
<TE ALIGN="RIGHT" WIDTH="69" HEIGHT="30" ACODE="EMP_COCST" VALIGN="MIDDLE">-</TE>
<TE ALIGN="RIGHT" WIDTH="53" HEIGHT="30" ACODE="EMP_CNT" VALIGN="MIDDLE">412</TE>
<TE ALIGN="RIGHT" WIDTH="78" HEIGHT="30" ACODE="EMP_AVYT" VALIGN="MIDDLE">5.9</TE>
<TE ALIGN="RIGHT" WIDTH="92" HEIGHT="30" ACODE="EMP_AICT" VALIGN="MIDDLE">18,528,221</TE>
<TE ALIGN="RIGHT" WIDTH="71" HEIGHT="30" ACODE="EMP_VICT" VALIGN="MIDDLE">44,971</TE>
<TE ALIGN="CENTER" WIDTH="48" HEIGHT="30" ACODE="NOTET" VALIGN="MIDDLE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P></P>

<P>
<SPAN USERMARK="F-GL B">바. 미등기임원 보수 현황</SPAN>
</P>

<TABLE-GROUP ACLASS="UNRESISTER" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="787" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="117"></COL>
<COL WIDTH="420"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="126" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="429" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="797" BORDER="1">

<COLGROUP>
<COL WIDTH="84"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="104"></COL>
<COL WIDTH="112"></COL>
<COL WIDTH="398"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="93" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="113" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">연간급여 총액</TH>
<TH WIDTH="121" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인평균 급여액</TH>
<TH WIDTH="407" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="93" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">미등기임원</TD>
<TE WIDTH="63" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_CNT"> 17 </TE>
<TE WIDTH="113" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_TOT">1,799,557</TE>
<TE WIDTH="121" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="URT_PAY_AVR">105,856</TE>
<TE WIDTH="407" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="URT_NOTE">2022년 12월 31일 현재 재직중인 미등기 임원의 보수 현황</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-8-2-0">2. 임원의 보수 등</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><이사ㆍ감사 전체의 보수현황></TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">가.  주주총회 승인금액</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="169"></COL>
<COL WIDTH="78"></COL>
<COL WIDTH="199"></COL>
<COL WIDTH="120"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="178" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">구 분</TH>
<TH WIDTH="87" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="208" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">주주총회 승인금액</TH>
<TH WIDTH="129" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">사내(외)이사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_NUM">6</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">3,000,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="178" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="PRT_PAY_SUB">감           사</TE>
<TE WIDTH="87" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_NUM">1</TE>
<TE WIDTH="208" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="PRT_PAY_KMY">50,000</TE>
<TE WIDTH="129" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>

<P>
<SPAN USERMARK="F-GL B">나. 보수지급금액</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">1)  이사ㆍ감사 전체</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_CMPT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="142"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">인원수</TH>
<TH WIDTH="151" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">1인당 평균보수액</TH>
<TH WIDTH="150" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="TRT_PAY_NUM">7 </TE>
<TE WIDTH="151" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_SUM">725,180</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="TRT_PAY_VIC">103,597</TE>
<TE WIDTH="150" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE5">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P>2) 유형별</P>

<TABLE-GROUP ACLASS="SUB_CMPP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="236"></COL>
<COL WIDTH="81"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
<COL WIDTH="80"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="245" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">구 분</TH>
<TH WIDTH="90" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">인원수</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">보수총액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">1인당평균보수액</TH>
<TH WIDTH="89" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">비고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">등기이사(사외이사, 감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="RRT_PAY_NUM">4 </TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_SUM">653,180</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="RRT_PAY_VIC">163,295</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE1">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" AUPDATECONT="N">사외이사(감사위원회 위원 제외)</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="ORT_PAY_NUM">2 </TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_SUM">48,000</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="ORT_PAY_VIC">24,000</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="NOTE2">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사위원회 위원</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="GRT_PAY_NUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_SUM">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="GRT_PAY_VIC">-</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE3">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="245" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N">감사</TD>
<TE WIDTH="90" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="AUD_PAY_NUM">1 </TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_SUM">24,000</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="AUD_PAY_VIC">24,000</TE>
<TE WIDTH="89" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="NOTE4">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL11">3) 이사ㆍ감사의 보수지급기준이사ㆍ감사의 보수는 주주총회의 승인을 받은 금액 내에서 해당 직위, 담당 직무 등을 감안하여 이사회에서 정한 기준에 따라 집행하고 있습니다</SPAN>
<SPAN USERMARK="F-GL B">다. 개인별 보수지급금액</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상인 이사ㆍ감사의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL">1. 개인별 보수지급금액</SPAN>
</P>

<TABLE-GROUP ACLASS="SUB_CMPK" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL">2) 산정기준 및 방법</P>

<TABLE BORDER="0" WIDTH="602" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR>
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="120" HEIGHT="30">이름</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="214" HEIGHT="30">보수의 종류</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="117" HEIGHT="30">총액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="149" HEIGHT="30">산정기준 및 방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="203">-</TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="99" HEIGHT="143">근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">급여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">상여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="53">주식매수선택권 행사이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="53">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">기타 근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">퇴직소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">기타소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">라.  보수지급금액 억 이상 중 상위 명의 개인별 보수 현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N"><보수지급금액 5억원 이상 중 상위 5명의 개인별 보수현황></TD>
</TR>
</TBODY>
</TABLE>
<P>1. 개인별 보수지급금액</P>

<TABLE-GROUP ACLASS="SUB_CMPK_HIGH" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="602" BORDER="1">

<COLGROUP>
<COL WIDTH="85"></COL>
<COL WIDTH="67"></COL>
<COL WIDTH="157"></COL>
<COL WIDTH="257"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="94" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">이름</TH>
<TH WIDTH="76" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">직위</TH>
<TH WIDTH="166" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액</TH>
<TH WIDTH="266" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="30">보수총액에 포함되지 않는 보수</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="94" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_NM">-</TE>
<TE WIDTH="76" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="30" ACODE="CMPK_LEV">-</TE>
<TE WIDTH="166" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_PAY">-</TE>
<TE WIDTH="266" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="30" ACODE="CMPK_NOTPAY">-</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>
<P></P>
<P>2. 산정기준 및 방법</P>

<TABLE BORDER="0" WIDTH="602" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="293"></COL>
</COLGROUP>

<TBODY>

<TR>
<TD WIDTH="300" HEIGHT="30" VALIGN="BOTTOM"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="302" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE BORDER="1" WIDTH="600" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="111"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="106"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="140"></COL>
</COLGROUP>

<THEAD>

<TR>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="120" HEIGHT="30">이름</TH>
<TH COLSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="214" HEIGHT="30">보수의 종류</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="117" HEIGHT="30">총액</TH>
<TH VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" ALIGN="CENTER" WIDTH="149" HEIGHT="30">산정기준 및 방법</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="6" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="120" HEIGHT="203">-</TD>
<TD ROWSPAN="4" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="99" HEIGHT="143">근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">급여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">상여</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="53">주식매수선택권 행사이익</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="53">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="53">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="115" HEIGHT="30">기타 근로소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">퇴직소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="214" HEIGHT="30">기타소득</TD>
<TD VALIGN="MIDDLE" ALIGN="RIGHT" WIDTH="117" HEIGHT="30">-</TD>
<TD VALIGN="MIDDLE" ALIGN="CENTER" WIDTH="149" HEIGHT="30">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P></P>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-9-0-0">IX. 계열회사 등에 관한 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11">당사는 보고서 작성기준일 지배회사는 5개의 계열회사를 두고 있습니다.</SPAN>
<SPAN USERMARK="F-GL16 0XFF1200 B">1. 계열회사 현황 등</SPAN>
<SPAN USERMARK="F-GL B">가. 계얄회사 현황(요약)</SPAN>
</P>

<TABLE-GROUP ACLASS="AFF_CMP_SMR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="253"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="262" HEIGHT="30" AUPDATECONT="N">(단위 : 사)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="1">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="60" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기업집단의 명칭</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="450" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계열회사의 수</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상장</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">비상장</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">계</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="BG_NM">대화</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="LST_COUNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="ULST_COUNT">5</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACODE="AFF_TOT">5</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="601" BORDER="0">

<COLGROUP>
<COL WIDTH="592"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="601" HEIGHT="30" AUPDATECONT="N">
<A REFNO="XII. 상세표|NEF-002|ADX-002">※상세 현황은 '상세표-2. 계열회사 현황(상세)' 참조</A>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<P></P>

<P>
<SPAN USERMARK="F-GL B">나. 계열회사간의 계통도</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1111">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="86"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="87"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="153" HEIGHT="106" ROWSPAN="2" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">-            피출자회사출자회사</TH>
<TH WIDTH="190" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">디에이치호림(주)(비상장)</TH>
<TH WIDTH="190" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(주)스페셜라이즈드메드(비상장)</TH>
<TH WIDTH="190" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">(주)리독스바이오(비상장/K-OCT등록)</TH>
<TH WIDTH="190" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">S&V Technologies GmbH(비상장)</TH>
<TH WIDTH="198" HEIGHT="53" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">BSC Medical Devices GmbH(비상장)</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식</TH>
<TH WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
<TH WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식</TH>
<TH WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
<TH WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식</TH>
<TH WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
<TH WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식</TH>
<TH WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
<TH WIDTH="102" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">소유주식</TH>
<TH WIDTH="96" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">지분율(%)</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="53">대화제약(주)(상장)</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">5,435,820</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">63.91</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">136,471</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">56.86</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">15,435,370</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">62.72</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">60</TD>
<TD WIDTH="102" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">60</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="54">디에이치호림(주)(비상장)</TD>
<TD WIDTH="95" HEIGHT="54" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="95" HEIGHT="54" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="95" HEIGHT="54" ALIGN="CENTER" VALIGN="MIDDLE">10,501</TD>
<TD WIDTH="95" HEIGHT="54" ALIGN="CENTER" VALIGN="MIDDLE">4.38</TD>
<TD WIDTH="95" HEIGHT="54" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="95" HEIGHT="54" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="95" HEIGHT="54" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="95" HEIGHT="54" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="102" HEIGHT="54" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="54" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" HEIGHT="53">(주)리독스바이오(비상장 /K-OCT등록)</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="95" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">40</TD>
<TD WIDTH="102" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="96" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">40</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">다. 임원 겸직현황</SPAN>
</P>

<TABLE ACLASS="NORMAL" WIDTH="772" BORDER="1" AFIXTABLE="N">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="210"></COL>
<COL WIDTH="145"></COL>
<COL WIDTH="200"></COL>
<COL WIDTH="89"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성    명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="219" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">겸직회사</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="154" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상장여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="209" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">직    위</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="98" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비    고</TH>
</TR>
</THEAD>

<TBODY ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="120">김수지</TD>
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">대화제약(주)</TD>
<TD WIDTH="154" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상장</TD>
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">자문위원(미등기임원)</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">디에이치호림(주)</TD>
<TD WIDTH="154" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비상장</TD>
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">사내이사(등기임원)</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(주)스페셜라이즈드메드</TD>
<TD WIDTH="154" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비상장</TD>
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">대표이사(등기임원)</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(주)리독스바이오</TD>
<TD WIDTH="154" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비상장(K-OCT 등록)</TD>
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">대표이사(등기임원)</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상    근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="60" ROWSPAN="2">고준진</TD>
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">대화제약(주)</TD>
<TD WIDTH="154" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상장</TD>
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">자문위원(미등기임원)</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">디에이치호림(주)</TD>
<TD WIDTH="154" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비사장</TD>
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">사내이사(등기임원)</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="60" ROWSPAN="2">이한구</TD>
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">대화제약(주)</TD>
<TD WIDTH="154" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상장</TD>
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">자문위원(미등기임원)</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(주)리독스바이오</TD>
<TD WIDTH="154" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비상장(K-OCT 등록)</TD>
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">대표이사(등기임원)</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="60" ROWSPAN="2">김은석</TD>
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">대화제약(주)</TD>
<TD WIDTH="154" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상장</TD>
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">대표이사(등기임원)</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(주)리독스바이오</TD>
<TD WIDTH="154" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비상장(K-OCT 등록)</TD>
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">사내이사(등기임원)</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="92" HEIGHT="120">강효원</TD>
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">대화제약(주)</TD>
<TD WIDTH="154" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상장</TD>
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상근감사(등기임원)</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">상   근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(주)리독스바이오</TD>
<TD WIDTH="154" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비상장(K-OCT 등록)</TD>
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">감사(등기임원)</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">(주)스페셜라이즈드메드</TD>
<TD WIDTH="154" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비상장</TD>
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">감사(등기임원)</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비상근</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="219" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">디에이치호림(주)</TD>
<TD WIDTH="154" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비상장</TD>
<TD WIDTH="209" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">감사(등기임원)</TD>
<TD WIDTH="98" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">비상근</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL B">라. 타법인 출자 현황(요약)</SPAN>
</P>

<TABLE-GROUP ACLASS="INV_PRT_SMR" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="617" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="270"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="279" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="620" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="40"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="91"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
<COL WIDTH="90"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="113" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출자목적</TH>
<TH COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="145" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">출자회사수</TH>
<TH COLSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="397" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">총 출자금액</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="49" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">상장</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">비상장</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">계</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">기초장부가액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="198" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" COLSPAN="2">증가(감소)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="83" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ROWSPAN="2">기말장부가액</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">취득(처분)</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="53" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">평가손익</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUPDATECONT="N">경영참여</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="49" HEIGHT="30" ACODE="MP_LST_CNT">0</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="MP_ULST_CNT">6</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="MP_TOT_CNT">6</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACODE="MP_BASE_PRC">12,875,549</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="MP_PTM">737,078</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="MP_PPM">-900,000</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="MP_FIN_PRC">12,712,627</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUPDATECONT="N">일반투자</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="49" HEIGHT="30" ACODE="ETC_LST_CNT">0</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="ETC_ULST_CNT">0</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="ETC_TOT_CNT">0</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACODE="ETC_BASE_PRC">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="ETC_PTM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="ETC_PPM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="ETC_FIN_PRC">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUPDATECONT="N">단순투자</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="49" HEIGHT="30" ACODE="SC_LST_CNT">8</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SC_ULST_CNT">2</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="SC_TOT_CNT">10</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACODE="SC_BASE_PRC">4,394,785</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="SC_PTM">20,840</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="SC_PPM">-462,140</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="SC_FIN_PRC">3,953,485</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" AUPDATECONT="N">계</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="49" HEIGHT="30" ACODE="TOT_LST_CNT">8</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="TOT_ULST_CNT">8</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="48" HEIGHT="30" ACODE="TOT_TOT_CNT">16</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="100" HEIGHT="30" ACODE="TOT_BASE_PRC">17,270,334</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="TOT_PTM">757,918</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="TOT_PPM">-1,362,140</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="99" HEIGHT="30" ACODE="TOT_FIN_PRC">16,666,112</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="593"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="602" HEIGHT="30" AUPDATECONT="N">
<A REFNO="XII. 상세표|NEF-003|ADX-003">※상세 현황은 '상세표-3. 타법인출자 현황(상세)' 참조</A>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-10-0-0">X. 대주주 등과의 거래내용</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL16 0XFF1200 B">1. 채무보증 내역 등</SPAN>
<SPAN USERMARK="F-GL B">가. 채무보증 내역</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11 U">"XI. 그 밖에 투자자 보호를 위하여 필요한 사항" 중 "2. 우발부채 등에 관한사항 중 나. 타인을 위하여 제공한 지급보증의 내역" 을 참조 하시기 바랍니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">나. 담보제공 내역</SPAN>
<SPAN USERMARK="F-GL11 U">"XI. 그 밖에 투자자 보호를 위하여 필요한 사항" 중 "2. 우발부채 등에 관한사항 중 다. 담보제공내역" 을 참조 하시기 바랍니다.</SPAN>
<SPAN USERMARK="F-GL B">다. 금전대여</SPAN>
<SPAN USERMARK="F-GL11">지배회사는 보고서 작성 기준일 현재 종속회사인 (주)스페셜라이즈드메드에게 387백만원을 연 4% 이율로 금전대여를 하였습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">라. 주요거래 내역</SPAN>
</P>
<P></P>
<P></P>

<P>
<SPAN USERMARK="F-GL11">1) 당기말과 전기말 현재 특수관계자와의 중요한 영업상의 거래내용</SPAN>
<SPAN USERMARK="F-GL11">                                                                                             (단위 : 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="552">

<COLGROUP>
<COL WIDTH="165"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="108"></COL>
<COL WIDTH="107"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="174" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="145" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">거래내역</TH>
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="117" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">누적</TH>
<TH WIDTH="116" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">누적</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" HEIGHT="90" ROWSPAN="3" VALIGN="MIDDLE"> 디에이치호림㈜</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매출</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,869</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">13,724</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매입</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">401,542</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">346,106</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">임대료수익</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,614</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,517</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE"> ㈜스페셜라이즈드메드</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매출</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,700</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매입</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">250,330</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">243,374</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" HEIGHT="60" ROWSPAN="2" VALIGN="MIDDLE"> ㈜리독스바이오</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매출</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,400</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매입</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">9,847,189</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,301,291</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="174" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">합 계</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매출</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,269</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">16,424</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">매입</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">10,499,061</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,890,771</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">임대료수익</TD>
<TD WIDTH="117" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,614</TD>
<TD WIDTH="116" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">94,517</TD>
</TR>
</TBODY>
</TABLE>

<P> 
<SPAN USERMARK="F-GL11">2) 당기말과 전기말 현재 특수관계자에 대한 채권ㆍ채무의 내역                                                                                                     (단위 : 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="873">

<COLGROUP>
<COL WIDTH="162"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="136"></COL>
<COL WIDTH="135"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="171" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">회사명</TH>
<TH WIDTH="123" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">거래내역</TH>
<TH WIDTH="290" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기</TH>
<TH WIDTH="289" HEIGHT="30" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">전기</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권 등</TH>
<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채무 등</TH>
<TH WIDTH="145" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권 등</TH>
<TH WIDTH="144" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채무 등</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="90" ROWSPAN="3" VALIGN="MIDDLE">디에이치호림(주)</TD>
<TD WIDTH="123" HEIGHT="30">외상매출금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">3,638</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,958</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30">미지급금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,166</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">36,179</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30">임대보증금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100,000</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="30" VALIGN="MIDDLE">(주)스페셜라이즈드메드</TD>
<TD WIDTH="123" HEIGHT="30">미지급금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">38,381</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">15,562</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="60" VALIGN="MIDDLE" ROWSPAN="2">(주)리독스바이오</TD>
<TD WIDTH="123" HEIGHT="30">외상매출금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">2,640</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30">외상매입금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,670,514</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">548,716</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="171" HEIGHT="120" ROWSPAN="4" VALIGN="MIDDLE">          합   계</TD>
<TD WIDTH="123" HEIGHT="30">외상매출금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">6,278</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">25,958</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30">미지급금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">74,547</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">51,741</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30">임대보증금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100,000</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">100,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="123" HEIGHT="30">외상매입금</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,670,514</TD>
<TD WIDTH="145" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">-</TD>
<TD WIDTH="144" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">548,716</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-0-0">XI. 그 밖에 투자자 보호를 위하여 필요한 사항</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-1-0">1. 공시내용 진행 및 변경사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">가. 단일판매 공급계약 체결</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1267">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="169"></COL>
<COL WIDTH="790"></COL>
<COL WIDTH="189"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신고일자</TH>
<TH WIDTH="178" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제목</TH>
<TH WIDTH="799" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신고내용</TH>
<TH WIDTH="198" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신고사항의 진행사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="283" VALIGN="MIDDLE">2016.09.08</TD>
<TD WIDTH="178" HEIGHT="283" ALIGN="CENTER" VALIGN="MIDDLE">단일판매 공급계약 체결</TD>
<TD WIDTH="799" HEIGHT="283">1. 판매 공급계약 내용 : 말레이시아 및 부루나이지역 완제의약품 판매공급계약2. 계약금액 : 17,981,814,801원(USD16,448,787.78)3. 계약상대방 : Ocean One Pharma Sdn Bhd4. 판매ㆍ공급지역 : 말레이시아, 브루나이5. 계약기간 : 2016년 09월 08일 부터 2021년 09월 08일 까지6. 주요 계약조건    ① 판매제품 : 비디카정(간질환치료제), 바라티스정(B형감염치료제) 등 8개 제품    ② 계약기간 : 제품의 허가 완료후 5년간이며, 계약만료일전 3개월 이내에 쌍방 중 어느 일방이 종료의사를 표시하        하지 않을 경우 2년씩 자동 연장됩니다.    ③ 말레이시아 및 브루나이내 허가를 완료 후 공급할 예정임.7. 기타사항    상기 종료일은 허가완료 기간이 포함되지 않은 기간으로 향후 허가 기간에 따라 변경 될수 있음.</TD>
<TD USERMARK=" B" WIDTH="198" HEIGHT="520" ALIGN="CENTER" ROWSPAN="2">(정정공시) 2021년 9월 8일 계약기간 연장 및 계약금액 변경으로 정정공시.(진행사항) 해당 개별 제품군 현지 인허가 추진 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="237" VALIGN="MIDDLE">2021.09.08(정정공시)</TD>
<TD WIDTH="178" HEIGHT="237" ALIGN="CENTER" VALIGN="MIDDLE">단일판매 공급계약 체결</TD>

<TD WIDTH="799" HEIGHT="237">1. 판매 공급계약 내용 : 말레이시아 및 부루나이지역 완제의약품 판매공급계약2. 계약금액 : 9,662,747,855원(USD8,349,388,.97)3. 계약상대방 : Eucogen Pharma Sdn Bhd4. 판매ㆍ공급지역 : 말레이시아, 브루나이5. 계약기간 : 2016년 09월 08일 부터 2026년 09월 07일 까지6. 주요 계약조건    ① 판매제품 : 비디카정(간질환치료제), 바라티스정(B형감염치료제) 등 5개 제품    ② 계약기간 :  5년간 유효하며, 계약 만료일전 3개월 이내에 쌍방 중 어느 일방이 종료의사를 표시하지 않는 경우        2년씩 자동연장됩니다.      ③ 말레이시아 및 브루나이내 허가를 완료 후 공급할 예정임
<SPAN USERMARK=" B">.</SPAN>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1264">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="167"></COL>
<COL WIDTH="793"></COL>
<COL WIDTH="185"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신고일자</TH>
<TH WIDTH="176" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제목</TH>
<TH WIDTH="802" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신고내용</TH>
<TH WIDTH="194" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신고사항의 진행사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="375" VALIGN="MIDDLE">2016.10.12</TD>
<TD WIDTH="176" HEIGHT="375" ALIGN="CENTER" VALIGN="MIDDLE"> 단일판매 공급계약 체결</TD>
<TD WIDTH="802" HEIGHT="375">1. 판매 공급계약 내용 : GCC(Gulf Cooperation Council) & MENA(Middle East and North Africa)권역 11개 국가 완제의약품 판매공급 계약2. 계약금액 : 22,476,954,620원(USD20,119,007)3. 계약상대방 : NOV0SCI사(아랍에미레이트)4. 판매ㆍ공급지역 : 사우디아라비아, 아랍에미레이트, 쿠웨이트, 카타르, 오만, 바레인, 레바논, 요르단, 이란, 알제리, 이집트  5. 계약기간 : 2016년 10월 12일 부터 2021년 10월 11일 까지6. 주요 계약조건    ① 판매제품 : 레스날렌패취(호흡기질환치료제), 가스트릭캡슐(소화기관치료제), 아세렌캡슐(골관절염치료제), 후                        로스판정(진경제), HA필러(주름개선의료기기)     ② 계약기간 : 제품의 허가 완료후 5년간이며, 계약만료일전 3개월 이내에 쌍방 중 어느 일방이 종료의사를 표시하                        지 않는 경우 2년씩 자동 연장됩니다.     ③ 사우디아라비아등 11개국에 제품의 허가를 완료 후 공급할 예정임.7. 기타사항    상기 종료일은 허가완료 기간이 포함되지 않은 기간으로 향후 허가 기간에 따라 변경 될수 있음.</TD>
<TD USERMARK=" B" WIDTH="194" HEIGHT="681" ALIGN="CENTER" ROWSPAN="2">(정정공시) 2021년 9월 8일 계약기간 연장 및 계약금액 변경으로 정정공시.(진행사항) 해당 개별 제품들에 대한 각 지역별 현지 인허가 추진 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="306" VALIGN="MIDDLE">2021.10.06(정정공시)</TD>
<TD WIDTH="176" HEIGHT="306" ALIGN="CENTER" VALIGN="MIDDLE">단일판매 공급계약 체결</TD>
<TD WIDTH="802" HEIGHT="306">1. 판매 공급계약 내용 : GCC(Gulf Cooperation Council) & MENA(Middle East and North Africa)권역 11개 국가 완제의약품 판매공급 계약2. 계약금액 :  11,942,752,371원(USD10,059,596)3. 계약상대방 : NOV0SCI사(아랍에미레이트)4. 판매ㆍ공급지역 : 사우디아라비아, 아랍에미레이트, 쿠웨이트, 카타르, 오만, 바레인, 레바논, 요르단, 이란, 알제리, 이집트  5. 계약기간 : 2016년 10월 12일 부터 2026년 10월 11일 까지6. 주요 계약조건    ① 판매제품 : 가스트릭캡슐(소화기관치료제), 후로스판정(진경제)    ② 계약기간 :  5년간 유효하며, 계약 만료일전 3개월 이내에 쌍방 중 어느 일방이 종료의사를 표시하지 않는 경우 2        년씩 자동연장됩니다    ③ 사우디아라비아등 11개국에 제품의 허가를 완료 후 공급할 예정임.</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1261">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="165"></COL>
<COL WIDTH="796"></COL>
<COL WIDTH="181"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신고일자</TH>
<TH WIDTH="174" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제목</TH>
<TH WIDTH="805" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신고내용</TH>
<TH WIDTH="190" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신고사항의 진행사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="605" VALIGN="MIDDLE">2018.06.21</TD>
<TD WIDTH="174" HEIGHT="605" ALIGN="CENTER" VALIGN="MIDDLE"> 단일판매 공급계약 체결</TD>
<TD WIDTH="805" HEIGHT="605">1. 판매 공급계약 내용 : 중국 Sinopharm Zhijun(shenzhen) Pharmaceutical 社에 미용의료기기인 amalian SF line 중국 권역 독점공급계약 체결2. 계약금액 : 15,310,331,427원(CNY 89,429,506)3. 계약상대방 : Sinopharm Zhijun(shenzhen) Pharmaceutical(중국)4. 판매ㆍ공급지역 : 중국 권역(중국, 홍콩, 마카오, 대만)5. 계약기간 : 계약기간 시작일은 중국권역내 허가완료일 이며 종료일은 계약기간 시작일 부터 5년간임. 6. 주요 계약조건 ①판매제품  - SF Fine(16mg/1ml),SF Fine(16mg/2ml)  - SF Midium(20mg/1ml), SF Midium(20mg/2ml)  - SF Advanced(24mg/1ml), SF Advanced(24mg/2ml) ②계약기간  -제품의 허가 완료후 10년간이며 계약만료일전 90일 이내에 쌍방 중 어느 일방이 종료의사를 표시하지 않는 경우 5년씩 자동연장.  -1~5년차 까지는 공급금액을 확정하였고, 6년차 부터 10년차 까지는 6년차에 재논의 예정입니다. ③계약금액:CNY 89,429,506  -1년차 :CNY  4,165,288  -2년차 :CNY  8,511,676  -3년차 :CNY 12,288,894  -4년차 :CNY 22,225,847  -5년차 :CNY 42,237,8017. 기타  년도별 계약금액은 상기 판매제품 종류별 평균가격과 종류별 예상판비율 및 의무공급수량을 감안하여 계산한 금액임</TD>
<TD USERMARK=" B" WIDTH="190" HEIGHT="605" ALIGN="CENTER">임상 최종보고서 2023년 3월 도출 및 2023년 상반기 인허가 접수 목표로 진행 중</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1262">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="166"></COL>
<COL WIDTH="797"></COL>
<COL WIDTH="180"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신고일자</TH>
<TH WIDTH="175" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제목</TH>
<TH WIDTH="806" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신고내용</TH>
<TH WIDTH="189" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신고사항의 진행사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="605" VALIGN="MIDDLE">2018.11.27</TD>
<TD WIDTH="175" HEIGHT="605" ALIGN="CENTER" VALIGN="MIDDLE"> 단일판매 공급계약 체결</TD>
<TD WIDTH="806" HEIGHT="605">1. 판매 공급계약 내용 : 알제리 REPARTIDIS社와 소염진통패치 2품목, 모기패치 1품목 공급계약 체결2. 조건부 계약금액 : 12,876,395,000원(USD 11,390,000)3. 계약상대방 : REPARTIDIS4. 판매ㆍ공급지역 : 알제리5. 계약기간 : 2018.11.25~2023.11.25 6. 주요 계약조건 계약 후 알제리내 허가를 완료 후 공급하는 조건부 계약입니다. ①판매제품 - PHEUFEN-FREE PLASTER - PLOCFEN CATAPLASMA - MOKICOOL PATCH ②계약기간  5년간이며 계약만료일전 3개월 이내에 쌍방 중 어느 일방이 종료의사를 표시하지 않는 경우 2년씩 자동 연장됩니다. 씩 자동연장. ③계약금액 : USD 11,390,000    - 1년차 : USD 1,766,000    - 2년차 : USD 2,136,000    - 3년차 : USD 2,496,000    - 4년차 : USD 2,496,000    - 5년차 : USD 2,496,000 7.상기 계약기간은 허가에 소요되는 기간을 포함한 기간으로 향후 허기가 지체될 경우 계약 기간내에 이행될 계약금액이 감소 될수 있습니다. </TD>
<TD USERMARK=" B" WIDTH="189" HEIGHT="605" ALIGN="CENTER">해당 개별 제품 현지 인허가 추진 중</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL B">나. 신규시설 투자 결정</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1100">

<COLGROUP>
<COL WIDTH="83"></COL>
<COL WIDTH="194"></COL>
<COL WIDTH="643"></COL>
<COL WIDTH="144"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="92" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신고일자</TH>
<TH WIDTH="203" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제목</TH>
<TH WIDTH="652" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신고내용</TH>
<TH WIDTH="153" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">신고사항의 진행사항</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="99" VALIGN="MIDDLE">2020.09.21</TD>
<TD WIDTH="203" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">신규시설 투자 등(횡성 공장내 제4공장 신설)</TD>
<TD WIDTH="652" HEIGHT="99">1. 투자금액 : 42,000,000,000원 (자기자본 대비 49.97%)2. 투자목적 : TDDS 특화 기술을 바탕으로 TDDS 전문 제품 생산 시설 확대를 통한 경쟁력 강화3. 투자기간 : 2020년 9월 21일부터 2023년 1월 31일까지 4. 소재지 : 강원도 횡성군 횡성읍 한우로 495 </TD>
<TD WIDTH="153" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">투자완료</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="92" HEIGHT="99" VALIGN="MIDDLE">2023.01.30</TD>

<TD WIDTH="203" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">신규시설 투자 등(횡성 공장내
<SPAN USERMARK=" U"> 제2공장 B동 </SPAN>신설)
</TD>

<TD WIDTH="652" HEIGHT="99">1. 투자금액 :
<SPAN USERMARK=" U"> 40,470,337,438원 (자기자본 대비 48.15%)</SPAN>2. 투자목적 : TDDS 특화 기술을 바탕으로 TDDS 전문 제품 생산 시설 확대를 통한 경쟁력 강화3. 투자기간 : 2020년 9월 21일부터 2023년 1월 31일까지 4. 소재지 : 강원도 횡성군 횡성읍 한우로 495 
</TD>
<TD WIDTH="153" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">투자완료(기 공시 정정 보고)</TD>
</TR>
</TBODY>
</TABLE>
<P USERMARK="F-GL11">※ 작성 기준일 이후 제출일 현재 신규시설 투자 등에 따른 이행 내역을 반형하였습니다. </P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-2-0">2. 우발부채 등에 관한 사항</TITLE>

<P>
<SPAN USERMARK="F-GL B">가. 금융기관과의 약정사항</SPAN>
</P>
<P></P>

<P>
<SPAN USERMARK="F-GL">당기말 현재 연결회사가 금융기관과 체결한 주요 약정사항은 다음과 같습니다.</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="0" WIDTH="614">

<COLGROUP>
<COL WIDTH="605"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="614" HEIGHT="30" ALIGN="RIGHT">(단위: 천원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="622">

<COLGROUP>
<COL WIDTH="222"></COL>
<COL WIDTH="187"></COL>
<COL WIDTH="186"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="231" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정사항</TH>
<TH WIDTH="196" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">한 도</TH>
<TH WIDTH="195" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">약정금융기관</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" VALIGN="MIDDLE"> 당좌차월</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">1,200,000</TD>
<TD WIDTH="195" HEIGHT="180" ROWSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE">기업은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" VALIGN="MIDDLE"> L/C 개설약정</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">USD 100,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" VALIGN="MIDDLE"> 시설자금대출</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">55,400,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" VALIGN="MIDDLE"> 회전자금대출한도약정</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">22,500,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" VALIGN="MIDDLE"> 구매자금대출</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,000,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" VALIGN="MIDDLE"> 일반자금대출</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,810,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" VALIGN="MIDDLE">일반자금대출</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">5,000,000</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">신한은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" VALIGN="MIDDLE"> 일반자금대출</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">7,500,000</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">우리은행</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="231" HEIGHT="30" VALIGN="MIDDLE"> 일반자금대출</TD>
<TD WIDTH="196" HEIGHT="30" ALIGN="RIGHT" VALIGN="MIDDLE">4,000,000</TD>
<TD WIDTH="195" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">하나은행</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL">
<SPAN USERMARK=" B">나. 타인을 위하여 제공한 지급보증의 내역</SPAN>
<SPAN USERMARK="F-11">당기말 현재 회사는 종속기업인 디에이치호림(주), (주)스페셜라이즈드메드, (주)리독스바이오가 금융기관과 체결한 구매자금대출에 대하여 아래와 같이 지급보증을 제공하고 있습니다.</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL11">1)  채무보증 내역 [2022.12.31현재]                                                                       (단위 : 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1058">

<COLGROUP>
<COL WIDTH="201"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="173"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="163"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="210" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성 명(법인명)</TH>
<TH WIDTH="78" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관 계</TH>
<TH WIDTH="598" HEIGHT="30" COLSPAN="6" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채 무 보 증 내 역</TH>
<TH WIDTH="172" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비 고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="78" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권자</TH>
<TH WIDTH="78" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채무내용</TH>
<TH WIDTH="182" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">보증기간</TH>
<TH WIDTH="260" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">거 래 내 역</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="84" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="92" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감</TH>
<TH WIDTH="84" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE">디에이치호림(주) 
<SPAN USERMARK="F-10">주1)</SPAN>
</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER">종속회사</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER">지급보증</TD>
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022.06.22 ~2023.06.16</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT">6,000,000</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">-2,400,000</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT">3,600,000</TD>
<TD WIDTH="172" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">구매자금대출보증 주1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="210" HEIGHT="32" VALIGN="MIDDLE">(주)스페셜라이즈드메드 
<SPAN USERMARK="F-10">주2)</SPAN>
</TD>
<TD WIDTH="78" HEIGHT="32" ALIGN="CENTER">종속회사</TD>
<TD WIDTH="78" HEIGHT="32" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="78" HEIGHT="32" ALIGN="CENTER">지급보증</TD>
<TD WIDTH="182" HEIGHT="32" VALIGN="MIDDLE" ALIGN="CENTER">2022.06.17 ~2023.06.16</TD>
<TD WIDTH="84" HEIGHT="32" ALIGN="RIGHT">240,000</TD>
<TD WIDTH="92" HEIGHT="32" ALIGN="RIGHT">-</TD>
<TD WIDTH="84" HEIGHT="32" ALIGN="RIGHT">240,000</TD>
<TD WIDTH="172" HEIGHT="32" ALIGN="CENTER" VALIGN="MIDDLE">일반자금대출보증 주2)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE">(주)리독스바이오</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER">종속회사</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER">지급보증</TD>
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">2022.05.26~2023.01.29</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT">-</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">1,200,000</TD>

<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT">
<SPAN USERMARK=" BC0X31FFFF">1,200,000</SPAN>
</TD>
<TD WIDTH="172" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE"> 회전자금대출보증</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="210" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">합     계</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="182" HEIGHT="30" VALIGN="MIDDLE" ALIGN="CENTER">-</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT">6,240,000</TD>
<TD WIDTH="92" HEIGHT="30" ALIGN="RIGHT">-1,200,000</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT">5,040,000</TD>
<TD WIDTH="172" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P USERMARK="F-GL10 0X1814FF">
<SPAN USERMARK=" 0X000000">주1) 디에이치호림(주)의 구매자금대출에 대해 2022년 4월 29일 디에이치호림(주) 지급보증 24억원 감소, 2022년 6월 22일 보증기간 1년 연장 하였습니다.주2) (주)스페셜라이즈드메드의 일반자금대출에 대해 2022년 6월 17일 보증기간 1년 연장 하였습니다</SPAN>
</P>

<P>
<SPAN USERMARK="F-GL B">다. 담보제공 내역</SPAN>
<SPAN USERMARK="F-GL11">[2022.12.31 현재]                                                                        (단위 : 천원)</SPAN>
</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="773">

<COLGROUP>
<COL WIDTH="126"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="96"></COL>
<COL WIDTH="142"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="74"></COL>
<COL WIDTH="75"></COL>
<COL WIDTH="44"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="135" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">성 명(법인명)</TH>
<TH WIDTH="78" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">관 계</TH>
<TH WIDTH="507" HEIGHT="30" COLSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담 보 제 공 내 역</TH>
<TH WIDTH="53" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비 고</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="105" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">채권자</TH>
<TH WIDTH="151" HEIGHT="60" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">담보내용</TH>
<TH WIDTH="251" HEIGHT="30" COLSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">거 래 내 역</TH>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="84" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기초</TH>
<TH WIDTH="83" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">증감</TH>
<TH WIDTH="84" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">당기말</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="30" VALIGN="MIDDLE">디에이치호림(주)</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER">종속회사</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER">기업은행</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="CENTER">대전사옥</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT">2,400,000</TD>
<TD WIDTH="83" HEIGHT="30" ALIGN="RIGHT">2,400,000</TD>

<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT" USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000">4,800,000</SPAN>
</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">주1)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="30" VALIGN="MIDDLE">디에이치호림(주)</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER">종속회사</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER">백제약품(주)</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="CENTER">자기주식 230,000주</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT">2,144,000</TD>
<TD WIDTH="83" HEIGHT="30" ALIGN="RIGHT">18,000</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT">2,162,000</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">주2)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="135" HEIGHT="30" VALIGN="MIDDLE">   합      계</TD>
<TD WIDTH="78" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="105" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="151" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT">4,544,000</TD>
<TD WIDTH="83" HEIGHT="30" ALIGN="RIGHT">2,418,000</TD>
<TD WIDTH="84" HEIGHT="30" ALIGN="RIGHT">6,962,000</TD>
<TD WIDTH="53" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>

<P>
<SPAN USERMARK="F-GL10">주1) 디에이치호림(주)의 구매자금대출에 대해 2022년 4월 29일 24억원 증액하여 담보제공 하였습니다.주2) 디에이치호림㈜와 판매계약을 맺고 있는 백제약품에 대화제약은 자사주 230,000주에 대하여 담보를 제공하고 있습니다. 금액 평가는 매 신고기준일의 코스닥시장거래의 종가기준(2022년 12월 29일, 9,400원)으로 평가하여 산출하였습니다.</SPAN>
</P>
<P></P>
<P></P>
<P USERMARK="F-GL"></P>
<P USERMARK="F-GL B">라. 견질 또는 담보용 어음ㆍ수표 현황</P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="291"></COL>
<COL WIDTH="291"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">(기준일 : )</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="300" HEIGHT="30">(단위 : 매, 백만원)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" WIDTH="600" BORDER="1" FRAME="BORDER" RULES="ALL">

<COLGROUP>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
<COL WIDTH="141"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">제 출 처</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">매 수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">금 액</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="150" HEIGHT="30" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">비 고</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">은 행</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">금융기관(은행제외)</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">법 인</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">기타(개인)</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
<TD ALIGN="CENTER" WIDTH="150" HEIGHT="30" VALIGN="MIDDLE">-</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-3-0">3. 제재 등과 관련된 사항</TITLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11">해당사항 없습니다. </SPAN>
</P>

<P></P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-0-11-4-0">4. 작성기준일 이후 발생한 주요사항 등 기타사항</TITLE>

<P>
<SPAN USERMARK="F-GL B">가. 정부의 인증</SPAN>
<SPAN USERMARK="F-GL11">1) 혁신형 제약기업 인증</SPAN>
<SPAN USERMARK="F-GL11">당사는 2012년 6월 20일에 혁신형 제약기업 인증을 시작으로 2015년 06월 20일 3년간 재인증, 2018년 6월 20일 부터 3년간 재인증, 2021년 6월 20일 부터 3년간 재인증되었습니다. 혁신형 제약기업 인증은 국가 R&D 사업에 우선 참여, 세제 지원, 인증마크 사용등의 지원을 받을 수 있는 제도입니다.  (1) 근거법령 :「제약산업 육성 및 지원에 관한 특별법」제7조제2항 및 같은법 시행                             규칙 제3조3항  (2) 인증부서 : 보건복지부  (3) 인증날짜 : 2021년 06월 20일  (4) 유효기간 : 2021년 06월 20일 부터 2024년 06월 19일 까지 (3년)</SPAN>
</P>

<P></P>
<PGBRK></PGBRK>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y" AASSOCNOTE="TTL_APPENDIX">XII. 상세표</TITLE>
<P></P>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y">1. 연결대상 종속회사 현황(상세)</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="593"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="602" HEIGHT="30" AUPDATECONT="N">
<A REFNO="I. 회사의 개요|ADX-001|NEF-001">☞ 본문 위치로 이동</A>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="SUB_CMPN" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="602" BORDER="0">

<COLGROUP>
<COL WIDTH="292"></COL>
<COL WIDTH="292"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="301" HEIGHT="30" AUPDATECONT="N"></TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="301" HEIGHT="30" AUNIT="WON" AUNITVALUE="2">(단위 : 천원)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1600" BORDER="1">

<COLGROUP>
<COL WIDTH="171"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="434"></COL>
<COL WIDTH="174"></COL>
<COL WIDTH="114"></COL>
<COL WIDTH="189"></COL>
<COL WIDTH="327"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="180" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">상호</TH>
<TH WIDTH="137" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">설립일</TH>
<TH WIDTH="443" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주소</TH>
<TH WIDTH="183" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주요사업</TH>
<TH WIDTH="123" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">최근사업연도말자산총액</TH>
<TH WIDTH="198" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">지배관계 근거</TH>
<TH WIDTH="336" VALIGN="MIDDLE" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N" ALIGN="CENTER" HEIGHT="53">주요종속회사 여부</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="CRP_NM">디에이치호림(주)</TE>
<TE WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="EST_DT">2007년 05월 17일</TE>
<TE WIDTH="443" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="ADR">서울시 서초구 남부순환로 2145</TE>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="M_IND">의약품 판매</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76" ACODE="KEY_IND">5,456,037</TE>
<TE WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="RUL_REL">의결권의 과반수 초과 소유</TE>
<TE WIDTH="336" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="M_SUB_COM">× (최근사업연도말 지배회사 자산총액 10%미만, 자산총액이 750억미만)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="CRP_NM">(주)스페셜라이즈드메드</TE>
<TE WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="EST_DT">2002년 11월 22일</TE>
<TE WIDTH="443" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="ADR">서울시 서초구 남부순환로 2145</TE>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="M_IND">컨텐츠 서비스</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76" ACODE="KEY_IND">145,961</TE>
<TE WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="RUL_REL">의결권의 과반수 초과 소유</TE>
<TE WIDTH="336" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="M_SUB_COM">× (최근사업연도말 지배회사 자산총액 10%미만, 자산총액이 750억미만)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="CRP_NM">(주)리독스바이오</TE>
<TE WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="EST_DT">2010년 08월 26일</TE>
<TE WIDTH="443" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="ADR">경기도 화성시 향남읍 제약공단3길 83</TE>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="M_IND">원료의약품 제조 및 판매</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="53" ACODE="KEY_IND">2,438,466</TE>
<TE WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="RUL_REL">의결권의 과반수 초과 소유</TE>
<TE WIDTH="336" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="53" ACODE="M_SUB_COM">○ (지배회사 자산총액 10% 초과)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="CRP_NM">S&V Technologies GmbH</TE>
<TE WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="EST_DT">2007년 08월 29일</TE>
<TE WIDTH="443" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="ADR">Bios Technologie Center GmbH NeuendorfstraBe 20a 16761 Hennigsdorf</TE>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="M_IND">화장품 및 의료기기 제조</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76" ACODE="KEY_IND">9,371,202</TE>
<TE WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="RUL_REL">의결권의 과반수 초과 소유</TE>
<TE WIDTH="336" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="M_SUB_COM">× (최근사업연도말 지배회사 자산총액 10%미만, 자산총액이 750억미만)</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="180" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="CRP_NM">BSC Medical Devices GmbH</TE>
<TE WIDTH="137" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="EST_DT">2008년 04월 18일</TE>
<TE WIDTH="443" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="ADR">BSC Medical Devices Gmbh Balansfrasse 57 D-81541 Munchen</TE>
<TE WIDTH="183" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="M_IND">의료기기 제조 및 판매</TE>
<TE WIDTH="123" VALIGN="MIDDLE" ALIGN="RIGHT" HEIGHT="76" ACODE="KEY_IND">336,864</TE>
<TE WIDTH="198" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="RUL_REL">의결권의 과반수 초과 소유</TE>
<TE WIDTH="336" VALIGN="MIDDLE" ALIGN="CENTER" HEIGHT="76" ACODE="M_SUB_COM">× (최근사업연도말 지배회사 자산총액 10%미만, 자산총액이 750억미만)</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P USERMARK="F-GL">※ 상기 최근사업연도말 자산총액은 2022년 기말 기준입니다. </P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y">2. 계열회사 현황(상세)</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<A REFNO="IX. 계열회사 등에 관한 사항|ADX-002|NEF-002">☞ 본문 위치로 이동</A>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="AFF_CMP" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="97"></COL>
<COL WIDTH="253"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20221231">2022년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="106" HEIGHT="30" AUPDATECONT="N">)</TD>
<TD ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="262" HEIGHT="30" AUPDATECONT="N">(단위 : 사)</TD>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="594" BORDER="1">

<COLGROUP>
<COL WIDTH="69"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="219"></COL>
<COL WIDTH="216"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="N" ADELETE="N">
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">상장여부</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">회사수</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">기업명</TH>
<TH ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="225" HEIGHT="30" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" AUPDATECONT="N">법인등록번호</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="60" AUPDATECONT="N">상장</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="60" ROWSPAN="2" ACODE="LST_COUNT">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACODE="LST_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="225" HEIGHT="30" ACODE="LST_BNUM">-</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACODE="LST_NM">-</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="225" HEIGHT="30" ACODE="LST_BNUM">-</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD ROWSPAN="5" ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="78" HEIGHT="150" AUPDATECONT="N">비상장</TD>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="63" HEIGHT="150" ROWSPAN="5" ACODE="ULST_COUNT">5</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACODE="ULST_NM">디에이치호림(주)</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="225" HEIGHT="30" ACODE="ULST_BNUM">110111-3681362</TE>
</TR>

<TR ACOPY="Y" ADELETE="N">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACODE="ULST_NM">(주)스페셜라이즈드메드</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="225" HEIGHT="30" ACODE="ULST_BNUM">110111-2659245</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACODE="ULST_NM">(주)리독스바이오(
<SPAN USERMARK=" U">K-OCT 등록)</SPAN>
</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="225" HEIGHT="30" ACODE="ULST_BNUM">110111-4421436</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACODE="ULST_NM">S&V Technologies  GmbH</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="225" HEIGHT="30" ACODE="ULST_BNUM">HRB 10630 N5P</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="228" HEIGHT="30" ACODE="ULST_NM">BSC Medical Devices GmbH</TE>
<TE ALIGN="CENTER" VALIGN="MIDDLE" WIDTH="225" HEIGHT="30" ACODE="ULST_BNUM">HRB 173696</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y">3. 타법인출자 현황(상세)</TITLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="610" BORDER="0">

<COLGROUP>
<COL WIDTH="601"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="610" HEIGHT="30" AUPDATECONT="N">
<A REFNO="IX. 계열회사 등에 관한 사항|ADX-003|NEF-003">☞ 본문 위치로 이동</A>
</TD>
</TR>
</TBODY>
</TABLE>

<TABLE-GROUP ACLASS="INV_PRT" ADELETETABLE="N">

<TABLE ACLASS="EXTRACTION" AFIXTABLE="Y" WIDTH="1620" BORDER="0">

<COLGROUP>
<COL WIDTH="71"></COL>
<COL WIDTH="143"></COL>
<COL WIDTH="204"></COL>
<COL WIDTH="1166"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">
<TD VALIGN="BOTTOM" WIDTH="80" HEIGHT="30" AUPDATECONT="N">(기준일 : </TD>
<TU ALIGN="CENTER" VALIGN="BOTTOM" WIDTH="152" HEIGHT="30" AUNIT="BASE_DT" AUNITVALUE="20231231">2023년 12월 31일</TU>
<TD VALIGN="BOTTOM" WIDTH="213" HEIGHT="30" AUPDATECONT="N">)</TD>
<TU ALIGN="RIGHT" VALIGN="BOTTOM" WIDTH="1175" HEIGHT="30" AUNIT="WONSTOCKPERCENT" AUNITVALUE="4">(단위 : 천원, 주, %)</TU>
</TR>
</TBODY>
</TABLE>

<TABLE ACLASS="EXTRACTION" AFIXTABLE="N" WIDTH="1624" BORDER="1">

<COLGROUP>
<COL WIDTH="197"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="128"></COL>
<COL WIDTH="69"></COL>
<COL WIDTH="99"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="62"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="87"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="83"></COL>
<COL WIDTH="162"></COL>
<COL WIDTH="112"></COL>
</COLGROUP>

<THEAD ALIGN="LEFT" VALIGN="TOP">

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="3" WIDTH="206" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">법인명</TH>
<TH ROWSPAN="3" WIDTH="63" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">상장여부</TH>
<TH ROWSPAN="3" WIDTH="137" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">최초취득일자</TH>
<TH ROWSPAN="3" WIDTH="78" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">출자목적</TH>
<TH ROWSPAN="3" WIDTH="108" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="113" AUPDATECONT="N">최초취득금액</TH>
<TH COLSPAN="3" WIDTH="247" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">기초잔액</TH>
<TH COLSPAN="3" WIDTH="246" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">증가(감소)</TH>
<TH COLSPAN="3" WIDTH="247" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">기말잔액</TH>
<TH COLSPAN="2" WIDTH="292" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="53" AUPDATECONT="N">최근사업연도재무현황</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH ROWSPAN="2" WIDTH="92" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">수량</TH>
<TH ROWSPAN="2" WIDTH="63" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">지분율</TH>
<TH ROWSPAN="2" WIDTH="92" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">장부가액</TH>
<TH COLSPAN="2" WIDTH="150" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N">취득(처분)</TH>
<TH ROWSPAN="2" WIDTH="96" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">평가손익</TH>
<TH ROWSPAN="2" WIDTH="92" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">수량</TH>
<TH ROWSPAN="2" WIDTH="63" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">지분율</TH>
<TH ROWSPAN="2" WIDTH="92" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">장부가액</TH>
<TH ROWSPAN="2" WIDTH="171" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">총자산</TH>
<TH ROWSPAN="2" WIDTH="121" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="60" AUPDATECONT="N">당기순손익</TH>
</TR>

<TR ACOPY="N" ADELETE="N">
<TH WIDTH="71" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N">수량</TH>
<TH WIDTH="79" ALIGN="CENTER" ACOPYCOL="N" ADELETECOL="N" AMOVECOL="N" VALIGN="MIDDLE" HEIGHT="30" AUPDATECONT="N">금액</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="N">
<TE WIDTH="206" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">디에이치호림(주)</TE>
<TU WIDTH="63" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="N">비상장</TU>
<TU WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20070517">2007년 05월 17일</TU>
<TE WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">경영참여</TE>
<TE WIDTH="108" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">600,000</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">5,435,820</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">63.91</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">-</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">-</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">-</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">5,435,820</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">63.91</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">-</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">4,668,525</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">-144,657</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="206" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">(주)스페셜라이즈드메드</TE>
<TU WIDTH="63" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="N">비상장</TU>
<TU WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20070706">2007년 07월 06일</TU>
<TE WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">경영참여</TE>
<TE WIDTH="108" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">344,000</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">146,972</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">61.24</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">-</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">-</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">-</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">146,972</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">61.24</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">-</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">265,097</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">17,627</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="206" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">(주)리독스바이오</TE>
<TU WIDTH="63" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="N">비상장</TU>
<TU WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20130822">2013년 08월 22일</TU>
<TE WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">경영참여</TE>
<TE WIDTH="108" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">1,085,760</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">15,137,370</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">61.5</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">7,547,755</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">298,000</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">737,078</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">-900,000</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">15,435,370</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">62.72</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">7,384,833</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">23,705,213</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">-419,535</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="206" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">킹고투자파트너스</TE>
<TU WIDTH="63" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="N">비상장</TU>
<TU WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20170821">2017년 08월 21일</TU>
<TE WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">단순투자</TE>
<TE WIDTH="108" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">1,100,000</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">220,000</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">8.54</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">951,439</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">-</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">58,895</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">220,000</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">8.54</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">1,010,334</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">11,827,639</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">841,274</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="206" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">킹고바이오그로스</TE>
<TU WIDTH="63" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="N">비상장</TU>
<TU WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20190624">2019년 06월 24일</TU>
<TE WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">단순투자</TE>
<TE WIDTH="108" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">500,000</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">500</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">4.17</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">491,445</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">-</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">-8,597</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">500</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">4.17</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">482,848</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">11,797,441</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">113,169</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="206" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">S&V Technologies GmbH</TE>
<TU WIDTH="63" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="N">비상장</TU>
<TU WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20170918">2017년 09월 18일</TU>
<TE WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">경영참여</TE>
<TE WIDTH="108" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">8,276,356</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">-</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">100</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">4,965,811</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">-</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">-</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">-</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">100</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">4,965,811</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">8,647,338</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">549,893</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="206" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">BSC Medical Devices GmbH</TE>
<TU WIDTH="63" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="N">비상장</TU>
<TU WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20170918">2017년 09월 18일</TU>
<TE WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">경영참여</TE>
<TE WIDTH="108" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">603,302</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">-</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">100</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">361,983</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">-</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">-</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">-</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">100</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">361,983</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">270,680</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">8,601</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="206" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">Haihe Biopharma Limited</TE>
<TU WIDTH="63" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="N">비상장</TU>
<TU WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20190128">2019년 01월 28일</TU>
<TE WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">단순투자</TE>
<TE WIDTH="108" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">3,375,048</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">666,667</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">0.444</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">564,044</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">-</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">-399,409</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">666,667</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">0.444</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">164,635</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">125,930,392</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">-97,744,338</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="206" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">JHK BioPharma Co., Ltd</TE>
<TU WIDTH="63" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="N">비상장</TU>
<TU WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20200109">2020년 01월 09일</TU>
<TE WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">경영참여</TE>
<TE WIDTH="108" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">419,675</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">-</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">25</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">-</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">-</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">-</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">-</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">25</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">-</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">195,297</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">-1,241,817</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="206" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">(주)키메디</TE>
<TU WIDTH="63" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="N">비상장</TU>
<TU WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20200508">2020년 05월 08일</TU>
<TE WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">단순투자</TE>
<TE WIDTH="108" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">499,995</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">66,666</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">7.54</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">66,528</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">-</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">54,791</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">66,666</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">7.54</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">121,319</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">2,583,785</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">-1,692,899</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="206" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">스마트마그나킹고 그린펀드</TE>
<TU WIDTH="63" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="N">비상장</TU>
<TU WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20210128">2021년 01월 28일</TU>
<TE WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">단순투자</TE>
<TE WIDTH="108" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">-</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">3,400</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">3.37</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">664,728</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">170,000</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">-13,151</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">3,400</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">3.37</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">821,577</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">19,707,215</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">-452,785</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="206" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">피코이노베이션</TE>
<TU WIDTH="63" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="N">비상장</TU>
<TU WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20210329">2021년 03월 29일</TU>
<TE WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">단순투자</TE>
<TE WIDTH="108" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">-</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">50,000</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">3.53</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">968,956</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN" USERMARK=" B">-</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM" USERMARK=" B">-</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">-36,259</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">50,000</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">3.53</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">932,697</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">51,171,448</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">-720,052</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="206" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">삼성전자</TE>
<TU WIDTH="63" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="Y">상장</TU>
<TU WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20201230">2020년 12월 30일</TU>
<TE WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">단순투자</TE>
<TE WIDTH="108" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">94,860</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">4,000</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">-</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">313,200</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-1,500</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">-125,292</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">-49,658</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">2,500</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">-</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">138,250</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">251,112,184,000</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">30,970,954,000</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="206" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">LG전자</TE>
<TU WIDTH="63" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="Y">상장</TU>
<TU WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20201202">2020년 12월 02일</TU>
<TE WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">단순투자</TE>
<TE WIDTH="108" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">297,439</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">1,500</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">-</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">207,000</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">-2,475</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">-74,775</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">1,500</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">-</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">129,750</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">29,593,524,000</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">-913,538</TE>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TE WIDTH="206" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PRM">POSCO</TE>
<TU WIDTH="63" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_YN" AUNITVALUE="Y">상장</TU>
<TU WIDTH="137" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" AUNIT="INV_GET" AUNITVALUE="20210420">2021년 04월 20일</TU>
<TE WIDTH="78" ALIGN="CENTER" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_OBJ">단순투자</TE>
<TE WIDTH="108" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_GTM">180,020</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTN">610</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPR">-</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTM">167,445</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTN">-60</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTM">-21,393</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPM">6,023</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTN">550</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPR">-</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTM">152,075</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTM">64,242,758,956</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPM">5,181,227,349</TE>
</TR>

<TR ACOPY="N" ADELETE="N">
<TD COLSPAN="5" WIDTH="592" ALIGN="CENTER" HEIGHT="30" AUPDATECONT="N" VALIGN="MIDDLE">합 계</TD>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTNT">-</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BPRT">-</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_BTMT">17,270,334</TE>
<TE WIDTH="71" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTNT">-</TE>
<TE WIDTH="79" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PTMT">757,918</TE>
<TE WIDTH="96" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_PPMT">-1,362,140</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTNT">-</TE>
<TE WIDTH="63" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LPRT">-</TE>
<TE WIDTH="92" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_LTMT">16,666,112</TE>
<TE WIDTH="171" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_NTMT">345,209,237,026</TE>
<TE WIDTH="121" ALIGN="RIGHT" HEIGHT="30" VALIGN="MIDDLE" ACODE="INV_TPMT">36,050,382,292</TE>
</TR>
</TBODY>
</TABLE>
</TABLE-GROUP>

<P>
<SPAN USERMARK="F-GL10">1) S&V, BSC는 독일소재 유한회사로 자본금은 주식으로 나누어지는 것이 아니고(이에 따라 주식수, 액면금액이라는 개념이 없음) 주주는 취득한 실수자본(우리나라 납입자본금)에 대한 지분을 보유하게 됩니다. 따라서 본 건 공시에는 발행주식총수, 양수주식수, 양수후 소유주식수는 기재하지 않았습니다.2) 최근 사업년도(2021년말) 재무현황의 "총자산" 금액은 별도재무제표 기준으로 작성되었습니다.3) (주)리독스바이오는 K-OCT 등록된 법인입니다.</SPAN>
</P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="">4. 매출실적 현황(상세)</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<A REFNO="II. 사업의 내용|ADX-1|NEF-1">☞ 본문 위치로 이동</A>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<P>
<SPAN USERMARK="F-GL11">                                                                                              (단위 : 천원, US$)</SPAN>
</P>

<TABLE BORDER="1" WIDTH="986" AFIXTABLE="N" ACLASS="NORMAL">

<COLGROUP>
<COL WIDTH="144"></COL>
<COL WIDTH="54"></COL>
<COL WIDTH="254"></COL>
<COL WIDTH="39"></COL>
<COL WIDTH="158"></COL>
<COL WIDTH="137"></COL>
<COL WIDTH="137"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="153" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53" ALIGN="CENTER">사업부문</TH>
<TH WIDTH="63" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53" ALIGN="CENTER">매출유형</TH>
<TH COLSPAN="2" WIDTH="311" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53" ALIGN="CENTER">품       목</TH>
<TH WIDTH="167" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53" ALIGN="CENTER">제39기 당기</TH>
<TH WIDTH="146" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53" ALIGN="CENTER">제38기</TH>
<TH WIDTH="146" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N" HEIGHT="53" ALIGN="CENTER">제37기</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="22" WIDTH="153" VALIGN="MIDDLE" HEIGHT="729" ALIGN="CENTER">의약품제조판매부문</TD>
<TD ROWSPAN="10" WIDTH="63" VALIGN="MIDDLE" HEIGHT="346" ALIGN="CENTER">제   품</TD>
<TD WIDTH="263" HEIGHT="30">세파메칠 정</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">6,421,114</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">6,146,726</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">6,869,658</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">후로스판 정</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">4,495,572</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">4,114,511</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">3,905,677</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">마그네스 정</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">3,191,381</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">2,956,166</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">2,713,126</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">OEM매출(파스류)</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">23,564,865</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">22,907,014</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">20,086,027</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="263" HEIGHT="113" VALIGN="MIDDLE">탑스타틴 정 외</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">수출</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="53">6,931,471  (US$5,040,366.13)</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="53">6,165,573 (US$5,365,638.51)</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="53">5,007,358(US$4,261,153.08)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">45,348,967</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">40,572,803</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">39,657,877</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">52,280,438</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">46,738,376</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">44,665,235</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="263" HEIGHT="113" VALIGN="MIDDLE" ALIGN="CENTER">소     계</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">수출</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="53">6,931,471  (US$5,040,366.13)</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="53">6,165,573 (US$5,365,638.51)</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="53">5,007,358(US$4,261,153.08)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">83,021,899</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">76,697,219</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">73,232,365</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">89,953,370</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">82,862,792</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">78,239,723</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="9" WIDTH="63" VALIGN="MIDDLE" HEIGHT="270" ALIGN="CENTER">상   품</TD>
<TD WIDTH="263" HEIGHT="30">아말리안</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">4,896,684</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">3,979,895</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">2,508,532</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">셀퓨전씨 엑스퍼트 베리덤 로션 엠디</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">380,083</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">603,907</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">504,383</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" HEIGHT="30">아라간플러스 주</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">335,910</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">285,002</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">382,075</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="263" HEIGHT="90" VALIGN="MIDDLE">엔슬림 정 외</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">수출</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">666,140</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">972,777</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">659,069</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">계</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">666,140</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">972,777</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">659,069</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="3" WIDTH="263" VALIGN="MIDDLE" HEIGHT="90" ALIGN="CENTER">소     계</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">수출</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">-</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">-</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">6,278,816</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">5,841,580</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">4,054,059</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">6,278,816</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">5,841,580</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">4,054,059</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="2" WIDTH="326" VALIGN="MIDDLE" HEIGHT="113" ALIGN="CENTER" ROWSPAN="3">기 타 매 출</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">수출</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="53">2,860,193 (US$1,999,995.00 )</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="53">1,168(US$998.58)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">100,000</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">467</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">30,000</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">2,960,193</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">467</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">31,168</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" ROWSPAN="3" WIDTH="479" VALIGN="MIDDLE" HEIGHT="113" ALIGN="CENTER" USERMARK=" BU">의약품제조판매부문 합계</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">수출</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="53">9,791,664(US$7,040,361.13)</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="53">6,165,573 (US$5,365,638.51)</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="53">5,008,526(US$4,262,151.66)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">89,400,715</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">82,539,266</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">77,316,424</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">99,192,379</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">88,704,839</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">82,324,950</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD ROWSPAN="7" WIDTH="153" VALIGN="MIDDLE" HEIGHT="210" ALIGN="CENTER">의약품도매부문</TD>
<TD ROWSPAN="6" WIDTH="63" VALIGN="MIDDLE" HEIGHT="180" ALIGN="CENTER">상   품</TD>
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">아스텔 프로그랍캅셀 1mg/100C</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">338,688</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">335,564</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">143,935</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">릴리 트루리시티 1.5mg/0.5ml/2Pen</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">142,538</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">101,352</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">80,315</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">애브비 마비렛정 84T</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">168,835</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">49,647</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">64,540</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">길리어 비리어드정 30T</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">126,424</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">123,650</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">98,811</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">한미 로수젯정 10/5mg/30T 외</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">22,442,429</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">19,957,142</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">19,492,883</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소     계</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">23,218,914</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">20,567,355</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">19,880,484</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="326" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" COLSPAN="2">기 타 매 출</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">407,214</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">351,265</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">342,800</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="479" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" COLSPAN="3" USERMARK=" BU">의약품도매부문 합계</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">23,626,128</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">20,918,620</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">20,223,284</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="479" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" COLSPAN="3" USERMARK=" BU">의료정보시스템부문 합계</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">352,034</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">386,757</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">370,150</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="153" VALIGN="MIDDLE" HEIGHT="376" ALIGN="CENTER" ROWSPAN="11">의약품원료제조부문</TD>
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="316" ALIGN="CENTER" ROWSPAN="9">제   품</TD>
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">Methylol Cephalexin Lysinate </TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">4,315,127</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">3,103,620</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">3,106,820</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">록소프로펜나트륨</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">1,254,906</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">1,111,006</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">519,125</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">플로로글루시놀무수물</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">504,118</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">359,594</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">283,938</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="113" ROWSPAN="3">Sodium Hyaluronate 외</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">수출</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="53">18,804(EUR14,500)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">3,915,955</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">3,250,763</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">1,829,519</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">3,915,955</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">3,250,763</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">1,848,323</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="113" ALIGN="CENTER" ROWSPAN="3">소     계</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">수출</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="53">18,804(EUR14,500)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">9,990,106</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">7,824,983</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">5,739,402</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">9,990,106</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">7,824,983</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">5,758,206</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="63" VALIGN="MIDDLE" HEIGHT="60" ALIGN="CENTER" ROWSPAN="2">상   품</TD>
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30">아말리안</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">3,814,848</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">2,248,208</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">1,709,070</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="263" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">소     계</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">3,814,848</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">2,248,208</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">1,709,070</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="479" VALIGN="MIDDLE" HEIGHT="113" ALIGN="CENTER" COLSPAN="3" ROWSPAN="3" USERMARK=" BU">의약품원료 부문 합계</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="53" ALIGN="CENTER">수출</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="53">-</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="53">18,804(EUR14,500)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">13,804,954</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">10,073,191</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">7,448,472</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">13,804,954</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">10,073,191</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">7,467,276</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="479" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" COLSPAN="3" USERMARK=" 0X1814FF">
<SPAN USERMARK=" 0X000000 BU">화장품, 의료기기 제조 및 판매 부문</SPAN>
</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">8,991,709</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">7,048,870</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">5,766,097</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="479" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER" COLSPAN="3">조   정(부문간 수익)</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">-</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">(14,055,513)</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">(9,973,445)</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">(6,805,896)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD COLSPAN="3" ROWSPAN="3" WIDTH="479" VALIGN="MIDDLE" HEIGHT="136" ALIGN="CENTER" USERMARK=" BU">합             계</TD>
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="76" ALIGN="CENTER">수출</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="76">9,791,664(US$7,040,361.13)</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="76">6,165,573 (US$5,365,638.51)</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="76">5,027,330(US$4,262,151.66)(EUR14,500)</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">내수</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30">122,120,029</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">110,993,259</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30">104,318,532</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="48" VALIGN="MIDDLE" HEIGHT="30" ALIGN="CENTER">합계</TD>
<TD WIDTH="167" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">131,911,693</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">117,158,831</TD>
<TD WIDTH="146" ALIGN="RIGHT" HEIGHT="30" USERMARK=" B">109,345,862</TD>
</TR>
</TBODY>
</TABLE>
<P></P>
<PGBRK></PGBRK>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="">5. 특허권 현황(상세)</TITLE>

<TABLE ACLASS="NORMAL" AFIXTABLE="Y" WIDTH="600" BORDER="0">

<COLGROUP>
<COL WIDTH="591"></COL>
</COLGROUP>

<TBODY>

<TR ACOPY="N" ADELETE="N">

<TD WIDTH="600" HEIGHT="30" AUPDATECONT="N">
<A REFNO="II. 사업의 내용|ADX-2|NEF-2">☞ 본문 위치로 이동</A>
</TD>
</TR>
</TBODY>
</TABLE>
<P></P>

<TABLE ACLASS="NORMAL" AFIXTABLE="N" BORDER="1" WIDTH="1578">

<COLGROUP>
<COL WIDTH="377"></COL>
<COL WIDTH="79"></COL>
<COL WIDTH="144"></COL>
<COL WIDTH="93"></COL>
<COL WIDTH="102"></COL>
<COL WIDTH="63"></COL>
<COL WIDTH="53"></COL>
<COL WIDTH="70"></COL>
<COL WIDTH="231"></COL>
<COL WIDTH="276"></COL>
</COLGROUP>

<THEAD>

<TR ACOPY="Y" ADELETE="Y">
<TH WIDTH="386" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">발 명 의 명 칭</TH>
<TH WIDTH="88" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">국     가</TH>
<TH WIDTH="153" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">등 록 번 호</TH>
<TH WIDTH="102" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">등 록 일</TH>
<TH WIDTH="111" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">특허만료일</TH>
<TH WIDTH="72" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">근거법령</TH>
<TH WIDTH="62" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">투입인원</TH>
<TH WIDTH="79" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">개발기간</TH>
<TH WIDTH="240" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">상 용 화 여 부</TH>
<TH WIDTH="285" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE" ACOPYCOL="Y" ADELETECOL="Y" AMOVECOL="N">기 대 효 과</TH>
</TR>
</THEAD>

<TBODY>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="386" HEIGHT="114" ROWSPAN="2" VALIGN="MIDDLE">화학색전용 파클리탁셀 가용화용 유성조성물OILY PACLITAXEL COMPOSITION AND FORMULATION FOR CHEMOEMBOLIZATION AND PREPARATION METHOD THEREOF (PCT/KR2002/001722) </TD>
<TD WIDTH="88" HEIGHT="63" ALIGN="CENTER" VALIGN="MIDDLE">대한민국</TD>
<TD WIDTH="153" HEIGHT="63" ALIGN="CENTER" VALIGN="MIDDLE">10-0539451</TD>
<TD WIDTH="102" HEIGHT="63" ALIGN="CENTER" VALIGN="MIDDLE">2005.12.22</TD>
<TD WIDTH="111" HEIGHT="63" ALIGN="CENTER" VALIGN="MIDDLE">2022.07.20</TD>
<TD WIDTH="72" HEIGHT="63" ALIGN="CENTER" VALIGN="MIDDLE">특허법</TD>
<TD WIDTH="62" HEIGHT="114" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">8명</TD>
<TD WIDTH="79" HEIGHT="114" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">2년</TD>

<TD WIDTH="525" HEIGHT="114" COLSPAN="2" ROWSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">리
<SPAN USERMARK="F-9">포</SPAN>락셀액(DHP107)로 개발 집중을 위해 개발 보류
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="51" ALIGN="CENTER" VALIGN="MIDDLE">인도</TD>
<TD WIDTH="153" HEIGHT="51" ALIGN="CENTER" VALIGN="MIDDLE">218216</TD>
<TD WIDTH="102" HEIGHT="51" ALIGN="CENTER" VALIGN="MIDDLE">2008.05.15</TD>
<TD WIDTH="111" HEIGHT="51" ALIGN="CENTER" VALIGN="MIDDLE">2022.09.13</TD>
<TD WIDTH="72" HEIGHT="51" ALIGN="CENTER" VALIGN="MIDDLE">특허법</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="386" HEIGHT="122" VALIGN="MIDDLE">화학색전용 파클리탁셀 혼합조성물, 그의 유중수형 에멀전 및 제조방법PACLITAXEL MIXED COMPOSITION AND WATER-IN-OIL TYPE EMULSION FORMULATION FOR CHEMOEMBOLIZATION AND PREPARATION METHOD THEREOF</TD>
<TD WIDTH="88" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">대한민국</TD>
<TD WIDTH="153" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">10-0497258</TD>
<TD WIDTH="102" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">2005.06.16</TD>
<TD WIDTH="111" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">2023.01.16</TD>
<TD WIDTH="72" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">특허법</TD>
<TD WIDTH="62" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">7명</TD>
<TD WIDTH="79" HEIGHT="122" ALIGN="CENTER" VALIGN="MIDDLE">3년</TD>

<TD WIDTH="525" HEIGHT="122" COLSPAN="2" ALIGN="CENTER" VALIGN="MIDDLE">리
<SPAN USERMARK="F-9">포</SPAN>락셀액(DHP107)로 개발 집중을 위해 개발 보류
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="386" HEIGHT="99" VALIGN="MIDDLE">난용성 약물의 가용화용 점막흡착성 조성물, 이를 이용한 난용성 약물의 가용화용 제형 및 이들의 제조방법Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof</TD>
<TD WIDTH="88" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">대한민국</TD>
<TD WIDTH="153" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">10-0533460</TD>
<TD WIDTH="102" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2005.11.29</TD>
<TD WIDTH="111" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2022.07.19</TD>
<TD WIDTH="72" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">특허법</TD>
<TD WIDTH="62" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">5명</TD>
<TD WIDTH="79" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">3년</TD>
<TD WIDTH="240" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">응용기술로 활용 중</TD>
<TD WIDTH="285" HEIGHT="99" VALIGN="MIDDLE">타약물의 전달체로 사용가능</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="386" HEIGHT="480" ROWSPAN="16" VALIGN="MIDDLE">파클리탁셀의 가용화용 조성물 및 이의 제조방법Composition for solubilization of paclitaxel and preparation method thereof(PCT/KR2003/001427)                                                                     </TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대한민국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">10-0533458</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2005.11.29</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022.07.19</TD>
<TD WIDTH="72" HEIGHT="480" ROWSPAN="16" ALIGN="CENTER" VALIGN="MIDDLE">특허법</TD>
<TD WIDTH="62" HEIGHT="480" ROWSPAN="16" ALIGN="CENTER" VALIGN="MIDDLE">9명</TD>
<TD WIDTH="79" HEIGHT="480" ROWSPAN="16" ALIGN="CENTER" VALIGN="MIDDLE">3년</TD>
<TD WIDTH="240" HEIGHT="480" ROWSPAN="16" ALIGN="CENTER" VALIGN="MIDDLE">국내 품목허가 승인 완료 </TD>
<TD WIDTH="285" HEIGHT="480" ROWSPAN="16" VALIGN="MIDDLE">리포락셀액(DHP107) 의 상용화를 위한 주요기술로 활용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">미국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">US 8,075,917 B2</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2011.12.13</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2026.06.01</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">영국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EP 1545499 B1</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2013.02.20</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.07.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">독일</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EP 1545499 B1</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2013.02.20</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.07.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">프랑스</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EP 1545499 B1</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2013.02.20</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.07.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">터키</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EP 1545499 B1</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2013.02.20</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.07.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">캐나다</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">CA 2,493,336 C</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2009.11.24</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.07.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">러시아</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">RU 2291693 C2</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2007.01.20</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.07.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">남아공</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">ZA 2004/9126B</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2005.06.29</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.07.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">베트남</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">1-0007236-000</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2008.08.25</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.07.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">중국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">ZL03817346.8</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2009.09.30</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.07.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">인도</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">240871</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2010.06.07</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.07.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">홍콩</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">HK 1082674 A1</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2010.05.20</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.07.17</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">일본</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">4744875</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2011.05.20</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.07.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">인도네시아</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">IDP0027774</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2011.03.15</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2023.07.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">브라질</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">BR PI0312002-3 B1</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017.11.28</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2027.11.28</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="386" HEIGHT="120" ROWSPAN="4" VALIGN="MIDDLE">고농도의 탁산을 포함하는 경구 투여용 약학 조성물(Pharmaceutical composition for oral administration comprising taxanes in high concentration)</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대한민국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">10-1612255</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2016.04.07</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2035.07.30</TD>
<TD WIDTH="72" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">특허법</TD>

<TD WIDTH="62" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">
<P>5명</P>
</TD>

<TD WIDTH="79" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1년</P>
</TD>
<TD WIDTH="240" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">비임상시험 중</TD>

<TD WIDTH="285" HEIGHT="120" ROWSPAN="4" VALIGN="MIDDLE">
<P>항암치료제 개발 중</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대한민국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">10-1612257</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2016.04.07</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2035.07.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대한민국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">10-1612259</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2016.04.07</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2035.07.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대한민국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">10-1612260</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2016.04.07</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2035.07.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="386" HEIGHT="99" VALIGN="MIDDLE">옥틸로늄 브로마이드를 함유하는 항암제 흡수증진제P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient(PCT/KR2003/001441)</TD>
<TD WIDTH="88" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">대한민국</TD>
<TD WIDTH="153" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">10-0503889</TD>
<TD WIDTH="102" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2005.07.18</TD>
<TD WIDTH="111" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2022.07.19</TD>
<TD WIDTH="72" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">특허법</TD>
<TD WIDTH="62" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">6명</TD>
<TD WIDTH="79" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">3년</TD>
<TD WIDTH="240" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">-</TD>
<TD WIDTH="285" HEIGHT="99" VALIGN="MIDDLE">경구용항암제 관련 부대 기술</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="386" HEIGHT="99" VALIGN="MIDDLE">방광내 투여를 통한 방광암 치료용 파클리탁셀 조성물 및 이의 제조방법Paclitaxel composition for the intravesical treatment of bladder tumor and preparation method thereof</TD>
<TD WIDTH="88" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">대한민국</TD>
<TD WIDTH="153" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">10-0573289</TD>
<TD WIDTH="102" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2006.04.17</TD>
<TD WIDTH="111" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2022.07.19</TD>
<TD WIDTH="72" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">특허법</TD>
<TD WIDTH="62" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">7명</TD>
<TD WIDTH="79" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">3년</TD>
<TD WIDTH="240" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">비임상시험 중</TD>
<TD WIDTH="285" HEIGHT="99" VALIGN="MIDDLE">경구용항암제 관련 부대 기술</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="386" HEIGHT="30" VALIGN="MIDDLE">파클리탁셀 조성물의 제조 방법</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대한민국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">10-0737742</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2007.07.04</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2025.12.04</TD>
<TD WIDTH="72" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">특허법</TD>
<TD WIDTH="62" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">3명</TD>
<TD WIDTH="79" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2년</TD>
<TD WIDTH="240" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">임상개발중인 약물의 생산에 활용</TD>
<TD WIDTH="285" HEIGHT="30" VALIGN="MIDDLE">항암 치료제 개발 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="386" HEIGHT="330" ROWSPAN="11" VALIGN="MIDDLE">탁산을 포함하는 경구 투여용 약학 조성물(Pharmaceutical composition for oral administration comprising Taxane)(PCT/KR/2015/007987)</TD>

<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대한민국</P>
</TD>

<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>10-1542364</P>
</TD>

<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2015.07.31</P>
</TD>

<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2034.10.31</P>
</TD>
<TD WIDTH="72" HEIGHT="330" ROWSPAN="11" ALIGN="CENTER" VALIGN="MIDDLE">특허법</TD>
<TD WIDTH="62" HEIGHT="330" ROWSPAN="11" ALIGN="CENTER" VALIGN="MIDDLE">4명</TD>
<TD WIDTH="79" HEIGHT="330" ROWSPAN="11" ALIGN="CENTER" VALIGN="MIDDLE">1년</TD>
<TD WIDTH="240" HEIGHT="330" ROWSPAN="11" ALIGN="CENTER" VALIGN="MIDDLE">상용화 제품에 적용</TD>
<TD WIDTH="285" HEIGHT="330" ROWSPAN="11" VALIGN="MIDDLE">리포락셀액(DHP107) 의 상용화를 위한 주요기술로 활용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>미국</P>
</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">US 10,653,663 B2</TD>

<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2020.05.19</P>
</TD>

<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2035.10.03</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">미국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">US 11,116,,744 B2</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.09.14</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2035.08.17</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">캐나다</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2,966,146</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2022.04.26</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2035.07.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>일본</P>
</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">JP 6521274 B2</TD>

<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2019.05.10</P>
</TD>

<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2035.07.30</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">중국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">ZL 201580059319.4</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017.08.01</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2035.07.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">인도</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">367317</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017.05.17</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.05.21</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">베트남</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">29318</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.07.22</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2035.07.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>러시아</P>
</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">RU 2017118733A</TD>

<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2019.03.28</P>
</TD>

<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2035.07.30</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">홍콩</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">HK1240118</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.08.27</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2035.07.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>남아공</P>
</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">ZA 2017/03562B</TD>

<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2018.11.28</P>
</TD>

<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2035.07.30</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="386" HEIGHT="90" ROWSPAN="3" VALIGN="MIDDLE">고농도탁산을 포함하는 경구 투여용 약학 조성물(PCT/KR2016/003552)</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">유럽</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EP3326628 B1</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.03.18</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2036.04.06</TD>
<TD WIDTH="72" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">특허법</TD>
<TD WIDTH="62" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">4명</TD>
<TD WIDTH="79" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">1년</TD>
<TD WIDTH="240" HEIGHT="90" ROWSPAN="3" ALIGN="CENTER" VALIGN="MIDDLE">임상개발중인 약물의 생산에 활용</TD>
<TD WIDTH="285" HEIGHT="90" ROWSPAN="3" VALIGN="MIDDLE">항암 치료제 개발 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">미국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">20190000792 A1</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.06.01</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2036.06.09</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">중국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">ZL 201680044874.4</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2020.11.06</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2036.04.06</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="386" HEIGHT="120" ROWSPAN="4" VALIGN="MIDDLE">고농도탁산을 포함하는 경구 투여용 약학 조성물(PCT/KR2016/003558)</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">미국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">US 10,987,335, B2</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.04.27</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2036.04.06</TD>
<TD WIDTH="72" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">특허법</TD>
<TD WIDTH="62" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">4명</TD>
<TD WIDTH="79" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">1년</TD>
<TD WIDTH="240" HEIGHT="120" ROWSPAN="4" ALIGN="CENTER" VALIGN="MIDDLE">임상개발중인 약물의 생산에 활용</TD>
<TD WIDTH="285" HEIGHT="120" ROWSPAN="4" VALIGN="MIDDLE">항암 치료제 개발 중</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">유럽</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EP 3326652 B1</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.10.19</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2036.04.06</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">중국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">ZL 201680044224 X</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.01.26</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2036.04.06</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">홍콩</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">HK1254993</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2021.08.27</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2036.04.06</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="386" HEIGHT="270" ROWSPAN="9" VALIGN="MIDDLE">스피노신을 포함하는 인지기능장애 질환 예방 또는 치료용 약학조성물Pharmaceutical composition comprising spinosin for prevention and treatment of cognitive disorder)(PCT/KR2003/001441)</TD>
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">대한민국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">10-1360109</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2014.02.03</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2031.11.30</TD>
<TD WIDTH="72" HEIGHT="270" ROWSPAN="9" ALIGN="CENTER" VALIGN="MIDDLE">특허법</TD>
<TD WIDTH="62" HEIGHT="270" ROWSPAN="9" ALIGN="CENTER" VALIGN="MIDDLE">8명</TD>
<TD WIDTH="79" HEIGHT="270" ROWSPAN="9" ALIGN="CENTER" VALIGN="MIDDLE">2년</TD>
<TD WIDTH="240" HEIGHT="270" ROWSPAN="9" ALIGN="CENTER" VALIGN="MIDDLE">건강기능 식품 또는 초기치매환자 대상 의약품 개발 예정</TD>
<TD WIDTH="285" HEIGHT="270" ROWSPAN="9" VALIGN="MIDDLE">천연물 의약품 치매치료제의 상용화를 위한 주요기술로 활용</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">일본</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">6040256</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2016.11.11</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2032.11.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">중국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">ZL201280068416.6</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2017.01.16</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2032.11.30</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>영국</P>
</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EP2786758</TD>

<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2017.11.22</P>
</TD>

<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2032.11.30</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>스위스</P>
</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EP2786758</TD>

<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2017.11.22</P>
</TD>

<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2032.11.30</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>프랑스</P>
</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EP2786758</TD>

<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2017.11.22</P>
</TD>

<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2032.11.30</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>독일</P>
</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">EP2786758</TD>

<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2017.11.22</P>
</TD>

<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2032.11.30</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>일본</P>
</TD>

<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>6261677</P>
</TD>

<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2017.12.22</P>
</TD>

<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2032.11.30</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">
<TD WIDTH="88" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">미국</TD>
<TD WIDTH="153" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">US 9,956,242 B2</TD>
<TD WIDTH="102" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2018.05.01</TD>
<TD WIDTH="111" HEIGHT="30" ALIGN="CENTER" VALIGN="MIDDLE">2033.01.18</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="386" HEIGHT="99" VALIGN="MIDDLE">
<P>인지기능장애 또는 퇴행성 뇌질환의 예방 또는 치료용 약학적 조성물</P>
<P>Pharmaceutical composition for prevention or treatment of cognitive </P>
</TD>
<TD WIDTH="88" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">대한민국</TD>
<TD WIDTH="153" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">10-1753057</TD>
<TD WIDTH="102" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2017.06.27</TD>
<TD WIDTH="111" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2035.09.18</TD>
<TD WIDTH="72" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">특허법</TD>
<TD WIDTH="62" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">6명</TD>
<TD WIDTH="79" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">2년</TD>
<TD WIDTH="240" HEIGHT="99" ALIGN="CENTER" VALIGN="MIDDLE">인체적용시험 진행중</TD>
<TD WIDTH="285" HEIGHT="99" VALIGN="MIDDLE">인지기능개선 건강기능식품 개발</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="386" HEIGHT="145" VALIGN="MIDDLE">
<P>플라본6-C-글루코스 유도체를 유효성분으로 함유하는 신경정신질환의 치료 또는 예방용 약학적 조성물</P>
<P>Pharmaceutical Composition for Treating or Preventing Neuropsychiatric Disease, Containing Flavone-6-C-Glucose Derivatives as Active Ingredients(PCT/KR2003/001441)</P>
</TD>
<TD WIDTH="88" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">미국</TD>
<TD WIDTH="153" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">US 10,251,902 B2</TD>

<TD WIDTH="102" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2019.04.09</P>
</TD>

<TD WIDTH="111" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2034.11.09</P>
</TD>

<TD WIDTH="72" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">
<P>특허법</P>
</TD>

<TD WIDTH="62" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">
<P>9명</P>
</TD>

<TD WIDTH="79" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2년</P>
</TD>
<TD WIDTH="240" HEIGHT="145" ALIGN="CENTER" VALIGN="MIDDLE"> 건강기능 식품 또는 초기치매환자 대상 의약품 개발 예정</TD>

<TD WIDTH="285" HEIGHT="145" VALIGN="MIDDLE">
<P>천연물 의약품 치매치료제의 상용화를 위한 주요기술로 활용 및 인지기능개선 건강기능식품 개발</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="386" HEIGHT="53" VALIGN="MIDDLE">
<P>산화안정성이 향상된 탁산을 포함하는 경구용 약학 조성물</P>
</TD>

<TD WIDTH="88" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대한민국</P>
</TD>

<TD WIDTH="153" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>10-2093100</P>
</TD>

<TD WIDTH="102" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2020.03.19</P>
</TD>

<TD WIDTH="111" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2038.07.11</P>
</TD>

<TD WIDTH="72" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>특허법</P>
</TD>

<TD WIDTH="62" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>4명</P>
</TD>

<TD WIDTH="79" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1년</P>
</TD>

<TD WIDTH="240" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>의약품 생산에 적용 가능</P>
</TD>

<TD WIDTH="285" HEIGHT="53" VALIGN="MIDDLE">
<P>경구용 항암제 등의 의약품 안정성 개선</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="386" HEIGHT="53" VALIGN="MIDDLE">
<P>히알루론산 합성효소 변이 단백질 및 이를 이용한 히알루론산 생산 방법</P>
</TD>

<TD WIDTH="88" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대한민국</P>
</TD>

<TD WIDTH="153" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>10-2135044</P>
</TD>

<TD WIDTH="102" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2020.07.13</P>
</TD>

<TD WIDTH="111" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2039.02.12</P>
</TD>

<TD WIDTH="72" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>특허법</P>
</TD>

<TD WIDTH="62" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>6명</P>
</TD>

<TD WIDTH="79" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1년</P>
</TD>

<TD WIDTH="240" HEIGHT="53" ALIGN="CENTER" VALIGN="MIDDLE">
<P>의약품 원료 생산에 적용 가능</P>
</TD>

<TD WIDTH="285" HEIGHT="53" VALIGN="MIDDLE">
<P>안전성이 높은 고분자 히알루론산 생산</P>
</TD>
</TR>

<TR ACOPY="Y" ADELETE="Y">

<TD WIDTH="386" HEIGHT="76" VALIGN="MIDDLE">
<P>비병원성 세균을 이용하여 히알루론산 생산을 위한 발현 시스템 및 상기 발현 시스템을 이용한 히알루론산 생산방법</P>
</TD>

<TD WIDTH="88" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>대한민국</P>
</TD>

<TD WIDTH="153" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>10-2152625</P>
</TD>

<TD WIDTH="102" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2020.09.01</P>
</TD>

<TD WIDTH="111" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>2039.02.12</P>
</TD>

<TD WIDTH="72" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>특허법</P>
</TD>

<TD WIDTH="62" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>6명</P>
</TD>

<TD WIDTH="79" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>1년</P>
</TD>

<TD WIDTH="240" HEIGHT="76" ALIGN="CENTER" VALIGN="MIDDLE">
<P>의약품 원료 생산에 적용 가능</P>
</TD>

<TD WIDTH="285" HEIGHT="76" VALIGN="MIDDLE">
<P>안전성이 높은 고분자 히알루론산 생산</P>
</TD>
</TR>
</TBODY>
</TABLE>
<PGBRK></PGBRK>
<P></P>
</SECTION-2>
</SECTION-1>

<SECTION-1 ACLASS="MANDATORY" APARTSOURCE="SOURCE">
<TITLE ATOC="Y">【 전문가의 확인 】</TITLE>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-1-0">1. 전문가의 확인</TITLE>
<P USERMARK="F-GL">해당 사항 없습니다. </P>
</SECTION-2>

<SECTION-2 ACLASS="MANDATORY">
<TITLE ATOC="Y" AASSOCNOTE="D-3-0-2-0">2. 전문가와의 이해관계</TITLE>
<P USERMARK="F-GL">해당 사항 없습니다. </P>
</SECTION-2>
</SECTION-1>
</BODY>
</DOCUMENT>